Citrus Sinensis ID: 046188
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 646 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9L5 | 792 | Wall-associated receptor | yes | no | 0.537 | 0.438 | 0.574 | 1e-115 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.597 | 0.528 | 0.541 | 1e-114 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.580 | 0.501 | 0.532 | 1e-113 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.588 | 0.499 | 0.503 | 1e-111 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.544 | 0.446 | 0.561 | 1e-111 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.537 | 0.462 | 0.548 | 1e-111 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.602 | 0.527 | 0.485 | 1e-110 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.529 | 0.468 | 0.563 | 1e-110 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.600 | 0.529 | 0.491 | 1e-109 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.582 | 0.488 | 0.508 | 1e-109 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 208/362 (57%), Positives = 270/362 (74%), Gaps = 15/362 (4%)
Query: 263 LGLGIGLGFLSLV-LLGCYL-YKVIGAKRSRMLKEKLFKQNGGYLLQQRL-SSCGSSEKA 319
L +G+G F SL+ ++G YL YK I +R K+K FK+NGG LLQQ+L S+ G EK
Sbjct: 373 LAIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKT 432
Query: 320 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEV 379
+F++ EL++AT+N++ +R LGQGG GTVYKGML DG IVAVK+SK +D+ ++E+FINEV
Sbjct: 433 IVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 492
Query: 380 VILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
VILSQINHR+IVKLLGCCLET+VPVLVYE+I NGNL H+HD E E
Sbjct: 493 VILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHD------------EFDENI 540
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
+W R+R+A ++AGA++Y+HSSAS PI+HRD+KS+NI+LD+K+ AKVSDFGTSR+V
Sbjct: 541 MATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTV 600
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
D THLTT V GT GY DPEYFQSSQ+TDKSDVYSFGVVL+EL+TG+K I R +E R L
Sbjct: 601 DHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTL 660
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619
YFI KENKL +I+DAR+ + A A++A CL L +KRP+M++VSM+L+
Sbjct: 661 ATYFILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDS 720
Query: 620 LR 621
+R
Sbjct: 721 IR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-114, Method: Compositional matrix adjust.
Identities = 217/401 (54%), Positives = 290/401 (72%), Gaps = 15/401 (3%)
Query: 248 CKPDGK-KFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIGAKRSRMLKEKLFKQNGGYLL 306
C+P+ K P K L G+ IGL L + +L+K+I +R+ +K FK+NGG LL
Sbjct: 341 CRPNPKITKPTKPPVLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLL 400
Query: 307 QQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK 365
+Q+L++ G+ E +KIF+++EL++ATDN++ R LGQGG GTVYKGML DGSIVAVKRSK
Sbjct: 401 KQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSK 460
Query: 366 AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQ 425
+D+ ++E+FINE+V+LSQINHR+IVKLLGCCLETEVP+LVYEYI NG+L +HD
Sbjct: 461 VVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD---- 516
Query: 426 QEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485
E + +++WE R+R+A E+AGA+ YMHS+AS PIFHRDIK++NILLD+K+
Sbjct: 517 ---------ESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYR 567
Query: 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
AKVSDFGTSRSV D+THLTT V GTFGY DPEYF SSQYT KSDVYSFGVVL+EL+TG+
Sbjct: 568 AKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGE 627
Query: 546 KPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSK 605
KP+ R EE R L +F+ KEN++++I+D R+ E+ E + AVA+LA CL K
Sbjct: 628 KPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGK 687
Query: 606 KRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLTNEISLAQNS 646
RP MK+VS +LE +R S L++ N+ + +A N+
Sbjct: 688 NRPNMKEVSNELERIRSSPEDLDVRTENEDEEEDQPMAINN 728
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 211/396 (53%), Positives = 288/396 (72%), Gaps = 21/396 (5%)
Query: 232 QCKNGFLVDEMLKGLHCKPDGKKFPVKLVTLL-GLGIGLGFLSLVLLGCY-LYKVIGAKR 289
QCK+ V+ + C+P K P +L ++ G+ IG L L G + LYK + +R
Sbjct: 316 QCKDQSCVN-LPGWFDCQP---KKPEQLKRVIQGVLIGSALL-LFAFGIFGLYKFVQKRR 370
Query: 290 SRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTV 348
+ K F++NGG LL+Q+L+ G+ E ++IF++ EL++ATDN+N++R LGQGG GTV
Sbjct: 371 KLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTV 430
Query: 349 YKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408
YKGML DG IVAVKRSKA+D+ ++E+FINEVV+L+QINHR+IVKLLGCCLETEVPVLVYE
Sbjct: 431 YKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 490
Query: 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPI 468
++ NG+L +HD E + +++WE R+ +A E+AGA++Y+HS+AS PI
Sbjct: 491 FVPNGDLCKRLHD-------------ESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPI 537
Query: 469 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDK 528
+HRDIK++NILLD++ AKVSDFGTSRSV D+THLTT V GTFGY DPEYFQSS++T+K
Sbjct: 538 YHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEK 597
Query: 529 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEED 588
SDVYSFGVVL+ELLTG+KP R EE R L A+F+ KEN++L+I+D R+ E + +
Sbjct: 598 SDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQ 657
Query: 589 IEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
+ +VA LA CL KKRP M++VS++LE +R S
Sbjct: 658 VMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 208/413 (50%), Positives = 280/413 (67%), Gaps = 33/413 (7%)
Query: 218 KSESCSANPEKFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLL 277
K +SC P F C+ K + + +G+ +G L + +
Sbjct: 326 KDQSCVNKPGWFTCEPKKPGQIKPVFQGVL-----------------IGSALLLFAFGIF 368
Query: 278 GCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQ 336
G LYK I +R F++NGG LL+Q+L+ G+ E +KIF++ EL++ATDN+N
Sbjct: 369 G--LYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNT 426
Query: 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
+R LGQGG GTVYKGML DG IVAVKRSKA+D+ ++E+FINEVV+L+QINHR+IVKLLGC
Sbjct: 427 NRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGC 486
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
CLETEVPVLVYE++ NG+L + D E + ++WE R+ +A E+AGA
Sbjct: 487 CLETEVPVLVYEFVPNGDLCKRLRD-------------ECDDYIMTWEVRLHIAIEIAGA 533
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
++Y+HS+AS PI+HRDIK++NILLD+K+ KVSDFGTSRSV D+THLTT V GTFGY D
Sbjct: 534 LSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVD 593
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 576
PEYFQSS++TDKSDVYSFGVVL+EL+TGK P + EE R A+F++ KEN+ L+I+
Sbjct: 594 PEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIV 653
Query: 577 DARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629
D R+ E + + + AVA+LA CL KKRP M++VS++LE +R S EI
Sbjct: 654 DERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSEI 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 401 bits (1031), Expect = e-111, Method: Compositional matrix adjust.
Identities = 206/367 (56%), Positives = 265/367 (72%), Gaps = 15/367 (4%)
Query: 260 VTLLGLGIGLGFLSLVLLGCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEK 318
VT++G+G G L LV+ +L K + +R K K FK+NGG LLQQ+L++ G+ EK
Sbjct: 376 VTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEK 435
Query: 319 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINE 378
+IF++ EL++ATDN+++SR LGQGG GTVYKGML DG VAVK+SK +D+ ++E+FINE
Sbjct: 436 TRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINE 495
Query: 379 VVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
VVILSQINHRH+VKLLGCCLETEVP LVYE+I NGNL HIH EE +
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIH-------------EESDD 542
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498
+ +W R+R+A ++AGA++Y+HS+AS PI+HRDIKS+NILLD+K+ KVSDFGTSRSV
Sbjct: 543 YTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVT 602
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEER 557
D TH TT + GT GY DPEY+ SSQYTDKSDVYSFGVVL+EL+TG+KP I ++ +E R
Sbjct: 603 IDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIR 662
Query: 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
L +F KEN+ EI+DAR+ E + AVA LA CL KKRP M++V DL
Sbjct: 663 GLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDL 722
Query: 618 EGLRRSQ 624
E + SQ
Sbjct: 723 EKILASQ 729
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1031), Expect = e-111, Method: Compositional matrix adjust.
Identities = 198/361 (54%), Positives = 275/361 (76%), Gaps = 14/361 (3%)
Query: 264 GLGIGLGFLSLVLLGCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSS-EKAKIF 322
GL +G L LVL L K + +R + K FK+NGG LL+Q+L++ G + + +KIF
Sbjct: 350 GLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIF 409
Query: 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVIL 382
+++EL++ATDN+N +R LGQGG GTVYKGML DG IVAVKRSK +D+ ++E+FINEV +L
Sbjct: 410 SSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVL 469
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
SQINHR+IVKL+GCCLETEVP+LVYE+I NG+L +H + + +++
Sbjct: 470 SQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLH-------------HDSDDYTMT 516
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
W+ R+R++ E+AGA+AY+HS+AS P++HRD+K++NILLD+K+ AKVSDFGTSRS+ D+T
Sbjct: 517 WDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQT 576
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
HLTT V GTFGY DPEYFQ+SQ+TDKSDVYSFGVVL+EL+TG+KP + R EE R LV++
Sbjct: 577 HLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSH 636
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
F K+N++L+I+D+R+ + + E + AVA+LA CL L KKRP M++VS++LE +R
Sbjct: 637 FNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
Query: 623 S 623
S
Sbjct: 697 S 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1025), Expect = e-110, Method: Compositional matrix adjust.
Identities = 201/414 (48%), Positives = 283/414 (68%), Gaps = 25/414 (6%)
Query: 216 PLKSESCSANPE------KFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKLVTLLGLGIGL 269
P+ +CS + F C C++ + ++ CKP G V+ T++ LG +
Sbjct: 288 PIHKHNCSGDSTCENKLGHFRCNCRSRYELNTTTN--TCKPKGNPEYVEWTTIV-LGTTI 344
Query: 270 GFLSLVL-LGCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSE-KAKIFTAEEL 327
GFL ++L + C +K+ K + L+++ F+QNGG +L QRLS G S KIFT E +
Sbjct: 345 GFLVILLAISCIEHKMKNTKDTE-LRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGM 403
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH 387
+ ATD Y+++R LGQGG GTVYKG+LPD SIVA+K+++ D +Q+EQFINEV++LSQINH
Sbjct: 404 KEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINH 463
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
R++VKLLGCCLETEVP+LVYE+I +G L H+H SSL+WE+R+
Sbjct: 464 RNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFD-------------SSLTWEHRL 510
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
R+A E+AG +AY+HSSASIPI HRDIK++NILLD+ +AKV+DFG SR +P DK L T
Sbjct: 511 RMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATM 570
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
VQGT GY DPEY+ + +KSDVYSFGVVL+ELL+G+K +C R + +++V+YF S
Sbjct: 571 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASAT 630
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
KEN+L EI+D +V E ++ +I+ A +A+ C RL ++RP MK+V+ +LE LR
Sbjct: 631 KENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALR 684
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 398 bits (1022), Expect = e-110, Method: Compositional matrix adjust.
Identities = 203/360 (56%), Positives = 266/360 (73%), Gaps = 18/360 (5%)
Query: 271 FLSLVLLGCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQR 329
F + + G LYK I +R + K FK+NGG LL+Q+L++ GS E +KIF++ EL++
Sbjct: 366 FFVIGIFG--LYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEK 423
Query: 330 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
ATDN++ R LGQGG GTVYK ML DGSIVAVKRSK +D+ ++E+FINE+V+LSQINHR+
Sbjct: 424 ATDNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRN 483
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IVKLLGCCLETEVP+LVYEYI NG+L +HD E + ++WE R+R+
Sbjct: 484 IVKLLGCCLETEVPILVYEYIPNGDLFKRLHD-------------EYDDYMMTWEVRLRI 530
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A E+AGA++YMHS+AS PIFHRDIK++NILLD+K+ AK+SDFGTSRSV D+THLTT V
Sbjct: 531 AVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVA 590
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
GTFGY DPEYF SSQYT KSDVYSFGVVL+EL+TG+KP+ R EE L YF+ KE
Sbjct: 591 GTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKE 650
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629
N+ ++I+D R+ E+ + + AVA+LA CL KRP M++VS+ LE +R S + L++
Sbjct: 651 NRAVDIIDIRIKDESKQ--VMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSSPKDLDV 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 396 bits (1018), Expect = e-109, Method: Compositional matrix adjust.
Identities = 199/405 (49%), Positives = 280/405 (69%), Gaps = 17/405 (4%)
Query: 219 SESCSANPEKFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKL-VTLLGLGIGLGFLSLVLL 277
+ +C F CQC +G D + C K+ P L T + LG +GFL ++L
Sbjct: 293 TSTCENTLGSFHCQCPSG--SDLNTTTMSCIDTPKEEPKYLGWTTVLLGTTIGFLIILLT 350
Query: 278 GCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSE-KAKIFTAEELQRATDNYNQ 336
Y+ + + +++ L+++ F+QNGG +L QRLS G S KIFT E ++ ATD YN+
Sbjct: 351 ISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNE 410
Query: 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
SR LGQGG GTVYKG+L D SIVA+K+++ D++Q+EQFINEV++LSQINHR++VKLLGC
Sbjct: 411 SRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGC 470
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
CLETEVP+LVYE+I +G L H+H SSL+WE+R+R+A EVAG
Sbjct: 471 CLETEVPLLVYEFISSGTLFDHLHGSMFD-------------SSLTWEHRLRIAIEVAGT 517
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+AY+HS ASIPI HRD+K++NILLD+ +AKV+DFG SR +P D+ LTT VQGT GY D
Sbjct: 518 LAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLD 577
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 576
PEY+ + +KSDVYSFGVVL+ELL+G+K +C R + ++LV+YF+S KEN+L EI+
Sbjct: 578 PEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEII 637
Query: 577 DARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
D +V E ++ +I+ A +A+ C R+ ++RP+MK+V+ +LE LR
Sbjct: 638 DGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALR 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 213/419 (50%), Positives = 285/419 (68%), Gaps = 43/419 (10%)
Query: 231 CQCKNGFLVDEMLKGLHCKP--------DGKKFPV----KLVTLLG-------------L 265
C C +GF + + G CK DG PV K V LLG +
Sbjct: 305 CSCASGFEGNPYIPG-ECKDINECVRGIDGN--PVCTAGKCVNLLGGYTCEYTNHRPLVI 361
Query: 266 GIGLGFLSLVLLGC--YLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIF 322
G+ F +LV +G +LYK I +R K+K FK+NGG LLQQ+L++ G+ + ++F
Sbjct: 362 GLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVF 421
Query: 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVIL 382
+ EL++AT+N++ +R LG+GG GTVYKGML DG IVAVK+SK +D+ ++E+FINEVVIL
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 481
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
SQINHR+IVKLLGCCLET+VP+LVYE+I NGNL H+HD + + + +
Sbjct: 482 SQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD------------DSDDYTMTT 529
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
WE R+R+A ++AGA++Y+HS+AS PI+HRDIKS+NI+LD+K AKVSDFGTSR+V D T
Sbjct: 530 WEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHT 589
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
HLTT V GT GY DPEYFQSSQ+TDKSDVYSFGVVL EL+TG+K + R +E R L Y
Sbjct: 590 HLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATY 649
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
F KEN+L +I+DAR+ + A A++A CL + +KRP+M+QVSM+LE +R
Sbjct: 650 FTLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 646 | ||||||
| 87162779 | 684 | Protein kinase; Peptidoglycan-binding Ly | 0.959 | 0.906 | 0.582 | 0.0 | |
| 357507639 | 776 | Wall-associated receptor kinase-like pro | 0.959 | 0.798 | 0.582 | 0.0 | |
| 356531931 | 666 | PREDICTED: wall-associated receptor kina | 0.941 | 0.912 | 0.597 | 0.0 | |
| 356566933 | 667 | PREDICTED: wall-associated receptor kina | 0.953 | 0.923 | 0.587 | 0.0 | |
| 255547606 | 594 | kinase, putative [Ricinus communis] gi|2 | 0.851 | 0.925 | 0.605 | 0.0 | |
| 290490602 | 678 | LysM type receptor kinase [Lotus japonic | 0.945 | 0.901 | 0.580 | 0.0 | |
| 290490588 | 678 | LysM type receptor kinase [Lotus japonic | 0.945 | 0.901 | 0.579 | 0.0 | |
| 357507635 | 679 | Wall-associated receptor kinase-like pro | 0.941 | 0.895 | 0.565 | 0.0 | |
| 255547604 | 541 | conserved hypothetical protein [Ricinus | 0.764 | 0.913 | 0.561 | 0.0 | |
| 290490590 | 486 | LysM type receptor kinase [Lotus japonic | 0.674 | 0.897 | 0.554 | 1e-147 |
| >gi|87162779|gb|ABD28574.1| Protein kinase; Peptidoglycan-binding LysM [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2022), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/664 (58%), Positives = 480/664 (72%), Gaps = 44/664 (6%)
Query: 6 LYTYLSIWLMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFIT 65
L +L ++++ LC + + NCQQ L+ DC + S KGYLCN PQ C SF+T
Sbjct: 19 LMKFLYLYIL-LCMLPYSI---NCQQILLNTTVTDCSGTPSAPKGYLCNSPQNSCNSFLT 74
Query: 66 FRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNAP 106
FRS+P ++ P SIAYLLGS+AS IIVP+ CSCSG++YQHN P
Sbjct: 75 FRSKPSYDNPTSIAYLLGSEASTIASINNISRNEKLPTNKTIIVPILCSCSGNIYQHNTP 134
Query: 107 YTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNG 166
YT++ DTYF + N TYQ LTTCQAL GQNYY +N+ G EV VP+ CACPT Q+ G
Sbjct: 135 YTVQKGDTYFHLVNETYQSLTTCQALKGQNYYASENIAIGAEVTVPVLCACPTTTQMAKG 194
Query: 167 VSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDD----LIFTFTPLLIPLKSESC 222
++ LL Y+ +G+T+ SIG +G D+QSIL+AN+L + ++F TP+L+PL+ +SC
Sbjct: 195 ITSLLVYIVNYGETVKSIGEAYGVDEQSILEANELQPSENRSVILFALTPILLPLRGKSC 254
Query: 223 SANPEKFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLY 282
+P+ F+C C G L D H G+KFP KLV LG+GIG GFL L LL LY
Sbjct: 255 KEDPDSFYCTCSQGRLADGSCNESH----GQKFPAKLVAALGVGIGAGFLVLFLLSYRLY 310
Query: 283 KVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQ 342
+ I KR+ + KEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATD+YNQSRFLGQ
Sbjct: 311 QYIKKKRASIRKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDDYNQSRFLGQ 370
Query: 343 GGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402
GG+GTVYKGMLPDG+IVAVK+SK +D+ QIE F+NEVVILSQINHR+IVKLLGCCLETE
Sbjct: 371 GGYGTVYKGMLPDGTIVAVKKSKHLDRNQIETFVNEVVILSQINHRNIVKLLGCCLETET 430
Query: 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS 462
P+LVYEYI +G LS HIH + SSLSWE+R+R+ACEVAGAV YMH
Sbjct: 431 PLLVYEYIHSGTLSQHIHGKDRD-------------SSLSWESRLRIACEVAGAVTYMHF 477
Query: 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS 522
SASIPIFHRDIK SNILLD+ +SAKVSDFGTSRS+P DKTHLTTAV GTFGY DPEYFQS
Sbjct: 478 SASIPIFHRDIKPSNILLDNNYSAKVSDFGTSRSIPLDKTHLTTAVGGTFGYMDPEYFQS 537
Query: 523 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAK 582
SQ+TDKSDVYSFGVVL+EL+TG+KPI E+E +N+ A+FIS+ KEN+L +ILD +
Sbjct: 538 SQFTDKSDVYSFGVVLVELITGRKPITFNDEDEGQNMTAHFISVMKENQLPQILDNALVN 597
Query: 583 EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLTNEISL 642
EA ++DI A+A LAM CLRLN KKRPTMK+VSM+LE LR+ Q L I + ++E SL
Sbjct: 598 EARKDDILAIANLAMRCLRLNGKKRPTMKEVSMELEALRKVQSSLHIKDDQESPSDEQSL 657
Query: 643 AQNS 646
+
Sbjct: 658 RHTT 661
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507639|ref|XP_003624108.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355499123|gb|AES80326.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/664 (58%), Positives = 480/664 (72%), Gaps = 44/664 (6%)
Query: 6 LYTYLSIWLMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFIT 65
L +L ++++ LC + + NCQQ L+ DC + S KGYLCN PQ C SF+T
Sbjct: 19 LMKFLYLYIL-LCMLPYSI---NCQQILLNTTVTDCSGTPSAPKGYLCNSPQNSCNSFLT 74
Query: 66 FRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNAP 106
FRS+P ++ P SIAYLLGS+AS IIVP+ CSCSG++YQHN P
Sbjct: 75 FRSKPSYDNPTSIAYLLGSEASTIASINNISRNEKLPTNKTIIVPILCSCSGNIYQHNTP 134
Query: 107 YTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNG 166
YT++ DTYF + N TYQ LTTCQAL GQNYY +N+ G EV VP+ CACPT Q+ G
Sbjct: 135 YTVQKGDTYFHLVNETYQSLTTCQALKGQNYYASENIAIGAEVTVPVLCACPTTTQMAKG 194
Query: 167 VSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDD----LIFTFTPLLIPLKSESC 222
++ LL Y+ +G+T+ SIG +G D+QSIL+AN+L + ++F TP+L+PL+ +SC
Sbjct: 195 ITSLLVYIVNYGETVKSIGEAYGVDEQSILEANELQPSENRSVILFALTPILLPLRGKSC 254
Query: 223 SANPEKFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLY 282
+P+ F+C C G L D H G+KFP KLV LG+GIG GFL L LL LY
Sbjct: 255 KEDPDSFYCTCSQGRLADGSCNESH----GQKFPAKLVAALGVGIGAGFLVLFLLSYRLY 310
Query: 283 KVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQ 342
+ I KR+ + KEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATD+YNQSRFLGQ
Sbjct: 311 QYIKKKRASIRKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDDYNQSRFLGQ 370
Query: 343 GGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402
GG+GTVYKGMLPDG+IVAVK+SK +D+ QIE F+NEVVILSQINHR+IVKLLGCCLETE
Sbjct: 371 GGYGTVYKGMLPDGTIVAVKKSKHLDRNQIETFVNEVVILSQINHRNIVKLLGCCLETET 430
Query: 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS 462
P+LVYEYI +G LS HIH + SSLSWE+R+R+ACEVAGAV YMH
Sbjct: 431 PLLVYEYIHSGTLSQHIHGKDRD-------------SSLSWESRLRIACEVAGAVTYMHF 477
Query: 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS 522
SASIPIFHRDIK SNILLD+ +SAKVSDFGTSRS+P DKTHLTTAV GTFGY DPEYFQS
Sbjct: 478 SASIPIFHRDIKPSNILLDNNYSAKVSDFGTSRSIPLDKTHLTTAVGGTFGYMDPEYFQS 537
Query: 523 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAK 582
SQ+TDKSDVYSFGVVL+EL+TG+KPI E+E +N+ A+FIS+ KEN+L +ILD +
Sbjct: 538 SQFTDKSDVYSFGVVLVELITGRKPITFNDEDEGQNMTAHFISVMKENQLPQILDNALVN 597
Query: 583 EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLTNEISL 642
EA ++DI A+A LAM CLRLN KKRPTMK+VSM+LE LR+ Q L I + ++E SL
Sbjct: 598 EARKDDILAIANLAMRCLRLNGKKRPTMKEVSMELEALRKVQSSLHIKDDQESPSDEQSL 657
Query: 643 AQNS 646
+
Sbjct: 658 RHTT 661
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531931|ref|XP_003534529.1| PREDICTED: wall-associated receptor kinase-like 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/653 (59%), Positives = 479/653 (73%), Gaps = 45/653 (6%)
Query: 14 LMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFITFRSQPPFN 73
+++LC F H L+ CQQ YL+ DC + S+ KGYLCNG QK C SF+ FRS+PP++
Sbjct: 13 ILLLCMFPHSLK---CQQAYLNGTVYDCSDNPSVPKGYLCNGLQKSCTSFLLFRSKPPYD 69
Query: 74 TPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNAPYTIKANDT 114
+P IAYLLGS+AS IIVPV CSCSG++YQHN PYT NDT
Sbjct: 70 SPEKIAYLLGSEASTIASINMISRNDKIPSNKSIIVPVFCSCSGNIYQHNTPYTASKNDT 129
Query: 115 YFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYM 174
Y+ + T+QGLTTCQA++G+NYY N+ G E+ VP CACPT Q G++ LL Y+
Sbjct: 130 YYELVKETFQGLTTCQAMMGRNYYAPVNIVIGAELTVPKLCACPTENQTARGITSLLVYL 189
Query: 175 ATWGDTISSIGHKFGADKQSILDANKLSEDDL------IFTFTPLLIPLKSESCSANPEK 228
+GDTI SIG +G D+QS+L+ANKL+E +F TP+L+PL +SC NP+K
Sbjct: 190 VNYGDTIKSIGRAYGVDEQSVLEANKLAEPQSSNRSMDLFALTPILVPLIGKSCKENPDK 249
Query: 229 FFCQCKNGFLVDEMLKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIGA 287
F+C+C D +LKG C + DG+KFP KLV LG+GIG GFL L LLG Y+ I
Sbjct: 250 FYCRCYQA--PDGILKGPFCGESDGQKFPAKLVAGLGVGIGAGFLCLFLLGYKSYQYIQK 307
Query: 288 KRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGT 347
KR +LKEKLF+QNGGYLLQ++LS G+ E AK+FTAEELQRATDNYN+SRFLGQGG+GT
Sbjct: 308 KRESILKEKLFRQNGGYLLQEKLSY-GNGEMAKLFTAEELQRATDNYNRSRFLGQGGYGT 366
Query: 348 VYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407
VYKGMLPDG+IVAVK+SK I++ QI+ F+NEVVILSQINHR+IVKLLGCCLETE P+LVY
Sbjct: 367 VYKGMLPDGTIVAVKKSKEIERNQIKTFVNEVVILSQINHRNIVKLLGCCLETETPILVY 426
Query: 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIP 467
E+I N LSHHIH + SLSW +R+R+ACEVAGAV YMH SASIP
Sbjct: 427 EFIPNETLSHHIHRRDNE-------------PSLSWVSRLRIACEVAGAVTYMHFSASIP 473
Query: 468 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD 527
IFHRDIK +NILLD +SAKVSDFGTSRSVP DKTHLTTAV GTFGY DPEYFQSSQ++D
Sbjct: 474 IFHRDIKPTNILLDSNYSAKVSDFGTSRSVPLDKTHLTTAVGGTFGYIDPEYFQSSQFSD 533
Query: 528 KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEE 587
KSDVYSFGVVL+EL+TG+KPI E+E +NLVA FISL K+N++ EI DARV K+A ++
Sbjct: 534 KSDVYSFGVVLVELITGRKPISFLYEDEGQNLVAQFISLMKKNQVSEIFDARVLKDARKD 593
Query: 588 DIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLTNEI 640
DI AVA LAM CLRLN KKRPTMK+VS +LE LR++Q L++ ++ T+ I
Sbjct: 594 DILAVANLAMRCLRLNGKKRPTMKEVSAELEALRKAQSSLQMSHDHEHTTSNI 646
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566933|ref|XP_003551679.1| PREDICTED: wall-associated receptor kinase-like 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/664 (58%), Positives = 484/664 (72%), Gaps = 48/664 (7%)
Query: 6 LYTYLSIW--LMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSF 63
L+ L+I+ +++LC F H L+ CQQ YL+ DC + S KGYLCNG QK C SF
Sbjct: 3 LFHNLNIFSTILLLCMFPHSLK---CQQAYLNGTVYDCSDNPSAPKGYLCNGLQKSCTSF 59
Query: 64 ITFRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHN 104
+ FRS+PP+++P IAYLLGS+AS IIVPV CSCSG++YQHN
Sbjct: 60 LLFRSKPPYDSPGIIAYLLGSEASTIASINRISRNDKIPSNKSIIVPVFCSCSGNIYQHN 119
Query: 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQID 164
PYT NDTY+ + T+QGLTTCQA++GQNYY N+ G E+ VP+ CACPT Q
Sbjct: 120 TPYTASKNDTYYELVKETFQGLTTCQAMMGQNYYASINIAIGAELTVPMLCACPTENQTA 179
Query: 165 NGVSYLLAYMATWGDTISSIGHKFGADKQSILDANKL-------SEDDLIFTFTPLLIPL 217
GV+ LL ++ +GDTI SIG +G D+QS+L+ANKL S DL+ TP+++PL
Sbjct: 180 RGVTSLLVHLVNYGDTIKSIGRAYGVDEQSVLEANKLAVSQSKNSSMDLL-ALTPIIVPL 238
Query: 218 KSESCSANPEKFFCQCKNGFLVDEMLKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVL 276
+SC NP+KF+C+C D KG C + DG+KFP KLV LG+GIG GFL L L
Sbjct: 239 IGKSCKENPDKFYCRCYQA--PDGSSKGPFCDESDGQKFPAKLVAGLGVGIGAGFLCLFL 296
Query: 277 LGCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQ 336
LG Y+ I KR +LKEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATDNYN+
Sbjct: 297 LGYKSYQYIQKKRETILKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDNYNR 356
Query: 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
SRFLGQGG+GTVYKGML DG+IVAVK+SK I++ QI+ F+NEVV+LSQINHR+IVKLLGC
Sbjct: 357 SRFLGQGGYGTVYKGMLLDGTIVAVKKSKEIERNQIQTFVNEVVVLSQINHRNIVKLLGC 416
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
CLETE P+LVYE+I NG LSHHIH + S SW +R+R+ACEVAGA
Sbjct: 417 CLETETPILVYEFIPNGTLSHHIHRRDNE-------------PSPSWISRLRIACEVAGA 463
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
VAYMH +ASI IFHRDIK +NILLD +SAKVSDFGTSRSVP DKTHLTTAV GTFGY D
Sbjct: 464 VAYMHFAASISIFHRDIKPTNILLDSNYSAKVSDFGTSRSVPLDKTHLTTAVGGTFGYID 523
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 576
PEYFQSSQ++DKSDVYSFGVVL+EL+TG+KPI E+E +NL+A FISL KEN++ EIL
Sbjct: 524 PEYFQSSQFSDKSDVYSFGVVLVELITGRKPISFLYEDEGQNLIAQFISLMKENQVFEIL 583
Query: 577 DARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLL 636
DA + KEA ++DI A+A LAM CLRLN KKRPTMK+VS +LE LR++Q L++ ++
Sbjct: 584 DASLLKEARKDDILAIANLAMRCLRLNGKKRPTMKEVSTELEALRKAQSSLQMNHDHEHT 643
Query: 637 TNEI 640
T++I
Sbjct: 644 TSDI 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547606|ref|XP_002514860.1| kinase, putative [Ricinus communis] gi|223545911|gb|EEF47414.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/624 (60%), Positives = 462/624 (74%), Gaps = 74/624 (11%)
Query: 25 QQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKL-CQSFITFRSQPPFNTPVSIAYLLG 83
Q SNCQQ YL+N QL+C + SISKGYLCNG ++ CQS+ITF S PP++TP+SIAY+LG
Sbjct: 20 QPSNCQQDYLNNTQLNCGVNPSISKGYLCNGNDQVPCQSYITFLSLPPYDTPISIAYVLG 79
Query: 84 SDASIIVPVSCSCSGSLYQHNAPYTIKA-NDTYFLVANNTYQGLTTCQALLGQNYYDEKN 142
S +YQHN PYTIK ++YF +ANNTYQGLTTCQAL GQNYYD ++
Sbjct: 80 S---------------IYQHNTPYTIKNLTESYFTIANNTYQGLTTCQALTGQNYYDPEH 124
Query: 143 LGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLS 202
L G+E++VPLRCACP+ Q +GV LL YM TWGDT+SSIG FGAD SIL+AN+LS
Sbjct: 125 LQVGMELMVPLRCACPSRNQTADGVISLLMYMVTWGDTLSSIGQAFGADAASILEANRLS 184
Query: 203 EDDLIFTFTPLLIPLKSESCSANPEKFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKLVTL 262
++ +IF FTP+L+PL+ E C A+PE FFCQC G + GL+C+ D KKFP KL+ L
Sbjct: 185 QNSIIFPFTPILVPLRRERCMADPENFFCQCPKG-----GVGGLNCRQDSKKFPTKLIIL 239
Query: 263 LGLGIGLGFLSLVLLGCYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIF 322
LG GIG+G L L L L+ + +R+R+ KE+LF+QNGG+LLQQ+LSSCG +KAK+F
Sbjct: 240 LGTGIGMGLLCLFLFSYKLFHFLKERRNRIRKERLFEQNGGFLLQQKLSSCGGGKKAKLF 299
Query: 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVIL 382
TAEELQRATDNYNQSRFLGQGG+GTV+KGMLPDGSIVAVKRSK ID+TQI QFINEVVIL
Sbjct: 300 TAEELQRATDNYNQSRFLGQGGYGTVFKGMLPDGSIVAVKRSKTIDRTQIAQFINEVVIL 359
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
SQINHR+IVKLLGCCLETE+P+LVYE+I NGNLS+HIH EQ QE SS
Sbjct: 360 SQINHRNIVKLLGCCLETELPLLVYEFIPNGNLSNHIH------EQDQE-------SSFP 406
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
WE R+R+A EVAGAVAYMHSSAS PIFHRDIKSSNILLDDK+SAKVSDFGTSR++P D+T
Sbjct: 407 WELRLRIASEVAGAVAYMHSSASSPIFHRDIKSSNILLDDKYSAKVSDFGTSRAIPFDRT 466
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
HLTTAVQGTFG E+ER+LVA+
Sbjct: 467 HLTTAVQGTFG---------------------------------------NEDERSLVAH 487
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
FIS KE++LL+ILD RVA+EA ED+ A+A+LA C+RLN KKRPTM++V+M+L+GLR+
Sbjct: 488 FISSMKEDRLLQILDPRVAREARREDMHAIAKLATSCVRLNGKKRPTMREVAMELDGLRK 547
Query: 623 SQRCLEIGKVNQLLTNEISLAQNS 646
S+RCL+I + LL ++ S A +
Sbjct: 548 SERCLQIDQELSLLRDDPSFAHRA 571
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490602|dbj|BAI79288.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/651 (58%), Positives = 472/651 (72%), Gaps = 40/651 (6%)
Query: 6 LYTYLSIWLMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFIT 65
L+ +L I L F+ Q N QQ YL++ DC + S KGYLCNG +K C SF+
Sbjct: 3 LHYHLQILSTTLLLFMFP-QPLNSQQLYLNSSVYDCTDNPSAPKGYLCNGLKKSCTSFLV 61
Query: 66 FRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNAP 106
F S+PP++ P+SIAYLLGS+AS +IVPV CSCSG++YQH+ P
Sbjct: 62 FTSKPPYDNPLSIAYLLGSEASTIASINNISMNGKIPTNKSVIVPVFCSCSGNIYQHSTP 121
Query: 107 YTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNG 166
YT+ NDTY+++ TYQGLTTCQA++GQNYY ++ G E+ VP+ CACPT+ I G
Sbjct: 122 YTVVKNDTYYMLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLIAKG 181
Query: 167 VSYLLAYMATWGDTISSIGHKFGADKQSILDANKL-------SEDDLIFTFTPLLIPLKS 219
VS+LL +M G+ ++SIG +G D+QS+ +AN L + + TP+L+PL+
Sbjct: 182 VSFLLVHMVRDGEMVNSIGEAYGVDEQSMREANGLPVVPSSANNSVTLNALTPILVPLRG 241
Query: 220 ESCSANPEKFFCQCKNGFLVDEMLKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLG 278
+SC NP+KF+C+C L D KGL C + DG+KFP KLV LG+GIG GFL L + G
Sbjct: 242 QSCKENPDKFYCKCSQA-LHDGSSKGLFCNESDGQKFPAKLVVPLGVGIGAGFLCLFVSG 300
Query: 279 CYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSR 338
LY+ I KR R+ EKLF+QNGGYLLQ++ S G+ EKAK+FTAEELQRATDNYN+SR
Sbjct: 301 YKLYQYIQKKRKRIHTEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSR 360
Query: 339 FLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
FLGQGG+G VYKGMLPDG+IVAVKRSK I+++QI+ F+NEVVILSQINHR+IVKLLGCCL
Sbjct: 361 FLGQGGYGMVYKGMLPDGTIVAVKRSKEIERSQIDTFVNEVVILSQINHRNIVKLLGCCL 420
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
ETE P+LVYE+I NG LS HIH ++ + SSL WE+R+R+ACEVAGA+A
Sbjct: 421 ETETPLLVYEFIPNGTLSQHIH-----------MKNYESSSSLPWESRLRIACEVAGALA 469
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
YMH SASIPIFHRDIK +NILLD F AKVSDFGTS+SVP DKTHLTT V+GTFGY DPE
Sbjct: 470 YMHFSASIPIFHRDIKPTNILLDSNFCAKVSDFGTSKSVPQDKTHLTTNVKGTFGYIDPE 529
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 578
YFQS Q+TDKSDVYSFGVVL+EL+TGK+PI E+E +NLV FISL KE++L +ILDA
Sbjct: 530 YFQSCQFTDKSDVYSFGVVLVELITGKRPISFFYEDEGQNLVGEFISLMKEDQLSQILDA 589
Query: 579 RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629
V KEA +DI ++A LA CLRLN KKRPTMK+VS +LE LR+ Q L+I
Sbjct: 590 VVVKEARIDDILSIASLARRCLRLNGKKRPTMKEVSAELEALRKVQNTLQI 640
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490588|dbj|BAI79281.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/651 (57%), Positives = 471/651 (72%), Gaps = 40/651 (6%)
Query: 6 LYTYLSIWLMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFIT 65
L+ +L I L F+ Q N QQ YL++ DC + S KGYLCNG +K C SF+
Sbjct: 3 LHYHLQILSTTLLLFMFP-QPLNSQQLYLNSSVYDCTDNPSAPKGYLCNGLKKSCTSFLV 61
Query: 66 FRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNAP 106
F S+PP++ P+SIAYLLGS+AS +IVPV CSCSG++YQH+ P
Sbjct: 62 FTSKPPYDNPLSIAYLLGSEASTIASINNISMNGKIPTNKSVIVPVFCSCSGNIYQHSTP 121
Query: 107 YTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNG 166
YT+ NDTY+++ TYQGLTTCQA++GQNYY ++ G E+ VP+ CACPT+ I G
Sbjct: 122 YTVVKNDTYYMLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLIAKG 181
Query: 167 VSYLLAYMATWGDTISSIGHKFGADKQSILDANKL-------SEDDLIFTFTPLLIPLKS 219
VS+LL +M G+ ++SIG +G D+QS+ +AN L + + TP+L+PL+
Sbjct: 182 VSFLLVHMVRDGEMVNSIGEAYGVDEQSMREANGLPVVPSSANNSVTLNALTPILVPLRG 241
Query: 220 ESCSANPEKFFCQCKNGFLVDEMLKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLG 278
+SC NP+KF+C+C L D KGL C + DG+KFP KLV LG+GIG GFL L + G
Sbjct: 242 QSCKENPDKFYCKCSQA-LHDGSSKGLFCNESDGQKFPAKLVVPLGVGIGAGFLCLFVSG 300
Query: 279 CYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSR 338
LY+ I KR R+ EKLF+QNGGYLLQ++ S G+ EKAK+FTAEELQRATDNYN+SR
Sbjct: 301 YKLYQYIQKKRKRIHTEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSR 360
Query: 339 FLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
FLGQGG+G VYKGMLPDG+IVAVKRSK I+++QI+ F+NEVVILSQINHR+IVKLLGCCL
Sbjct: 361 FLGQGGYGMVYKGMLPDGTIVAVKRSKEIERSQIDTFVNEVVILSQINHRNIVKLLGCCL 420
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
ETE P+LVYE+I NG LS HIH ++ + SSL WE+R+R+ACEVAGA+A
Sbjct: 421 ETETPLLVYEFIPNGTLSQHIH-----------MKNYESSSSLPWESRLRIACEVAGALA 469
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
YMH SASIPIFHRDIK +NILLD F AKVSDFGTS+SVP DKTHLTT V+GTFGY DPE
Sbjct: 470 YMHFSASIPIFHRDIKPTNILLDSNFCAKVSDFGTSKSVPQDKTHLTTNVKGTFGYIDPE 529
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 578
YFQS Q+TDKSDVYSFGVVL+EL+TGK+PI E+E +NLV FISL KE++L +ILD
Sbjct: 530 YFQSCQFTDKSDVYSFGVVLVELITGKRPISFFYEDEGQNLVGEFISLMKEDQLSQILDP 589
Query: 579 RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629
V KEA +DI ++A LA CLRLN KKRPTMK+VS +LE LR+ Q L+I
Sbjct: 590 VVVKEARIDDILSIASLARRCLRLNGKKRPTMKEVSAELEALRKVQNTLQI 640
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507635|ref|XP_003624106.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|87162780|gb|ABD28575.1| Protein kinase [Medicago truncatula] gi|355499121|gb|AES80324.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/651 (56%), Positives = 468/651 (71%), Gaps = 43/651 (6%)
Query: 6 LYTY-LSIWLMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFI 64
LY Y L ++ LC F Q NCQQ YL+N DC ++ KGYLCNG +K C SF+
Sbjct: 3 LYNYILHFTVLFLCMFS---QLFNCQQVYLNNTVFDCTNPSTVPKGYLCNGLKKSCTSFL 59
Query: 65 TFRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNA 105
F+S+P ++ P IAYLL S+AS IIVPV CSC G++YQH+
Sbjct: 60 VFKSKPLYDNPTKIAYLLRSEASAIASINKIPLNEKIPSNKSIIVPVFCSCDGNIYQHST 119
Query: 106 PYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDN 165
Y++K NDTY+ + TYQGLTTCQAL+GQNYY ++ E+ VP+ CACPTA
Sbjct: 120 SYSVKQNDTYYELVKETYQGLTTCQALMGQNYYAPVSIQLDAELTVPILCACPTANLTAK 179
Query: 166 GVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLS------EDDLIFTFTPLLIPLKS 219
GV+ LL +M +G+T+ SIG +G D+ S+ +AN+LS ++F TP+L+PL+
Sbjct: 180 GVTSLLVHMVNYGETVKSIGEAYGVDEHSMREANELSGLQSANSSVILFASTPILVPLRR 239
Query: 220 ESCSANPEKFFCQCKNGFLVDEMLKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLG 278
++C N ++F+C+C DE KG++C + +K P KLV G+GIG L L LL
Sbjct: 240 KNCKENSDRFYCKCSEALHGDESSKGIYCDESPRRKVPAKLVAASGMGIGTVLLCLFLLS 299
Query: 279 CYLYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSR 338
C LY+ I +R+ KEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATDNYN+SR
Sbjct: 300 CKLYQHIKKRRASTHKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDNYNRSR 359
Query: 339 FLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
FLGQGG+GTVYKGMLPDG+IVAVK+SK +++ QIE F+NEVVILSQINHR+IVKLLGCCL
Sbjct: 360 FLGQGGYGTVYKGMLPDGTIVAVKKSKELERNQIETFVNEVVILSQINHRNIVKLLGCCL 419
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
ETE P+LVYE+I NG LS HIH Q+ SSLSWENR+R+ACEVAGAVA
Sbjct: 420 ETETPLLVYEFIPNGTLSQHIHMKDQE-------------SSLSWENRLRIACEVAGAVA 466
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
YMH SASIPIFHRDIK +NILLD FSAKVSDFGTSRS+P DKTHLTT V GT+GY DPE
Sbjct: 467 YMHFSASIPIFHRDIKPTNILLDSNFSAKVSDFGTSRSIPLDKTHLTTFVGGTYGYIDPE 526
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 578
YFQS+Q+T+KSDVYSFGVVL+EL+T +KPI E++ +NL+A+FIS+ KEN++ +I+DA
Sbjct: 527 YFQSNQFTNKSDVYSFGVVLVELITSRKPISFYDEDDGQNLIAHFISVMKENQVSQIIDA 586
Query: 579 RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629
R+ KEA ++ I A++ LA CLRLN KKRPTMK+VS +LE LR++Q EI
Sbjct: 587 RLQKEAGKDTILAISSLARRCLRLNHKKRPTMKEVSAELETLRKAQSSFEI 637
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547604|ref|XP_002514859.1| conserved hypothetical protein [Ricinus communis] gi|223545910|gb|EEF47413.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/584 (56%), Positives = 409/584 (70%), Gaps = 90/584 (15%)
Query: 63 FITFRSQPPFNTPVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQH 103
F+TF S+PP+++P++I+YLLGS+AS IIVP+SCSC+ S+Y H
Sbjct: 4 FLTFSSRPPYDSPITISYLLGSEASSIALINNVSSIFTFLSEKSIIVPISCSCTSSIYHH 63
Query: 104 NAPYTIK-ANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQ 162
N Y I+ + DTYF +ANNTYQGLTTCQA++ QN Y + L G E+IVPLRCACPT Q
Sbjct: 64 NTSYFIQDSTDTYFTIANNTYQGLTTCQAIMDQNNYPSQGLPVGSELIVPLRCACPTQNQ 123
Query: 163 IDNGVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKSESC 222
+NGV LL +M TWGDTI+SI + FG D+ SIL ANKLSE+ I+ FTP+L+PL +E+
Sbjct: 124 TENGVISLLVHMVTWGDTIASIANSFGVDEASILAANKLSENSTIYPFTPILVPLTNENR 183
Query: 223 SANPE-KFFCQCKNGFLVDEMLKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYL 281
NP F CQ NG + + G++C +G+GIGL V + +L
Sbjct: 184 LTNPAANFSCQYPNGSVAVGGVDGMYCTSRS----------VGIGIGL----TVFIPVHL 229
Query: 282 YKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLG 341
EELQRATDNY+QSRFLG
Sbjct: 230 ------------------------------------------QEELQRATDNYSQSRFLG 247
Query: 342 QGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401
QGGF TVYKGMLPDGSIVAVKRSK ID+TQIEQFINEVVILSQINHR+IVKLLGCCLETE
Sbjct: 248 QGGFSTVYKGMLPDGSIVAVKRSKTIDRTQIEQFINEVVILSQINHRNIVKLLGCCLETE 307
Query: 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 461
P+LVYE+I NG LS HI++ Q+ SSL WE+R R+A EVAGA+AYMH
Sbjct: 308 FPLLVYEFISNGTLSQHIYNQDQE-------------SSLPWEHRFRIASEVAGALAYMH 354
Query: 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521
S+AS PIFHRDIKS+NILLDDK+SAKVSDFGTSRS+P D+THLTT VQGTFGY DPEYF
Sbjct: 355 SAASFPIFHRDIKSANILLDDKYSAKVSDFGTSRSIPFDRTHLTTVVQGTFGYLDPEYFY 414
Query: 522 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 581
+SQ+T+KSDVYSFGVVL+EL TG+KPI TR E+ERNLVA+FIS+AKEN+LL++LDARVA
Sbjct: 415 TSQFTEKSDVYSFGVVLIELFTGEKPISSTRAEDERNLVAHFISMAKENRLLDLLDARVA 474
Query: 582 KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625
KEA ED+ ++A+L + C+R N K RP++++V+M+L+G+ +S +
Sbjct: 475 KEARREDVYSIAKLVIKCVRSNGKNRPSIREVAMELDGIMKSHQ 518
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490590|dbj|BAI79282.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1363), Expect = e-147, Method: Compositional matrix adjust.
Identities = 268/483 (55%), Positives = 336/483 (69%), Gaps = 47/483 (9%)
Query: 15 MILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGYLCNGPQKLCQSFITFRSQPPFNT 74
++L F H L N QQ YL++ DC + S KGYLCNG +K C SF+ F S+PP++
Sbjct: 14 LLLFMFPHSL---NSQQIYLNSSVYDCTNNPSAPKGYLCNGLKKSCTSFLVFTSKPPYDN 70
Query: 75 PVSIAYLLGSDAS-------------------IIVPVSCSCSGSLYQHNAPYTIKANDTY 115
PVSIAYLLGS+AS +IVPV CSCSG++YQH+ PYT+ NDTY
Sbjct: 71 PVSIAYLLGSEASTIASMNNISMNDKIPSNKSVIVPVFCSCSGNIYQHSTPYTVVKNDTY 130
Query: 116 FLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMA 175
+++ TYQGLTTCQA++GQNYY ++ G E+ VP+ CACPT+ GVS+LL +M
Sbjct: 131 YMLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLTTKGVSFLLVHMV 190
Query: 176 TWGDTISSIGHKFGADKQSILDANKL-------SEDDLIFTFTPLLIPLKSESCSANPEK 228
G+T+ SIG +G D+QS+ +AN L + ++ TP+L+PL+ +SC NP+K
Sbjct: 191 RDGETVKSIGEAYGVDEQSMGEANGLPVVPSSANNSVILNALTPILVPLRGQSCKENPDK 250
Query: 229 FFCQCKNGFLVDEMLKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIGA 287
F+C+C L D K L C + DG+KFP KLV LG+GIG GFL L L G LY+ I
Sbjct: 251 FYCKCSQA-LHDGSSKELFCDESDGQKFPAKLVVSLGVGIGAGFLCLFLSGYKLYQCIQK 309
Query: 288 KRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGT 347
KR + KEKLF+QNGGYLLQ++ S G+ EKAK+FTAEELQRATDNYN+SRFLGQGG+G
Sbjct: 310 KRKCVHKEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSRFLGQGGYGM 369
Query: 348 VYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407
VYKGMLPDG+IVAVKRSK I++ QI+ F+NEVVILSQINHR+IVKLLGCCLETE P+LVY
Sbjct: 370 VYKGMLPDGTIVAVKRSKEIERNQIDSFVNEVVILSQINHRNIVKLLGCCLETETPLLVY 429
Query: 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIP 467
E+I NG LS HIH SSL WE+R+R+ACEVAGA+AYMH SASIP
Sbjct: 430 EFIPNGTLSQHIHSS----------------SSLPWESRLRIACEVAGALAYMHFSASIP 473
Query: 468 IFH 470
IFH
Sbjct: 474 IFH 476
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 646 | ||||||
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.526 | 0.465 | 0.564 | 1.7e-103 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.507 | 0.414 | 0.574 | 4.1e-102 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.509 | 0.439 | 0.559 | 1.6e-100 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.507 | 0.426 | 0.554 | 2e-100 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.509 | 0.438 | 0.555 | 3.9e-99 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.595 | 0.521 | 0.460 | 2.7e-97 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.509 | 0.417 | 0.563 | 1.4e-96 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.504 | 0.452 | 0.545 | 5.4e-96 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.501 | 0.412 | 0.544 | 1.6e-93 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.5 | 0.422 | 0.538 | 1.1e-92 |
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 1.7e-103, Sum P(2) = 1.7e-103
Identities = 200/354 (56%), Positives = 261/354 (73%)
Query: 282 YKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFL 340
+K+I +R+ +K FK+NGG LL+Q+L++ G+ E +KIF+++EL++ATDN++ R L
Sbjct: 376 FKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVL 435
Query: 341 GQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400
GQGG GTVYKGML DGSIVAVKRSK +D+ ++E+FINE+V+LSQINHR+IVKLLGCCLET
Sbjct: 436 GQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLET 495
Query: 401 EVPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 460
EVP+LVYEYI NG+L +HD R+R+A E+AGA+ YM
Sbjct: 496 EVPILVYEYIPNGDLFKRLHDESDDYTMTWEV-------------RLRIAIEIAGALTYM 542
Query: 461 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 520
HS+AS PIFHRDIK++NILLD+K+ AKVSDFGTSRSV D+THLTT V GTFGY DPEYF
Sbjct: 543 HSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYF 602
Query: 521 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 580
SSQYT KSDVYSFGVVL+EL+TG+KP+ R EE R L +F+ KEN++++I+D R+
Sbjct: 603 LSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRI 662
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQ 634
E+ E + AVA+LA CL K RP MK+VS +LE +R S L++ N+
Sbjct: 663 KDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVRTENE 716
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 4.1e-102, Sum P(2) = 4.1e-102
Identities = 196/341 (57%), Positives = 252/341 (73%)
Query: 282 YKVIGAKRSRMLKEKLFKQNGGYLLQQRL-SSCGSSEKAKIFTAEELQRATDNYNQSRFL 340
YK I +R K+K FK+NGG LLQQ+L S+ G EK +F++ EL++AT+N++ +R L
Sbjct: 394 YKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRIL 453
Query: 341 GQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400
GQGG GTVYKGML DG IVAVK+SK +D+ ++E+FINEVVILSQINHR+IVKLLGCCLET
Sbjct: 454 GQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLET 513
Query: 401 EVPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 460
+VPVLVYE+I NGNL H+HD R+R+A ++AGA++Y+
Sbjct: 514 KVPVLVYEFIPNGNLFEHLHDEFDENIMATWNI------------RLRIAIDIAGALSYL 561
Query: 461 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 520
HSSAS PI+HRD+KS+NI+LD+K+ AKVSDFGTSR+V D THLTT V GT GY DPEYF
Sbjct: 562 HSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYF 621
Query: 521 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 580
QSSQ+TDKSDVYSFGVVL+EL+TG+K I R +E R L YFI KENKL +I+DAR+
Sbjct: 622 QSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARI 681
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
+ A A++A CL L +KRP+M++VSM+L+ +R
Sbjct: 682 RDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.6e-100, Sum P(2) = 1.6e-100
Identities = 192/343 (55%), Positives = 256/343 (74%)
Query: 282 YKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFL 340
YK + +R + K F++NGG LL+Q+L+ G+ E ++IF++ EL++ATDN+N++R L
Sbjct: 363 YKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVL 422
Query: 341 GQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400
GQGG GTVYKGML DG IVAVKRSKA+D+ ++E+FINEVV+L+QINHR+IVKLLGCCLET
Sbjct: 423 GQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLET 482
Query: 401 EVPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 460
EVPVLVYE++ NG+L +HD R+ +A E+AGA++Y+
Sbjct: 483 EVPVLVYEFVPNGDLCKRLHDESDDYTMTWEV-------------RLHIAIEIAGALSYL 529
Query: 461 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 520
HS+AS PI+HRDIK++NILLD++ AKVSDFGTSRSV D+THLTT V GTFGY DPEYF
Sbjct: 530 HSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYF 589
Query: 521 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 580
QSS++T+KSDVYSFGVVL+ELLTG+KP R EE R L A+F+ KEN++L+I+D R+
Sbjct: 590 QSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRI 649
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
E + + + +VA LA CL KKRP M++VS++LE +R S
Sbjct: 650 KDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.0e-100, Sum P(2) = 2.0e-100
Identities = 189/341 (55%), Positives = 249/341 (73%)
Query: 282 YKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFL 340
YK I +R K+K FK+NGG LLQQ+L++ G+ + ++F + EL++AT+N++ +R L
Sbjct: 380 YKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRIL 439
Query: 341 GQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400
G+GG GTVYKGML DG IVAVK+SK +D+ ++E+FINEVVILSQINHR+IVKLLGCCLET
Sbjct: 440 GEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLET 499
Query: 401 EVPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 460
+VP+LVYE+I NGNL H+HD R+R+A ++AGA++Y+
Sbjct: 500 DVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEV------------RLRIAVDIAGALSYL 547
Query: 461 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 520
HS+AS PI+HRDIKS+NI+LD+K AKVSDFGTSR+V D THLTT V GT GY DPEYF
Sbjct: 548 HSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYF 607
Query: 521 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 580
QSSQ+TDKSDVYSFGVVL EL+TG+K + R +E R L YF KEN+L +I+DAR+
Sbjct: 608 QSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARI 667
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
+ A A++A CL + +KRP+M+QVSM+LE +R
Sbjct: 668 RDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 3.9e-99, P = 3.9e-99
Identities = 191/344 (55%), Positives = 266/344 (77%)
Query: 288 KRSRMLKEKLF-KQNGGYLLQQRLSSCGSS-EKAKIFTAEELQRATDNYNQSRFLGQGGF 345
KR +++++++F K+NGG LL+Q+L++ G + + +KIF+++EL++ATDN+N +R LGQGG
Sbjct: 373 KRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQ 432
Query: 346 GTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405
GTVYKGML DG IVAVKRSK +D+ ++E+FINEV +LSQINHR+IVKL+GCCLETEVP+L
Sbjct: 433 GTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPIL 492
Query: 406 VYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMHSSAS 465
VYE+I NG+L +H H R+R++ E+AGA+AY+HS+AS
Sbjct: 493 VYEHIPNGDLFKRLH-HDSDDYTMTWDV------------RLRISVEIAGALAYLHSAAS 539
Query: 466 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY 525
P++HRD+K++NILLD+K+ AKVSDFGTSRS+ D+THLTT V GTFGY DPEYFQ+SQ+
Sbjct: 540 TPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQF 599
Query: 526 TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAS 585
TDKSDVYSFGVVL+EL+TG+KP + R EE R LV++F K+N++L+I+D+R+ + +
Sbjct: 600 TDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCT 659
Query: 586 EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629
E + AVA+LA CL L KKRP M++VS++LE +R S LE+
Sbjct: 660 LEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLEL 703
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 2.7e-97, Sum P(3) = 2.7e-97
Identities = 185/402 (46%), Positives = 257/402 (63%)
Query: 221 SCSANPEKFFCQCKNGFLVDEMLKGLHCKPDGKKFPXXXXXXXXXXXXXXXXXXXXXXXX 280
+C F C C++ + ++ CKP G
Sbjct: 299 TCENKLGHFRCNCRSRYELNTTTNT--CKPKGNPEYVEWTTIVLGTTIGFLVILLAISCI 356
Query: 281 XYKVIGAKRSRMLKEKLFKQNGGYLLQQRLSSCGSSE-KAKIFTAEELQRATDNYNQSRF 339
+K+ K + L+++ F+QNGG +L QRLS G S KIFT E ++ ATD Y+++R
Sbjct: 357 EHKMKNTKDTE-LRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRI 415
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LGQGG GTVYKG+LPD SIVA+K+++ D +Q+EQFINEV++LSQINHR++VKLLGCCLE
Sbjct: 416 LGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLE 475
Query: 400 TEVPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAY 459
TEVP+LVYE+I +G L H+H +R+R+A E+AG +AY
Sbjct: 476 TEVPLLVYEFISSGTLFDHLHG-------------SMFDSSLTWEHRLRMAVEIAGTLAY 522
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 519
+HSSASIPI HRDIK++NILLD+ +AKV+DFG SR +P DK L T VQGT GY DPEY
Sbjct: 523 LHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEY 582
Query: 520 FQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDAR 579
+ + +KSDVYSFGVVL+ELL+G+K +C R + +++V+YF S KEN+L EI+D +
Sbjct: 583 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIIDGQ 642
Query: 580 VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
V E ++ +I+ A +A+ C RL ++RP MK+V+ +LE LR
Sbjct: 643 VMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALR 684
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
Identities = 194/344 (56%), Positives = 246/344 (71%)
Query: 283 KVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 341
K + +R K K FK+NGG LLQQ+L++ G+ EK +IF++ EL++ATDN+++SR LG
Sbjct: 399 KFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILG 458
Query: 342 QGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401
QGG GTVYKGML DG VAVK+SK +D+ ++E+FINEVVILSQINHRH+VKLLGCCLETE
Sbjct: 459 QGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETE 518
Query: 402 VPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 461
VP LVYE+I NGNL HIH+ R+R+A ++AGA++Y+H
Sbjct: 519 VPTLVYEFIPNGNLFQHIHEESDDYTKTWGM-------------RLRIAVDIAGALSYLH 565
Query: 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521
S+AS PI+HRDIKS+NILLD+K+ KVSDFGTSRSV D TH TT + GT GY DPEY+
Sbjct: 566 SAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYG 625
Query: 522 SSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEERNLVAYFISLAKENKLLEILDARV 580
SSQYTDKSDVYSFGVVL+EL+TG+KP I ++ +E R L +F KEN+ EI+DAR+
Sbjct: 626 SSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARI 685
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
E + AVA LA CL KKRP M++V DLE + SQ
Sbjct: 686 RDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQ 729
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 5.4e-96, Sum P(2) = 5.4e-96
Identities = 187/343 (54%), Positives = 248/343 (72%)
Query: 287 AKRSRML---KEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLGQ 342
A R R + K K F++NGG LLQQ+ S GS + K+F++ +L+ ATD +N SR LGQ
Sbjct: 339 ANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQ 398
Query: 343 GGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402
GG GTVYKGML DG IVAVK+SKA+ + +E+FINE+++LSQINHR++VK+LGCCLETEV
Sbjct: 399 GGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEV 458
Query: 403 PVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMHS 462
P+LVYE+I N NL H+H+ R+ +ACEVA A++Y+HS
Sbjct: 459 PILVYEFIPNRNLFDHLHNPSEDFPMSWEV-------------RLCIACEVADALSYLHS 505
Query: 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS 522
+ SIPI+HRD+KS+NILLD+K AKVSDFG SRSV D THLTT VQGT GY DPEY QS
Sbjct: 506 AVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQS 565
Query: 523 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAK 582
+ +T KSDVYSFGV+L+ELLTG+KP+ L R +E R L AYF+ + ++L EILDAR+ +
Sbjct: 566 NHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKE 625
Query: 583 EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625
E E++ AVA+LA CL LNS+ RPTM+ V ++L+ ++ ++
Sbjct: 626 ECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRK 668
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 1.6e-93, P = 1.6e-93
Identities = 184/338 (54%), Positives = 247/338 (73%)
Query: 283 KVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 341
K + +R K+K FK+NGG LLQQ L++ G EKA+IFT++EL++AT+N++++R LG
Sbjct: 392 KFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLG 451
Query: 342 QGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401
GG GTVYKGML DG VAVK+SK ID+ ++++FINEVVILSQINHRH+VKLLGCCLETE
Sbjct: 452 HGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETE 511
Query: 402 VPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 461
VP+LVYE+I NGNL HIH+ R+R+A ++AGA++Y+H
Sbjct: 512 VPILVYEFIINGNLFKHIHEEEADDYTMIWGM------------RLRIAVDIAGALSYLH 559
Query: 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521
S+AS PI+HRDIKS+NILLD+K+ AKV+DFGTSRSV D+TH TT + GT GY DPEY++
Sbjct: 560 SAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYR 619
Query: 522 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA-KENKLLEILDARV 580
SSQYT+KSDVYSFGV+L EL+TG KP+ + + +E +A +A KE +L +I+DAR+
Sbjct: 620 SSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARI 679
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
++ E + AVA LAM CL + RP M++V +LE
Sbjct: 680 RDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELE 717
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
Identities = 182/338 (53%), Positives = 242/338 (71%)
Query: 283 KVIGAKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 341
K++ +R K K FK+NGG LLQQ+L++ G EK K+F++ EL++ATDN+N +R +G
Sbjct: 402 KLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIG 461
Query: 342 QGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401
QGG GTVYKGML DG VAVK+S +D+ ++++FINEV+ILSQINHRH+VKLLGCCLETE
Sbjct: 462 QGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETE 521
Query: 402 VPVLVYEYICNGNLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 461
VP+LVYE+I NGNL H+H+ R+R+A +++GA +Y+H
Sbjct: 522 VPILVYEFIPNGNLFQHLHEEFDDYTALWGV-------------RMRIAVDISGAFSYLH 568
Query: 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521
++A PI+HRDIKS+NILLD+K+ AKVSDFGTSRSV D TH TT + GT GY DPEY+
Sbjct: 569 TAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYG 628
Query: 522 SSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEERNLVAYFISLAKENKLLEILDARV 580
SS +T+KSDVYSFGVVL+EL+TG+KP I L+ +E L YF +EN+L EI+DAR+
Sbjct: 629 SSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARI 688
Query: 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
+ E + AVA LA+ CL+ K RP M++VS LE
Sbjct: 689 RNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALE 726
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 646 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-15 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| pfam01476 | 43 | pfam01476, LysM, LysM domain | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-50
Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 40/281 (14%)
Query: 340 LGQGGFGTVYKGMLPDGSI-----VAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKL 393
LG+G FG VYKG L VAVK K + QIE+F+ E I+ +++H +IVKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
LG C E E ++V EY+ G+L ++ ++ + LS + + A ++
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK--------------ELSLSDLLSFALQI 112
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A + Y+ S HRD+ + N L+ + K+SDFG SR + +D + +
Sbjct: 113 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKL 572
+ PE + ++T KSDV+SFGV+L E+ T G++P A + K+
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-------YPGMSNAEVLEYLKKGYR 222
Query: 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
L + +L + C + + RPT ++
Sbjct: 223 LPK---------PPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHRHIV 391
Y LG+G FG VY G +VA+K K K E+ + E+ IL ++ H +IV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L + + LV EY G+L + + L E++
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-------LSEDE---------ARFYLR 104
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++ A+ Y+H S I HRD+K NILLD+ K++DFG +R + + LTT V GT
Sbjct: 105 QILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GT 159
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
Y PE Y D++S GV+L ELLTGK P + L+ F + K
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKP 214
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ ++ EA +L L + +KR T ++
Sbjct: 215 PFPPPEWDISPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-50
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 340 LGQGGFGTVYKGML----PDGSI-VAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKL 393
LG+G FG VYKG L + VAVK K + QIE+F+ E I+ +++H ++VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
LG C E E +V EY+ G+L ++ ++ LS + + A ++
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR---------------PKLSLSDLLSFALQI 111
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A + Y+ S HRD+ + N L+ + K+SDFG SR + +D + +
Sbjct: 112 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKL 572
+ PE + ++T KSDV+SFGV+L E+ T G++P + + K
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP------YPGMS-NEEVLEYLKNGYR 221
Query: 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
L + +L + C + + RPT ++
Sbjct: 222 LPQ---------PPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-49
Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 51/295 (17%)
Query: 340 LGQGGFGTVYKGMLPDGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLL 394
LG+G FG VYKG L VAVK K + + + F+ E ++ ++ H ++V+LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G C E E LV EY+ G+L ++ + + + E S+LS ++ + A ++A
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLR-------KSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT-------- 506
+ Y+ S HRD+ + N L+ + K+SDFG SR V +D +
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 507 --AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563
A PE + +T KSDV+SFGV+L E+ T G P +
Sbjct: 173 WMA---------PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---------------Y 208
Query: 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
L+ E +LE L E + + EL + C +L+ + RPT ++ LE
Sbjct: 209 PGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-49
Identities = 78/224 (34%), Positives = 117/224 (52%), Gaps = 25/224 (11%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
LG+GGFGTVY G VA+K K + +E+ + E+ IL ++NH +IVKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ LV EY G+L + +++ + LS + +R+ ++ +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---------------LSEDEILRILLQILEGL 105
Query: 458 AYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
Y+H S I HRD+K NILLD D K++DFG S+ + +DK+ L T V GT Y
Sbjct: 106 EYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMA 161
Query: 517 PE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI--CLTREEEER 557
PE Y++KSD++S GV+L EL K I L ++ E+R
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKR 205
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 88/284 (30%), Positives = 130/284 (45%), Gaps = 34/284 (11%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHI 390
Y R LG G FGTVYK G IVAVK K + + E+ IL +++H +I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V+L+ + + LV EY G+L ++ LS + ++A
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----------------PLSEDEAKKIA 104
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
++ + Y+HS I HRD+K NILLD+ K++DFG ++ + + LTT V G
Sbjct: 105 LQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-G 160
Query: 511 TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
T Y PE + Y K DV+S GV+L ELLTGK P + E L L
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPP 218
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ E + ++EA +L CL + KRPT +++
Sbjct: 219 LEFDEPKWSSGSEEA--------KDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 1e-46
Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 50/290 (17%)
Query: 340 LGQGGFGTVYKGML-PDGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKL 393
LG+G FG VYKG L DG VAVK K + + E+F+ E I+ +++H +IV+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
LG C + E +V EY+ G+L + H + L+ ++ +++A ++
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---------------KLTLKDLLQMALQI 111
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A + Y+ S HRD+ + N L+ + K+SDFG SR + D + + G
Sbjct: 112 AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGG 164
Query: 514 YFD-----PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567
PE + ++T KSDV+SFGV+L E+ T G++P EE + L
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELL 217
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
++ L + +E + EL + C + + RPT ++ DL
Sbjct: 218 EDGYRLPRPE-----NCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 45/281 (16%)
Query: 338 RFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQ--IEQFINEVVILSQINHRHIVKLL 394
LG+G FG+VY + D G ++AVK + ++ +E E+ ILS + H +IV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 395 GCCLETEVPVL-VY-EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
G + E L ++ EY+ G+LS + L E +R
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK----------------FGKLP-EPVIRKYTR 108
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP-NDKTHLTTAVQG 510
++ +AY+HS+ I HRDIK +NIL+D K++DFG ++ + + T +V+G
Sbjct: 109 QILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA--YFISLAK 568
T + PE + +Y +D++S G ++E+ TGK P E N +A Y I +
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW-----SELGNPMAALYKIGSSG 220
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT 609
E EI + SE EA L CLR + KKRPT
Sbjct: 221 EPP--EIPE-----HLSE---EAKDFLRK-CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 87/284 (30%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRS--KAIDKTQIEQFINEVVILSQINHRH 389
Y + +G+G FG VY DG + +K + + + E +NEV IL ++NH +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
I+K E +V EY G+LS I ++Q+++ + EEQ L W
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQ---ILDW------ 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
++ A+ Y+HS I HRDIK NI L K+ DFG S+ + + T V
Sbjct: 109 FVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV- 164
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
GT Y PE Q+ Y KSD++S G VL EL T K P E NL + LA
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF------EGENL----LELA-- 212
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
K+L+ + + S E + L L+ + ++RP++ Q+
Sbjct: 213 LKILKGQYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
+G+GGFG VYK G VA+K K K + E+ INE+ IL + H +IVK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC---EVAG 455
+ + +V E+ G+L + Q L E Q +A E+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST------NQTLTESQ------------IAYVCKELLK 109
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+ Y+HS I HRDIK++NILL K+ DFG S + + K T GT +
Sbjct: 110 GLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWM 164
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE Y K+D++S G+ +EL GK P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-33
Identities = 80/293 (27%), Positives = 122/293 (41%), Gaps = 35/293 (11%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQINH-R 388
+Y R LG+G FG VY D +VA+K ++E+F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IVKL + LV EY+ G+L + ++ LS +
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-------------GPLSESEALF 105
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTH---- 503
+ ++ A+ Y+HS I HRDIK NILLD D K+ DFG ++ +P+ +
Sbjct: 106 ILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 504 -LTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
L + GT GY PE + SD++S G+ L ELLTG P + +
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
I L L E +A ++L L + K R +
Sbjct: 223 TLKIILELPTPSLASPLS----PSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 30/290 (10%)
Query: 338 RFLGQGGFGTVYKG----MLPDGS--IVAVKRSK-AIDKTQIEQFINEVVILSQINHRHI 390
R LG+G FG V+ G + P+ +VAVK K + F E +L+ H +I
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
VK G C E + P++V+EY+ +G+L+ + H + + L+ +++A
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD--AAFLKSPDSPMGELTLSQLLQIA 128
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQ 509
++A + Y+ AS HRD+ + N L+ K+ DFG SR V D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 568
+ PE ++T +SDV+SFGVVL E+ T GK+P ++ L+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY-GLSN 230
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
E +++E + + V ++ +GC + + ++R +K + L+
Sbjct: 231 E-EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 77/284 (27%), Positives = 122/284 (42%), Gaps = 49/284 (17%)
Query: 339 FLGQGGFGTVYKGML-PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGC 396
LGQG G VYK P G I A+K+ D+ +Q + E+ L ++VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+ +V EY+ G+L+ + +K E L+ +A ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL--------KKVGKIPEPVLAY--------IARQILKG 111
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+ Y+H+ I HRDIK SN+L++ K K++DFG S+ + N T V GT Y
Sbjct: 112 LDYLHTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMS 168
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 576
PE Q Y+ +D++S G+ LLE GK P + E++
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFP----------------FLPPGQPSFFELM 212
Query: 577 DARV--------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
A A+E S E + ++ CL+ + KKRP+ +
Sbjct: 213 QAICDGPPPSLPAEEFSPEFRDFIS----ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 83/285 (29%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 333 NYNQSRFLGQGGFG--TVYKGMLPDGSIVAVKRS--KAIDKTQIEQFINEVVILSQINHR 388
+Y R LG+G FG T+Y+ D S+V K + + + +NE+VILS + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+I+ ++ ++ EY G L I +++ Q EEE L L
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLF------ 108
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ AV+Y+H I HRDIK+ NI L K+ DFG S+ + ++ + T V
Sbjct: 109 ---QIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
GT Y PE Q +Y KSD+++ G VL ELL L R + N + + + +
Sbjct: 163 -GTPYYMSPELCQGVKYNFKSDIWALGCVLYELL------TLKRTFDATNPLNLVVKIVQ 215
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
N V S E I V L+ + +KRPT +V
Sbjct: 216 GNY------TPVVSVYSSELISLVHS----LLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 74/214 (34%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG+G FG V D G + A+K + K I + ++E + E ILS+INH IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 396 CCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 453
+TE + LV EY G L H+ + S E R R A E+
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL----------------SKEGRFS-EERARFYAAEI 102
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A+ Y+HS I +RD+K NILLD K++DFG ++ + ++ + T GT
Sbjct: 103 VLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPE 158
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE Y D +S GV+L E+LTGK P
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR--SKAIDKTQIEQFINEVVILSQINHRH 389
NY +G+G FG VYKG+ L G VA+K+ + I + ++ + E+ +L + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IVK +G ++ ++ EY NG+L I E SL V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE------------SL-------V 101
Query: 450 AC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
A +V +AY+H + HRDIK++NIL K++DFG + + ND +
Sbjct: 102 AVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDA 157
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+V GT + PE + S + SD++S G ++ELLTG P
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 42/284 (14%)
Query: 339 FLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI-----EQFINEVVILSQINHRHIVK 392
+G+G FGTV K DG I+ K ID + +Q ++EV IL ++ H +IV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILV---WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 393 LLGCCL--ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+ + +V EY G+L+ I Q+ +++++ +EEE R+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIW---------RIL 111
Query: 451 CEVAGAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ A+ H S + HRD+K +NI LD + K+ DFG ++ + +D + T V
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
GT Y PE Y +KSD++S G ++ EL P RN + LA
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF------TARN----QLQLAS 220
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
+ K + R+ S E + E+ L ++ KRP+ ++
Sbjct: 221 KIKEGKF--RRIPYRYSSE----LNEVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 71/215 (33%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 338 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
R +G+G FG V D + A+K + K ++K + +NE IL ++NH +V L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 452
+ E LV + + G+L +H+ QK + EEQ V+ CE
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFSEEQ----------VKFWICE 108
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ A+ Y+HS I HRDIK NILLD++ ++DF + V D LTT+ GT
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GY PE Y+ D +S GV E L GK+P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 73/272 (26%), Positives = 131/272 (48%), Gaps = 37/272 (13%)
Query: 340 LGQGGFGTVYKGMLP-DGSIVAVKRS--KAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
+G+G FG V+K + D + A+K+ +++ + E+ I+E +L++++ +I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
L+ +V EY NG+L + ++ + L E+Q W R ++
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK-----MQRGRPLPEDQ-----VW----RFFIQILLG 113
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+A++HS I HRDIKS N+ LD + K+ D G ++ + +D T+ + GT Y
Sbjct: 114 LAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLS 169
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 576
PE + Y +KSDV++ GVVL E TGK P + N A + + +
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRG------- 216
Query: 577 DARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608
V S+ + +A+L CL + ++RP
Sbjct: 217 ---VFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 27/219 (12%)
Query: 338 RFLGQGGFGTVYKGML--PDGSIV--AVKR-SKAIDKTQIEQFINEVVILSQINHRHIVK 392
R +G+G FG VY G L DG + AVK ++ D ++EQF+ E +I+ +H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 393 LLGCCLETE-VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
LLG CL +E P++V Y+ +G+L + I K + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK---------------DLIGFGL 105
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN---DKTHLTTAV 508
+VA + Y+ AS HRD+ + N +LD+ F+ KV+DFG +R + + H T
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ + E Q+ ++T KSDV+SFGV+L EL+T P
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 336 QSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVK 392
+ +G G FG VY + L G ++AVK R + D I++ +E+ +L + H ++VK
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
G + E V ++ C+G LEE E + E+ +RV
Sbjct: 64 YYGVEVHRE-KVYIFMEYCSGG----------------TLEELLEHGRILDEHVIRVYTL 106
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++ +AY+HS I HRDIK +NI LD K+ DFG + + N+ T + VQ
Sbjct: 107 QLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163
Query: 512 FG---YFDPEYFQSSQYTDK---SDVYSFGVVLLELLTGKKP 547
G Y PE + +D++S G V+LE+ TGK+P
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
R LG G FG V++G+ + VA+K K+ D + + F EV L ++ H+H++ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
E ++ E + G+L + + Q L + +AC+VA +
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL--------------IDMACQVAEGM 117
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
AY+ SI HRD+ + NIL+ + KV+DFG +R + + +L++ + + + P
Sbjct: 118 AYLEEQNSI---HRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAP 173
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
E ++ KSDV+SFG++L E+ T G+ P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 36/255 (14%)
Query: 337 SRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHI 390
+ LG+G FG V G VAVK ++ F E+ IL ++H +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 391 VKLLGCCLET--EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
VK G C + L+ EY+ +G+L ++ H+ Q K+ L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL---------------L 113
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+ ++ + Y+ S I HRD+ + NIL++ + K+SDFG ++ +P DK +
Sbjct: 114 FSSQICKGMDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170
Query: 509 QGTFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC--------LTREEEERN 558
G F PE ++S+++ SDV+SFGV L EL T P + + +
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230
Query: 559 LVAYFISLAKENKLL 573
+V + L KE + L
Sbjct: 231 IVTRLLELLKEGERL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 340 LGQGGFGTVY----KGMLP--DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
LG+G FG V+ +LP D +VAVK K ++ + F E +L+ + H+HIV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
G C E ++V+EY+ +G+L+ + H + E+ L+ + +A ++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAG-GEDVAPGQLTLGQMLAIASQI 131
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTF 512
A + Y+ AS+ HRD+ + N L+ K+ DFG SR + D +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T +SD++SFGVVL E+ T GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 75/299 (25%), Positives = 136/299 (45%), Gaps = 38/299 (12%)
Query: 340 LGQGGFGTVYKGM------LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHRHIVK 392
LG+G FG V K + VAVK + +++ ++E +L Q+NH H++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQ--------QQEQKQELEEEQELSSLSWE 444
L G C + +L+ EY G+L + + ++ + + + +L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+ + A +++ + Y+ A + + HRD+ + N+L+ + K+SDFG SR V + +++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 505 TTAVQGTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561
+ +G + E YT +SDV+SFGV+L E++T G P
Sbjct: 185 KRS-KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-------------- 229
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
+ +A E L +L E E E + L + C + KRPT +S +LE +
Sbjct: 230 -YPGIAPER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCL 398
+G+G FG VYKG+L + VAVK ++ +F+ E IL Q +H +IVKL+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+ + +V E + G+L + + + K+ L+ ++ + A +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ---------------MSLDAAAGME 107
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT----FGY 514
Y+ S I HRD+ + N L+ + K+SDFG SR ++ + T G +
Sbjct: 108 YLESKNCI---HRDLAARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKW 161
Query: 515 FDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544
PE +YT +SDV+S+G++L E +
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSK--AIDKTQIEQFINEVVILSQINHRHIVKLLG 395
R LG G FG V+ G + VAVK K + E F+ E I+ ++ H +V+L
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYA 68
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
C E E +V EY+ G+L + + E L V +A ++A
Sbjct: 69 VCSEEEPIYIVTEYMSKGSL--------------LDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT---F 512
+AY+ S I HRD+ + NIL+ + K++DFG +R + +D+ TA +G
Sbjct: 115 GMAYLESRNYI---HRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPI 168
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T KSDV+SFG++L E++T G+ P
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
+G+G G VYK G VA+K+ + + K E INE++I+ H +IV L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+ +V EY+ G+L+ I + + E Q V EV +
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQ---------IAYVCREVLQGLE 130
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+HS I HRDIKS NILL S K++DFG + + +K+ + V GT + PE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ Y K D++S G++ +E+ G+ P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 35/220 (15%)
Query: 340 LGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+G G FG V +G L VA+K ++ + DK +++ F+ E I+ Q +H +I++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
G ++ +++ EY+ NG+L + ++ + + V + +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK---------------FTVGQLVGMLRGI 115
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA-----V 508
A + Y+ + + HRD+ + NIL++ KVSDFG SR + + + TT +
Sbjct: 116 ASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ T PE ++T SDV+SFG+V+ E+++ G++P
Sbjct: 173 RWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 338 RFLGQGGFGTVYK-GMLPDGSIVAVKRSKAIDKTQIEQF--INEVVILSQINHRHIVK-- 392
+ LG+G +G+VYK L D A+K +Q E+ +NE+ IL+ +NH +I+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 393 ---LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
L G L +V EY G+LS I +++++++ + E+ W R+
Sbjct: 66 EAFLDGNKL-----CIVMEYAPFGDLSKAI---SKRKKKRKLIPEQ-----EIW----RI 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
++ + +H I HRD+KS+NILL K+ D G S+ + K ++
Sbjct: 109 FIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
GT Y PE ++ Y+ KSD++S G +L E+ T P ++ R
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------------ 210
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
K+ + S++ + L++ K RP ++
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFI----RSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 80/299 (26%), Positives = 143/299 (47%), Gaps = 40/299 (13%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGM---LPDGSI---VAVKR-SKAIDKTQIEQFINE 378
EL R + R LGQG FG VY+G+ + G VA+K ++ + +F+NE
Sbjct: 2 ELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 379 VVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
++ + N H+V+LLG + ++V E + G+L ++ + ++ E E L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL------RSRRPEAENNPGL 113
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498
+ + +++A E+A +AY+ A+ HRD+ + N ++ + + K+ DFG +R +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI- 169
Query: 499 NDKTHLTTAVQGTFG--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP-ICLTREE 554
+ + +G + PE + +T KSDV+SFGVVL E+ T ++P L+ EE
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
V F+ + L++ E + + EL C + N K RPT ++
Sbjct: 230 -----VLKFV---IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK---AIDKTQIEQFINEVVILSQIN 386
N+ + +G+G F VYK + L DG +VA+K+ + +D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H +++K L +E +V E G+LS I + ++QK+ + E W+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERT-----IWKYF 112
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
V ++ A+ +MHS I HRDIK +N+ + K+ D G R + KT
Sbjct: 113 V----QLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAH 164
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566
++ GT Y PE + Y KSD++S G +L E+ + P ++ NL + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKI 220
Query: 567 AK-ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
K + L A SEE + +L C+ + +KRP + V
Sbjct: 221 EKCDYPPLP------ADHYSEE----LRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
+G+G FG V G G VAVK K D T + F+ E +++ + H ++V+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 459
+V EY+ G+L + + + ++ ++ A +V + Y
Sbjct: 72 GNPLYIVTEYMAKGSLV--------------DYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 519
+ HRD+ + N+L+ + AKVSDFG ++ + V+ T PE
Sbjct: 118 LEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEA 170
Query: 520 FQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDA 578
+ +++ KSDV+SFG++L E+ + G+ P R L +++
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRI-----------------PLKDVVPH 211
Query: 579 RVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
V K EA E V ++ C L+ KRPT KQ+ L
Sbjct: 212 -VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 43/282 (15%)
Query: 338 RFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ-----IEQFINEVVILSQINHRHIV 391
LG G FG+VY+G+ L DG AVK D Q ++Q E+ +LS++ H +IV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+ LG E + + E + G+L+ + + E L Q L L
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL---------- 115
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
Y+H ++ HRDIK +NIL+D K++DFG ++ V + + +G+
Sbjct: 116 ------EYLHDRNTV---HRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGS 164
Query: 512 FGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570
+ PE Q Y +D++S G +LE+ TGK P + VA + +
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSK 218
Query: 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
+L I D ++ EA + + CL+ + RPT +
Sbjct: 219 ELPPIPD-HLSDEAK--------DFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 76/298 (25%), Positives = 136/298 (45%), Gaps = 45/298 (15%)
Query: 338 RFLGQGGFGTVYKGML--PDGSI--VAVKRSKA--IDKTQIEQFINEVVILSQINHRHIV 391
+ LG+G FG+V +G L DGS VAVK K ++IE+F++E + +H +++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 392 KLLGCCLETE------VPVLVYEYICNGNL-SHHIHDHQQQQEQKQELEEEQELSSLSWE 444
KL+G C E P+++ ++ +G+L S ++ +K L Q L
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QTL------ 115
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTH 503
++ ++A + Y+ + I HRD+ + N +L + + V+DFG S+ + + D
Sbjct: 116 --LKFMVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562
+ + E YT KSDV++FGV + E+ T G+ P E +
Sbjct: 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY--- 227
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
L N+L + E+ ++ + +L C R + K RPT ++ LE +
Sbjct: 228 ---LRHGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 26/212 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LG G FG V+ G VA+K + ++ + FI E ++ +++H ++V+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 459
+V EY+ NG L +++ +E+K +L E L + +V A+ Y
Sbjct: 71 QRPIFIVTEYMANGCLLNYL------RERKGKLGTEWLLD---------MCSDVCEAMEY 115
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT---FGYFD 516
+ S+ I HRD+ + N L+ + KVSDFG +R V +D+ T+ QGT +
Sbjct: 116 LESNGFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAP 169
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE F S+++ KSDV+SFGV++ E+ + GK P
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 65/223 (29%), Positives = 115/223 (51%), Gaps = 34/223 (15%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKR---------SKAIDKTQIEQFINEVVILSQINHRH 389
+G G FG+VY GM G ++AVK+ SK ++ ++ E+ +L ++ H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV+ LG L+ + + EY+ G+++ ++++ +E Q L L+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN------- 120
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--- 506
Y+H+ I HRDIK +NIL+D+K K+SDFG S+ + + T
Sbjct: 121 ---------YLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 507 --AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
++QG+ + PE + + YT K+D++S G +++E+LTGK P
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 77/288 (26%), Positives = 136/288 (47%), Gaps = 30/288 (10%)
Query: 340 LGQGGFGTVYKG--MLPDG----SIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
LG+G FG VYKG P+ + VA+K + A K Q ++F E ++S + H +IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ-QEFRQEAELMSDLQHPNIV 71
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
LLG C + + +++EY+ +G+L + + + E +E SSL + + +A
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQG 510
++A + Y+ +S HRD+ + N L+ + + K+SDFG SR + D + +
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569
+ PE ++T +SD++SFGVVL E+ + G +P +E
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------------- 234
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
++E++ +R E+ V L + C +RP K + L
Sbjct: 235 --VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 340 LGQGGFGTVYKG--MLPDGSI--VAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLL 394
LG G FG+V KG ++ G VAVK K ++F+ E +++Q++H IV+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G C E +LV E G L ++ + E A +VA
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRR----------EIPVSDLKEL------AHQVA 105
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF-- 512
+AY+ S + HRD+ + N+LL ++ AK+SDFG SR++ + G +
Sbjct: 106 MGMAYLESKHFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
++ PE +++ KSDV+S+GV L E + G KP
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 24/211 (11%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G G FG V+ G + VA+K R A+ + E FI E ++ +++H +V+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
E LV+E++ +G LS ++ + S E + + +V +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQR---------------GKFSQETLLGMCLDVCEGM 113
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
AY+ SS I HRD+ + N L+ + KVSDFG +R V +D+ +T + + P
Sbjct: 114 AYLESSNVI---HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
E F S+Y+ KSDV+SFGV++ E+ + GK P
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/246 (28%), Positives = 116/246 (47%), Gaps = 37/246 (15%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGM---LPDGSI---VAVKRSKAIDKTQIEQ-FINEVV 380
+ D+ R LG G FG VY+G+ ++ VAVK Q E F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 381 ILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSS 440
I+S+ NH++IV+L+G E ++ E + G+L + +++ + E+ SS
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP---------SS 112
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGTSRSV 497
L+ ++ + A +VA Y+ + I HRDI + N LL K AK++DFG +R +
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDI 169
Query: 498 -------PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI- 548
+ L + PE F +T K+DV+SFGV+L E+ + G P
Sbjct: 170 YRASYYRKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223
Query: 549 CLTREE 554
T +E
Sbjct: 224 GRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 3e-24
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF----INEVVILSQINHR 388
Y + LG+G +G VYK G IVA+K+ + +D + E + E+ +L ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDN-EEEGIPSTALREISLLKELKHP 58
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IVKLL LV+EY C+ +L ++ + S+ ++
Sbjct: 59 NIVKLLDVIHTERKLYLVFEY-CDMDLKKYLDKRPGP-------LSPNLIKSIMYQ---- 106
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+ +AY HS I HRD+K NIL++ K++DFG +R+ T V
Sbjct: 107 ----LLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 509 QGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
T Y PE S Y+ D++S G + E++TGK
Sbjct: 160 V-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 30/294 (10%)
Query: 338 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG V+ + P D +VAVK K + F E +L+ + H HIV
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
K G C+E + ++V+EY+ +G+L+ + H E EL+ + +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ---SQMLHIAQ 127
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQG 510
++A + Y+ AS HRD+ + N L+ + K+ DFG SR V D +
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569
+ PE ++T +SDV+S GVVL E+ T GK+P Y +S
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------WYQLS---N 228
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
N+++E + + + V +L +GC + R +K++ L+ L ++
Sbjct: 229 NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 74/229 (32%), Positives = 115/229 (50%), Gaps = 29/229 (12%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKA-IDKTQIEQFINEVV 380
E+QR ++ R +G+G FG VY+G M P+ VAVK K + E+F+ E
Sbjct: 2 EIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 381 ILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
I+ Q +H HIVKL+G TE PV +V E G L ++ Q K L +L+
Sbjct: 60 IMRQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL------QVNKYSL----DLA 107
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
SL + + +++ A+AY+ S HRDI + N+L+ K+ DFG SR + +
Sbjct: 108 SL-----ILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ + + + + PE ++T SDV+ FGV + E+L G KP
Sbjct: 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 80/316 (25%), Positives = 141/316 (44%), Gaps = 72/316 (22%)
Query: 340 LGQGGFGTVY------------KGMLPDGS-----IVAVK--RSKAIDKTQIEQFINEVV 380
LG+G FG V+ K + + +VAVK R A D + + F+ EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED-FLKEVK 71
Query: 381 ILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSS 440
ILS+++ +I +LLG C ++ EY+ NG+L+ + H + S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC-----NSKS 126
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PN 499
LS+ + +A ++A + Y+ S+ HRD+ + N L+ ++ K++DFG SR++ +
Sbjct: 127 LSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 500 DKTHLTTAVQGTFGYFD-------P------EYFQSSQYTDKSDVYSFGVVLLELLT--G 544
D Y+ P E ++T KSDV++FGV L E+LT
Sbjct: 184 D-------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230
Query: 545 KKPI-CLTREEEERNLVAYFISLAKENKLLEILD--ARVAKEASEEDIEAVAELAMGCLR 601
++P LT ++ N +F +++ L K+ + EL + C R
Sbjct: 231 EQPYEHLTDQQVIENAGHFF----RDDGRQIYLPRPPNCPKD--------IYELMLECWR 278
Query: 602 LNSKKRPTMKQVSMDL 617
+ + RPT +++ + L
Sbjct: 279 RDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 336 QSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHI 390
+ + +G G FG V++G+L VA+K K + Q + F++E I+ Q +H +I
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
++L G + + +++ EY+ NG L ++ DH + E SS +R
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDH------------DGEFSSYQLVGMLR-- 114
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK--THLTTAV 508
G A M + + HRD+ + NIL++ KVSDFG SR + +D T+ T+
Sbjct: 115 ----GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ + PE ++T SDV+SFG+V+ E+++ G++P
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 340 LGQGGFGTVYKGM-LPDGS----IVAVKR-SKAIDKTQIEQFINEVVILSQINHRHIVKL 393
LG G FGTVYKG+ +P+G VA+K + ++ ++E +++ ++H H+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
LG CL + L+ + + G L ++ +H+ + L+W ++
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHK---------DNIGSQYLLNW------CVQI 118
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTF 512
A ++Y+ + HRD+ + N+L+ K++DFG ++ + D+ +
Sbjct: 119 AKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ E YT KSDV+S+GV + EL+T G KP
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 50/287 (17%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVK----------RSKAIDKTQIEQFINEVVILSQINHR 388
+G+G +G VY + + G ++AVK R + K ++ +E+ L ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IV+ LG E + EY+ G++ + + + +EQ EQ L L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL------- 121
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTA 507
AY+HS I HRD+K+ N+L+D K+SDFG S+ + + +
Sbjct: 122 ---------AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 508 VQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565
+QG+ + PE S Y+ K D++S G V+LE+ G++P + EE +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEEA----IAAMFK 223
Query: 566 LAKENK---LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT 609
L + + + ++ A + C +N RPT
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVA--------LDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
R LG G FG V++G+ + + VAVK K + F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
E +V E + G+L ++ +L + +A +VA +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--------------GAGRALKLPQLIDMAAQVASGM 116
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
AY+ + I HRD+ + N+L+ + KV+DFG +R + D + + P
Sbjct: 117 AYLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
E ++++ KSDV+SFG++L E++T G+ P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 339 FLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 397
LG+G FG V+KG L D + VAVK K +++ +F++E IL Q +H +IVKL+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ + +V E + G+ + +++K EL+ +Q V+ A + A +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL------RKKKDELKTKQ---------LVKFALDAAAGM 106
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
AY+ S I HRD+ + N L+ + K+SDFG SR + + Q + P
Sbjct: 107 AYLESKNCI---HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLT 543
E +Y+ +SDV+S+G++L E +
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
LG+G +G+VYK + G +VA+K + +++ I E+ IL Q + +IVK G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV- 457
+ +V EY G++S + + K L EE+ +A + +
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIM-----KITNKT-LTEEE------------IAAILYQTLK 110
Query: 458 --AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
Y+HS+ I HRDIK+ NILL+++ AK++DFG S + D V GT +
Sbjct: 111 GLEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGTPFWM 166
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE Q Y +K+D++S G+ +E+ GK P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 26/212 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LG G FG V G VA+K K ++ ++FI E ++ +++H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC-T 69
Query: 400 TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+ P+ +V EY+ NG L +++ +H ++ + Q LE + +V +A
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE---------------MCKDVCEGMA 114
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF--GYFD 516
Y+ S I HRD+ + N L+DD+ KVSDFG SR V +D+ T++V F +
Sbjct: 115 YLESKQFI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 169
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE S+++ KSDV++FGV++ E+ + GK P
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 11/218 (5%)
Query: 338 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG V+ + P D +VAVK K + F E +L+ + H HIV
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
K G C + + ++V+EY+ +G+L+ + H + + Q L + +A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQG 510
++A + Y+ AS HRD+ + N L+ K+ DFG SR V D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T +SDV+SFGV+L E+ T GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 75/312 (24%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIE-----QFINEVVILSQINHRHIVKL 393
+G+G +G VYK G +VA+K+ I + I E+ +L ++ H +IV+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK---IRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 394 LGCCLETEVP--VLVYEYI---CNGNLSHHIHDHQQQQEQ---KQELEEEQELSSLSWEN 445
+V+EY+ G L + Q + KQ LE
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE------------ 111
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
+ Y+HS+ I HRDIK SNIL+++ K++DFG +R +
Sbjct: 112 ----------GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158
Query: 506 TAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKP---------------IC 549
T T Y PE +++Y + D++S G +L EL GK +C
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218
Query: 550 LTREEEE----RNLVAYFISLA----KENKLLEILDARVAKEASEEDIEAVAELAMGCLR 601
+ +E L +F +L + +L E + A +L L
Sbjct: 219 GSPTDENWPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSA--------LDLLDKLLT 269
Query: 602 LNSKKRPTMKQV 613
L+ KKR + Q
Sbjct: 270 LDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 74/286 (25%), Positives = 131/286 (45%), Gaps = 42/286 (14%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
LG G +G VY+G+ VAVK K D ++E+F+ E ++ +I H ++V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
++ E++ GNL ++ + QE++++ + +A +++ A+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC-----------NRQEVNAVVL---LYMATQISSAME 118
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+ I HRD+ + N L+ + KV+DFG SR + D + + PE
Sbjct: 119 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLT-GKKP---ICLTREEEERNLVAYFISLAKENKLLE 574
++++ KSDV++FGV+L E+ T G P I L+ ++ E
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYE 216
Query: 575 ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
+L+ E E V EL C + N RP+ ++ E +
Sbjct: 217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 65/232 (28%), Positives = 115/232 (49%), Gaps = 20/232 (8%)
Query: 332 DNYNQSRFLGQGGFGTVYK----GMLP--DGSIVAVK--RSKAIDKTQIEQFINEVVILS 383
+N R +GQG FG V++ G+LP ++VAVK + +A Q + F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 63
Query: 384 QINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHD------HQQQQEQKQELEEEQE 437
+ +H +IVKLLG C + L++EY+ G+L+ + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
LS ++ +A +VA +AY+ + HRD+ + N L+ + K++DFG SR++
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 498 -PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
D + + PE ++YT +SDV+++GVVL E+ + G +P
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 75/295 (25%), Positives = 146/295 (49%), Gaps = 38/295 (12%)
Query: 330 ATDNYNQSRFLGQGGFGTVY----KGMLPDG--SIVAVK--RSKAIDKTQIEQFINEVVI 381
A + SR LGQG FG VY KG++ D + VA+K A + +IE F+NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASV 62
Query: 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
+ + N H+V+LLG + + +++ E + G+L ++ + + E+E +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL------RSLRPEMENNPVQAPP 116
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501
S + +++A E+A +AY++++ + HRD+ + N ++ + F+ K+ DFG +R + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDI-YET 172
Query: 502 THLTTAVQGTFG--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558
+ +G + PE + +T SDV+SFGVVL E+ T ++P
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----------- 221
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ ++ E L +++ + + + + + EL C + N K RP+ ++
Sbjct: 222 ----YQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 49/235 (20%)
Query: 340 LGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQI-----EQFIN-EVVILSQIN-HRHIV 391
+G+G F TV A+K +DK Q+ +++ E +L+++N H I+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKI---LDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
KL + E V EY NG L +I + SL + A
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKY----------------GSLDEKCTRFYAA 109
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ-- 509
E+ A+ Y+HS I HRD+K NILLD K++DFGT++ + + + +
Sbjct: 110 EILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 510 -----------------GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE SD+++ G ++ ++LTGK P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 52/285 (18%)
Query: 340 LGQGGFGTVYKGML--PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGC 396
LG G G V K +L P G I+AVK + I++ +Q + E+ IL + N +IV G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 397 CL-ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
++ + EY+ G+L + +E + + E L ++A V
Sbjct: 68 FYNNGDI-SICMEYMDGGSLD------KILKEVQGRIPERI----LG-----KIAVAVLK 111
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+ Y+H I HRD+K SNIL++ + K+ DFG S + N L GT Y
Sbjct: 112 GLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYM 166
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575
PE Q + Y+ KSD++S G+ L+EL TG+ P Y + + E+
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFP--------------YPPENDPPDGIFEL 212
Query: 576 LDARV--------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
L V + + S + + V CL + ++RP+ K+
Sbjct: 213 LQYIVNEPPPRLPSGKFSPDFQDFVNL----CLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 49/290 (16%)
Query: 340 LGQGGFGTVYKG--MLPDGSI--VAVKRSKAIDKTQI-EQFINEVVILSQINHRHIVKLL 394
LG G FG V +G G + VAVK K+ + I + F+ E I+ ++H ++++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G L T ++V E G+L + L A ++A
Sbjct: 63 GVVL-THPLMMVTELAPLGSLLDRLRKDA--------------LGHFLISTLCDYAVQIA 107
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT--F 512
+ Y+ S I HRD+ + NILL K+ DFG R++P ++ H F
Sbjct: 108 NGMRYLESKRFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 571
+ PE ++ ++ SDV+ FGV L E+ T G++P + L+ +
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP---------------WAGLSGS-Q 208
Query: 572 LLEILDARVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
+L+ +D + EA +DI V + C N RPT + L
Sbjct: 209 ILKKIDKEGERLERPEACPQDIYNV---MLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 31/290 (10%)
Query: 340 LGQGGFGTVYKGML------PDGSIVAVKRSK--AIDKTQIEQFINEVVILSQI-NHRHI 390
LG+G FG V K + S VAVK K A +K + ++E+ ++ I H++I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNI 78
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+ LLG C + +V EY +GNL + + E + +L+ ++ V A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQ 509
+VA + ++ AS HRD+ + N+L+ + K++DFG +R + + D TT +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 568
+ PE YT +SDV+SFGV+L E+ T G P EE L K
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLK 248
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
E +E + E + L C +RPT KQ+ DL+
Sbjct: 249 EGYRME----KPQNCTQE-----LYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 33/223 (14%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN-----EVVILSQIN 386
Y + + LG+G + VYK G IVA+K+ K ++ + + IN E+ +L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQ---QQQEQKQELEEEQELSSLSW 443
H +I+ LL LV+E+ +L I D + K + L +L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEF-METDLEKVIKDKSIVLTPADIKSYM-----LMTLR- 113
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
+ Y+HS+ I HRD+K +N+L+ K++DFG +RS +
Sbjct: 114 ------------GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158
Query: 504 LTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
+T V T Y PE F + Y D++S G + ELL
Sbjct: 159 MTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID----KTQIEQFINEVVILSQIN 386
D+Y +G G VY + LP+ VA+KR ID +T +++ EV +SQ N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCN 57
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H ++VK + + LV Y+ G+L I + +E +++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKSSY----PRGGLDEAIIAT------ 106
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHL 504
V EV + Y+HS+ I HRDIK+ NILL + S K++DFG S S+ D+T
Sbjct: 107 --VLKEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161
Query: 505 T-TAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKP 547
GT + PE + Y K+D++SFG+ +EL TG P
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 67/246 (27%), Positives = 123/246 (50%), Gaps = 35/246 (14%)
Query: 335 NQSRF---LGQGGFGTV----------YKGMLPDG-----SIVAVKRSKA-IDKTQIEQF 375
Q R LG+G FG V + G +VAVK +A + KT F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 376 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEE 435
+ E+ I+S++ + +I++LLG C+ + ++ EY+ NG+L+ + Q+E +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL----SQREIESTFTHA 120
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
+ S+S N + +A ++A + Y+ AS+ HRD+ + N L+ + ++ K++DFG SR
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 496 SVPNDKTHLTTAVQG----TFGYFDPEYFQSSQYTDKSDVYSFGVVLLEL--LTGKKPIC 549
++ + + +QG + E ++T SDV++FGV L E+ L ++P
Sbjct: 178 NLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
Query: 550 LTREEE 555
L +E+
Sbjct: 235 LLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 81/292 (27%), Positives = 141/292 (48%), Gaps = 42/292 (14%)
Query: 340 LGQGGFGTVYKGML-PDGSI--VAVKRSK-AI-DKTQIEQFINEVVILSQINHRHIVKLL 394
LG+G FG+V +G L D SI VAVK K AI ++++E F++E V + + +H ++++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 395 GCCLETE------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
G CL+T PV++ ++ +G+L H + + + Q L + V+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQYLPTQM---------LVK 116
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTA 507
++A + Y+ S + I HRD+ + N +L++ + V+DFG S+ + N D
Sbjct: 117 FMTDIASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 566
+ + E YT KSDV+SFGV + E+ T G+ P E + L
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYL 227
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
+ N+L + D ++ + L C LN K RP+ + + +LE
Sbjct: 228 RQGNRLKQPPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 29/226 (12%)
Query: 338 RFLGQGGFGTVYKGMLPD------GSI-VAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
FLG G FG VY+G D G I VAVK R A D+ + E F+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IVKLLG CL E ++ E + G+L ++ D + ++ L L L +
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLL----TLKEL-----LD 110
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-----KVSDFGTSRSV-PNDKT 502
+ +VA Y+ I HRD+ + N L+ +K K+ DFG +R + +D
Sbjct: 111 ICLDVAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T +SDV+SFGV++ E+LT G++P
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-----SKAIDKTQIEQFINEVVILSQIN 386
N+ + + LGQG FG VY D G +AVK+ K ++ E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H IV+ GC + E + EY+ G++ + + E Q L
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------- 115
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT- 505
V Y+HS+ I HRDIK +NIL D + K+ DFG S+ + + T
Sbjct: 116 ---------GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG 163
Query: 506 -TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+V GT + PE Y K+DV+S G ++E+LT K P
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 75/304 (24%), Positives = 151/304 (49%), Gaps = 48/304 (15%)
Query: 340 LGQGGFGTVY----KGMLP-------------DGSIVAVK--RSKAIDKTQIEQFINEVV 380
LG+G FG V+ +GM +VAVK R A +K F+ E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIK 71
Query: 381 ILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSS 440
I+S++ +I++LL C+ ++ ++ EY+ NG+L+ + H+ Q+ ++ ++ +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA-----DVVT 126
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 500
+S+ + +A ++A + Y+ +S+ HRD+ + N L+ ++ K++DFG SR++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 501 KTHLTTAVQG----TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPIC-LTRE 553
+ +QG + E ++T SDV++FGV L E+LT ++P L+ E
Sbjct: 184 DYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ N +F ++ L + A +++ +L + C R N+K+RP+ +++
Sbjct: 241 QVIENTGEFFRDQGRQVYLPK--PALCP--------DSLYKLMLSCWRRNAKERPSFQEI 290
Query: 614 SMDL 617
L
Sbjct: 291 HATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 30/226 (13%)
Query: 334 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKR------SKAIDKTQIEQFINEVVILSQINH 387
+ + LG+G +GTVY G+ G ++AVK+ + + + E+ EV +L + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+IV+ LG CL+ + E++ G++S L L +
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSIS-------------SILNRFGPLPEPVFCKYT 108
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-----SVPNDKT 502
+ ++ VAY+H++ + HRDIK +N++L K+ DFG +R + +
Sbjct: 109 K---QILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
++ ++ GT + PE S Y KSD++S G + E+ TGK P+
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 67/237 (28%), Positives = 118/237 (49%), Gaps = 36/237 (15%)
Query: 320 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAI------DKTQI 372
+I EL+R + LG G FGTVYKG+ +P+G V + + I K +
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 373 EQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL 432
E F++E +I++ ++H H+V+LLG CL + LV + + +G L ++H+H+ +
Sbjct: 55 E-FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL-- 110
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
L+W ++A + Y+ + HRD+ + N+L+ K++DFG
Sbjct: 111 -------LLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG 154
Query: 493 TSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+R + D K + + + E ++T +SDV+S+GV + EL+T G KP
Sbjct: 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN--EVVILSQINHRHI 390
Y + +G+G +G VYK G IVA+K+ K +++ E+ +L ++NH +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+KLL LV+E+ + +L I D Q+ L E + S ++
Sbjct: 61 IKLLDVFRHKGDLYLVFEF-MDTDLYKLIKDRQR------GLPESL-IKSYLYQ------ 106
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
+ +A+ HS I HRD+K N+L++ + K++DFG +RS + T V
Sbjct: 107 --LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-V 160
Query: 511 TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
T Y PE Y+ D++S G + ELL+ +
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 26/211 (12%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN--EVVILSQIN-HRHIVKLLG 395
LG G FG+VY G +VA+K+ K + E+ +N EV L ++N H +IVKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
E + V+EY GNL +Q +++K + E + S+ ++ +
Sbjct: 66 VFRENDELYFVFEY-MEGNL------YQLMKDRKGKPFSESVIRSIIYQ--------ILQ 110
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+A++H FHRD+K N+L+ K++DFG +R + + + T V T Y
Sbjct: 111 GLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYR 165
Query: 516 DPEYF-QSSQYTDKSDVYSFGVVLLELLTGK 545
PE +S+ Y+ D+++ G ++ EL T +
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLL 394
+G+G FG VYK + +VA+K ID + +IE E+ LSQ +I K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G L+ ++ EY G+ + K +E ++ + +R EV
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL---------KPGKLDETYIAFI-----LR---EVL 108
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514
+ Y+H I HRDIK++NILL ++ K++DFG S + + + T V GT +
Sbjct: 109 LGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFW 164
Query: 515 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 549
PE + S Y +K+D++S G+ +EL G+ P+
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 39/285 (13%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF--INEVVILSQINHRH 389
Y + R +G+G FG V+ D +V +K+ T+ E+ NE +L ++H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
I++ LE + ++V EY G L+ +I Q+ L+E+ L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFV------- 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ A+ ++H+ I HRD+K+ NILLD K K+ DFG S+ + + K+ T V
Sbjct: 109 --QILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV 162
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
GT Y PE + Y KSD+++ G VL EL + L R E NL A +
Sbjct: 163 -GTPCYISPELCEGKPYNQKSDIWALGCVLYELAS------LKRAFEAANLPALVL---- 211
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
K++ A ++ S + + +L + L L+ KRP + Q+
Sbjct: 212 --KIMSGTFAPISDRYSPD----LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
Y + +GQG GTVY + + G VA+K+ + + E INE++++ + H +IV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 451
L L + +V EY+ G+L+ + + E ++ C
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCR 122
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
E A+ ++HS+ I HRDIKS NILL S K++DFG + +++ +T V GT
Sbjct: 123 ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 67/292 (22%), Positives = 131/292 (44%), Gaps = 42/292 (14%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQ------FINEVVILSQI 385
+ + + LG G F + Y+ + G+++AVK+ + T EQ E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
NH HI+++LG E L E++ G++SH + + +E ++
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE------------AVI--- 105
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKT-- 502
+ ++ ++Y+H + I HRD+K +N+L+D +++DFG + + T
Sbjct: 106 -INYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 503 -HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
+ GT + PE + QY DV+S G V++E+ T K P E+ N +A
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLA 218
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ +I A A E + ++ + CL L + RP +++
Sbjct: 219 L---------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 333 NYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQINHR 388
Y +G+G G V+K G VA+K+ + Q + E+ L H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQACQHP 59
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
++VKLL VLV EY +LS + D EE+ L ++ +R
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEY-MPSDLSEVLRD------------EERPLPEAQVKSYMR 106
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+ + VAYMH++ I HRD+K +N+L+ K++DFG +R ++ L +
Sbjct: 107 MLLK---GVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160
Query: 509 QGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 544
T Y PE + + +Y D+++ G + ELL G
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 340 LGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 397
+G+G FG V+ G L D + VAVK + ++ +F+ E IL Q +H +IV+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ + +V E + G+ + E L + +++ A +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---------------RTEGPRLKVKELIQMVENAAAGM 107
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA--VQGTFGYF 515
Y+ S I HRD+ + N L+ +K K+SDFG SR D + +T Q +
Sbjct: 108 EYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWT 163
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLE 574
PE +Y+ +SDV+SFG++L E + G P ++ R E
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR----------------E 207
Query: 575 ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
++ V E +AV L C + +RP+ V +L
Sbjct: 208 AIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LG G FG V+ G + VAVK K E F+ E I+ ++ H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVV-- 70
Query: 400 TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+E P+ +V EY+ G+L + D + + +L N V +A +VA +A
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGR--------------ALKLPNLVDMAAQVAAGMA 116
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT---FGYF 515
Y+ I HRD++S+NIL+ D K++DFG +R + +++ TA QG +
Sbjct: 117 YIERMNYI---HRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWT 170
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE ++T KSDV+SFG++L EL+T G+ P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 340 LGQGGFGTVYK---GMLPD--GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLL 394
LG+G FG+V L D G +VAVK+ + + F E+ IL + H +IVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 395 GCCLETEVP--VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
G C LV EY+ G+L ++ H+++ + ++ L A +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL---------------YASQ 116
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG-- 510
+ + Y+ S + HRD+ + NIL++ + K+ DFG ++ +P DK + G
Sbjct: 117 ICKGMEYLGSKRYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 511 -TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
F Y PE S+++ SDV+SFGVVL EL T ++ + A F+ +
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGN 224
Query: 570 NK--------LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
+K L+E+L A + + C + +RP+ ++++ +E +R
Sbjct: 225 DKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 69/287 (24%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 340 LGQGGFGTVYKGMLP------DGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHRHIVK 392
LG+G FG V+ ++V VK K D+ +F E+ + +++H+++V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
LLG C E E ++ EY G+L + + + K E + LS+ + +V + +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFL----RATKSKDEKLKPPPLST---KQKVALCTQ 125
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+A + ++ ++ + HRD+ + N L+ + KVS S+ V N + +
Sbjct: 126 IALGMDHLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 571
+ PE Q ++ KSDV+SFGV++ E+ T G+ P F L+ E
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---------------FYGLSDEEV 227
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
L + ++ E + +L C +N K RP+ ++ L
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQI---EQFINEVVILSQINHRH 389
Y + +G+G FG +Y S V + + K + E EV++L+++ H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV E +V EY G+L I Q+ L E ++ LSW
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI------NRQRGVLFSEDQI--LSW------ 106
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+++ + ++H I HRDIKS NI L + AK+ DFG +R + ND L
Sbjct: 107 FVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTC 162
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE Q+ Y +K+D++S G VL EL T K P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 338 RFLGQGGFGTV----YKGMLPD-GSIVAVKRSKAIDKTQIEQ-FINEVVILSQINHRHIV 391
R LG+G FG V Y G +VAVK K Q + E+ IL + H +IV
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 392 KLLGCCLET--EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
K GCC E + L+ EY+ G+L ++ H L+ +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-----------------KLNLAQLLLF 112
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A ++ +AY+HS I HRD+ + N+LLD+ K+ DFG +++VP +
Sbjct: 113 AQQICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 510 G---TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543
G F ++ E + ++++ SDV+SFGV L ELLT
Sbjct: 170 GDSPVF-WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 64/213 (30%), Positives = 114/213 (53%), Gaps = 24/213 (11%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQI--EQFINEVVILSQINHRHIVKLLG 395
+ LG G FG V+ G VA+K AI++ + E FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIK---AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
C + + +V E++ NG L +++ ++++ +L ++ LS + +V
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL------RQRQGKLSKDMLLS---------MCQDVCE 111
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+ Y+ ++ I HRD+ + N L+ KVSDFG +R V +D+ ++ + +
Sbjct: 112 GMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE F S+Y+ KSDV+SFGV++ E+ T GK P
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 68/224 (30%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ 384
D++ + LG G FG V ML G A+K SKA + Q+E +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
I H +V L G + LV EY+ G L H+ + E
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-------RKSGRFPEPV-------- 102
Query: 445 NRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
R A +V A+ Y+HS I +RD+K N+LLD K++DFG ++ V
Sbjct: 103 --ARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T + GT Y PE S Y D ++ G+++ E+L G P
Sbjct: 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 83/298 (27%), Positives = 141/298 (47%), Gaps = 52/298 (17%)
Query: 332 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKAI-DKTQIEQFINEVVILSQ 384
+N + + LG G FG V + G+ ++ VAVK K ++ E ++E+ I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 385 I-NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+ NH +IV LLG C +++ EY C G+L + + +K+E S L+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-------RKRE-------SFLTL 140
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
E+ + + +VA +A++ S I HRD+ + N+LL K+ DFG +R + ND +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 504 LTTAVQGT----FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558
+ V+G + PE + YT +SDV+S+G++L E+ + G P
Sbjct: 198 V---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY------PGMP 248
Query: 559 LVAYFISLAKENKLLEILDARVAK--EASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614
+ + F L KE R+A+ A E + ++ C + KRPT KQ+
Sbjct: 249 VDSKFYKLIKEG-------YRMAQPEHAPAE----IYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LG G FG V+ G + VA+K K E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 400 TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
T+ P+ ++ EY+ NG+L + + E L+ + +A ++A +A
Sbjct: 71 TQEPIYIITEYMENGSLVDFL--------------KTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
++ I HRD++++NIL+ + K++DFG +R + +++ + + PE
Sbjct: 117 FIERKNYI---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEERNL 559
+T KSDV+SFG++L E++T G+ P +T E +NL
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 63/250 (25%), Positives = 117/250 (46%), Gaps = 34/250 (13%)
Query: 319 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRS-KAIDKTQIEQFI 376
A+I EL++ + LG G FGTV+KG+ +P+G + + + K I Q
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 377 NEV----VILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL 432
E+ + + ++H +IV+LLG C + LV + G+L H+ H+
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHR--------- 103
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
SL + + ++A + Y+ + HR++ + NILL +++DFG
Sbjct: 104 ------DSLDPQRLLNWCVQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFG 154
Query: 493 TSRSV-PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 550
+ + P+DK + + + + E +YT +SDV+S+GV + E+++ G +P
Sbjct: 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 551 TREEEERNLV 560
R E +L+
Sbjct: 215 MRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 74/295 (25%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 330 ATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVK--RSKAIDKTQIEQFINEVVI 381
+ + R LGQG FG VY+G D + VAVK A + +IE F+NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASV 62
Query: 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
+ H+V+LLG + + ++V E + +G+L ++ + + E E
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL------RSLRPEAENNPGRPPP 116
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501
+ + +++A E+A +AY+++ + HRD+ + N ++ F+ K+ DFG +R + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI-YET 172
Query: 502 THLTTAVQGTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558
+ +G + PE + +T SD++SFGVVL E+ + ++P
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----------- 221
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ L+ E L ++D + + E V +L C + N K RPT ++
Sbjct: 222 ----YQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ LG G FG V+ G + + VAVK K ++ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ E ++ EY+ G+L + + E + + + ++A +
Sbjct: 71 TKEEPIYIITEYMAKGSL--------------LDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
AY+ I HRD++++N+L+ + K++DFG +R + +++ + + P
Sbjct: 117 AYIERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
E +T KSDV+SFG++L E++T GK P
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 340 LGQGGFGTVYKG-MLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
+G G +G VYK + G +VA+K K E E+ +L + H +IV G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+ +V EY C G I+ Q + L E Q +++ V E +A
Sbjct: 71 RRDKLWIVMEY-CGGGSLQDIY-----QVTRGPLSELQ----IAY-----VCRETLKGLA 115
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ------GTF 512
Y+H + I HRDIK +NILL + K++DFG S LT + GT
Sbjct: 116 YLHETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTP 165
Query: 513 GYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKP 547
+ PE Y K D+++ G+ +EL + P
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF---INEVVILSQINHRH 389
+ R +G G FG VY + +VA+K+ K E++ I EV L Q+ H +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
++ GC L LV EY C G+ S + H K+ L+E V +
Sbjct: 77 TIEYKGCYLREHTAWLVMEY-CLGSASDILEVH------KKPLQE------------VEI 117
Query: 450 ACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
A GA+ AY+HS I HRDIK+ NILL + + K++DFG++ V + +
Sbjct: 118 AAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-- 172
Query: 507 AVQGTFGYFDPEY---FQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
GT + PE QY K DV+S G+ +EL K P+
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 340 LGQGGFGTVY---KGMLPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ +G +G V+ K G I A+K ++ I K Q++Q + E ILSQ ++VKL
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 394 LGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
+ + + LV EY+ G+L+ + + + SL + E
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLEN----------------VGSLDEDVARIYIAE 101
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-------SVPNDKTHLT 505
+ A+ Y+HS I HRD+K NIL+D K++DFG S+ ND
Sbjct: 102 IVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT Y PE ++ D +S G +L E L G P
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 6e-19
Identities = 80/298 (26%), Positives = 136/298 (45%), Gaps = 43/298 (14%)
Query: 338 RFLGQGGFGTVYKGMLP--DGSI--VAVKRSKA--IDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG+V + L DGS VAVK KA + IE+F+ E + + +H +++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 392 KLLGCCLETE------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
KL+G L + +P+++ ++ +G+L + + EE +L +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL--------LMSRIGEEP--FTLPLQT 114
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHL 504
VR ++A + Y+ S I HRD+ + N +L++ + V+DFG S+ + D
Sbjct: 115 LVRFMIDIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563
A + + E + YT SDV++FGV + E++T G+ P E + Y
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL 228
Query: 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
I K N+L + D +E V EL C K RP+ + + LE +
Sbjct: 229 I---KGNRLKQPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 33/295 (11%)
Query: 340 LGQGGFGTVYKGMLP-DGSIV--AVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLL 394
+G+G FG V + M+ DG + A+K K + F E+ +L ++ +H +I+ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G C + EY GNL + + + +E S+L+ + ++ A +VA
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTF 512
+ Y+ I HRD+ + N+L+ + ++K++DFG SR V KT V+
Sbjct: 130 TGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISLAKEN 570
+ E S YT KSDV+SFGV+L E+++ G P C +T E
Sbjct: 184 -WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---------------- 226
Query: 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625
L E L E + V EL C R +RP Q+S+ L + +++
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 59/217 (27%), Positives = 110/217 (50%), Gaps = 12/217 (5%)
Query: 340 LGQGGFGTVYKGML-----PDGSIVAVKRSKAIDKTQ-IEQFINEVVILSQINHRHIVKL 393
LG+ FG +YKG L +VA+K K I+ Q +F E ++++++H +IV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACE 452
LG + + +++EY+ G+L + + +E+ + SSL + + +A +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGT 511
+A + Y+ S + H+D+ + NIL+ ++ K+SD G SR + D +
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE +++ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 48/290 (16%)
Query: 340 LGQGGFGTVYKGMLPDG--SIVAVK----RSKAIDKTQ------IEQFINEVVIL-SQIN 386
LG G FG VYK + +++A+K + A K + I ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H +IV+ LE + +V + I L H +E+KQ EE+ W
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFTEER-----IWNIF 119
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
V++ A+ Y+H I HRD+ +NI+L + ++DFG ++ ++ LT+
Sbjct: 120 VQMVL----ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTS 172
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566
V GT Y PE ++ Y +K+DV++FG +L ++ T + P T +SL
Sbjct: 173 VV-GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----------MLSL 221
Query: 567 AKENKLLEILDARVAKEASEEDI--EAVAELAMGCLRLNSKKRPTMKQVS 614
A +I++A E E + E V ++ CL +++ RP + QVS
Sbjct: 222 A-----TKIVEAVY--EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LGQG FG V+ G + VA+K K E F+ E ++ ++ H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-- 70
Query: 400 TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+E P+ +V EY+ G+L + + + L V +A ++A +A
Sbjct: 71 SEEPIYIVTEYMSKGSL--------------LDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+ + HRD++++NIL+ + KV+DFG +R + +++ + + PE
Sbjct: 117 YVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKK---PICLTREEEERNLVAYFISLAKENKLLEI 575
++T KSDV+SFG++L EL T + P + RE +L+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------------------VLDQ 215
Query: 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
++ E E++ +L C R ++RPT + + LE
Sbjct: 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKR--SKAIDKTQIEQF-INEVVILSQINHRHIVKLLG 395
LG+GGFG V + G + A K+ K + K + EQ +NE IL +++ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 396 CCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 453
ET+ + LV + G+L +HI++ + E R A ++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---------------EARAIFYAAQI 104
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
+ ++H I +RD+K N+LLDD + ++SD G + + K GT G
Sbjct: 105 ICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPG 159
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557
Y PE Q Y D ++ G L E++ G+ P +E+ E+
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 340 LGQGGFGTVYKG---MLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLL 394
LG G FGTV KG M VAVK ++ D ++ + E ++ Q+++ +IV+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G C E E +LV E G L+ + ++ E+ N + +V+
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEK----------------NITELVHQVS 105
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF-- 512
+ Y+ + + HRD+ + N+LL + AK+SDFG S+++ D+ + G +
Sbjct: 106 MGMKYLEETNFV---HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV 162
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
++ PE +++ KSDV+SFGV++ E + G+KP
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 71/233 (30%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKAIDKTQIEQF-INEVVILSQINHRH 389
+ Q R LG+GGFG V + G + A K+ K I K + E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V L + LV + G+L HI+ + EE + V
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRA---------VFY 107
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A E+ + +H I +RD+K NILLDD ++SD G + VP +T
Sbjct: 108 AAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC-----LTREEEER 557
GT GY PE ++ +YT D ++ G +L E++ G+ P + REE ER
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 340 LGQGGFGTVYK-GMLPDGSIVAVKRSKAID-KTQI-EQFINEVVILSQINHRHIVKLLGC 396
LG G G+V K +P G+++A K+ I K+ + +Q + E+ I+ + +IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
L + E++ G+L I+ ++ + E ++A V
Sbjct: 72 FLNENNICMCMEFMDCGSLDR-IY---------------KKGGPIPVEILGKIAVAVVEG 115
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+ Y+++ I HRDIK SNIL++ + K+ DFG S + N + GT Y
Sbjct: 116 LTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMS 170
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 576
PE Q +YT KSDV+S G+ ++EL GK P + +++ I L++L
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI--------LDLL 222
Query: 577 DARVAKEA---SEEDIEAVAELAMG-CLRLNSKKRPTMKQV 613
V + D + CL + +RPT +Q+
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 79/300 (26%), Positives = 123/300 (41%), Gaps = 54/300 (18%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQI--EQFINEVVILSQINHRHIVKLLGC 396
+G+G +G V K G IVA+K+ K + + + + EV +L Q+ H +IV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
LV+EY L + + L + + S W+ + A
Sbjct: 69 FRRKGRLYLVFEY-VERTL------LELLEASPGGLPPD-AVRSYIWQ--------LLQA 112
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYF 515
+AY HS I HRDIK NIL+ + K+ DFG +R++ LT V T Y
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYR 168
Query: 516 DPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPI---------------CL------TRE 553
PE + Y DV++ G ++ ELL G +P+ CL +E
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227
Query: 554 EEERNLVAYFISLA-KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
N F +A E E L+ R + S ++ + CLR++ K+R T +
Sbjct: 228 LFSSN--PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLK----ACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 76/315 (24%), Positives = 130/315 (41%), Gaps = 37/315 (11%)
Query: 316 SEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKAIDKTQIEQ 374
S+ +K T ++ + N + +G G YKG + VK ++
Sbjct: 677 SKVSKSITINDILSSLKEEN---VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-SS 732
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
I + + ++ H +IVKL+G C + L++EYI NLS
Sbjct: 733 EIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS------------------ 771
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
+ L +LSWE R ++A +A A+ ++H S + ++ I++D K +
Sbjct: 772 -EVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554
+ D ++ Y PE ++ T+KSD+Y FG++L+ELLTGK P
Sbjct: 830 GLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEAS--EEDIEAVAELAMGCLRLNSKKRPTMKQ 612
++V + + L +D + + S + +I V LA+ C + RP
Sbjct: 885 HG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943
Query: 613 VSMDLEG-LRRSQRC 626
V LE R S C
Sbjct: 944 VLKTLESASRSSSSC 958
|
Length = 968 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 29/230 (12%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKAIDKTQIEQFINEVVILSQ 384
E + D + LG+G +G VY + +A+K D ++ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDH---QQQQEQKQELEEEQELSSL 441
+ HR+IV+ LG E + E + G+LS + + EQ +Q L L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPN 499
Y+H + I HRDIK N+L++ +S K+SDFGTS+ +
Sbjct: 122 K----------------YLHDNQ---IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAG 161
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKP 547
T GT Y PE Y +D++S G ++E+ TGK P
Sbjct: 162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 47/277 (16%)
Query: 358 IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415
+VAVK R A +K F+ EV ILS++ +I++LLG C++ + ++ EY+ NG+L
Sbjct: 48 LVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 416 SHHIHDHQ---QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472
+ + H +++ + L ++S+ + + VA ++A + Y+ +S+ HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 473 IKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDV 531
+ + N L+ + + K++DFG SR++ D + + E ++T SDV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 532 YSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASE--EDI 589
++FGV L E+L L KE E+ D +V + A E D
Sbjct: 224 WAFGVTLWEIL----------------------MLCKEQPYGELTDEQVIENAGEFFRDQ 261
Query: 590 -------------EAVAELAMGCLRLNSKKRPTMKQV 613
+ + EL + C + ++RP+ +
Sbjct: 262 GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 77/280 (27%), Positives = 128/280 (45%), Gaps = 42/280 (15%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
+G+G FG V +G G VAVK K D T + F+ E ++++++H+++V+LLG L
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC-DVTA-QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 459
+ + V E + GNL + + + +L ++ + +VA + Y
Sbjct: 71 NGLYI-VMELMSKGNLVNFLRTRGRALVSVIQL--------------LQFSLDVAEGMEY 115
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 519
+ S + HRD+ + NIL+ + AKVSDFG +R + V+ T PE
Sbjct: 116 LESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEA 168
Query: 520 FQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDA 578
+ +++ KSDV+S+GV+L E+ + G+ P Y KE K E ++
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAP--------------YPKMSLKEVK--ECVEK 212
Query: 579 RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
E E V L C KKRP+ ++ LE
Sbjct: 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLLG 395
+G+G FG V+KG+ D V K ID + +IE E+ +LSQ + ++ K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
L+ ++ EY+ G+ + + +E Q + L E+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--------RAGPFDEFQIATMLK---------EILK 112
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+ Y+HS I HRDIK++N+LL ++ K++DFG + + + + T V GT +
Sbjct: 113 GLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE Q S Y K+D++S G+ +EL G+ P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 340 LGQGGFGTVYKGML-PDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG GGFG V + A+K K ++ Q E +E IL + NH IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
+ + ++ EY G L + D +E + R +AC V
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-------FDE--------YTARFYIAC-VVL 104
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGY 514
A Y+H+ I +RD+K N+LLD K+ DFG ++ + + KT T GT Y
Sbjct: 105 AFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEY 158
Query: 515 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE + Y D +S G++L ELLTG+ P
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
DN+ + +G+G G V G VAVK+ + + E NEVVI+ H +I
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V++ L + +V E++ G L+ + + +EQ +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ------------------IATV 120
Query: 451 CE-VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG----TSRSVPNDKTHLT 505
C V A++++H+ I HRDIKS +ILL K+SDFG S+ VP K+
Sbjct: 121 CLAVLKALSFLHAQGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--- 174
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT + PE Y + D++S G++++E++ G+ P
Sbjct: 175 --LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 342 QGGFGTVYKGMLPDGSI-----VAVKRSK-AIDKTQIEQFINEVVILSQINHRHIVKLLG 395
+G FG ++ G+L D V VK K + Q+ + E +L ++H++I+ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 396 CCLE-TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
C+E E P ++Y Y+ GNL + Q+ L E +LS + V +A ++A
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFL--------QQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTFG 513
++Y+H + H+DI + N ++D++ K++D SR + P D L
Sbjct: 128 CGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ E + +Y+ SDV+SFGV+L EL+T G+ P
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-18
Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 39/291 (13%)
Query: 339 FLGQGGFGTVYKGMLPDGSI---VAVKRSKA-IDKTQIEQFINEVVILSQINHR-HIVKL 393
+G+G FG V K + + A+KR K K F E+ +L ++ H +I+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
LG C L EY +GNL + + + S+LS + + A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A + Y+ I HRD+ + NIL+ + + AK++DFG SR V+ T G
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMG 171
Query: 514 -----YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISL 566
+ E S YT SDV+S+GV+L E+++ G P C +T E
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------ 219
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
L E L E + V +L C R +RP+ Q+ + L
Sbjct: 220 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 94/327 (28%), Positives = 142/327 (43%), Gaps = 53/327 (16%)
Query: 340 LGQGGFGTVY--------KGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQI-NHR 388
LG+G FG V K VAVK + A DK + ++E+ ++ I H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHK 78
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQ----ELEEEQELSSLSWE 444
+I+ LLG C + ++ EY GNL ++ + +L EEQ L+++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ----LTFK 134
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTH 503
+ V A +VA + Y+ S I HRD+ + N+L+ + K++DFG +R V N D
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562
TT + + PE YT +SDV+SFGV+L E+ T G P EE
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------- 244
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAM---GCLRLNSKKRPTMKQVSMDLEG 619
L KE R+ K A+ EL M C +RPT KQ+ DL+
Sbjct: 245 LFKLLKEGH-------RMDKPAN-----CTHELYMIMRECWHAVPSQRPTFKQLVEDLD- 291
Query: 620 LRRSQRCLEIGKVNQLLTNEISLAQNS 646
R L + ++ L + Q S
Sbjct: 292 -----RVLTVTSTDEYLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVK-RSKAIDKTQIEQFINEVVILSQINH---R 388
Y + +G+G +G VY+G +P G +VA+K + + EV +LSQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+I K G L+ ++ EY G++ + L + ++ +R
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV--------------RTLMKAGPIAEKYISVIIR 108
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
EV A+ Y+H + HRDIK++NIL+ + + K+ DFG + + + + +T V
Sbjct: 109 ---EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 509 QGTFGYFDPEYFQSSQYTD-KSDVYSFGVVLLELLTGKKPIC 549
GT + PE +Y D K+D++S G+ + E+ TG P
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
LGQG FG V+ G + VA+K K E F+ E I+ ++ H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-- 70
Query: 400 TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+E P+ +V E++ G+L + +E + L V +A ++A +A
Sbjct: 71 SEEPIYIVTEFMGKGSL--------------LDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+ I HRD++++NIL+ D K++DFG +R + +++ + + PE
Sbjct: 117 YIERMNYI---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKK---PICLTREEEERNLVAYFISLAKENKLLEI 575
++T KSDV+SFG++L EL+T + P + RE +LE
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------------------VLEQ 215
Query: 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
++ + E++ EL C + + +RPT + + LE
Sbjct: 216 VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 71/251 (28%), Positives = 110/251 (43%), Gaps = 67/251 (26%)
Query: 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSKAI-DKTQIEQFINE 378
FTAE+L+ + +G+G FGTV K ML P G+I+AVKR ++ D+ + ++ + +
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMD 52
Query: 379 V-VILSQINHRHIVKLLGCCLETEVPVLVYE---YICN-------GNLSHHIHDHQQQQE 427
+ V++ + +IVK G L E +IC ++++
Sbjct: 53 LDVVMRSSDCPYIVKFYG--------ALFREGDCWICMELMDISLDKFYKYVYEV----- 99
Query: 428 QKQELEEEQELSSLSWENRVRVACEVAGAVAYM------HSSASIPIFHRDIKSSNILLD 481
K + E E+ G +A + + I HRD+K SNILLD
Sbjct: 100 LKSVIPE-----------------EILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD 142
Query: 482 DKFSAKVSDFGTSRSVPND--KTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGV 536
+ K+ DFG S + + KT G Y PE S Y +SDV+S G+
Sbjct: 143 RNGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSARDGYDVRSDVWSLGI 198
Query: 537 VLLELLTGKKP 547
L E+ TGK P
Sbjct: 199 TLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 76/263 (28%), Positives = 116/263 (44%), Gaps = 57/263 (21%)
Query: 311 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAI-- 367
SS SS + +A ++ + +G G GTVYK + P G + A+K I
Sbjct: 53 SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK---VIYG 109
Query: 368 --DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVPVLVYEYICNGNLS-HHI 419
+ T Q E+ IL +NH ++VK C + E+ VL+ E++ G+L HI
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEGTHI 164
Query: 420 HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479
D EQ L+ VA ++ +AY+H I HRDIK SN+L
Sbjct: 165 AD-------------EQFLAD--------VARQILSGIAYLHRRH---IVHRDIKPSNLL 200
Query: 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD---------KSD 530
++ + K++DFG SR + ++V GT Y PE TD D
Sbjct: 201 INSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN----TDLNHGAYDGYAGD 255
Query: 531 VYSFGVVLLELLTGKKPICLTRE 553
++S GV +LE G+ P + R+
Sbjct: 256 IWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLLG 395
+G+G FG VYKG+ D V K ID + +IE E+ +LSQ + +I + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
L+ ++ EY+ G+ + + LEE + L E+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--------KPGPLEETYIATILR---------EILK 112
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+ Y+HS I HRDIK++N+LL ++ K++DFG + + + + T V GT +
Sbjct: 113 GLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE + S Y K+D++S G+ +EL G+ P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 75/287 (26%), Positives = 137/287 (47%), Gaps = 54/287 (18%)
Query: 340 LGQGGFGTVYKGMLPD--GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G+G FG V ML D G+ VAVK K D T + F+ E +++Q+ H ++V+LLG
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIKN-DATA-QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+E + + +V EY+ G+L ++ + S L + ++ + +V A
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--------------SVLGGDCLLKFSLDVCEA 114
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+ Y+ ++ + HRD+ + N+L+ + AKVSDFG ++ + + V+ T
Sbjct: 115 MEYLEANNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----A 167
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEI 575
PE + +++ KSDV+SFG++L E+ + G+ P L ++
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------------------PRIPLKDV 208
Query: 576 LDARVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
+ RV K +A + V ++ C L++ RP+ Q+ LE
Sbjct: 209 V-PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 338 RFLGQGGFGTV----YKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVK 392
+ LG+G FG V KG ++ +K+ + +E + E +L+ H + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 393 LLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-A 450
L C +T+ + V EY+ G+L HI Q+ E R R A
Sbjct: 61 LH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFD--------------EPRARFYA 102
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQ 509
E+ + ++H I +RD+K N+LLD + K++DFG + + T T+
Sbjct: 103 AEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
GT Y PE Y D ++ GV+L E+L G+ P E+E
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 334 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKAIDKTQIEQF-INEVVILSQINHRH 389
+ Q R LG+GGFG V + G + A KR K I K + E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V L + LV + G+L HI++ EEE+ L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALF---------Y 107
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A E+ + +H ++ +RD+K NILLDD ++SD G + +P +
Sbjct: 108 AAEILCGLEDLHRENTV---YRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRV 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
GT GY PE + +YT D + G ++ E++ G+ P +E+ +R V
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
Y + +GQG GTVY + + G VA+K+ + + E INE++++ + + +IV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 451
L L + +V EY+ G+L+ + + E ++ C
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCR 122
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
E A+ ++HS+ + HRDIKS NILL S K++DFG + +++ +T V GT
Sbjct: 123 ECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 39/290 (13%)
Query: 340 LGQGGFGTVYKGMLPDGSI---VAVKRSKA-IDKTQIEQFINEVVILSQIN-HRHIVKLL 394
+G+G FG V K + + A+KR K K F E+ +L ++ H +I+ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G C L EY +GNL + + + S+LS + + A +VA
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG- 513
+ Y+ I HRD+ + NIL+ + + AK++DFG SR V+ T G
Sbjct: 135 RGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKTMGR 184
Query: 514 ----YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISLA 567
+ E S YT SDV+S+GV+L E+++ G P C +T E L +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 240
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
R+ K + +D V +L C R +RP+ Q+ + L
Sbjct: 241 -----------RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 60/250 (24%)
Query: 330 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF----INEVVILSQ 384
+Y LG+G FG VYK + G +VA+K K + + + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKK 63
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL-----EEEQELS 439
+ H ++V L+ + E + + ++ + + +LS
Sbjct: 64 LKHPNVVPLID---------MAVER------------PDKSKRKRGSVYMVTPYMDHDLS 102
Query: 440 SLSWENRVRVACEVAGA----------VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489
L V++ + + Y+H + I HRDIK++NIL+D++ K++
Sbjct: 103 GLLENPSVKL--TESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIA 157
Query: 490 DFGTSR----SVPNDK------THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVL 538
DFG +R PN K T T + T Y PE +YT D++ G V
Sbjct: 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217
Query: 539 LELLTGKKPI 548
E+ T +PI
Sbjct: 218 AEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKAIDKTQIEQF-INEVVILSQINHRH 389
+ R LG+GGFG V + G + A K+ K I K + E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V L + LV + G+L HI++ +EE+ V
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-----FDEERA---------VFY 107
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A E+ + +H I +RD+K NILLDD ++SD G + +P +T
Sbjct: 108 AAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI-----CLTREEEER 557
GT GY PE ++ +YT D + G ++ E++ GK P + REE ER
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 60/222 (27%), Positives = 111/222 (50%), Gaps = 27/222 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKR-SKAIDKTQIEQFINEVVILSQINH 387
+ + + LG G FGTVYKG+ +P+G VA+K +A ++ ++E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
H+ +LLG CL + V L+ + + G L ++ +H+ Q L L+W
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYL--------LNW---- 114
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND-KTHLTT 506
++A + Y+ + HRD+ + N+L+ K++DFG ++ + D K +
Sbjct: 115 --CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ + E YT +SDV+S+GV + EL+T G KP
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 84/307 (27%), Positives = 134/307 (43%), Gaps = 47/307 (15%)
Query: 332 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVI 381
D + LG+G FG V K + VAVK + A +K + ++E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEM 73
Query: 382 LSQI-NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQ----ELEEEQ 436
+ I H++I+ LLG C + ++ EY GNL ++ + + + +EQ
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496
+++++ V +VA + Y+ S I HRD+ + N+L+ + K++DFG +R
Sbjct: 134 ----MTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARD 186
Query: 497 VPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREE 554
V N D TT + + PE YT +SDV+SFGV++ E+ T G P E
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAM---GCLRLNSKKRPTMK 611
E L KE R+ K A+ EL M C RPT K
Sbjct: 247 E-------LFKLLKEGH-------RMDKPAN-----CTNELYMMMRDCWHAIPSHRPTFK 287
Query: 612 QVSMDLE 618
Q+ DL+
Sbjct: 288 QLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 340 LGQGGFGTVYKG---MLPDGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG G FG V KG M VA+K K +K+ ++ + E I+ Q+++ +IV+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
C E E +LV E G L+ + + + ++ N V + +V+
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE---------------ITVSNVVELMHQVSM 106
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF--G 513
+ Y+ + HRD+ + N+LL ++ AK+SDFG S+++ D ++ G +
Sbjct: 107 GMKYLEGKNFV---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
++ PE +++ +SDV+S+G+ + E + G+KP
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 87/309 (28%), Positives = 139/309 (44%), Gaps = 41/309 (13%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYK----GMLPDG----SIVAVK--RSKAIDKTQIEQF 375
E+ R D + LG+G FG V G+ + + VAVK +S A +K +
Sbjct: 14 EVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDL 70
Query: 376 INEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
I+E+ ++ I H++I+ LLG C + ++ EY GNL ++ + +
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
+ LS+++ V A +VA + Y+ S I HRD+ + N+L+ + K++DFG +
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLA 187
Query: 495 RSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTR 552
R + + D TT + + PE YT +SDV+SFGV+L E+ T G P
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 553 EEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAM---GCLRLNSKKRPT 609
EE L KE R+ K ++ EL M C +RPT
Sbjct: 248 VEE-------LFKLLKEGH-------RMDKPSN-----CTNELYMMMRDCWHAVPSQRPT 288
Query: 610 MKQVSMDLE 618
KQ+ DL+
Sbjct: 289 FKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIV 391
+ +G G FG V G L VA+K KA +K Q F++E I+ Q +H +I+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNII 68
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
L G +++ ++V EY+ NG+L + H Q +++
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF------------------TVIQLVG 110
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+ G + M + + HRD+ + NIL++ KVSDFG SR + +D T G
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 512 FG--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T SDV+S+G+V+ E+++ G++P
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLLG 395
+G+G FG V+KG+ D V K ID + +IE E+ +LSQ + ++ K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
L+ ++ EY+ G+ + + L+E Q + L E+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQIATILR---------EILK 112
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+ Y+HS I HRDIK++N+LL + K++DFG + + + + T V GT +
Sbjct: 113 GLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575
PE + S Y K+D++S G+ +EL G+ P E + + + K N
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPP------HSELHPMKVLFLIPKNNP--PT 220
Query: 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
L+ +K + E CL RPT K++
Sbjct: 221 LEGNYSK--------PLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 25/225 (11%)
Query: 340 LGQGGFGTVYK----GMLPD----GSIVAVK--RSKAIDKTQIEQFINEVVILSQIN-HR 388
LG+G FG V + G+ VAVK + A DK + I+E+ ++ I H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEMELMKLIGKHK 78
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQ----ELEEEQELSSLSWE 444
+I+ LLG C + ++ EY GNL + + ++ EEQ LS++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ----LSFK 134
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTH 503
+ V A +VA + Y+ S I HRD+ + N+L+ + K++DFG +R V + D
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
T+ + + PE YT +SDV+SFG+++ E+ T G P
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
Y + +GQG GTV+ + + G VA+K+ + + E INE++++ ++ + +IV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 451
L L + +V EY+ G+L+ + + + Q + C
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ------------------IAAVCR 122
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
E A+ ++H++ + HRDIKS N+LL S K++DFG + +++ +T V GT
Sbjct: 123 ECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
Y + +GQG GTVY M + G VA+++ + + E INE++++ + + +IV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 451
L L + +V EY+ G+L+ + + E ++ C
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCR 123
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
E A+ ++HS+ + HRDIKS NILL S K++DFG + +++ +T V GT
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKR-SKAI--DKTQIEQFINEVVILSQINHRHIVKLLG 395
+GQGG+G V+ D G IVA+KR K++ ++ + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEVA 454
+ E L EY+ G+ +++ L LS E+ R E+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNN----------------LGVLS-EDHARFYMAEMF 111
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514
AV +H + HRD+K N L+D K++DFG S+ + +V G+ Y
Sbjct: 112 EAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDY 164
Query: 515 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC-LTREEEERNL 559
PE + Y D +S G +L E L G P T E NL
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 68/239 (28%), Positives = 103/239 (43%), Gaps = 58/239 (24%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQ 384
R+ + + +G+G +G VY+ G IVA+K+ D I + E+ +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLN 62
Query: 385 INHRHIVKLLGCCLETEVPV--------LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQ 436
+ H +IV+L EV V LV EY C EQ
Sbjct: 63 LRHPNIVELK------EVVVGKHLDSIFLVMEY-C-----------------------EQ 92
Query: 437 ELSSLSWENRVR------VAC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487
+L+SL +N V C ++ + Y+H + I HRD+K SN+LL DK K
Sbjct: 93 DLASL-LDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148
Query: 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
++DFG +R+ +T V T Y PE + YT D+++ G +L ELL K
Sbjct: 149 IADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGC 396
+G+G +G VYK G +VA+K I ++ +I++ N + S NH +I G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--NHPNIATFYGA 71
Query: 397 CLETEVPV------LVYEYICNG----NLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
++ P LV E C G +L + + + L+EE +++ R
Sbjct: 72 FIKKNPPGNDDQLWLVMEL-CGGGSVTDLVKGLRK------KGKRLKEEW----IAYILR 120
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
E +AY+H + I HRDIK NILL K+ DFG S + + T
Sbjct: 121 -----ETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 507 AVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPIC 549
+ GT + PE + Y +SDV+S G+ +EL GK P+C
Sbjct: 173 FI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 72/220 (32%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF---INEVVILSQINHRHIVKLLG 395
+G G FG VY +VAVK+ K E++ I EV L Q+ H + ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
C L+ LV EY C G+ S + H K+ L+E V +A G
Sbjct: 89 CYLKEHTAWLVMEY-CLGSASDLLEVH------KKPLQE------------VEIAAITHG 129
Query: 456 AV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT-SRSVPNDKTHLTTAVQGT 511
A+ AY+HS I HRDIK+ NILL + K++DFG+ S+S P + GT
Sbjct: 130 ALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGT 180
Query: 512 FGYFDPEY---FQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+ PE QY K DV+S G+ +EL K P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 75/250 (30%), Positives = 112/250 (44%), Gaps = 40/250 (16%)
Query: 309 RLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAI 367
R S E A++F E+ ++ + R +G G FG VY + +VA+K+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS 61
Query: 368 DKTQIEQF---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQ 424
K E++ I EV L +I H + ++ GC L LV EY C G+ S + H
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVH-- 118
Query: 425 QQEQKQELEEEQELSSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLD 481
K+ L+E V +A GA+ AY+HS I HRDIK+ NILL
Sbjct: 119 ----KKPLQE------------VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLT 159
Query: 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY---FQSSQYTDKSDVYSFGVVL 538
+ K++DFG++ + + GT + PE QY K DV+S G+
Sbjct: 160 EPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214
Query: 539 LELLTGKKPI 548
+EL K P+
Sbjct: 215 IELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/219 (27%), Positives = 113/219 (51%), Gaps = 29/219 (13%)
Query: 338 RFLGQGGFGTVYKGM-LPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHI 390
+ LG G FGTVYKG+ +PDG VA+K R K ++ ++E +++ + ++
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYV 71
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+LLG CL + V LV + + G L ++ +++ + Q+L L+W
Sbjct: 72 CRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GSQDL--------LNW------C 115
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQ 509
++A ++Y+ + + HRD+ + N+L+ K++DFG +R + D+T + +
Sbjct: 116 VQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ E ++T +SDV+S+GV + EL+T G KP
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQI-EQFINEVV-------ILSQINHRHIV 391
LG+G FGTVY ++ D VA +R K + + + E NE V +LS+++H IV
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
K LE + ++ EY +L + +E K + E W
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKL------EELKHTGKTLSENQVCEW------FI 113
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++ V YMH I HRD+K+ NI L + K+ DFG SR + L T GT
Sbjct: 114 QLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGT 168
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566
Y PE + Y KSD++S G +L E+ CL E +N ++ + +
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM------CCLAHAFEGQNFLSVVLRI 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHR 388
N+ + +G+G F VY+ L DG VA+K+ + +D I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+++K +E +V E G+LS I ++Q+ E W+ V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE--------KTVWKYFV- 113
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ A+ +MHS + HRDIK +N+ + K+ D G R + KT ++
Sbjct: 114 ---QLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL 166
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE + Y KSD++S G +L E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 15/229 (6%)
Query: 333 NYNQSRF---LGQGGFGTVYKGML----PDGSIVAVKRSKAIDKTQI---EQFINEVVIL 382
N + RF LG+ FG VYKG L P AV DK + E+F +E ++
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
S++ H +IV LLG + + +++ Y + +L + + +++ S+L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDK 501
+ V + ++A + ++ S + H+D+ + N+L+ DK + K+SD G R V D
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC 549
L + PE +++ SD++S+GVVL E+ + G +P C
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 338 RFLGQGGFGTVYKG-MLPDGSIVAVKRSKA---IDKTQIEQFINEVVILS-QINHRHIVK 392
R LG+G FG V + G + AVK K + +E + E ILS NH + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
L C + V E++ G+L HI ++ E + A E
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF----------------YAAE 104
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGT 511
+ A+ ++H I +RD+K N+LLD + K++DFG + + N KT T+ GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGT 159
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
Y PE Q Y D ++ GV+L E+L G P E++
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
LG G FG VYK + G++ A K + + ++E ++ E+ IL+ NH +IVKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAV 457
++ E+ C G I LE ++ L+ E +++V C ++ A+
Sbjct: 80 WDGKLWIMIEF-CPGGAVDAIM-----------LELDRGLT----EPQIQVICRQMLEAL 123
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFD 516
Y+H S+ I HRD+K+ N+LL K++DFG S N KT + GT +
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMA 178
Query: 517 PEY-----FQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE + + Y K+D++S G+ L+E+ + P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 75/282 (26%), Positives = 117/282 (41%), Gaps = 40/282 (14%)
Query: 334 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKAIDKTQIEQF-INEVVILSQINHRH 389
+ R LG+GGFG V + G + A K+ K I K + E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V L + LV + G+L HI++ + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--------------PGFDEQRAIFY 107
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A E+ + + I +RD+K NILLDD+ ++SD G + +P +T
Sbjct: 108 AAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
GT GY PE + +YT D + G ++ E++ G+ P +E +R
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR------------ 210
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611
E +D RV KE EE E +E A R+ K P +
Sbjct: 211 ----EEVDRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 340 LGQGGFGTVYKGML-PDG---SIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLL 394
+G G FG V +G L G VA+K K+ + Q F++E I+ Q +H +I+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
G ++ +++ E++ NG L + + Q + + +R
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ------------FTVIQLVGMLR------ 113
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH--LTTAVQGTF 512
G A M + + HRD+ + NIL++ KVSDFG SR + +D + T+++ G
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 513 G--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T SDV+S+G+V+ E+++ G++P
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 47/236 (19%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF----INEVVILS 383
R+ D Y + + +G +G VY+ G IVA+K+ K ++K + E F + E+ IL
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEK-EKEGFPITSLREINILL 59
Query: 384 QINHRHIVKLLGCCLETEVPV--------LVYEYICNG--NLSHHIHDHQQQQEQKQELE 433
++ H +IV + EV V +V EY+ + +L + Q E K +
Sbjct: 60 KLQHPNIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493
Q LS VA++H + I HRD+K+SN+LL+++ K+ DFG
Sbjct: 114 --QLLS----------------GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL 152
Query: 494 SRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+R + T V T Y PE + +Y+ D++S G + ELLT KKP+
Sbjct: 153 AREYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 65/226 (28%), Positives = 91/226 (40%), Gaps = 48/226 (21%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 397
LG+G G+V K L + G I A+K ++ Q + E+ I +IVK G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR---VRVACEVA 454
L+ + E E L S+ + + R+ +V
Sbjct: 69 LD---------------------ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL 107
Query: 455 GAVA--------YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
G +A Y+HS I HRDIK SNILL K K+ DFG S L
Sbjct: 108 GKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS-------GELVN 157
Query: 507 AVQGTFG----YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
++ GTF Y PE Q Y+ SDV+S G+ LLE+ + P
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 397
LG G GTVYK L I+AVK +++ Q ++E+ IL + + +I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ E++ G+L + E L R+A V +
Sbjct: 69 FVENRISICTEFMDGGSLDVY------------RKIPEHVLG--------RIAVAVVKGL 108
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
Y+ S + I HRD+K SN+L++ + K+ DFG S + N + GT Y P
Sbjct: 109 TYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAP 162
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
E QY SDV+S G+ +EL G+ P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
LG G FG VYK + G A K + + ++E F+ E+ ILS+ H +IV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAV 457
++ E+ G L + LE E+ L+ E ++R C ++ A+
Sbjct: 73 YENKLWILIEFCDGGALDSIM------------LELERGLT----EPQIRYVCRQMLEAL 116
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
++HS I HRD+K+ NILL K++DFG S + T + GT + P
Sbjct: 117 NFLHSHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAP 172
Query: 518 EY-----FQSSQYTDKSDVYSFGVVLLELLTGKKP 547
E F+ + Y K+D++S G+ L+EL + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK---AIDKTQIEQFINEVVILSQINHR 388
N+ + +G+G F VY+ L D VA+K+ + +D + + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+++K L +E +V E G+LS I ++Q+ L E+ + W+ V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR----LIPERTV----WKYFV- 113
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ AV +MHS + HRDIK +N+ + K+ D G R + KT ++
Sbjct: 114 ---QLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL 166
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE + Y KSD++S G +L E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 31/197 (15%)
Query: 356 GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415
G VAVK + + E NEVVI+ H+++V++ L E ++ E++ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE-VAGAVAYMHSSASIPIFHRDIK 474
+ + + L EEQ + CE V A+ Y+HS I HRDIK
Sbjct: 106 TDIV--------SQTRLNEEQ----------IATVCESVLQALCYLHSQGVI---HRDIK 144
Query: 475 SSNILLDDKFSAKVSDFG----TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSD 530
S +ILL K+SDFG S+ VP K+ + GT + PE + Y + D
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEVISRTPYGTEVD 199
Query: 531 VYSFGVVLLELLTGKKP 547
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 340 LGQGGFGTV----YKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN---HRHIVK 392
LG+G FG V YK +I A+K+ I + ++E + E I N H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 393 LLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
L C +TE V V EY G+L HIH + + A
Sbjct: 67 LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-----------------FYAA 108
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHLTTAVQ 509
V + Y+H + I +RD+K N+LLD + K++DFG + D+ T+
Sbjct: 109 CVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFC 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
GT + PE + YT D + GV++ E+L G+ P EEE
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 75/284 (26%)
Query: 332 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKA-IDKTQIEQFINEVVILSQ 384
DN + LG G FG V + G+ + ++ VAVK KA + E ++E+ ILS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 385 I-NHRHIVKLLGCCLETEVPVLVY-EYICNGNL---------------------SHHIHD 421
+ H++IV LLG C PVLV EY C G+L S D
Sbjct: 98 LGQHKNIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSD 156
Query: 422 HQQQQEQKQELEEEQELSSLSWENRV---------------------------------R 448
++ +K+ + + SS + V R
Sbjct: 157 YKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLR 216
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+ +VA + ++ S I HRD+ + N+LL D AK+ DFG +R + ND ++ V
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---V 270
Query: 509 QGT----FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+G + PE YT +SDV+S+G++L E+ + GK P
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 74/244 (30%), Positives = 107/244 (43%), Gaps = 52/244 (21%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQF----INEVVIL 382
+R D ++ +G+G +G VYK D G +VA+K+ + + E F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKIL 60
Query: 383 SQINHRHIVKLLGCCLETEVPV----------LVYEY-------ICNGNLSHHIHDHQQQ 425
Q+NHR+IV L + + + LV+EY + L H DH +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 426 QEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485
KQ LE + Y H HRDIK SNILL++K
Sbjct: 121 F-MKQLLE----------------------GLNYCHKKN---FLHRDIKCSNILLNNKGQ 154
Query: 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTG 544
K++DFG +R ++++ T T Y PE + Y DV+S G +L EL T
Sbjct: 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT- 213
Query: 545 KKPI 548
KKPI
Sbjct: 214 KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 76/327 (23%)
Query: 340 LGQGGFGTVYK------GMLPDGSIVAVKRSKAIDKTQIEQ--FINEVVILSQI-NHRHI 390
LG+G FG V + VAVK K T E + E+ IL I +H ++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGHHLNV 73
Query: 391 VKLLGCCLETEVPVLV-YEYICNGNLSHHIHDHQ-----------QQQEQKQELEEEQEL 438
V LLG C + P++V EY GNLS+++ + +++E KQ+ ++Q L
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 439 SS----------------------------------LSWENRVRVACEVAGAVAYMHSSA 464
S L+ E+ + + +VA + ++ S
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193
Query: 465 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA-VQGTFGYFDPEYFQSS 523
I HRD+ + NILL + K+ DFG +R + D ++ + + PE
Sbjct: 194 CI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 524 QYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAK 582
YT +SDV+SFGV+L E+ + G P + +EE F KE
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG---------TRM 295
Query: 583 EASEEDIEAVAELAMGCLRLNSKKRPT 609
A E + + + C N + RPT
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 333 NYNQSRFLGQGGFGT--VYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
YN R +G+G FG + + + D + + +E E V+L+++ H +I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V +V EY G+L I Q+ +L E + L W
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKL------QRGKLFPEDTI--LQW------F 106
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
++ V ++H + HRDIKS NI L K+ DFG++R + + + T V G
Sbjct: 107 VQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T Y PE +++ Y +KSD++S G +L EL T K P
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 67/252 (26%), Positives = 97/252 (38%), Gaps = 55/252 (21%)
Query: 332 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQINH 387
D++ + +G+G FG V+ G + A+K S I + QI E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNL-SHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
IVKL + E LV EY+ G+L + I K EE R
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--------KDVFPEE--------TAR 104
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS------------ 494
+A E+ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 105 FYIA-ELVLALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 495 -----------------RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV 537
R + + V GT Y PE + + Y + D +S GV+
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 538 LLELLTGKKPIC 549
L E+L G P
Sbjct: 220 LYEMLYGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 49/236 (20%)
Query: 339 FLGQGGFGTVYKGM-LPDGSIVAVKRSKAI----DKTQIEQFIN----------EVVILS 383
LG+G +G V K G IVA+K+ K I D T+ Q + E+ I++
Sbjct: 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 384 QINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+I H +I+ L+ +E + LV + + +L + + E + + Q L+ L+
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLN- 133
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
+H HRD+ +NI ++ K K++DFG +R
Sbjct: 134 ---------------VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 504 LTTAVQG-------------TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
T + T Y PE + +Y D++S G + ELLTGK
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ LG G FG V+ + VAVK K +E F+ E ++ + H +VKL
Sbjct: 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
T+ P+ ++ E++ G+L + K + +Q L L + + ++A
Sbjct: 71 --TKEPIYIITEFMAKGSLLDFL---------KSDEGSKQPLPKL-----IDFSAQIAEG 114
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+A++ I HRD++++NIL+ K++DFG +R + +++ + +
Sbjct: 115 MAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE +T KSDV+SFG++L+E++T G+ P
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSK-AIDKTQIEQFIN----EVVILSQIN 386
N+ + LG+G FG VY D G +AVK+ D + + +N E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 387 HRHIVKLLGCCLETEVPVL--VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H IV+ GC + E L EY+ G++ K +L+ L+ E
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI-------------KDQLKAYGALT----E 105
Query: 445 NRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
N R ++ V+Y+HS+ I HRDIK +NIL D + K+ DFG S+ +
Sbjct: 106 NVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 504 LT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T +V GT + PE Y K+DV+S ++E+LT K P
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSK-AIDKTQIEQFIN----EVVILSQIN 386
N+ + LGQG FG VY D G +AVK+ + + + + +N E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 387 HRHIVKLLGCCLETEVPVL--VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H IV+ GC + L E++ G++ K +L+ L+ E
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI-------------KDQLKSYGALT----E 105
Query: 445 NRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
N R ++ V+Y+HS+ I HRDIK +NIL D + K+ DFG S+ +
Sbjct: 106 NVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162
Query: 504 LT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T +V GT + PE Y K+D++S G ++E+LT K P
Sbjct: 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 338 RFLGQGGFGTV----YKGMLPDG----SIVAVKRSKAIDK-TQIEQFINEVVILSQINHR 388
R LG+G FG V Y P+G VAVK K I E+ IL + H
Sbjct: 10 RDLGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 389 HIVKLLGCCLET--EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+IVK G C E L+ E++ +G+L ++ ++ + KQ+L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL-------------- 112
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
+ A ++ + Y+ S + HRD+ + N+L++ + K+ DFG ++++ DK + T
Sbjct: 113 -KYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 507 A--VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543
+ ++ PE S++ SDV+SFGV L ELLT
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 340 LGQGGFGTVYKGMLPDG----SIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG+G FG V L +I A+K+ ++ +E + E +L+ + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 396 CCLETEVPVL-VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 453
C +T+ + V EY+ G+L HI Q + + R R A E+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEA------------RARFYAAEI 105
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
+ ++H I +RD+K N+LLD K++DFG + N + +T GT
Sbjct: 106 ICGLQFLHKKGII---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPD 161
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
Y PE + +Y + D +SFGV+L E+L G+ P E+E
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
DN+ + +G+G G V + G +VAVK+ + + E NEVVI+ H ++
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V++ L + +V E++ G L+ + + +EQ V
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-----------------VC 122
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG----TSRSVPNDKTHLTT 506
V A++ +H+ I HRDIKS +ILL K+SDFG S+ VP K+
Sbjct: 123 LAVLKALSVLHAQGVI---HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS---- 175
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT + PE Y + D++S G++++E++ G+ P
Sbjct: 176 -LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 69/242 (28%), Positives = 111/242 (45%), Gaps = 40/242 (16%)
Query: 317 EKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF 375
+ A++F ++ ++ ++ R +G G FG VY + + +VA+K+ K E++
Sbjct: 3 DVAELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 376 ---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL 432
I EV L ++ H + ++ GC L LV EY C G+ S + H K+ L
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVH------KKPL 112
Query: 433 EEEQELSSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489
+E V +A GA+ AY+HS I HRD+K+ NILL + K+
Sbjct: 113 QE------------VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLG 157
Query: 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEY---FQSSQYTDKSDVYSFGVVLLELLTGKK 546
DFG++ + + GT + PE QY K DV+S G+ +EL K
Sbjct: 158 DFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 547 PI 548
P+
Sbjct: 213 PL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQINH 387
D+ + + +G G FG V+ A+K + I Q + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
I++L + ++ EY+ G L ++ +S + N
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR------------------NSGRFSNST 102
Query: 448 RV--ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
+ A E+ A+ Y+HS I +RD+K NILLD + K++DFG ++ + D+T
Sbjct: 103 GLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW-- 156
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT Y PE QS + D ++ G+++ E+L G P
Sbjct: 157 -TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 38/223 (17%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
R LG G FG + +G L S VA+ R+ DK + F+ E + L Q +H +IV
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSNIV 69
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L G ++V EY+ NG L + H+ Q L Q + L
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ------LVAGQLMGMLP--------- 114
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+A + Y+ + + H+ + + +L++ K+S F R + DK+ A+ T
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSE---AIYTT 165
Query: 512 FG------YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE Q ++ SDV+SFG+V+ E+++ G++P
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGC 396
LG G FG VYK + ++A +K ID + ++E ++ E+ IL+ +H +IVKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAG 455
++ E+ G + + LE E+ L+ E ++RV C +
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVM------------LELERPLT----EPQIRVVCKQTLE 114
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGY 514
A+ Y+H + I HRD+K+ NIL K++DFG S N +T + GT +
Sbjct: 115 ALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYW 169
Query: 515 FDPEYF-----QSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE + Y K+DV+S G+ L+E+ + P
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 40/252 (15%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPD--GS-----IVAVKRSKAIDKTQIEQFINEVVILSQI 385
++N LG+G FG V ML + G+ I +K+ I +E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 386 NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
+ L C +T + V EY+ G+L +HI QQ K +E
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGK--FKEPHA------- 103
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTH 503
V A E+A + ++HS I +RD+K N++LD + K++DFG + ++ KT
Sbjct: 104 --VFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT- 157
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE------ER 557
T GT Y PE Y D ++FGV+L E+L G+ P E+E E
Sbjct: 158 -TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
Query: 558 NLVAYFISLAKE 569
N V+Y SL+KE
Sbjct: 217 N-VSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 332 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRH 389
D++ + LG G G V K P G I+A K K I Q I E+ +L + N +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV G + E++ G+L Q L+E + + E +V
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD-------------QVLKEAKRIPE---EILGKV 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
+ V +AY+ I HRD+K SNIL++ + K+ DFG S + + + +
Sbjct: 109 SIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 163
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
GT Y PE Q + Y+ +SD++S G+ L+EL G+ PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 340 LGQGGFGTV----YKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG G FG V +KG +I +K+ + + Q++ E IL +++H IV ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR--VACEV 453
+ + E++ G L H+ + + N V E+
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR------------------KAGRFPNDVAKFYHAEL 127
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A Y+HS I +RD+K N+LLD+K KV+DFG ++ VP D+T + GT
Sbjct: 128 VLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGTPE 180
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE QS + D ++ GV+L E + G P
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKT-----QIEQFINEVVILSQIN 386
N+ + + LGQG FG VY D G +A K+ + ++ ++ E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 387 HRHIVKLLGCCLE--TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H IV+ GC + + + EY+ G++ + + E Q L +S
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS-- 120
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
Y+HS+ I HRDIK +NIL D + K+ DFG S+ +
Sbjct: 121 --------------YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 505 T--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T +V GT + PE Y K+DV+S G ++E+LT K P
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 30/218 (13%)
Query: 338 RFLGQGGFGTVY---KGMLPD-GSIVAVK-RSKAIDKTQIEQFI-NEVVILSQINHRHIV 391
+ LGQG FG V+ K PD G + A+K KA K + E IL+++NH IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
KL +TE + L+ +++ G+L + K+ + E+++ + +A
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRL--------SKEVMFTEEDV-------KFYLA 105
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQ 509
E+A A+ ++HS + I +RD+K NILLD++ K++DFG S+ S+ ++K +
Sbjct: 106 -ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFC 159
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE +T +D +SFGV++ E+LTG P
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 32/174 (18%)
Query: 468 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD 527
I HRD+K SNIL++ + K+ DFG S + + + + GT Y PE Q + YT
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTV 177
Query: 528 KSDVYSFGVVLLELLTGKKPI----------CLTREEEE-------RNLVAYFISLAKEN 570
+SD++S G+ L+E+ G+ PI R E R + + +
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237
Query: 571 KLLEILDARVAKEA--------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616
+ E+LD V + S+E + V + CL+ N K+R +K+++
Sbjct: 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK----CLKKNPKERADLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 71/244 (29%), Positives = 112/244 (45%), Gaps = 34/244 (13%)
Query: 338 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ LG+G FG V KG +I +K+ + ++ + E IL+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 394 LGCCLETEVPVL-VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
L CC +T+ + V EY+ G+L I Q+ +K + E R R A
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFD------------EPRSRFYAA 103
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQG 510
EV A+ ++H I +RD+K NILLD + K++DFG + + N T TT G
Sbjct: 104 EVTLALMFLHRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCG 158
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--ERNL---VAYFIS 565
T Y PE Q +Y D ++ GV++ E++ G+ P E++ E L V Y +
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW 218
Query: 566 LAKE 569
L+KE
Sbjct: 219 LSKE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 334 YNQSRFLGQGGFGTVYKGML----PDGSIVAVKR---SKAIDKTQIEQFINEVVILSQIN 386
Y + + +G+G FG K +L DG +K SK K + E+ EV +LS +
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMK 57
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H +IV+ E +V +Y G+L I+ Q+ L E ++ L W
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKIN------AQRGVLFPEDQI--LDW--- 106
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
++ A+ ++H I HRDIKS NI L + K+ DFG +R V N L
Sbjct: 107 ---FVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELAR 159
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
GT Y PE ++ Y +KSD+++ G VL E+ T K
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 56/231 (24%)
Query: 338 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKAID----KTQIEQFINEVVILSQI-NHRH 389
+ LG+G +G V+K + D +VA+K K D T ++ E++ L ++ +H +
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 390 IVKLLGCCLETEVPV----------LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
IVKLL V LV+EY+ +L I + LE+
Sbjct: 69 IVKLLN--------VIKAENDKDIYLVFEYM-ETDLHAVI--------RANILEDVH--- 108
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
+ + ++ A+ Y+HS I HRD+K SNILL+ K++DFG +RS+
Sbjct: 109 ------KRYIMYQLLKALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 500 DKTHLTTAVQ----GTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
+ + V T Y PE S++YT D++S G +L E+L GK
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 334 YNQSRFLGQGGFGTVYKGML---PDGSIVAVKRSKAIDKTQIEQF----INEVVILSQIN 386
Y +G+G +G VYK DG A+K+ K DK Q E+ +L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELK 60
Query: 387 HRHIVKLLGCCLE-TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H ++V L+ LE + V L+++Y +L I H+Q K+ + SL W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQA---KRVSIPPSMVKSLLWQ 116
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPND 500
+ V Y+HS+ + HRD+K +NIL+ ++ K+ D G +R
Sbjct: 117 --------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 501 KTHLTTA--VQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
L V T Y PE ++ YT D+++ G + ELLT +PI RE +
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAK 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 29/196 (14%)
Query: 356 GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415
G VAVK+ + + E NEVVI+ +H ++V + L + +V E++ G L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475
+ + + +EQ V V A++Y+H+ I HRDIKS
Sbjct: 107 TDIVTHTRMNEEQI-----------------ATVCLSVLRALSYLHNQGVI---HRDIKS 146
Query: 476 SNILLDDKFSAKVSDFG----TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDV 531
+ILL K+SDFG S+ VP K+ + GT + PE Y + D+
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-----LVGTPYWMAPEVISRLPYGTEVDI 201
Query: 532 YSFGVVLLELLTGKKP 547
+S G++++E++ G+ P
Sbjct: 202 WSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 332 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRH 389
D++ + LG G G V+K P G I+A K K I Q I E+ +L + N +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV G + E++ G+L Q +K EQ L +V
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKKAGRIPEQILG--------KV 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
+ V + Y+ I HRD+K SNIL++ + K+ DFG S + + + +
Sbjct: 109 SIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 163
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
GT Y PE Q + Y+ +SD++S G+ L+E+ G+ PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 340 LGQGGFGTVYKGML--PDGSIVAVKRSKA-IDKTQIEQFINEV-VILSQINHRHIVKLLG 395
LG+G +G V K M P G+I+AVKR +A ++ + ++ + ++ + + ++ + V G
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 396 CCL-ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
E +V +IC + + ++ K E L ++A +
Sbjct: 68 ALFREGDV------WICMEVMDTSLDKFYKKVYDKGLTIPEDILG--------KIAVSIV 113
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514
A+ Y+HS S+ HRD+K SN+L++ K+ DFG S + + A G Y
Sbjct: 114 KALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GCKPY 169
Query: 515 FDPEYF----QSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE Y KSDV+S G+ ++EL TG+ P
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 340 LGQGGFGTVYKGMLP-DGSIVAVK--RSKAIDKTQIEQFI--NEVVILSQINHRHIVKLL 394
+G+G FG V DG AVK + KAI K + ++ I V+L + H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 453
+ V +Y+ G L H L+ E+ E R R A E+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFH-------------LQRERSFP----EPRARFYAAEI 105
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGTF 512
A A+ Y+HS + I +RD+K NILLD + ++DFG + + + KT T+ GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTP 160
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE + Y D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 34/220 (15%)
Query: 340 LGQGGFGTVYKGMLPDGSIVA---VKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLG 395
+G G FG V G G A VK +A + F+ EV ++NH ++++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV--RVACEV 453
C+E+ +LV E+ G+L K L + + + + V R+ACEV
Sbjct: 63 QCIESIPYLLVLEFCPLGDL-------------KNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGTF 512
A + ++H + I H D+ N L S K+ D+G + P D + T
Sbjct: 110 ASGLLWLHQADFI---HSDLALRNCQLTADLSVKIGDYGLALEQYPED--YYITKDCHAV 164
Query: 513 G--YFDPEYFQSSQ-------YTDKSDVYSFGVVLLELLT 543
+ PE + T KS+++S GV + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
+G+G +G VYKG G IVA+K R ++ ++ I E+ +L ++ H +IV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
++ L++E+ LS + + + Q ++ E S L ++
Sbjct: 68 LMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLY---------QILQG 113
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VP-NDKTHLTTAVQGTFG 513
+ + HS + HRD+K N+L+D+K K++DFG +R+ +P TH T
Sbjct: 114 ILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLW 166
Query: 514 YFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPI 548
Y PE S Y+ D++S G + E+ T KKP+
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 47/231 (20%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIE--QFINEVVILSQINHRHI 390
Y + +G G +G V + G VA+K+ + I+ + + E+ +L + H +I
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 391 VKLLGCCLETEVPV-----------LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
+ LL ++ +V E + D + + Q L ++
Sbjct: 62 IGLL------DILRPPSPEDFNDVYIVTELM--------ETDLHKVIKSPQPLTDD---- 103
Query: 440 SLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV- 497
++ ++ + Y+HS+ I HRD+K SNIL++ K+ DFG +R V
Sbjct: 104 ------HIQYFLYQILRGLKYLHSANVI---HRDLKPSNILVNSNCDLKICDFGLARGVD 154
Query: 498 --PNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
++K LT V T Y PE SS+YT D++S G + ELLT K
Sbjct: 155 PDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 340 LGQGGFGTVYK-GMLPDGSIVAVKR--SKAIDKTQ-IEQFINEVVILSQINHRHIVKLLG 395
LG+GGFG V M G + A K+ K + K + E + E IL++++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 396 CCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
+T+ + LV + G+L +HI++ ++EE ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYN----------VDEEN--PGFPEPRACFYTAQII 107
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514
+ ++H I +RD+K N+LLD+ + ++SD G + + D T GT G+
Sbjct: 108 SGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKGYAGTPGF 163
Query: 515 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE Q +Y D ++ GV L E++ + P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 32/248 (12%)
Query: 333 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR 388
++N LG+G FG V KG +I +K+ I +E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 389 HIVKLLGCCLET-EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+ L C +T + V EY+ G+L + I Q++ + V
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI----------------QQVGRFKEPHAV 104
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
A E+A + ++HS I +RD+K N++LD + K++DFG + D T
Sbjct: 105 FYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKT 160
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE------ERNLVA 561
GT Y PE Y D ++FGV+L E+L G+ P E+E E N VA
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VA 219
Query: 562 YFISLAKE 569
Y S++KE
Sbjct: 220 YPKSMSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 35/238 (14%)
Query: 333 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKAID-----KTQIEQFINEVVILS 383
N+ R LG G +G V+ G G + A+K K KT E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA-EHTRTERQVLE 59
Query: 384 QINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+ + L +T+ + L+ +Y+ G L H++ Q++ E
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-------QREHFTES------- 105
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E RV +A E+ A+ ++H + I +RDIK NILLD + ++DFG S+ ++
Sbjct: 106 -EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 503 HLTTAVQGTFGYFDPEYFQ--SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
+ GT Y PE + S + D +S GV+ ELLTG P + + E+N
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV---DGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 338 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ LG+G FG V+ KG +I A+K+ + +E + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 394 LGCCLET-EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
L C +T E V EY+ G+L HI Q A E
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI----------------QSCHKFDLPRATFYAAE 104
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGT 511
+ + ++HS I +RD+K NILLD K++DFG + ++ D T GT
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGT 159
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
Y PE +Y D +SFGV+L E+L G+ P EEE
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 32/258 (12%)
Query: 334 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
Y R LG G G V+ + D VAVK+ D ++ + E+ I+ +++H +IVK
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 393 LLGCCLETEVPVLVYEYICNGN--LSHHIHDHQQ-------QQEQKQELEEEQELSSLSW 443
VYE + L+ + + Q+ + +L E LS
Sbjct: 67 -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPND-- 500
E+ ++ + Y+HS+ + HRD+K +N+ ++ + K+ DFG +R V
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 501 -KTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
K +L+ + + Y P + YT D+++ G + E+LTGK E E+
Sbjct: 171 HKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 559 LVAYFISLAKENKLLEIL 576
L+ + + +E E+L
Sbjct: 230 LILESVPVVREEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 44/242 (18%)
Query: 333 NYNQSRFLGQGGFGTVY---KGMLPD-GSIVA---------VKRSKAIDKTQIEQFINEV 379
N+ + LG G +G V+ K D G + A V+++K ++ T+ E+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTER----- 55
Query: 380 VILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
+L + + L +TE + L+ +Y+ G + H++ Q+ E++
Sbjct: 56 NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-------QRDNFSEDE-- 106
Query: 439 SSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
VR + E+ A+ ++H + I +RDIK NILLD + ++DFG S+
Sbjct: 107 --------VRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155
Query: 498 PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPICLTREEEE 556
+++ T + GT Y PE + K+ D +S G+++ ELLTG P L E E
Sbjct: 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL---EGE 212
Query: 557 RN 558
RN
Sbjct: 213 RN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 32/248 (12%)
Query: 333 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR 388
++N LG+G FG V KG +I +K+ I +E + E +L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 389 HIVKLLGCCLET-EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+ L C +T + V EY+ G+L +HI +Q + +E Q V
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQA---------V 104
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
A E++ + ++H I +RD+K N++LD + K++DFG + D T
Sbjct: 105 FYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRT 160
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE------ERNLVA 561
GT Y PE Y D +++GV+L E+L G+ P E+E E N V+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VS 219
Query: 562 YFISLAKE 569
Y SL+KE
Sbjct: 220 YPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 34/204 (16%)
Query: 356 GSIVAVK--RSKAI-DKTQIEQFINEVVILSQINHRHIVKLL--GCCLETEVPVLVYEYI 410
G VA+K R+ A ++ Q +F E + +++ H +IV LL G + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH 470
L ++ L + L + R+ +V A+A H+ I H
Sbjct: 62 PGRTL-------------REVLAADGALPA---GETGRLMLQVLDALACAHNQG---IVH 102
Query: 471 RDIKSSNILL---DDKFSAKVSDFGTSRSVPN----DKTHLT--TAVQGTFGYFDPEYFQ 521
RD+K NI++ + AKV DFG +P D LT T V GT Y PE +
Sbjct: 103 RDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR 162
Query: 522 SSQYTDKSDVYSFGVVLLELLTGK 545
T SD+Y++G++ LE LTG+
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 31/216 (14%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVV------ILSQINHRHIVK 392
LG+GGFG V + + G + A K+ +DK ++++ E + IL ++N IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 393 LLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
L E++ + LV + G+L +HI++ ++ L E + +
Sbjct: 58 L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER--------------GLEMERVIHYSA 102
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++ + ++HS + I +RD+K N+LLDD+ + ++SD G + + + KT T GT
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGT 157
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GY PE + Y+ D ++ G + E++ G+ P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 67/273 (24%), Positives = 110/273 (40%), Gaps = 60/273 (21%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSK-AIDKTQIEQFINEVVILSQ 384
D + LG G FG V + + VAVK K ++ + ++E+ IL
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66
Query: 385 I-NHRHIVKLLGCCLETEVPVLV-YEYICNGNLSHHIH---------------------- 420
I NH ++V LLG C + P++V E+ GNLS+ +
Sbjct: 67 IGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126
Query: 421 ---------------------DHQQQQEQKQELEEEQE---LSSLSWENRVRVACEVAGA 456
Q +E + S L+ E+ + + +VA
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARG 186
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT-AVQGTFGYF 515
+ ++ S I HRD+ + NILL + K+ DFG +R + D ++ + + +
Sbjct: 187 MEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE YT +SDV+SFGV+L E+ + G P
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 31/244 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDG----SIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
R +G+G + V L ++ VK+ D I+ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 394 LGCCLETEVPVL-VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
L C +TE + V EY+ G+L H+ Q Q++ EE S E
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFYS----------AE 104
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTAVQG 510
++ A+ Y+H I +RD+K N+LLD + K++D+G + P D T + G
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCG 158
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP--ICLTREEEERNLVAYFISLAK 568
T Y PE + Y D ++ GV++ E++ G+ P I + + ++N Y +
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218
Query: 569 ENKL 572
E ++
Sbjct: 219 EKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 338 RFLGQGGFGTVYKGMLPDG----SIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ LG+G FG V L ++ A+K+ + +E + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 394 LGCCLET-EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
L C +T E V E++ G+L HI D + + A E
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF----------------YAAE 104
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ + ++HS I +RD+K N++LD K++DFG + +T GT
Sbjct: 105 IVCGLQFLHSKGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTP 160
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
Y PE Q +YT D +SFGV+L E+L G+ P E+E
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK--RSKAIDKTQIEQF-INEVVILSQINHRHIVKLLG 395
+G+GGFG VY D G + A+K K I Q E +NE ++LS ++ ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 396 CCLETEVP---VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
P + + + G+L +H+ H E++ A E
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF----------------YATE 105
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ + +MH+ + +RD+K +NILLD+ ++SD G + K H A GT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 159
Query: 513 GYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKP 547
GY PE Q + Y +D +S G +L +LL G P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 60/211 (28%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 342 QGGFGTVY---KGMLPDG-SIVAVKRSKAIDKTQIEQFINEVVIL-SQINHRHIVKLLGC 396
+G FG+VY K D +I +K+S I K Q+ E I+ Q ++ KL
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+ LV EY+ G+ + I + L L + + EV
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI----------------KTLGGLPEDWAKQYIAEVVLG 109
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
V +H I HRDIK N+L+D K++DFG SR+ +K GT Y
Sbjct: 110 VEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLA 161
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE SD +S G V+ E L G P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 338 RFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFI--NEVVILSQINHRHIVK 392
+ +G+G FG V + AVK + KAI K + E+ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
L + V +YI G L +H+ Q ++ LE R R A
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL------QRERCFLEP-----------RARFYAA 103
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTAVQ 509
E+A A+ Y+HS + I +RD+K NILLD + ++DFG + N T+
Sbjct: 104 EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFC 157
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE Y D + G VL E+L G P
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 37/239 (15%)
Query: 334 YNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSKAIDKTQIE------QFINEVVILSQIN 386
Y+ R +G+GG G VY P S VA+K+ I + E +F+ E I + +
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKK---IREDLSENPLLKKRFLREAKIAADLI 60
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H IV + C + + YI L + Q++ +EL E+ + +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF----- 115
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV-SDFGTSRS--------- 496
+ + ++ + Y+HS + HRD+K NILL F V D+G +
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLL 171
Query: 497 -----VPNDKTHLTT---AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
N T + GT Y PE ++ +D+Y+ GV+L ++LT P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-AIDKTQIEQF-INEVVILSQI---NH 387
Y + +G+G +GTVYK L G VA+K+ + + + I + E+ +L Q+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 388 RHIVKLLGCC----LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+IV+LL C + E+ + LV+E+ + +L+ ++ K L E + L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKC-----PKPGLPPET-IKDLM 113
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
++ V ++HS I HRD+K NIL+ K++DFG +R + + +
Sbjct: 114 R--------QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEM 161
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLEL 541
LT+ V T Y PE S Y D++S G + EL
Sbjct: 162 ALTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 338 RFLGQGGFGTVYKGMLP-DGSIVAVK--RSKAIDKTQIEQFI--NEVVILSQINHRHIVK 392
+ +G+G FG V DGS AVK + K I K + + I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
L E V +Y+ G L H L+ E+ E R R A
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFH-------------LQRERCFL----EPRARFYAA 103
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQG 510
EVA A+ Y+HS + I +RD+K NILLD + ++DFG + V ++T T+ G
Sbjct: 104 EVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCG 158
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T Y PE + Y D + G VL E+L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 338 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ LG+G FG V K ++ +K+ I K ++ + E +L H + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 452
+ V EY+ G L H L E+ S E+R R E
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFH-------------LSRERVFS----EDRTRFYGAE 103
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ A+ Y+HS I +RD+K N++LD K++DFG + D + T GT
Sbjct: 104 IVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTP 159
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 338 RFLGQGGFGTVYKGMLPDG----SIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
R +G+G + V L ++ VK+ D I+ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 394 LGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
L C +T + LV EY+ G+L H+ Q Q++ EE A E
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHM------QRQRKLPEEHARF----------YAAE 104
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTAVQG 510
+ A+ ++H I +RD+K N+LLD K++D+G + P D T + G
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCG 158
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570
T Y PE + +Y D ++ GV++ E++ G+ P + + + N Y + E
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
Query: 571 KL 572
+
Sbjct: 219 PI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK--RSKAIDKTQIEQF-INEVVILSQINHRHIVKLLG 395
+G+GGFG VY D G + A+K K I Q E +NE ++LS ++ ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 396 CCLETEVP---VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
P + + + G+L +H+ H E + A E
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF----------------YAAE 105
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ + +MH+ + +RD+K +NILLD+ ++SD G + K H A GT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 159
Query: 513 GYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKP 547
GY PE Q Y +D +S G +L +LL G P
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 68/255 (26%), Positives = 100/255 (39%), Gaps = 64/255 (25%)
Query: 338 RFLGQGGFGTVYKGMLPD-GSIVAVKR---SKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ +G+G FG V D G I A+K+ S+ ++K Q+ E IL++ ++ +VKL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
+ L+ EY+ G D +K EE E R +A E
Sbjct: 67 YYSFQDENYLYLIMEYLPGG-------DMMTLLMKKDTFTEE--------ETRFYIA-ET 110
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ---- 509
A+ +H I HRDIK N+LLD K K+SDFG + K+H T +
Sbjct: 111 ILAIDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSH 165
Query: 510 -----------------------------------GTFGYFDPEYFQSSQYTDKSDVYSF 534
GT Y PE F + Y + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 535 GVVLLELLTGKKPIC 549
GV++ E+L G P C
Sbjct: 226 GVIMYEMLVGYPPFC 240
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 340 LGQGGFGTVYKGMLPDGSIV----AVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
+G+G FG V + D + ++++ + ++++ + E +L+Q+N IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
E LV +I G L HH+ Q+E + +L + ++ E+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTA-----------ELLC 104
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
A+ +H + +RD+K NILLD + + DFG + + T GT Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYL 160
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
PE YT D ++ GV+L E+LTG P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIV-AVKR-SK--AIDKTQIEQFINEVVI 381
+L+ ++++ + +G+G FG V V A+K SK I ++ F E I
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
++ N IV+L + + +V EY+ G+L + + ++ ++ E+
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--------DIPEK------ 142
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS-RSVPND 500
W R A EV A+ +HS I HRD+K N+LLD K++DFGT + N
Sbjct: 143 -WA-RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196
Query: 501 KTHLTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKP 547
TAV GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFI---NEVVILSQINHRHIVKLLG 395
+G G G VYK G ++AVK+ + + + I +VV+ S + +IVK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYG 81
Query: 396 CCLETEVPVLVYEYI---CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
T+ V + + C L I Q E L ++ VA
Sbjct: 82 Y-FITDSDVFICMELMSTCLDKLLKRI----------QGPIPEDILGKMT------VA-- 122
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ A+ Y+ + HRD+K SNILLD + K+ DFG S + + K +A G
Sbjct: 123 IVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCA 178
Query: 513 GYFDPEYFQSSQYTDK----SDVYSFGVVLLELLTGKKP 547
Y PE K +DV+S G+ L+EL TG+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 77/252 (30%), Positives = 104/252 (41%), Gaps = 61/252 (24%)
Query: 325 EELQRATDNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVI 381
+ Y SR LG G GTV + DG AVK + + + + EV
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 382 LSQINHRHIVKLLGCCLE--------TEVPV----LVYEYICNGNLSHHIHDHQQQQEQK 429
L + IVK C E V LV +Y G+L
Sbjct: 85 LLNCDFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDL-------------- 126
Query: 430 QELEEEQELSSLSWENRVRVACEVAG--------AVAYMHSSASIPIFHRDIKSSNILLD 481
QE+ S + NR E AG AV ++HS I HRDIKS+NILL
Sbjct: 127 -----RQEIKSRAKTNRTFREHE-AGLLFIQVLLAVHHVHSKHMI---HRDIKSANILLC 177
Query: 482 DKFSAKVSDFGTSR----SVPND--KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFG 535
K+ DFG S+ +V +D +T GT Y PE ++ Y+ K+D++S G
Sbjct: 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 536 VVLLELLTGKKP 547
V+L ELLT K+P
Sbjct: 233 VLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 58/240 (24%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQ-FINEVVILSQINHRH 389
Y ++G+G +G V P G VA+K+ + Q + E+ IL + H +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 390 IVKLLG-----------------CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL 432
I+ +L +ET++ Y+ I +LS+ DH Q
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDL----YKLIKTQHLSN---DHIQY------- 110
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
++ + Y+HS+ + HRD+K SN+LL+ K+ DFG
Sbjct: 111 ----------------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFG 151
Query: 493 TSRSVPNDKTH---LTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+R + H LT V T Y PE S YT D++S G +L E+L+ +P+
Sbjct: 152 LARIADPEHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
D Y + +G+G +G VYK G +VA+K R + ++ + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 389 -HIVKLLGCCLETEVPV------LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
+IV+LL E LV+EY+ + +L + + + +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLP---------- 108
Query: 442 SWENRVRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSR--SV 497
++ ++ VA+ H + HRD+K N+L+D K K++D G R S+
Sbjct: 109 --AKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 498 PNDK-THLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 544
P TH T Y PE S+ Y+ D++S G + E+
Sbjct: 164 PVKSYTHEIV----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 60/284 (21%), Positives = 118/284 (41%), Gaps = 55/284 (19%)
Query: 348 VYKGMLPDGSIV--AVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP-- 403
+YKG+ + ++ K+ K I+ NE+ L +I+ +I+K+ G ++
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 404 --VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 461
L+ EY G L ++ L++E+ LS++ ++ +A + + ++
Sbjct: 96 RLSLILEYCTRGYL-------------REVLDKEK---DLSFKTKLDMAIDCCKGLYNLY 139
Query: 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGYFDPEY 519
+ P ++++ S + L+ + + K+ G + S P K YF +
Sbjct: 140 KYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV------YFSYKM 191
Query: 520 FQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILD 577
S+YT K D+YS GVVL E+ TGK P E + + +N L++
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF------ENLTTKEIYDLIINKNNSLKL-- 243
Query: 578 ARVAKEASEEDIEAVAEL---AMGCLRLNSKKRPTMKQVSMDLE 618
++ E+ C +S KRP +K++ +L
Sbjct: 244 ----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 338 RFLGQGGFGTVYKGMLP-DGSIVAVK--RSKAI--DKTQIEQFINEVVILSQINHRHIVK 392
+ +G+G FG V DG AVK + K + K Q V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
L TE V +++ G L H L+ E+ E R R A
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFH-------------LQRERSFP----EPRARFYAA 103
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
E+A A+ Y+HS I I +RD+K NILLD + ++DFG + ++ TT GT
Sbjct: 104 EIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGT 159
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE + Y + D + G VL E+L G P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 57/262 (21%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
D++ + +G+G FG V D G I A+K ++ ++K Q+ E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+VK+ + L+ E++ G++ + +K L EE ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-------KKDTLSEEATQFYIA----- 108
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG--------------- 492
E A+ +H I HRDIK N+LLD K K+SDFG
Sbjct: 109 ----ETVLAIDAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 493 -TSRSVPND------------------KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 533
+ + P+D + L + GT Y PE F + Y D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 534 FGVVLLELLTGKKPICLTREEE 555
GV++ E+L G P C +E
Sbjct: 222 LGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 332 DNYNQSRFLGQGGFGTV----YK-GMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN 386
+++N R LG G FG V YK P +I ++SK I + Q++ +E IL+ IN
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H V L G + LV E++ G + +++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------------------ 131
Query: 447 VRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
V C A + + S+ I +RD+K N+LLD K++DFG ++ V T
Sbjct: 132 --VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT Y PE + + +D ++ G+ + E+L G P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 29/243 (11%)
Query: 318 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKAIDKTQIEQFI 376
+ + E L TD + +G+G +G VYK DGS+ AVK I E+
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 377 NEVVILSQI-NHRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQ 430
E IL + NH ++VK G + + V LV E +CNG + K
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE-LCNGG--------SVTELVKG 117
Query: 431 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490
L Q L + ++ + GA+ + + I HRD+K +NILL + K+ D
Sbjct: 118 LLICGQRL------DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171
Query: 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS-----DVYSFGVVLLELLTGK 545
FG S + + + T+V GT + PE Q D S DV+S G+ +EL G
Sbjct: 172 FGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 546 KPI 548
P+
Sbjct: 231 PPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKAIDKTQIEQF-INEVVILSQINHR 388
+ Y + +G+G +G V+K + G IVA+K+ ++ D I++ + E+ +L Q+ H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
++V L+ LV+EY C+ + + + + + E + + W+
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEY-CDHTVLNELEKNPRGVP-------EHLIKKIIWQ---- 108
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
AV + H I HRD+K NIL+ + K+ DFG +R + T V
Sbjct: 109 ----TLQAVNFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 509 QGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTG 544
T Y PE +QY DV++ G V ELLTG
Sbjct: 162 -ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
D+Y + LG+G + TVYKG +G +VA+K R + + T I E +L + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IV L E LV+EY+ + +L ++ H L EN
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHP---------------GGLHPENVKL 107
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTT 506
++ ++Y+H I HRD+K N+L+ D K++DFG +R SVP +H +
Sbjct: 108 FLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYS 161
Query: 507 AVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 544
T Y P+ S++Y+ D++ G + +E++ G
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/240 (24%), Positives = 106/240 (44%), Gaps = 30/240 (12%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPDG-------SIVAVKRSKAIDKTQI-EQFINEVVILSQ 384
N+ + LG G +G V+ G ++ +K++ + K + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 385 INHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
I + L +T+ + L+ +YI G L H+ ++ +EQ+ ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI----------- 109
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
+ E+ A+ ++H + I +RDIK NILLD ++DFG S+ D+
Sbjct: 110 -----YSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 504 LTTAVQGTFGYFDPEYFQSSQYT-DKS-DVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
+ GT Y P+ + DK+ D +S GV++ ELLTG P + E+ + ++
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 36/226 (15%)
Query: 339 FLGQGGFGTVYKGM-LPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLG 395
+G G +G VYKG + G + A+K ++ +I+Q IN + S +HR+I G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 70
Query: 396 CCLETEVP------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
++ P LV E+ G+++ I + + L+EE W +
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEE-------W---IAY 115
Query: 450 AC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
C E+ ++++H + HRDIK N+LL + K+ DFG S + T +
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 509 QGTFGYFDPEYFQSSQYTD-----KSDVYSFGVVLLELLTGKKPIC 549
GT + PE + D KSD++S G+ +E+ G P+C
Sbjct: 173 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 66/302 (21%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKR------SKAIDKTQIEQFINEVVILSQINHRHIVK 392
+G+G +G V K + G IVA+K+ K + K + E+ +L Q+ H ++V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLVN 64
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR-VAC 451
L+ + LV+E++ H + D ++ + E+RVR
Sbjct: 65 LIEVFRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLD------------ESRVRKYLF 107
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHLTTAVQ 509
++ + + HS I HRDIK NIL+ K+ DFG +R++ P + + T
Sbjct: 108 QILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYV 161
Query: 510 GTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPI---------------CLT-- 551
T Y PE ++Y D+++ G ++ E+LTG +P+ CL
Sbjct: 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNL 220
Query: 552 ----REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKR 607
+E ++N + + L E K +E L+ R K + V +LA CLR++ R
Sbjct: 221 IPRHQEIFQKNPLFAGMRLP-EVKEIEPLEKRFPKLSGL-----VLDLAKQCLRIDPDDR 274
Query: 608 PT 609
P+
Sbjct: 275 PS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ--IEQFINEVVILSQINHRH 389
N+ Q LG+G + TVYKG G IVA+K +D + I E+ ++ ++ H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHEN 59
Query: 390 IVKLLGCCLETEVP-VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
IV+L + TE +LV+EY + +L ++ H + + S +++
Sbjct: 60 IVRLHDV-IHTENKLMLVFEY-MDKDLKKYMDTHGVRGALDPNT-----VKSFTYQ---- 108
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+ +A+ H + + HRD+K N+L++ + K++DFG +R+ + V
Sbjct: 109 ----LLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161
Query: 509 QGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 545
T Y P+ S+ Y+ D++S G ++ E++TG+
Sbjct: 162 V-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSK-AIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
LG+G +G+VYK + P G +A+K + +D+++ Q I E+ IL + +IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ EY+ G+L D E E L R+ V +
Sbjct: 69 FIEGAVYMCMEYMDAGSL-----DKLYAGGVATEGIPEDVLR--------RITYAVVKGL 115
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND--KTHLTTAVQGTFGYF 515
++ +I HRD+K +N+L++ K+ DFG S ++ KT++ G Y
Sbjct: 116 KFLKEEHNI--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYM 168
Query: 516 DPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKP 547
PE +S YT +SDV+S G+ +LE+ G+ P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 65/279 (23%)
Query: 340 LGQGGFGTVYKG------MLPDGSIVAVKRSK-AIDKTQIEQFINEVVILSQINHR-HIV 391
LG+G FG V + VAVK K ++ ++E+ IL I H ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 392 KLLGCCLETEVPVLVYEYICN-GNLSHHIHDHQQQ----------------------QEQ 428
LLG C + P++V C GNLS+++ + + ++
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 429 KQELE--------------EEQELSS---------------LSWENRVRVACEVAGAVAY 459
K+ L+ EE+ LS L+ E+ + + +VA + +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA-VQGTFGYFDPE 518
+ S I HRD+ + NILL + K+ DFG +R + D ++ + + PE
Sbjct: 195 LASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEE 556
YT +SDV+SFGV+L E+ + G P + +EE
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 327 LQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVIL 382
LQ ++Y+ + +G+G FG V +K ++ + + + I ++ F E I+
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+ N +V+L + + +V EY+ G+L + + ++ ++
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--------------- 142
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
W EV A+ +HS I HRD+K N+LLD K++DFGT + D+T
Sbjct: 143 WAKFY--TAEVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGTCMKM--DET 195
Query: 503 ---HLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKP 547
TAV GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD---GSIVA---VKRSKAIDKTQIEQFINEVVILSQI 385
+++ +G+G FG V ++ + G I A +K+S + + + F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
N I +L + + LV EY G+L ++ ++ Q + E+
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD----------------ED 102
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
+ +A V +HS + HRDIK N+L+D K++DFG++ + +K +
Sbjct: 103 MAQFY--LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160
Query: 506 TAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE + Y + D +S GV+ E++ G+ P
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 33/244 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK--RSKAIDKTQIEQFINEVVIL---SQINHRHIVKL 393
+G G +GTVYK P G VA+K R + + + EV +L +H +IV+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 394 LGCCL------ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+ C ET+V LV+E++ Q+ + L++ L E
Sbjct: 68 MDVCATSRTDRETKV-TLVFEHV--------------DQDLRTYLDKVPP-PGLPAETIK 111
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
+ + + ++H++ I HRD+K NIL+ K++DFG +R + + + LT
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPV 167
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
V T Y PE S Y D++S G + E+ K C E ++ + I L
Sbjct: 168 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
Query: 568 KENK 571
E+
Sbjct: 227 PEDD 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 340 LGQGGFGTVYKGMLP-DGSIVAVKRSK-AIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
LG+G + TV+KG ++VA+K + ++ I EV +L + H +IV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
LV+EY+ + KQ L+ L +S N ++ +
Sbjct: 73 HTERCLTLVFEYL--------------DSDLKQYLDNCGNL--MSMHNVKIFMFQLLRGL 116
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGYF 515
+Y H I HRD+K N+L+++K K++DFG +R SVP KT+ V T Y
Sbjct: 117 SYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVV--TLWYR 170
Query: 516 DPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
P+ S++Y+ D++ G +L E+ TG+ + +EE +L+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 42/222 (18%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQ--------FINEVVILSQINHRHI 390
+G+G +G VYK G IVA+K K ++E I E+ +L ++NH +I
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALK------KIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V+LL LV+E++ + +L ++ D L + S ++
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPL-----IKSYLYQ------ 107
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VP-NDKTHLTTA 507
+ +AY HS + HRD+K N+L+D + + K++DFG +R+ VP TH
Sbjct: 108 --LLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV- 161
Query: 508 VQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
T Y PE S QY+ D++S G + E++ ++P+
Sbjct: 162 ---TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 30/217 (13%)
Query: 338 RFLGQGGFGTVY------KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ LG+G FG V G I+ ++ I K ++ + E +L H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-A 450
L + V EY G L H L E+ + E R R
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFH-------------LSRERVFT----EERARFYG 101
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
E+ A+ Y+HS + +RDIK N++LD K++DFG + +D + T G
Sbjct: 102 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-G 157
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 66/262 (25%), Positives = 107/262 (40%), Gaps = 57/262 (21%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
+++ + +G+G FG V D G + A+K ++ ++K Q+ E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+VK+ + L+ E++ G++ + +K L EE E +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-------KKDTLTEE--------ETQF 105
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT-------------- 493
+A E A+ +H I HRDIK N+LLD K K+SDFG
Sbjct: 106 YIA-ETVLAIDSIHQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 494 --SRSVPNDKT------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 533
+ S+P+D T L + GT Y PE F + Y D +S
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 534 FGVVLLELLTGKKPICLTREEE 555
GV++ E+L G P C +E
Sbjct: 222 LGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 28/183 (15%)
Query: 367 IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQ 426
ID Q E+ + E + NH +V L C V E++ G+L H+ Q
Sbjct: 39 IDWVQTEKHVFE----TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM------Q 88
Query: 427 EQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486
Q++ EE + E++ A+ ++H I +RD+K N+LLD +
Sbjct: 89 RQRKLPEEHARF----------YSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHI 135
Query: 487 KVSDFGTSRS--VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544
K++D+G + P D T+ GT Y PE + Y D ++ GV++ E++ G
Sbjct: 136 KLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
Query: 545 KKP 547
+ P
Sbjct: 193 RSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 41/226 (18%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SKAIDKTQIEQFINEVVILSQI 385
N+ + +G+G +G VYK G +VA+K+ ++ + T I E+ +L ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKEL 56
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
NH +IVKLL LV+E++ Q+L++ + S LS
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFL------------------HQDLKKFMDASPLSGIP 98
Query: 446 RVRVAC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPND 500
+ ++ +A+ HS + HRD+K N+L++ + + K++DFG +R+ VP
Sbjct: 99 LPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 545
+T+ V T Y PE + Y+ D++S G + E++T +
Sbjct: 155 RTYTHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 46/235 (19%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDK-TQIEQFINEVVILSQINHR 388
Y +G G +G V + G VA+K+ A D T ++ + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 389 HIVKLLGCCLETEVP----VLVYEYICNGNLSHHIHDHQQQQEQKQELEEE-------QE 437
+I+ + L V V + +L H IH Q L EE Q
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMESDLHHIIH-------SDQPLTEEHIRYFLYQL 116
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
L L Y+HS+ + HRD+K SN+L+++ ++ DFG +R +
Sbjct: 117 LRGLK----------------YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 498 ---PNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
P + + T T Y PE +YT D++S G + E+L G++ +
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
E +LSQ+ H +IV + + + C G +H + +EQK +L E +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH-----KLKEQKGKLLPENQ 103
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
+ + W ++A A+ Y+H I HRD+K+ N+ L KV D G +R +
Sbjct: 104 V--VEW------FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
Query: 498 PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557
N +T + GT Y PE F + Y KSDV++ G + E+ T K ++
Sbjct: 153 ENQCDMASTLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF----NAKDM 207
Query: 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
N + Y I E KL + K+ S E + EL L +KRP++K +
Sbjct: 208 NSLVYRII---EGKL-----PPMPKDYSPE----LGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 56/183 (30%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 368 DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQE 427
D+ Q +E+ L+ +H IVK + +L+ EY G+L+ I +Q
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQR 159
Query: 428 QKQELE-EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486
K+ L +E E+ L ++ + A+ +HS + HRD+KS+NI L
Sbjct: 160 LKEHLPFQEYEVGLLFYQ--------IVLALDEVHSRK---MMHRDLKSANIFLMPTGII 208
Query: 487 KVSDFGTSRSVPNDKTHLTTAVQ--GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544
K+ DFG S+ +D L A GT Y PE ++ +Y+ K+D++S GV+L ELLT
Sbjct: 209 KLGDFGFSKQY-SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 545 KKP 547
+P
Sbjct: 268 HRP 270
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 31/198 (15%)
Query: 362 KRSKAIDKTQIEQFINEVVILSQINHRHIVKL---LGCCLETEVPVLVYEYICNGNLSHH 418
KR KA + I Q NE++ L ++NH +I+K+ L T + Y++ +L
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSF 252
Query: 419 IHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478
++D + L + R + ++ AV Y+H + HRDIK NI
Sbjct: 253 MYDEAFDWKD----------RPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENI 298
Query: 479 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVL 538
L+ + DFGT+ ++ GT PE Y + +D++S G++L
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
Query: 539 LELLT---------GKKP 547
L++L+ G KP
Sbjct: 359 LDMLSHDFCPIGDGGGKP 376
|
Length = 501 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ-IEQF-INEVVILSQINHRH 389
Y + +G+G +GTV+K IVA+KR + D + + + E+ +L ++ H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 390 IVKLLGCCLETEVPVLVYEYI----------CNGNLSHHIHDHQQQQEQKQELEEEQELS 439
IV+L + LV+EY CNG++ I + Q L+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI----VKSFMFQLLK------ 110
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--V 497
+A+ HS + HRD+K N+L++ K++DFG +R+ +
Sbjct: 111 ----------------GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
Query: 498 PNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
P +A T Y P+ F + Y+ D++S G + EL +P+
Sbjct: 152 P---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH-RHIVKLLGCC 397
+G G +G VYKG + G + A+K + + E+ E+ +L + +H R+I G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 398 LETEVP------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
++ P LV E+ G+++ +L + + ++L + +
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVT--------------DLVKNTKGNALKEDWIAYICR 128
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
E+ +A++H+ I HRDIK N+LL + K+ DFG S + T + GT
Sbjct: 129 EILRGLAHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 184
Query: 512 FGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPIC 549
+ PE + Y +SD++S G+ +E+ G P+C
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 340 LGQGGFGTVYKG--MLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGC 396
LG+G + TV+KG L + ++VA+K + + I EV +L + H +IV L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+ LV+EY+ ++ KQ +++ + S+ N ++
Sbjct: 73 VHTDKSLTLVFEYL--------------DKDLKQYMDDCGNIMSM--HNVKIFLYQILRG 116
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGY 514
+AY H + HRD+K N+L++++ K++DFG +R SVP KT+ V T Y
Sbjct: 117 LAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVV--TLWY 170
Query: 515 FDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
P+ SS+Y+ + D++ G + E+ +G+ + E+E +L+
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 39/229 (17%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQ--------FINEVVIL 382
D Y + +G+G +G VYK +A+K K ++EQ I E+ +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALK------KIRLEQEDEGVPSTAIREISLL 55
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL-SSL 441
++ H +IV+L + LV+EY+ +L D ++ + + + L +
Sbjct: 56 KEMQHGNIVRLQDVVHSEKRLYLVFEYL---DL-----DLKKHMDSSPDFAKNPRLIKTY 107
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-KVSDFGTSRSVPND 500
++ + +AY HS + HRD+K N+L+D + +A K++DFG +R+
Sbjct: 108 LYQ--------ILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156
Query: 501 KTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
T V T Y PE S Y+ D++S G + E++ +KP+
Sbjct: 157 VRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 28/238 (11%)
Query: 318 KAKIFTAEELQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKAIDKTQIE 373
K I +L+ ++Y + +G+G FG V +K ++ + + + I ++
Sbjct: 29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 374 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELE 433
F E I++ N +V+L + +V EY+ G+L + + ++ ++
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK------ 142
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493
W R A EV A+ +HS I HRD+K N+LLD K++DFGT
Sbjct: 143 ---------WA-RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGT 188
Query: 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKP 547
+ + GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 39/216 (18%)
Query: 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQ-------FINEVVILSQINHRHIV 391
LG+G + TVYKG G +VA+K + ++E I E +L + H +IV
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK------EIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
L + LV+EY + +L ++ D LS N
Sbjct: 67 TLHDIIHTKKTLTLVFEY-LDTDLKQYMDDCG---------------GGLSMHNVRLFLF 110
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQ 509
++ +AY H + HRD+K N+L+ ++ K++DFG +R SVP+ KT+ V
Sbjct: 111 QLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV- 165
Query: 510 GTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 544
T Y P+ S++Y+ D++ G + E+ TG
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 338 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ LG+G FG V K ++ +K+ + K ++ + E +L H + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 452
+ V EY G L H L E+ S E+R R E
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFH-------------LSRERVFS----EDRARFYGAE 103
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ A+ Y+HS ++ +RD+K N++LD K++DFG + D + T GT
Sbjct: 104 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTP 160
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 340 LGQGGFGTVYKG--MLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGC 396
LG+G + TVYKG L D ++VA+K + + I EV +L + H +IV L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+ LV+EY+ ++ KQ L++ ++ N ++
Sbjct: 73 IHTEKSLTLVFEYL--------------DKDLKQYLDDCGNSINM--HNVKLFLFQLLRG 116
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGY 514
+ Y H + HRD+K N+L++++ K++DFG +R S+P KT+ V T Y
Sbjct: 117 LNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVV--TLWY 170
Query: 515 FDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
P+ S+ Y+ + D++ G + E+ TG+ + EE+ + +
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIE--QFINEVVILSQINHRH 389
+ LG+GG+G V++ G+ I A+K + I + Q + E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV L+ L+ EY+ G L H LE E + E+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMH-------------LERE----GIFMED---T 101
Query: 450 AC----EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
AC E++ A+ ++H I +RD+K NILLD + K++DFG + ++ T +T
Sbjct: 102 ACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 549
GT Y PE S + D +S G ++ ++LTG P
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 32/233 (13%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
+G+G FG VY+ D I A+K + + + K ++ I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 396 CCLETEVPV---LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
+ LV +Y+ G L H+ Q+E + E+R +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL-----QKEGRFS------------EDRAKFYIA 103
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQG 510
E+ A+ ++H I +RD+K NILLD + DFG S+ N T G
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCG 158
Query: 511 TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
T Y PE YT D +S GV++ E+ G P ++ +A+
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 31/231 (13%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKT--QIEQFINEVVILSQINH 387
+D + +G+G +G V+K + +GS AVK I +IE N + LS +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DH 74
Query: 388 RHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
++VK G + +V LV E +CNG + D + ++ E EE ++ +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLE-LCNGG---SVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E + + ++H + +I HRD+K +NILL + K+ DFG S + + +
Sbjct: 131 HEALM--------GLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 503 HLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPI 548
T+V GT + PE Q Y + DV+S G+ +EL G P+
Sbjct: 180 RRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 338 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ LG+G FG V K ++ +K+ I K ++ + E +L H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 452
+ V EY G L H L E+ S E+R R E
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFH-------------LSRERVFS----EDRARFYGAE 103
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ A+ Y+HS + +RD+K N++LD K++DFG + +D + T GT
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 159
Query: 513 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAI-DKTQIEQFINEVVILSQINHRHI 390
Y Q + +G G G V G VAVK+ S+ ++T ++ E+V+L +NH++I
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 391 VKLLGC-----CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
+ LL LE V + + + NL IH EL+ E+ +S L ++
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---------MELDHER-MSYLLYQ- 131
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
+ C + ++HS+ I HRD+K SNI++ + K+ DFG +R+ + +
Sbjct: 132 ---MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMM 179
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544
T T Y PE Y + D++S G ++ EL+ G
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 43/228 (18%)
Query: 340 LGQGGFGTVYKGM---LPDGSIVAVKRS--KAIDKTQ---IEQFINEVVILSQINHRHIV 391
LGQG F ++KG+ + D + K +DK+ E F ++SQ++H+H+V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
G C+ + ++V EY+ G+L + L++ + L ++SW ++ VA
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTY-------------LKKNKNLINISW--KLEVAK 107
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSA----KVSDFGTSRSV-PNDKT 502
++A A+ ++ + H ++ + N+LL D K K+SD G S +V P +
Sbjct: 108 QLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-- 162
Query: 503 HLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTG-KKPI 548
+ + PE ++ Q + +D +SFG L E+ +G KP+
Sbjct: 163 ----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN--EVVILSQIN-HRHIVKLLG 395
+G+G F V K G A+K K K+ +EQ N E+ L +++ H +I++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 396 CCLE--TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEE-------QELSSLSWENR 446
+ T LV+E + + NL I K+ L E+ Q L SL
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGR------KRPLPEKRVKSYMYQLLKSLD---- 114
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
+MH + IFHRDIK NIL+ D K++DFG+ R + T
Sbjct: 115 ------------HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYT 156
Query: 507 AVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLT 543
T Y PE + Y K D+++ G V E+L+
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 78/317 (24%), Positives = 136/317 (42%), Gaps = 74/317 (23%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRS------KAID-----KTQIEQFINEVV 380
+ Y + +G G FG V+ +V KR+ KAI + + Q + EV
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 381 ILSQINHRHIVKLLGCCLE--TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
++ ++ H++IV+ + L + ++ E+ G+LS +I Q+ + ++EE
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHA-- 119
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIP----IFHRDIKSSNILLDDKFS--------- 485
V + ++ A+AY H+ P + HRD+K NI L
Sbjct: 120 -------IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 486 --------AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF--QSSQYTDKSDVYSFG 535
AK+ DFG S+++ + + + GT Y+ PE ++ Y DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 536 VVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAEL 595
++ EL +GK P + N + IS K L I K S+E + L
Sbjct: 231 CIIYELCSGKTPF------HKANNFSQLISELKRGPDLPI------KGKSKE----LNIL 274
Query: 596 AMGCLRLNSKKRPTMKQ 612
L L++K+RP+ Q
Sbjct: 275 IKNLLNLSAKERPSALQ 291
|
Length = 1021 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVA---VKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLG 395
+G G FG V + + VA VK KA + +F+ + + H +I++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
C+E +LV+EY G+L ++ Q + Q L + R+ACE+A
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ------------RMACEIAA 110
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGTFGY 514
V +MH H D+ N L + KV D+G S D +
Sbjct: 111 GVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 515 FDPEY---FQ----SSQYTDKSDVYSFGVVLLELL 542
PE F +++ T S+V++ GV L EL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 43/234 (18%)
Query: 333 NYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKAIDKTQI-EQFINEVVILSQI-N 386
Y + LGQG +G V + ++ K + K + ++ + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 387 HRHIVKLLGCCLETEVP-------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
H++I C + ++ + +YE + +L I Q L + S
Sbjct: 61 HKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP-------LTDAHFQS 109
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
+ ++ C + Y+HS+ + HRD+K N+L++ K+ DFG +R
Sbjct: 110 FI-----YQILC----GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSE 157
Query: 500 DKT----HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPI 548
+ +T V T Y PE S Q YT DV+S G +L ELL G+KP+
Sbjct: 158 NPGENAGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 24/227 (10%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGCCL 398
+G+G +G VYK DG K I+ T I E+ +L ++ H +++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 399 -ETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACEVAG 455
++ V L+++Y +L H I H+ + K+ ++ + + SL ++ +
Sbjct: 69 SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ--------ILD 119
Query: 456 AVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSR--SVPNDKTHLTTAVQ 509
+ Y+H++ + HRD+K +NIL+ ++ K++D G +R + P V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 510 GTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
TF Y PE ++ YT D+++ G + ELLT +PI R+E+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+Y + +G G +G VYK L G + AVK K E+ ++ + H +IV
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
G L E + EY G+L H ++ E ++ C
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYH-----------------VTGPLSELQIAYVC 112
Query: 452 -EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
E +AY+HS + HRDIK +NILL D K++DFG + + + + G
Sbjct: 113 RETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-G 168
Query: 511 TFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPI 548
T + PE ++ Y D+++ G+ +EL + P+
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF----INEVVILSQIN 386
Y + +GQG FG V+K IVA+K K + + + E F + E+ IL +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLK 69
Query: 387 HRHIVKLLGCCLETEVP--------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
H ++V L+ C P LV+E+ C +L+ + + K L E +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLL----SNKNVKFTLSEIK-- 122
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--S 496
+V + + Y+H + I HRD+K++NIL+ K++DFG +R S
Sbjct: 123 ---------KVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFS 170
Query: 497 VP-NDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+ N K + T T Y PE Y D++ G ++ E+ T + PI
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 24/213 (11%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
+G G +G VYK + G + A+K K E++++ H +IV G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+ + E+ G+L H LS V+ E +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH----------------VTGPLSESQIAYVSRETLQGLY 120
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+HS + HRDIK +NILL D K++DFG S + + + GT + PE
Sbjct: 121 YLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
Query: 519 YF---QSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+ Y D+++ G+ +EL + P+
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+A V +HS + HRDIK N+LLD +++DFG+ + D T ++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 513 GYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE Q+ +Y + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND--KTHLTTAVQGTFG 513
A+ Y+H++ +FHRD+K NIL + K+ DFG +R ND T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 514 YFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGK 545
Y PE S S+YT D++S G + E+LTGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 340 LGQGGFGTVYKG--MLPDGSIVAVKRSKAIDKTQIEQF----INEVVILSQIN---HRHI 390
+G+G +G V+K + G VA+KR + +T E I EV +L + H ++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 391 VKLLGCCL------ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
V+L C ET++ LV+E++ Q+ L++ E + E
Sbjct: 67 VRLFDVCTVSRTDRETKL-TLVFEHV--------------DQDLTTYLDKVPE-PGVPTE 110
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+ ++ + ++HS + HRD+K NIL+ K++DFG +R
Sbjct: 111 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--A 165
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
T+V T Y PE S Y D++S G + E+ +KP+
Sbjct: 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 66/300 (22%)
Query: 340 LGQGGFGTVYKGML---PDGSI------VAVKRSKAIDKTQI--EQFINEVVILSQINHR 388
LGQG F +YKG+L D I V+V K + F ++SQ++H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL-KVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
H+VKL G C+ E ++V EY+ G L +H E+ SL W ++
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH-------------REKNNVSLHW--KLD 105
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFS----AKVSDFGTSRSVPNDK 501
VA ++A A+ Y+ + H ++ NIL+ K+SD G +V + +
Sbjct: 106 VAKQLASALHYLEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
Query: 502 THLTTAVQGTFGYFDPEYFQ--SSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEER 557
+ + PE + + T +D +SFG LLE+ + G++P+ L+ E+ER
Sbjct: 163 ERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER 217
Query: 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
++ L + D +A L C + KRP+ + + DL
Sbjct: 218 --------FYQDQHRLPMP-----------DCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 41/227 (18%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKR-----SKAIDKTQIEQFINEVVILSQI 385
D Y +G G +G V VA+K+ AI + + E+ +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHM 71
Query: 386 NHRHIVKLLGC-----CLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
+H +++ LL LE V LV + G ++I Q+ + + Q L
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
L Y+HS+ I HRD+K SNI +++ K+ DFG +R
Sbjct: 130 GLK----------------YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH--T 168
Query: 500 DKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
D +T V T Y PE Y D++S G ++ ELLTGK
Sbjct: 169 DD-EMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 41/128 (32%), Positives = 69/128 (53%), Gaps = 12/128 (9%)
Query: 425 QQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484
Q+ E+ EE EL+ L E+ + + +VA ++++ S I HRD+ + NILL
Sbjct: 196 DQDVTSEILEEDELA-LDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGR 251
Query: 485 SAKVSDFGTSRSVPNDKTHLTTAVQGT----FGYFDPEYFQSSQYTDKSDVYSFGVVLLE 540
K+ DFG +R + ND ++ V+G + PE + YT +SDV+S+G++L E
Sbjct: 252 ITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 541 LLT-GKKP 547
+ + G P
Sbjct: 309 IFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 46/220 (20%), Positives = 82/220 (37%), Gaps = 28/220 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRS--KAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
+ + K P ++VAVK+ + K ++ E++ Q+ H +I+ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
+ +V + G+ + H + L L+ ++ +V
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-----------LPELAIAFILK---DVLN 112
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG-- 513
A+ Y+HS I HR +K+S+ILL +S S S+
Sbjct: 113 ALDYIHSKGFI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 514 ----YFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKP 547
+ PE Q + Y +KSD+YS G+ EL G P
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+HS+ + HRD+K SN+LL+ K+ DFG +R ++K T T Y PE
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPE 178
Query: 519 -YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
S+YT DV+S G + ELL G+KP+
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 59/227 (25%), Positives = 108/227 (47%), Gaps = 24/227 (10%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLGCCL 398
+G+G +G VYK DG K I+ T I E+ +L ++ H +++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 399 -ETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACEVAG 455
+ V L+++Y +L H I H+ + K+ ++ + + SL ++ +
Sbjct: 69 SHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------ILD 119
Query: 456 AVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSR--SVPNDKTHLTTAVQ 509
+ Y+H++ + HRD+K +NIL+ ++ K++D G +R + P V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 510 GTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
TF Y PE ++ YT D+++ G + ELLT +PI R+E+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+ Y+H+ I HRD+K+ NI ++D + D G ++ L A GT
Sbjct: 170 LRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVETNA 224
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELL 542
PE +Y K+D++S G+VL E+L
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQ-----FINEVVILS 383
A +Y LG+G + TVYKG+ +G +VA+K + + E+ I E +L
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLK 58
Query: 384 QINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+ H +IV L E V+EY+ + +L+ ++ H L
Sbjct: 59 GLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHP---------------GGLHP 102
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDK 501
N ++ +AY+H I HRD+K N+L+ K++DFG +R S+P+ +
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-Q 158
Query: 502 THLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGK 545
T+ + V T Y P+ ++ Y+ D++ G + +E+L G+
Sbjct: 159 TYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 334 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRH 389
Y + +G G G V Y +L D ++ K S+ ++T ++ E+V++ +NH++
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
I+ LL P E + L + D Q + EL+ E+ +S L ++ +
Sbjct: 78 IISLL----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER-MSYLLYQ----M 128
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
C + ++HS+ I HRD+K SNI++ + K+ DFG +R+ + + T
Sbjct: 129 LC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYV 179
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
T Y PE Y + D++S G ++ E++ K
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGTFGYF 515
+ Y+HS+ I HRDIK N+L++ K+ DFG +R P++ H+T V + Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 516 DPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 545
PE S+ YT D++S G + ELL +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 334 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKR-SKAI-DKTQIEQFINEVVILSQINHR 388
Y + +G G G V Y + G VA+K+ S+ + T ++ E+V++ +NH+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 389 HIVKLLGC-----CLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+I+ LL LE V LV E + + NL I +L+ E+ +S L
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ---------MDLDHER-MSYLL 124
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
++ + C + ++HS+ I HRD+K SNI++ + K+ DFG +R+
Sbjct: 125 YQ----MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSF 172
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
+T V T Y PE Y + D++S G ++ E++ G
Sbjct: 173 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
E+ IL I+HR I+ L+ +V + + D ++
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRS-------- 179
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS-RS 496
L E + + + A+AY+H I HRD+K+ NI LD+ +A + DFG + +
Sbjct: 180 -GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 497 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+ T GT PE Y K+D++S G+VL E+ +
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+A V + S + HRDIK NIL+D +++DFG+ + D T ++ GT
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 167
Query: 513 GYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE Q+ +Y + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+HS+ + HRD+K SNIL+++ K+ DFG +R D T T Y PE
Sbjct: 123 YVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR--IQD--PQMTGYVSTRYYRAPE 175
Query: 519 YFQSSQ-YTDKSDVYSFGVVLLELLTGK 545
+ Q Y + D++S G + E+L GK
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+A V + S + HRDIK N+LLD +++DFG+ + D T + GT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 513 GYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKP 547
Y PE Q+ +Y + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQ--IEQFINEVVILSQINHRHIVKLLGC 396
+G+G +G V K + IVA+K+ K ++ + E + E+ +L + +IV+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAG 455
LV+EY+ +K LE +E+ + +VR ++
Sbjct: 69 FRRRGKLYLVFEYV-----------------EKNMLELLEEMPNGVPPEKVRSYIYQLIK 111
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
A+ + H + I HRDIK N+L+ K+ DFG +R++ T T Y
Sbjct: 112 AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
PE + Y D++S G +L EL G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 33/138 (23%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 414 NLSHHIHDHQQQQEQKQELEEEQELSS-----LSWENRVRVACEVAGAVAYMHSSASIPI 468
++ +D + + E + LS L+ + + +VA + ++ S +
Sbjct: 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV-- 259
Query: 469 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF---GYFDPEYFQSSQY 525
HRD+ + N+LL K+ DFG +R + +D +++ TF + PE + Y
Sbjct: 260 -HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLY 316
Query: 526 TDKSDVYSFGVVLLELLT 543
T SDV+S+G++L E+ +
Sbjct: 317 TTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 334 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKR-SKAI-DKTQIEQFINEVVILSQINHR 388
Y + +G G G V Y +L VA+K+ S+ ++T ++ E+V++ +NH+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 389 HIVKLLGC-----CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+I+ LL LE V + + + NL I + EL+ E+ +S L +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---------QMELDHER-MSYLLY 133
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
+ + C + ++HS+ I HRD+K SNI++ + K+ DFG +R+ +
Sbjct: 134 Q----MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSF 180
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
+ T T Y PE Y + D++S G ++ E++ G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/268 (23%), Positives = 98/268 (36%), Gaps = 69/268 (25%)
Query: 332 DNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
++++ + +G+G FG V G I A+K +S+ K Q+ E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+V L + + L+ E++ G+L + + E R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------------TRF 105
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS------------- 494
+A E A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 106 YMA-ECVLAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 495 ---------------RSVPNDKTHLTTAVQ------------------GTFGYFDPEYFQ 521
SV D +LT + + GT Y PE F
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 522 SSQYTDKSDVYSFGVVLLELLTGKKPIC 549
Y + D +S G ++ E L G P C
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPPFC 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 8/106 (7%)
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 500
LS+ + V + +VA + ++ S + HRD+ + N+L+ + K+ DFG +R + D
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 501 KTHLTTAVQGTF---GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543
+++ TF + PE ++ YT SDV+SFG++L E+ T
Sbjct: 293 SNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 37/248 (14%)
Query: 340 LGQGGFGTVYKGMLPDG---SIVAVKRSKAIDKTQIE-QFINEVVILSQINHRHIVKLLG 395
+G G FG V G + G + V VK + Q + +F+ E + H ++++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV--RVACEV 453
C E +LV E+ G+L K L ++ ++ + R+ACE+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDL-------------KGYLRSCRKAELMTPDPTTLQRMACEI 109
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT-AVQGTF 512
A + ++H + I H D+ N LL + K+ D+G S + + ++T +
Sbjct: 110 ALGLLHLHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 513 GYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564
+ PE T +S+V+S GV + EL G +P R + ++ Y +
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYTV 223
Query: 565 SLAKENKL 572
+E +L
Sbjct: 224 ---REQQL 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 29/161 (18%)
Query: 342 QGGFGTVYKGMLPDGS----IVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G FG VY G + S + VK++ I+K + Q E L+ IV L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YS 72
Query: 398 LETEVPV-LVYEYICNGNLSH--HIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
L++ V LV EY+ G++ HI+ + +EE + +S EVA
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGY---------FDEEMAVKYIS---------EVA 114
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
A+ Y+H I HRD+K N+L+ ++ K++DFG S+
Sbjct: 115 LALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 61/263 (23%), Positives = 119/263 (45%), Gaps = 39/263 (14%)
Query: 298 FKQNGGYLLQQRLS----SCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML 353
F+ N L ++ S + ++ K+ + + +Y +G G FG VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 354 PDGS-IVAVKRSKAIDKTQIEQFIN-EVVILSQINHRHIVKL-----LGCCLETEVPV-- 404
D S VA+K+ Q Q+ N E++I+ +NH +I+ L C + E +
Sbjct: 88 IDTSEKVAIKKV-----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 405 -LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS 463
+V E+I +H + + + + S++ + A+AY+HS
Sbjct: 143 NVVMEFI-----PQTVHKYMKHYARNNHALPLFLVKLYSYQ--------LCRALAYIHSK 189
Query: 464 ASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQ 521
I HRD+K N+L+D + K+ DFG+++++ + ++ + F Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLG 244
Query: 522 SSQYTDKSDVYSFGVVLLELLTG 544
++ YT D++S G ++ E++ G
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 67/257 (26%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIV-AVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
+ +G G FG V D + + A+K ++ + + Q E IL++ ++ +VKL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 394 LGCCLETEVPVLVYEYICNGNL-SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
+ + V +YI G++ S I + + EE +L+ R +A E
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI---------RLGIFEE-DLA------RFYIA-E 109
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG-------------------- 492
+ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 110 LTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 493 --TSRSVPN-----DKTHLTT---------------AVQGTFGYFDPEYFQSSQYTDKSD 530
S D+ L ++ GT Y PE + YT D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 531 VYSFGVVLLELLTGKKP 547
+S GV+L E+L G+ P
Sbjct: 227 WWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 63/250 (25%), Positives = 95/250 (38%), Gaps = 61/250 (24%)
Query: 338 RFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVV-------ILSQINHRH 389
+ LG+G G V+ L G + A+K +DK ++ + N+V IL+ ++H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALK---VLDKKEMIKR-NKVKRVLTEQEILATLDHPF 62
Query: 390 IVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+ L +TE + LV +Y G L L + Q LS E R
Sbjct: 63 LPTLY-ASFQTETYLCLVMDYCPGGELFR--------------LLQRQPGKCLS-EEVAR 106
Query: 449 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----------DDKFSAKVSD------ 490
A EV A+ Y+H I +RD+K NILL D + V
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 491 --FGTSRSVPNDKTHLTTAVQ---------GTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 539
G+ RS N T + + GT Y PE + D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 540 ELLTGKKPIC 549
E+L G P
Sbjct: 224 EMLYGTTPFK 233
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 332 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH 387
+++ + + G +G VY K ++ + + I + QI+Q E IL+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE-N 445
+V + C ET+ + +V EY+ G+ + + + + +L +
Sbjct: 61 PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLL----------------KNIGALPVDMA 103
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR---------- 495
R+ A E A+ Y+H+ I HRD+K N+L+ K++DFG S+
Sbjct: 104 RMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 496 ---SVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ D + L V GT Y PE Y D ++ G++L E L G P
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 51/232 (21%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 322 FTAEELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI--EQ 374
F EE+ + + Y + +G G +G+V + G VA+K+ +++I ++
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
E+ +L + H +++ LL + + + + L Q+ L E
Sbjct: 61 AYRELTLLKHMQHENVIGLL----DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE 116
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
++ + L ++ + + Y+HS+ I HRD+K N+ +++ K+ DFG +
Sbjct: 117 DK-VQYLVYQ--------MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 545
R + T T Y PE + Y D++S G ++ E+LTGK
Sbjct: 165 RHADAEMTGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 11/136 (8%)
Query: 369 KTQIEQFINEVVILSQINHRHIVKLL-----GCCLETEVPVLVYEYICNGNLS----HHI 419
K N V +L + +++K+ G E EV +L + + L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAIL--QLLARKGLPVPKVLAS 61
Query: 420 HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479
+ E E + L +S E + +A ++A +A +H + + H D+ NIL
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL 121
Query: 480 LDDKFSAKVSDFGTSR 495
+DD + D+ +
Sbjct: 122 VDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+HS+ I HRD+K SN+ +++ K+ DFG +R ++ T T Y PE
Sbjct: 135 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPE 187
Query: 519 YFQS-SQYTDKSDVYSFGVVLLELLTGK 545
+ Y D++S G ++ ELLTG+
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT------SRSVPNDKT 502
VA ++ A+ Y+H I HRDIK+ N+L++ + DFG S S P
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP---- 317
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 540
+ GT PE YT D++S G+V+ E
Sbjct: 318 -FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 30/104 (28%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 444 ENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E+R++ + ++ + Y+H++ I HRD+K N+ +++ K+ DFG +R ++ T
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 503 HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 545
T Y PE + YT D++S G ++ E+LTGK
Sbjct: 174 GYVV----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 8e-06
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
++ + +KL + VL+ +YI +G+L + +K+ E E+ +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--------KKEGKLSEAEVKKI---- 114
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGTSRSVPNDKTHL 504
+R E A+ +H I H DIK N+L D K + D+G + + +
Sbjct: 115 -IRQLVE---ALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY- 166
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
GT YF PE + Y D ++ GV+ ELLTGK P +EE
Sbjct: 167 ----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 5/94 (5%)
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGT 511
V A+ Y+H + I HRDIK+ NI ++ + DFG + P D + GT
Sbjct: 191 VLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGT 246
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
PE Y D++S G+VL E+ T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
Y+HS+ I HRD+K SN+ +++ ++ DFG +R ++ T T Y PE
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPE 185
Query: 519 YFQS-SQYTDKSDVYSFGVVLLELLTGK 545
+ Y D++S G ++ ELL GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 62/258 (24%), Positives = 97/258 (37%), Gaps = 69/258 (26%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG G FG V D ++ A+K + +++ Q+ E IL++ ++ +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
+ + V +YI G++ + + E+ E R +A E+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL--------IRMEVFPEVLA-------RFYIA-ELTL 112
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV------------------ 497
A+ +H I HRDIK NIL+D K++DFG
Sbjct: 113 AIESVHKMGFI---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 498 ---PND----------------------KTH---LTTAVQGTFGYFDPEYFQSSQYTDKS 529
P+D K H L ++ GT Y PE YT
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 530 DVYSFGVVLLELLTGKKP 547
D +S GV+L E+L G+ P
Sbjct: 230 DWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 18/108 (16%)
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN------------ 499
+ A+ Y H+ + + H D+K NIL++ S V D T+R++P
Sbjct: 239 QTGVALDYFHTE--LHLMHTDLKPENILMET--SDTVVDPVTNRALPPDPCRVRICDLGG 294
Query: 500 --DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
D+ H TA+ T Y PE + +D++S G ++ EL TGK
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 340 LGQGGFGTVYK----GMLPDGSI--VAVKRSK-AIDKTQIEQFINEVVILSQI-NHRHIV 391
LG G FG V + G+ + VAVK K + T+ E ++E+ +LS + NH +IV
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 392 KLLGCCLETEVPVLVYEYICNGNL 415
LLG C +++ EY C G+L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDL 126
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 23/157 (14%)
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
++V L + + LV ++ G L HI E+ + R
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK----------------R 89
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
A E+ A+ +H I RD+ +NILLDD+ +++ F V + + AV
Sbjct: 90 WAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEV--EDSCDGEAV 144
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
+ Y PE S+ T+ D +S G +L ELLTGK
Sbjct: 145 ENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF---------GTSRSVPNDKTHLTT 506
+ Y+H + I HR+IK+S+IL+ +S G V D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 507 AVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKP 547
+V + PE + Y KSD+YS G+ EL TG+ P
Sbjct: 170 SVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 60/258 (23%), Positives = 94/258 (36%), Gaps = 69/258 (26%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLG 395
LG G FG V D ++ A+K + D + Q+ E IL++ ++ +V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
+ + V +YI G++ + E L+ R +A E+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE------------DLA---RFYIA-ELTC 112
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS--------------------- 494
AV +H I HRDIK NIL+D K++DFG
Sbjct: 113 AVESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 495 -------------------------RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS 529
R+ + L ++ GT Y PE + YT
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229
Query: 530 DVYSFGVVLLELLTGKKP 547
D +S GV+L E+L G+ P
Sbjct: 230 DWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|144899 pfam01476, LysM, LysM domain | Back alignment and domain information |
|---|
Score = 36.6 bits (86), Expect = 0.001
Identities = 13/39 (33%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 178 GDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIP 216
GDT+SSI ++G + + + N LS + ++ L IP
Sbjct: 6 GDTLSSIAKRYGITVEELAELNGLSSPN-LYVGQKLKIP 43
|
The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 56/253 (22%), Positives = 106/253 (41%), Gaps = 52/253 (20%)
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
F ++SQ++H H+ + G C+ ++V E++ +G L L +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-------------VCLRK 109
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-------K 487
E+ ++W ++ VA ++A A++Y+ + H ++ + NILL A K
Sbjct: 110 EKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLEL-LTGK 545
+SD G S + + + + + PE + + +D +SFG LLE+ G+
Sbjct: 165 LSDPGVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 546 KPI-CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNS 604
P+ T E+ER K+++L E + +A L CL
Sbjct: 220 VPLKERTPSEKER-------FYEKKHRL------------PEPSCKELATLISQCLTYEP 260
Query: 605 KKRPTMKQVSMDL 617
+RP+ + + DL
Sbjct: 261 TQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 54/253 (21%), Positives = 105/253 (41%), Gaps = 52/253 (20%)
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
F ++ Q++H+HIV L G C+ ++V E++ G L +H
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-------------R 97
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----DDKFSA--K 487
+ ++ + W + +VA ++A A++Y+ + H ++ + NILL D + K
Sbjct: 98 KSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152
Query: 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLEL-LTGK 545
+SD G +V + + + + PE + S+ + +D +SFG L E+ G+
Sbjct: 153 LSDPGIPITVLSRQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207
Query: 546 KPIC-LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNS 604
P+ T E+ER + + K L A+L C+ +
Sbjct: 208 IPLKDKTLAEKERFYEGQCMLVTPSCKEL-------------------ADLMTHCMNYDP 248
Query: 605 KKRPTMKQVSMDL 617
+RP + + D+
Sbjct: 249 NQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 30/109 (27%), Positives = 56/109 (51%), Gaps = 8/109 (7%)
Query: 338 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKAIDKTQIEQ-FINEVVILSQIN-HRH 389
R LG G FG V +G S VAVK K ++ +Q ++E+ I++ + H +
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
IV LLG C ++ ++ EY G+L +++H ++ + + +++L
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDL 151
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 646 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.83 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.58 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 98.5 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 98.36 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 98.32 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.31 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| smart00257 | 44 | LysM Lysin motif. | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 97.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.89 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.82 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.8 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 97.79 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.65 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 97.65 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.57 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 97.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.49 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.37 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 97.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.17 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-58 Score=484.48 Aligned_cols=291 Identities=48% Similarity=0.816 Sum_probs=259.2
Q ss_pred cccccCHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEE
Q 046188 318 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397 (646)
Q Consensus 318 ~~~~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~ 397 (646)
..+.|+++|++.||++|+..++||+|+||.||+|.+.+|..||||++.........+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999988899999998875443144599999999999999999999999
Q ss_pred EeCC-ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 398 LETE-VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 398 ~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
.+.+ ..+||||||++|+|.++|+.... . +|+|.+|++||.++|+||+|||+...|+|+||||||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~-------------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG-------------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC-------------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 9988 49999999999999999988542 1 7999999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecCCccccCC-CCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 477 NILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
|||||+++++||+|||+|+..+. ........ .||.+|+|||++..+..|.|+|||||||+|+||+||++|.+...+..
T Consensus 207 NILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 207 NILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred HeeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 99999999999999999976654 22221111 79999999999999999999999999999999999999988766555
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhc-ccCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVA-KEASE-EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
...+..|....+.+..+.+++|+++. ..++. .....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 66689999888988899999999987 66665 6888899999999999999999999999999766543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=411.01 Aligned_cols=255 Identities=31% Similarity=0.490 Sum_probs=224.9
Q ss_pred CcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCC
Q 046188 335 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
...+.||+|.||.||.|.++....||+|.++.. ....++|.+|+.+|++++|+|||+++|+|..++..+||||||++|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 346789999999999999976679999998875 2345688999999999999999999999999889999999999999
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCc
Q 046188 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494 (646)
Q Consensus 415 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 494 (646)
|.+||.... ...+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||
T Consensus 288 Ll~yLr~~~--------------~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 288 LLDYLRTRE--------------GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred HHHHhhhcC--------------CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 999998732 347899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhH
Q 046188 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLL 573 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 573 (646)
+...++.........-+..|.|||.+..+.+|.|||||||||+||||+| |+.|+...... .+.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~ 414 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVL 414 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHH
Confidence 9766665555555667789999999999999999999999999999999 78876544322 244
Q ss_pred HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 574 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.++...+.+.|..|+..+++||..||+.+|++|||++.+...|+.+...
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 56677777888999999999999999999999999999999999988764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=404.11 Aligned_cols=259 Identities=34% Similarity=0.539 Sum_probs=216.2
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-ceEEEEEeccC
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEYICN 412 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-~~~LV~Ey~~~ 412 (646)
..+.||+|+||+||+|.++....||||++.... ....++|.+|+.+|++++|||||+|+|+|.+.. ...+||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999644449999987632 223668999999999999999999999999887 78999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-cEEEeec
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDF 491 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI~Df 491 (646)
|+|.++++... ...++|..+++||.|||+||.|||+.+. ||||||||+||||+.++ ++||+||
T Consensus 125 GsL~~~l~~~~--------------~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 125 GSLSVLLHKKR--------------KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CcHHHHHhhcc--------------cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence 99999998841 2479999999999999999999999884 99999999999999997 9999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ--SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|+++...... ...+...||+.|||||.+. ...++.|+|||||||+||||+||+.||....... ..
T Consensus 189 Glsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~------ 255 (362)
T KOG0192|consen 189 GLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VA------ 255 (362)
T ss_pred ccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HH------
Confidence 9998764322 2233367999999999999 6699999999999999999999999997554311 11
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
..+.....+...+..+...+..|+.+||+.||..||++.||+..|+.+......
T Consensus 256 ---~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 256 ---SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 112223334455666788999999999999999999999999999999875443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=424.46 Aligned_cols=273 Identities=27% Similarity=0.468 Sum_probs=226.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
+.+....+.||+|+||.||+|... +...||||.++..... ..++|.+|+++|..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345556788999999999999853 2457999999986655 778999999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++|+|||..|+|.+||..............+ ...+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~--~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQD--TPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 9999999999999999876543221111000 1346999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCcccc-ccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTT-AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
..+||+||||+|..-..+.+... ...-.++||+||.+..+++|++||||||||+|||+++ |+.|++....++.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV----- 714 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV----- 714 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-----
Confidence 99999999999987544443333 3456789999999999999999999999999999999 9999876544331
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.+... +..+ -+.|.+++..+++||..||+.+|.+||++.||-..|+...+.+
T Consensus 715 --Ie~i~--------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 --IECIR--------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --HHHHH--------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22222 2233 5678999999999999999999999999999999999877643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=372.66 Aligned_cols=251 Identities=29% Similarity=0.405 Sum_probs=209.5
Q ss_pred cCccccccCcEEEEEEEcC-CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc-eEEEEEeccC
Q 046188 336 QSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV-PVLVYEYICN 412 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~-~~LV~Ey~~~ 412 (646)
..+.||+|..|+|||++++ +++.+|+|.+.. .+....+++.+|++++++.+||+||+++|.|..+.. ..++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3678999999999999965 688999999854 345556789999999999999999999999999985 9999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
|+|.+++... .++++...-+|+.+|++||.|||+ ++ ||||||||+||||+..|.+||+||
T Consensus 163 GSLd~~~k~~----------------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 163 GSLDDILKRV----------------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 9999999763 368999999999999999999996 66 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|.+..+.+. ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+....+. .....+.
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~L--------- 290 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFEL--------- 290 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHH---------
Confidence 999987443 445678999999999999999999999999999999999999998654111 1111111
Q ss_pred hHHHhhhhhcccCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 572 LLEILDARVAKEASEE-DIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+..+++.. ....|.+ +++++..++..||++||.+||+++|+++|=--
T Consensus 291 l~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 291 LCAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred HHHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 11222211 1233444 78889999999999999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=405.51 Aligned_cols=260 Identities=26% Similarity=0.461 Sum_probs=226.0
Q ss_pred CCcCccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 334 YNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..+.++||.|.||.|++|+++- ...||||.+|.. .+++..+|+.|+.||.++.||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3456889999999999999752 357999999974 45667799999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
||+||+|+.||+.+.. .++|.+...+..+||.||.||.+.+ +|||||.++||||+.+..+|+
T Consensus 711 yMENGsLDsFLR~~DG---------------qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG---------------QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred hhhCCcHHHHHhhcCC---------------ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEe
Confidence 9999999999988754 5999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCcccc--ccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTT--AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||||+|.+.++.....+ ...-..+|.|||.+...++|.++|||||||+|||.++ |.+|+......+
T Consensus 773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---------- 842 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------- 842 (996)
T ss_pred ccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------
Confidence 999999987655432222 2334579999999999999999999999999999887 999987554332
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
+...++..++.+.|++|+..|.+||+.||++|..+||.+.||+..|.++-..-..+
T Consensus 843 ------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 843 ------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred ------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 33445566677789999999999999999999999999999999999998665544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=365.15 Aligned_cols=203 Identities=33% Similarity=0.554 Sum_probs=182.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
..+|...+.||+|+|++||+|+++ ++..||||.+... .++..+.+..|+++|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999965 5899999987654 6677788899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC----
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---- 483 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---- 483 (646)
|||++|+|.+|++.. ..+++.....++.|+|.||++||+++ ||||||||+||||+.+
T Consensus 89 EyC~gGDLs~yi~~~----------------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----------------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARND 149 (429)
T ss_pred EeCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCC
Confidence 999999999999874 36999999999999999999999999 9999999999999765
Q ss_pred --CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 484 --FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 484 --~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
-.+||+|||+|+.+.. .....+.+|++-|||||++..++|+.|+|+||.|++||||++|+.||......
T Consensus 150 ~~~~LKIADFGfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred CCceEEecccchhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 5689999999998853 34455688999999999999999999999999999999999999999754443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=379.80 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=213.6
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.+|...+.||+|||..||.++. ..|+.||+|++.. ....+.+...+|++|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 7899999998654 23456778899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|+|++|+|.++++. +.++++.+++.+..||+.||.|||+++ |+|||||..|+||+++.++|
T Consensus 98 ELC~~~sL~el~Kr----------------rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----------------RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred EecCCccHHHHHHh----------------cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEE
Confidence 99999999999974 347999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||||..+..+.. ...+.+|||.|+|||++....++..+||||+||+||-|+.|++||....-.+. ..
T Consensus 159 IgDFGLAt~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~--- 228 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YN--- 228 (592)
T ss_pred ecccceeeeecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HH---
Confidence 999999998754432 33457899999999999999999999999999999999999999974322111 11
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+... ....|...+....+||.++|+.||.+|||+++|+.+=-
T Consensus 229 ------~Ik~~--~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 229 ------KIKLN--EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred ------HHHhc--CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 11111 11234566678899999999999999999999997643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=352.42 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=210.7
Q ss_pred cCCCcCccccccCcEEEEEEE-cCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEE-EEeCCc-eEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGC-CLETEV-PVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~-~~~~~~-~~LV 406 (646)
.+|.+.++||+|+||+|||+. +.+|..||.|.++- .+....++...|+.+|++++|||||++++. +.++.. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999999 56899999998764 455667789999999999999999999994 444444 7999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC-CCCeEecCCCCCCEEECCCCc
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA-SIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-~~~ivHrDIk~~NILl~~~~~ 485 (646)
|||++.|+|...++..+.. ...+++...|+++.|++.||+.+|+.- ...|+||||||.||+|+.+|.
T Consensus 99 mE~c~~GDLsqmIk~~K~q------------kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ------------KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred HHhhcccCHHHHHHHHHhc------------cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 9999999999998765432 457899999999999999999999922 013999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+||||++.+.... ......+|||.||+||.+.+..|+.|+||||+||++|||..-..||.... +..
T Consensus 167 vKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~---- 235 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS---- 235 (375)
T ss_pred eeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH----
Confidence 9999999999885543 33455789999999999999999999999999999999999999997542 111
Q ss_pred HHhhchhHHHhhhhhcccCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEAS-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+.+-+...-..+.| ...+..+.+|+..|+..||..||+.-.+++.+..
T Consensus 236 ------L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 236 ------LCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------HHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111111112234 5678899999999999999999997666666554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=404.31 Aligned_cols=266 Identities=28% Similarity=0.526 Sum_probs=221.2
Q ss_pred cCCCcCccccccCcEEEEEEEcCC--CC----EEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD--GS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~--g~----~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++.+..+.||+|.||.||+|...+ |. .||||.++.. +.++..+|++|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455567889999999999999653 43 4999998764 5667789999999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+++|||++|+|..||++.+..... ...|+..+.+.|+.|||+|+.||++++ +|||||.++|+||++..
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~---------~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQ---------PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERR 839 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCC---------CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccC
Confidence 999999999999999887542211 357999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccc-cccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTA-VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||||+.+.+...+.... ..-..+|||||.+.++.+|.|+|||||||+|||++| |..|+......+ .
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v 913 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------V 913 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------H
Confidence 99999999999764443332222 234568999999999999999999999999999999 777775433322 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
+..+...+ +.+.|..|+..+++||..||+.+|++||++..|++.+..+.....
T Consensus 914 ~~~~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 914 LLDVLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11122222 345688899999999999999999999999999999998876644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=359.75 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=204.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH-------HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK-------TQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~-------~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
.+.|...+.||+|+||.|-+|.. ++|+.||||+++.... ....+..+|+++|++++|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35677889999999999999994 5799999998754211 112235699999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.||||||++||+|.+++-.+. .+.+....-++.|++.|+.|||+.| |+||||||+|||+..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk----------------~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK----------------YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSN 311 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc----------------ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEecc
Confidence 999999999999999997754 4666777889999999999999999 999999999999976
Q ss_pred C---CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCC---CCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 483 K---FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY---TDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 483 ~---~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
+ ..+||+|||+|+... ......+.+||+.|.|||++.+... ..|+|+||+||+||-+++|.+||.......
T Consensus 312 ~~e~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~- 388 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP- 388 (475)
T ss_pred CCcceEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-
Confidence 5 889999999999875 4455677899999999999977543 348899999999999999999996432211
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 557 RNLVAYFISLAKENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+. .++...++. .......+++..+||.+||..||++|||+.|++++-.
T Consensus 389 -sl~------------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 389 -SLK------------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred -cHH------------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 011 111111111 1223456788999999999999999999999998765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=366.35 Aligned_cols=244 Identities=26% Similarity=0.471 Sum_probs=207.7
Q ss_pred CCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 334 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
...++-||+|+.|.||+|+++ ++.||||+++...+ .+|+-|++++|+||+.|.|+|.....+++||||+..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 344778999999999999994 78999999875322 4788999999999999999999999999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
-|.+.|+.. .+++......|..+||.||+|||.+. |||||||+-||||+.+..+||+|||-
T Consensus 198 qL~~VLka~----------------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 198 QLYEVLKAG----------------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred cHHHHHhcc----------------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccc
Confidence 999999874 36888999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhH
Q 046188 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 573 (646)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 573 (646)
++...+- .....+.||..|||||++.+.+.++|+||||||||||||+||..|+...+... -+.
T Consensus 259 S~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIw 321 (904)
T KOG4721|consen 259 SKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIW 321 (904)
T ss_pred hHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEE
Confidence 9876433 22345789999999999999999999999999999999999999975322110 111
Q ss_pred HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 574 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.+-...+....|..+++-+.-|+++||+..|.+||++++|+.+|+-..
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 122233444567788888999999999999999999999999998543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=345.96 Aligned_cols=242 Identities=29% Similarity=0.445 Sum_probs=203.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|+..+.||+|+||.||.++.+ +++.+|+|.++. ....+.+...+|..||.+++||.||+++-.|.+.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999954 589999998865 2344566788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
+||+.||.|..+|.+. ..+++....-++.+|+.||.|||+.+ ||||||||+|||||.+|.+
T Consensus 104 ld~~~GGeLf~hL~~e----------------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----------------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHI 164 (357)
T ss_pred EeccCCccHHHHHHhc----------------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcE
Confidence 9999999999999764 35888888899999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
+|+||||++..... ...+.+.+||+.|||||++....++..+|.||+|+++|||++|.+||....... +....
T Consensus 165 ~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I 237 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKI 237 (357)
T ss_pred EEeccccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHH
Confidence 99999999965332 233445799999999999999999999999999999999999999997543211 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
... + ....+.-.+....+++.+.|+.||++|.
T Consensus 238 ~~~---------k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKG---------K-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcC---------c-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111 1 1223333567789999999999999996
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.13 Aligned_cols=262 Identities=29% Similarity=0.500 Sum_probs=217.9
Q ss_pred HhcCCCcCccccccCcEEEEEEEcCC--C--CE-EEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLPD--G--SI-VAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~~--g--~~-VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
..++....++||+|+||.||+|++.. + .. ||||..+. ....+..+|++|+.+|++++|||||+++|++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34555566899999999999999643 2 23 89999885 45778889999999999999999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++|||++.||+|.++|.+... .+++.++++++.+.|.||+|||+++ ++||||.++|+|++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~---------------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK---------------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYS 296 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC---------------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheec
Confidence 99999999999999999988642 5999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCcccc-ccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTT-AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l 559 (646)
.++.+||+||||++... ...... ...-..+|+|||.+..+.++.++|||||||++||+++ |..|+......+.
T Consensus 297 ~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--- 371 (474)
T KOG0194|consen 297 KKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--- 371 (474)
T ss_pred CCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---
Confidence 99999999999988643 111111 1235679999999999999999999999999999999 8889875543321
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
...+.-...+...+...+..+..++.+||..||++||+|.++.+.|+.+......
T Consensus 372 ------------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 372 ------------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1112122334445566778899999999999999999999999999998876553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.83 Aligned_cols=275 Identities=27% Similarity=0.435 Sum_probs=209.7
Q ss_pred HhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
..++|...++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||++++|++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346888899999999999999973 235689999987533 33456789999999999 8999999999987654
Q ss_pred -ceEEEEEeccCCCchhhhhhhhhhHHHH--------HH--------------------------------------HHH
Q 046188 402 -VPVLVYEYICNGNLSHHIHDHQQQQEQK--------QE--------------------------------------LEE 434 (646)
Q Consensus 402 -~~~LV~Ey~~~gsL~~~l~~~~~~~~~~--------~~--------------------------------------~~~ 434 (646)
..++||||+++|+|.+++.......... .. ...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5789999999999999997643210000 00 000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-cccccccCCc
Q 046188 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFG 513 (646)
Q Consensus 435 ~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~ 513 (646)
.....++++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 001235899999999999999999999998 999999999999999999999999999865332221 1223346788
Q ss_pred ccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHH
Q 046188 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAV 592 (646)
Q Consensus 514 y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 592 (646)
|+|||++.+..++.++||||||++||||++ |..||......+. +.....++ .....+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDG---------TRMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcC---------CCCCCCCCCCHHH
Confidence 999999999999999999999999999997 9999864332111 11111111 0111233455678
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 593 AELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 593 ~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=348.70 Aligned_cols=260 Identities=21% Similarity=0.345 Sum_probs=208.1
Q ss_pred ccccCHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEE
Q 046188 319 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLG 395 (646)
Q Consensus 319 ~~~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g 395 (646)
.+.++.++++ ......||+|++|.||+|.+ +|+.||||+++.... ...+.|.+|+.+|++++||||++++|
T Consensus 12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3445566653 22346799999999999998 689999999875432 22567889999999999999999999
Q ss_pred EEEe--C--CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEe
Q 046188 396 CCLE--T--EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFH 470 (646)
Q Consensus 396 ~~~~--~--~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivH 470 (646)
++.+ + ...++||||+++|+|.+++... ..++|...++++.|++.||.|||+. + ++|
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~H 146 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE----------------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPY 146 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhC----------------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCC
Confidence 9977 3 3578999999999999999753 3589999999999999999999985 6 779
Q ss_pred cCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 471 RDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 471 rDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
|||||+|||+++++.+||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 147 rdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf 222 (283)
T PHA02988 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222 (283)
T ss_pred CcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999998653321 12357899999999976 68899999999999999999999999
Q ss_pred CCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
......+ ...... ........+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 223 ~~~~~~~------~~~~i~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 223 ENLTTKE------IYDLII---------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCHHH------HHHHHH---------hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 7543221 111111 1111122334566789999999999999999999999999998763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.91 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=210.6
Q ss_pred hcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHH-HHHHHHHHHHhhcC-ccCceeEEEEEEeCC-ceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI-EQFINEVVILSQIN-HRHIVKLLGCCLETE-VPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~-~~~~~Ei~il~~l~-H~niv~l~g~~~~~~-~~~LV 406 (646)
-++|...++||.|+||+||+|+ ...|+.||||+|+..-.... -.-++|++-|++++ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3578889999999999999999 45789999999886322211 12368999999999 999999999999888 89999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||| ..+|.+.++.+. ..+++..+..|+.||++||+|+|.+| ++|||+||+|||+..+..+
T Consensus 89 fE~M-d~NLYqLmK~R~---------------r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~i 149 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRN---------------RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVI 149 (538)
T ss_pred HHhh-hhhHHHHHhhcC---------------CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEeccccee
Confidence 9999 789999997763 47999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcc-ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+||.... ....+.++.|.+|.|||++ ..+-|+.+.|+||+||+++|+.+-++-|.+..+.++.. .+.+
T Consensus 150 KiaDFGLARev~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~ 224 (538)
T KOG0661|consen 150 KIADFGLAREVRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICE 224 (538)
T ss_pred Eeccccccccccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHH
Confidence 9999999998744 3344667899999999976 56789999999999999999999999887665443322 2233
Q ss_pred HHhhchhH---------HHhhhhhccc-------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 566 LAKENKLL---------EILDARVAKE-------ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 566 ~~~~~~~~---------~~~d~~l~~~-------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
++...... ..|.-.+... .-...+....+|+.+|+++||.+|||+.|.+++-
T Consensus 225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 33322211 1122111110 0122567889999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.69 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=204.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
+.|+..-++|+|+||.|||.+.+ +|+.||||++... ++.-.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677788999999999999966 5999999997653 23344557899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++..-|.+ |... ...++.+...+++.|+++|+.|+|+++ ++||||||+||||+.++.+||
T Consensus 82 ~~dhTvL~e-Le~~---------------p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKL 142 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY---------------PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKL 142 (396)
T ss_pred ecchHHHHH-HHhc---------------cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEe
Confidence 996554443 3332 235888999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH-----
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY----- 562 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~----- 562 (646)
+|||+|+.+.. .....+.++.|.+|.|||.+.+ -+|+..+||||.||++.||++|.+-|....+-+...+...
T Consensus 143 CDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 143 CDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred ccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 99999998864 3344556788999999999877 7899999999999999999999988876554443222111
Q ss_pred ---HHHHHh-hc-----hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 563 ---FISLAK-EN-----KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 563 ---~~~~~~-~~-----~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...++. ++ ++.+.-++...+..-+.....+.++++.||+.||++|++-+|++.+
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 11 1111111111111112345578999999999999999999998854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.41 Aligned_cols=265 Identities=26% Similarity=0.457 Sum_probs=230.7
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
++++-...+....++||-|.||.||.|+|+. .-.||||.++.. ....++|++|+.+|+.++|||+|+|+|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455445667778999999999999999864 457999999874 56788999999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
|+|.|||.+|+|.+||+.... ..++--..+.+|.||+.||+||...+ +|||||.++|+|+.++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr--------------~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEn 401 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR--------------SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN 401 (1157)
T ss_pred EEEEecccCccHHHHHHHhch--------------hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhcccccc
Confidence 999999999999999987543 24666778999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
..+||+||||++.+..+.........-.+.|.|||.+..+.++.|+|||+|||+|||+.| |..|+...+.
T Consensus 402 hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------- 472 (1157)
T KOG4278|consen 402 HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------- 472 (1157)
T ss_pred ceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------
Confidence 999999999999997766655555566789999999999999999999999999999999 7778754321
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
..+.++++..++.+.|..|++.+++||++||+++|.+||++.||.+.++.+-.+
T Consensus 473 -------SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 473 -------SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred -------HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 123456677777888999999999999999999999999999999999987654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=349.23 Aligned_cols=259 Identities=30% Similarity=0.439 Sum_probs=208.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC--ceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--~~~LV~E 408 (646)
.++...+.||+|+||+||++... +|+..|||.+...+....+.+.+|+.+|++++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999965 48999999887654333667889999999999999999999855444 5889999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~k 487 (646)
|+++|+|.+++.+... .|++....+++.||++||.|||+++ |+||||||+||||+. ++.+|
T Consensus 97 y~~~GsL~~~~~~~g~---------------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~K 158 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---------------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVK 158 (313)
T ss_pred ccCCCcHHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEE
Confidence 9999999999987531 6999999999999999999999999 999999999999999 79999
Q ss_pred EeecCCccccCC--CCCccccccccCCcccChhccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPN--DKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||+++.... ..........||+.|||||++..+. ...++|||||||++.||+||+.|+... .....+
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~-- 231 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEA-- 231 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHH--
Confidence 999999987653 2222334578999999999998643 335999999999999999999998532 000111
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+..+.........|...+....+++.+|++.||++|||+.+++.+.-....
T Consensus 232 -------~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 232 -------LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 111111112235566677889999999999999999999999998875443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.77 Aligned_cols=265 Identities=26% Similarity=0.428 Sum_probs=216.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.+...+.++||+|.||.|.......+..||||+++..... ...+|.+|+++|.+++||||++|+|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3556667899999999999999877799999999985544 457999999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
|++|+|..|+..+.. ..+.-...++|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+
T Consensus 617 mEnGDLnqFl~ahea--------------pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKia 679 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--------------PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIA 679 (807)
T ss_pred HhcCcHHHHHHhccC--------------cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEec
Confidence 999999999987643 22455667889999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCchHHhhcHHHHHHHH
Q 046188 490 DFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 490 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|||+++.+-.+..+ .....+-.++|||||.+..+++|.++|||+|||+|||+++ ...|+.....+. ..+-...+
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~ 756 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEF 756 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhh
Confidence 99999976544443 3345667889999999999999999999999999999876 667764332211 11111122
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
+..... ......|.-++..++++|.+||..|..+||+++++...|....
T Consensus 757 ~~~~~~------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRDQGR------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCCc------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 221111 1122346778889999999999999999999999999987643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.85 Aligned_cols=263 Identities=26% Similarity=0.335 Sum_probs=207.6
Q ss_pred cCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV 406 (646)
+.|+.+++||+|+||.||||+ ..+|+.||+|+++... ........+||.||++++||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345567789999999999999 5579999999987643 33445667999999999999999999998876 578999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
+||| .-+|.-++.... -.++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+
T Consensus 197 FeYM-dhDL~GLl~~p~---------------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~L 257 (560)
T KOG0600|consen 197 FEYM-DHDLSGLLSSPG---------------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVL 257 (560)
T ss_pred Eecc-cchhhhhhcCCC---------------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCE
Confidence 9999 557777776542 26899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||||+.+........+..+.|.+|.|||.+.+ ..|+.++|+||.||||.||+.|++.+....+.+..+.+ ..
T Consensus 258 KiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI---fk 334 (560)
T KOG0600|consen 258 KIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI---FK 334 (560)
T ss_pred EeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH---HH
Confidence 999999999876665555666778999999999887 47999999999999999999999999877665543322 22
Q ss_pred HHhhchhHHHh--------hhhhcccC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEIL--------DARVAKEA-------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~--------d~~l~~~~-------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+........|- ..+....+ ....+....+|+..+|..||.+|.|+.++++.
T Consensus 335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 22211100010 00000111 12334677899999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.73 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=209.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~L 405 (646)
..+|...+.||+|+|++|++|+. ..++.+|||++... .....+-...|-+.|.+| +||.|++|+-.|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 35788899999999999999994 46899999987541 222233456788899999 89999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|+||++||+|.++|++. ..+++.....+|.+|+.||+|||++| ||||||||+|||||+|++
T Consensus 152 vLe~A~nGdll~~i~K~----------------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmh 212 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY----------------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGH 212 (604)
T ss_pred EEEecCCCcHHHHHHHh----------------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCc
Confidence 99999999999999875 46899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC----------cc--ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 486 AKVSDFGTSRSVPNDKT----------HL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~----------~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
+||+|||-|+.+..... .. ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||....+
T Consensus 213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 99999999998743211 11 1447899999999999999999999999999999999999999964322
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
- ..| .++++ +.-+++...++.+.+|+.+.|..||.+|++.+||.++.
T Consensus 293 y------liF---------qkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 293 Y------LIF---------QKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred H------HHH---------HHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 111 22222 12345666668899999999999999999999988764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.46 Aligned_cols=255 Identities=22% Similarity=0.398 Sum_probs=207.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|.+. .+..||+|.++.. .......+.+|+.++++++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56788899999999999999853 3568999998764 334456789999999999999999999999998999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..++|.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 85 ~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 85 TEYMSNGALDSFLRKHE---------------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred EEeCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcE
Confidence 99999999999986532 26899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
|++|||.+...............++..|+|||.+.++.++.++||||||+++||+++ |+.||......+. ..
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~------~~- 219 (266)
T cd05064 147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV------IK- 219 (266)
T ss_pred EECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HH-
Confidence 999999876543222222222345678999999999999999999999999999875 9999865433211 11
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
. +........+..++..+.+++.+||+.+|.+||++.||.+.|+++
T Consensus 220 ~---------~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 A---------VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H---------HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 111111223445667899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=340.87 Aligned_cols=270 Identities=25% Similarity=0.372 Sum_probs=204.3
Q ss_pred CCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhh--cCccCceeEEEEEEeCC----ceEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQ--INHRHIVKLLGCCLETE----VPVLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~H~niv~l~g~~~~~~----~~~LV 406 (646)
.....++||+|.||.||||.+ +++.||||++.. .+.+.|.+|-+|.+. ++|+||+++++.-.... ..+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 344567899999999999999 469999999875 455678888888776 58999999999876544 67899
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc------CCCCCeEecCCCCCCEEE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS------SASIPIFHRDIKSSNILL 480 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~------~~~~~ivHrDIk~~NILl 480 (646)
+||.++|+|.+||..+ .++|....+|+..+++||+|||+ +.+|+|+|||||++||||
T Consensus 287 t~fh~kGsL~dyL~~n-----------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv 349 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN-----------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV 349 (534)
T ss_pred eeeccCCcHHHHHHhc-----------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence 9999999999999875 68999999999999999999996 447899999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCC-CC-----CccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQ-YT-----DKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-~s-----~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
.+|+++.|+|||+|..+..+.. ......+||.+|||||++.+.. +. .+.||||+|.|||||++.-..++....
T Consensus 350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 9999999999999998753322 2223368999999999997642 22 379999999999999997655532111
Q ss_pred HHhhcHHHHHHHHHhh----chhHHHh-hhhhcccCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 554 EEERNLVAYFISLAKE----NKLLEIL-DARVAKEASE-----EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~----~~~~~~~-d~~l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.+-... |...+.+ +.+++.+ ..+.+..++. .....+.+.+..||..|++.|.|+.=+.+.+..+...
T Consensus 430 p~Yqlp---fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 430 PEYQLP---FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CcccCc---hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 110000 1111111 1111111 1111111111 3356789999999999999999999999999998877
Q ss_pred hhh
Q 046188 624 QRC 626 (646)
Q Consensus 624 ~~~ 626 (646)
...
T Consensus 507 ~~~ 509 (534)
T KOG3653|consen 507 WED 509 (534)
T ss_pred CCc
Confidence 655
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=355.37 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=213.3
Q ss_pred cCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
..|....+||+|+.|.||.+. ..+++.||||++........+-.++|+.+|+..+|+|||++++.+...+..+.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777899999999999998 4578899999987765556667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+.+... .+++.++..|+.++++||+|||.++ |+|||||++|||++.++.+||+|
T Consensus 353 ~ggsLTDvVt~~-----------------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----------------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred CCCchhhhhhcc-----------------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEee
Confidence 999999998653 5899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++..+..... ....++||+.|||||++....|++|+||||||++.+||+-|.+||....+- ....-+..++
T Consensus 413 FGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng 485 (550)
T KOG0578|consen 413 FGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNG 485 (550)
T ss_pred eeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcC
Confidence 999987754433 445678999999999999999999999999999999999999998753221 1111111111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
......+...+..+.+++.+||+.|+++||++.|++++=
T Consensus 486 --------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 486 --------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred --------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 112234566778899999999999999999999999863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=357.44 Aligned_cols=268 Identities=27% Similarity=0.509 Sum_probs=214.5
Q ss_pred CHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC
Q 046188 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400 (646)
Q Consensus 323 ~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~ 400 (646)
+.++++...+.+.....||+|.||+||+|.+. | .||||.++. ....+.+.|.+|+..+++-+|.||+-+.|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 33666666777778899999999999999995 3 599999775 3456788999999999999999999999999887
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
.. .+|..++++-+|..++|..+. .+...+.+.||.|||+||.|||.++ |||||||+.||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et---------------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET---------------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFL 521 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh---------------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEE
Confidence 76 999999999999999998643 5888999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCC-CCCccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 481 DDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
.++++|||+||||+..... ..........|...|||||++.. .+|+..+||||||+|+|||++|..|+.....+.
T Consensus 522 ~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq- 600 (678)
T KOG0193|consen 522 HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ- 600 (678)
T ss_pred ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-
Confidence 9999999999999875421 11111122347789999999864 579999999999999999999999986221110
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.-+...+- +.+.+ .....++..+|.+|+..||.+++++||.+.+|+..|+.+..+
T Consensus 601 ------IifmVGrG~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 601 ------IIFMVGRGY----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ------eEEEecccc----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 110111110 00111 112345678899999999999999999999999999888764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.06 Aligned_cols=249 Identities=35% Similarity=0.566 Sum_probs=196.7
Q ss_pred cCccccccCcEEEEEEEcC-----CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 336 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~-----~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++++++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 2568999999763 344578999999999999999999999999988889999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.++|.... ...+++.++++|+.|+++||.|||+.+ ++|+||+++|||+++++.+||+
T Consensus 83 ~~~g~L~~~L~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~ 145 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--------------KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLS 145 (259)
T ss_dssp -TTEBHHHHHHHTC--------------TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEE
T ss_pred cccccccccccccc--------------ccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 99999999998752 136999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 490 DFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 490 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|||+++....... ...........|+|||.+....++.++||||||+++|||++ |+.|+......+ .....
T Consensus 146 ~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~- 218 (259)
T PF07714_consen 146 DFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL- 218 (259)
T ss_dssp STTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-
Confidence 9999987632222 22233457789999999999889999999999999999999 678865432211 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
........+..++..+.+++.+||+.||++||+|.+|++.|
T Consensus 219 ---------~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 ---------KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112233445567899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=390.10 Aligned_cols=270 Identities=27% Similarity=0.438 Sum_probs=217.1
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~ 400 (646)
++.+++. ..|...+.||+|+||.||+|+. .+|..||||+++..... ..+|++++++++|||||+++|+|.++
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3444443 4577889999999999999996 47899999998753321 23568899999999999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+...++++||||||+||++
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 99999999999999999984 37899999999999999999997756669999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+.++..++. ||........ ....+|++|+|||++.+..++.|+|||||||++|||+||+.|+..... ......
T Consensus 817 ~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~ 889 (968)
T PLN00113 817 DGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIV 889 (968)
T ss_pred CCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHH
Confidence 999988886 6665443211 123578999999999999999999999999999999999999854322 223344
Q ss_pred HHHHHHHhhchhHHHhhhhhcc--cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 561 AYFISLAKENKLLEILDARVAK--EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.|............++|+.+.. ..+.+....+.+++.+||+.||++||+|+||++.|+++..+.
T Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 4544444444556667776643 234566778899999999999999999999999999987643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.25 Aligned_cols=253 Identities=25% Similarity=0.491 Sum_probs=216.0
Q ss_pred cCccccccCcEEEEEEEc-CCCC----EEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 336 QSRFLGQGGFGTVYKGML-PDGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~-~~g~----~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..++||+|+||+||||.+ .+|+ +||||.+... ..+...++++|+-+|.+++|||++||+|+|..+. ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 367899999999999994 4454 6899987653 3445678999999999999999999999998766 7899999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++.|+|.+|++.++. .+.-...+.|..|||+||.|||++. +|||||.++||||.+-..+||.
T Consensus 779 mP~G~LlDyvr~hr~---------------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD---------------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred cccchHHHHHHHhhc---------------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEE
Confidence 999999999988754 6888899999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccc-cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 490 DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|||+++....+..... ....-.+.|||-|.+....++.++|||||||++||++| |..|++....++
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------ 908 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------ 908 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------
Confidence 9999998865444333 33445678999999999999999999999999999999 999987654433
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+++....+.+.|+.+...++.++.+||..|+..||+++++...+.++...
T Consensus 909 ----I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 909 ----IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2334444445567889999999999999999999999999999999987654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.29 Aligned_cols=255 Identities=23% Similarity=0.439 Sum_probs=208.8
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..++||+|++|.||+|...++..||+|+++.... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 57888999999999999999987788999998775432 35678899999999999999999999998889999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.++++... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 85 KGSLLDFLKSDE--------------GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred CCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCC
Confidence 999999986542 236899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++..|+|||++..+.++.++||||||+++|||++ |+.||........ . ... ..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~---~~~-~~- 219 (261)
T cd05072 148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---M---SAL-QR- 219 (261)
T ss_pred ccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---H---HHH-Hc-
Confidence 9998764433222233446778999999998889999999999999999998 8888864332211 1 110 00
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
....+.....+..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 220 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 --------GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011112223456789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.26 Aligned_cols=263 Identities=25% Similarity=0.319 Sum_probs=208.1
Q ss_pred cCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHH--HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKT--QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|...++||+|.||.||+|+ ..+|+.||||+++..... -.....+|++.|+.++|+||+.|+++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778899999999999999 457999999998754322 23367899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|| ..+|...+++.. -.|+..+...++.++++||+|||++. |+||||||.|+|++++|.+||
T Consensus 82 fm-~tdLe~vIkd~~---------------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKi 142 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKN---------------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKI 142 (318)
T ss_pred ec-cccHHHHhcccc---------------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEe
Confidence 99 678988887753 37899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+|+.+....... +..+.|..|.|||.+.+ .+|+..+|+||.||++.||+-|.+-|.+..+-+. +...| ..+
T Consensus 143 ADFGLAr~f~~p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If-~~L 218 (318)
T KOG0659|consen 143 ADFGLARFFGSPNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIF-RAL 218 (318)
T ss_pred ecccchhccCCCCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHH-HHc
Confidence 9999999886544332 33378999999999877 5789999999999999999999877765544332 22222 222
Q ss_pred hhch---------hHHHhhhh-----hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 568 KENK---------LLEILDAR-----VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 568 ~~~~---------~~~~~d~~-----l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... +.+.++-. ........+.....+|+.+++..||.+|+++.|.+++=
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 2211 11111111 11112234456679999999999999999999998763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.52 Aligned_cols=275 Identities=24% Similarity=0.427 Sum_probs=205.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-----------------CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-----------------GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKL 393 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-----------------g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l 393 (646)
++|...++||+|+||.||++.+++ +..||+|.++.. ......+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997532 336999988754 34455679999999999999999999
Q ss_pred EEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHH---HHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 046188 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQE---LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH 470 (646)
Q Consensus 394 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 470 (646)
++++.+.+..++||||+++|+|.+++............ .........++|..+++++.|++.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99999999999999999999999998654211000000 000011246899999999999999999999999 999
Q ss_pred cCCCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh--CCCC
Q 046188 471 RDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKP 547 (646)
Q Consensus 471 rDIk~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt--G~~p 547 (646)
|||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322 12223456789999999998899999999999999999997 4556
Q ss_pred CCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 548 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 548 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+......+ ............. .......+..++..+.+|+.+||+.||.+|||+.||.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 54332211 1111111111100 00011123345577899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=352.67 Aligned_cols=272 Identities=27% Similarity=0.425 Sum_probs=208.0
Q ss_pred hcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~ 402 (646)
.++|+..+.||+|+||.||+|+. .++..||||+++.. .....+.+.+|+.+++.+ +||||++++|+|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999973 23568999998753 234456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHH-------------------------HHHH--------------------------
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQE-------------------------QKQE-------------------------- 431 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~-------------------------~~~~-------------------------- 431 (646)
.++||||+++|+|.+++........ ....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975431000 0000
Q ss_pred --------HHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 046188 432 --------LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503 (646)
Q Consensus 432 --------~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~ 503 (646)
.........++|..+++++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 000011236899999999999999999999998 999999999999999999999999999876433221
Q ss_pred c-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhc
Q 046188 504 L-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 581 (646)
Q Consensus 504 ~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 581 (646)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... . +.. .+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~---------~~~~~~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYK---------MIKEGYR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHH---------HHHhCcc
Confidence 1 122345678999999999999999999999999999998 888875432211 0 111 1111111
Q ss_pred ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 582 KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 582 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
...+...+..+.+|+.+||+.||++||++.||++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 122233346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=337.45 Aligned_cols=269 Identities=28% Similarity=0.482 Sum_probs=210.7
Q ss_pred cCCCcCccccccCcEEEEEEEcCC------CCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|+..+.||+|+||.||+|.... ...||+|.++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998532 2579999887533 344567899999999999999999999999888999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
++|||+++|+|.+++.....................+++...+.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999764321100000000001246899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------ 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999986533222 22233456789999999998899999999999999999998 9999865433211
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.+.+........+..++..+.+|+.+||+.||.+||++.||+++|+.
T Consensus 236 ----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111112223455667889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.08 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=204.2
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..+.||+|+||.||++.+.++..+|+|..+.... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45777889999999999999987788999998764322 24578899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.++++... ..++|..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 83 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 83 NGCLLNYLRQRQ---------------GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred CCcHHHHHHhCc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCC
Confidence 999999886532 25899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++..|+|||.+....++.++||||||+++|||++ |+.||......+. ........
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~ 218 (256)
T cd05114 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGF 218 (256)
T ss_pred CCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCC
Confidence 9998654332222223345678999999988889999999999999999999 8888864432211 11111110
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
....+......+.+++.+||+.+|.+||++.|+++.|+
T Consensus 219 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 ----------RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112233467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=333.91 Aligned_cols=258 Identities=26% Similarity=0.478 Sum_probs=214.3
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++..+|+..++||+|+||.||+|...++..+|+|.++.........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999987889999999887666566788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 83 ~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl 145 (261)
T cd05148 83 LMEKGSLLAFLRSPE--------------GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKV 145 (261)
T ss_pred ecccCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEE
Confidence 999999999997643 236899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++......... .....++..|+|||.+..+.++.++||||||++++||++ |+.|+......+. +.
T Consensus 146 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~------~~--- 215 (261)
T cd05148 146 ADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV------YD--- 215 (261)
T ss_pred ccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH------HH---
Confidence 999999876433221 223346778999999988899999999999999999998 8888854332111 11
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.+........+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 216 -------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 216 -------QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------HHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111122233445567889999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.89 Aligned_cols=273 Identities=27% Similarity=0.442 Sum_probs=209.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~ 402 (646)
.++|...+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++.+ +|+||++++|+|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999998731 2357999998753 334456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHH-----------------------------------------------------
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQK----------------------------------------------------- 429 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~----------------------------------------------------- 429 (646)
.++||||+++|+|.+++..........
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999996543210000
Q ss_pred -HHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-cccc
Q 046188 430 -QELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTA 507 (646)
Q Consensus 430 -~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~ 507 (646)
..........++++.+.++|+.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 00000011236899999999999999999999998 999999999999999999999999999865433221 1122
Q ss_pred cccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCH
Q 046188 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASE 586 (646)
Q Consensus 508 ~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 586 (646)
..++..|||||++....++.++||||||+++|||++ |+.||........ ....+........+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~~~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKRGYQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHcccCccCCC
Confidence 345678999999998899999999999999999997 9999864322110 111111111112223
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 587 EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 587 ~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
..+..+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 34567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.20 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=208.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|...+.||+|++|.||+|... .++.||+|.++... ...+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999964 47899999987543 34567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 85 ~~~~L~~~~~~~~--------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d 147 (263)
T cd05052 85 TYGNLLDYLRECN--------------RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 147 (263)
T ss_pred CCCcHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCC
Confidence 9999999986532 235899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+. +.
T Consensus 148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~----- 216 (263)
T cd05052 148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YE----- 216 (263)
T ss_pred CccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH-----
Confidence 99998764433222222334678999999998999999999999999999998 8888764332211 11
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.+......+.+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 217 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 217 -----LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111122233445567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=334.06 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=207.9
Q ss_pred hcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.+.|+..+.||.|..++||+|+ ...++.||||++.-.. ..+.+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3678889999999999999999 4568999999976432 2336788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
||.+|++.+.+..... ..+++..+.-|..++++||.|||.+| .||||||+.||||+++|.+||
T Consensus 105 fMa~GS~ldIik~~~~--------------~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--------------DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred hhcCCcHHHHHHHHcc--------------ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEE
Confidence 9999999999987643 35889999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCC---ccccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 489 SDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 489 ~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+|||.+..+-+... ......+||+.|||||++.. ..|+.|+||||||++.+||.+|..||....+... .
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------L 241 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------L 241 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------H
Confidence 99998776533221 11145789999999999654 4588999999999999999999999975433221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+.+. -....-..+..+........+.+++..||++||.+|||+.+++++
T Consensus 242 l~tLqn~-pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 242 LLTLQND-PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHhcCC-CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111110 000000111112223344588999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=318.84 Aligned_cols=236 Identities=28% Similarity=0.410 Sum_probs=204.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||.|+||.|.+++.+ +|..+|+|.++.. ...+.+...+|..+|+.+.||+++++.+.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777899999999999999954 6889999998753 3456677889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|.|..+|++. .+++......+|.||+.||+|||+.+ |++||+||+|||||.+|.+|
T Consensus 124 eyv~GGElFS~Lrk~----------------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----------------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred eccCCccHHHHHHhc----------------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEE
Confidence 999999999999874 46899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||.|+..... +-+.+|||.|+|||.+....+..++|.|||||++|||+.|.+||....+.. .
T Consensus 185 itDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------i----- 249 (355)
T KOG0616|consen 185 ITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------I----- 249 (355)
T ss_pred EEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------H-----
Confidence 9999999987433 456799999999999999999999999999999999999999998654311 1
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCC
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKR 607 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 607 (646)
...++...+ .+|......+.+|+...|+.|-.+|
T Consensus 250 ----Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 ----YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 112222222 3566777888999999999999999
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.33 Aligned_cols=259 Identities=24% Similarity=0.466 Sum_probs=207.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.+|+..+.||+|+||.||+|++. +++ .||||.++.. .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 344 3899998754 344566889999999999999999999999764 5689
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|+||+++|+|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~g~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~ 147 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQH 147 (316)
T ss_pred eeecCCCCCHHHHHHhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCc
Confidence 999999999999987642 25889999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ +
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~ 220 (316)
T cd05108 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------I 220 (316)
T ss_pred EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 9999999998764333221 122334678999999999999999999999999999998 999986432221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
.. ++........+..+...+.+++.+||+.||.+||++.+++..|.++.....
T Consensus 221 ~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 221 SS---------ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred HH---------HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 11 111111112233445678999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.22 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=203.3
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++++++|+|++++.+++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999995 468999999875422 2233467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 81 ~~~~g~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl 143 (285)
T cd05631 81 IMNGGDLKFHIYNMG--------------NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRI 143 (285)
T ss_pred ecCCCcHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEE
Confidence 999999988875432 235899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++........ .....||..|+|||.+.+..++.++|||||||++|||++|+.||......... ......
T Consensus 144 ~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~-- 216 (285)
T cd05631 144 SDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRR-- 216 (285)
T ss_pred eeCCCcEEcCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHH--
Confidence 99999987543222 23346899999999999999999999999999999999999999754322110 000000
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
+ ......++...+..+.+|+.+||+.||.+||+ ++|++++
T Consensus 217 ------~--~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 217 ------V--KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ------h--hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 01112334455678899999999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.18 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=207.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|.+.. ...||||.++.. ......+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999642 357999988653 344556789999999999999999999999998899999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++.++++++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 84 TEYMENGSLDKFLREND---------------GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC 145 (266)
T ss_pred EEcCCCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCE
Confidence 99999999999986642 26899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCC-CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 487 KVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 487 kI~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
||+|||+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+. .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~---- 218 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---I---- 218 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---H----
Confidence 999999999774222 222222345678999999998899999999999999999998 9888754332211 0
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
. .+......+.+...+..+.+++.+||+.+|++||++.||+++|+++
T Consensus 219 ~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 219 K---------AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred H---------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 1111111122334567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=347.80 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=221.8
Q ss_pred cCCCcCccccccCcEEEEEEEcCC---CC--EEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD---GS--IVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~---g~--~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
+.....++||.|.||.||+|++.+ |+ .||||.-+. ......+.|+.|+.+|++++||||++|+|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344456789999999999999643 33 699998876 455668899999999999999999999999975 45689
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|||.++-|.|.+||..++. .|+......++.||..||.|||+.. +|||||..+|||+.+..-
T Consensus 468 vmEL~~~GELr~yLq~nk~---------------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD---------------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQC 529 (974)
T ss_pred EEecccchhHHHHHHhccc---------------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcce
Confidence 9999999999999988653 6889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||+++.+.++..+......-.+.|||||.+...++|.++|||.|||.+||++. |..||......
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------- 599 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------- 599 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------
Confidence 9999999999998777766666667789999999999999999999999999999987 99998754322
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.+...++.+-+.+.|+.|+..++.|+.+||++||.+||.+.||...|+.+.+.
T Consensus 600 ------DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 600 ------DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ------ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 22223344445678899999999999999999999999999999999988763
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.58 Aligned_cols=266 Identities=22% Similarity=0.267 Sum_probs=202.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|+||.||+++.+ +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999965 5789999987643 22334577899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 81 ~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl 141 (287)
T cd07848 81 YVEKNMLELLEEM----------------PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKL 141 (287)
T ss_pred cCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEE
Confidence 9988776544322 236899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH-----
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF----- 563 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~----- 563 (646)
+|||+++..............|++.|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 142 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 142 CDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred eeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 999999876443333333456899999999999888999999999999999999999999754432211110000
Q ss_pred ----HHHHhhchhHHHhhhhhc------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ----ISLAKENKLLEILDARVA------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ----~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..............+... ..+....+..+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000000 00111245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.57 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=208.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46788899999999999999998777889999987543 23457889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 84 KYGSLLEYLQGGA--------------GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred cCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECC
Confidence 9999999986532 136899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++...............+..|+|||++.+..++.++||||||+++|||++ |+.||........ .
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~------ 214 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV------L------ 214 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------H------
Confidence 99998764322221122223468999999998899999999999999999999 8888854322110 0
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
..++.......+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 215 ----QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----HHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111122334456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.61 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=211.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|...+.||+|+||.||||+.+ +.+.||+|.... ..+++.+.+.+|++|+++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 578999997643 345567789999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+.+ +|..+|... ..|++++...|+.|++.||.|||+++ |.|||+||+|||++.++.+|+
T Consensus 82 ~a~g-~L~~il~~d----------------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~Kl 141 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----------------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKL 141 (808)
T ss_pred hhhh-hHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceee
Confidence 9966 999999764 36999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||+|+.+.. ...+.+.+.|||-|||||.+.+++|+..+|.||+||++||+.+|++||.... .......+..
T Consensus 142 cdFg~Ar~m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~ 214 (808)
T KOG0597|consen 142 CDFGLARAMST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK 214 (808)
T ss_pred chhhhhhhccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc
Confidence 99999998755 3445567889999999999999999999999999999999999999996321 1111111111
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
++ -..|...+..+..++...|.+||.+|.+..+++.+-
T Consensus 215 d~-----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 215 DP-----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CC-----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 11 123556677899999999999999999999998763
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=346.49 Aligned_cols=274 Identities=24% Similarity=0.407 Sum_probs=211.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~ 402 (646)
.++|...++||+|+||.||+|... .+..||||+++.. .....+.+.+|++++++++ ||||++++|++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999842 1346999998753 3344567999999999996 9999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHH-------------------------------------------------------
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQE------------------------------------------------------- 427 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~------------------------------------------------------- 427 (646)
.+|||||+++|+|.++++.......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999976432100
Q ss_pred -------------------------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 428 -------------------------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 428 -------------------------~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.............+++.++++++.|+++||+|||+.+ ++||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0000011111236899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 560 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 999999999999875332221 1222346788999999998899999999999999999997 8888754321110
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+... +........+...+..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 349 --~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 --FYNK---------IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHH---------HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111 11111122334456778999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.51 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=205.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc--CccCceeEEEEEEeCC----ceE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI--NHRHIVKLLGCCLETE----VPV 404 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l--~H~niv~l~g~~~~~~----~~~ 404 (646)
..+....+.||+|.||.||+|.++ |+.||||++...++ ..+.+|.+|.+.+ +|+||+.+++.-..+. .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 356777899999999999999995 89999999886443 4677888888864 9999999998866543 578
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEecCCCCCCEE
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-----SASIPIFHRDIKSSNIL 479 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-----~~~~~ivHrDIk~~NIL 479 (646)
||.+|.+.|||.|||..+ .++.+..++++..+|.||++||- +|+|.|.|||||+.|||
T Consensus 286 LvTdYHe~GSL~DyL~r~-----------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN-----------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred EeeecccCCcHHHHHhhc-----------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 999999999999999763 68999999999999999999994 68999999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCcc---ccccccCCcccChhccccCC----C--CCccchhhHHHHHHHHHhC------
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSSQ----Y--TDKSDVYSFGVVLLELLTG------ 544 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~----~--s~ksDVwSfGvvl~ElltG------ 544 (646)
|.+++.+.|+|+|||-....+.... ...-+||.+|||||++.... + -..+||||||.|+||+...
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9999999999999998775543322 23357999999999997642 1 2369999999999999762
Q ss_pred ----CCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 545 ----KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 545 ----~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
+.||+...+.+. ..+....+.-..+++..++.++ ...+....+.+||+.||..+|..|-|+-.|-+.|.++
T Consensus 429 ~eey~~Pyyd~Vp~DP--s~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDP--SFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred ehhhcCCcccCCCCCC--CHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 234432211110 0011111111112221111111 2356778899999999999999999999999999998
Q ss_pred Hhh
Q 046188 621 RRS 623 (646)
Q Consensus 621 ~~~ 623 (646)
.++
T Consensus 504 ~~~ 506 (513)
T KOG2052|consen 504 SNS 506 (513)
T ss_pred hcC
Confidence 864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=332.57 Aligned_cols=263 Identities=27% Similarity=0.483 Sum_probs=206.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-----CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-----~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~ 404 (646)
.+|...+.||+|+||+||++... +++.||+|+++.......+.+.+|++++++++||||+++.+++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999742 4789999998877667777899999999999999999999987643 3578
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++.... ..++|..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~ 145 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---------------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESEN 145 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCC
Confidence 9999999999999986532 25899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCcc--ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++|..+.......
T Consensus 146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------- 217 (284)
T cd05081 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------- 217 (284)
T ss_pred eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------
Confidence 99999999998764332211 11122345699999999888999999999999999999987765322110
Q ss_pred HHHHHhh--------chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 563 FISLAKE--------NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 563 ~~~~~~~--------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
+...... ..+.+.+........+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 011122222222223344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=333.17 Aligned_cols=273 Identities=27% Similarity=0.450 Sum_probs=213.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.+|...+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 345699999887666666788999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++++|.+++.....................++|..++.++.|++.||+|||+++ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 99999999999999764321000000000011235899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999986543221 12223456788999999999999999999999999999999 9999864433211
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
......+ .....+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQG---------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCC---------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111 11112233456789999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.35 Aligned_cols=264 Identities=27% Similarity=0.365 Sum_probs=207.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..+.||+|+||.||+++.. +|..+|+|.++.. .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368899999999999999999964 5889999987653 33445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl 145 (331)
T cd06649 84 HMDGGSLDQVLKEA----------------KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKL 145 (331)
T ss_pred cCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEE
Confidence 99999999998653 358899999999999999999998532 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..+.....
T Consensus 146 ~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~ 219 (331)
T cd06649 146 CDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVV 219 (331)
T ss_pred ccCcccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhccccc
Confidence 9999998653321 23346899999999999989999999999999999999999999654332211 00000000
Q ss_pred ------------------------------hchhHHHhhhhh---cccC-CHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046188 569 ------------------------------ENKLLEILDARV---AKEA-SEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614 (646)
Q Consensus 569 ------------------------------~~~~~~~~d~~l---~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 614 (646)
.....+..+... .... .......+.+|+.+||+.||++|||++|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000001111110 1111 123456789999999999999999999999
Q ss_pred HHHH
Q 046188 615 MDLE 618 (646)
Q Consensus 615 ~~L~ 618 (646)
++..
T Consensus 300 ~h~~ 303 (331)
T cd06649 300 NHTF 303 (331)
T ss_pred cChH
Confidence 8865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=327.54 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=203.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|...+.||+|+||.||+|...++..+|+|.++.... ..+++.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35777889999999999999987667799998775332 34578899999999999999999999998888999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ..++|.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 83 ~~~l~~~i~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 83 NGCLLNYLREHG---------------KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred CCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCC
Confidence 999999986532 25899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. ..... ..
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~-~~ 217 (256)
T cd05113 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------VEKVS-QG 217 (256)
T ss_pred ccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHh-cC
Confidence 9998664332222222345678999999998889999999999999999999 9988754332210 11111 00
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.....+......+.+++.+||+.||.+||++.+|+..|+
T Consensus 218 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 ---------LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111122234578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=341.07 Aligned_cols=252 Identities=28% Similarity=0.373 Sum_probs=207.0
Q ss_pred HhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC----CH-HHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCc
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI----DK-TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV 402 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~----~~-~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~ 402 (646)
...+|...+.||+|+||.|+.|.. .+|+.||||..... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356888999999999999999984 46899999965442 11 22345568999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+.+|+|.+++... .++.+.+...++.|++.|++|+|+++ |+||||||+|||+|.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----------------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----------------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDG 155 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecC
Confidence 99999999999999999772 36888999999999999999999999 999999999999999
Q ss_pred C-CcEEEeecCCccccCCCCCccccccccCCcccChhccccCC-CC-CccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 483 K-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 483 ~-~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+ +++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||......
T Consensus 156 ~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----- 229 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----- 229 (370)
T ss_pred CCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-----
Confidence 9 999999999999874 2233445678999999999999877 75 7999999999999999999999752211
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHH-HHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEED-IEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..+.. +.... -.+|... +..+..|+.+|+..||.+|+++.||+.+=.
T Consensus 230 -~l~~k---------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 230 -NLYRK---------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred -HHHHH---------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 11111 11111 1234444 678899999999999999999999995433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.59 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=198.9
Q ss_pred ccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999987642 2334557789999999999999999999999999999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|.+++... ..+++.+...++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 81 ELFFHLSRE----------------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred cHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999888653 36899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhH
Q 046188 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 573 (646)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 573 (646)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......
T Consensus 142 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~~----- 209 (323)
T cd05571 142 CKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILM----- 209 (323)
T ss_pred CcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------HHHHHc-----
Confidence 97542221 122345699999999999999999999999999999999999999865432211 111100
Q ss_pred HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 574 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
. ...++......+.+++.+||+.||++|| ++.+++++
T Consensus 210 ----~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 210 ----E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ----C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 0123444567789999999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=329.97 Aligned_cols=266 Identities=27% Similarity=0.494 Sum_probs=209.2
Q ss_pred cCCCcCccccccCcEEEEEEEcCC------CCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|...+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467788999999999999998633 478999998764433 4568999999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++........... ........+++.++..++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLK--SPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhc--ccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 99999999999999976532111000 00011346899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |+.||......+. ..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~- 235 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE- 235 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH-
Confidence 999999999986532221 11223346788999999999999999999999999999998 9999864433221 10
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. +........+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 236 --~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 --C----------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --H----------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 0111111223345577899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=325.56 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=202.8
Q ss_pred CCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+|+..+.||+|+||.||+|..+++..+|+|....... ...++.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4777889999999999999987777899998764322 234688899999999999999999999988899999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
++|.+++.... ..++|..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 84 ~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 84 GCLLNYLRERK---------------GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred CCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcc
Confidence 99999987542 25899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~------ 213 (256)
T cd05059 146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VES------ 213 (256)
T ss_pred cceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHH------
Confidence 998654322222222234568999999998899999999999999999999 7888864332211 000
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
+........+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 ----VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111111222334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.94 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=204.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999964 6889999987642 2234556889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.....++.|++.||+|||+++ ++||||||+|||++.++.+|
T Consensus 81 e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 81 EYVPGGELFSYLRNS----------------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred eCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence 999999999998653 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .....
T Consensus 142 l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i- 210 (291)
T cd05612 142 LTDFGFAKKLRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKI- 210 (291)
T ss_pred EEecCcchhccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-
Confidence 99999998754321 23468999999999998889999999999999999999999986543221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~L~ 618 (646)
.... ...+......+.+|+.+||+.||.+||+ +.|++++-.
T Consensus 211 --------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 211 --------LAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred --------HhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 1111 1233344567899999999999999995 888887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.96 Aligned_cols=270 Identities=27% Similarity=0.479 Sum_probs=212.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.+|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999842 345699999887666667789999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++++|.+++......... .........+++.+++.++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVL---MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCcccc---ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 99999999999999754321000 000011235999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------~ 232 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------I 232 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------H
Confidence 99999999986533221 11223345778999999998889999999999999999998 8888764432211 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
. ....+.. ...+...+..+.+++.+||+.||.+|||+.|++..|+.+...
T Consensus 233 ~-~i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 E-CITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred H-HHHcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 1111110 111223446789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.98 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=204.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+|... +++.||||+++.. .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 5889999988642 1234557889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 81 e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 141 (333)
T cd05600 81 EYVPGGDFRTLLNNL----------------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIK 141 (333)
T ss_pred eCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEE
Confidence 999999999998653 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +....
T Consensus 142 L~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~ 211 (333)
T cd05600 142 LTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLK 211 (333)
T ss_pred EEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHH
Confidence 999999986533 22345689999999999999999999999999999999999999975443221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ..+............+..+.+++.+||+.+|.+||++.|++++
T Consensus 212 ~~~---~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 212 YWK---ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hcc---ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 0000000000012345678899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.28 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=205.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..++||+|+||.||+|...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888899999999999999987788899998875332 2356889999999999999999999875 456799999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+++|.++++... ...+++.+++.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 84 KGSLLDFLKDGE--------------GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred CCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCc
Confidence 999999987532 235899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|++...............++..|+|||.+....++.++||||||+++|||++ |..||......+ ...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~------ 214 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLE------ 214 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHH------
Confidence 9998764333222222345678999999988889999999999999999999 888885432211 111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.+......+.+.+.+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 215 ----QVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----HHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111111223344556789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=339.92 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=202.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999964 5889999987642 2234557889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 98 e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----------------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred cCCCCChHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEE
Confidence 999999999998653 35888899999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....
T Consensus 159 l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~-- 226 (329)
T PTZ00263 159 VTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEK-- 226 (329)
T ss_pred EeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHH--
Confidence 99999998764322 23468999999999999889999999999999999999999986433211 1111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
+.... ...+......+.+|+.+||+.||.+||+ +++++.+
T Consensus 227 -------i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 227 -------ILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------HhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 1123334567889999999999999997 7888766
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=333.50 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=199.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999854 68899999876432 22334677899999999999999999999988889999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ |+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+
T Consensus 85 ~~-~~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 85 LD-SDLKQYLDNCG---------------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred CC-cCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEC
Confidence 96 58988886432 25789999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... ......
T Consensus 146 DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~ 221 (288)
T cd07871 146 DFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLG 221 (288)
T ss_pred cCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhC
Confidence 9999986532221 1223457899999998865 5689999999999999999999999976543332111 111111
Q ss_pred h---ch---------hHHHhhhhhcc----cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 E---NK---------LLEILDARVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~---~~---------~~~~~d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. .. ......+.... .........+.+|+.+||+.||.+|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00 11111111000 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.51 Aligned_cols=257 Identities=24% Similarity=0.430 Sum_probs=203.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+.++++++||||++++|++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35667889999999999999963 344 47888875432 334567888999999999999999999885 445789
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
++||+++|+|.+++.... ..++|..++.|+.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 i~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~ 147 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---------------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCc
Confidence 999999999999997542 36899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+........
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------- 220 (279)
T cd05111 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------- 220 (279)
T ss_pred EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 99999999987643222 22233457789999999998999999999999999999998 9999865432221
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.. ++........+..+...+.+++.+||..||.+||++.|+++.|..+...
T Consensus 221 ~~---------~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 221 PD---------LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HH---------HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11 1111111112223445678899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=331.95 Aligned_cols=274 Identities=28% Similarity=0.440 Sum_probs=211.9
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
...++|+..+.||+|+||.||++... +...+|+|.++.. ......++.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467888999999999999999853 2367999988753 344556788999999999 899999999999998
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..+++|||+++|+|.++++....................++|..+++++.|++.||.|||+.+ ++||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 8999999999999999999764321110000000011347999999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 99999999999999876432221 1122335678999999988899999999999999999998 8888754332211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
+ +.+........+......+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 244 ----~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----F----------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----H----------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 111111122234445677899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.86 Aligned_cols=274 Identities=28% Similarity=0.434 Sum_probs=208.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCC-HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC-C
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLET-E 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~-~ 401 (646)
.++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457888999999999999999732 24689999987532 33456788999999999 899999999988754 4
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHH---------------------------------------------HHHHHHHhh
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQE---------------------------------------------QKQELEEEQ 436 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~---------------------------------------------~~~~~~~~~ 436 (646)
..+++|||+++|+|.+++........ .........
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999865321000 000000001
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCcc-ccccccCCccc
Q 046188 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYF 515 (646)
Q Consensus 437 ~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~ 515 (646)
....++|..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1247999999999999999999999998 9999999999999999999999999998764332222 22344677899
Q ss_pred ChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHH
Q 046188 516 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAE 594 (646)
Q Consensus 516 aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 594 (646)
|||++.+..++.++|||||||++|||++ |..||......+. +..... .......+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLK---------EGTRMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHh---------ccCCCCCCccCCHHHHH
Confidence 9999999999999999999999999998 9999864322111 111111 11111223344567899
Q ss_pred HHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 595 LAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 595 Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
++.+||+.+|++||++.||+++|+++.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=329.21 Aligned_cols=264 Identities=26% Similarity=0.453 Sum_probs=206.2
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
++++|+..+.||+|+||.||+|... .+..||||+++.. ......++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998753 2467999987643 33445678899999999999999999999998889
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++|+|.+++........ .......++|..++.++.|+++||.|||+.+ ++||||||+||++++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~ 154 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEME------NNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 154 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCcccc------ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcC
Confidence 9999999999999999976432100 0001235789999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 560 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++ |..|+........
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---- 230 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---- 230 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence 9999999999998653322211 112345778999999998899999999999999999999 6778754332210
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. ...+. . ....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 231 --~~-~~~~~--------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 --LR-FVMEG--------G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --HH-HHHcC--------C-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11 11111 0 11223344567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.61 Aligned_cols=272 Identities=27% Similarity=0.442 Sum_probs=209.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-CC--EEEEEeccc-CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSKA-IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g~--~VAVK~l~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|...+ +. .+++|.++. ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998643 33 478888875 3344556789999999999 799999999999998899999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
+||+++|+|.+++.....................+++..++.|+.|++.||+|||+++ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999764321100000000011236899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||......+ ...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~- 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE- 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH-
Confidence 99999998743211 11111223567999999988889999999999999999998 999986443221 011
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.+........+..++..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 ---------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111122233445577899999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=318.94 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=200.8
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCch
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLS 416 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 416 (646)
+.||+|+||.||+|...++..+|+|..+... ......+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998788999999877543 333457889999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 417 HHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 417 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
+++.... ..++|..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 81 SFLRKKK---------------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcccee
Confidence 9886532 25889999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 497 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
.............++..|+|||++..+.++.++||||||+++||+++ |..||........ ...
T Consensus 143 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~~~---------- 206 (250)
T cd05085 143 EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------REQ---------- 206 (250)
T ss_pred ccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHH----------
Confidence 43322222222334678999999998899999999999999999998 8889864432211 000
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+........+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 207 VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111112233445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=351.95 Aligned_cols=253 Identities=25% Similarity=0.306 Sum_probs=206.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-C-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-D-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.|...+.||+|++|.||+|... + ++.||+|............+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999843 3 6788999876655666667888999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++..... ...++++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|
T Consensus 148 ~gg~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 148 SGGDLNKQIKQRLK------------EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred CCCCHHHHHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEe
Confidence 99999999865321 1346899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++....... .......||++|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~---- 282 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQ---- 282 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH----
Confidence 999987643222 22334569999999999999999999999999999999999999986433211 1111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
++... ....+...+..+.+++.+||+.||++||++.+++.+
T Consensus 283 -----~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 283 -----VLYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -----HHhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11111 112233455678999999999999999999999754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.27 Aligned_cols=247 Identities=28% Similarity=0.467 Sum_probs=198.9
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
+.||+|+||.||+|... +++.||+|..... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 6889999987643 344556789999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++.... ..++|.+++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 142 (252)
T cd05084 81 LTFLRTEG---------------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142 (252)
T ss_pred HHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCc
Confidence 99986532 35899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCCcccc-ccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhH
Q 046188 496 SVPNDKTHLTT-AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLL 573 (646)
Q Consensus 496 ~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 573 (646)
........... ....+..|+|||.+.++.++.++||||||+++|||++ |..|+........ .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----------------~ 206 (252)
T cd05084 143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------R 206 (252)
T ss_pred ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----------------H
Confidence 65322111111 1123457999999999999999999999999999998 8888754322111 1
Q ss_pred HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 574 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..+........+...+..+.+++.+||+.||++||++.||.+.|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 207 EAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111111122334445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=326.39 Aligned_cols=269 Identities=26% Similarity=0.452 Sum_probs=206.8
Q ss_pred cCCCcCccccccCcEEEEEEEc-----CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||.||+|.. .++..||+|.++.. .......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677789999999999999984 24578999998753 34445678899999999999999999999999899999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHH-HHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQE-LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
||||+++|+|.+++............ .........+++.+.+.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998643210000000 000001235899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986533221 12223346778999999988889999999999999999999 888886433211
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
... .+........+..++..+.+++.+||+.||++||++.+|.++|..
T Consensus 235 ~~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIE---------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 111111112334455778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=323.12 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=206.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|...++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467888999999999999999988889999998875332 3457889999999999999999999864 45689999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|
T Consensus 83 ~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 83 ENGSLVDFLKTPE--------------GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred CCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEcc
Confidence 9999999986532 236899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||++...............++..|+|||.+....++.++||||||+++|||++ |+.||......+. ..
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~----- 214 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV------IQ----- 214 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH------HH-----
Confidence 99998764332222223346778999999998889999999999999999999 9999864332211 01
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.+......+.+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 215 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 -----NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111122333445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.08 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=197.3
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ceE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 404 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~~ 404 (646)
+|+..+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999954 6899999987642 2234456889999999999999999999986432 479
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+ +++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 81 lv~e~~-~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 140 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADC 140 (338)
T ss_pred EEEecC-CCCHHHHHHhc----------------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCC
Confidence 999999 47888887542 35899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC--ccccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 485 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.+||+|||+++....... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........
T Consensus 141 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~-- 218 (338)
T cd07859 141 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD-- 218 (338)
T ss_pred cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH--
Confidence 999999999986532211 12234568999999999865 678999999999999999999999986543322111
Q ss_pred HHHHHHHh-----------hchhHHHhhh---hhcccC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 561 AYFISLAK-----------ENKLLEILDA---RVAKEA---SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~-----------~~~~~~~~d~---~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... .....+.++. ...... .......+.+++.+||+.||++||++.|++++
T Consensus 219 -~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 219 -LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred -HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111100 0111111110 000000 01234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=329.20 Aligned_cols=264 Identities=26% Similarity=0.375 Sum_probs=209.5
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC--------------HHHHHHHHHHHHHHhhcCccC
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID--------------KTQIEQFINEVVILSQINHRH 389 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~--------------~~~~~~~~~Ei~il~~l~H~n 389 (646)
.+-.+..++|...+.||+|.||.|-+|+. .+++.||||.+.... ....+...+||.||++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 33344567899999999999999999994 468999999764311 112357889999999999999
Q ss_pred ceeEEEEEEeC--CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 046188 390 IVKLLGCCLET--EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIP 467 (646)
Q Consensus 390 iv~l~g~~~~~--~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 467 (646)
||+|+.+..+. +..|||+||+..|.+...-... ..|+..+.++++.+++.||+|||.++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~----------------~els~~~Ar~ylrDvv~GLEYLH~Qg--- 230 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----------------PELSEQQARKYLRDVVLGLEYLHYQG--- 230 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCc----------------ccccHHHHHHHHHHHHHHHHHHHhcC---
Confidence 99999998764 5789999999999886543221 12899999999999999999999999
Q ss_pred eEecCCCCCCEEECCCCcEEEeecCCccccCCCC----CccccccccCCcccChhccccCC----CCCccchhhHHHHHH
Q 046188 468 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK----THLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLL 539 (646)
Q Consensus 468 ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSfGvvl~ 539 (646)
||||||||+|+||+++|++||+|||.+.....+. .......+|||.|+|||...++. .+.+.||||+||+||
T Consensus 231 iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLY 310 (576)
T KOG0585|consen 231 IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLY 310 (576)
T ss_pred eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHH
Confidence 9999999999999999999999999998763221 11122367999999999887643 367899999999999
Q ss_pred HHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 540 ELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 540 ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
-|+.|+.||.....-+ ....++...+..+...+..+.+.+|++++|++||+.|.+..+|..+...
T Consensus 311 CllfG~~PF~~~~~~~---------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 311 CLLFGQLPFFDDFELE---------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HhhhccCCcccchHHH---------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 9999999996432211 1123333444333344667889999999999999999999999999886
Q ss_pred HHh
Q 046188 620 LRR 622 (646)
Q Consensus 620 i~~ 622 (646)
.+.
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.11 Aligned_cols=258 Identities=25% Similarity=0.466 Sum_probs=203.9
Q ss_pred CCcCccccccCcEEEEEEEcCC----CCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc-----
Q 046188 334 YNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV----- 402 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~----- 402 (646)
|...+.||+|+||.||+|.... +..||||+++.. .....+.+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999987743 34456688999999999999999999999876544
Q ss_pred -eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 403 -PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 403 -~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
.++++||+++|+|..++....... ....+++.....++.|++.||+|||+.+ ++||||||+||+++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~ 147 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG----------LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLR 147 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC----------CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEEC
Confidence 799999999999999986543210 0236899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l 559 (646)
+++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |..|+......+
T Consensus 148 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---- 223 (273)
T cd05035 148 EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---- 223 (273)
T ss_pred CCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998764332221 112335678999999988889999999999999999999 888875433211
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
..... ........+..+...+.+++.+||+.||.+||++.|+++.|+++
T Consensus 224 --~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 --IYDYL----------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHHH----------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 11111223445567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=322.16 Aligned_cols=255 Identities=27% Similarity=0.492 Sum_probs=206.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CC---CEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g---~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|+.. ++ ..+|+|..+.. .....+.+.+|++++++++|+|++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 56788899999999999999964 23 37999988754 344566789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++.... ..++|.++..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 85 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 85 TEYMENGALDKYLRDHD---------------GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLEC 146 (268)
T ss_pred EEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcE
Confidence 99999999999986532 36899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||++........... .....+..|+|||++..+.++.++||||||+++|||++ |+.|+......+ ..
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~ 220 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VM 220 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HH
Confidence 9999999986643222111 11223567999999998889999999999999999998 999986433211 11
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
... ......+.+.+.+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 221 ~~i----------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KAI----------NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHH----------hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 11111222334557789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=320.07 Aligned_cols=245 Identities=28% Similarity=0.457 Sum_probs=197.9
Q ss_pred cccccCcEEEEEEEc---CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 339 FLGQGGFGTVYKGML---PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~---~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
.||+|+||.||+|.+ .++..+|+|+++.. .....+++.+|+.+++.++|+||++++|++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 25788999987643 2345667899999999999999999999885 45678999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|.+++... ..+++..+.+++.|++.||+|||+++ ++||||||+||++++++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~ 141 (257)
T cd05116 81 PLNKFLQKN----------------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGL 141 (257)
T ss_pred cHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcc
Confidence 999998542 35889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 494 SRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 494 a~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
++.......... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------------- 207 (257)
T cd05116 142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------------- 207 (257)
T ss_pred ccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------
Confidence 987643332211 12234578999999988889999999999999999998 9999864432211
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.+.++.....+.+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 208 --~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 208 --TQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --HHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11111111223344556788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=321.25 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=209.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+|+.. +++.||||.++. ........+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999954 689999997653 23444567889999999999999999999999989999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++...... ...+++...+.++.|+++||.|||+++ ++|+||||+||+++.++.++
T Consensus 82 e~~~~~~L~~~~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ------------KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EecCCCcHHHHHHHhhhc------------cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEE
Confidence 999999999988653220 235889999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+...... ....... .
T Consensus 147 l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~ 220 (267)
T cd08228 147 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-I 220 (267)
T ss_pred ECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-H
Confidence 999999887643221 122345888999999998888999999999999999999999998543211 1111111 0
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.. .......+...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 221 ~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 EQ--------CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hc--------CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 00111112345577999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.73 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=204.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..++||+|+||.||+|...+...||+|+++.... ..+.+.+|+.++++++|+||+++++++. ++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 56888999999999999999976667899999875332 2357889999999999999999999874 456799999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ...++|..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 84 KGSLLDFLKGEM--------------GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred CCcHHHHHhhcc--------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccC
Confidence 999999997532 135899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++..|+|||+..++.++.++||||||+++|||++ |+.||......+. ...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~----- 215 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQ----- 215 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHH-----
Confidence 9998764333222223446778999999988889999999999999999999 7777754322110 000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
+........+.+.+..+.+++.+||+.||++||++.++++.|+..
T Consensus 216 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 216 -----VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001111122345567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.74 Aligned_cols=266 Identities=28% Similarity=0.429 Sum_probs=205.9
Q ss_pred CcCccccccCcEEEEEEEc-----CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC--ceEEE
Q 046188 335 NQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLV 406 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--~~~LV 406 (646)
...+.||+|+||+||++.. .+++.||+|..+... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988652 357789999887543 334567889999999999999999999987643 57899
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++... .++|.+++.++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~~~~~-----------------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----------------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred ecCCCCCCHHHHHHHc-----------------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcE
Confidence 9999999999998542 5899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~ 225 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQ 225 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccc
Confidence 99999999876433221 11223456679999999988899999999999999999999999754321110 0000000
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.......+.+.++.......+...+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000111222233333333344556678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.39 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=205.0
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
..++|+.++.||+|+||.||.++-+ +|+.+|+|+++.. ...+++....|-.+|...++|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999954 6999999998763 35567778899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||++||++..+|... ..|+......++.+++-|++-||++| +|||||||+|+|||..|+
T Consensus 219 iMEylPGGD~mTLL~~~----------------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GH 279 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK----------------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGH 279 (550)
T ss_pred EEEecCCccHHHHHHhc----------------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCC
Confidence 99999999999999764 47999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCC-----------------------CCC----cc-------------------ccccccCCcccChhc
Q 046188 486 AKVSDFGTSRSVPN-----------------------DKT----HL-------------------TTAVQGTFGYFDPEY 519 (646)
Q Consensus 486 ~kI~DfGla~~~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~ 519 (646)
+||+||||+.-+.. +.. .. ....+|||.|||||+
T Consensus 280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV 359 (550)
T KOG0605|consen 280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV 359 (550)
T ss_pred EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence 99999999853210 000 00 012469999999999
Q ss_pred cccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh-hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHh
Q 046188 520 FQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE-RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMG 598 (646)
Q Consensus 520 l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~ 598 (646)
+.+..|+..+|.||+|||||||+.|.+||....+.+. +.+..| ...+..+.......+..+||.+
T Consensus 360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw--------------r~~l~fP~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNW--------------RETLKFPEEVDLSDEAKDLITR 425 (550)
T ss_pred HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--------------hhhccCCCcCcccHHHHHHHHH
Confidence 9999999999999999999999999999987655431 111111 0112222223344778899999
Q ss_pred ccccCCCCCCC---HHHHHH
Q 046188 599 CLRLNSKKRPT---MKQVSM 615 (646)
Q Consensus 599 Cl~~dP~~RPs---~~evl~ 615 (646)
|+. ||++|.- ++||-+
T Consensus 426 ll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 426 LLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred Hhc-CHHHhcCcccHHHHhc
Confidence 999 9999965 555544
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.50 Aligned_cols=265 Identities=26% Similarity=0.454 Sum_probs=210.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC-----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-Cce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~-----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-~~~ 403 (646)
.++|...+.||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++..+ ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999755 688999988753 345567788999999999999999999998764 578
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++++||+++|+|.+++........ .....+++.+++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~ 153 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEA--------NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEE 153 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccccc--------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCC
Confidence 999999999999999866432100 01246999999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+ .
T Consensus 154 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~-- 228 (280)
T cd05043 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M-- 228 (280)
T ss_pred CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H--
Confidence 99999999999865332221 1222346778999999988889999999999999999999 999986433211 1
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
. ..... ......+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 229 -~-~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 -A-AYLKD---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -H-HHHHc---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 11111 11111223345678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.35 Aligned_cols=242 Identities=25% Similarity=0.371 Sum_probs=198.6
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||++... +|+.||+|+++.. .......+.+|+.+++.++||||+++.+++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 6899999988642 2344567889999999999999999999999999999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 81 ELFFHLSRE----------------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred CHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcC
Confidence 998888653 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhH
Q 046188 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 573 (646)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 573 (646)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. .......
T Consensus 142 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~~---- 210 (328)
T cd05593 142 CKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME---- 210 (328)
T ss_pred CccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhccC----
Confidence 87542221 122335699999999999988999999999999999999999999865432211 1110000
Q ss_pred HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 574 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
....+......+.+++.+||+.||.+|| ++.|++++
T Consensus 211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 -------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0123344556788999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.59 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=195.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC--CCCEEEEEecccCC--HHHHHHHHHHHHHHhhc---CccCceeEEEEEEe-----
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCLE----- 399 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~--~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~~----- 399 (646)
++|+..+.||+|+||.||+|... +|+.||||+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999852 46789999876422 22233556777777665 69999999999863
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
....++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil 142 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--------------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 142 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEE
Confidence 345799999995 78988886532 235899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+++++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 143 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-- 218 (290)
T cd07862 143 VTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-- 218 (290)
T ss_pred EcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--
Confidence 999999999999999865432 2233456899999999998889999999999999999999999999765432211
Q ss_pred HHHHHHHHh---hchhHHH---hhhhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAK---ENKLLEI---LDARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~---~~~~~~~---~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+..... ....... ....+. .....+....+.+++.+||+.||++|||+.|++++
T Consensus 219 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 219 -GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred -HHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 11111110 0000000 000000 00112344677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.63 Aligned_cols=243 Identities=29% Similarity=0.437 Sum_probs=207.8
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~ 404 (646)
..++|...++||+|.||.|+++..+ +++.+|||.++.. ...+++..+.|..|+...+ ||.+++|+.++...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468999999999999999999965 5789999998863 3556777888999888875 999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+.||++..+.+. ..++...+..+|..|+.||+|||+++ ||+||||.+|||||.+|
T Consensus 446 fvmey~~Ggdm~~~~~~-----------------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT-----------------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEG 505 (694)
T ss_pred EEEEecCCCcEEEEEec-----------------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccC
Confidence 99999999996555543 36889999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+||||++..-. ....+.+.+|||.|||||++.+..|+..+|.|||||+||||+.|..||...++++. |.
T Consensus 506 h~kiADFGlcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------Fd 578 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FD 578 (694)
T ss_pred cEEecccccccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HH
Confidence 999999999997532 22356678999999999999999999999999999999999999999987655442 22
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 610 (646)
.+..++ ..||...+.+...|++++|.++|++|.-+
T Consensus 579 sI~~d~-----------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVNDE-----------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcCC-----------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222221 23677778889999999999999999876
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.33 Aligned_cols=268 Identities=24% Similarity=0.393 Sum_probs=205.6
Q ss_pred CCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
+|...+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666788999999999999853 246899999875433 334578899999999999999999999999899999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
++||+.+++|.+++.....................+++..+++++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998643211000000000011235899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ |..|+......+ ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH
Confidence 99999999886533221 12223346789999999988889999999999999999998 777875432211 01
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
. .+.+. .....+.+++..+.+++.+||+.+|.+||++++|+..|+.
T Consensus 237 ~---------~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 E---------MIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---------HHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11111 1123345566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.85 Aligned_cols=275 Identities=26% Similarity=0.394 Sum_probs=211.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
.++|...+.||+|+||.||+++.. ++..||+|.++.. .....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457788899999999999999731 2457999988653 344566788999999999 899999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
...++||||+++|+|.+++.....................++|.+++.++.|+++||+|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 9999999999999999999764321100000000001236899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 999999999999998764332221 222346678999999988889999999999999999998 777775332211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.... .. .......+..++..+.+++.+||+.+|.+||++.|+++.|+++....
T Consensus 248 ---~~~~-~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 ---LFKL-LK---------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHH-HH---------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1111 11 11111223345677899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.88 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=195.2
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+|+..+.||+|+||.||+|... +|+.||||.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4455788999999999999954 6899999998653 3334567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 155 ~~~~L~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 155 DGGSLEGTH--------------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred CCCcccccc--------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcc
Confidence 999986432 3456777889999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+++....... ......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+.. .....
T Consensus 212 fG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA---SLMCA 287 (353)
T ss_pred cccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHH
Confidence 999987542211 1233568999999998743 23356899999999999999999998633221110 00000
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. ........+......+.+|+.+||+.||++||++.|++++-.
T Consensus 288 ~----------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 288 I----------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred H----------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0 000111223445577899999999999999999999999754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=319.54 Aligned_cols=247 Identities=26% Similarity=0.460 Sum_probs=198.4
Q ss_pred cccccCcEEEEEEEcC---CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCC
Q 046188 339 FLGQGGFGTVYKGMLP---DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
.||+|+||.||+|.+. ++..||+|..+... ....+.+.+|+.++++++|+||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999853 35579999887643 334567899999999999999999999885 456799999999999
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCc
Q 046188 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494 (646)
Q Consensus 415 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 494 (646)
|.+++.... ..+++..+++++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 81 L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~ 142 (257)
T cd05115 81 LNKFLSGKK---------------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLS 142 (257)
T ss_pred HHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcc
Confidence 999986532 36899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 495 RSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 495 ~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
+.......... ....++..|+|||.+....++.++||||||+++|||++ |..||......+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------------- 207 (257)
T cd05115 143 KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--------------- 207 (257)
T ss_pred ccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---------------
Confidence 86543322111 11234578999999988889999999999999999996 9999864432211
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
...+........+..++..+.+++.+||..||++||++.+|.+.|+.+
T Consensus 208 -~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 208 -MSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111111122234455667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.81 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=198.0
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||++... +|+.||+|.++.. .......+.+|+.++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999953 6899999987642 2344556788999999999999999999999999999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 81 ELFFHLSRE----------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred cHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHH
Confidence 998887543 36899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhH
Q 046188 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 573 (646)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 573 (646)
++...... .......||+.|+|||.+.++.++.++|||||||++|||++|+.||........ .....
T Consensus 142 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~------ 208 (323)
T cd05595 142 CKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELIL------ 208 (323)
T ss_pred hccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHh------
Confidence 87542221 112335689999999999999999999999999999999999999864432211 11111
Q ss_pred HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 574 ~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
... ...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 209 ---~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 209 ---MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---cCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 000 123344557789999999999999998 89988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=321.26 Aligned_cols=257 Identities=27% Similarity=0.496 Sum_probs=200.2
Q ss_pred CcCccccccCcEEEEEEEcCC-CC--EEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------Cce
Q 046188 335 NQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EVP 403 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~-g~--~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------~~~ 403 (646)
...+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999654 33 5999987643 355567889999999999999999999987542 246
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
+++|||+++|+|.+++...... .....++|.....++.|++.||+|||+++ |+||||||+|||++++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG----------DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNEN 148 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc----------CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCC
Confidence 8999999999999988543210 00235899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~-- 223 (272)
T cd05075 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I-- 223 (272)
T ss_pred CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H--
Confidence 999999999998764332211 122345678999999999999999999999999999999 788875432211 1
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
......+. ....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 224 --~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 --YDYLRQGN---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111110 1112334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=325.08 Aligned_cols=271 Identities=27% Similarity=0.450 Sum_probs=209.4
Q ss_pred CCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
+|...+.||+|+||.||+|... ....+++|.+... .....+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999852 2357899987643 34456678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHH--------HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQ--------ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~--------~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
++||+.+|+|.+++........... ..........+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999875432110000 0000111246899999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHH
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~ 555 (646)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998653322211 122345678999999988889999999999999999998 988885433221
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+ .+.+........+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 238 ---~-------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---L-------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---H-------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111112222344455778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.43 Aligned_cols=276 Identities=27% Similarity=0.400 Sum_probs=211.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
.++|...+.||+|+||.||++... ++..+|+|.++.. ......++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999999742 2346999998753 234556788999999999 799999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.+++.....................++|.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999764321000000000001235899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 999999999999998653222111 112234578999999998889999999999999999998 888875432211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
.+. .+......+.+......+.+++.+||+.+|.+||+|.||++.|.++.....
T Consensus 251 ---~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 251 ---LFK----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---HHH----------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 111 111111122344556788999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.37 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=196.0
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|+||.||++... +++.||+|+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5789999987642 234456788999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 81 FHHLQRE----------------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred HHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 9998653 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+.....
T Consensus 142 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~------- 207 (312)
T cd05585 142 LNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ------- 207 (312)
T ss_pred cCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-------
Confidence 643222 22234569999999999999999999999999999999999999986433211 1111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT---MKQVSMD 616 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~~evl~~ 616 (646)
. ...++......+.+++.+||+.||.+||+ +.|++.+
T Consensus 208 --~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 208 --E--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred --C--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1 11234445577899999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=320.67 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=209.4
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|++|.||++.. .+++.+|||.+.. ......+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 4789999997654 23344567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++..... ....++|..++.++.|+++||.|||+.+ ++|+||||+||+++.++.++
T Consensus 82 e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 82 ELADAGDLSRMIKHFKK------------QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EecCCCCHHHHHHHhhc------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999864321 1236899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... ......
T Consensus 147 l~dfg~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-- 219 (267)
T cd08229 147 LGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-- 219 (267)
T ss_pred ECcchhhhccccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh--
Confidence 9999998866433221 223468899999999998889999999999999999999999985432211 011110
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
+.........+......+.+++.+||+.||++||||.+|++.++++.
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 -------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00001111112345678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=324.00 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=205.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC------CCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
+++|...+.||+|++|.||+|...+ +..||+|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999743 4679999876533 33445789999999999999999999999988889
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++........ ....++|.++++++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~ 152 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPE---------RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK 152 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEecc
Confidence 999999999999999976532100 1236899999999999999999999998 9999999999999865
Q ss_pred C---cEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 484 F---SAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 484 ~---~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
+ .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-- 230 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-- 230 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 4 69999999998763222111 112233568999999998999999999999999999997 8888864432211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. +.+........+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 231 ----~----------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ----M----------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----H----------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 111111112234445678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.83 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=200.6
Q ss_pred CCCcCccccccCcEEEEEEEc----CCCCEEEEEecccC----CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCce
Q 046188 333 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKAI----DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~----~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~ 403 (646)
+|+..+.||+|+||.||++.. .+++.||+|.++.. .....+.+.+|+.+++++ +|+||+++.+++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 35789999987542 223345678899999999 599999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++... ..+++.+...++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~ 141 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----------------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSE 141 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCC
Confidence 9999999999999998653 35899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
+.+||+|||+++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ..
T Consensus 142 ~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~ 218 (332)
T cd05614 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SE 218 (332)
T ss_pred CCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HH
Confidence 9999999999987543333333446799999999998765 4788999999999999999999998643221110 00
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
+.. .+.. .....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 219 ~~~--------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 219 VSR--------RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHH--------HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 110 0000 11123344556789999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.22 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=202.2
Q ss_pred cCCCcCccccccCcEEEEEEEcCC--CCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD--GSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~--g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578889999999999999998543 368999987532 233456788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 110 ~Ey~~~g~L~~~i~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----------------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred EeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCE
Confidence 9999999999998653 35889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 171 kL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i 240 (340)
T PTZ00426 171 KMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKI 240 (340)
T ss_pred EEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHH
Confidence 99999999865322 1235689999999999988899999999999999999999999975432210 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
.... ..++......+.+++.+||+.||.+|+ +++|++++
T Consensus 241 ---------~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 241 ---------LEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---------hcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 122334456678999999999999995 89998876
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.65 Aligned_cols=266 Identities=25% Similarity=0.373 Sum_probs=204.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..++||+|+||.||++... ++..+|+|.++.. .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999965 5888999987653 33445678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||+++++.+|
T Consensus 84 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~k 144 (333)
T cd06650 84 HMDGGSLDQVLKKA----------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIK 144 (333)
T ss_pred cCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEE
Confidence 99999999998653 3588899999999999999999974 5 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH-----
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY----- 562 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~----- 562 (646)
|+|||++...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..............
T Consensus 145 L~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (333)
T cd06650 145 LCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221 (333)
T ss_pred EeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCC
Confidence 9999999765322 12234689999999999988899999999999999999999999865432211000000
Q ss_pred ----------------HHHHHh----hchhHHHhhhhhccc---CC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 563 ----------------FISLAK----ENKLLEILDARVAKE---AS-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 563 ----------------~~~~~~----~~~~~~~~d~~l~~~---~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...... ........+...... .+ ......+.+|+.+||++||++|||+.|++++--
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000 000011111111110 11 123456899999999999999999999987644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.63 Aligned_cols=258 Identities=24% Similarity=0.437 Sum_probs=205.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..++||+|+||+||+|.+. +|+ .||+|.++.. .....+++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56778899999999999999853 444 4899988653 34455678899999999999999999999975 45689
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
++||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 ~~~~~~~g~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK---------------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNH 147 (279)
T ss_pred EEEcCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence 999999999999987542 26899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~--- 221 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP--- 221 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---
Confidence 9999999998764322211 122235678999999998899999999999999999998 888875433211 11
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
..+........+...+..+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 222 ----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 222 ----------DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----------HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111111111223345567899999999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=318.73 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=203.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|...+.||+|++|.||+|...++..+|+|+...... ..+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 46778889999999999999987777899998765332 2356889999999999999999999875 456799999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 84 KGSLLDFLKEGD--------------GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred CCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCC
Confidence 999999997532 235899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++..|+|||...++.++.++||||||+++|||++ |+.|+......+. ...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~----- 215 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV------LEQ----- 215 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH-----
Confidence 9998764332222223346778999999998899999999999999999999 8888864332210 010
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+........+...+..+.+++.+||+.||.+||++++|++.|+.
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 -----VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111112334556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=316.85 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=205.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||+|... +++.|++|.+.. ......+++.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999964 688999998753 3445667889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+
T Consensus 81 ~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~ 143 (256)
T cd08529 81 AENGDLHKLLKMQR--------------GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIG 143 (256)
T ss_pred CCCCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEc
Confidence 99999999997642 236899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||+++....... ......|++.|+|||++.++.++.++||||||+++|||++|+.||........ ...
T Consensus 144 df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~---- 212 (256)
T cd08529 144 DLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------ILK---- 212 (256)
T ss_pred ccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHH----
Confidence 9999987643322 22334688999999999999999999999999999999999999865432110 000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+.. ......+......+.+++.+||+.+|++||++.+++++
T Consensus 213 -----~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 -----IIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----HHc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 11122233455779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.62 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=202.7
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
..++|+..+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568889999999999999999954 5889999987542 22334457789999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++... .++...+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 121 v~Ey~~gg~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----------------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCC
Confidence 99999999999988542 4778888899999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+||+|||+++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......
T Consensus 181 ~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------ 254 (370)
T cd05596 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------ 254 (370)
T ss_pred EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------
Confidence 99999999987643332223345799999999988653 47889999999999999999999997543221
Q ss_pred HHHHHHhhchhHHHhhhhhcccCC--HHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEAS--EEDIEAVAELAMGCLRLNSKK--RPTMKQVSMDL 617 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~L 617 (646)
.+.. +++......++ ...+..+.+++.+||+.+|.+ ||++.|++.+-
T Consensus 255 ~~~~---------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 255 TYSK---------IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHH---------HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 1111 11111001111 234577889999999999988 99999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.76 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=204.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||+||+|... +|+.||||+++.. .......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999964 6899999998642 1234557889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 81 EYMPGGDLMNLLIRK----------------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred cCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 999999999998753 36899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCC----------------------------CccccccccCCcccChhccccCCCCCccchhhHHHHHH
Q 046188 488 VSDFGTSRSVPNDK----------------------------THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 539 (646)
Q Consensus 488 I~DfGla~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ 539 (646)
|+|||++....... ........||+.|+|||.+.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999998764332 11223356899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHH
Q 046188 540 ELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-MKQVSMDL 617 (646)
Q Consensus 540 ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~evl~~L 617 (646)
||++|+.||......+. ...... +. ..+..+.....+..+.+++.+||+ ||.+||+ +.|++++.
T Consensus 222 ell~g~~Pf~~~~~~~~------~~~i~~------~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 222 EMLYGFPPFYSDTLQET------YNKIIN------WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred hhccCCCCCCCCCHHHH------HHHHhc------cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 99999999975442211 111110 00 111111111245778899999997 9999999 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=333.98 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=208.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..|+..++||+|.||.||||.. ..++.||+|.+.. ..+.+.++..+|+.+|.+++++||.+++|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3566778999999999999995 4688999999764 3455678899999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+.+|++.+.|... ..+.+....-|..++..||.|||.++ .+|||||+.|||+..+|.+|++
T Consensus 93 ~~gGsv~~lL~~~----------------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG----------------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred hcCcchhhhhccC----------------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEE
Confidence 9999999999763 23577788889999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++-.+....... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..
T Consensus 154 DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------------- 218 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------------- 218 (467)
T ss_pred ecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--------------
Confidence 999998875544433 56789999999999998899999999999999999999999986443311
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..-++-+.........++..+.+++..||.+||+.||++.+++++
T Consensus 219 --vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 219 --VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111111111222233566789999999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=323.47 Aligned_cols=267 Identities=26% Similarity=0.451 Sum_probs=208.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.+|...++||+|+||.||++... ++..+|+|..+.......+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999632 356899999887777777789999999999999999999999999889999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
+|||+++|+|.+++............ ........+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAG-GEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcc-cccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999765421111000 00011236899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H
Confidence 99999999976533221 11222345788999999999999999999999999999998 8888754332211 0
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. .+........+..++..+.+++.+||+.||.+||++.||.+.|+
T Consensus 235 ~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 E----------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H----------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 01111111223344567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=339.12 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=198.4
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|...+.||+|+||.||++.. .+++.||+|+... ..+.+|+.++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999995 4688999997542 35678999999999999999999999999999999998
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
.++|.+++... ..+++.+++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 166 -~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 166 -KTDLYCYLAAK----------------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred -CCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEe
Confidence 57888877542 35899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH-----hhcHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE-----ERNLVAYFIS 565 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~-----~~~l~~~~~~ 565 (646)
||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ...+. .+..
T Consensus 226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~-~i~~ 304 (391)
T PHA03212 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK-LIIR 304 (391)
T ss_pred CCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH-HHHH
Confidence 99997543222222334579999999999999899999999999999999999998875432110 11111 1111
Q ss_pred HHhh----------chhHHHh---hhhh-cc--cC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 566 LAKE----------NKLLEIL---DARV-AK--EA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 566 ~~~~----------~~~~~~~---d~~l-~~--~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... ..+.+.. .... .. .. ....+..+.+|+.+||+.||.+|||+.|++++=
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0000 0011110 0000 00 00 012355788999999999999999999998754
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=340.19 Aligned_cols=277 Identities=26% Similarity=0.387 Sum_probs=212.2
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcC-ccCceeEEEEEE
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQIN-HRHIVKLLGCCL 398 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~ 398 (646)
++...++|...++||+|+||.||+|+++ .++.||||+++.. .....+.+.+|+++|.++. ||||++++|++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344567778899999999999999853 2458999998754 2334457889999999997 999999999999
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHH------H------------------------------------------
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQK------Q------------------------------------------ 430 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~------~------------------------------------------ 430 (646)
..+..++||||+++|+|.++++......... .
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9889999999999999999997653210000 0
Q ss_pred ----------------------------------HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 431 ----------------------------------ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 431 ----------------------------------~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
..........++|...+.|+.|++.||+|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 0000011235899999999999999999999988 999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchH
Q 046188 477 NILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREE 554 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 554 (646)
|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532221 11222356789999999998889999999999999999998 88887543221
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
+. . .+.+........+...+..+.+|+.+||+.+|.+||+++||++.|+++.
T Consensus 349 ~~------~---------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQ------F---------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH------H---------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1 1111111122234445678999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=317.84 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=206.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..+.||+|++|.||+|.. .|+.||+|..+.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4678889999999999999997 488999999876544 56688999999999999999999999998889999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+++|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~ 146 (256)
T cd05039 84 KGSLVDYLRSRG--------------RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDF 146 (256)
T ss_pred CCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccc
Confidence 999999986542 126899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++....... ....+..|+|||++..+.++.++||||||+++|||++ |..|+......+. ..
T Consensus 147 g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~----- 210 (256)
T cd05039 147 GLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VP----- 210 (256)
T ss_pred ccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HH-----
Confidence 99987632211 2235678999999998899999999999999999997 9888864432211 00
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.+........+...+..+.+++.+||..+|++||++.|+++.|+.+
T Consensus 211 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 211 ----HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111111222334567889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=320.91 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=200.2
Q ss_pred ccccccCcEEEEEEEcCC-CC--EEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLPD-GS--IVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999643 43 5788988753 344556788999999999 899999999999998899999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++.....................+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 9999999764321000000000011235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
+++..... ........+..|+|||++....++.++||||||+++|||++ |..||......+ .+...
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~----- 224 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL----- 224 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHH-----
Confidence 98643211 11111224567999999988889999999999999999997 999985432211 11111
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
......+.+......+.+++.+||+.||.+||++.|++..|.++.
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111223344567899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.13 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=208.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|...+.||+|++|.||+|..+++..||||.++.... ..+++.+|+.++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 468888999999999999999987778899998875332 3457889999999999999999999999888899999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 84 SKGSLLDFLKSGE--------------GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred CCCCHHHHHhccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECc
Confidence 9999999997643 136899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------~~~---- 216 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV------LEQ---- 216 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH----
Confidence 99998764322222222335678999999998889999999999999999999 8988854332110 111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+........+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 ------VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11111112233345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=319.72 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=205.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-C---CCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-D---GSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~---g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.+|+..+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++.+++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3379999887532 34456889999999999999999999999988999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++.+++.++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---------------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVC 145 (267)
T ss_pred EEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeE
Confidence 99999999999986532 25899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||+++.......... ....++..|+|||++.++.++.++||||||+++||+++ |+.|+......+. .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~------~ 219 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV------I 219 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH------H
Confidence 9999999987644322211 11223568999999998889999999999999999887 9999864332211 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
... .+. ...+.+...+..+.+++.+||+.+|.+||+|.++++.|.++
T Consensus 220 ~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 220 KAI-EEG---------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHH-hCC---------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111 110 11122334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.60 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=203.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC-----HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID-----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|...+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999985 368999999865321 2234578899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|+||+++++|.+++... ..+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.
T Consensus 82 v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~ 142 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----------------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGN 142 (263)
T ss_pred EEEECCCCcHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 99999999999988653 35889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++.......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~ 216 (263)
T cd06625 143 VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------I 216 (263)
T ss_pred EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------H
Confidence 99999999976533221111 234578899999999998899999999999999999999999854322111 0
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ...........+......+.+++.+||..+|.+||++.|++++
T Consensus 217 ~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 F---------KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred H---------HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 1111111123344556778999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.78 Aligned_cols=260 Identities=27% Similarity=0.331 Sum_probs=208.1
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE- 401 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~- 401 (646)
+.+...++|...+.||+|+||+||++.. .+|+.||||.+.. ........+.+|+.++..++|+|++++.+.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344557999999999999999999984 4689999998754 34455667889999999999999999988765432
Q ss_pred -------ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 402 -------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 402 -------~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ |+|||||
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLK 170 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAK------------TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 25799999999999999975432 1346899999999999999999999998 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCC-CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
|+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 171 P~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred HHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999998754321 2223345799999999999999999999999999999999999999864332
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+ .+.... .. .....+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 251 ~~------~~~~~~---------~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EE------VMHKTL---------AG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH------HHHHHh---------cC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 111111 10 0112344556789999999999999999999999875
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=328.31 Aligned_cols=273 Identities=27% Similarity=0.443 Sum_probs=208.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC--EEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS--IVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~--~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|... ++. .+|+|+++.. .......+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999964 343 4688877653 344556788999999999 899999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.++++....................+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 9999999999999765321100000000001236899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++..... .......++..|+|||++....++.++||||||+++|||+| |..||......+ .+..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 235 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHH
Confidence 99999998743211 11111224668999999988889999999999999999998 999986433211 1111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
. ........+...+..+.+|+.+||+.+|++||++.+++.+|.++.....
T Consensus 236 ~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 236 L----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred H----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1 0111112233345678999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.49 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=203.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.+++.++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999954 6889999988752 2234556788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+|
T Consensus 81 e~~~~~~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---------------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred CCCCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEE
Confidence 9999999999987642 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ------SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
|+|||++...............||+.|+|||++. ...++.++|||||||++|||++|+.||.......
T Consensus 143 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------ 216 (330)
T cd05601 143 LADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------ 216 (330)
T ss_pred eccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------
Confidence 9999999876544333333456899999999986 4567899999999999999999999986443221
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+......... +..+.....+..+.+|+..||+ +|.+||++.+++.+
T Consensus 217 ~~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 217 TYNNIMNFQRF-------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHcCCCc-------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111111000 0011112345678899999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.54 Aligned_cols=260 Identities=25% Similarity=0.418 Sum_probs=210.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|++|.||+|... +|+.||+|.++. ......+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999975 789999998753 23344667889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++..... ....+++.+++.++.++++||.|||+.+ ++||||+|+||+++.++.++
T Consensus 82 e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 82 ELADAGDLSRMIKHFKK------------QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVK 146 (267)
T ss_pred ecCCCCCHHHHHHHhcc------------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEE
Confidence 99999999999865321 0235899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........
T Consensus 147 l~d~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-- 219 (267)
T cd08224 147 LGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-- 219 (267)
T ss_pred EeccceeeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh--
Confidence 9999998865432211 2234588899999999988899999999999999999999999854321 11111111
Q ss_pred hhchhHHHhhhhhcccCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASE-EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
+........+. .....+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 --------IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111112222 45567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=331.53 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=196.6
Q ss_pred ccccccCcEEEEEEEc----CCCCEEEEEecccC----CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 338 RFLGQGGFGTVYKGML----PDGSIVAVKRSKAI----DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~----~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+.||+|+||.||++.. .+++.||||.++.. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 35789999987642 122344677899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++... ..+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 142 (323)
T cd05584 82 LSGGELFMHLERE----------------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLT 142 (323)
T ss_pred CCCchHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEe
Confidence 9999999988653 35788889999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 143 Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~---- 211 (323)
T cd05584 143 DFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDK---- 211 (323)
T ss_pred eCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHH----
Confidence 999987543222 12233568999999999998889999999999999999999999986543211 1111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
+.... ...+......+.+++.+||+.||++|| ++.+++.+
T Consensus 212 -----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 212 -----ILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -----HHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11111 123344556789999999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=327.21 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=198.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++.+++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999965 688999998764322 223457789999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+ .++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl 144 (303)
T cd07869 84 YV-HTDLCQYMDKHP---------------GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKL 144 (303)
T ss_pred CC-CcCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence 99 578888776532 35889999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++....... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ . ........
T Consensus 145 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~ 221 (303)
T cd07869 145 ADFGLARAKSVPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-Q-LERIFLVL 221 (303)
T ss_pred CCCCcceeccCCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-H-HHHHHHHh
Confidence 99999976432221 1223468899999998865 4578899999999999999999999975432111 1 11111111
Q ss_pred hhchhHHH--------hhhh-hcccCC---------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEI--------LDAR-VAKEAS---------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~--------~d~~-l~~~~~---------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.......+ .++. .....+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred CCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 10000000 0000 000000 0122457899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.46 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=207.1
Q ss_pred hcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~ 402 (646)
.++|...+.||+|+||.||++.. ..+..||||.++.. .....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35788899999999999999973 12457999988754 334456789999999999 79999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+.+|+|.++++.... ..+++.++..++.|++.||+|||+++ ++|+||||+|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~ 176 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE--------------SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTH 176 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcC
Confidence 9999999999999999865321 24899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 560 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.|+......+.
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---- 252 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---- 252 (302)
T ss_pred CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----
Confidence 999999999999866433221 1222345778999999998889999999999999999998 9999764332111
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
+.. ..+.......+...+..+.+++.+||..+|++||++.|+++.|+++
T Consensus 253 --~~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 --FYK---------LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111 1111111122233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.35 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=203.2
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++.+++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999954 68899999886422 1223457789999999999999999999999889999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 81 ~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 81 LMNGGDLKFHIYNMG--------------NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred ccCCCcHHHHHHhcC--------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEE
Confidence 999999998886432 236899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||+++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.
T Consensus 144 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~---- 214 (285)
T cd05605 144 SDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVE---- 214 (285)
T ss_pred eeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHH----
Confidence 99999987543222 12346899999999999888999999999999999999999999753321110 0010
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
..+. .....++...+..+.+|+.+||+.||.+|| ++++++.+
T Consensus 215 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 215 -----RRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----HHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1111 111223445667789999999999999999 88898776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=319.92 Aligned_cols=254 Identities=25% Similarity=0.469 Sum_probs=203.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CC---CEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g---~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.|+..+.||+|+||.||+|... ++ ..||||.++.. .....++|..|+.++++++||||+++.+++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999964 23 36999998754 4555678999999999999999999999999888999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++.+++.++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 85 e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 85 EFMENGALDSFLRQND---------------GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ecCCCCcHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEE
Confidence 9999999999986542 25899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCc--ccccc--ccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 488 VSDFGTSRSVPNDKTH--LTTAV--QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 488 I~DfGla~~~~~~~~~--~~~~~--~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
|+|||+++........ ..... ..+..|+|||++..+.++.++||||||+++|||++ |..||......+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~------ 220 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------ 220 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH------
Confidence 9999998765432211 11111 12457999999999999999999999999999886 9999864432211
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
... +......+.+.+++..+.+++.+||+.+|++||++++|+..|+++
T Consensus 221 ~~~----------i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 221 INA----------IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHH----------HHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 001111122344556789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.48 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=202.3
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
....++|+..+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999964 578999998753 1223345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----------------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~ 178 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-----------------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKH 178 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCC
Confidence 9999999999999988542 4788899999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+.+||+|||+++..............||+.|+|||.+... .++.++|||||||++|||++|+.||.......
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---- 254 (370)
T cd05621 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---- 254 (370)
T ss_pred CCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----
Confidence 9999999999987643332223345799999999998653 37889999999999999999999996543211
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCC--HHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEAS--EEDIEAVAELAMGCLRLNSKK--RPTMKQVSMDL 617 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~L 617 (646)
.+ ..+++.......+ ...+..+.+++..|++.++.+ ||++.|++++-
T Consensus 255 --~~---------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 255 --TY---------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred --HH---------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 11 1122211111112 234567888999999865544 89999999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=304.71 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=213.8
Q ss_pred hcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ceE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 404 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~~ 404 (646)
.++|.+.++||+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999999 6678999999998887888899999999999999999999999876543 489
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
|+++|...|+|.+.+...... ...+++.+.++|+.++.+||++||+.. |++.||||||.|||+.+.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k------------g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK------------GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSG 166 (302)
T ss_pred EEeehhccccHHHHHHHHhhc------------CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCC
Confidence 999999999999999765431 347999999999999999999999988 5799999999999999999
Q ss_pred cEEEeecCCccccCCCCCcc--------ccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 485 SAKVSDFGTSRSVPNDKTHL--------TTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
.++|.|||.+...+-.-... -..-..|..|.|||.+. +...++++|||||||+||+|+.|..||...-.
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 99999999987653211111 11134788999999885 34578999999999999999999999853211
Q ss_pred HHhhcHHHHHHHHHhhchh-HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKL-LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
. .+++ ..+..+.+..+.....++.+.+++++|++.||.+||++.+++..+..+
T Consensus 247 ~--------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 Q--------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred c--------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1 1111 112222222222233678899999999999999999999999998865
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.50 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=207.1
Q ss_pred cCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467788999999999999998543 2479999877544 4556789999999999999999999999875 457899
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~ 146 (270)
T cd05056 85 MELAPLGELRSYLQVNK---------------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCV 146 (270)
T ss_pred EEcCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCe
Confidence 99999999999996532 25899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++..............++..|+|||.+....++.++||||||+++|||++ |..||......+. ...
T Consensus 147 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~ 220 (270)
T cd05056 147 KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGR 220 (270)
T ss_pred EEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH
Confidence 999999998764433222222334568999999988889999999999999999996 9999865433211 111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
... . .....+..++..+.+++.+||..+|.+|||+.+++..|+.+...
T Consensus 221 ~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 IEN-G---------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHc-C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 100 0 01122344567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=337.75 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=201.1
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ceE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 404 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~~ 404 (646)
+|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 46899999988642 3344567889999999999999999999998766 689
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 81 lv~e~~~-~~l~~~~~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~ 140 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----------------QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNC 140 (372)
T ss_pred EEeeccc-cCHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCC
Confidence 9999995 6777776442 36899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||+++..............+++.|+|||.+.+. .++.++|||||||++|||++|+.||......... ..+
T Consensus 141 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i 217 (372)
T cd07853 141 VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLI 217 (372)
T ss_pred CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHH
Confidence 999999999987543333333344678999999998764 4789999999999999999999999755433211 111
Q ss_pred HHHHhhchh----------HHHhhhhh-c-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 564 ISLAKENKL----------LEILDARV-A-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 564 ~~~~~~~~~----------~~~~d~~l-~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
......... ...+.... . ..........+.+|+.+||+.||++|||+.|++++-
T Consensus 218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 111111100 00000000 0 011122356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=337.52 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=197.7
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.|...+.||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 46889999998642 23445678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 82 YIPGGDMMSLLIRM----------------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred cCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEE
Confidence 99999999998653 35888999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCC----------------------------------------------CccccccccCCcccChhcccc
Q 046188 489 SDFGTSRSVPNDK----------------------------------------------THLTTAVQGTFGYFDPEYFQS 522 (646)
Q Consensus 489 ~DfGla~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~l~~ 522 (646)
+|||+++...... ........||+.|+|||.+.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 9999976431100 001123569999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHh--cc
Q 046188 523 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMG--CL 600 (646)
Q Consensus 523 ~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~--Cl 600 (646)
..++.++|||||||++|||++|+.||......+.. ...... ...+..+........+.+++.+ |+
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ------LKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH------HHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccC
Confidence 88999999999999999999999999754332210 000000 0001111111234566777777 55
Q ss_pred ccCCCCCCCHHHHHHH
Q 046188 601 RLNSKKRPTMKQVSMD 616 (646)
Q Consensus 601 ~~dP~~RPs~~evl~~ 616 (646)
..+|..||++.|++.+
T Consensus 290 ~~~~~~R~~~~~~l~h 305 (381)
T cd05626 290 AEERLGRNGADDIKAH 305 (381)
T ss_pred cccccCCCCHHHHhcC
Confidence 6677779999999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.84 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=197.1
Q ss_pred ccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||++.. .+|+.||+|.++.. .......+.+|+++++.++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999987642 2334567788999999999999999999999999999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
+|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 81 ELFFHLSRE----------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred cHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCC
Confidence 998887543 368999999999999999999997 67 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .....
T Consensus 142 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~----- 209 (325)
T cd05594 142 LCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL----- 209 (325)
T ss_pred CCeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHh-----
Confidence 9875432221 22335699999999999999999999999999999999999999865432211 01000
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
.. ...++......+.+++.+||+.||++|+ ++.+++++
T Consensus 210 ----~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 ----ME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----cC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00 0122334456789999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.07 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=200.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||++... +|+.||||+++.. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999964 6899999998642 2334456788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 E~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 81 EYLPGGDMMTLLMKK----------------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred CCCCCcHHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEE
Confidence 999999999998653 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCc-------------------------------------cccccccCCcccChhccccCCCCCccc
Q 046188 488 VSDFGTSRSVPNDKTH-------------------------------------LTTAVQGTFGYFDPEYFQSSQYTDKSD 530 (646)
Q Consensus 488 I~DfGla~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksD 530 (646)
|+|||++......... ......||+.|+|||++....++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 9999998754221100 011246999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-
Q 046188 531 VYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT- 609 (646)
Q Consensus 531 VwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs- 609 (646)
||||||++|||++|..||......+. ....... ...+........+..+.+++.+|+. +|.+|++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~ 287 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNPQET------YRKIINW-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN 287 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCHHHH------HHHHHcC-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence 99999999999999999975432211 1111100 0001111111234567889999996 9999998
Q ss_pred --HHHHHHH
Q 046188 610 --MKQVSMD 616 (646)
Q Consensus 610 --~~evl~~ 616 (646)
+.|++.+
T Consensus 288 ~~~~~ll~h 296 (364)
T cd05599 288 NGVNEIKSH 296 (364)
T ss_pred CCHHHHhcC
Confidence 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.02 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=210.0
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.-|+..+.||+|+.|.|-.|+. .+|+.+|||.+... .......+.+|+.||+.++|||++++++++.+...+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3466788899999999999995 47999999987543 2233446779999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|-|.+++... .+|+..+..+++.||+.|+.|+|..+ |+|||+||+|+|||..+++|
T Consensus 92 Eyv~gGELFdylv~k----------------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK----------------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred EecCCchhHHHHHhh----------------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEe
Confidence 999999999999764 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+|..-..+ ..-.+.+|.+.|.|||++.+.+| +.++||||.||+||.|+||+.||+.+ +.+.
T Consensus 153 IADFGMAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~-------- 219 (786)
T KOG0588|consen 153 IADFGMASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRV-------- 219 (786)
T ss_pred eeccceeecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHH--------
Confidence 9999999864332 33445689999999999999887 57999999999999999999999732 1111
Q ss_pred HhhchhHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 567 AKENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
++.+--. .+.|...+.+..+|+.+|+..||.+|.|++||++|-.-..
T Consensus 220 --------LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 220 --------LLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred --------HHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 1111111 2345677788999999999999999999999999876443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.38 Aligned_cols=254 Identities=24% Similarity=0.435 Sum_probs=206.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|+..+.||+|+||.||+|...++..+|+|.++.. ....+.+.+|+.++++++|+|++++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999777788999987753 3345678899999999999999999999877 7789999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ...++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 83 ~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 83 AKGSLLDFLKSDE--------------GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred CCCcHHHHHHhCC--------------ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECC
Confidence 9999999986632 235889999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||++...............++..|+|||++..+.++.++|+||||++++|+++ |+.||........ . ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~----~~--- 215 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I----RA--- 215 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---H----HH---
Confidence 99998664333222223345678999999998889999999999999999999 8888864322111 0 00
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+......+.+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 ------LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------HhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111112233445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.54 Aligned_cols=268 Identities=25% Similarity=0.430 Sum_probs=207.5
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
...++|+..+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.+++.++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999743 24579999876433 334456889999999999999999999999888
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+++|+|.+++........ .......+++....+++.|++.||.|||+++ ++||||||+||+++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~ 153 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAE------NNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVA 153 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccc------cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEc
Confidence 99999999999999999976432100 0011245788899999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l 559 (646)
+++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+......+
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---- 229 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---- 229 (288)
T ss_pred CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 9999999999999865322211 1112235678999999998899999999999999999999 677875432221
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
... . +.+... ...+...+..+.+++.+||+.||++||++.|+++.|.+..
T Consensus 230 --~~~-~--------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 --VLK-F--------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --HHH-H--------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 011 1 111111 1123344578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.38 Aligned_cols=270 Identities=25% Similarity=0.391 Sum_probs=204.7
Q ss_pred cCCCcCccccccCcEEEEEEEc-----CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--Cce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~ 403 (646)
..|...+.||+|+||.||++.+ .++..||+|.++... ....+.+.+|+.++++++|||++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567789999999999999974 247889999987543 44456789999999999999999999998875 467
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++++|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 145 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---------------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 145 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCC
Confidence 89999999999999986532 25899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++++.|..............
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05079 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP 225 (284)
T ss_pred CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence 99999999999876432221 1223456778999999988889999999999999999999877643211000000000
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.... .........+......+.+..++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQ-MTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccc-ccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 000000111111111222344567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.35 Aligned_cols=263 Identities=27% Similarity=0.453 Sum_probs=208.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC------CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|...+.||+|+||.||+|...+ +..||+|.+... .......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998642 368999998654 334456788999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++......... ......++|..++.++.|++.||.|||+.+ ++||||||+||+++++
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~ 155 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAEN------NPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED 155 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhh------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCC
Confidence 9999999999999999764321100 011346899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 230 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV----- 230 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-----
Confidence 9999999999986543222 12223346789999999988889999999999999999998 8888754332211
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. .+........+...+..+.+++.+||+.+|++|||+.|++..|+
T Consensus 231 -~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 -LK----------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HH----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 11111112234445678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.67 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=202.0
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe-CCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-~~~~~LV~Ey~ 410 (646)
++|...+.||+|+||.||++.. .|..||+|..+... ..+.+.+|+.++++++|+|++++++++.. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 47889999887533 34578899999999999999999998654 45689999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ...+++..+++++.|++.||+|||+++ ++||||||+||++++++.+||+|
T Consensus 83 ~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 83 AKGSLVDYLRSRG--------------RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred CCCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecC
Confidence 9999999986542 235899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ ....
T Consensus 146 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~---- 211 (256)
T cd05082 146 FGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR---- 211 (256)
T ss_pred CccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH----
Confidence 99988653222 22335678999999998889999999999999999998 888875432211 1111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 212 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ------VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111111223344567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=330.53 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=195.4
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHH---hhcCccCceeEEEEEEeCCceEEE
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVIL---SQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il---~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
|+..+.||+|+||.||+|... +|+.||||.++.. .....+.+.+|+.++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999854 6889999998642 223345566666554 567899999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|..+++. ..+++.+++.++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 81 ~E~~~~~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----------------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred EcCCCCCcHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcE
Confidence 999999999887743 25899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ....
T Consensus 141 kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i 213 (324)
T cd05589 141 KIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSI 213 (324)
T ss_pred EeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 999999987542221 122345689999999999999999999999999999999999999865432211 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
.... ..++...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ---------~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 214 ---------VNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---------HhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111 123344556788999999999999999 56666664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.90 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=206.6
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567788888899999999999999954 57889999987766667778999999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL--SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
+|+||+++++|.+++..... .+ ++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~ 143 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG---------------PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNT 143 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc---------------cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcC
Confidence 99999999999999975421 34 78888999999999999999998 999999999999986
Q ss_pred -CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 483 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 483 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
++.+||+|||++........ ......+++.|+|||++.... ++.++||||||+++|||++|+.|+..........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~- 221 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM- 221 (268)
T ss_pred CCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-
Confidence 67999999999876532222 122235789999999986644 7889999999999999999999985432111000
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ..-.......+......+.+++.+||+.+|.+||++.|++.+
T Consensus 222 ---~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 ---FK----------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---hh----------hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 000011122344556778999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.48 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=202.4
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
.+|+..+.||+|+||.||+|...++..+|+|.++.... ...++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777889999999999999986688999998765322 23468899999999999999999999998889999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+++|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 83 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 144 (256)
T cd05112 83 HGCLSDYLRAQR---------------GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDF 144 (256)
T ss_pred CCcHHHHHHhCc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCC
Confidence 999999986532 25889999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++.+|+|||.+.++.++.++||||||+++|||++ |+.|+......+ .......
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-- 216 (256)
T cd05112 145 GMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINA-- 216 (256)
T ss_pred cceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhC--
Confidence 9998654332222222335678999999998899999999999999999998 888886433221 0111100
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
......+...+..+.+|+.+||+.+|++||++.|+++.|
T Consensus 217 --------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 --------GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 011111222356799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=330.51 Aligned_cols=249 Identities=23% Similarity=0.404 Sum_probs=196.9
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||++... +++.||||.++.. .......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 5889999988752 223445678899999988 799999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~~~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 81 GDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCc
Confidence 9998887542 36999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH--hhcHHHHHHHHHhhc
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--ERNLVAYFISLAKEN 570 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~ 570 (646)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......+.....
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--- 217 (329)
T cd05588 142 MCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--- 217 (329)
T ss_pred cccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---
Confidence 987532211 12234578999999999999999999999999999999999999996422111 111111111111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT------MKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------~~evl~~ 616 (646)
.... ...|...+..+.+++.+||+.||.+||+ +.|++++
T Consensus 218 -----~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 218 -----LEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----HcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111 1233445567899999999999999997 6777755
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.72 Aligned_cols=258 Identities=25% Similarity=0.353 Sum_probs=215.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCCC-CEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEE-EEEeC------Cc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDG-SIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLG-CCLET------EV 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g-~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g-~~~~~------~~ 402 (646)
-++++.+.|.+|||+.||.+....+ ..+|+|++-..++...+...+|+++|++|+ |+|||.+++ ..... -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4566788999999999999997665 999999998888899999999999999996 999999999 33321 24
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.+|.||||.+|.|.++|..+.. ..|++.++++|+.|+++|+++||... |||||||||-+||||+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--------------~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--------------TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSA 181 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--------------ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcC
Confidence 6899999999999999987644 25999999999999999999999987 77999999999999999
Q ss_pred CCcEEEeecCCccccCCCC-Cccc-------cccccCCcccChhcc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 483 KFSAKVSDFGTSRSVPNDK-THLT-------TAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~-~~~~-------~~~~gt~~y~aPE~l---~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
++..||||||.|....... .... -...-|+-|+|||.+ .+..+++|+|||||||+||-|+....||+..
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9999999999987542111 1100 012358999999976 4668899999999999999999999999632
Q ss_pred chHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
. -..+++..+..+-.+.+...|.+||..||+.||.+||++.+|+..+.+|...
T Consensus 262 g-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 262 G-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred c-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1 1235566655555568889999999999999999999999999999999864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.02 Aligned_cols=248 Identities=29% Similarity=0.476 Sum_probs=198.7
Q ss_pred ccccccCcEEEEEEEcCC----CCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLPD----GSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
++||+|+||.||+|++.. +..+|+|..+.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899998875433 34567889999999999999999999876 4467999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 80 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~ 140 (257)
T cd05060 80 GPLLKYLKKR----------------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFG 140 (257)
T ss_pred CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEecccc
Confidence 9999999753 25899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcccc--ccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 493 TSRSVPNDKTHLTT--AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 493 la~~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
+++........... ...++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~------ 211 (257)
T cd05060 141 MSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML------ 211 (257)
T ss_pred ccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH------
Confidence 99876433322211 1224568999999998999999999999999999998 999985433211 11111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
........+...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 212 -------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 -------ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -------HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111112234445678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.96 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=195.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||+||++... +++.||||+++.. .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999854 5889999998642 2233456788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 81 E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 81 EFLPGGDMMTLLMKK----------------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred cCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEE
Confidence 999999999998653 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCC----------------------------------ccccccccCCcccChhccccCCCCCccchhh
Q 046188 488 VSDFGTSRSVPNDKT----------------------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 533 (646)
Q Consensus 488 I~DfGla~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS 533 (646)
|+|||+++....... .......||+.|+|||.+.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 999999875422110 0012357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccc--cCCCCCCCHH
Q 046188 534 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLR--LNSKKRPTMK 611 (646)
Q Consensus 534 fGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~--~dP~~RPs~~ 611 (646)
|||++|||++|+.||......+. +....... ..+..+........+.+++.+++. .++..||+++
T Consensus 222 lGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ 288 (363)
T cd05628 222 LGVIMYEMLIGYPPFCSETPQET------YKKVMNWK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE 288 (363)
T ss_pred hHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHH
Confidence 99999999999999965432211 11111100 000000001123455666666443 3444679999
Q ss_pred HHHHH
Q 046188 612 QVSMD 616 (646)
Q Consensus 612 evl~~ 616 (646)
||+++
T Consensus 289 ei~~h 293 (363)
T cd05628 289 EIKTN 293 (363)
T ss_pred HHhCC
Confidence 99987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.22 Aligned_cols=275 Identities=26% Similarity=0.401 Sum_probs=209.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
.++|...+.||+|+||.||++... ....+|+|.++.. ......++.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999741 2457999987753 344566788999999999 699999999999988
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.+++.....................++|.++.+++.|++.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 8899999999999999999764320000000000001236899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
++++.+||+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998664322111 112234567999999998889999999999999999999 888875432211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
+...... ......+..++..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 245 ----~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 ----LFKLLRE---------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----HHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111111 1111233445567889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.27 Aligned_cols=275 Identities=27% Similarity=0.413 Sum_probs=206.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC-
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE- 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~- 401 (646)
.++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 246789999987532 33456788999999999 7899999999887654
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHH---------------------HHH------------------------------
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQE---------------------QKQ------------------------------ 430 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~---------------------~~~------------------------------ 430 (646)
..++||||+++|+|.++++....... ...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999975321000 000
Q ss_pred HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccc
Q 046188 431 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQ 509 (646)
Q Consensus 431 ~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~ 509 (646)
.-........++|.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0000001235899999999999999999999998 99999999999999999999999999986532221 1122234
Q ss_pred cCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHH
Q 046188 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEED 588 (646)
Q Consensus 510 gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 588 (646)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +.....++ .....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~---------~~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEG---------TRMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhcc---------CCCCCCCCC
Confidence 5678999999988889999999999999999997 8888754321110 11111111 111112223
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 589 IEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 589 ~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
...+.+++.+||+.||++||++.||+++|+.+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 45689999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.87 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=195.9
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 5789999987642 233455677898888876 899999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 81 GDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCC
Confidence 9998887542 36899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH--hhcHHHHHHHHHhhc
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--ERNLVAYFISLAKEN 570 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~ 570 (646)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-- 218 (329)
T cd05618 142 MCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-- 218 (329)
T ss_pred ccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--
Confidence 997542211 12234568999999999999999999999999999999999999985321111 0111111111111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT------MKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------~~evl~~ 616 (646)
.. ....|......+.+++.+||+.||++||+ +.+++++
T Consensus 219 ------~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 219 ------EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ------cC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 11234455677889999999999999998 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.98 Aligned_cols=251 Identities=30% Similarity=0.516 Sum_probs=195.5
Q ss_pred ccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEe-CCceEEEEEecc
Q 046188 338 RFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLVYEYIC 411 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-~~~~~LV~Ey~~ 411 (646)
+.||+|+||.||+|...+ +..||+|+.... .....+.+.+|+.+++.++|||++++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998532 357999988543 34556788899999999999999999998764 456799999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+||
T Consensus 81 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~df 142 (262)
T cd05058 81 HGDLRNFIRSET---------------HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADF 142 (262)
T ss_pred CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCc
Confidence 999999986542 24788889999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCC---ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC-CCCCCchHHhhcHHHHHHHHH
Q 046188 492 GTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 492 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+++....... .......++..|+|||.+....++.++||||||+++|||++|+. |+......+ . .....
T Consensus 143 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~---~~~~~ 216 (262)
T cd05058 143 GLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---I---TVYLL 216 (262)
T ss_pred cccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHh
Confidence 99986533211 11122345778999999988899999999999999999999654 443222111 1 11110
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
. ......+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 217 ~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 Q----------GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred c----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 00111122345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.22 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=202.1
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|+..+.||+|+||.||+|+. .+++.||+|+.+.........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788899999999999999995 468899999987654455567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.++++.. ..+++.++..++.|+++||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 89 ~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 89 GGGSLQDIYHVT----------------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred CCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECc
Confidence 999999998642 35889999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
||+++....... ......++..|+|||.+. ...++.++||||||+++|||++|+.|+......+... . .
T Consensus 150 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~ 221 (267)
T cd06646 150 FGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-M 221 (267)
T ss_pred Cccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-e
Confidence 999986532211 122345888999999874 3457889999999999999999999985332211100 0 0
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
... .+..+... .....+..+.+++.+||+.||++||++++|+++|
T Consensus 222 ~~~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 SKS---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ecC---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 00001110 1123346789999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.79 Aligned_cols=268 Identities=23% Similarity=0.331 Sum_probs=209.5
Q ss_pred HhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecc--cCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe-----CC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSK--AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-----TE 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~--~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-----~~ 401 (646)
....|...+.||+|+||.|+.+.. .+|+.||||++. -......++..+|+++|++++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666678999999999999995 468999999987 3556677789999999999999999999999875 24
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..|+|+|+| +.+|...++.. ..|+......+..|+++||.|+|+.+ ++|||+||+|+|++
T Consensus 100 DvYiV~elM-etDL~~iik~~----------------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n 159 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ----------------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLN 159 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC----------------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeec
Confidence 679999999 77888888664 34899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCC-CCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
.+..+||+|||+|+..... .....+..+.|.+|.|||.+.. ..||...||||.||++.||++|++-|.+.+.-+...+
T Consensus 160 ~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l 239 (359)
T KOG0660|consen 160 ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL 239 (359)
T ss_pred cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence 9999999999999987432 2223355778999999998754 6799999999999999999999999987665444333
Q ss_pred HHHHHHH--------HhhchhHHHhhhhhcc-cC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 560 VAYFISL--------AKENKLLEILDARVAK-EA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 560 ~~~~~~~--------~~~~~~~~~~d~~l~~-~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
....... ...++....+...... .. -+.......+|+.+||..||.+|+|++|.+++-
T Consensus 240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 240 ILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 2222111 1111222222211110 00 123446778999999999999999999999874
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.32 Aligned_cols=271 Identities=25% Similarity=0.429 Sum_probs=203.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCC---------------CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD---------------GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLG 395 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~---------------g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g 395 (646)
++|...+.||+|+||.||++...+ ...||+|.++.. .....+.+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 235899988753 3444567899999999999999999999
Q ss_pred EEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 046188 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475 (646)
Q Consensus 396 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~ 475 (646)
++...+..++||||+++++|.+++........ .........++|..+++++.|++.||+|||+.+ ++||||||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp 157 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIEST----FTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLAT 157 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhcccccc----ccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccCh
Confidence 99999999999999999999999865321000 000001235789999999999999999999998 99999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCc
Q 046188 476 SNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPICLTR 552 (646)
Q Consensus 476 ~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~~~ 552 (646)
+||++++++.+||+|||++......... ......++..|+|||.+..+.++.++||||||++++||++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999999865332221 1222345778999999998899999999999999999998 556665433
Q ss_pred hHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 553 EEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.... ........... +.......+...+..+.+|+.+||+.||++||+|.+|++.|.
T Consensus 238 ~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQV---IENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHH---HHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2211 11011111000 000111122334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.06 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=210.2
Q ss_pred cCccccccCcEEEEEEEcCC--CC--EEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 336 QSRFLGQGGFGTVYKGMLPD--GS--IVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~--g~--~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
..++||+|.||.|++|.|.. |+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35789999999999999853 43 6999999876554 66799999999999999999999999987 6678999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
+.|+|.+.|++.. ...|-......++.|||.||+||.+++ +|||||..+|+||-..-.+||+|
T Consensus 193 plGSLldrLrka~--------------~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--------------KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred ccchHHHHHhhcc--------------ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeec
Confidence 9999999998822 346778888999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 491 fGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|||.+.+...+.... ....-...|+|||.+....++.++|||+|||+||||+| |..|+-.-.+..
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------------ 323 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------------ 323 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------------
Confidence 999998864443322 22335568999999999999999999999999999999 677775433221
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+.+.+|.+-+.+.|..|++.++++|+.||..+|++|||+..|.+.+-.
T Consensus 324 ----IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 324 ----ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ----HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 334455555566788999999999999999999999999999855543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=312.59 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=203.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHH--HHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQ--IEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~--~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV 406 (646)
+.|...++|++|+||.||+|+.+ +++.||+|+++...... --..++||.+|.+.+|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45667889999999999999954 68999999988643221 11357899999999999999999988765 468999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+ .-+|...++... .++...+..-+..|+++|++|||.+. |+|||||++|+|++..|.+
T Consensus 156 Me~~-EhDLksl~d~m~---------------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 156 MEYV-EHDLKSLMETMK---------------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred HHHH-HhhHHHHHHhcc---------------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcE
Confidence 9999 557777776653 36888999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+||.+..... ..+..+.|.+|.|||.+.+ ..|++..|+||+||++.||+++++-|.+..+-++.+ . +..
T Consensus 217 KiaDFGLAR~ygsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~-If~ 292 (419)
T KOG0663|consen 217 KIADFGLAREYGSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--K-IFK 292 (419)
T ss_pred EecccchhhhhcCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--H-HHH
Confidence 9999999998865533 3455678999999999877 468999999999999999999999887655443322 2 222
Q ss_pred HHhhc---hhHHH--------------hhhhhcccCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKEN---KLLEI--------------LDARVAKEASEE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~---~~~~~--------------~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+... .+..+ ....+...++.. ..+.-++|+..+|..||.+|.|+.|.+++
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 22211 11100 011112222222 44677899999999999999999998765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.89 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=214.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc-eEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV-PVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~-~~LV~ 407 (646)
++|...+.+|+|+||.++..+.+ ++..+++|++.. ......+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999988754 577899998654 333444578899999999999999999999999998 89999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
+|++||+|.+.+...+. ..++.+..+.++.|++.|++|||+.. |+|||||+.|||++.+..+|
T Consensus 84 ~Y~eGg~l~~~i~~~k~--------------~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~Vk 146 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG--------------VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVK 146 (426)
T ss_pred eecCCCCHHHHHHHHhh--------------ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCcee
Confidence 99999999999977652 35788999999999999999999888 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+|+.+.... .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..+ +
T Consensus 147 LgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L-------- 214 (426)
T KOG0589|consen 147 LGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L-------- 214 (426)
T ss_pred ecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H--------
Confidence 99999999886544 23455789999999999999999999999999999999999999996543221 1
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
..+ +-.....+.|...+..+..|+..|++.+|..||++.+++.+-.-
T Consensus 215 ----i~k-i~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l 261 (426)
T KOG0589|consen 215 ----ILK-INRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHL 261 (426)
T ss_pred ----HHH-HhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence 111 11222345677788899999999999999999999999988443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.68 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=197.4
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|+||+||++... +|+.||+|++.... ....+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 68899999876422 22345677899999999999999999999998899999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 81 RYHIYNVDE------------ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred HHHHHhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccce
Confidence 988754321 0246899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .... ...
T Consensus 146 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~---------~~~ 213 (280)
T cd05608 146 ELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELK---------QRI 213 (280)
T ss_pred ecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHH---------Hhh
Confidence 6643322 223356899999999999999999999999999999999999998653321110 0000 011
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
... ...++...+..+.+++.+||+.||++|| ++++++.+
T Consensus 214 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 LND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111 1123445567789999999999999999 77778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.28 Aligned_cols=241 Identities=25% Similarity=0.393 Sum_probs=192.2
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|... +++.||||.++.. .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5789999987642 223344556677777654 899999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++.+...++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~~~~~----------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 81 GDLMFHIQSS----------------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCc
Confidence 9999888653 35889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+.....
T Consensus 142 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~---- 210 (316)
T cd05592 142 MCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILN---- 210 (316)
T ss_pred CCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc----
Confidence 998643222 22234568999999999999899999999999999999999999997543221 1111110
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK-QVSM 615 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~ 615 (646)
....++......+.+++.+||+.||.+||++. ++++
T Consensus 211 -------~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 -------DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 01123344556788999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.19 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=198.6
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCcc-CceeEEEEEEeCCceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHR-HIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~-niv~l~g~~~~~~~~~LV~ 407 (646)
+|+..+.||+|+||.||+|... +++.||||.++.. .....+.+..|+.++..++|+ +|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999964 5789999987642 234456778899999999765 5888999998888999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 81 E~~~~g~L~~~~~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 81 EYVNGGDLMYHIQQV----------------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred cCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEE
Confidence 999999999888653 35889999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..
T Consensus 142 L~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~-- 212 (324)
T cd05587 142 IADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQS-- 212 (324)
T ss_pred EeecCcceecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHH--
Confidence 999999875322111 22345689999999999999999999999999999999999999965432211 111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM-----KQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~~ 616 (646)
+... ...++...+..+.+++.+||+.||.+|++. .++.++
T Consensus 213 -------i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 213 -------IMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -------HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 112344455678899999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.87 Aligned_cols=242 Identities=25% Similarity=0.371 Sum_probs=196.1
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|... +++.||||.++.. .....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 5789999987642 233445677899998876 799999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 81 GDLMFQIQRS----------------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecc
Confidence 9999888653 35889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +......
T Consensus 142 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~--- 211 (321)
T cd05591 142 MCKEGILNGV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHD--- 211 (321)
T ss_pred cceecccCCc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcC---
Confidence 9876432221 22345689999999999998999999999999999999999999975433221 1111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-------TMKQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-------s~~evl~~ 616 (646)
. ...+......+.+++.+||+.||++|| ++.+++++
T Consensus 212 ------~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 212 ------D--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 112223446788999999999999999 88888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.14 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=204.7
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|+..+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999985 468899999887655555677889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 100 ~~~~L~~~~~~-----------------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~d 159 (296)
T cd06654 100 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 159 (296)
T ss_pred CCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECc
Confidence 99999998853 25789999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ . .....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~-- 230 (296)
T cd06654 160 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIAT-- 230 (296)
T ss_pred cccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhc--
Confidence 999886533221 12234688999999999988899999999999999999999999865432211 0 00000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........+......+.+++.+||..||++||++.||+.+
T Consensus 231 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 ------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000111233455678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=311.18 Aligned_cols=247 Identities=28% Similarity=0.492 Sum_probs=200.9
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCch
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLS 416 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 416 (646)
++||+|++|.||++...+++.||+|..+.... ...+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999976689999998775433 35668899999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 417 HHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 417 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
+++.... ..+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~l~~~~---------------~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 81 TFLRKKK---------------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccc
Confidence 9986532 25889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCccc-cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHH
Q 046188 497 VPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLE 574 (646)
Q Consensus 497 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 574 (646)
......... ....++..|+|||.+.++.++.++||||||+++|||++ |..|+......... +
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----------------~ 206 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----------------E 206 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----------------H
Confidence 542221111 11234567999999998899999999999999999999 77777543322110 1
Q ss_pred HhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 575 ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 575 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+........+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 207 RIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11111112234455678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.12 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 46899999987542 2334567888999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 81 EFLPGGDLMTMLIKY----------------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred eCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEE
Confidence 999999999998653 35888999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCC----------------------------------------------ccccccccCCcccChhccc
Q 046188 488 VSDFGTSRSVPNDKT----------------------------------------------HLTTAVQGTFGYFDPEYFQ 521 (646)
Q Consensus 488 I~DfGla~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~l~ 521 (646)
|+|||+++....... .......||+.|+|||.+.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 999999963311000 0001246999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccc
Q 046188 522 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLR 601 (646)
Q Consensus 522 ~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~ 601 (646)
+..++.++|||||||++|||++|+.||......+. +....... ..+..+........+.+++.+|++
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET------YRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH------HHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc
Confidence 98999999999999999999999999965433211 11111100 000001111234568899999997
Q ss_pred cCCCCC---CCHHHHHHHH
Q 046188 602 LNSKKR---PTMKQVSMDL 617 (646)
Q Consensus 602 ~dP~~R---Ps~~evl~~L 617 (646)
+|.+| +++.|++.+-
T Consensus 289 -~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 289 -NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred -CHhhcCCCCCHHHHhcCC
Confidence 66665 6999998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.60 Aligned_cols=270 Identities=26% Similarity=0.429 Sum_probs=207.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|+..+.||+|+||.||++... ++..||+|.++... .....++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999887543 34456788999999999999999999999998899
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHH------HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQ------ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~------~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
++||||+++|+|.+++........... ..........+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975432100000 0000011235899999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHH
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~ 555 (646)
|++++++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876532221 11122234678999999998899999999999999999998 878875432221
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
... ....+ .. ...+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus 241 ------~~~-~~~~~--------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------VIY-YVRDG--------NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHH-HHhcC--------CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 11111 11 12233455789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=316.28 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=208.0
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
-+|++.+.||+|+||.|-++.. ..|+.||||.++. .++++.-.+.+||+||+.++||||+.++.+|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3677788899999999999995 5799999997654 34555667889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||..+|.|.+|+... ..|++.+..+++.||..|+.|+|.++ ++|||||.+|||||.|+++|
T Consensus 133 EYaS~GeLYDYiSer----------------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 133 EYASGGELYDYISER----------------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred EecCCccHHHHHHHh----------------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCee
Confidence 999999999999764 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++..+... ....+++|.+-|.+||.+.+.+| ++.+|-||+||+||-|+.|..||++.+.. .++
T Consensus 194 IADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lv------ 262 (668)
T KOG0611|consen 194 IADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLV------ 262 (668)
T ss_pred eeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHH------
Confidence 9999999877443 33456799999999999999887 57999999999999999999999754321 111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+++-.....++ ..+....-||++||..+|++|-|+.+|..+-.
T Consensus 263 ------rQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 263 ------RQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------HHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 12222222211 22234568999999999999999999998865
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.54 Aligned_cols=270 Identities=26% Similarity=0.414 Sum_probs=208.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-----CCCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEe--CCce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLE--TEVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-----~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~--~~~~ 403 (646)
+.|...+.||+|+||.||+|.+. ++..+|||.++..... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3678999998765443 56689999999999999999999999887 4578
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++++|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~ 145 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---------------DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESE 145 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---------------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCC
Confidence 99999999999999997642 25899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCcc--ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 225 (284)
T cd05038 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI 225 (284)
T ss_pred CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc
Confidence 999999999998765322211 112235567999999988899999999999999999999999875432111000000
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.........+.+.+........+..++..+.+++.+||+.+|++||+|.||+++|+++
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 226 -AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000000111222222222223344557899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.41 Aligned_cols=271 Identities=25% Similarity=0.430 Sum_probs=206.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC-----------------CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCcee
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD-----------------GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVK 392 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~-----------------g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~ 392 (646)
..+|+..+.||+|+||.||++...+ +..||+|.+... .....+.+.+|+.++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999988532 245899998753 3445678899999999999999999
Q ss_pred EEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 393 l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
+++++..++..++|+||+++++|.+++.......... ......+++..++.++.|++.||.|||+++ ++|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~d 155 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-----ACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRD 155 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-----cccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 9999999999999999999999999997643210000 001236899999999999999999999998 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh--CCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPIC 549 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~ 549 (646)
|||+||++++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ |..|+.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986533221 22233456789999999988889999999999999999998 566664
Q ss_pred CCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 550 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...... ............ +.......+..++..+.+++.+||+.||.+||++.||++.|.
T Consensus 236 ~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQ---VIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHH---HHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 322111 111111111100 011111123344567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=311.94 Aligned_cols=255 Identities=32% Similarity=0.518 Sum_probs=204.9
Q ss_pred ccccccCcEEEEEEEcCC----CCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLPD----GSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|...+ +..|++|..+..... ..+.+.+|+++++.++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 788999998764433 367888999999999999999999999998899999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
++|.+++....... .......+++.++++++.|+++||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg 150 (262)
T cd00192 81 GDLLDYLRKSRPVF-------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFG 150 (262)
T ss_pred CcHHHHHhhccccc-------cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccc
Confidence 99999997642100 0000146999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 493 TSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 493 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
.+........ .......++..|+|||.+....++.++||||||++++||++ |..|+......+ ... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~-~~~-- 221 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLE-YLR-- 221 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHH-HHH--
Confidence 9987754321 22233457889999999988889999999999999999999 588886543221 011 111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.......+...+..+.+++.+||+.||.+||++.|++.+|+
T Consensus 222 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 -------KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122334455678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.76 Aligned_cols=248 Identities=27% Similarity=0.465 Sum_probs=200.7
Q ss_pred ccccccCcEEEEEEEcCC--C--CEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLPD--G--SIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~--g--~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999877555 566789999999999999999999999988 888999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++..... ..++|...+.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 80 ~~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg 142 (257)
T cd05040 80 GSLLDRLRKDAL--------------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFG 142 (257)
T ss_pred CcHHHHHHhccc--------------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccc
Confidence 999999876421 36899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 493 TSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 493 la~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+......+. .......
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~ 216 (257)
T cd05040 143 LMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKE 216 (257)
T ss_pred ccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhc
Confidence 99876432221 1123457789999999998899999999999999999999 9999854332211 1111100
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
......+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 217 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 ---------GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---------CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011123344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.53 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=194.9
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|... +++.||||.++.. .....+.+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5889999987642 223455677888888876 699999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~i~~~----------------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 81 GDLMFHIQKS----------------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred chHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCC
Confidence 9999888653 35889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~---- 210 (320)
T cd05590 142 MCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILN---- 210 (320)
T ss_pred CCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhc----
Confidence 987642221 122335689999999999998999999999999999999999999965432211 111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM------KQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~evl~~ 616 (646)
.. ...+......+.+++.+||+.||.+||++ ++++++
T Consensus 211 -----~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 211 -----DE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -----CC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 00 11233345678899999999999999998 555554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.59 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=198.3
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+|+..+.||+|+||.||+|... +++.||||.++.. .....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999964 5789999987642 223344567788888877 5899999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 81 E~~~~g~L~~~~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 81 EYVNGGDLMYQIQQV----------------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred cCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEE
Confidence 999999999888553 35889999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 142 L~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------~~--- 211 (323)
T cd05616 142 IADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQ--- 211 (323)
T ss_pred EccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH------HH---
Confidence 99999997543221 122345689999999999999999999999999999999999999975433211 11
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM-----KQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~~ 616 (646)
.+.... ..++...+..+.+++.+||+.||.+|++. .++.++
T Consensus 212 ------~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 212 ------SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ------HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111111 12344456778999999999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.26 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=196.1
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
+|...+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999995 46889999987642 23345678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 82 YIPGGDMMSLLIRM----------------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred CCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999998653 25788889999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCC----------------------------------------------CccccccccCCcccChhcccc
Q 046188 489 SDFGTSRSVPNDK----------------------------------------------THLTTAVQGTFGYFDPEYFQS 522 (646)
Q Consensus 489 ~DfGla~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~l~~ 522 (646)
+|||++....... ........||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 9999975321000 000123468999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhcccc
Q 046188 523 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRL 602 (646)
Q Consensus 523 ~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~ 602 (646)
..++.++|||||||++|||++|+.||......+. ...... + ...+..+........+.+++.+|+ .
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~------~-~~~~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET------QMKVIN------W-QTSLHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHH------HHHHHc------c-CCCcCCCCcccCCHHHHHHHHHHc-c
Confidence 9999999999999999999999999975433221 001000 0 011111111233456677777765 5
Q ss_pred CCCCCCC---HHHHHHH
Q 046188 603 NSKKRPT---MKQVSMD 616 (646)
Q Consensus 603 dP~~RPs---~~evl~~ 616 (646)
+|.+|++ +.|++.+
T Consensus 289 ~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 289 GPEDRLGKNGADEIKAH 305 (382)
T ss_pred CHhHcCCCCCHHHHhcC
Confidence 9999987 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.15 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=205.5
Q ss_pred HHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe
Q 046188 324 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399 (646)
Q Consensus 324 ~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~ 399 (646)
..++....++|+..+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556689999999999999999999964 578999998753 122334567889999999999999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
++..++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----------------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIl 174 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----------------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNML 174 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEE
Confidence 99999999999999999988542 4778888999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
++.++.+||+|||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 175 l~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 254 (371)
T cd05622 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (371)
T ss_pred ECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999987644333333456799999999998653 37889999999999999999999997543221
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKK--RPTMKQVSMDLE 618 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~L~ 618 (646)
.+........ .+........+..+.+++.+|+..++.+ ||++.|++++..
T Consensus 255 ------~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 255 ------TYSKIMNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ------HHHHHHcCCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1111111100 0111112245567889999999854443 789999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.06 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=196.6
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 5789999998752 233455678899999888 699999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|..++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 81 GDLMFHMQRQ----------------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccc
Confidence 9998887542 36899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---- 216 (327)
T cd05617 142 MCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL---- 216 (327)
T ss_pred cceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH----
Confidence 987532211 122345699999999999999999999999999999999999999964322221111111111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM------KQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~evl~~ 616 (646)
.. ....+...+..+.+++.+||+.||.+||++ .++..+
T Consensus 217 ----~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 217 ----EK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ----hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11 112344455678899999999999999985 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.13 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=201.7
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
|+..+.||+|+||.||+|... ++..+++|..........+.+.+|+++++.++|+|++++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556788999999999999965 4778899988766666777899999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ...++|..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 87 ~~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg 148 (282)
T cd06643 87 GAVDAVMLEL---------------ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG 148 (282)
T ss_pred CcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccc
Confidence 9998887653 236899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
++....... .......++..|+|||++. +..++.++|||||||++|||++|+.|+......+. .....
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~ 221 (282)
T cd06643 149 VSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIA 221 (282)
T ss_pred ccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHh
Confidence 987653221 1223346889999999884 34578899999999999999999999864322110 11110
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
... .+ ....+...+..+.+++.+||+.||.+||++.+++++-
T Consensus 222 ~~~------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 222 KSE------PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred hcC------CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 000 00 1112334456789999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.37 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=194.5
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|+||.||++... +|+.+|+|++.... ......+..|++++++++||||+++.+++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 58999999875421 12233456799999999999999999999998999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 81 KYHIYNVG--------------ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred HHHHHhcc--------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeee
Confidence 98886532 235899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...... ..
T Consensus 144 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~---------~~ 210 (277)
T cd05607 144 ELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKR---------RT 210 (277)
T ss_pred ecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHH---------Hh
Confidence 764322 12334689999999999988899999999999999999999999864322111 000000 01
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
....... .....+..+.+|+.+||+.||++||+++|+++.+.
T Consensus 211 ~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 211 LEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred hcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1111100 11234567899999999999999999987765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.86 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=200.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999854 57889999876432 22234677899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 86 ~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~ 146 (309)
T cd07872 86 LD-KDLKQYMDDCG---------------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLA 146 (309)
T ss_pred CC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEC
Confidence 96 47877775432 25889999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++........ .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... +.....
T Consensus 147 Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~ 222 (309)
T cd07872 147 DFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLG 222 (309)
T ss_pred ccccceecCCCccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhC
Confidence 99999765322221 123457899999998865 4678999999999999999999999976543322111 111111
Q ss_pred h---chhHH------Hhhhhhcc-------cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 569 E---NKLLE------ILDARVAK-------EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 569 ~---~~~~~------~~d~~l~~-------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. ..... +.+..... ......+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 0 00000 00000000 001123456789999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.96 Aligned_cols=270 Identities=24% Similarity=0.449 Sum_probs=205.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-----------------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-----------------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKL 393 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-----------------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l 393 (646)
++|+..+.||+|+||.||++... ++..||+|.++.. .....+++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57888999999999999998532 2346999998753 34455688999999999999999999
Q ss_pred EEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 394 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
++++.+.+..++||||+++|+|.+++......... .......+++.+.+.++.|++.||+|||+.+ ++||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA-----EKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc-----ccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 99999999999999999999999999764321100 0111235889999999999999999999999 999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh--CCCCCCC
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPICL 550 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~ 550 (646)
||+|||+++++.+||+|||+++........ ......++..|+|||....+.++.++||||||+++|||++ |..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999865332221 1222345678999999888889999999999999999998 6677754
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
....+. ........... ......+.+..++..+.+++.+||+.||.+||++.||++.|+
T Consensus 237 ~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQV---IENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHHH---HHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 322211 00000000000 000011123344578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.06 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=198.9
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+|...+.||+|+||.||+|.. .+++.||+|..... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999984 46889999987543 3444567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|..+. .+++.....++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|
T Consensus 82 ~~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 82 DGGSLDVYR--------------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred CCCChHHhh--------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEee
Confidence 999986442 4678888899999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++....... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||...............
T Consensus 139 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------- 208 (279)
T cd06619 139 FGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL------- 208 (279)
T ss_pred CCcceeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-------
Confidence 99998653321 22346899999999999888999999999999999999999998643221111000000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...+.+..............+.+++.+||+.||++||+++|++++-.
T Consensus 209 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 209 -LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred -HHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 00011111001011223456889999999999999999999988743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.97 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=192.6
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|... +++.||||.++.. .....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5789999987652 122344566788888764 899999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 81 GDLMFHIQSC----------------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCC
Confidence 9999988652 35889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~i~~---- 210 (316)
T cd05619 142 MCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL------FQSIRM---- 210 (316)
T ss_pred cceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh----
Confidence 987542211 122345689999999999998999999999999999999999999865432211 111100
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK-QVSM 615 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~ 615 (646)
.. ..++......+.+++.+||+.||.+||++. ++.+
T Consensus 211 ---~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 ---DN----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CC----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 00 112333456688999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.48 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=189.1
Q ss_pred cccccCcEEEEEEEcCC-------------------------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeE
Q 046188 339 FLGQGGFGTVYKGMLPD-------------------------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKL 393 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~~~-------------------------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l 393 (646)
+||+|+||.||+|.+.. ...|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13589998876555555678899999999999999999
Q ss_pred EEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 394 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
+|++.+....++||||+++|+|..++.... ..+++..++.++.|+++||+|||+.+ |+||||
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 143 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---------------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNV 143 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCC
Confidence 999999999999999999999999886532 36889999999999999999999998 999999
Q ss_pred CCCCEEECCCC-------cEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHH-hC
Q 046188 474 KSSNILLDDKF-------SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELL-TG 544 (646)
Q Consensus 474 k~~NILl~~~~-------~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~Ell-tG 544 (646)
||+|||+++++ .+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999997643 48999999986542221 1246788999998865 56799999999999999995 68
Q ss_pred CCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 545 KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 545 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+.|+......+.. . ...... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 219 ~~p~~~~~~~~~~---~-------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 219 EVPLKERTPSEKE---R-------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CCCccccChHHHH---H-------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 8887643322110 0 011111 111122346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.82 Aligned_cols=263 Identities=26% Similarity=0.381 Sum_probs=204.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|+||.||++... ++..+|+|.++.. .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999954 5788999987653 333455788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++||||||+|||+++++.+||
T Consensus 81 ~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l 141 (308)
T cd06615 81 MDGGSLDQVLKKA----------------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL 141 (308)
T ss_pred cCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEE
Confidence 9999999998653 358899999999999999999998 46 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...+.....
T Consensus 142 ~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~ 215 (308)
T cd06615 142 CDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVS 215 (308)
T ss_pred ccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccc
Confidence 9999987653221 2234688999999999888899999999999999999999999864332111 111100000
Q ss_pred h--------------------chhHHHhhhhhcc---cCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 569 E--------------------NKLLEILDARVAK---EAS-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 569 ~--------------------~~~~~~~d~~l~~---~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
. ....+..+..... ..+ ......+.+++.+||+.||++||++.||+++.--
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0 0000111111100 011 1244568999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.80 Aligned_cols=239 Identities=23% Similarity=0.401 Sum_probs=189.4
Q ss_pred ccccccCcEEEEEEEcCC-------------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 338 RFLGQGGFGTVYKGMLPD-------------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~-------------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999887655555667889999999999999999999999988899
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|..++.... ..+++..+++++.|+++||+|||+.+ ++||||||+|||++.++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~ 142 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---------------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREG 142 (262)
T ss_pred EEEecccCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCC
Confidence 9999999999988876532 36899999999999999999999998 99999999999998766
Q ss_pred c-------EEEeecCCccccCCCCCccccccccCCcccChhccc-cCCCCCccchhhHHHHHHHHH-hCCCCCCCCchHH
Q 046188 485 S-------AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELL-TGKKPICLTREEE 555 (646)
Q Consensus 485 ~-------~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSfGvvl~Ell-tG~~p~~~~~~~~ 555 (646)
. +|++|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|..|+......+
T Consensus 143 ~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 143 IDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred ccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 4 899999998765322 1235788999999886 466899999999999999998 4777765332111
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
. .... .... .........+.+|+.+||+.||.+||++.+|++.|
T Consensus 218 ~-------~~~~---------~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 K-------ERFY---------EGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred H-------HHHH---------hcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 0000 0000 01111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.12 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=199.5
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC------
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET------ 400 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~------ 400 (646)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678888999999999999999954 57899999876533 2335678899999998 799999999998753
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
...++||||+++|+|.+++.... ...++|..+..++.|++.||+|||+.+ ++||||||+||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili 144 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--------------GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL 144 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEE
Confidence 35789999999999999987532 236899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
++++.+||+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......
T Consensus 145 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~ 223 (272)
T cd06637 145 TENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223 (272)
T ss_pred CCCCCEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9999999999999986532221 223356899999999986 3457889999999999999999999985432211
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. . .... .......+...+..+.+++.+||+.||.+||++.|++++
T Consensus 224 ~~-----~-~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 224 AL-----F-LIPR---------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HH-----H-HHhc---------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 10 0 0000 000011122344678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=311.76 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=204.6
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|+..+.||+|+||.||+|...+ ++.+++|.++.... .+++.+|++++++++|+|++++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999764 78999999875322 678999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.... ..++|..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|
T Consensus 81 ~~~~L~~~l~~~~---------------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 81 GAGSVSDIMKITN---------------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred CCCcHHHHHHhCc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcc
Confidence 9999999986532 36899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ... ..
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~~-~~- 213 (256)
T cd06612 143 FGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FMI-PN- 213 (256)
T ss_pred cccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hhh-cc-
Confidence 999987643321 222345788999999999889999999999999999999999998643222110 000 00
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. .......+......+.+++.+||+.||.+||++.||+++
T Consensus 214 ----~--~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 ----K--PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred ----C--CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0 000011233345678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.45 Aligned_cols=275 Identities=27% Similarity=0.387 Sum_probs=210.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
.+|...+.||+|+||.||++... ++..||+|..+.. .....+++.+|+.+++++ +|+||+++++++.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999742 1236899987753 344567889999999999 8999999999999988
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..+++|||+++|+|.+++.....................++|.+++.++.|+++||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 999999999999999999764321000000000001236899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCcc-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l 559 (646)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 99999999999998654322111 122334568999999999899999999999999999998 788875433221
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
.+... ......+.+......+.+++.+||+.+|.+||++.|+++.|+++.....
T Consensus 245 --~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 --LFKLL----------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --HHHHH----------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11111 1111122334455678999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.06 Aligned_cols=238 Identities=27% Similarity=0.356 Sum_probs=193.3
Q ss_pred ccccccCcEEEEEEEc----CCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 338 RFLGQGGFGTVYKGML----PDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999886422 2234457789999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 82 ~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Df 142 (318)
T cd05582 82 GGDLFTRLSKE----------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDF 142 (318)
T ss_pred CCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeec
Confidence 99999988552 35899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 143 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i----- 210 (318)
T cd05582 143 GLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMI----- 210 (318)
T ss_pred cCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHH-----
Confidence 9998653322 122345689999999999988889999999999999999999999865432211 1111
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
.... ...+...+..+.+++.+||+.||++||++.+
T Consensus 211 ----~~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 ----LKAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----HcCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111 1233345567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.20 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=206.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.+|...+.||+|+||.||+|... +|+ .+|+|..+... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46777899999999999999854 333 58999876543 4455688899999999999999999999987 77899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---------------DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQH 147 (279)
T ss_pred EEecCCCCcHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCe
Confidence 999999999999987643 25899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccc-cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++.......... ....++..|+|||.+....++.++||||||+++||+++ |+.|+......+.
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------- 220 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI------- 220 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------
Confidence 99999999987643322211 11224568999999988889999999999999999999 9999865432211
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.. .+........+..+...+.+++.+||..||.+||++.++++.|+.+...
T Consensus 221 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 221 PD---------LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HH---------HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11 1111111122333456788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.92 Aligned_cols=253 Identities=34% Similarity=0.528 Sum_probs=200.6
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHH--HHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIE--QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~--~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
|+..+.||+|+||+||+++.. +++.+|+|........... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 4678999998775544332 3456999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.. ...+++..++.++.|+++||.+||+.+ ++|+||||+||++++++.++|+|
T Consensus 81 ~~~~L~~~l~~----------------~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~D 141 (260)
T PF00069_consen 81 PGGSLQDYLQK----------------NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLID 141 (260)
T ss_dssp TTEBHHHHHHH----------------HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESS
T ss_pred ccccccccccc----------------ccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 99999999973 246899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||.+.... ..........++..|+|||.+. +...+.++||||+|+++|||++|..|+........... +.....
T Consensus 142 fg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~- 216 (260)
T PF00069_consen 142 FGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILK- 216 (260)
T ss_dssp GTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHH-
T ss_pred cccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhccc-
Confidence 99998642 2222334456899999999998 78899999999999999999999999875422221111 111000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ ........+.+++.+||+.||++||++.+++++
T Consensus 217 ----~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 217 ----RPLPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ----THHHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ----cccccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 001112789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.74 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=197.5
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
+|+..+.||+|+||.||++... +++.||||.+... .....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999954 5889999987642 12334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 82 YIPGGDMMSLLIRL----------------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred CCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEE
Confidence 99999999998653 35788888999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCC------------------------------------------CCccccccccCCcccChhccccCCCC
Q 046188 489 SDFGTSRSVPND------------------------------------------KTHLTTAVQGTFGYFDPEYFQSSQYT 526 (646)
Q Consensus 489 ~DfGla~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s 526 (646)
+|||++..+... .........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 999997532100 00011234699999999999999999
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCC
Q 046188 527 DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKK 606 (646)
Q Consensus 527 ~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~ 606 (646)
.++|||||||++|||++|+.||......+.. ...... ...+........+..+.+++.+|+ .+|.+
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~ 288 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQ------LKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAED 288 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCCHHHHH------HHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhh
Confidence 9999999999999999999999755432211 000000 001111111233456777888866 59999
Q ss_pred CC---CHHHHHHH
Q 046188 607 RP---TMKQVSMD 616 (646)
Q Consensus 607 RP---s~~evl~~ 616 (646)
|+ ++.|++.+
T Consensus 289 R~~~~t~~ell~h 301 (376)
T cd05598 289 RLGKNGADEIKAH 301 (376)
T ss_pred cCCCCCHHHHhCC
Confidence 99 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.68 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=196.0
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||++... +++.||||.++.. .......+..|+++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999987642 223455677899999888 799999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 81 GDLMFHIQRS----------------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccC
Confidence 9998887653 36899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......
T Consensus 142 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~----- 209 (318)
T cd05570 142 MCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSIL----- 209 (318)
T ss_pred CCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHH-----
Confidence 987532211 12233468999999999999999999999999999999999999986543221 111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM-----KQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~~ 616 (646)
.. ...++...+..+.+++.+||+.||.+||++ .+++.+
T Consensus 210 ----~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 210 ----ED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----cC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11 112233455678999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.82 Aligned_cols=251 Identities=24% Similarity=0.430 Sum_probs=205.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|+..+.||.|++|.||+|.. .+|+.|++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999984 468999999886654455667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 99 ~~~~L~~~~~~-----------------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~d 158 (296)
T cd06655 99 AGGSLTDVVTE-----------------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTD 158 (296)
T ss_pred CCCcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 99999998753 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||......... ......
T Consensus 159 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~- 230 (296)
T cd06655 159 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATN- 230 (296)
T ss_pred Cccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc-
Confidence 999886543322 122346889999999999888999999999999999999999998654432211 000000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.......+......+.+++.+||+.||.+||++.+|+.+=
T Consensus 231 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 231 -------GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred -------CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0000112334456788999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=350.69 Aligned_cols=274 Identities=22% Similarity=0.347 Sum_probs=210.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..++||+|+||.||+|... +|+.||||+++.. .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999954 5889999987642 2334567899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++......... .......+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l-----~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESL-----SKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EcCCCCCHHHHHHHhhhcccc-----chhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEE
Confidence 999999999999753221000 0001235788999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCC-----------------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 046188 488 VSDFGTSRSVPNDKT-----------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 550 (646)
Q Consensus 488 I~DfGla~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 550 (646)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986521100 011224699999999999999999999999999999999999999864
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHHHHHhhhhhh
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKR-PTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R-Ps~~evl~~L~~i~~~~~~~ 627 (646)
....... ... ...++... ....+.+..+.+++.+||+.||++| ++++++.+.|+...+....|
T Consensus 234 ~~~~ki~-----~~~--------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w 297 (932)
T PRK13184 234 KKGRKIS-----YRD--------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEW 297 (932)
T ss_pred cchhhhh-----hhh--------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccc
Confidence 3221110 000 00111100 0012344678899999999999999 56788888888876654443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=310.60 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=203.5
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+|+..+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.++++++|+|++++.+.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999954 688999998753 23445667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ...+++...+.++.|++.||.|||+++ ++|+||||+||++++++.++|+|
T Consensus 81 ~~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~d 143 (255)
T cd08219 81 DGGDLMQKIKLQR--------------GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGD 143 (255)
T ss_pred CCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcc
Confidence 9999999886532 235789999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||+++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ ..... .+
T Consensus 144 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~-~~ 215 (255)
T cd08219 144 FGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVC-QG 215 (255)
T ss_pred cCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHh-cC
Confidence 999986643222 22335688999999999988899999999999999999999999864332110 11110 11
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.....+...+..+.+++.+||+.||++||++.||+..
T Consensus 216 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 ---------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112233445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.24 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=198.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+++.. +++.||+|.+.. ......+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999954 588999999764 22234456888999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 81 e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---------------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred ecCCCCcHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEE
Confidence 9999999999986532 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
|+|||++...............||+.|+|||++.. +.++.++|||||||++|||++|+.||......+ .
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~ 216 (331)
T cd05597 143 LADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T 216 (331)
T ss_pred EEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------H
Confidence 99999997664433322333468999999999863 457889999999999999999999986433211 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNS--KKRPTMKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP--~~RPs~~evl~~ 616 (646)
............ + .......+..+.+++.+|+..++ ..||++.+++.+
T Consensus 217 ~~~i~~~~~~~~-----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 YGKIMNHKEHFQ-----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHcCCCccc-----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111100000 0 01111245667888888775544 348899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.16 Aligned_cols=240 Identities=26% Similarity=0.392 Sum_probs=192.1
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|... +|+.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 58899999886421 22344566788888754 899999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~i~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 81 GDLMFHIQDK----------------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccC
Confidence 9999888652 35889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ + ......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~~~~---- 210 (316)
T cd05620 142 MCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FESIRV---- 210 (316)
T ss_pred CCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHh----
Confidence 987532221 12234568999999999999999999999999999999999999996543221 1 111000
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK-QVS 614 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl 614 (646)
. ....+......+.+++.+||+.||.+||++. ++.
T Consensus 211 -----~--~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 211 -----D--TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 1122333456788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.69 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=205.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|...+.||+|+||.||+|+.. +.+.|++|.+...... ..+++.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999953 2467999987654433 4568899999999999999999999999888899
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++......... .....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~-------~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEK-------LKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQR 154 (275)
T ss_pred EEEEecCCCcHHHHHHhccccccc-------ccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCC
Confidence 999999999999999765321000 00125899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
.++|+|||+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||....... . .
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~---~ 228 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V---L 228 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H---H
Confidence 99999999987653332222233456778999999988888999999999999999999 777874322211 0 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. .. ...+....+...+..+.+++.+||+.||.+||++.|++..|+
T Consensus 229 ~~-~~--------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 229 NR-LQ--------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HH-HH--------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10 01 011111122344568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.56 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=203.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||.||+|... +|+ .||+|.+.... .....++.+|+.++++++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46677889999999999999853 444 47899876533 33345788999999999999999999998754 4679
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~g~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---------------DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNH 147 (303)
T ss_pred eehhcCCCCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCc
Confidence 999999999999986542 25889999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~------- 220 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI------- 220 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 999999999876432221 1222345778999999998899999999999999999997 8888854322111
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.... ........+..+...+.+++.+||..+|++||++.++++.|+.+....
T Consensus 221 ~~~~---------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 221 PDLL---------EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHH---------HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111 111111122334567899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=339.05 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=196.2
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--------
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-------- 400 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-------- 400 (646)
...+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++||||+++.+++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 68899999875432 1334799999999999999999987532
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
...++||||++ ++|.+++..... ....+++.....++.|++.||+|||+.+ |+||||||+|||+
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl 203 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYAR------------NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLI 203 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhh------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEE
Confidence 13568999996 577777654321 1346899999999999999999999999 9999999999999
Q ss_pred CCCC-cEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 481 DDKF-SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~-~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
+.++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||......+.
T Consensus 204 ~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-- 279 (440)
T PTZ00036 204 DPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-- 279 (440)
T ss_pred cCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--
Confidence 9664 799999999987643222 223468999999998865 4689999999999999999999999975443221
Q ss_pred HHHHHHHHHhhchhH--HHhh-------------hhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 559 LVAYFISLAKENKLL--EILD-------------ARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 559 l~~~~~~~~~~~~~~--~~~d-------------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+.. +.......... ..+. ..+...++...+..+.+|+.+||++||.+|||+.|++++-.
T Consensus 280 ~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 280 LVR-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHH-HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 111 11111111000 0011 11111223334567899999999999999999999997643
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.82 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=193.5
Q ss_pred ccccccCcEEEEEEEcCC---CCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~---g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998543 4579999887543 233457889999999999999999999999888899999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|.++++..... ....+++..+.+++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~ 146 (269)
T cd05087 81 DLKGYLRSCRKA-----------ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGL 146 (269)
T ss_pred cHHHHHHHhhhc-----------ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccc
Confidence 999999764321 0225678888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcc-ccccccCCcccChhccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 494 SRSVPNDKTHL-TTAVQGTFGYFDPEYFQSS-------QYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 494 a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
++......... .....++..|+|||++... .++.++||||||+++|||++ |+.||......+.. ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~-- 221 (269)
T cd05087 147 SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY-- 221 (269)
T ss_pred cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH--
Confidence 97643322211 1234577889999988642 35789999999999999996 99998644322210 00
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
... .......++.+ .......+.+++..|| .+|++|||++||+..|+
T Consensus 222 -~~~-~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 -TVR-EQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -Hhh-cccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000 10111111111 1123456788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=297.21 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=208.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|-||.||.|+.+ ++-.||+|++.... ..-...+.+|++|-+.++||||+++++++.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 57888999999999999999964 57799999875421 112236789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||..+|+|...|.... ...++......+..|+|.||.|+|..+ ++||||||+|+|++.++..|
T Consensus 102 Eya~~gel~k~L~~~~--------------~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--------------MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred EecCCchHHHHHHhcc--------------cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence 9999999999998543 245788888899999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||.+-..+ .......+||..|++||...+...+.++|+|++|++.||++.|.+||......+
T Consensus 165 iAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------------ 229 (281)
T KOG0580|consen 165 IADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------------ 229 (281)
T ss_pred ccCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------------
Confidence 99999987643 233456789999999999999999999999999999999999999986433111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...++..- .-.+|...+....++|.+|+.++|.+|.+..|++.+-.
T Consensus 230 ---tYkrI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 230 ---TYKRIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---HHHHHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11111111 12345566678899999999999999999999998754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=316.06 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=201.5
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++|+|++++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999954 68899999875421 22234577899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 82 ~~g~~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 82 MNGGDLKFHIYHMG--------------EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred cCCCcHHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 99999999885432 235899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++......... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .......
T Consensus 145 Dfg~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~-- 217 (285)
T cd05630 145 DLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLV-- 217 (285)
T ss_pred eccceeecCCCccc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhh--
Confidence 99999765432221 2346899999999999999999999999999999999999999653221100 0000000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMDLE 618 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~L~ 618 (646)
+ .....++......+.+|+.+||+.||.+||| +.|++++-.
T Consensus 218 -------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 218 -------K-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred -------h-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0 0111223344566889999999999999999 889988543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=323.62 Aligned_cols=241 Identities=25% Similarity=0.383 Sum_probs=194.5
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~ 407 (646)
+|+..+.||+|+||.||++... +|+.||+|.++.. .....+.+..|..+++.+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999854 6889999987642 2234456778899988885 577888999999888999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.+++.|+.|++.||.|||+.+ ++||||||+|||+++++.+|
T Consensus 81 Ey~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ik 141 (323)
T cd05615 81 EYVNGGDLMYHIQQV----------------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred cCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 999999999888542 36899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 142 L~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~--- 211 (323)
T cd05615 142 IADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------FQ--- 211 (323)
T ss_pred EeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HH---
Confidence 99999988643222 122335689999999999998999999999999999999999999875432211 11
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 610 (646)
.++... ..++...+..+.+++.+||+.||.+|++.
T Consensus 212 ------~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 212 ------SIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------HHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111 12344455678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.79 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=198.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 4788999987531 2223445788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 81 ey~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---------------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred eccCCCcHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEE
Confidence 9999999999997532 36889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
|+|||++...............||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ .
T Consensus 143 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~ 216 (332)
T cd05623 143 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T 216 (332)
T ss_pred EeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------H
Confidence 9999999765433333333456999999999986 3467899999999999999999999996543221 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 616 (646)
+........... ........+..+.+++.+|+..++.+ |+++.|++++
T Consensus 217 ~~~i~~~~~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 YGKIMNHKERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhCCCcccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111111100000 01111234567888999988655444 7899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.29 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=200.4
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 68899999876422 22334577899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 82 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 82 MNGGDLKFHIYNMG--------------NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred ccCccHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEe
Confidence 99999998886532 236999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++........ .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||........... ...
T Consensus 145 Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~---- 215 (285)
T cd05632 145 DLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDR---- 215 (285)
T ss_pred cCCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHH----
Confidence 9999976533221 1234689999999999988999999999999999999999999865433211100 000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
..... ...++......+.+|+..||+.||++||+ +.+++.+
T Consensus 216 ----~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 ----RVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----hhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00000 01223344567889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=312.62 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=199.4
Q ss_pred ccccccCcEEEEEEEcCC-------CCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 338 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~-------g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+.||+|+||.||+|...+ ++.+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 2579999875432 34566788999999999999999999999998899999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-----
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----- 484 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----- 484 (646)
+++|+|.+++........ ....++|.+++.++.|++.||.|||+.+ ++|+||||+||+++.+.
T Consensus 81 ~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 81 MEGGDLLSYLRDARVERF---------GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred cCCCcHHHHHHHhhhccc---------CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCc
Confidence 999999999976432100 1235899999999999999999999998 99999999999999887
Q ss_pred cEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.|+......+ .
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~--- 222 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V--- 222 (269)
T ss_pred ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H---
Confidence 8999999999865332211 1122345678999999999999999999999999999998 999885432211 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. .++.......+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 223 ~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 223 LQ----------HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HH----------HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 01111111233445677899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.06 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=203.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+.|+..+.||+|+||.||+|... +++.|++|.+........+.+.+|+.++++++|+|++++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999964 48899999988777777788999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 92 ~~~~l~~~~~~~~---------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 92 PGGAVDAIMLELD---------------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred CCCcHHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEcc
Confidence 9999988875432 36899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||++....... .......+++.|+|||++. ...++.++|||||||++|||++|+.|+....... ....
T Consensus 154 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~ 226 (292)
T cd06644 154 FGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLK 226 (292)
T ss_pred Cccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHH
Confidence 99987642221 1122345788999999884 3456889999999999999999999985432211 1111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... .+ ....+......+.+++.+||+.||++||++.|++++
T Consensus 227 ~~~~~------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 227 IAKSE------PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HhcCC------Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11000 00 011233445678899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=320.89 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=200.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999864 57899999876432 22334677899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ ++|.+++.... ..+++.....++.|+++||+|||+.+ ++||||||+||++++++.+||+
T Consensus 86 ~~-~~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 86 LD-KDLKQYLDDCG---------------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred cc-cCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEEC
Confidence 96 68888876532 35889999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||++......... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+.....
T Consensus 147 dfg~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~ 222 (301)
T cd07873 147 DFGLARAKSIPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILG 222 (301)
T ss_pred cCcchhccCCCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcC
Confidence 99999765322211 122357889999998765 45788999999999999999999999755433221 11111111
Q ss_pred ---hchhHHHhhh---------hhccc----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ---ENKLLEILDA---------RVAKE----ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ---~~~~~~~~d~---------~l~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+..+++. ..... .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111111110 00000 012234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=323.72 Aligned_cols=237 Identities=27% Similarity=0.397 Sum_probs=189.3
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHH-HHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~-il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||+||+|+.. +|+.||||++... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 6899999987642 1223344555554 56789999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 81 GELFFHLQRE----------------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccC
Confidence 9999888653 35889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~----- 209 (323)
T cd05575 142 LCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNIL----- 209 (323)
T ss_pred CCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHH-----
Confidence 987542221 22234568999999999999999999999999999999999999986543221 111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
... ...+...+..+.+++.+||+.||.+||++.
T Consensus 210 ----~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 210 ----NKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----cCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111 112233456789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.57 Aligned_cols=251 Identities=26% Similarity=0.478 Sum_probs=201.9
Q ss_pred CCCcCccccccCcEEEEEEEcCCCCEEEEEecccCC------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
+|...+.||+|+||.||+|...+|+.+|||.++... ....+.+.+|++++++++|+||+++.+++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998788999999875421 22345688999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 81 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 81 MEFVPGGSISSILNRF----------------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred EecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeE
Confidence 9999999999998653 25789999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCC-----CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 487 KVSDFGTSRSVPNDK-----THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 487 kI~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---- 217 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---- 217 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----
Confidence 999999987652111 11122345889999999999888999999999999999999999998643322110
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... ......+......+.+++.+||+.+|.+||++.|++.+
T Consensus 218 --~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 218 --FYIGAHR--------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --HHhhhcc--------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 01112233455778999999999999999999999763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.09 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=205.0
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|+||.||.++. .+++.+++|++.. .......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999998884 4688999998654 2345566788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++.... ...+++.++..++.|+++||.|||+.+ ++||||+|+||++++++.+||+
T Consensus 81 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~ 143 (256)
T cd08221 81 ANGGTLYDKIVRQK--------------GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLG 143 (256)
T ss_pred cCCCcHHHHHHhcc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEEC
Confidence 99999999987542 136899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .....
T Consensus 144 d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~--- 213 (256)
T cd08221 144 DFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI--- 213 (256)
T ss_pred cCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH---
Confidence 9999987643332 2233468999999999988888999999999999999999999986433211 11111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..... ...+......+.+++.+||+.+|++||++.|+++++
T Consensus 214 ------~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 214 ------VQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ------HcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111 112234456789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.30 Aligned_cols=247 Identities=28% Similarity=0.467 Sum_probs=200.0
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|...+.||+|+||.||+|.. +++.||+|..+... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999986 67889999987532 345788999999999999999999998654 4799999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 82 ~~~L~~~l~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 82 KGNLVNFLRTRG--------------RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred CCCHHHHHHhcC--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCC
Confidence 999999986542 235889999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++...... .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||......+. .
T Consensus 145 g~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~------ 207 (254)
T cd05083 145 GLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------K------ 207 (254)
T ss_pred ccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------H------
Confidence 9987643221 12234568999999998899999999999999999998 8888864432211 0
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+.+......+.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 208 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 208 ---ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---HHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111111122233455778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.66 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=199.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++..++|+||+++.+++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999964 5789999987642 2233445788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 81 Ey~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---------------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred eCCCCCcHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEE
Confidence 9999999999997532 25889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
|+|||+++..............||++|+|||++.. +.++.++||||||+++|||++|+.||......+ .
T Consensus 143 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~ 216 (331)
T cd05624 143 LADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T 216 (331)
T ss_pred EEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------H
Confidence 99999998764433322333569999999999875 567889999999999999999999996443221 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~ 616 (646)
+.......... .+ .....+.+..+.+++.+|+..++++ |+++++++++
T Consensus 217 ~~~i~~~~~~~-----~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 217 YGKIMNHEERF-----QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHcCCCcc-----cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111110000 00 0111234567889999999866554 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.58 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=203.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+|++++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999954 58899999876532 44556788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+
T Consensus 81 ~~~~~L~~~~~~~-----------------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~ 140 (274)
T cd06609 81 CGGGSCLDLLKPG-----------------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLA 140 (274)
T ss_pred eCCCcHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEc
Confidence 9999999998642 5899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++|+.||........ ... .
T Consensus 141 d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~-- 210 (274)
T cd06609 141 DFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-I-- 210 (274)
T ss_pred ccccceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-h--
Confidence 9999987643321 22234688899999999988899999999999999999999999864332110 000 0
Q ss_pred chhHHHhhhhhcccCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........+.. .+..+.+++.+||+.||++||++++++++
T Consensus 211 -------~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 211 -------PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -------hhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00111111111 45678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.71 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=202.1
Q ss_pred CCCcCccccccCcEEEEEEEcCC--CCEEEEEeccc----------CCHHHHHHHHHHHHHHhh-cCccCceeEEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPD--GSIVAVKRSKA----------IDKTQIEQFINEVVILSQ-INHRHIVKLLGCCLE 399 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~--g~~VAVK~l~~----------~~~~~~~~~~~Ei~il~~-l~H~niv~l~g~~~~ 399 (646)
+|+..+.||+|+||.||+|.... ++.+|+|.+.. .......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 68899997642 223345567889988875 799999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNI 478 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NI 478 (646)
++..++||||+++++|.+++..... ....+++..+++++.|++.||.|||+ .+ ++|+||+|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~ni 145 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE------------KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNI 145 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHE
Confidence 9999999999999999998854321 12468999999999999999999996 56 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
++++++.+||+|||++....... ......++..|+|||.+.++.++.++||||||+++|||++|+.|+........
T Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-- 221 (269)
T cd08528 146 MLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-- 221 (269)
T ss_pred EECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--
Confidence 99999999999999998754332 22345688999999999988899999999999999999999999854322110
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. .+.+..............+.+++.+||+.||++||++.|+..+++
T Consensus 222 ----~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ----AT---------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----HH---------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 111111111111133467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=315.93 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=198.7
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999964 68899999876432 22345678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ ++|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+
T Consensus 81 ~~-~~l~~~~~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 143 (285)
T cd07861 81 LS-MDLKKYLDSLPK-------------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLA 143 (285)
T ss_pred CC-CCHHHHHhcCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEEC
Confidence 96 788888865322 246899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||++....... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ ....+.....
T Consensus 144 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~ 220 (285)
T cd07861 144 DFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGT 220 (285)
T ss_pred cccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 999998653222 112233568899999988654 578899999999999999999999875433211 1111110000
Q ss_pred --h------chhHH-------HhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 --E------NKLLE-------ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 --~------~~~~~-------~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+ ..+.. +..... .......+..+.+++.+||+.||++|||+.+|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 221 PTEDVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CChhhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000 000000 00112245677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=326.47 Aligned_cols=261 Identities=25% Similarity=0.328 Sum_probs=198.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
.++|...+.||+|+||.||++... +|+.||||+++.. .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999853 5889999998642 3344567889999999999999999999986543
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+++ +|.+.++. .+++..+..++.|+++||.|||+++ |+||||||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------------------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~ 157 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 157 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEC
Confidence 46999999954 56555422 4788889999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
.++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+. ..
T Consensus 158 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~ 232 (359)
T cd07876 158 SDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WN 232 (359)
T ss_pred CCCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 9999999999999864322 122335689999999999999999999999999999999999999975432211 11
Q ss_pred HHHHHHhhc----------hhHHHhhhhhc------------------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 046188 562 YFISLAKEN----------KLLEILDARVA------------------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613 (646)
Q Consensus 562 ~~~~~~~~~----------~~~~~~d~~l~------------------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 613 (646)
......... ....+...... ..........+.+|+.+||+.||++|||+.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 111100000 00001100000 00111224568899999999999999999999
Q ss_pred HHHHH
Q 046188 614 SMDLE 618 (646)
Q Consensus 614 l~~L~ 618 (646)
+++-.
T Consensus 313 l~hp~ 317 (359)
T cd07876 313 LRHPY 317 (359)
T ss_pred hcCch
Confidence 99754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=318.55 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=204.8
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|...+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999995 468999999987655555567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 99 ~~~~L~~~~~~-----------------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 99 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred CCCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECc
Confidence 99999998853 25789999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....
T Consensus 159 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~-- 229 (297)
T cd06656 159 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT-- 229 (297)
T ss_pred CccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eecc--
Confidence 999986543322 1223458889999999998889999999999999999999999986433211100 0000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........+......+.+++.+||+.||++||++.+|+++
T Consensus 230 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 ------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011233445678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.70 Aligned_cols=250 Identities=32% Similarity=0.525 Sum_probs=202.2
Q ss_pred CcCccccccCcEEEEEEEcCC-----CCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 335 NQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~-----g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
...+.||.|+||.||++...+ +..||+|.++..... ..+.+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999653 378999998765433 56788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 82 ~~~~~~l~~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 82 YMEGGDLLDYLRKNRP--------------KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred ccCCCCHHHHHHhhhh--------------ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEE
Confidence 9999999999876432 12899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++..............+++.|+|||.+....++.++||||||++++||++ |..|+....... .....
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~- 217 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEYL- 217 (258)
T ss_pred cccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-
Confidence 9999998765442222222347789999999988889999999999999999998 777765422211 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
........+...+..+.+++.+||..||++|||+.|+++.|
T Consensus 218 ---------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 ---------KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111122333567799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.07 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=205.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677888999999999999964 5789999987643 245567889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||++++++.++|+
T Consensus 84 ~~~~~L~~~i~~-----------------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~ 143 (277)
T cd06640 84 LGGGSALDLLRA-----------------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLA 143 (277)
T ss_pred CCCCcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEc
Confidence 999999998853 25788999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........
T Consensus 144 dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------ 210 (277)
T cd06640 144 DFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------------ 210 (277)
T ss_pred ccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------------
Confidence 9999987643221 122345788999999998888999999999999999999999998643322110
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..+........+...+..+.+++.+||+.+|++||++.+++.+--
T Consensus 211 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 211 ----FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred ----hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 011111122334556678999999999999999999999988744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.75 Aligned_cols=248 Identities=25% Similarity=0.415 Sum_probs=201.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.|+..+.||+|+||.||+|... +++.||+|..+.. .....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556778999999999999854 5789999987643 2445567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 85 ~~~~L~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06642 85 GGGSALDLLKP-----------------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred CCCcHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcc
Confidence 99999988853 25889999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ..
T Consensus 145 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~------ 211 (277)
T cd06642 145 FGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF------ 211 (277)
T ss_pred ccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh------
Confidence 999986543221 12234578899999999988899999999999999999999999753322110 00
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.+........+...+..+.+++.+||+.+|++||+|.|++.+-
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 212 ----LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ----hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0111111122234456789999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.96 Aligned_cols=250 Identities=25% Similarity=0.442 Sum_probs=196.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-----CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--Cce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~ 403 (646)
.+|...+.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+.++++++||||+++.+++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999854 5889999987532 223455788999999999999999999998753 467
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~ 142 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----------------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSA 142 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCC
Confidence 8999999999999998653 35889999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++....... .......++.+|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----- 217 (266)
T cd06651 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----- 217 (266)
T ss_pred CCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----
Confidence 9999999999986532111 111234588999999999988899999999999999999999999864321110
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... ........+......+.+++ +||..+|++||+++||+++
T Consensus 218 -~~~~~---------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 218 -IFKIA---------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -HHHHh---------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11000 00011223334445667776 6888999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=326.60 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=198.7
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----- 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~----- 401 (646)
..++|...+.||+|+||.||++... .++.||||+++.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999853 5889999988642 3344567889999999999999999999986432
Q ss_pred -ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 402 -VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 402 -~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
..++||||++ ++|.+++.. .+++..+..++.|+++||+|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~------------------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill 152 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh------------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEE
Confidence 4699999995 466655532 4788899999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~ 228 (355)
T cd07874 153 KSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW--N 228 (355)
T ss_pred CCCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H
Confidence 99999999999999865322 2223356899999999999889999999999999999999999999754432211 0
Q ss_pred HHHHHHHh---------hchhHHHhhh----------hh--------cccCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 046188 561 AYFISLAK---------ENKLLEILDA----------RV--------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613 (646)
Q Consensus 561 ~~~~~~~~---------~~~~~~~~d~----------~l--------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 613 (646)
........ ......+++. .. ....+......+.+|+.+||+.||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 00000000 0001111110 00 000112234578899999999999999999999
Q ss_pred HHHH
Q 046188 614 SMDL 617 (646)
Q Consensus 614 l~~L 617 (646)
+++-
T Consensus 309 l~hp 312 (355)
T cd07874 309 LQHP 312 (355)
T ss_pred hcCc
Confidence 9873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.12 Aligned_cols=240 Identities=23% Similarity=0.419 Sum_probs=191.4
Q ss_pred ccccccCcEEEEEEEcCC--------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 338 RFLGQGGFGTVYKGMLPD--------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887765555667889999999999999999999999998899999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc----
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---- 485 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---- 485 (646)
+++|+|.++++... ..++|..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 81 ~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~ 142 (258)
T cd05078 81 VKFGSLDTYLKKNK---------------NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTG 142 (258)
T ss_pred CCCCcHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccC
Confidence 99999999997642 25899999999999999999999999 999999999999987765
Q ss_pred ----EEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCC-CCCCCchHHhhcH
Q 046188 486 ----AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKK-PICLTREEEERNL 559 (646)
Q Consensus 486 ----~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~~l 559 (646)
+|++|||++...... ....++..|+|||++.+. .++.++||||||+++|||++|.. |+.........
T Consensus 143 ~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-- 215 (258)
T cd05078 143 NPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-- 215 (258)
T ss_pred CCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--
Confidence 699999998754321 224578899999999864 57899999999999999999964 44322111100
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+... ....+......+.+++.+||+.||++|||+++|++.|+
T Consensus 216 --------------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 --------------QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------------HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11223334467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.25 Aligned_cols=249 Identities=26% Similarity=0.498 Sum_probs=200.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH---------HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK---------TQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~---------~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
+|.....||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999853 578999997653211 223568899999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~ 141 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----------------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----------------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcC
Confidence 99999999999999999653 35888999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCc-----cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 483 KFSAKVSDFGTSRSVPNDKTH-----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
++.+||+|||+++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~- 220 (267)
T cd06628 142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA- 220 (267)
T ss_pred CCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-
Confidence 999999999999876422111 11124578899999999988899999999999999999999999864322110
Q ss_pred cHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 558 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. .... ......+...+..+.+++.+||+.||.+||++.||+++
T Consensus 221 -----~~---------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 -----IF---------KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----HH---------HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00 0001 11122334456778999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.61 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=206.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|+..+.||+|++|.||+|... +++.+++|..........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999964 5788999998766555677889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++.... ..+++.++..++.|++.||.|||+++ ++|+||+|+||++++++.+||+
T Consensus 82 ~~~~~l~~~~~~~~---------------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~ 143 (262)
T cd06613 82 CGGGSLQDIYQVTR---------------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLA 143 (262)
T ss_pred CCCCcHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEEC
Confidence 99999999886542 36899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+.......... ..
T Consensus 144 d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~ 216 (262)
T cd06613 144 DFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LI 216 (262)
T ss_pred ccccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH
Confidence 9999986543211 12234678899999998776 88999999999999999999999986543221110 00
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... +.+ .....+...+..+.+++.+||+.||.+||++.+|+.+
T Consensus 217 ~~~~-----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 217 SKSN-----FPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Hhcc-----CCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000 0011223445678999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.52 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=201.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-ceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-~~~LV~E 408 (646)
+|+..+.||+|++|.||++... +++.||+|++... .....+.+.+|++++++++|+|++++.+.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999954 5789999987542 3344567889999999999999999999876544 5789999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 81 ~~~~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l 143 (257)
T cd08223 81 FCEGGDLYHKLKEQK--------------GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKV 143 (257)
T ss_pred ccCCCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEE
Confidence 999999999997532 236899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++........ ......+++.|+|||.+.+..++.++||||||++++||++|+.||....... ......
T Consensus 144 ~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~- 215 (257)
T cd08223 144 GDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII- 215 (257)
T ss_pred ecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-
Confidence 99999987643222 2233468899999999999999999999999999999999999986433211 111110
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+ .....+......+.+++.+||+.||++||++.+++++
T Consensus 216 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 EG---------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hc---------CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01 1112334455789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.48 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=201.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-----HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+|++++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999975 78999999865432 33556788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 81 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~ 141 (258)
T cd06632 81 LELVPGGSLAKLLKKY----------------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVV 141 (258)
T ss_pred EEecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 9999999999998653 35889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||++....... ......++..|++||.+.... ++.++|+||||+++|||++|+.||........ ...
T Consensus 142 kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~ 213 (258)
T cd06632 142 KLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFK 213 (258)
T ss_pred EEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHH
Confidence 999999988754332 223456889999999987766 89999999999999999999999864331110 000
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ........+......+.+++.+||+.+|.+||++.+++.+
T Consensus 214 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 214 IG---------RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HH---------hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00 0000112333455778899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.53 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=201.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999854 58899999987665555667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++... ..+++.+.+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 89 GGGSLQDIYHVT----------------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred CCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECc
Confidence 999999988642 36899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
||++....... .......|+..|+|||.+. .+.++.++|||||||++|||++|+.|+......... ....
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~ 222 (267)
T cd06645 150 FGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMT 222 (267)
T ss_pred ceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhh
Confidence 99987653221 1123346899999999874 456889999999999999999999998543321110 0000
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ...+.... ....+..+.+++.+||+.||++||++++|+++
T Consensus 223 ~~~----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 223 KSN----FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccC----CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 00000000 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.21 Aligned_cols=259 Identities=18% Similarity=0.283 Sum_probs=193.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..+|...+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++......++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999964 4678999975432 234689999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+ .|+|.+++... ...++|..+++|+.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 139 ~-~~~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 139 Y-SSDLYTYLTKR---------------SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred c-CCcHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEe
Confidence 8 57888888653 236899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH--------hhcHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--------ERNLVA 561 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~--------~~~l~~ 561 (646)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+++..++....... ...+..
T Consensus 200 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~ 277 (357)
T PHA03209 200 DLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277 (357)
T ss_pred cCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHH
Confidence 999997542221 1223568999999999999999999999999999999999766653221111 001111
Q ss_pred HHHHHHh-hc---------hhHHHhhhhhcc--cC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAK-EN---------KLLEILDARVAK--EA-------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~-~~---------~~~~~~d~~l~~--~~-------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... .. ....+++..... .. .......+.+|+.+||+.||.+|||+.|++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 278 IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1100000 00 000111100000 00 01123455679999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.93 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=191.6
Q ss_pred ccccccCcEEEEEEEcCC---CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~---g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||+|...+ ...+++|.+... .......+.+|+.+++.++|+||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997533 357899987643 3344567889999999999999999999999999999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|.+++....... ....++...++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 146 (269)
T cd05042 81 DLKNYLRSNRGMV-----------AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGL 146 (269)
T ss_pred cHHHHHHhccccc-----------cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccc
Confidence 9999997653210 123568888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcc-ccccccCCcccChhcccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 494 SRSVPNDKTHL-TTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 494 a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
++......... .....++..|+|||++.. ..++.++||||||+++|||++ |..|+......+. ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~ 220 (269)
T cd05042 147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LK 220 (269)
T ss_pred ccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HH
Confidence 87643222111 122345678999998643 356889999999999999999 6777754322210 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...... ...+.++. .+...+..+.+++..|| .||++||+++||++.|.
T Consensus 221 ~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 QVVREQ-DIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhhcc-CccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 01111111 22334566778889998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.47 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=204.0
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|+||.||++.. .+|+.||+|++.. ......+++.+|+.++++++|+||+++.+++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 4688999998754 2344556788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++..... ..+++.++++++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~ 143 (256)
T cd08218 81 CEGGDLYKKINAQRG--------------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLG 143 (256)
T ss_pred CCCCcHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEe
Confidence 999999998865321 25789999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++........ ......|++.|+|||++.++..+.++|+||||++++||++|+.|+......+ .......
T Consensus 144 d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~- 215 (256)
T cd08218 144 DFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIR- 215 (256)
T ss_pred eccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhc-
Confidence 9999986543221 1223458889999999998889999999999999999999999986432221 1111111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ....+......+.+++.+||+.+|.+||++.||+++
T Consensus 216 --------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 216 --------GS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --------CC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 112334456778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=317.06 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=193.3
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhc---CccCceeEEEEEEeC-----C
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCLET-----E 401 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~~~-----~ 401 (646)
+|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999964 68899999876421 11123455677766655 799999999998642 3
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~ 142 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--------------PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVT 142 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 4789999996 58888876532 235899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+++.+||+|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||++|++||......+. +..
T Consensus 143 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~ 218 (288)
T cd07863 143 SGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK 218 (288)
T ss_pred CCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH
Confidence 99999999999998654221 12334688999999999988999999999999999999999999865433221 111
Q ss_pred HHHHHHhhchhHHH----------hhhhh---cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEI----------LDARV---AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~----------~d~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
............+ ..+.. ...........+.+++.+||+.||++|||+.|++.+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 219 -IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred -HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111110000000 00000 001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.53 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=206.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|++|.||+|... ++..+|+|..+.......+.+.+|++++++++|+|++++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457888899999999999999964 5889999998876677778899999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++.... ..+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 84 ~~~~~L~~~~~~~~---------------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~ 145 (280)
T cd06611 84 CDGGALDSIMLELE---------------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLA 145 (280)
T ss_pred cCCCcHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEc
Confidence 99999999986532 36899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|||++........ ......+++.|+|||.+. ...++.++||||||+++|||++|+.||........ ..
T Consensus 146 d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~ 218 (280)
T cd06611 146 DFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LL 218 (280)
T ss_pred cCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HH
Confidence 9999876532221 122345889999999874 34567899999999999999999999864322110 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...... .+ ....+......+.+++.+||+.||.+||++.+++++-.
T Consensus 219 ~~~~~~------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 219 KILKSE------PP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred HHhcCC------CC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 110000 00 01123344567889999999999999999999988743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=323.21 Aligned_cols=241 Identities=25% Similarity=0.368 Sum_probs=190.5
Q ss_pred ccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHH-HHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~-il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||++.. .+|+.||+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 46899999987642 2223345555654 56779999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|..++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 81 GELFFHLQRE----------------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecC
Confidence 9998887542 36899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+.....
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~---- 210 (325)
T cd05604 142 LCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILH---- 210 (325)
T ss_pred CcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHc----
Confidence 987542211 12234568999999999999999999999999999999999999986543221 1111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
..+ ..+......+.+++.+|++.||.+||++++.++
T Consensus 211 -----~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 211 -----KPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -----CCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 111 112234566889999999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.00 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=204.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|+||+||++... +|+.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999954 58899999876432 33456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+++|+|.+++... ..+++..+..++.+++.||.|||+ ++ ++||||||+||++++++.++|
T Consensus 85 ~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l 145 (284)
T cd06620 85 MDCGSLDRIYKKG----------------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKL 145 (284)
T ss_pred CCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEE
Confidence 9999999887552 358999999999999999999997 46 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc-HHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN-LVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~~~~ 567 (646)
+|||++....... .....|+..|+|||.+.++.++.++|||||||++|||++|+.||......+... ....+..
T Consensus 146 ~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-- 220 (284)
T cd06620 146 CDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-- 220 (284)
T ss_pred ccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH--
Confidence 9999987542221 123468999999999988889999999999999999999999987543321100 0000000
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
....++............+..+.+++.+||+.||.+||++.|++++..-+
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 221 ---LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ---HHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 01111111111111122456789999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=322.23 Aligned_cols=241 Identities=26% Similarity=0.379 Sum_probs=189.9
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHH-HHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEV-VILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei-~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||++... +++.||+|.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57889999876421 12223444444 456788999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++.....++.|+++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 81 GELFYHLQRE----------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred CcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCC
Confidence 9999988653 25778888899999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+....
T Consensus 142 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~----- 209 (325)
T cd05602 142 LCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNIL----- 209 (325)
T ss_pred CCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHH-----
Confidence 997542221 12234569999999999999999999999999999999999999997543221 111111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
... ...+...+..+.+++.+||+.||.+||++.+.+.
T Consensus 210 ----~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 210 ----NKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----hCC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 111 1122344567899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.40 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=197.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||++... +++.||||.++.. .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 5889999988642 2334556788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 81 EFLPGGDMMTLLMKK----------------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred eCCCCccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEE
Confidence 999999999998653 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCC----------------------------------ccccccccCCcccChhccccCCCCCccchhh
Q 046188 488 VSDFGTSRSVPNDKT----------------------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 533 (646)
Q Consensus 488 I~DfGla~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS 533 (646)
|+|||+++....... .......||+.|+|||++.+..++.++||||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 999999875421100 0112346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC---H
Q 046188 534 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT---M 610 (646)
Q Consensus 534 fGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---~ 610 (646)
|||++|||++|+.||......+. +....... ..+..+........+.+++.+++ .||.+|++ +
T Consensus 222 lGvilyel~tG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 287 (360)
T cd05627 222 LGVIMYEMLIGYPPFCSETPQET------YRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGV 287 (360)
T ss_pred ccceeeecccCCCCCCCCCHHHH------HHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCH
Confidence 99999999999999975443221 11111100 00000001113456778888876 49999985 6
Q ss_pred HHHHHH
Q 046188 611 KQVSMD 616 (646)
Q Consensus 611 ~evl~~ 616 (646)
.|++++
T Consensus 288 ~ei~~h 293 (360)
T cd05627 288 EEIKSH 293 (360)
T ss_pred HHHhcC
Confidence 777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=321.65 Aligned_cols=237 Identities=27% Similarity=0.417 Sum_probs=188.5
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHH-HHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~-il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|+.. +|+.||+|.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999987542 1223344555554 67889999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|..++... ..+++.+...++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 81 GELFFHLQRE----------------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCC
Confidence 9998887542 35788899999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .....
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i------ 208 (321)
T cd05603 142 LCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNI------ 208 (321)
T ss_pred CCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHH------
Confidence 987532221 12234568999999999998899999999999999999999999996543211 11111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
.... ...+......+.+++.+||+.||.+||+..
T Consensus 209 ---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 ---LHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---hcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111 123344556789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.15 Aligned_cols=238 Identities=27% Similarity=0.480 Sum_probs=189.5
Q ss_pred ccccccCcEEEEEEEcCCCC-----------EEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 338 RFLGQGGFGTVYKGMLPDGS-----------IVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~-----------~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
+.||+|+||.||+|...+.. .+++|.++..... ...+.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788877654333 5688899999999999999999999988 778999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC--
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-- 484 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-- 484 (646)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 79 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~ 140 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---------------NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLN 140 (259)
T ss_pred EEcCCCCcHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccc
Confidence 99999999999987642 25899999999999999999999998 99999999999999887
Q ss_pred -----cEEEeecCCccccCCCCCccccccccCCcccChhccccC--CCCCccchhhHHHHHHHHHhC-CCCCCCCchHHh
Q 046188 485 -----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTG-KKPICLTREEEE 556 (646)
Q Consensus 485 -----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~ 556 (646)
.+||+|||++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+......+.
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred cCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 799999999986533 1223467789999998876 789999999999999999994 666543321111
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. .+ . .. ...+......+.+++.+||..+|.+||++.||++.|+
T Consensus 216 ~~---~~----~--------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 ER---FY----Q--------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HH---HH----h--------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 0 00 0111111267899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.76 Aligned_cols=269 Identities=24% Similarity=0.337 Sum_probs=204.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccC-ceeEEEEEEeCC------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRH-IVKLLGCCLETE------ 401 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~n-iv~l~g~~~~~~------ 401 (646)
..|...++||+|+||+||+|+. .+|+.||+|+++...+ ..-....+|+.+|++++|+| |++|.+++..+.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566677899999999999994 4789999998765433 23345679999999999999 999999998877
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..+||+||+ .-+|..++....... ..++......++.|+++||+|||+++ |+||||||+||||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~------------~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~ 154 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP------------QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLIS 154 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEEC
Confidence 789999998 778999987654210 24666889999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++|.+||+|||+|+...-.... .+..++|..|.|||.+.+. .|+...||||+||++.||++++.-|....+.+ .+.
T Consensus 155 ~~G~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~ 231 (323)
T KOG0594|consen 155 SSGVLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLF 231 (323)
T ss_pred CCCcEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHH
Confidence 9999999999999976433222 3445789999999999886 78999999999999999999998887665422 222
Q ss_pred HHHHHHHhhc---hhHHHh---hhh--hcccC-C-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHH
Q 046188 561 AYFISLAKEN---KLLEIL---DAR--VAKEA-S-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGL 620 (646)
Q Consensus 561 ~~~~~~~~~~---~~~~~~---d~~--l~~~~-~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i 620 (646)
..+ ..+... .+..+. +-. ..... + +.......+++.+||+.+|.+|.|++.++.+ +..+
T Consensus 232 ~If-~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 232 RIF-RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHH-HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 222 222211 111110 100 00000 1 1111467899999999999999999999987 5544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.91 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=203.7
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV~ 407 (646)
+|+..+.||+|+||.||++.. .+++.+|+|.++. ......+.+.+|+.++++++|+|++++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999985 4678999998764 3345566788999999999999999999988653 4578999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEecCCCCCCEEECC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-----SSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-----~~~~~~ivHrDIk~~NILl~~ 482 (646)
||+++++|.+++..... ....+++..++.++.|+++||.||| +.+ ++|+||+|+||++++
T Consensus 81 e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~ 145 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK------------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDA 145 (265)
T ss_pred hhccCCCHHHHHHHHhh------------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEec
Confidence 99999999999966422 1347999999999999999999999 666 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.......
T Consensus 146 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------- 217 (265)
T cd08217 146 NNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------- 217 (265)
T ss_pred CCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------
Confidence 999999999999876443321 233468999999999998889999999999999999999999986543211
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... .+........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 218 ~~~---------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 218 LAS---------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHH---------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 111111123344556788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.06 Aligned_cols=202 Identities=24% Similarity=0.389 Sum_probs=161.1
Q ss_pred CccccccCcEEEEEEEcC---CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEEEEecc
Q 046188 337 SRFLGQGGFGTVYKGMLP---DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVYEYIC 411 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV~Ey~~ 411 (646)
.++||+|+||+||+|... +++.||+|.++.... ...+.+|+.++++++||||+++++++... ...++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 468999999999999854 457899998865322 23567899999999999999999998653 4578999998
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----CCCCcEE
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAK 487 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~k 487 (646)
+++|.+++........ ......+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 83 ~~~l~~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 83 EHDLWHIIKFHRASKA-------NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred CCCHHHHHHhcccccc-------cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 4688887754322100 001235899999999999999999999999 9999999999999 4668999
Q ss_pred EeecCCccccCCCCC--ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 488 VSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 488 I~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999999987643221 12234568999999999876 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.35 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=203.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|+||.||++... +|..||+|.++.. .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999965 6899999987643 344456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+++++|.+++..... ...+++..+.+++.|++.||.|||+ .+ ++||||||+||+++.++.+||
T Consensus 81 ~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l 144 (286)
T cd06622 81 MDAGSLDKLYAGGVA-------------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKL 144 (286)
T ss_pred cCCCCHHHHHHhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEE
Confidence 999999988865321 2368999999999999999999997 46 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCC------CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
+|||++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||....... ....
T Consensus 145 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~ 218 (286)
T cd06622 145 CDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQ 218 (286)
T ss_pred eecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHH
Confidence 999999765322 122345788999999986543 4889999999999999999999986432211 1110
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+..+.+. .....+.+....+.+++.+||+.+|.+||++.+++.+-.
T Consensus 219 ---------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 219 ---------LSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ---------HHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 1111111 112234456678899999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.30 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=204.6
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 399 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~ 399 (646)
+.++.+..+.++|+..+.||+|+||.||++... +++.+|+|..+.... ....+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334666778899999999999999999999854 578999998765322 234677899999999 69999999998853
Q ss_pred -----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 400 -----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 400 -----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
++..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||+.+ ++|||||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk 151 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------------GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVK 151 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhcc------------CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCC
Confidence 34679999999999999988643210 236889999999999999999999998 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCC
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPIC 549 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~ 549 (646)
|+||++++++.+||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+.
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 152 GNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred HHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999986533221 2223468999999998753 457889999999999999999999986
Q ss_pred CCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 550 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
....... ...... ...+.+ ..+......+.+++.+||+.||++||++.||++++
T Consensus 231 ~~~~~~~------~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 231 DLHPMRA------LFKIPR------NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCchhHH------Hhhccc------cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 4322111 000000 000000 11222345688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.49 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=196.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|...+.||+|+||.||++... .++.||||.... ..+.+|+.+|++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36888899999999999999965 478899996432 24568999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
.++|.+++... ...++|.++++|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 243 -~~~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 243 -RSDLYTYLGAR---------------LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred -CCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcc
Confidence 57888887543 236999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchH-Hh----hcHHHHHH
Q 046188 491 FGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE-EE----RNLVAYFI 564 (646)
Q Consensus 491 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~-~~----~~l~~~~~ 564 (646)
||+++....... .......||..|+|||++.+..++.++|||||||+||||++|..++...... .. ..+...+.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 999987543221 1223456999999999999999999999999999999999988765432211 10 11111111
Q ss_pred HHHh--h-------chhHHHhhhh----hcccCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 SLAK--E-------NKLLEILDAR----VAKEAS-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 ~~~~--~-------~~~~~~~d~~----l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... . .++...+... ...... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1000 0 0000000000 000000 0123467899999999999999999999976
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.92 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=206.5
Q ss_pred ccCHHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEE
Q 046188 321 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCL 398 (646)
Q Consensus 321 ~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~ 398 (646)
+++.+++..++++|+..+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 456677777889999999999999999999996 4688999998865322 234677899999999 8999999999987
Q ss_pred eCC-----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 399 ETE-----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 399 ~~~-----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
..+ ..++||||+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ ++||||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dl 154 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI------------CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDV 154 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 543 57999999999999998865321 1246899999999999999999999998 999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-----CCCCccchhhHHHHHHHHHhCCCCC
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-----QYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
||+||++++++.+||+|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.|+
T Consensus 155 kp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 155 KGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred CHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 99999999999999999999886543221 11234588899999987653 3688999999999999999999998
Q ss_pred CCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ ........ . +. ...+......+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~------~~~~~~~~-~-----~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 234 FDMHPVKT------LFKIPRNP-P-----PT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCcHHHH------HHHHhcCC-C-----CC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 64432111 00110000 0 00 01122344578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.56 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=198.3
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET------ 400 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------ 400 (646)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999953 5889999998642 234456788999999999999999999987643
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------------------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 159 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 159 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------------------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEE
Confidence 24699999995 466666532 4788899999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+.++.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 160 ~~~~~~kL~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-- 235 (364)
T cd07875 160 KSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN-- 235 (364)
T ss_pred CCCCcEEEEeCCCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 99999999999999865322 12233568999999999999999999999999999999999999997654322111
Q ss_pred HHHHHHHhh----------chhHHHhhhhh------------------cccCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 561 AYFISLAKE----------NKLLEILDARV------------------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 561 ~~~~~~~~~----------~~~~~~~d~~l------------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
.+...... ........... ...........+.+|+.+||+.||.+|||+.|
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 236 -KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred -HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 01000000 00000000000 00011112356889999999999999999999
Q ss_pred HHHHH
Q 046188 613 VSMDL 617 (646)
Q Consensus 613 vl~~L 617 (646)
++++-
T Consensus 315 ~L~hp 319 (364)
T cd07875 315 ALQHP 319 (364)
T ss_pred HhcCc
Confidence 99873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.94 Aligned_cols=271 Identities=25% Similarity=0.399 Sum_probs=222.0
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcCC------CCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEE
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCC 397 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~ 397 (646)
.|+.....++....++-+|.||.||+|.+++ .+.|-+|.++. .+.-+...++.|.-++..+.|||+..+.|++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4555566778888899999999999997643 45678888775 4455677899999999999999999999999
Q ss_pred EeCC-ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 398 LETE-VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 398 ~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
.++. .++.+|.++.-|+|+.||...+.. +......++..+...++.|++.|++|||+++ +||.||.++
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~--------~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaR 425 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGD--------DPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAAR 425 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccC--------CCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhh
Confidence 8754 678899999999999999854421 1112346888999999999999999999999 999999999
Q ss_pred CEEECCCCcEEEeecCCcccc-CCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchH
Q 046188 477 NILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREE 554 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 554 (646)
|.+||+..++||+|-.++|.+ +.+.......-..+..||+||.+.+..++.++|||||||+||||+| |+.|+..-++.
T Consensus 426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 999999999999999999986 3333334444456778999999999999999999999999999999 88897655444
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+. ...+..+.+...|.+|+++++.+|.-||+.+|++||+++|++.-|+..-.
T Consensus 506 Em----------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 506 EM----------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HH----------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 31 12233334445678899999999999999999999999999999987754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.66 Aligned_cols=268 Identities=20% Similarity=0.285 Sum_probs=195.5
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc------cCceeEEEEEE
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINH------RHIVKLLGCCL 398 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H------~niv~l~g~~~ 398 (646)
++...+++|...++||+|+||+||+|... .++.||||+++... ....++..|+.++++++| .+++++.+++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455688999999999999999999854 57899999986532 223345667777777654 45889999887
Q ss_pred eC-CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCC
Q 046188 399 ET-EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSS 476 (646)
Q Consensus 399 ~~-~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~ 476 (646)
.+ ...++|||++ +++|.+++... ..+++..+..|+.||+.||.|||+ .+ |+||||||+
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~ 261 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH----------------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPE 261 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHH
Confidence 65 4678999987 78888888653 368999999999999999999997 47 999999999
Q ss_pred CEEECCCC----------------cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHH
Q 046188 477 NILLDDKF----------------SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 540 (646)
Q Consensus 477 NILl~~~~----------------~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~E 540 (646)
|||++.++ .+||+|||++..... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 262 NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 262 NILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred HEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 99998765 499999998864321 2234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchHHhhcHHHHHHH-----HHh---hchhHHHh----------hhhh----cccC---CHHHHHHHHHH
Q 046188 541 LLTGKKPICLTREEEERNLVAYFIS-----LAK---ENKLLEIL----------DARV----AKEA---SEEDIEAVAEL 595 (646)
Q Consensus 541 lltG~~p~~~~~~~~~~~l~~~~~~-----~~~---~~~~~~~~----------d~~l----~~~~---~~~~~~~l~~L 595 (646)
|++|+.||......+.......... +.. .....++. ++.. .... .......+.+|
T Consensus 338 lltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 417 (467)
T PTZ00284 338 LYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL 417 (467)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHH
Confidence 9999999976543322211111000 000 00000010 0000 0000 00123567899
Q ss_pred HHhccccCCCCCCCHHHHHHHHH
Q 046188 596 AMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 596 i~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+.+||++||.+|||++|++++=.
T Consensus 418 i~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 418 IYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred HHHhCCcChhhCCCHHHHhcCcc
Confidence 99999999999999999998644
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.51 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=199.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC---CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP---DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
..+|...+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999743 3578999987653 23457999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|++ .++|.+++.. ...++|.+++.|+.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 166 e~~-~~~l~~~l~~----------------~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~ 225 (392)
T PHA03207 166 PKY-KCDLFTYVDR----------------SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAV 225 (392)
T ss_pred hhc-CCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEE
Confidence 998 4788888733 236999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.||..............+...
T Consensus 226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred EccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 999999986543322 2223457999999999999999999999999999999999999998654322111111111111
Q ss_pred Hhhc----------hhHHHh---hhhhcccCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKEN----------KLLEIL---DARVAKEAS-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~----------~~~~~~---d~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... .+...+ .......+. ......+.+++.+||+.||++||++.|++.+=
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1000 000000 000011010 11235678899999999999999999999874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.89 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=200.7
Q ss_pred CCcCccccccCcEEEEEEEcC----CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
|...+.||+|+||.||+|.+. .++.||||.++.. .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999987653 3445667889999999999999999999887542
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++++||+++|+|.+++...... .....+++...++++.|++.||+|||+.+ |+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~ 147 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----------EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLN 147 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEc
Confidence 247899999999999888543210 00235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l 559 (646)
+++.+||+|||+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+......+ .
T Consensus 148 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~ 224 (273)
T cd05074 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I 224 (273)
T ss_pred CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H
Confidence 9999999999999876432221 1122345678999999998889999999999999999999 888875433211 1
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.. ...... ....+......+.+++.+||+.+|.+||++.|+++.|+++
T Consensus 225 ~~---~~~~~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 YN---YLIKGN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HH---HHHcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 111100 0112234456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.71 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=202.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~~L 405 (646)
-.|...+++|.|+||.||+|+.. +++.||||+.-...+ .-.+|+.+|+++.|||||+|+-++.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 45777899999999999999964 468999998765332 1237999999999999999999887532 2347
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC-C
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-F 484 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~ 484 (646)
||||| .-+|.++++..... ...++.....-+..||.+||.|||+++ |+||||||+|+|+|.+ |
T Consensus 100 Vleym-P~tL~~~~r~~~~~------------~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg 163 (364)
T KOG0658|consen 100 VLEYM-PETLYRVIRHYTRA------------NQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTG 163 (364)
T ss_pred HHHhc-hHHHHHHHHHHhhc------------CCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCC
Confidence 99999 56888888753221 236778888889999999999999998 9999999999999976 9
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||.|+....++.. .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+. + ..+
T Consensus 164 ~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L-~eI 238 (364)
T KOG0658|consen 164 VLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--L-VEI 238 (364)
T ss_pred eEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--H-HHH
Confidence 9999999999988554433 34567899999998876 5799999999999999999999999876544332 2 223
Q ss_pred HHHHhhchhHH--Hhhhh--------hc-----ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHHhh
Q 046188 564 ISLAKENKLLE--ILDAR--------VA-----KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~--~~d~~--------l~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 623 (646)
..+++.....+ .|.+. +. .-..........+++.++|+++|.+|.++.|++.+ ...++..
T Consensus 239 ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 239 IKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 33333221111 12221 11 11233455778999999999999999999999864 4555544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=305.58 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=189.8
Q ss_pred ccccccCcEEEEEEEcCCC---CEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 338 RFLGQGGFGTVYKGMLPDG---SIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g---~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.||+|+||.||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975333 356677765432 345668999999999999999999999999988999999999999
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
+|.++++..... ...+++...+.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 81 DLKSYLSQEQWH------------RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145 (268)
T ss_pred cHHHHHHhhhcc------------cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEeccccc
Confidence 999999764321 234677788899999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC-CccccccccCCcccChhcccc-------CCCCCccchhhHHHHHHHHHhC-CCCCCCCchHHhhcHHHHHH
Q 046188 494 SRSVPNDK-THLTTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLTG-KKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 494 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~l~~~~~ 564 (646)
+....... ........++..|+|||++.. ..++.++||||||+++|||+++ ..|+......+ .+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~ 219 (268)
T cd05086 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLN 219 (268)
T ss_pred ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 86432211 111223457889999998743 2457899999999999999974 56664332211 111
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... ......++.+. ......+.+++..|| .+|++||+++||++.|.
T Consensus 220 ~~~~~-~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 220 HVIKD-QQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHhh-cccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 11112222222 224466788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=305.30 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=198.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-----CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--Cce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~ 403 (646)
++|+..+.||+|+||.||+|... +|+.||||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999964 5889999986531 223456788999999999999999999998764 457
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++++|.+++... ..+++...++++.|++.||+|||+.+ ++|+||||+||+++.+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~ 142 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----------------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSV 142 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCC
Confidence 8999999999999988642 35788999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 143 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----- 217 (265)
T cd06652 143 GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----- 217 (265)
T ss_pred CCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----
Confidence 9999999999986532111 112234588999999999888899999999999999999999999864321110
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+.. ..........+......+.+++.+|+. +|++||+++||+++
T Consensus 218 -~~~---------~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 -IFK---------IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -HHH---------HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011 011111122345566778899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.01 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=200.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|++|.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999965 58899999875422 2233467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|..++... ..++|.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 81 ~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l 141 (286)
T cd07847 81 YCDHTVLNELEKNP----------------RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141 (286)
T ss_pred ccCccHHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEE
Confidence 99998887776432 35899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... .......
T Consensus 142 ~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~~~ 218 (286)
T cd07847 142 CDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY--LIRKTLG 218 (286)
T ss_pred CccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhC
Confidence 99999987643321 1223457889999999876 557899999999999999999999987544332211 1000000
Q ss_pred hh-chhHHHh----------hhhhcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KE-NKLLEIL----------DARVAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~-~~~~~~~----------d~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ....+.. .+...... ....+..+.+++.+||+.||++||++.|++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 0000000 00000000 01234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.76 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=194.9
Q ss_pred cCcccccc--CcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 336 QSRFLGQG--GFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 336 ~~~~IG~G--~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
..++||+| +|++||++.. .+|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7899999985 46899999998653 2334456778999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++|
T Consensus 82 ~~~~l~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~ 144 (327)
T cd08227 82 AYGSAKDLICTHFM--------------DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 144 (327)
T ss_pred CCCcHHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcc
Confidence 99999999865421 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCc------cccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 491 FGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 491 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
|+........... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~- 221 (327)
T cd08227 145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE- 221 (327)
T ss_pred cchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH-
Confidence 9876543211110 1112346778999999876 4588999999999999999999999864322110 000
Q ss_pred HHHHHhhchhHHHhh-------------------h-----------------hhcccCCHHHHHHHHHHHHhccccCCCC
Q 046188 563 FISLAKENKLLEILD-------------------A-----------------RVAKEASEEDIEAVAELAMGCLRLNSKK 606 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d-------------------~-----------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~ 606 (646)
... ......++ . .............+.+++.+||+.||++
T Consensus 222 ---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 222 ---KLN-GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred ---Hhc-CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 000 00000000 0 0000112234567899999999999999
Q ss_pred CCCHHHHHHH
Q 046188 607 RPTMKQVSMD 616 (646)
Q Consensus 607 RPs~~evl~~ 616 (646)
|||++|++++
T Consensus 298 Rpt~~ell~~ 307 (327)
T cd08227 298 RPSASTLLNH 307 (327)
T ss_pred cCCHHHHhcC
Confidence 9999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.11 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=201.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 688999998765433 3677899999999999999999999999988999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++... ..+++..+..|+.|++.||.|||+.+ ++|+||+|+||++++++.+||+
T Consensus 81 ~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~ 141 (264)
T cd06626 81 CSGGTLEELLEHG----------------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLG 141 (264)
T ss_pred CCCCcHHHHHhhc----------------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEc
Confidence 9999999998653 25889999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccc---cccccCCcccChhccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 490 DFGTSRSVPNDKTHLT---TAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 490 DfGla~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~---~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
|||++........... ....++..|+|||++.... .+.++||||||+++|||++|+.||........ ..
T Consensus 142 d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~ 216 (264)
T cd06626 142 DFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IM 216 (264)
T ss_pred ccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HH
Confidence 9999987643332221 1346788999999998766 88999999999999999999999864321110 00
Q ss_pred HHHHhhchhHHHhhhhhcccCCH--HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASE--EDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~--~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... . .....+. .....+.+++.+||+.+|.+||++.|++.+
T Consensus 217 ~~~~~--------~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 217 FHVGA--------G--HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHhc--------C--CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 0 0111122 235678899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.39 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=202.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|++|.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 5789999987642 23334678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++++.+..+... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||
T Consensus 81 ~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 81 YVERTLLELLEAS----------------PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred cCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEE
Confidence 9988777655433 235899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH-
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL- 566 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~- 566 (646)
+|||++...............++..|+|||++.+. .++.++||||||+++|||++|+.|+......+...........
T Consensus 142 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (288)
T cd07833 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221 (288)
T ss_pred EeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999987654433233345678999999999887 7899999999999999999999998654332211100000000
Q ss_pred -------H-hhchh-----HHHhhhh-hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 -------A-KENKL-----LEILDAR-VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 -------~-~~~~~-----~~~~d~~-l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. .+... .+..++. ....++...+..+.+++.+||..+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000 0000000 0111223346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.56 Aligned_cols=262 Identities=25% Similarity=0.338 Sum_probs=202.3
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999964 68899999876533 33456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++|+||||+||++++++.++|+
T Consensus 81 ~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~ 141 (286)
T cd07832 81 M-PSDLSEVLRDEE---------------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIA 141 (286)
T ss_pred c-CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEe
Confidence 9 999999986542 36899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||++...............++..|+|||.+.+. .++.++||||||++++||++|+.++......+. .........
T Consensus 142 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~ 218 (286)
T cd07832 142 DFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLG 218 (286)
T ss_pred eeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcC
Confidence 9999987654332223345689999999988654 468999999999999999999777754332211 111111111
Q ss_pred hch---------hHHHhhhhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENK---------LLEILDARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~---------~~~~~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... +..+..-... .....+....+.+++.+||+.||.+||++++++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000000 00111334788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.54 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=196.7
Q ss_pred HHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-----
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET----- 400 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~----- 400 (646)
...++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 467899999986532 22345677899999999999999999987643
Q ss_pred -CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 401 -EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 401 -~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
...++++|++ +++|.+++.. ..+++..+..++.|+++||.|||+++ |+||||||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil 150 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----------------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVA 150 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEE
Confidence 3468999987 7888777643 25899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
+++++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus 151 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-- 224 (343)
T cd07878 151 VNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-- 224 (343)
T ss_pred ECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--
Confidence 999999999999999865332 223468999999999876 5688999999999999999999999865432211
Q ss_pred HHHHHHHHHhh-----------chhHHHhhhhhcccCC--------HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 559 LVAYFISLAKE-----------NKLLEILDARVAKEAS--------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 559 l~~~~~~~~~~-----------~~~~~~~d~~l~~~~~--------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
...+...... ......+. .+. ..+ ......+.+|+.+||+.||.+|||+.|++.+=
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 225 -LKRIMEVVGTPSPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred -HHHHHHHhCCCCHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0011110000 00000000 000 000 11234578999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.70 Aligned_cols=267 Identities=22% Similarity=0.314 Sum_probs=189.2
Q ss_pred CccccccCcEEEEEEEcC---CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe--CCceEEEEEecc
Q 046188 337 SRFLGQGGFGTVYKGMLP---DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYIC 411 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~--~~~~~LV~Ey~~ 411 (646)
.++||+|+||.||+|... ++..||+|.++.... ...+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 356899998875322 2357789999999999999999999864 346789999985
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----CCCCcEE
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAK 487 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~k 487 (646)
++|.+++........ ......+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+|
T Consensus 84 -~~l~~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07867 84 -HDLWHIIKFHRASKA-------NKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred -CcHHHHHHhhhcccc-------CCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEE
Confidence 578777754321100 011235899999999999999999999998 9999999999999 5678999
Q ss_pred EeecCCccccCCCCC--ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc------
Q 046188 488 VSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN------ 558 (646)
Q Consensus 488 I~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~------ 558 (646)
|+|||+++....... .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||.....+....
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~ 232 (317)
T cd07867 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232 (317)
T ss_pred EeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHH
Confidence 999999987643222 12233568999999999876 457899999999999999999999986443221100
Q ss_pred HHHHHHHHHhhc---hhHH---------Hhhhh---------h---cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046188 559 LVAYFISLAKEN---KLLE---------ILDAR---------V---AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614 (646)
Q Consensus 559 l~~~~~~~~~~~---~~~~---------~~d~~---------l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 614 (646)
............ .... ..... + ...........+.+|+.+||+.||.+|||+.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred HHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 000000000000 0000 00000 0 0000111234578899999999999999999998
Q ss_pred HH
Q 046188 615 MD 616 (646)
Q Consensus 615 ~~ 616 (646)
++
T Consensus 313 ~h 314 (317)
T cd07867 313 QD 314 (317)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.98 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=203.3
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.|...+.||.|+||.||.++. ++.+.||||++.-..+ ...+++++|+..|++++|||.+.+.||+..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 456678899999999999994 5788999999876433 346688999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|| -|+-.|.+.-++ .+|..-++.-|..+.+.||.|||+++ .||||||+.||||++.|.+||
T Consensus 107 YC-lGSAsDlleVhk---------------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK---------------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred HH-hccHHHHHHHHh---------------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeee
Confidence 99 677777776553 37888899999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+|||.|...... ..++|||.|||||++ ..|+|+-|+||||+|++..||.-.++|+..... ......
T Consensus 168 aDFGSAsi~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYH 236 (948)
T KOG0577|consen 168 ADFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH 236 (948)
T ss_pred ccccchhhcCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHH
Confidence 999999876433 346899999999987 458999999999999999999999999764321 111111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+..++ .|.+. ..+.+..+.+++..||++-|.+|||.++++.+--
T Consensus 237 IAQNe------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 237 IAQNE------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHhcC------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 11111 12221 3566778999999999999999999999987643
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.71 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=200.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 58899999875422 2234567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.++.... ..++|.+++.++.|+++||.|||+.+ ++||||+|+||++++++.+||
T Consensus 81 ~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l 141 (286)
T cd07846 81 FVDHTVLDDLEKYP----------------NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKL 141 (286)
T ss_pred cCCccHHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEE
Confidence 99998888776432 25899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .......
T Consensus 142 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~---~~~~~~~ 217 (286)
T cd07846 142 CDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL---YHIIKCL 217 (286)
T ss_pred EeeeeeeeccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHHHh
Confidence 99999987643322 2233457889999998875 45788999999999999999999988644322110 0000000
Q ss_pred hh--chhHHHhh------hhhcc---------cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KE--NKLLEILD------ARVAK---------EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~--~~~~~~~d------~~l~~---------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. .......+ ..... ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000000 00000 0112345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=302.99 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=201.6
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||++.. .+++.+|||.+... .....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 36889999987542 334566788999999999999999999999988899999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC-CcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kI 488 (646)
+++++|.+++.... ...+++..+.+++.++++||.|||+++ ++|+||+|+||+++++ +.+||
T Consensus 81 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l 143 (256)
T cd08220 81 APGGTLAEYIQKRC--------------NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143 (256)
T ss_pred CCCCCHHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEE
Confidence 99999999997642 235899999999999999999999998 9999999999999855 46899
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++........ .....++..|+|||.+....++.++||||||+++|||++|+.|+....... .....
T Consensus 144 ~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~-- 213 (256)
T cd08220 144 GDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKI-- 213 (256)
T ss_pred ccCCCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHH--
Confidence 99999987643321 223458889999999998888999999999999999999999985433211 11111
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ......+......+.+++.+||+.||.+|||+.|++.+
T Consensus 214 -------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 214 -------MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -------Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 01112233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.18 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=202.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 48999999876432 234567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++
T Consensus 81 e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 81 DYCPGGELFRLLQRQP--------------GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIM 143 (316)
T ss_pred EecCCCCHHHHHHhCC--------------CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEE
Confidence 9999999999986532 236899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCc----------------------------cccccccCCcccChhccccCCCCCccchhhHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTH----------------------------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 539 (646)
Q Consensus 488 I~DfGla~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ 539 (646)
|+|||++......... ......||..|+|||.+.+..++.++||||||+++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence 9999998764321110 111235788999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 046188 540 ELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT----MKQVSM 615 (646)
Q Consensus 540 ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs----~~evl~ 615 (646)
||++|+.||........ + ..+.+...........+..+.+++.+||+.||++||+ ++|++.
T Consensus 224 ~l~~g~~pf~~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 224 EMLYGTTPFKGSNRDET------F---------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHhhCCCCCCCCchHHH------H---------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99999999864432211 1 1111111111111224678999999999999999999 666666
Q ss_pred H
Q 046188 616 D 616 (646)
Q Consensus 616 ~ 616 (646)
+
T Consensus 289 ~ 289 (316)
T cd05574 289 H 289 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=305.93 Aligned_cols=254 Identities=24% Similarity=0.448 Sum_probs=198.6
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC----------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID----------KTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~----------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
+|...+.||+|++|.||+|... +|+.||+|.++... ....+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999853 68899999865311 112346788999999999999999999999989
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~ 142 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----------------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVD 142 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEc
Confidence 999999999999999998653 35889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 482 DKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
+++.+||+|||+++....... .......++..|+|||.+.... ++.++||||||+++||+++|+.|+......+.
T Consensus 143 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-- 220 (272)
T cd06629 143 ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-- 220 (272)
T ss_pred CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--
Confidence 999999999999986533211 1123346889999999987654 78999999999999999999999853322110
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ . ............+..+.+++.+||+.||.+||++.||+++
T Consensus 221 ----~~~~~~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 ----MFKLGNKR-S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----HHHhhccc-c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000 0 0001111122345788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=341.35 Aligned_cols=278 Identities=26% Similarity=0.436 Sum_probs=220.7
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcC----C----CCEEEEEeccc-CCHHHHHHHHHHHHHHhhc-CccCceeEEE
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLP----D----GSIVAVKRSKA-IDKTQIEQFINEVVILSQI-NHRHIVKLLG 395 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~----~----g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~g 395 (646)
.++...++....+.||+|.||.|++|... . ...||||.++. ....+.+.+..|+++|+.+ +|+|++.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44555566666779999999999999843 1 34799999885 3445777899999999999 6999999999
Q ss_pred EEEeCCceEEEEEeccCCCchhhhhhhh-hhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 396 CCLETEVPVLVYEYICNGNLSHHIHDHQ-QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 396 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
+|..++..++|+||++.|+|.++|+..+ ........ ....+...|+..+.+.++.|||.|++||++.. +|||||.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~-~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG-VFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccC-CCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 9999889999999999999999998876 10000000 00000024999999999999999999999998 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCcccccccc--CCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG--TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLT 551 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~ 551 (646)
++|||++++..+||+|||+|+.......+......+ ...|||||.+....++.|+|||||||+||||+| |..|+...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999776555544333333 456999999999999999999999999999999 66776431
Q ss_pred chHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
... ..+.+.+....+.+.|..+..+++++|+.||+.+|++||++.|+++.++.+..
T Consensus 526 ~~~---------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 PPT---------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CcH---------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111 11223444445566788889999999999999999999999999999998543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.32 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=200.4
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
|.....||+|+||.||++... ++..||||++........+.+.+|+.++++++|+|++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333567999999999999853 5889999998765555667788999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
++|.+++.. ..+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||
T Consensus 104 ~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg 163 (292)
T cd06658 104 GALTDIVTH-----------------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163 (292)
T ss_pred CcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCc
Confidence 999988743 25889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. .
T Consensus 164 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~------~ 230 (292)
T cd06658 164 FCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRR------I 230 (292)
T ss_pred chhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH------H
Confidence 9876533221 12234588999999999888899999999999999999999999864332211 110 1
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+.+.+. ........+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111 112234568899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=304.13 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=205.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||.|++|.||+|... ++..+|+|++.... ......+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 67899999876432 23567889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++..... ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+
T Consensus 81 ~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~ 144 (267)
T cd06610 81 LSGGSLLDIMKSSYP-------------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIA 144 (267)
T ss_pred cCCCcHHHHHHHhcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEc
Confidence 999999999875421 136899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCc---cccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 490 DFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 490 DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
|||++......... ......|+..|+|||++... .++.++|+||||+++|||++|+.|+....... .+..
T Consensus 145 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~ 218 (267)
T cd06610 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLML 218 (267)
T ss_pred ccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHH
Confidence 99998876433222 22334688999999998877 78999999999999999999999986432211 0111
Q ss_pred HHhhchhHHHhhhhhcccC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEA-SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ..+.+.... ....+..+.+++.+||+.||++||++.|++++
T Consensus 219 ~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 219 TLQN------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HhcC------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1110 001111110 12445678999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.26 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=202.9
Q ss_pred CHHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe-
Q 046188 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE- 399 (646)
Q Consensus 323 ~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~- 399 (646)
+..++..+...|+..+.||+|+||.||+|.. .+++.+|+|...... .....+..|+.+++++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778999999999999999999996 458899999875532 3345678899999998 79999999999863
Q ss_pred -----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 400 -----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 400 -----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
.+..+++|||+++|+|.+++..... ..+++..++.++.|+++||.|||+.+ ++|+||+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~ 148 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--------------NALKEDWIAYICREILRGLAHLHAHK---VIHRDIK 148 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 3467999999999999998865332 35888899999999999999999999 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCC
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPIC 549 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~ 549 (646)
|+||++++++.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 149 ~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 149 GQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 9999999999999999999876532211 122346889999999875 3467889999999999999999999986
Q ss_pred CCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 550 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ . ...............+..+.+++.+||+.||.+||++.||+++
T Consensus 228 ~~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 228 DMHPMRAL------F---------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccCHHhhh------h---------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 43321110 0 0000000111122345679999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=304.79 Aligned_cols=253 Identities=25% Similarity=0.497 Sum_probs=202.7
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
+|+..+.||+|++|.||+|.. .+++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999984 568899999876422 2235678899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF- 484 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~- 484 (646)
||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 81 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----------------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred EEeccCCCcHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 99999999999998642 36889999999999999999999999 99999999999998775
Q ss_pred cEEEeecCCccccCCCCC---ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
.+||+|||++........ .......++..|+|||.+.+..++.++||||+|++++||++|+.|+........ ..
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~ 218 (268)
T cd06630 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LA 218 (268)
T ss_pred EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HH
Confidence 699999999887643211 112234688999999999888899999999999999999999999854322111 00
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. .+..........+......+.+++.+||+.+|.+||++.|++.+
T Consensus 219 ~~---------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 219 LI---------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HH---------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00 01111111233455566788999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.24 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=198.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+.|...+.||+|+||.||+|... +|+.||+|++... .....+++.+|+++++.++|||++++.+++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999964 6889999987532 2344567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+|
T Consensus 95 e~~~-g~l~~~~~~~---------------~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 95 EYCL-GSASDILEVH---------------KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred HhhC-CCHHHHHHHc---------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEE
Confidence 9995 6777766433 236899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||++...... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+........ ..
T Consensus 156 L~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~ 224 (307)
T cd06607 156 LADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY 224 (307)
T ss_pred EeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH
Confidence 9999998765322 2245788999999874 45688999999999999999999999864332211 00
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... ......+......+.+++.+||+.||++||++.+|+.+..
T Consensus 225 ~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 225 HIAQN---------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHhcC---------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000 0001112334567899999999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.24 Aligned_cols=241 Identities=26% Similarity=0.359 Sum_probs=187.4
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc---CccCceeEEEEEEeCCceEEEEEeccC
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI---NHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
||+|+||+||+|... +++.||||++... .......+..|..++... +||||+++.+++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 5899999987542 122334456677777665 699999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~l~~~----------------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 81 GELFWHLQKE----------------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred ChHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCC
Confidence 9999888642 36899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
+++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....... +.
T Consensus 142 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~-~~ 213 (330)
T cd05586 142 LSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAF-GK 213 (330)
T ss_pred cCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHc-CC
Confidence 997643222 122345699999999998764 47899999999999999999999986543221 1111110 00
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP----TMKQVSMD 616 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP----s~~evl~~ 616 (646)
..+. .......+.+++.+||+.||.+|| ++.|++++
T Consensus 214 ------~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 214 ------VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ------CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0000 112345678999999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.87 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=197.1
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||+|... +|+.||+|+++... ......+.+|+.++++++|+|++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999964 68899999876422 22234677899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ ++|.+++.... ..+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 81 ~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~ 141 (284)
T cd07839 81 CD-QDLKKYFDSCN---------------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLA 141 (284)
T ss_pred CC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEEC
Confidence 96 67887775432 36899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++........ .....++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ .+ ........
T Consensus 142 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~ 218 (284)
T cd07839 142 DFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLG 218 (284)
T ss_pred ccchhhccCCCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhC
Confidence 99999865332211 2234578899999988764 468999999999999999999998654332211 11 11111111
Q ss_pred hch------hHHHhhhhhc---------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENK------LLEILDARVA---------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~------~~~~~d~~l~---------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ..+..+.... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 0000010000 01112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.09 Aligned_cols=247 Identities=24% Similarity=0.417 Sum_probs=201.1
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
-|+..+.||+|+||.||+|.. .+++.||||..... .....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 356678899999999999985 36889999987543 2344567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.. ..+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~l~~~i~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~d 144 (277)
T cd06641 85 GGGSALDLLEP-----------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLAD 144 (277)
T ss_pred CCCcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEee
Confidence 99999998853 25889999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......++..|+|||.+.+..++.++|||||||++|||++|..|+....... ....
T Consensus 145 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~----- 212 (277)
T cd06641 145 FGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL----- 212 (277)
T ss_pred cccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-----
Confidence 999876543221 1223457889999999988888999999999999999999999985332211 0000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+........+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 -----IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111112233445678899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.84 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=206.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|++|.||+++.. +++.|+||++..... ...+.+.+|+.++++++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999965 489999999876443 4566889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|
T Consensus 81 ~~~~~L~~~l~~~----------------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l 141 (264)
T cd06623 81 MDGGSLADLLKKV----------------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKI 141 (264)
T ss_pred cCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEE
Confidence 9999999998653 368999999999999999999999 88 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......
T Consensus 142 ~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~-- 215 (264)
T cd06623 142 ADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAI-- 215 (264)
T ss_pred ccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHH--
Confidence 999999876433222 1234578899999999998999999999999999999999999864432111 1111111
Q ss_pred hchhHHHhhhhhcccCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ......+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus 216 -------~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 -------CD-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------hc-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 111122333 56789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=296.98 Aligned_cols=248 Identities=31% Similarity=0.474 Sum_probs=204.6
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
+|+..+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999877555566788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+||
T Consensus 81 ~~~L~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 142 (253)
T cd05122 81 GGSLKDLLKSTN---------------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDF 142 (253)
T ss_pred CCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeec
Confidence 999999986532 36899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|.+........ .....++..|++||.+.....+.++||||||++++||++|+.|+......... .....
T Consensus 143 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~--- 211 (253)
T cd05122 143 GLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT--- 211 (253)
T ss_pred ccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh---
Confidence 99987654332 23456889999999999888999999999999999999999998643221110 00000
Q ss_pred hHHHhhhhhcccC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 572 LLEILDARVAKEA--SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 572 ~~~~~d~~l~~~~--~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...... +......+.+++.+||+.||.+|||+.|++++
T Consensus 212 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 -------NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -------cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000111 11125678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.67 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=199.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999964 57899999876532 234557889999999999999999999999988999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 81 e~~~g~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 81 EYVEGGDCATLLKNI----------------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred ecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEE
Confidence 999999999998553 35899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCC--------------CCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 488 VSDFGTSRSVPND--------------KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 488 I~DfGla~~~~~~--------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
|+|||+++..... .........++..|+|||.+....++.++|+||||+++|||++|+.||.....
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998742100 00011124578899999999888899999999999999999999999864332
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.+ ......... ...+ ......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 222 ~~------~~~~~~~~~----~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 222 EE------LFGQVISDD----IEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HH------HHHHHHhcc----cCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 21 111110000 0000 0111345668999999999999999996555555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=309.62 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=204.3
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999984 367899999986554555667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 99 ~~~~L~~~~~~~-----------------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~d 158 (293)
T cd06647 99 AGGSLTDVVTET-----------------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 158 (293)
T ss_pred CCCcHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEcc
Confidence 999999998542 4789999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++........ ......+++.|+|||.+..+.++.++||||||+++||+++|+.||.......... ....
T Consensus 159 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~-- 229 (293)
T cd06647 159 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT-- 229 (293)
T ss_pred Ccceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--
Confidence 999876543222 1223458889999999988889999999999999999999999986443221100 0000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+......+......+.+++.+||+.+|++||++.+++.+
T Consensus 230 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 ------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111223345678899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.24 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=207.1
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
..+++|+..+.||+|++|.||+|... +++.+++|.++.... ..+.+.+|++++++++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999975 588999999876544 4567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 95 e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~ 156 (286)
T cd06614 95 EYMDGGSLTDIITQNF---------------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156 (286)
T ss_pred eccCCCcHHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEE
Confidence 9999999999997642 26999999999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||++........ ......++..|++||.+.+..++.++||||||+++|||++|+.|+......... ....
T Consensus 157 l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~ 229 (286)
T cd06614 157 LADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLIT 229 (286)
T ss_pred ECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH
Confidence 999999876533221 122345788999999998888999999999999999999999998643322110 0000
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. ... .....+...+..+.+++.+||+.+|.+||++.+|+++.-
T Consensus 230 ~-~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 230 T-KGI-------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred h-cCC-------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 0 000 001112224567899999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=304.46 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=202.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+|+..+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++.+..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999975 58899999876542 345567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++++|.+++.... ..+++....+++.|+++||+|||+ .+ ++|+||||+||++++++.+||+
T Consensus 82 ~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 82 DGGSLDKILKEVQ---------------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred CCCcHHHHHHHcc---------------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 9999999986532 368899999999999999999999 87 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||.+........ ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...........
T Consensus 144 d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-- 217 (265)
T cd06605 144 DFGVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-- 217 (265)
T ss_pred ecccchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh--
Confidence 9999876532211 11568889999999998899999999999999999999999986442111 11111111111
Q ss_pred chhHHHhhhhhcccCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ....+.. ....+.+++.+||..||++||++.|++.+
T Consensus 218 -------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 -------NEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -------cCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 110 0111222 55678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=311.60 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=198.5
Q ss_pred CccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 337 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999854 6889999998654444556788999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++.. ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 106 ~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 106 TDIVSQ-----------------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred HHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHh
Confidence 887643 25889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+. ..... ...
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~-~~~---- 233 (297)
T cd06659 166 QISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRLR-DSP---- 233 (297)
T ss_pred hcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHh-ccC----
Confidence 6533221 12335688999999999988899999999999999999999999864432211 11100 000
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.+. ..........+.+++.+||+.+|.+||++.|++++-
T Consensus 234 -~~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 234 -PPK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred -CCC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 000 011122345688999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.36 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=201.3
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
.|...+.||+|++|.||++.. .+++.+++|+++.......+.+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 345567999999999999985 4688999998876555556678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+||
T Consensus 100 ~~~L~~~~~~-----------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~ 159 (285)
T cd06648 100 GGALTDIVTH-----------------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDF 159 (285)
T ss_pred CCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEccc
Confidence 9999998854 25889999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. ......
T Consensus 160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~--- 229 (285)
T cd06648 160 GFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRD--- 229 (285)
T ss_pred ccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHh---
Confidence 99876543222 12234588999999999888899999999999999999999999864332111 111100
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+.. ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 230 ---~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 ---NLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ---cCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000011 1122245679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.58 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=202.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|++|.||++... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999964 5899999987642 2234567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+|
T Consensus 81 e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 81 EYVPGGELFSHLRKS----------------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred ecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEE
Confidence 999999999998653 36899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++..... .....+++.|+|||.+.+...+.++||||||+++|||++|+.||........ ...
T Consensus 142 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-- 209 (290)
T cd05580 142 ITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI------YEK-- 209 (290)
T ss_pred EeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH--
Confidence 9999999876443 2234688999999999888889999999999999999999999864432110 010
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
+... ....+......+.+++.+||+.||.+|| +++|++.+
T Consensus 210 -------~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 -------ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -------HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 1123334457789999999999999999 77777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.55 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=193.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHH-HhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVI-LSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~i-l~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|+||.||++... +|+.||+|+++... ......+..|+.+ ++..+|||++++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999964 68999999876532 2233455566665 666799999999999999899999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|++ |+|.+++...... ...+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+|
T Consensus 81 ~~~-~~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~k 144 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK------------GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVK 144 (283)
T ss_pred hhc-ccHHHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEE
Confidence 995 7888887653220 23689999999999999999999987 6 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
|+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+....... ...
T Consensus 145 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~ 217 (283)
T cd06617 145 LCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQL 217 (283)
T ss_pred Eeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHH
Confidence 99999998653221 1122457889999998865 446889999999999999999999985322110 001
Q ss_pred HHHHhhchhHHHhhhhhcccCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEAS-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ..... .....+ ...+..+.+++.+||+.+|++||++.+++++
T Consensus 218 ~---------~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 218 K---------QVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred H---------HHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11110 001111 2245678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.25 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=201.8
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC-----
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE----- 401 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~----- 401 (646)
.++++|+..+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999964 578999998775443 345788999999999 7999999999997644
Q ss_pred -ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 402 -VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 402 -~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
..++||||+++++|.+++..... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~ 146 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK------------KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh------------cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEE
Confidence 37999999999999999865431 0246899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
++++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||++++||++|+.||.......
T Consensus 147 ~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 225 (275)
T cd06608 147 TKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225 (275)
T ss_pred ccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence 999999999999987653322 12223458899999998753 346789999999999999999999986432211
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ........ .+ ....+......+.+++.+||..||.+|||+.|++++
T Consensus 226 ~------~~~~~~~~------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 A------LFKIPRNP------PP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred H------HHHhhccC------CC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 01111000 00 111223355678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=308.18 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=198.0
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788899999999999999864 68899999876432 22335688999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+. ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+
T Consensus 81 ~~-~~l~~~~~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~ 142 (284)
T cd07860 81 LH-QDLKKFMDASP--------------LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLA 142 (284)
T ss_pred cc-cCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEe
Confidence 95 68888886532 236899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++....... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+ .....+.....
T Consensus 143 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~ 219 (284)
T cd07860 143 DFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGT 219 (284)
T ss_pred eccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 9999886533221 112234688999999887644 5889999999999999999999986543322 11111111100
Q ss_pred hc-h----hHHH----------hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 EN-K----LLEI----------LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~-~----~~~~----------~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. . ...+ ....+ ..........+.+++.+||+.||.+||+++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 220 PDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 0 0000 00000 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.86 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=198.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-----HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-----TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-----~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
+|+..+.||+|++|.||+|... +|+.||||+++.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999964 688999999865332 2334567899999999999999999999998899999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+ +|+|.+++.... ..+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.+
T Consensus 81 ~e~~-~~~L~~~i~~~~---------------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~ 141 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---------------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVL 141 (298)
T ss_pred Eccc-CCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCE
Confidence 9999 999999986532 25899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++........ .....++..|+|||.+.+ ..++.++||||||+++|||++|..++......+. ......
T Consensus 142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~- 217 (298)
T cd07841 142 KLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFE- 217 (298)
T ss_pred EEccceeeeeccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHH-
Confidence 99999999876443221 122346788999998865 4578999999999999999999777754332211 111111
Q ss_pred HHhhc---------hhHHHhhhhhccc-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKEN---------KLLEILDARVAKE-----ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~---------~~~~~~d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... .+........... ........+.+++.+||+.||++|||+.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0000000000001 112335678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=342.24 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=200.0
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--Cce
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 403 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~ 403 (646)
...++|.+.+.||+|+||.||++... .+..||+|.+.. ........+..|+.++++++||||+++++++.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999954 577899998754 3344566789999999999999999999988654 458
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEecCCCCCCEE
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSAS----IPIFHRDIKSSNIL 479 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~----~~ivHrDIk~~NIL 479 (646)
+|||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+.+. .+|+||||||+|||
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~------------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM------------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 9999999999999999764220 2469999999999999999999998542 23999999999999
Q ss_pred ECC-----------------CCcEEEeecCCccccCCCCCccccccccCCcccChhcccc--CCCCCccchhhHHHHHHH
Q 046188 480 LDD-----------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLE 540 (646)
Q Consensus 480 l~~-----------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~E 540 (646)
|+. .+.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+|||
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 964 3359999999998753322 2234569999999999854 458899999999999999
Q ss_pred HHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 541 LLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 541 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
|++|+.||....... ..+..+... +.+ . ....+..+.+|+..||+.+|.+||++.|++.+
T Consensus 236 LLTGk~PF~~~~~~~-----qli~~lk~~--------p~l--p-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 236 LCSGKTPFHKANNFS-----QLISELKRG--------PDL--P-IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHCCCCCCcCCcHH-----HHHHHHhcC--------CCC--C-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 999999986432211 111111000 000 0 11234678999999999999999999999854
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.11 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=199.8
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.|+..+.||+|+||.||+|+. .++..||+|++... .......+.+|+.++++++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366788899999999999995 36889999987532 23345578899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+. |+|.+++... ..+++|.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||
T Consensus 106 ~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl 166 (317)
T cd06635 106 YCL-GSASDLLEVH---------------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKL 166 (317)
T ss_pred CCC-CCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEE
Confidence 995 6787776543 236899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+|||++...... ....++..|+|||++. .+.++.++|||||||++|||++|+.|+........ ...
T Consensus 167 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~ 235 (317)
T cd06635 167 ADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH 235 (317)
T ss_pred ecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHH
Confidence 999998754322 2245788999999873 46789999999999999999999999864322111 011
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+................+.+++.+||+.+|.+||++.+|++++..+..
T Consensus 236 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 236 ---------IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ---------HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 111111111122345678999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=290.46 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=206.7
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--------CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--------IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 399 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--------~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~ 399 (646)
....|...+.||.|..++|-+...+ +|...|+|++.. ....-.+.-.+|+.||+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3467888899999999999888754 578889987532 1122345567899999998 69999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
+.-.++|+|.|+.|.|.|+|... -.++++...+|+.|+.+|++|||..+ ||||||||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~----------------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENIL 155 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK----------------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENIL 155 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh----------------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhhee
Confidence 99999999999999999999763 36999999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
+|++.++||+|||++..+..+.. -+..+|||+|+|||.+.- ..|+..+|.||.||+||-|+.|.+||+...
T Consensus 156 lddn~~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk- 232 (411)
T KOG0599|consen 156 LDDNMNIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK- 232 (411)
T ss_pred eccccceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-
Confidence 99999999999999998865443 456789999999998853 457889999999999999999999986321
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
++. . ++-++..... .+.-.+.+....+|+.+||+.||.+|.|++|.+.+---
T Consensus 233 ----Qml--M--------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 233 ----QML--M--------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred ----HHH--H--------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 000 0 1223333222 22234666788999999999999999999999987543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.58 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=199.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV 406 (646)
++|+..+.||+|++|.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++.+++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999965 588999998864322 2233567899999999999999999999877 789999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||++ ++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 ~e~~~-~~L~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~ 145 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---------------QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGIL 145 (293)
T ss_pred ehhcC-cCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcE
Confidence 99996 58988886532 25899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++........ .....+++.|+|||.+.+. ..+.++|+||||+++|||++|+.||.......... ....
T Consensus 146 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~---~~~~ 221 (293)
T cd07843 146 KICDFGLAREYGSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN---KIFK 221 (293)
T ss_pred EEeecCceeeccCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHH
Confidence 99999999876443211 1234578899999988764 46889999999999999999999987543322110 0000
Q ss_pred HHhh-----------------chhHHHhhhhhcccCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKE-----------------NKLLEILDARVAKEASEE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~-----------------~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ..........+...++.. ....+.+++.+||+.||++|||+.|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000001111111222222 46778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.08 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=206.6
Q ss_pred cccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCchh
Q 046188 339 FLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSH 417 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 417 (646)
+||+|+||+||.|+..+ ...+|||.+...+....+-+.+||.+-++++|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 56799999888777777888999999999999999999999998888889999999999999
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-CCCcEEEeecCCc
Q 046188 418 HIHDHQQQQEQKQELEEEQELSSL--SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTS 494 (646)
Q Consensus 418 ~l~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kI~DfGla 494 (646)
.|+..= .+| ++...-.+..||++||.|||++. |||||||-+||||+ -.|.+||+|||-+
T Consensus 662 LLrskW---------------GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 662 LLRSKW---------------GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred HHHhcc---------------CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccc
Confidence 997642 355 66777888999999999999999 99999999999996 5789999999999
Q ss_pred cccCCCCCccccccccCCcccChhccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+.+. +-+..+.++.||..|||||++..|+ |+.++|||||||.+.||.||++||....... ..++
T Consensus 724 KRLA-ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMF----- 789 (1226)
T KOG4279|consen 724 KRLA-GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMF----- 789 (1226)
T ss_pred hhhc-cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhh-----
Confidence 8763 3445566788999999999998864 7889999999999999999999996432211 1111
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
++---+...+.|.+.+.....++.+|+..||.+||++.++++.-
T Consensus 790 -kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 790 -KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred -hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 11112234567888889999999999999999999999998753
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.46 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=199.3
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcC---ccCceeEEEEEEeCCceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~---H~niv~l~g~~~~~~~~~LV~ 407 (646)
.|+..+.||+|+||.||+|.. .+++.||+|.++.. .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 46889999987643 3445567889999999997 999999999999988999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++.. ..+++...+.++.|+++||.|||+.+ ++|+||+|+||++++++.++
T Consensus 82 e~~~~~~L~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~ 141 (277)
T cd06917 82 EYAEGGSVRTLMKA-----------------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVK 141 (277)
T ss_pred ecCCCCcHHHHHHc-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEE
Confidence 99999999988753 25899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++......... .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||........ ...
T Consensus 142 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~- 213 (277)
T cd06917 142 LCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML- 213 (277)
T ss_pred EccCCceeecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-
Confidence 9999999876433321 2234688999999988754 468899999999999999999999864322111 000
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... ..+.+.. ......+.+++.+||+.||++||++.|++.+-
T Consensus 214 ~~~~-----~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 214 IPKS-----KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred cccC-----CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 0000 0011111 11446789999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.54 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=196.8
Q ss_pred HhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++++|...+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|+.+++.++|+||+++.+++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999985 3688999998764322 22335678999999999999999999999888999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+. ++|.+++.... ..+++.++..++.|+++||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 83 e~~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 143 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---------------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELK 143 (291)
T ss_pred eccc-CCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEE
Confidence 9995 77777765432 25788899999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.......+ .+.. ....
T Consensus 144 l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~ 220 (291)
T cd07870 144 LADFGLARAKSIPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTV 220 (291)
T ss_pred EeccccccccCCCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHH
Confidence 9999999864322111 1223478899999998754 478899999999999999999999875433211 1111 1110
Q ss_pred Hhhc---------hhHHHhhhhhcccC---------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKEN---------KLLEILDARVAKEA---------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~---------~~~~~~d~~l~~~~---------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... .+............ .......+.+++.+|++.||.+|||+.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000 00000000000000 00124567899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.34 Aligned_cols=251 Identities=30% Similarity=0.402 Sum_probs=211.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~L 405 (646)
...|...+.||+|.||.||+++.+ +|+.+|+|.+.... ....+.+.+|+.+|+++. |||||.+.+.+++.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457888899999999999999965 49999999875422 234568889999999998 9999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC--
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-- 483 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-- 483 (646)
|||++.+|.|.+.+... .+++.....++.|+++++.|||+.+ ++||||||+|+|+...
T Consensus 114 vmEL~~GGeLfd~i~~~-----------------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----------------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDE 173 (382)
T ss_pred EEEecCCchHHHHHHHc-----------------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccC
Confidence 99999999999998652 2888999999999999999999999 9999999999999543
Q ss_pred --CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 --FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 --~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+|++|||++..... .......+||+.|+|||.+....++.++||||.||++|.|++|..||.........
T Consensus 174 ~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~---- 247 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF---- 247 (382)
T ss_pred CCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH----
Confidence 5799999999998755 34455678999999999999999999999999999999999999999865543321
Q ss_pred HHHHHHhhchhHHHhhh--hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDA--RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~--~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. .+... ....+.-+..+..+.+++..|+..||.+|+|+.+++++-.
T Consensus 248 --~---------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 248 --L---------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred --H---------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1 11111 2233344566788999999999999999999999999743
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.81 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=196.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 688999998764321 1223567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ ++|.+++.... ..+++.....++.|+++||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~-~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 85 LD-TDLKQYMDDCG---------------GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred CC-CCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEEC
Confidence 97 58988886532 26889999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++........ .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ . .........
T Consensus 146 dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~-~~~~~~~~~ 222 (291)
T cd07844 146 DFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-Q-LHKIFRVLG 222 (291)
T ss_pred ccccccccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-H-HHHHHHhcC
Confidence 99998754322111 122346789999998865 4578999999999999999999999864431111 0 111111111
Q ss_pred h---chhHHHh--------------hhhhcccC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 E---NKLLEIL--------------DARVAKEA-SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~---~~~~~~~--------------d~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ....... ...+.... .......+.+++.+||+.||++||++.|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 223 TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred CCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000000 00000000 01112567899999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.79 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=207.6
Q ss_pred CCCcCccccccCcEEEEEEEcCC-CCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.|+..+.||+|.-|+||++.+++ +...|+|++... ......+...|-+||+.++||.++.|++.+..++..+||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45557889999999999999764 589999998653 23345567789999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
||+||+|...++++.. ..++...+..+|.+++-||+|||-.| ||.|||||+||||-++|.+.|
T Consensus 158 yCpGGdL~~LrqkQp~--------------~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG--------------KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred cCCCccHHHHHhhCCC--------------CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEe
Confidence 9999999998877543 57999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCC---------------------------------CCC----------------------ccccccccCCc
Q 046188 489 SDFGTSRSVPN---------------------------------DKT----------------------HLTTAVQGTFG 513 (646)
Q Consensus 489 ~DfGla~~~~~---------------------------------~~~----------------------~~~~~~~gt~~ 513 (646)
+||.|+..... ... ..+...+||..
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998754310 000 11223579999
Q ss_pred ccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHH
Q 046188 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVA 593 (646)
Q Consensus 514 y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 593 (646)
|+|||++.+...+.++|.|+|||+||||+.|+.||-+.... ..+..++...+........+..+.
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~ak 365 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAK 365 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHH
Confidence 99999999999999999999999999999999999754432 223444444444333446678899
Q ss_pred HHHHhccccCCCCCCC----HHHHHHH
Q 046188 594 ELAMGCLRLNSKKRPT----MKQVSMD 616 (646)
Q Consensus 594 ~Li~~Cl~~dP~~RPs----~~evl~~ 616 (646)
+||++.|.+||.+|.- +.||-++
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcC
Confidence 9999999999999998 7777654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.08 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=206.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecc--cCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK--AIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~--~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..|++.++||+||.+.||++...+.+.+|+|++. ..+.....-|.+|++.|.++ .|.+||+|++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4688889999999999999998888899999754 45677788899999999999 49999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|- +.+|..+|..... ....| .+..+..|++.|+.++|+++ |||.||||.|+|+-. |.+||
T Consensus 441 ~G-d~DL~kiL~k~~~--------------~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKL 500 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS--------------IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKL 500 (677)
T ss_pred cc-cccHHHHHHhccC--------------CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEe
Confidence 85 7799999977543 23345 78889999999999999999 999999999999976 48999
Q ss_pred eecCCccccCCCCCc-cccccccCCcccChhccccC-----------CCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 489 SDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSS-----------QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 489 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
+|||+|..+..+... .....+||..||+||.+... +++.++||||+||+||+|+.|+.||..-
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----- 575 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----- 575 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----
Confidence 999999988655443 34457899999999988543 2567999999999999999999997411
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHH-HHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDI-EAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~-~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+ .-.++..++||.-..+||..-. .++.++|+.||+.||++||++.|++++
T Consensus 576 ~n---------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 IN---------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HH---------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11 1134667778766555543222 238999999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.18 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=198.9
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEEEE
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVYE 408 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV~E 408 (646)
|+..+.||+|++|.||+|... +|+.+|+|++... .....+.+.+|+.++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999965 5789999998764 233455788999999999999999999999987 78999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++ ++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||
T Consensus 81 ~~~-~~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l 141 (287)
T cd07840 81 YMD-HDLTGLLDSPE---------------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKL 141 (287)
T ss_pred ccc-ccHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEE
Confidence 996 58888875431 36899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... ......
T Consensus 142 ~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~ 218 (287)
T cd07840 142 ADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELC 218 (287)
T ss_pred ccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHh
Confidence 9999998765433222233456788999997764 457899999999999999999999986544322111 111110
Q ss_pred hh---chhHH--------------HhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KE---NKLLE--------------ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~---~~~~~--------------~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ..... .....+...+...++..+.+++.+||+.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00000 000000011111135678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=297.96 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=205.5
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||++... +++.+++|.+... ......++.+|++++++++|+||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 6789999987642 344556788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+
T Consensus 81 ~~~~~L~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~ 145 (256)
T cd08530 81 APFGDLSKAISKRKKK------------RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIG 145 (256)
T ss_pred cCCCCHHHHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEe
Confidence 9999999998663221 246899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||+++..... ......+++.|++||.+.+..++.++|+||||+++|||++|+.|+......+. ...
T Consensus 146 d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~--- 212 (256)
T cd08530 146 DLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-------RYK--- 212 (256)
T ss_pred eccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH---
Confidence 99999876443 22234578899999999998899999999999999999999999865432211 000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.........+......+.+++.+||+.+|++||++.|++++
T Consensus 213 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 213 ------VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------HhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111122334556779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.21 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=200.7
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|+||.||+|..+ +|..+|+|..... .....+.+.+|+.++++++|+|++++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 5789999987542 123445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-cEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI 488 (646)
+++++|.+++.... ...++|..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||
T Consensus 81 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l 143 (257)
T cd08225 81 CDGGDLMKRINRQR--------------GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKL 143 (257)
T ss_pred CCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEe
Confidence 99999999986532 235899999999999999999999998 99999999999999885 5699
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||.+........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ......
T Consensus 144 ~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~- 215 (257)
T cd08225 144 GDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC- 215 (257)
T ss_pred cccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-
Confidence 99999987643221 2223458899999999988889999999999999999999999986432211 111111
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ...+......+.+++.+||+.+|++|||+.|++.+
T Consensus 216 --------~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 216 --------QGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --------cccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111 11223344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=301.53 Aligned_cols=262 Identities=27% Similarity=0.322 Sum_probs=202.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC--ceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--~~~LV~ 407 (646)
++|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.. ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999964 57899999876432 234567899999999999999999999987543 679999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++..... ....+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++
T Consensus 81 e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~ 145 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK------------RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVK 145 (287)
T ss_pred EecCCCCHHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEE
Confidence 99999999998764322 1346899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||++........ ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .......... .
T Consensus 146 l~dfg~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~ 220 (287)
T cd06621 146 LCDFGVSGELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSY-I 220 (287)
T ss_pred Eeecccccccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHH-H
Confidence 999999876532211 2345788999999999889999999999999999999999998654220 0011111111 1
Q ss_pred hhchhHHHhhhhhcccC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEA--SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~--~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... +.+.... .......+.+++.+||+.+|.+|||+.||+++-.
T Consensus 221 ~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 221 VNMPN-----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred hcCCc-----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 11000 1111111 1223567899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.38 Aligned_cols=263 Identities=23% Similarity=0.352 Sum_probs=199.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+|+..+.||+|++|.||+|+.. +|+.||||+++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999964 58899999876532 223456778999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
+ |+|.+++..... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 81 ~-~~l~~~~~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d 143 (284)
T cd07836 81 D-KDLKKYMDTHGV-------------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLAD 143 (284)
T ss_pred C-ccHHHHHHhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEee
Confidence 7 588888765432 236899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh-
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK- 568 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~- 568 (646)
||+++....... ......++..|++||.+.+. .++.++||||||+++|||++|+.||......+... . ......
T Consensus 144 ~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~-~~~~~~~ 219 (284)
T cd07836 144 FGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL--K-IFRIMGT 219 (284)
T ss_pred cchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--H-HHHHhCC
Confidence 999986533221 11223578899999988654 56889999999999999999999986544322111 1 111100
Q ss_pred --hchhHHHhh-hhhc-----------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 --ENKLLEILD-ARVA-----------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 --~~~~~~~~d-~~l~-----------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+..+..+.+ +.+. .......+..+.+++.+||+.||.+||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 0000 01112335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.84 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=196.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCc-----
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV----- 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~----- 402 (646)
++|+..+.||+|+||.||+|... +|+.||||+.+... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999954 68999999865432 122356788999999995 6999999999987665
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++ +|.+++...... ....+++..++.++.||++||+|||+.+ ++||||||+||+++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~ 145 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-----------PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDK 145 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEec
Confidence 7999999974 898888654220 0236899999999999999999999998 999999999999998
Q ss_pred -CCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 483 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 483 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+++........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+. ..
T Consensus 146 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~ 222 (295)
T cd07837 146 QKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LL 222 (295)
T ss_pred CCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH
Confidence 899999999999865322111 122346788999998865 4578999999999999999999999865433221 11
Q ss_pred HHHHHHHhhchh---------HHHhh-h----hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 561 AYFISLAKENKL---------LEILD-A----RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~~~~~---------~~~~d-~----~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+. ....... ..... + .............+.+++.+||+.||.+||++.|++.+
T Consensus 223 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 223 HIFK-LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHH-HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1111 1000000 00000 0 00000112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=295.24 Aligned_cols=251 Identities=29% Similarity=0.485 Sum_probs=206.6
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 407 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV~ 407 (646)
+|+..+.||+|++|.||+|... +++.|++|...... ....+.+.+|++++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999975 68899999876543 34567889999999999999999999999988 7899999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++... ..++|..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+|
T Consensus 81 e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~ 141 (260)
T cd06606 81 EYVSGGSLSSLLKKF----------------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVK 141 (260)
T ss_pred EecCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEE
Confidence 999999999998653 26899999999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||.+......... ......++..|+|||.+.....+.++||||||++++||++|+.|+...... .....
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~-- 214 (260)
T cd06606 142 LADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALY-- 214 (260)
T ss_pred EcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHH--
Confidence 9999999876443221 123346889999999998888999999999999999999999998654311 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...........+......+.+++.+|++.||++||++.|++.+
T Consensus 215 -------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 215 -------KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -------hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111112223444556789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.33 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=208.6
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
-|+++.+||+|+||+|||+..+ .|+.||||++.. ..+.+++.+|+.||++...|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4566789999999999999965 599999999876 4567899999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
-|+..+.++..+ .+|++.++..++.+.++||+|||... -+|||||+.||||+-+|.+||+||
T Consensus 112 AGSiSDI~R~R~---------------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADF 173 (502)
T KOG0574|consen 112 AGSISDIMRARR---------------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADF 173 (502)
T ss_pred CCcHHHHHHHhc---------------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhc
Confidence 999999997653 48999999999999999999999988 789999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|.|-.+.+ .-.....+.||+.|||||++..-.|..++||||+|+...||.-|++|+....+.. .
T Consensus 174 GVAGQLTD-TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------A------ 237 (502)
T KOG0574|consen 174 GVAGQLTD-TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------A------ 237 (502)
T ss_pred cccchhhh-hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------e------
Confidence 99976532 2223345789999999999999999999999999999999999999986432210 0
Q ss_pred hHHHhhh---hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 572 LLEILDA---RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 572 ~~~~~d~---~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
-++-| ......|...+..+.+++++||-+.|++|-|+.+++++
T Consensus 238 --IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 --IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 01111 11122456677889999999999999999999998876
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=297.40 Aligned_cols=242 Identities=29% Similarity=0.374 Sum_probs=197.1
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|++|.||+++.. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 48899999875422 23446788999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 81 WTILRDR----------------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred HHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 9999663 25889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
...... ......++..|++||.+....++.++|+||||+++|||++|+.|+....... .... ..+
T Consensus 142 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~---------~~~ 206 (262)
T cd05572 142 KLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY---------NDI 206 (262)
T ss_pred ccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH---------HHH
Confidence 764432 1223467889999999988889999999999999999999999986543211 1111 111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSM 615 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~ 615 (646)
.+......++......+.+++.+||+.||++||+ ++|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 207 LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111122344444678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.50 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=197.5
Q ss_pred CCCcCccccccCcEEEEEEEcC---CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP---DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPV 404 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~ 404 (646)
+|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999964 47899999887632 33345678899999999999999999999987 7789
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-- 482 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 482 (646)
+||||++ ++|.+++...... ....+++...+.|+.|++.||.|||+.+ ++||||||+||++++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~ 145 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQA-----------KRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEG 145 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccC-----------CCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCC
Confidence 9999996 4677766543220 0136889999999999999999999999 999999999999999
Q ss_pred --CCcEEEeecCCccccCCCCC--ccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHh-
Q 046188 483 --KFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE- 556 (646)
Q Consensus 483 --~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~- 556 (646)
++.+||+|||+++....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||........
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 225 (316)
T cd07842 146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225 (316)
T ss_pred CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence 99999999999987643222 112234678899999987664 578999999999999999999999865433220
Q ss_pred ------hcHHHHHHHHHhhc------------hhHHHhhhhhcccCC---------H--HHHHHHHHHHHhccccCCCCC
Q 046188 557 ------RNLVAYFISLAKEN------------KLLEILDARVAKEAS---------E--EDIEAVAELAMGCLRLNSKKR 607 (646)
Q Consensus 557 ------~~l~~~~~~~~~~~------------~~~~~~d~~l~~~~~---------~--~~~~~l~~Li~~Cl~~dP~~R 607 (646)
..+...+ ..+... ......+......++ . .....+.+++.+||+.||++|
T Consensus 226 ~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 304 (316)
T cd07842 226 SNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304 (316)
T ss_pred cchhHHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence 0011111 111000 000000000001111 0 334578899999999999999
Q ss_pred CCHHHHHHH
Q 046188 608 PTMKQVSMD 616 (646)
Q Consensus 608 Ps~~evl~~ 616 (646)
||+.|++++
T Consensus 305 ps~~eil~~ 313 (316)
T cd07842 305 ITAEEALEH 313 (316)
T ss_pred cCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.84 Aligned_cols=265 Identities=28% Similarity=0.370 Sum_probs=198.4
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC----
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETE---- 401 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~---- 401 (646)
...++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999965 58899999886432 223346778999999999999999999987654
Q ss_pred ------ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 046188 402 ------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475 (646)
Q Consensus 402 ------~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~ 475 (646)
..++|+||+++ +|..++... ...+++.+++.++.|++.||+|||+.+ |+||||||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p 144 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---------------LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKC 144 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 68999999975 666666543 236899999999999999999999998 99999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 476 SNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 476 ~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 145 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999998764333222222346788999998765 45789999999999999999999998654322
Q ss_pred HhhcHHHHHHHHHhhc---hhHHHhhh--------------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 555 EERNLVAYFISLAKEN---KLLEILDA--------------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~---~~~~~~d~--------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+. ...+....... ....+... ..... ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 AQ---LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HH---HHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21 11111111110 00000000 00000 11235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=317.62 Aligned_cols=244 Identities=25% Similarity=0.438 Sum_probs=196.1
Q ss_pred CccccccCcEEEEEEEcC-CCCEEEEEeccc----CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc--eEEEEEe
Q 046188 337 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA----IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV--PVLVYEY 409 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~----~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~--~~LV~Ey 409 (646)
..+||+|+|-+||||... +|-.||--.++. ......++|..|+.+|+.|+|+||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999964 477777543322 235567899999999999999999999999988765 6789999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kI 488 (646)
+..|+|..|+.+.+ .++.+....|+.||++||.|||++. |||+|||||.+||||+. .|.+||
T Consensus 125 ~TSGtLr~Y~kk~~----------------~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR----------------RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred ccCCcHHHHHHHhc----------------cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceee
Confidence 99999999998754 5888999999999999999999987 78999999999999986 489999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|+|||....... ...+.|||.|||||... ..|.+.+||||||+.|+||+|+..|+. +-.+..+.++.+..
T Consensus 188 GDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 188 GDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTS 258 (632)
T ss_pred cchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHc
Confidence 9999999864332 23478999999999887 789999999999999999999999974 33343333333322
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ....- +..-....+.++|.+||.. ..+|||+.|++.+
T Consensus 259 G-iKP~s--------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 259 G-IKPAA--------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred C-CCHHH--------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 11111 1111134678999999999 9999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=290.58 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=202.4
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+++|+..+.||+|.|+.||+... .+|+.+|+|.+.. ......+++.+|+.|-+.++||||++|.+...++...|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45777788999999999999874 4688888886432 23346778889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC---CC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KF 484 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~ 484 (646)
|+|.||+|..-+-... ..++...-..+.||+++|.|+|.++ |||||+||.|+||-+ .-
T Consensus 90 e~m~G~dl~~eIV~R~----------------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE----------------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred ecccchHHHHHHHHHH----------------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCC
Confidence 9999999977665431 3567778889999999999999999 999999999999953 34
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
-+||+|||+|..+. .........|||+|||||++...+++..+|||+-||+||-|+.|..||...+... + +.
T Consensus 151 ~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l---ye 222 (355)
T KOG0033|consen 151 AVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YE 222 (355)
T ss_pred ceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H---HH
Confidence 69999999999886 2333445679999999999999999999999999999999999999998532211 1 11
Q ss_pred HHHhhchhHHHhhhhh--cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARV--AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+++.... ...+-+...+...+|+.+||..||.+|.|+.|.+.+-.
T Consensus 223 ---------~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 223 ---------QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ---------HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 1111111 11223455677899999999999999999999886644
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.90 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=200.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc-----CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--Cce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA-----IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~-----~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~ 403 (646)
.+|+..+.||+|+||.||+|... +++.||+|.+.. ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999954 588999998642 1234456788999999999999999999998764 357
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++|+||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~ 142 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----------------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSA 142 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC
Confidence 8999999999999988642 35889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCC--CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDK--THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.++|+|||+++...... ........++..|+|||.+.+...+.++|+||||+++|||++|+.||........
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 217 (264)
T cd06653 143 GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----- 217 (264)
T ss_pred CCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----
Confidence 999999999998653211 1111234688999999999988889999999999999999999999864321110
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+..........+......+.+++.+||+ +|.+||+..+++.+
T Consensus 218 ----------~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 218 ----------IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----------HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111112233456667889999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.09 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=199.5
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~ 403 (646)
.++|...+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 46899999998643 2334556888999999999999999999876543 47
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++|+||++ ++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----------------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~ 142 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----------------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTN 142 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCC
Confidence 99999995 477666533 36899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc--cccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+.+||+|||+++........ ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 143 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~ 219 (336)
T cd07849 143 CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---L 219 (336)
T ss_pred CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 99999999999875332211 1123468899999998654 5688999999999999999999999865432211 1
Q ss_pred HHHHHHHhh---chhHHHhhhhh---------cccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHH
Q 046188 561 AYFISLAKE---NKLLEILDARV---------AKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 621 (646)
Q Consensus 561 ~~~~~~~~~---~~~~~~~d~~l---------~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~ 621 (646)
..+...... +....+.+... .... ....+..+.+++.+||+.||.+||++.|++++ ++...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 220 NLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 111111111 01111111000 0000 01234668899999999999999999999998 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.76 Aligned_cols=265 Identities=26% Similarity=0.316 Sum_probs=198.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~L 405 (646)
.++|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999964 589999998764321 1223456899999999999999999998765 45799
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||++ ++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~-~~l~~~l~~~~---------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 146 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---------------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGC 146 (309)
T ss_pred EEecCC-CCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 999995 58888876532 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+.
T Consensus 147 ~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~ 222 (309)
T cd07845 147 LKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLII 222 (309)
T ss_pred EEECccceeeecCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 999999999876433211 122345788999998865 45789999999999999999999998754433211 1111
Q ss_pred HHHhhc---hhHHHhhhh------hcc-cC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKEN---KLLEILDAR------VAK-EA------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~---~~~~~~d~~------l~~-~~------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...... ....+.+.. +.. .. .......+.+++.+||+.||++|||+.|++.+-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 111100 000000000 000 00 0113566789999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.85 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=197.5
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
|+..+.||+|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999954 68999999876432 223356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
+++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|
T Consensus 81 -~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 142 (283)
T cd07835 81 -DLDLKKYMDSSPL--------------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLAD 142 (283)
T ss_pred -CcCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEee
Confidence 5789988865421 26899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++........ .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ....+......
T Consensus 143 f~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 219 (283)
T cd07835 143 FGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTP 219 (283)
T ss_pred cccccccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence 9999765322111 1223468899999987664 568899999999999999999999865433221 11111110000
Q ss_pred c--------hhHHHhhhh------hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 N--------KLLEILDAR------VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~--------~~~~~~d~~------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. .+.+..... .........+..+.+++.+||+.||.+||+++|++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000 0001112334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=299.49 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=193.7
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeC--CceEEEEE
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLVYE 408 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~--~~~~LV~E 408 (646)
|+..+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999954 68899999876532 222234557888999885 99999999999987 78999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++ |+|.+++.... ..++|.+++.++.|++.||+|||+.+ ++||||+|+||+++. +.+||
T Consensus 81 ~~~-~~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl 140 (282)
T cd07831 81 LMD-MNLYELIKGRK---------------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKL 140 (282)
T ss_pred cCC-ccHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEE
Confidence 996 68888775532 36899999999999999999999998 999999999999999 99999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++....... .....++..|+|||.+.. +.++.++|||||||++|||++|+.||......+. ........
T Consensus 141 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~ 215 (282)
T cd07831 141 ADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVL 215 (282)
T ss_pred EecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHc
Confidence 99999987643222 122457889999997644 5578899999999999999999999965443221 11111111
Q ss_pred hhc--hhHHHhhhhhc-------------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KEN--KLLEILDARVA-------------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~--~~~~~~d~~l~-------------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... .+.+....... .......+..+.+++.+||+.||++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 216 GTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 100 00000000000 00012346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.52 Aligned_cols=252 Identities=30% Similarity=0.432 Sum_probs=206.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999964 5889999997653 235566788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++..... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~ 145 (258)
T cd08215 81 ADGGDLSQKIKKQKK------------EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLG 145 (258)
T ss_pred cCCCcHHHHHHHhhc------------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEEC
Confidence 999999999876431 0247999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++....... .......+++.|+|||.+....++.++||||||+++++|++|+.|+....... ......
T Consensus 146 d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-- 216 (258)
T cd08215 146 DFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-- 216 (258)
T ss_pred CccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh--
Confidence 999998764432 22233468889999999988889999999999999999999999986433211 111111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ......+......+.+++.+||..+|++||++.|++++
T Consensus 217 -------~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 217 -------K-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------c-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 01122333455778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=302.81 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=194.7
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|...+.||+|+||.||++... +++.||+|++... .......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999954 5889999987643 2344567889999999996 99999999999988899999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+. ++|.++...... .....+++.....++.|+++||+|||+. + ++||||||+||++++++.+||
T Consensus 85 ~~-~~l~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 85 MD-ISLDKFYKYVYE-----------VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred cc-CCHHHHHHHHHH-----------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEE
Confidence 85 455544322110 0124689999999999999999999975 6 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+|||+++....... .....|+..|+|||.+... .++.++||||||+++|||++|+.||..... .......
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~ 222 (288)
T cd06616 150 CDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQ 222 (288)
T ss_pred eecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhh
Confidence 99999976533221 1223578899999998776 689999999999999999999999853321 1111111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ..+.+....+...+..+.+|+.+||+.||.+||+++||+.+
T Consensus 223 ~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 VVKG------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hcCC------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 01111122223456779999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.32 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=202.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
+|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5778899999999999999965 5889999987642 22456788999999999999999999999999899999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.+++... .++++..+..|+.|+++||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 81 ~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 81 LLLGGDLRYHLSQK----------------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred CCCCCCHHHHHHhc----------------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEE
Confidence 99999999998653 26889999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++....... ......|+..|+|||.+....++.++|+||||+++|+|++|+.|+........ ..+.....
T Consensus 142 ~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~ 215 (258)
T cd05578 142 TDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQE 215 (258)
T ss_pred eecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhc
Confidence 9999998764332 22334588899999999888899999999999999999999999875442211 11111110
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM--KQVS 614 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~--~evl 614 (646)
. .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 216 ~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 T----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 1122344455788999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.81 Aligned_cols=270 Identities=27% Similarity=0.373 Sum_probs=200.7
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC--ce
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE--VP 403 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~--~~ 403 (646)
..++|+..+.||+|+||.||+|... +|+.+|||++.. ........+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999965 578999998753 2233455677899999999 9999999999986543 57
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||++ ++|.+++... .++|..++.++.|++.||+|||+.+ |+||||||+||+++++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~ 143 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----------------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSD 143 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC
Confidence 99999996 6888777542 5789999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCC----ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 484 FSAKVSDFGTSRSVPNDKT----HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
+.+||+|||+++....... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||......+...
T Consensus 144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999987643322 12233568999999998755 457889999999999999999999986544322111
Q ss_pred HHHHHH--------HHHhhchhHHHhhhhhc------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHH
Q 046188 559 LVAYFI--------SLAKENKLLEILDARVA------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGL 620 (646)
Q Consensus 559 l~~~~~--------~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i 620 (646)
...... ..........+++.... .......+..+.+++.+||+.||++|||+.+++++ +++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000 00000000111110000 00111245678999999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.77 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=203.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..+.||+|++|.||++... +++.|++|....... ...+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999854 578999999876443 4567899999999999999999999999998899999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+
T Consensus 81 ~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~ 141 (254)
T cd06627 81 AENGSLRQIIKKF----------------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLA 141 (254)
T ss_pred CCCCcHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEe
Confidence 9999999998653 36899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++......... .....++..|+|||.......+.++||||||+++|||++|+.|+........ .....
T Consensus 142 d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~-- 212 (254)
T cd06627 142 DFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIV-- 212 (254)
T ss_pred ccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh--
Confidence 99999876443321 2234578899999999888889999999999999999999999864321110 00000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
.......+......+.+++.+||+.+|++||++.|++.
T Consensus 213 --------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 213 --------QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --------ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01111233444577899999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.07 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=188.1
Q ss_pred cccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHh---hcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 339 FLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILS---QINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~---~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++ ..+|+|++.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999875421 112223444544433 3479999999999998889999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++... ..++|.....|+.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 81 ~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 81 GGDLHYHLSQH----------------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred CCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccC
Confidence 99999888643 36999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|++........ ....|+..|+|||.+.. ..++.++|||||||+++||++|..||.......... ....
T Consensus 142 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~---- 210 (279)
T cd05633 142 GLACDFSKKKP---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRM---- 210 (279)
T ss_pred CcceeccccCc---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHH----
Confidence 99976533221 22458999999998864 457899999999999999999999986433211110 1100
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
........+...+..+.+++.+||+.||.+|| +++|++++
T Consensus 211 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 ------TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00111223445567889999999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.61 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=197.8
Q ss_pred CccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 337 SRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
..+||+|+||.||++.. .+|+.||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 46899999987655555566788999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++.. ..+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.
T Consensus 105 ~~~~~~-----------------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 105 TDIVTH-----------------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred HHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccce
Confidence 887643 25789999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
....... ......++..|+|||.+....++.++||||||+++|||++|+.|+......... .... ..
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~---------~~ 231 (292)
T cd06657 165 QVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR---------DN 231 (292)
T ss_pred ecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH---------hh
Confidence 6543221 122345889999999998888899999999999999999999998643322110 0000 00
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+.+. ........+.+++.+||+.||.+||++.+++.+
T Consensus 232 ~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 232 LPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111110 112234567899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=324.44 Aligned_cols=270 Identities=21% Similarity=0.268 Sum_probs=191.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC--CCEEEEE------------------ecccCCHHHHHHHHHHHHHHhhcCccCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD--GSIVAVK------------------RSKAIDKTQIEQFINEVVILSQINHRHI 390 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~--g~~VAVK------------------~l~~~~~~~~~~~~~Ei~il~~l~H~ni 390 (646)
.++|...+.||+|+||+||++..+. +...++| +++ ........+.+|+.+|++++|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999987532 2222222 111 112234567899999999999999
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 046188 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH 470 (646)
Q Consensus 391 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 470 (646)
+++++++.+.+..++|+|++ .++|.+++....... .......+...|+.|++.||+|||+++ |+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-----------~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiH 290 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDW-----------KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIH 290 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccc-----------cccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999998 567777775432100 112345677889999999999999998 999
Q ss_pred cCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 046188 471 RDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 550 (646)
Q Consensus 471 rDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 550 (646)
|||||+|||++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.++..
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999999999999999987654433333446799999999999999999999999999999999998864432
Q ss_pred -CchHHhhcHHHHHHHHH--hh------chhHHHhhhhhcccCC---------HHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 551 -TREEEERNLVAYFISLA--KE------NKLLEILDARVAKEAS---------EEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 551 -~~~~~~~~l~~~~~~~~--~~------~~~~~~~d~~l~~~~~---------~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
........+...+.... .+ .++.++++.......+ ......+.+++.+||+.||.+|||+.|
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e 450 (501)
T PHA03210 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE 450 (501)
T ss_pred CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence 22111122211111100 00 0111121111000000 012235677899999999999999999
Q ss_pred HHHH
Q 046188 613 VSMD 616 (646)
Q Consensus 613 vl~~ 616 (646)
++.+
T Consensus 451 lL~h 454 (501)
T PHA03210 451 LLAL 454 (501)
T ss_pred HhhC
Confidence 9875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=295.81 Aligned_cols=242 Identities=29% Similarity=0.398 Sum_probs=195.0
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999998765332 4556788999999999999999999999988899999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++.
T Consensus 81 ~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 81 ASLLENV----------------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred HHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccch
Confidence 9998653 26899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCC-------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 496 SVPNDKT-------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 496 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
....... .......++..|++||.......+.++||||||+++|||++|+.|+......+ .+....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~- 214 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNIL- 214 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-
Confidence 6533211 12233457889999999988888999999999999999999999986543221 111111
Q ss_pred hchhHHHhhhhhcccCCHH--HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEE--DIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~--~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... ..+.. .+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 215 --------~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 215 --------NGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --------cCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0000 11112 257789999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=304.18 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=194.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------ 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~------ 402 (646)
++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999964 68899999875422 2223356689999999999999999999876543
Q ss_pred --eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 403 --PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 403 --~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
.++||||+. ++|.+++... ...+++.+.+.++.|+++||+|||+++ ++|+||||+||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~ 152 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---------------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILI 152 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEE
Confidence 499999995 5777777542 225899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc---cccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
+.++.+||+|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 153 TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999866332211 11234578899999988664 468899999999999999999999865543322
Q ss_pred hcHHHHHHHHHhhchh-----HHHhhh-hhcccC---------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 557 RNLVAYFISLAKENKL-----LEILDA-RVAKEA---------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~-----~~~~d~-~l~~~~---------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......+......+.. .+..+. ...... +......+.+++.+||+.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 2111111100000000 000000 000000 00123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.84 Aligned_cols=269 Identities=22% Similarity=0.327 Sum_probs=203.3
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----c
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----V 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~ 402 (646)
.++|...+.||+|+||+||+|.. .+++.||||+++.. .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788899999999999999995 36899999987642 2333456778999999999999999999886542 4
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+. ++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~ 143 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----------------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNA 143 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 799999995 7888877542 36899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||+++...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+. ..
T Consensus 144 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~ 219 (337)
T cd07858 144 NCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LK 219 (337)
T ss_pred CCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HH
Confidence 9999999999998764332 12233457889999998765 4688999999999999999999999865432221 11
Q ss_pred HHHHHHh-----------hchhHHHhhhhhc------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHHh
Q 046188 562 YFISLAK-----------ENKLLEILDARVA------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLRR 622 (646)
Q Consensus 562 ~~~~~~~-----------~~~~~~~~d~~l~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 622 (646)
.+..... .......+..... .......+..+.+++.+||+.||++||+++|++++ ++.+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 220 LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 1111111 1111111110000 00112345678999999999999999999999998 666544
Q ss_pred h
Q 046188 623 S 623 (646)
Q Consensus 623 ~ 623 (646)
.
T Consensus 300 ~ 300 (337)
T cd07858 300 P 300 (337)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=300.08 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=200.0
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
|+..+.||+|++|.||++... +|+.+++|+++.... .....+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999964 688999998765322 24557888999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
+ ++|.+++.... ..+++.+++.++.|+++||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 81 ~-~~l~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 141 (283)
T cd05118 81 D-TDLYKLIKDRQ---------------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141 (283)
T ss_pred C-CCHHHHHHhhc---------------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEee
Confidence 6 48888876532 36899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||.+........ ......++..|+|||.+.+. ..+.++||||||+++|+|++|+.||......+... ........
T Consensus 142 f~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~ 217 (283)
T cd05118 142 FGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGT 217 (283)
T ss_pred eeeeEecCCCcc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCC
Confidence 999987644331 12234578899999998776 78999999999999999999999986544322110 01111000
Q ss_pred ---chhHHHhh------hhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 ---NKLLEILD------ARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ---~~~~~~~d------~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.....+.+ .... .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 0000 01123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.30 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=198.9
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------ 400 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------ 400 (646)
..++|+..+.||+|+||.||+|... +|+.||||.+.. ......+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999953 689999998754 2334455778899999999999999999998643
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~ 151 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 151 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 24699999994 577776632 3788889999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+.... .
T Consensus 152 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~ 226 (353)
T cd07850 152 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---W 226 (353)
T ss_pred CCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---H
Confidence 999999999999998754322 12334578899999999999999999999999999999999999875442211 0
Q ss_pred HHHHHHHhhc----------hhHHHhhh---------------hhc----ccCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 561 AYFISLAKEN----------KLLEILDA---------------RVA----KEASEEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 561 ~~~~~~~~~~----------~~~~~~d~---------------~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
..+....... .....++. ... ...+......+.+++.+||+.||++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 0010000000 00001110 000 000123456788999999999999999999
Q ss_pred HHHHHH
Q 046188 612 QVSMDL 617 (646)
Q Consensus 612 evl~~L 617 (646)
|++.+=
T Consensus 307 eiL~~~ 312 (353)
T cd07850 307 DALQHP 312 (353)
T ss_pred HHhcCh
Confidence 999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.42 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=198.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+.|+..+.||+|++|.||+|+.. +++.+|+|.+.. ......+++.+|+++++.++|+|++++.+++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999954 578999998753 23344567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+|
T Consensus 95 e~~~-~~l~~~~~~~---------------~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 95 EYCL-GSASDLLEVH---------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred EccC-CCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEE
Confidence 9995 6887777543 235899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||++...... ....++..|+|||.+. .+.++.++|||||||++|||++|+.|+......+.. .
T Consensus 156 l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~ 224 (308)
T cd06634 156 LGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------Y 224 (308)
T ss_pred ECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------H
Confidence 9999998765322 2245788999999874 356788999999999999999999997543221110 0
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.... ..............+.+++.+||+.+|.+||++.+++.+...+.
T Consensus 225 ~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 225 HIAQ---------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHhh---------cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0000 00001112244567899999999999999999999998766443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.43 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=201.1
Q ss_pred CCCcCccccccCcEEEEEEEc----CCCCEEEEEecccCC----HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCce
Q 046188 333 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKAID----KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~ 403 (646)
+|+..+.||+|++|.||++.. .+++.||||.++... ....+.+.+|+.+++++ +|+||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999874 256889999876421 22345678899999999 699999999999888889
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++... ..+++.....++.|+++||.|||+.+ ++||||+|+||+++.+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~ 141 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----------------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSE 141 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----------------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCC
Confidence 9999999999999998642 25889999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.++|+|||+++..............|+..|+|||.+.+.. .+.++||||||+++|||++|..|+....... ....
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~ 219 (288)
T cd05583 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSE 219 (288)
T ss_pred CCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHH
Confidence 99999999999876433322233356889999999987655 7889999999999999999999985322110 0001
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
..... ... ....+......+.+++.+||+.||++|||+.++.+.|+...
T Consensus 220 ~~~~~---------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 220 ISRRI---------LKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HHHHH---------Hcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 01110 000 11233344567899999999999999999988877776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.70 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=196.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|++|.||+|... +|+.||+|+..... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999964 68899999875432 2234567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~k 487 (646)
|++ ++|.+++..... ..+++.....++.|++.||+|||+++ ++||||+|+||+++. ++.+|
T Consensus 82 ~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~k 143 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--------------FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALK 143 (294)
T ss_pred ccc-ccHHHHHHhCCC--------------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEE
Confidence 995 678777754321 24678888999999999999999998 999999999999985 56799
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ....+ ..
T Consensus 144 l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~ 219 (294)
T PLN00009 144 LADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RI 219 (294)
T ss_pred EcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HH
Confidence 999999976533211 1123457889999998866 4578999999999999999999999875433221 11111 11
Q ss_pred Hhhc---------hhHHHhhh--hhcc----cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKEN---------KLLEILDA--RVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~---------~~~~~~d~--~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... .+...... .... ......+..+.+++.+||+.||++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000000 0000 0112344668899999999999999999999874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.81 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=193.9
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|++++++++|||++++.+.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999875421 22344667899999999999999999999998999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++..... ..+++.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.
T Consensus 81 ~~~l~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 81 KYHIYNVGE--------------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred HHHHHHcCc--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchh
Confidence 999875431 26899999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
...... ......++..|+|||.+.++.++.++||||||++++||++|+.||......... ..+.. . .
T Consensus 144 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~----~----~ 210 (277)
T cd05577 144 ELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKR----R----T 210 (277)
T ss_pred hhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHh----c----c
Confidence 654321 122345788999999998888999999999999999999999998643321100 00000 0 0
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
. ......+......+.+++.+||+.||.+|| ++.+++.+
T Consensus 211 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 211 L--EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred c--cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 0 011123344567789999999999999999 66666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=312.63 Aligned_cols=263 Identities=26% Similarity=0.353 Sum_probs=204.0
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-c-----cCceeEEEEEEeCCceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-H-----RHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H-----~niv~l~g~~~~~~~~~L 405 (646)
+|.+.+.||+|+||.|-|+.. .+++.||||+++... .-......|+.+|..++ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999995 469999999998643 33445678999999997 4 489999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--C
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--K 483 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~ 483 (646)
|+|.+ .-+|.++++.+.- ..++......|+.||+.||..||+.+ |||+||||+||||.+ .
T Consensus 266 VfELL-~~NLYellK~n~f--------------~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF--------------RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKR 327 (586)
T ss_pred eehhh-hhhHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCc
Confidence 99998 7899999988753 47999999999999999999999999 999999999999964 3
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
..+||+|||.|...... .. ...-+..|.|||++.+.+|+.+.|+||||||+.||++|.+-|.+..+.+.......+
T Consensus 328 ~~vKVIDFGSSc~~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred CceeEEecccccccCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 47999999999865321 11 455678999999999999999999999999999999997777665544432211111
Q ss_pred HH-----HHhh-chhHHHhhh-----------------------------hhcccC-----------CHHHHHHHHHHHH
Q 046188 564 IS-----LAKE-NKLLEILDA-----------------------------RVAKEA-----------SEEDIEAVAELAM 597 (646)
Q Consensus 564 ~~-----~~~~-~~~~~~~d~-----------------------------~l~~~~-----------~~~~~~~l~~Li~ 597 (646)
.. ++.. .+...+++. ...... .......+.++++
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 00 0000 000111111 000001 1134467899999
Q ss_pred hccccCCCCCCCHHHHHHHHH
Q 046188 598 GCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 598 ~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+||++||.+|+|..|.+++-.
T Consensus 484 ~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred HHhccCchhcCCHHHHhcCcc
Confidence 999999999999999998754
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.38 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=205.4
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ceE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 404 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~~ 404 (646)
+|...+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 48899999887533 344567889999999999999999999988765 789
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||++ ++|.+++... ..+++..++.++.|+++||.|||+.+ ++||||||+|||+++++
T Consensus 81 lv~e~~~-~~l~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~ 140 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----------------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNC 140 (330)
T ss_pred EEecchh-hhHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 9999997 5788877542 36899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC--ccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
.++|+|||++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+...
T Consensus 141 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~--- 217 (330)
T cd07834 141 DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN--- 217 (330)
T ss_pred CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---
Confidence 999999999987644321 122334578899999999887 78999999999999999999999987654332111
Q ss_pred HHHHHHh-----------hchhHHHhhhh-hc-----ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHHh
Q 046188 562 YFISLAK-----------ENKLLEILDAR-VA-----KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLRR 622 (646)
Q Consensus 562 ~~~~~~~-----------~~~~~~~~d~~-l~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 622 (646)
....... .......+... .. .......+..+.+++.+||+.||.+||++.+++.+ ++++..
T Consensus 218 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 1111100 00011111100 00 00112245678999999999999999999999987 555554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.27 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=194.7
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCC-HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|++|.||+|...+ ++.||||.++... ......+..|+.++.+.. |+||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999764 8899999986532 334456677887777775 9999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|+ .++|.+++... ...+++..+.+++.|+++||+|||+ .+ ++||||+|+||++++++.+|
T Consensus 95 ~~-~~~l~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 95 LM-STCLDKLLKRI---------------QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred cc-CcCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEE
Confidence 98 45666665432 2368999999999999999999997 46 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
|+|||++......... ....++..|+|||.+.... ++.++||||||+++|||++|+.||....... +..
T Consensus 156 L~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~ 228 (296)
T cd06618 156 LCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVL 228 (296)
T ss_pred ECccccchhccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHH
Confidence 9999999765432221 2234788999999987543 7889999999999999999999985422111 111
Q ss_pred HHHHhhchhHHHhhhhhc-ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVA-KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. +++.... .+........+.+++.+||+.||.+||++.+++++-.
T Consensus 229 ~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 229 TK---------ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HH---------HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11 1111100 0111124567899999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.85 Aligned_cols=265 Identities=21% Similarity=0.332 Sum_probs=200.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC----Cce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET----EVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~----~~~ 403 (646)
.++|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999954 68999999876532 23445677899999999999999999987632 357
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~ 143 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----------------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNED 143 (334)
T ss_pred EEEEehhh-hhHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC
Confidence 99999995 6888887642 35899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCC---ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 484 FSAKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+.+||+|||+++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.........
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-- 221 (334)
T cd07855 144 CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-- 221 (334)
T ss_pred CcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH--
Confidence 9999999999976533221 11223468899999998765 46889999999999999999999999654332211
Q ss_pred HHHHHHHHh-----------hchhHHHhhhh-hcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 560 VAYFISLAK-----------ENKLLEILDAR-VAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 560 ~~~~~~~~~-----------~~~~~~~~d~~-l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..+..... .....+..+.. ..... ....+..+.+++.+||+.||++||++.+++.+-.
T Consensus 222 -~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 222 -KLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred -HHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 11111111 01111111100 00011 1234577999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.76 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=195.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------c
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------V 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------~ 402 (646)
++|...+.||+|+||.||+|+. .+|+.||||+++.. .......+.+|+.++++++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 7899999999999999999995 46899999987642 2223346789999999999999999999987543 4
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++|+||+. .+|..++ ...+++..+..++.|++.||+|||+++ ++||||||+||+++.
T Consensus 95 ~~lv~e~~~-~~l~~~~------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~ 152 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM------------------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNE 152 (342)
T ss_pred EEEEecccc-cCHHHHH------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 589999985 3555443 125889999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..
T Consensus 153 ~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~ 225 (342)
T cd07879 153 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LT 225 (342)
T ss_pred CCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 999999999999865321 123457889999999876 4688999999999999999999999975432211 11
Q ss_pred HHHHHHh-----------hchhHHHhhhh--h-cccC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHHh
Q 046188 562 YFISLAK-----------ENKLLEILDAR--V-AKEA---SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLRR 622 (646)
Q Consensus 562 ~~~~~~~-----------~~~~~~~~d~~--l-~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 622 (646)
....... +.......... . .... .......+.+++.+||+.||.+||++.|++.+ ++..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1111000 00000110000 0 0000 01234568899999999999999999999976 766654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=298.24 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=193.8
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
|...+.||+|+||.||+|+.. +|+.|++|++... .....+.+.+|++++++++|+|++++.+++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999953 6889999987532 234456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+. |+|.+++... ...++|.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+
T Consensus 103 ~~-~~l~~~l~~~---------------~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~ 163 (313)
T cd06633 103 CL-GSASDLLEVH---------------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 163 (313)
T ss_pred CC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEe
Confidence 94 6777777543 236899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|||++..... .....|+..|+|||++. .+.++.++||||||+++|||++|..|+........ ....
T Consensus 164 dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~ 232 (313)
T cd06633 164 DFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHI 232 (313)
T ss_pred ecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH
Confidence 9999865322 12346888999999974 46688899999999999999999999864432111 0100
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ............+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 233 AQND---------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HhcC---------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0011112234568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=297.28 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=198.1
Q ss_pred CCCcCccccccCcEEEEEEEc----CCCCEEEEEecccCC----HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCce
Q 046188 333 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKAID----KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~ 403 (646)
+|+..+.||+|+||.||++.. .+|+.||+|.++... ....+.+.+|+.+++++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 368899999886422 22345678899999999 599999999999988889
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++++|.+++... ..+++.....++.|+++||.|||+.+ ++||||+|+|||++++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~ 141 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----------------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSN 141 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCC
Confidence 9999999999999998653 35889999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++..............|+..|+|||.+..+ ..+.++||||||+++|||++|+.|+....... ....
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~ 219 (290)
T cd05613 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAE 219 (290)
T ss_pred CCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHH
Confidence 9999999999987644332223345688999999998753 46789999999999999999999985322111 0111
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
.... ... ....++......+.+++.+||+.||++|| ++.+++.+
T Consensus 220 ~~~~---------~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 220 ISRR---------ILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHH---------hhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1110 000 01223444567789999999999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=294.80 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=195.3
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhc---CccCceeEEEEEEeCCc-----
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQI---NHRHIVKLLGCCLETEV----- 402 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~~~~~----- 402 (646)
|+..+.||+|+||.||+|..+ +++.||+|+++.. .......+.+|+.+++++ +|+|++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999975 4899999998642 222234566788777666 69999999999988776
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.+++|||+. ++|.+++.... ...++|.+++.++.|+++||.|||+.+ ++|+||+|+||++++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--------------~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~ 142 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--------------KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTS 142 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEcc
Confidence 899999996 58888876532 125899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......+. ....
T Consensus 143 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~ 218 (287)
T cd07838 143 DGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKI 218 (287)
T ss_pred CCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHH
Confidence 99999999999987643322 1223478899999999998999999999999999999999998865433221 1111
Q ss_pred HHHHHhhchh---------HHHhhhhhc---ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 563 FISLAKENKL---------LEILDARVA---KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~---------~~~~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+......... ......... .....+....+.+++.+||+.||.+||++.|++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 1110000000 000000000 01112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=301.48 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=194.7
Q ss_pred cccccc--CcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQG--GFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G--~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
..||+| +||+||++... +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 89999999953 6899999987642 344456788999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+
T Consensus 84 ~~l~~~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~ 146 (328)
T cd08226 84 GSANSLLKTYFP--------------EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLS 146 (328)
T ss_pred CCHHHHHHhhcc--------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechH
Confidence 999998876432 25889999999999999999999998 9999999999999999999999998
Q ss_pred CccccCCCCCcc------ccccccCCcccChhccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 493 TSRSVPNDKTHL------TTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 493 la~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+.......... .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~ 224 (328)
T cd08226 147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLK 224 (328)
T ss_pred HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhc
Confidence 654332111100 0112346679999998763 478999999999999999999999865432111 000000
Q ss_pred H----------------HHhh-----------ch-----hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 565 S----------------LAKE-----------NK-----LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 565 ~----------------~~~~-----------~~-----~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
. .... .. .....+..+....+..+...+.+|+.+||+.||++|||+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e 304 (328)
T cd08226 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS 304 (328)
T ss_pred CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence 0 0000 00 00011111112223456678999999999999999999999
Q ss_pred HHHHHH
Q 046188 613 VSMDLE 618 (646)
Q Consensus 613 vl~~L~ 618 (646)
++++-.
T Consensus 305 ~l~~~~ 310 (328)
T cd08226 305 LLSHAF 310 (328)
T ss_pred HhhCHH
Confidence 987644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=290.26 Aligned_cols=241 Identities=27% Similarity=0.340 Sum_probs=187.1
Q ss_pred ccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHH-hhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVIL-SQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il-~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|++|.||+|... +|+.||||.++... ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 58899999876432 12223344555444 455899999999999998999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 82 GDCASLIKTL----------------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecc
Confidence 9999998653 35889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++.... .....++..|+|||.+.+..++.++||||||+++|||++|..||....... .+.... ...
T Consensus 143 ~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~- 209 (260)
T cd05611 143 LSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNIL-SRR- 209 (260)
T ss_pred cceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hcc-
Confidence 9886432 123457889999999988888999999999999999999999986433221 111110 000
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
...........+..+.+++.+||+.||++||++.++.+
T Consensus 210 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 210 -----INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred -----cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 00011112234567899999999999999997765544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=295.48 Aligned_cols=257 Identities=18% Similarity=0.245 Sum_probs=181.6
Q ss_pred cCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccCCHHH-H----------HHHHHHHHHHhhcCccCceeEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAIDKTQ-I----------EQFINEVVILSQINHRHIVKLLGC 396 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~~~~~-~----------~~~~~Ei~il~~l~H~niv~l~g~ 396 (646)
++|...++||+|+||.||+|...+ +..+|+|......... . .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999644 3466776533221110 0 112233445566789999999998
Q ss_pred EEeCC----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 397 CLETE----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 397 ~~~~~----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
+.... ..++++|+. ..++.+.+.. ....++..+..|+.|+++||+|||+.+ ++|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrD 151 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKR----------------IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGD 151 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHh----------------hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 76544 235666665 2344444432 123578888999999999999999998 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 546 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~ 546 (646)
|||+|||++.++.+||+|||+++....... .......||+.|+|||...+..++.++|||||||++|||++|+.
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999987632211 11122469999999999999999999999999999999999999
Q ss_pred CCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 547 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 547 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
||........ .... ...+.+..+..+... ....+..+.+++..||+.+|++||++.++.+.|
T Consensus 232 P~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 232 PWKGFGHNGN--LIHA----AKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCccccchH--HHHH----hHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9965422111 0000 000111111111111 122357789999999999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.76 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=195.1
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455556666666665 6899999997653 445667899999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++..... ..+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+.
T Consensus 87 ~~~l~~~~~--------------~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 87 EDLLKTHFP--------------EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred HHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccce
Confidence 999976432 35888999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCC------ccccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 496 SVPNDKT------HLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 496 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTV 227 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccC
Confidence 6532111 11123457788999999876 3578899999999999999999999875432211 111000000
Q ss_pred ----hhc-------hhHH----Hhhhh----hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 ----KEN-------KLLE----ILDAR----VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ----~~~-------~~~~----~~d~~----l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
... .... ..++. ............+.+++.+||+.||++|||++|++++-.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 0000 00000 011123344567899999999999999999999998755
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.19 Aligned_cols=269 Identities=22% Similarity=0.304 Sum_probs=202.3
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEE
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCL 398 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~ 398 (646)
...+++...+++|...+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|+.++++++|+||+++.+++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 44567778889999999999999999999984 46889999988653 2223456788999999999999999999886
Q ss_pred eC------CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 399 ET------EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 399 ~~------~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
.. ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ ++|||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~d 145 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRD 145 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 43 2357888876 7888877643 25899999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
|||+||++++++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 146 lkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 146 LKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred CChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865322 223457889999998866 56788999999999999999999998654
Q ss_pred chHHhhcHHHHHHHHHh-----------hchhHHHh---hhhhcccC---CHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046188 552 REEEERNLVAYFISLAK-----------ENKLLEIL---DARVAKEA---SEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~-----------~~~~~~~~---d~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 614 (646)
...... . .+..... .......+ +......+ .......+.+++.+|++.||.+||++.+++
T Consensus 222 ~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 222 DHIDQL--K-LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred CHHHHH--H-HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 332211 0 0100000 00000000 00000000 012345688999999999999999999999
Q ss_pred HHHH
Q 046188 615 MDLE 618 (646)
Q Consensus 615 ~~L~ 618 (646)
.+=.
T Consensus 299 ~h~~ 302 (345)
T cd07877 299 AHAY 302 (345)
T ss_pred cChh
Confidence 8743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=297.54 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=211.4
Q ss_pred cCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.-|+..+.||+|.|..|-+++ .-.|+.||||++... +.-....+++|+.-|+.++|||||+|+.+.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346667889999999999998 347999999987653 23344568899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE-CCCCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-DDKFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl-~~~~~~k 487 (646)
.-++|+|.+|+.++.. .|++....+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+|
T Consensus 98 LGD~GDl~DyImKHe~---------------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---------------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred ecCCchHHHHHHhhhc---------------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceE
Confidence 9999999999988743 6899999999999999999999999 9999999999977 5568899
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++..+..+.. -+..+|...|-|||.+.+-.|. +++||||+||+||.|++|+.||....+.
T Consensus 160 LTDFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------ 225 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------ 225 (864)
T ss_pred eeeccccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch------------
Confidence 999999988755443 3456899999999999987774 6899999999999999999999644332
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+.+.-+||-+. ..|...+..+.+||..||..||++|.+.+||+..-+
T Consensus 226 ---ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 226 ---ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ---hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 23444566543 357788889999999999999999999999987644
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.47 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=190.9
Q ss_pred HHHhcCCCcCccc--cccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCce
Q 046188 328 QRATDNYNQSRFL--GQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 328 ~~~t~~~~~~~~I--G~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~ 403 (646)
....++|+..+.+ |+|+||.||++... ++..+|+|.......... |+.....+ +|+|++++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334567777766 99999999999953 678899998764221111 22222222 799999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++... ..++|.++..++.|+++||.|||+.+ ++||||||+||+++.+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE----------------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRA 145 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCC
Confidence 9999999999999998653 26899999999999999999999999 9999999999999999
Q ss_pred C-cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 484 F-SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 484 ~-~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
+ .++|+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+
T Consensus 146 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~ 219 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL 219 (267)
T ss_pred CCeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH
Confidence 8 99999999988653221 2357899999999998889999999999999999999999987432221 111111
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-MKQVSMD 616 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~evl~~ 616 (646)
. ..... ....+...+..+.+++.+||+.||.+||+ ++|++++
T Consensus 220 ~----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 220 L----------KRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred H----------Hhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 00110 11222345677899999999999999996 6888753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.08 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=203.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|++|.||+|... +|+.||+|..... .....+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999964 6899999987542 2334467889999999998 99999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++... ..+++..++.|+.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 81 ~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 81 LEYAPNGELLQYIRKY----------------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHI 141 (280)
T ss_pred EcCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCE
Confidence 9999999999998653 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCC-------------------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCC
Q 046188 487 KVSDFGTSRSVPNDKT-------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547 (646)
Q Consensus 487 kI~DfGla~~~~~~~~-------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p 547 (646)
+|+|||++........ .......++..|+|||.......+.++||||||++++|+++|+.|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 9999999987643221 112234578899999999888899999999999999999999999
Q ss_pred CCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 046188 548 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM----KQVSMD 616 (646)
Q Consensus 548 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~----~evl~~ 616 (646)
+....... .+. ... ......+...+..+.+++.+||+.||.+||++ +|++.+
T Consensus 222 ~~~~~~~~------~~~---------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 222 FRGSNEYL------TFQ---------KIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCccHHH------HHH---------HHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 86443111 011 111 11122344446778999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=294.62 Aligned_cols=260 Identities=28% Similarity=0.379 Sum_probs=195.7
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-HHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEec
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
|+..+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999975 478999998765322 22234457999999999 999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
+|+|.+++.... ...++|.++..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|
T Consensus 81 -~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d 142 (283)
T cd07830 81 -EGNLYQLMKDRK--------------GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIAD 142 (283)
T ss_pred -CCCHHHHHHhcc--------------cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEee
Confidence 889998886642 136899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||++........ .....++..|+|||.+. ...++.++|+||||++++||++|+.||......+... ........
T Consensus 143 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~---~~~~~~~~ 217 (283)
T cd07830 143 FGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY---KICSVLGT 217 (283)
T ss_pred cccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH---HHHHhcCC
Confidence 999986543222 12345788999999875 4557899999999999999999999986543322110 01100000
Q ss_pred c---------hhHHHhhhhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 N---------KLLEILDARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~---------~~~~~~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. .+...++..+. ..........+.+++.+||+.||++||+++|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 00000000000 00011124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=336.30 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=204.4
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEE-cCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
+...+-++....+||.|.||.||-+. .++|+..|+|..+. ..........+|+.++..++|||+|+++|+-.+++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 44456678888999999999999999 55799999997654 2233445677899999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
+|.||||++|+|.+.+...+ -+++.....+..|++.|+.|||++| ||||||||.||+|+.+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr----------------i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR----------------IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFN 1370 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc----------------hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecC
Confidence 99999999999999997643 2455566678899999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCcc---ccccccCCcccChhccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 484 FSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
|.+|++|||.|..+....... .....||+.|||||.+.+.. ..-++||||+|||++||+||++|+...+.+
T Consensus 1371 g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--- 1447 (1509)
T KOG4645|consen 1371 GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--- 1447 (1509)
T ss_pred CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---
Confidence 999999999999875443221 23467999999999997643 356899999999999999999998533221
Q ss_pred cHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 558 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+.....+ ...-....|...+.+-.+++.+||+.||++|.++.|++++
T Consensus 1448 --~aIMy~V----------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 --WAIMYHV----------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --hHHHhHH----------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111 1111234566677788999999999999999998877765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.57 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=187.3
Q ss_pred cccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHH---HHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 339 FLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVV---ILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~---il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
.||+|+||.||++... +++.||+|.+.... ......+..|.. +++..+||||+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999853 58899999865421 111222334443 4444579999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++... ..++|..+..|+.|+++||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 g~~L~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~df 141 (278)
T cd05606 81 GGDLHYHLSQH----------------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (278)
T ss_pred CCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccC
Confidence 99999887542 36999999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|++....... .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... ....
T Consensus 142 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~---- 210 (278)
T cd05606 142 GLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRM---- 210 (278)
T ss_pred cCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHH----
Confidence 9987653221 1234689999999998754 58899999999999999999999986542211110 0000
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
........+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 211 ------~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 211 ------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ------hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00011223334467899999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=290.11 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=196.1
Q ss_pred CCCcCccccccCcEEEEEEEcCC-CCEEEEEecccC-----CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
+|...+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999998543 444555554431 222334567899999999999999999999988899999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++...... ...+++.+++.++.|+++||.|||+.+ ++|+||+|+||++++ +.+
T Consensus 81 ~e~~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT------------GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc------------ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCE
Confidence 9999999999998653221 346999999999999999999999998 999999999999986 469
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++...... .......+++.|+|||.+....++.++|+||||+++|+|++|..|+....... ....
T Consensus 145 ~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~- 216 (260)
T cd08222 145 KIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLR- 216 (260)
T ss_pred eecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH-
Confidence 999999988753322 22233457889999999988888999999999999999999999985322111 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ......+...+..+.+++.+||+.||++||++.|++++
T Consensus 217 --------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 217 --------IVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --------HHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111 11122344556788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.25 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=203.2
Q ss_pred CCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
.|.++-.||.|+||.||+++.++ +-..|-|.+........++|+-||+||..+.||+||+|++.|..++.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34556679999999999999765 34456677777777889999999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
||-....+... ...|+..++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+||
T Consensus 113 GGAVDaimlEL---------------~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---------------GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred CchHhHHHHHh---------------ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecc
Confidence 99988877554 237999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhcc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYF-----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|.+..... .......+.|||.|||||+. .+.+|+.++||||||+.|.||..+.+|-.. .+....+..+
T Consensus 175 GVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKi 247 (1187)
T KOG0579|consen 175 GVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKI 247 (1187)
T ss_pred cccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHH
Confidence 99865421 12233457899999999976 457899999999999999999999998532 1222222111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+ -|.+ -.|......+.+++.+||.+||..||++.+++++
T Consensus 248 aKSe------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 248 AKSE------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhcC------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1110 0111 1355667789999999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.09 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=193.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
.++|+..+.||+|++|.||+|... +++.+|||++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999954 58899999875422 112335678999999999999999999876543
Q ss_pred --ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 402 --VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 402 --~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
..++|+||++ ++|...+... ...+++.++..++.|+++||.|||+.+ ++||||||+||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~---------------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil 147 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP---------------SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 3589999985 4666666542 236899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCc----------cccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCC
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTH----------LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
+++++.+||+|||+++........ ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||
T Consensus 148 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred ECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 999999999999999865322111 11234578889999987654 5789999999999999999999998
Q ss_pred CCCchHHhhcHHHHHHHHHhh---ch------hHHHhhhhhcccCC-------HHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 549 CLTREEEERNLVAYFISLAKE---NK------LLEILDARVAKEAS-------EEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~---~~------~~~~~d~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
.......... .+...... .. +....+.......+ ......+.+++.+||+.||.+|||+.|
T Consensus 228 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 228 QGKSDIDQLH---LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred CCCCHHHHHH---HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 6544322111 11111100 00 00000000000000 122356889999999999999999999
Q ss_pred HHHH
Q 046188 613 VSMD 616 (646)
Q Consensus 613 vl~~ 616 (646)
++.+
T Consensus 305 ll~~ 308 (311)
T cd07866 305 ALEH 308 (311)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.72 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=196.1
Q ss_pred cCCCc-CccccccCcEEEEEEEcC-CCCEEEEEecccCCHHH--------------HHHHHHHHHHHhhcCccCceeEEE
Q 046188 332 DNYNQ-SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQ--------------IEQFINEVVILSQINHRHIVKLLG 395 (646)
Q Consensus 332 ~~~~~-~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~--------------~~~~~~Ei~il~~l~H~niv~l~g 395 (646)
++|.. .+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45554 467999999999999954 68999999875432111 124678999999999999999999
Q ss_pred EEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 046188 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475 (646)
Q Consensus 396 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~ 475 (646)
++..++..++||||+. |+|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~ 147 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----------------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSP 147 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 9999999999999996 6888887542 35889999999999999999999998 99999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCC-------------CccccccccCCcccChhccccC-CCCCccchhhHHHHHHHH
Q 046188 476 SNILLDDKFSAKVSDFGTSRSVPNDK-------------THLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLEL 541 (646)
Q Consensus 476 ~NILl~~~~~~kI~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~El 541 (646)
+||+++.++.+||+|||+++...... ........++..|+|||.+.+. .++.++||||||+++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999998654111 1111123467889999998764 468999999999999999
Q ss_pred HhCCCCCCCCchHHhhcHHHHHHHHHhhch---hHHHhh------------hhhcccCCHHHHHHHHHHHHhccccCCCC
Q 046188 542 LTGKKPICLTREEEERNLVAYFISLAKENK---LLEILD------------ARVAKEASEEDIEAVAELAMGCLRLNSKK 606 (646)
Q Consensus 542 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d------------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~ 606 (646)
++|+.||......+. ...+........ +.+..+ +... .........+.+++.+||+.||++
T Consensus 228 ~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~ 303 (335)
T PTZ00024 228 LTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLE 303 (335)
T ss_pred HhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchh
Confidence 999999875543221 111111111110 000000 0000 001123467889999999999999
Q ss_pred CCCHHHHHHHHH
Q 046188 607 RPTMKQVSMDLE 618 (646)
Q Consensus 607 RPs~~evl~~L~ 618 (646)
||++.|++.+-.
T Consensus 304 R~s~~~~l~~~~ 315 (335)
T PTZ00024 304 RISAKEALKHEY 315 (335)
T ss_pred ccCHHHHhcCcc
Confidence 999999997544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=293.01 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=198.5
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
|+..+.||+|++|.||+|+.. +++.+|+|.++... ....+.+.+|+.++++++|+|++++.+++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 48999999877542 333456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
+ ++|.+++.... ..+++..+.+++.|+++||+|||+.+ ++||||+|+||++++++.+||+|
T Consensus 81 ~-~~l~~~i~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d 141 (282)
T cd07829 81 D-MDLKKYLDKRP---------------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLAD 141 (282)
T ss_pred C-cCHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEec
Confidence 7 68999987642 26899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++....... ......++..|+|||.+... .++.++||||||+++|||++|+.||......+. ...+......
T Consensus 142 ~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~ 217 (282)
T cd07829 142 FGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGT 217 (282)
T ss_pred CCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCC
Confidence 999987643322 12223457789999998776 789999999999999999999999865432211 1111111110
Q ss_pred c---hhHHHh-----hhhh-------cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 N---KLLEIL-----DARV-------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~---~~~~~~-----d~~l-------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ....+. +... ...........+.+++.+||+.||++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred CcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 000000 0000 000011225678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.74 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=198.7
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe-CCc
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEV 402 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-~~~ 402 (646)
+...+++|+..+.||+|+||.||++... +++.||||++.. ......+.+.+|++++++++|||++++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999844 789999998653 222334567889999999999999999999876 457
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++++||+ +++|.+++.. ..+++.....++.|+++||.|||+.+ ++||||+|+||++++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----------------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~ 143 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----------------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINE 143 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECC
Confidence 89999998 6688877743 25778888899999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 144 ~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~---~ 216 (328)
T cd07856 144 NCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF---S 216 (328)
T ss_pred CCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 999999999999854321 123457889999998766 56899999999999999999999998654332111 1
Q ss_pred HHHHHHh-----------hchhHHHhh-hhhcccCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAK-----------ENKLLEILD-ARVAKEAS-----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~-----------~~~~~~~~d-~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... .....+++. -......+ ......+.+++.+||+.+|++||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 217 IITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111110 000011110 00011111 1234688999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.79 Aligned_cols=269 Identities=27% Similarity=0.433 Sum_probs=204.6
Q ss_pred CCcCccccccCcEEEEEEEc-CCCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------CceEE
Q 046188 334 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EVPVL 405 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------~~~~L 405 (646)
|...+.||+|+||.||+|+. ..|+.||||..+. ......+...+|+++|++++|+|||+++++-.+. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999995 4699999998765 2344566788999999999999999999986543 35689
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC----
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---- 481 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~---- 481 (646)
||||+.+|||...|.+... ...|+..+.+.+..+++.||.|||+++ |+||||||.||++-
T Consensus 95 vmEyC~gGsL~~~L~~PEN-------------~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Ged 158 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-------------AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGED 158 (732)
T ss_pred EEeecCCCcHHHHhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCC
Confidence 9999999999999987544 457999999999999999999999999 99999999999993
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
..-.-||+|||.|+.+.++. .....+||..|++||.+.. +.++..+|.|||||++||++||..||......... .
T Consensus 159 gq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~--~ 234 (732)
T KOG4250|consen 159 GQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN--K 234 (732)
T ss_pred CceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc--c
Confidence 33357999999999886554 5667899999999999984 88999999999999999999999999765433211 1
Q ss_pred HHHHHHHhh---ch---hHHHhhhhh----ccc----CCHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHHHHHHh
Q 046188 561 AYFISLAKE---NK---LLEILDARV----AKE----ASEEDIEAVAELAMGCLRLNSKKRP--TMKQVSMDLEGLRR 622 (646)
Q Consensus 561 ~~~~~~~~~---~~---~~~~~d~~l----~~~----~~~~~~~~l~~Li~~Cl~~dP~~RP--s~~evl~~L~~i~~ 622 (646)
...+..... +. ..+-....+ ..+ ........+-..+..+|..+|++|. ...+....+..|..
T Consensus 235 ~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 235 EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111111110 00 000000000 011 1233445666778888889999998 77777777776654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.55 Aligned_cols=262 Identities=21% Similarity=0.340 Sum_probs=197.1
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC---
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE--- 401 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--- 401 (646)
....++|...+.||+|+||.||++.. .+|..||||+++.. .....+.+.+|+.++++++|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999984 46899999987542 2333456789999999999999999999987653
Q ss_pred ---ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 402 ---VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 402 ---~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Ni 149 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-----------------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNL 149 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 348999998 7788877643 25889999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
++++++.+||+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||........
T Consensus 150 ll~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~- 224 (343)
T cd07880 150 AVNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ- 224 (343)
T ss_pred EEcCCCCEEEeecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 99999999999999998653321 23457889999998876 4578999999999999999999999875432211
Q ss_pred cHHHH----------HHHHHhhchhHHHhhh--hhc----ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 558 NLVAY----------FISLAKENKLLEILDA--RVA----KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 558 ~l~~~----------~~~~~~~~~~~~~~d~--~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... +............... ... ..........+.+++.+|++.||.+|||+.+++.+
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 225 -LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred -HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000010000 000 00112334568899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.03 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=193.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC----------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET---------- 400 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~---------- 400 (646)
.+|...+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999954 5889999988665555567788999999999999999999876543
Q ss_pred ----CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 401 ----EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 401 ----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
...++||||++ ++|.+++.. ..+++...+.++.|+++||.|||+.+ ++||||||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~ 143 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----------------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 24689999996 588777643 25889999999999999999999999 999999999
Q ss_pred CEEEC-CCCcEEEeecCCccccCCCCC--ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCc
Q 046188 477 NILLD-DKFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTR 552 (646)
Q Consensus 477 NILl~-~~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 552 (646)
||+++ +++.+||+|||+++....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 144 Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred HEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99997 566799999999986532211 11122357889999997654 557889999999999999999999997544
Q ss_pred hHHhhcHHHHHHHHHh--h---c----hhHHHhh-hhhccc-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 553 EEEERNLVAYFISLAK--E---N----KLLEILD-ARVAKE-----ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~--~---~----~~~~~~d-~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+.... ....... . . .....+. ...... ........+.+++.+||+.||.+||++.|++.+
T Consensus 224 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 224 ELEQMQL--ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHH--HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 3221110 0000000 0 0 0000000 000000 011234668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.53 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=192.5
Q ss_pred CCCcCccccccCcEEEEEEEcC-C--CCEEEEEecccC--CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC----Cc
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-D--GSIVAVKRSKAI--DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET----EV 402 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~--g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~----~~ 402 (646)
+|+..+.||+|+||.||++... . +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999964 3 678999987642 222345678899999999 599999999976532 34
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++++||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~ 140 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----------------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNA 140 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcC
Confidence 678888885 7888888542 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCc---cccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 483 KFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
++.+||+|||+++........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~-- 218 (332)
T cd07857 141 DCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ-- 218 (332)
T ss_pred CCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH--
Confidence 999999999999865432211 1223468999999998765 4678999999999999999999999865432211
Q ss_pred HHHHHHHHHh---hchhHHHhhhh-------h----cc---cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 559 LVAYFISLAK---ENKLLEILDAR-------V----AK---EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 559 l~~~~~~~~~---~~~~~~~~d~~-------l----~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......... .+.+..+.++. . .. .........+.+++.+||+.||.+|||+.|++.+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 219 -LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred -HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111000 00000000000 0 00 0011124678999999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=302.59 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=197.8
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc----
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV---- 402 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~---- 402 (646)
..++|...+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999964 5789999987642 23344567889999999999999999998766554
Q ss_pred --eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 403 --PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 403 --~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ ++||||||+||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----------------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill 151 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----------------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAV 151 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 79999998 6788888753 25899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
++++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~-- 225 (343)
T cd07851 152 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL-- 225 (343)
T ss_pred CCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--
Confidence 99999999999999865332 223457889999998865 36788999999999999999999998654332211
Q ss_pred HHHHHHHHh-----------hchhHHHhhhhhcc---c---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAK-----------ENKLLEILDARVAK---E---ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~-----------~~~~~~~~d~~l~~---~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ ......++...... . .....+..+.+++.+||+.||.+|||+.||+.+
T Consensus 226 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 226 -KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred -HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 11111100 00011111110000 0 011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=290.75 Aligned_cols=245 Identities=29% Similarity=0.438 Sum_probs=203.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+.|+.-++||+|+||.||-.+.+ +|+.+|.|++.... +......++|-.||++++.+.||.+--.+...+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46778899999999999998854 68999999764321 122335678999999999999999998999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
..|+||+|.-||..... +.+++...+.+|.+|+.||++||... ||.||+||+|||||+.|+++
T Consensus 265 tlMNGGDLkfHiyn~g~--------------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN--------------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred EeecCCceeEEeeccCC--------------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeE
Confidence 99999999999987642 46899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|+|||..+..+.... ..+||.||||||++.++.|+...|.||+||+||||+.|+.||....+...
T Consensus 328 ISDLGLAvei~~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------- 394 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------- 394 (591)
T ss_pred eeccceEEecCCCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----------
Confidence 99999999886654432 33799999999999999999999999999999999999999853322111
Q ss_pred hhchhHHHhhhhh---cccCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 568 KENKLLEILDARV---AKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 568 ~~~~~~~~~d~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
.+-+|.+. ..+++...++...+|....|++||.+|.-.+
T Consensus 395 -----~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 395 -----REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -----HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11112211 2356777888899999999999999996554
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.60 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=207.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
...|...+.||+|.|+.|..|+.. .+..||||.... .+....+.+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999953 689999998765 23444556889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+.+|.+.+++.++. ++.......++.|+..|++|+|++. |+|||||++||||+.+.++|
T Consensus 135 eya~~ge~~~yl~~~g----------------r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnik 195 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG----------------RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIK 195 (596)
T ss_pred EeccCchhHHHHHhcc----------------cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhccccccccee
Confidence 9999999999998754 4666788899999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++..+.. .......+|++.|.|||++.+..+ ++++|+||+|++||-|+.|..||+...-.+-+
T Consensus 196 IaDfgfS~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------- 264 (596)
T KOG0586|consen 196 IADFGFSTFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------- 264 (596)
T ss_pred eeccccceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------
Confidence 999999998753 334456789999999999988765 68999999999999999999999754322110
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...+-.+++ .+.-....+.++++++|..+|.+|+++++|.++-.
T Consensus 265 ------~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 265 ------PRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ------chheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 111111222 22233446779999999999999999999988765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=280.67 Aligned_cols=236 Identities=33% Similarity=0.439 Sum_probs=193.1
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 340 LGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
||+|+||.||++... +++.+|+|.++... ......+.+|++++++++|+|++++++.+.+++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 58899999876532 23456788999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 81 FSHLSKE----------------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred HHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcce
Confidence 9998653 25899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
...... .......++..|++||...+...+.++|+||||+++|||++|+.||....... . ... +
T Consensus 142 ~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~---~~~---------~ 205 (250)
T cd05123 142 ELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---I---YEK---------I 205 (250)
T ss_pred ecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHH---------H
Confidence 764322 12234567889999999988888999999999999999999999986443211 0 111 1
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
.. .....+...+..+.+++.+||..||++||++.+
T Consensus 206 ~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 206 LK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred hc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11 111233344577899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=279.86 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=204.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..++||+|.||.|-..+-+ .|+.+|+|+++. ..+.+...-+.|-.+|+..+||.+..|.-.+...+..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 67888999999999999998843 689999999876 34556666778999999999999999988899999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+.||.|.-+|...+ .+++.....+-..|+.||.|||+.+ ||.||+|.+|.|||.+|.+|
T Consensus 248 eyanGGeLf~HLsrer----------------~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER----------------VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred EEccCceEeeehhhhh----------------cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceE
Confidence 9999999999997643 4777777888899999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++.-... ...+...+|||.|+|||++....|+..+|.|.+||+||||++|+.||+..+.+.
T Consensus 309 itDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k------------ 375 (516)
T KOG0690|consen 309 ITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK------------ 375 (516)
T ss_pred eeecccchhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH------------
Confidence 9999999864322 233456899999999999999999999999999999999999999998543321
Q ss_pred hhchhHHHh-hhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 568 KENKLLEIL-DARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~-d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
+.+++ -.. ..+|....+....|+...|.+||.+|. .+.||.++
T Consensus 376 ----LFeLIl~ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 376 ----LFELILMED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ----HHHHHHhhh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11111 111 135666667788999999999999994 35555443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=278.02 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=200.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-----CCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEe-CCce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-----g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-~~~~ 403 (646)
..|+....||+|+||.||+|+-.+ ...+|||+++...+ .-.....+|+.+++.++|||++.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468889999999999999997432 23799999876422 223467799999999999999999999988 6678
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
+|++||+ .-+|...++.++... ...++......|+.||+.|+.|||++- |+||||||.||||..+
T Consensus 104 ~l~fdYA-EhDL~~II~fHr~~~-----------~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 104 WLLFDYA-EHDLWHIIKFHRASK-----------AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGD 168 (438)
T ss_pred EEEehhh-hhhHHHHHHHhccch-----------hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEecc
Confidence 9999998 457888887665421 236888999999999999999999999 9999999999999877
Q ss_pred ----CcEEEeecCCccccCCCCCc--cccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 484 ----FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 484 ----~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
|++||+|||+++.+.+.-.. ....++.|..|.|||.+.+. .||.+.||||.||++.||+|-++-|......-.
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 99999999999988554332 23457789999999998874 689999999999999999998777754332211
Q ss_pred hc------HHHHHHHHHhhch-----------------------------hHHHhhhhhcccCCHHHHHHHHHHHHhccc
Q 046188 557 RN------LVAYFISLAKENK-----------------------------LLEILDARVAKEASEEDIEAVAELAMGCLR 601 (646)
Q Consensus 557 ~~------l~~~~~~~~~~~~-----------------------------~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~ 601 (646)
.. -.+.+.+++.... +..+++..-. -+...++|+.++|+
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~------k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKV------KDPSALDLLQKLLT 322 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcC------CCchHHHHHHHHhc
Confidence 11 1111122222111 1111111110 11336789999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 046188 602 LNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 602 ~dP~~RPs~~evl~~L~ 618 (646)
.||.+|.|+++.+++.=
T Consensus 323 yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 323 YDPIKRITAEQALEHPY 339 (438)
T ss_pred cCchhhccHHHHhcccc
Confidence 99999999999988754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=271.16 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=191.8
Q ss_pred CccccccCcEEEEEEEcC-CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 337 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA-IDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+..||.|+.|.||+.+.+ .|...|||.+.. .++++.++++..+.++.+-+ .|.||+.+|+|..+...++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 556999999999999965 588999999865 56667778888888887775 899999999999998888999987 33
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
.+..++... ..++++.-.=++...+++||.||.++.. |+|||+||+|||+|+.|++|++|||+
T Consensus 176 C~ekLlkri---------------k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 176 CAEKLLKRI---------------KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHHHHh---------------cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccc
Confidence 344444433 2367777777889999999999998663 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
+-.+.+... .+...|.+.|||||.+.- ..|..++||||||+.|+||.||..|+..-..+-+. ...++.++
T Consensus 239 sGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-----ltkvln~e 311 (391)
T KOG0983|consen 239 SGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-----LTKVLNEE 311 (391)
T ss_pred cceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-----HHHHHhcC
Confidence 977643322 233458999999999864 46888999999999999999999998753322111 11111110
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
-|.+. .....+..+.+++..||++|+.+||...+++++
T Consensus 312 ------PP~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 ------PPLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------CCCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111 122366788999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=314.53 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=176.9
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce---
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP--- 403 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~--- 403 (646)
+-..+|++.+.||+||||.|||++.+ ||+.+|||++.-. ..+......+|++.|++++|||||+++..+.+....
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34467888899999999999999955 8999999987543 445566788999999999999999998765432111
Q ss_pred --------------------------------------------------------------------------------
Q 046188 404 -------------------------------------------------------------------------------- 403 (646)
Q Consensus 404 -------------------------------------------------------------------------------- 403 (646)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------------------EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCC--CHHH
Q 046188 404 ------------------------------------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL--SWEN 445 (646)
Q Consensus 404 ------------------------------------~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l--~~~~ 445 (646)
|+-||||+..+|.++++.+ .. .-..
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N-----------------~~~~~~d~ 698 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN-----------------HFNSQRDE 698 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc-----------------ccchhhHH
Confidence 1111111111111111111 11 2456
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccC----------------CCC-Ccccccc
Q 046188 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP----------------NDK-THLTTAV 508 (646)
Q Consensus 446 ~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~----------------~~~-~~~~~~~ 508 (646)
.|+++.+|++||.|+|+.+ ||||||||.||+||++..+||+|||+|.... .+. ....+..
T Consensus 699 ~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 699 AWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ 775 (1351)
T ss_pred HHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence 7899999999999999999 9999999999999999999999999998721 001 1123456
Q ss_pred ccCCcccChhccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhccc--
Q 046188 509 QGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKE-- 583 (646)
Q Consensus 509 ~gt~~y~aPE~l~~~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-- 583 (646)
+||.-|+|||.+.+. .|+.|+|+||+|||++||+.- |.... +... . +..+-++.+..+
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM--ERa~----i--------L~~LR~g~iP~~~~ 838 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM--ERAS----I--------LTNLRKGSIPEPAD 838 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchH--HHHH----H--------HHhcccCCCCCCcc
Confidence 799999999999764 499999999999999999963 43221 1111 1 111112222211
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 584 ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 584 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
+.......=..++.++++.||.+|||+.|++.
T Consensus 839 f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 839 FFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 22333344578999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=312.79 Aligned_cols=145 Identities=30% Similarity=0.432 Sum_probs=130.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...++||+|+||.||+|... +++.||||+++.. .......+..|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 6889999988642 2334567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+.+++|.+++... ..+++...+.|+.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 84 Ey~~g~~L~~li~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 84 EYLIGGDVKSLLHIY----------------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred eCCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEE
Confidence 999999999998653 25888999999999999999999998 99999999999999999999
Q ss_pred EeecCCcc
Q 046188 488 VSDFGTSR 495 (646)
Q Consensus 488 I~DfGla~ 495 (646)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=274.56 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 324 AEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 324 ~~el~~~t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
++++-+.| .+.||+|+|++|--.+ +.+|..+|||++.........+..+|++++.+. .|+||++|+++|+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 56666666 3579999999998877 568999999998877666778899999999999 4999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..|||||.|.||+|..++++.+ .+++.+..++..+||.||.+||.++ |.|||+||+|||..
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~----------------~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK----------------HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCE 210 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh----------------hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeec
Confidence 9999999999999999998753 5889999999999999999999999 99999999999996
Q ss_pred CCC---cEEEeecCCccccC--CC----CCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCC
Q 046188 482 DKF---SAKVSDFGTSRSVP--ND----KTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKP 547 (646)
Q Consensus 482 ~~~---~~kI~DfGla~~~~--~~----~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p 547 (646)
... -+||+||.+..-.. .+ ....-.+.+|+..|||||+.. ...|+.+.|.||+||+||-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 544 48999998875431 11 111223357888999999763 24578899999999999999999999
Q ss_pred CCCCchHHh----hcHHHHHHHHHhhchhHH-HhhhhhcccCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 548 ICLTREEEE----RNLVAYFISLAKENKLLE-ILDARVAKEASE----EDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 548 ~~~~~~~~~----~~l~~~~~~~~~~~~~~~-~~d~~l~~~~~~----~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
|....+.+- ......-.. .+.+ +-+.. -++|+ ..+....+++...+..|+.+|.++.+++.+
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~-----~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQN-----KLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccCccCCcCCccCCCccHHHHH-----HHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 976554321 111111111 1111 11111 13343 344567789999999999999999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=274.60 Aligned_cols=220 Identities=23% Similarity=0.230 Sum_probs=176.5
Q ss_pred cCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCchhhhhh
Q 046188 343 GGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHD 421 (646)
Q Consensus 343 G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~ 421 (646)
|.+|.||++.. .+++.+|+|+++... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 468899999987532 233455555566799999999999999999999999999999999865
Q ss_pred hhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 046188 422 HQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501 (646)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~ 501 (646)
. ..+++.....++.|+++||+|||+.+ ++||||||+||++++++.++++|||.+.......
T Consensus 79 ~----------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~ 139 (237)
T cd05576 79 F----------------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC 139 (237)
T ss_pred h----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc
Confidence 3 25899999999999999999999998 9999999999999999999999999887653221
Q ss_pred CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhc
Q 046188 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 581 (646)
Q Consensus 502 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 581 (646)
....++..|+|||.+..+.++.++||||+|+++|||++|+.|+....... .....
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~ 194 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTT 194 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccc
Confidence 12345678999999988888999999999999999999998764221100 00000
Q ss_pred ccCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 582 KEASEEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 582 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
...+......+.+++.+||+.||++||++.
T Consensus 195 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 195 LNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 122333456789999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-33 Score=311.13 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=214.6
Q ss_pred HHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe
Q 046188 324 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399 (646)
Q Consensus 324 ~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~ 399 (646)
..+++-..++|.+.+.||+|+||.|..++.+ .++.+|+|+++. ....+..-|..|-.+|..-+.+-|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4556666789999999999999999999964 588999999876 223445578899999999999999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
+..+|||||||+||+|...|.+. .+++...+..++..|+-||.-||+.| +|||||||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----------------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvL 207 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----------------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVL 207 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----------------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeE
Confidence 99999999999999999999764 35888889999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc----c-CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ----S-SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
||..|.+||+|||.+-.+..++.-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||+...
T Consensus 208 ld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-- 285 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-- 285 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--
Confidence 999999999999999888766666666778999999999984 2 678999999999999999999999997432
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCC--HHHHHHHHHHHHhccccCCCCCCC---HHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEAS--EEDIEAVAELAMGCLRLNSKKRPT---MKQVSMDL 617 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPs---~~evl~~L 617 (646)
+.. ....+|+-.-...+| .+.+....+||.+.+. +|..|-. ++++-.|.
T Consensus 286 ----lve---------TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 286 ----LVE---------TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ----HHH---------HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 111 122344433333344 4577888999999885 6777877 88877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=268.27 Aligned_cols=236 Identities=31% Similarity=0.430 Sum_probs=192.1
Q ss_pred CcEEEEEEEcC-CCCEEEEEecccCCHHH-HHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCchhhhhh
Q 046188 344 GFGTVYKGMLP-DGSIVAVKRSKAIDKTQ-IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHD 421 (646)
Q Consensus 344 ~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~ 421 (646)
+||.||+|... +|+.+++|+........ .+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999975 48999999987644433 67889999999999999999999999998999999999999999998865
Q ss_pred hhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 046188 422 HQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501 (646)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~ 501 (646)
. ..+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~ 141 (244)
T smart00220 81 R----------------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG 141 (244)
T ss_pred c----------------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc
Confidence 3 23889999999999999999999998 9999999999999999999999999998764432
Q ss_pred CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhc
Q 046188 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 581 (646)
Q Consensus 502 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 581 (646)
......++..|++||.+....++.++||||||++++||++|..|+......+. .. +.+.....
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~~---------~~~~~~~~ 204 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------LF---------KKIGKPKP 204 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------HH---------HHHhccCC
Confidence 22345678899999999988899999999999999999999999864211110 01 11111000
Q ss_pred ccCCH--HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 582 KEASE--EDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 582 ~~~~~--~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
..... .....+.+++.+||..+|++||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 205 PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00001 14567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=294.17 Aligned_cols=278 Identities=19% Similarity=0.240 Sum_probs=187.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-----------------CCCCEEEEEecccCCHHHHHHHH--------------HHH
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-----------------PDGSIVAVKRSKAIDKTQIEQFI--------------NEV 379 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-----------------~~g~~VAVK~l~~~~~~~~~~~~--------------~Ei 379 (646)
.++|+..++||+|+||.||+|.. .+++.||||+++.......++|. .|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999963 23568999998754433333333 466
Q ss_pred HHHhhcCccCc-----eeEEEEEEe--------CCceEEEEEeccCCCchhhhhhhhhhH-HHHHH-------HHHhhhc
Q 046188 380 VILSQINHRHI-----VKLLGCCLE--------TEVPVLVYEYICNGNLSHHIHDHQQQQ-EQKQE-------LEEEQEL 438 (646)
Q Consensus 380 ~il~~l~H~ni-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~l~~~~~~~-~~~~~-------~~~~~~~ 438 (646)
.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++...... ....+ .......
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 678888753 346799999999999999997642110 00000 0011112
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChh
Q 046188 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518 (646)
Q Consensus 439 ~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 518 (646)
..++|..+..|+.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 35788999999999999999999998 999999999999999999999999999765433222222234588999999
Q ss_pred ccccCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCCCchHHhhcHHHHHHHHHhh-chhHH
Q 046188 519 YFQSSQY----------------------TDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVAYFISLAKE-NKLLE 574 (646)
Q Consensus 519 ~l~~~~~----------------------s~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~~~-~~~~~ 574 (646)
.+..... ..+.||||+||+++||++|.. |+........ ........ ..++.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-----~~~~~~~~~~~~r~ 455 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-----ELRQYDNDLNRWRM 455 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-----HHhhccchHHHHHh
Confidence 8754321 235799999999999999875 5532111000 00000000 00111
Q ss_pred HhhhhhcccCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 046188 575 ILDARVAKEASEEDIEAVAELAMGCLRLNS---KKRPTMKQVSMD 616 (646)
Q Consensus 575 ~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP---~~RPs~~evl~~ 616 (646)
+.......+..........+|+.++|..+| .+|+|+.|+++|
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111111223345778899999999876 689999999876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=276.07 Aligned_cols=240 Identities=27% Similarity=0.390 Sum_probs=199.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
.+|+.+..||+|+||.|-+|..+ ..+.+|||+++.. ...+.+--+.|-++|... +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47888999999999999999865 3578999998762 233444456677788776 568899999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+.+|+|--++... ..+.+..+..+|.+||-||-+||+.+ |+.||||..|||||.+|.+
T Consensus 429 MEyvnGGDLMyhiQQ~----------------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV----------------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred EEEecCchhhhHHHHh----------------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCce
Confidence 9999999998888663 45778889999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++..--+. ..+.+.+||+.|+|||.+...+|+..+|.|||||+||||+.|++||+..++++.
T Consensus 490 Ki~DFGmcKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---------- 558 (683)
T KOG0696|consen 490 KIADFGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---------- 558 (683)
T ss_pred EeeecccccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----------
Confidence 999999998643222 234568999999999999999999999999999999999999999987654431
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
...+++... .||...+.+...+.+..|.+.|.+|.
T Consensus 559 -----F~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 -----FQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----HHHHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 223333332 46777778888999999999999994
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=298.84 Aligned_cols=273 Identities=20% Similarity=0.283 Sum_probs=174.1
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-C----CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEE------EE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-D----GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC------CL 398 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~----g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~------~~ 398 (646)
..++|...+.||+|+||.||+|+.. + +..||||+++.... .+.+..| .+++..+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999964 4 68999998765322 1111221 1222222222222211 23
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHH----HHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL----EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~----~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
++...+|||||+++++|.+++............+ .............+..|+.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 4567899999999999999987542110000000 00000111234456789999999999999998 9999999
Q ss_pred CCCEEECC-CCcEEEeecCCccccCCCCCccccccccCCcccChhccccC----------------------CCCCccch
Q 046188 475 SSNILLDD-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----------------------QYTDKSDV 531 (646)
Q Consensus 475 ~~NILl~~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~ksDV 531 (646)
|+|||+++ ++.+||+|||+++..............++++|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999987654444444556789999999965322 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh-chhHH---Hhhhhhccc------CCHHHHHHHHHHHHhccc
Q 046188 532 YSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE-NKLLE---ILDARVAKE------ASEEDIEAVAELAMGCLR 601 (646)
Q Consensus 532 wSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~---~~d~~l~~~------~~~~~~~~l~~Li~~Cl~ 601 (646)
|||||+||||+++..+.... .......+... ..... ...+....+ ..........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999977654211 11111111110 01111 111110000 001112345689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 046188 602 LNSKKRPTMKQVSMD 616 (646)
Q Consensus 602 ~dP~~RPs~~evl~~ 616 (646)
.||.+|||+.|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=277.22 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=198.3
Q ss_pred hcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecc--cCCHH-----HHHHHHHHHHHHhhcCccCceeEEEEEE-eCC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--AIDKT-----QIEQFINEVVILSQINHRHIVKLLGCCL-ETE 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~--~~~~~-----~~~~~~~Ei~il~~l~H~niv~l~g~~~-~~~ 401 (646)
.++|-.+++||+|||+.||++. +.+.+.||||+-. ..... -.+...+|..|-+.+.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567677899999999999999 5568899999732 22111 2345678999999999999999999986 456
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
.++-|+||++|.+|.-||+.++ .++++++..|++||+.||.||.+.. |||||-||||.||||-
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----------------lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv 604 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----------------LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLV 604 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----------------hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEe
Confidence 7889999999999999998764 4889999999999999999999875 7799999999999994
Q ss_pred ---CCCcEEEeecCCccccCCCCCc------cccccccCCcccChhcccc----CCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 482 ---DKFSAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 482 ---~~~~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
.-|.+||+||||++.+.++... .+....||.+|++||.+-- .+++.|+||||.||++|..+.|+.||
T Consensus 605 ~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 605 NGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred cCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 4588999999999988644332 3344679999999998753 36789999999999999999999999
Q ss_pred CCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... .++.+..+...-+ ...+.-+-...+...+|++||++.-++|....++..+
T Consensus 685 GhnqsQQ---------dILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 685 GHNQSQQ---------DILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred CCchhHH---------HHHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 6432211 1111111111111 1111123345667899999999999999988887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=244.45 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=196.8
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+|+..++||+|.||+||+|+.+ .++.||+|+++.. ++.--...++|+-+++.++|.|||+++++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556778999999999999954 5899999987653 333345778999999999999999999999888999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+ .-+|..+.... ...++.+....++.|+++||.++|+++ +.|||+||.|.|++.+|++|++
T Consensus 83 c-dqdlkkyfdsl---------------ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkla 143 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL---------------NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_pred h-hHHHHHHHHhc---------------CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEec
Confidence 9 55666666543 346888999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH-
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA- 567 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~- 567 (646)
|||+++.+.-.-... ..-+.|..|.+|.++.+. .|++..|+||-||++.|+....+|.....+. ..++...|+..-
T Consensus 144 dfglarafgipvrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~ 221 (292)
T KOG0662|consen 144 DFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGT 221 (292)
T ss_pred ccchhhhcCCceEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCC
Confidence 999999875433222 233578999999998774 5789999999999999999866665443322 222333333221
Q ss_pred -hhc---hhHHHhhhhhcccCCH---------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 -KEN---KLLEILDARVAKEASE---------EDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 -~~~---~~~~~~d~~l~~~~~~---------~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.++ .+...-|-.....++. .....-.+++.+.+.-+|.+|.++++.+++
T Consensus 222 p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 222 PTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 1112222222222221 112234678888899999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=285.61 Aligned_cols=243 Identities=25% Similarity=0.297 Sum_probs=196.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++.|.....+|.|+|+.|-++... +++..+||++... ..+..+|+.++... +|||++++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 667888888999999999998853 5788999987653 12334677666665 79999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE-CCCCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-DDKFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl-~~~~~~k 487 (646)
.+.++-|.+.+.... ....++..|+.+|+.|+.|||+++ +||||+||+|||+ ++.+.++
T Consensus 397 ~l~g~ell~ri~~~~-----------------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lr 456 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-----------------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLR 456 (612)
T ss_pred hccccHHHHHHHhcc-----------------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEE
Confidence 999998877765532 222677789999999999999999 9999999999999 6899999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||.++....+ ....+-|..|.|||.+....+++++|+||||++||||++|+.||.....+.
T Consensus 457 ltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------------ 520 (612)
T KOG0603|consen 457 LTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------------ 520 (612)
T ss_pred EEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------------
Confidence 9999999977544 222346789999999999999999999999999999999999986543321
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
+++..-....+....+....+|+.+||+.||.+||+|.++..+=..
T Consensus 521 ------ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 521 ------EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111111223345667788999999999999999999999887665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=264.52 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=195.6
Q ss_pred ccCHHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-HHHHHHHHHHHHHhh-cCccCceeEEEEE
Q 046188 321 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-TQIEQFINEVVILSQ-INHRHIVKLLGCC 397 (646)
Q Consensus 321 ~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~-l~H~niv~l~g~~ 397 (646)
.|+.+.++. ...||.|+||+|+|-..+ .|+..|||+++.... .+.++++.|.+...+ -+.||||+++|.+
T Consensus 60 ~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 355555544 567999999999998864 689999999876443 556678888876544 4789999999999
Q ss_pred EeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 398 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
..++..++.||.| ..||..+...-.. .....+++.-.-.|....+.||.||.+.-+ |+||||||+|
T Consensus 133 F~EGdcWiCMELM-d~SlDklYk~vy~-----------vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSN 198 (361)
T KOG1006|consen 133 FSEGDCWICMELM-DISLDKLYKRVYS-----------VQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSN 198 (361)
T ss_pred hcCCceeeeHHHH-hhhHHHHHHHHHH-----------HHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhh
Confidence 9999999999999 5666554432211 113468888888899999999999987654 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
||||..|.+||+|||++-.+.+. ...+.-.|...|||||.+... .+..++||||+|++|+|+.||+-|+.....
T Consensus 199 ILldr~G~vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-- 274 (361)
T KOG1006|consen 199 ILLDRHGDVKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-- 274 (361)
T ss_pred eEEecCCCEeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--
Confidence 99999999999999998765322 222334588899999998653 478899999999999999999999854322
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhh-hcc-cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDAR-VAK-EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~-l~~-~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+.+..+... |+. +.. ....+....+..++.-|+.+|...||...++.++
T Consensus 275 ---vfeql~~Vv~g-------dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 ---VFEQLCQVVIG-------DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---HHHHHHHHHcC-------CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12222222111 111 111 1123456789999999999999999999998875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=264.23 Aligned_cols=266 Identities=22% Similarity=0.346 Sum_probs=192.5
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--------C
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--------E 401 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--------~ 401 (646)
.|....+||+|.||.||+|+.+ +|+.||+|+.-.. ...--...++|+++|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445678999999999999954 5778999874321 122234567899999999999999999887532 2
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..||||.+++ -+|.-.|.... .+++..++.+++.++.+||.|+|... |+|||+|+.|+||+
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~---------------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK---------------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLIT 158 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc---------------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEc
Confidence 4799999984 46666665432 36888999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCC---CccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 482 DKFSAKVSDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
.++.+||+|||+++.+.... ....+..+.|..|.+||.+.+ ..++++.|||+-||+|.||+||.+-+....+....
T Consensus 159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 99999999999998774322 222334557999999998776 57899999999999999999999887765544333
Q ss_pred cHHHHHHHHHhhc--------hhHHHhhhh-hcc-cC--------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 558 NLVAYFISLAKEN--------KLLEILDAR-VAK-EA--------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 558 ~l~~~~~~~~~~~--------~~~~~~d~~-l~~-~~--------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.+..........+ .+.+-+... +.. .+ |-.-.+..++|+..++..||.+|+++.+++.+-
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 3322221111111 111111000 000 00 001123567899999999999999999988654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=286.56 Aligned_cols=262 Identities=21% Similarity=0.402 Sum_probs=210.4
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 399 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~ 399 (646)
..++.+...++-|++.+.||+|.+|.||+++ .++++.+|+|++....+. .++...|.+||+.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4455556667889999999999999999999 457899999988764333 23556788888887 79999999999873
Q ss_pred -----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 400 -----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 400 -----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
++.++||||||.+||..|.++.... .++.|..+..|+..++.||++||.+. ++|||||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g--------------~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDik 150 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG--------------NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIK 150 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcc--------------cchhhHHHHHHHHHHHHHHHHHhhcc---eeeeccc
Confidence 4678999999999999999977542 47999999999999999999999998 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCC
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPIC 549 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~ 549 (646)
-.|||++.++.+|+.|||++..+.... .......||+.|||||++.. ..|+..+|+||+|++-.||--|.+|+.
T Consensus 151 G~NiLLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 151 GQNVLLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred CceEEEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 999999999999999999998764322 22344679999999999864 346779999999999999999999987
Q ss_pred CCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 550 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+.. ......+ .|......+..-...+.++|..||.+|-.+||++.+++++
T Consensus 230 DmHPmr------aLF~IpR--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 230 DMHPMR------ALFLIPR--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred Ccchhh------hhccCCC--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 543321 1111111 1222223456677889999999999999999999998865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=257.67 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=196.4
Q ss_pred hcCCCcC-ccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC----Cce
Q 046188 331 TDNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET----EVP 403 (646)
Q Consensus 331 t~~~~~~-~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~----~~~ 403 (646)
|++|++. ++||-|-.|.|-....+ +|+.+|+|.+.... ...+|+++--.. .|||||.+++++.+. ..+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4566544 57999999999888743 68999999987532 345677765444 699999999998753 356
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD- 482 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 482 (646)
.+|||.|+||.|...+..+.. ..+++.+.-+|+.||+.|+.|||+.+ |.||||||+|+|.+.
T Consensus 135 LiVmE~meGGeLfsriq~~g~--------------~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t 197 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--------------QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTT 197 (400)
T ss_pred EeeeecccchHHHHHHHHccc--------------ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecC
Confidence 789999999999998877543 46999999999999999999999999 999999999999964
Q ss_pred --CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 483 --KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 483 --~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
|-.+||+|||+|+.... .....+.+-|+.|.|||++...+++...|+||+||++|-|++|.+||+...+... .
T Consensus 198 ~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---s 272 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---S 272 (400)
T ss_pred CCCcceEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---C
Confidence 56799999999997533 2233445789999999999999999999999999999999999999986543210 0
Q ss_pred HHHHHHHhhchhHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. +-...+...... .+.-...++...++++.+|..+|.+|.|+.|++.+-.
T Consensus 273 p--------gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 273 P--------GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred h--------hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 0 101111111111 1112455677889999999999999999999987654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=272.09 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=195.2
Q ss_pred CccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCC
Q 046188 337 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
.+.||+|.||+||-|+.+ +|+.||||.+.. ...++...+.+|+.||++++||.||.|.-.|+..+..+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999954 799999997643 23344467889999999999999999999999999999999999544
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC---CCcEEEee
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFSAKVSD 490 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~kI~D 490 (646)
-|.-.|... ..+|+...-..++.||+.||.|||.++ |+|.||||+||||.+ -..+||+|
T Consensus 649 MLEMILSsE---------------kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 649 MLEMILSSE---------------KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred HHHHHHHhh---------------cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecc
Confidence 454444332 347888888899999999999999999 999999999999954 35799999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||.|+..++ ......++||+.|+|||++.+..|...-|+||.||++|--++|.-||..+.+- .+.+.. .
T Consensus 711 FGfARiIgE--ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----ndQIQN----A 779 (888)
T KOG4236|consen 711 FGFARIIGE--KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----NDQIQN----A 779 (888)
T ss_pred ccceeecch--hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----hHHhhc----c
Confidence 999998854 34456688999999999999999999999999999999999999998532211 111110 0
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+|-| ..--.+......+||...|+..-.+|.+...-+.+..
T Consensus 780 ---aFMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 780 ---AFMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ---ccccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 11111 0111344566789999999999999999887766544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=263.96 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=201.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc--c----CceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINH--R----HIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--~----niv~l~g~~~~~~~~ 403 (646)
+.+|.+...+|+|+||.|-....+ .+..||||+++...+ ..+..+-|+++|+++++ | -+|.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999988754 378999999987543 34456679999999943 2 367788888888999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD- 482 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 482 (646)
++|+|.+ |-|+.+||..+. ..+.+..+...|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~--------------y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN--------------YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSS 228 (415)
T ss_pred EEEEecc-ChhHHHHhccCC--------------ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEecc
Confidence 9999998 679999998754 247889999999999999999999999 999999999999941
Q ss_pred -------------------CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh
Q 046188 483 -------------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543 (646)
Q Consensus 483 -------------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt 543 (646)
+..+||+|||.|....... ..++.|..|.|||++.+-.++..+||||+||+|.|+.+
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 3468999999998753332 44678999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHhhcHHHHHHH-----HHh---------hch-----------hHHHhhhhh----cccCCHHHHHHHHH
Q 046188 544 GKKPICLTREEEERNLVAYFIS-----LAK---------ENK-----------LLEILDARV----AKEASEEDIEAVAE 594 (646)
Q Consensus 544 G~~p~~~~~~~~~~~l~~~~~~-----~~~---------~~~-----------~~~~~d~~l----~~~~~~~~~~~l~~ 594 (646)
|..-|+..+..+...+.+.+.. +.. .++ .....++.. .....+.+...|.+
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 9999887654443221111100 000 000 000111000 01123455678999
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 046188 595 LAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 595 Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
|+.+||..||.+|+|+.|++.+
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=286.36 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=188.2
Q ss_pred CCCcCccccccCcEE-EEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEec
Q 046188 333 NYNQSRFLGQGGFGT-VYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~-Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
-|...+.+|.|+.|+ ||+|.+ +|+.||||++-.. ......+|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 345557789999876 799999 6899999987642 233556899999988 6999999999988888999999998
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-----CCc
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KFS 485 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~~ 485 (646)
..+|.+++..... . .....-...+.+..|+++||++||+.+ ||||||||.||||+. ..+
T Consensus 586 -~~sL~dlie~~~~-d-----------~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~r 649 (903)
T KOG1027|consen 586 -ACSLQDLIESSGL-D-----------VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLR 649 (903)
T ss_pred -hhhHHHHHhcccc-c-----------hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCccee
Confidence 8899999977411 0 111222456788899999999999988 999999999999975 368
Q ss_pred EEEeecCCccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCchHHhhcHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG-KKPICLTREEEERNLVAY 562 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~l~~~ 562 (646)
++|+|||+++....+..... ....||.||+|||++....-+..+||||+||++|..++| .+||...-..+ .+
T Consensus 650 a~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N---- 724 (903)
T KOG1027|consen 650 AKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN---- 724 (903)
T ss_pred EEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh----
Confidence 99999999999866554433 346799999999999998888899999999999999996 88885321110 00
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
-...+..+..+ .+ ..++ ...+||.+|++.||..||++.+|+.
T Consensus 725 --Il~~~~~L~~L------~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 725 --ILTGNYTLVHL------EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --hhcCccceeee------cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00011111100 11 1112 6789999999999999999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=252.06 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=197.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
.+|+..+.||+|+|..|-.+.+. +.+.+|+|+++. .+.++..-...|-.+..+- +||.+|-|..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57888999999999999999864 567899998765 2233333344566665554 799999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
.||+++|+|--++...+ .|+++.+..+...|.-||.|||+.| |+.||+|..|+|+|..|.+
T Consensus 330 ieyv~ggdlmfhmqrqr----------------klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR----------------KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred EEEecCcceeeehhhhh----------------cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCce
Confidence 99999999988887643 5889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH-hhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE-ERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~-~~~l~~~~~~ 565 (646)
||+|+|+.+.--. ....+.+.+|||.|+|||.+.+..|...+|.|++||+|+||+.|+.||+....++ +.+.-++..+
T Consensus 391 kltdygmcke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq 469 (593)
T KOG0695|consen 391 KLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ 469 (593)
T ss_pred eecccchhhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence 9999999986432 2334556899999999999999999999999999999999999999997543221 2222333332
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
+.. +..+ ..|...+.....+++..|.+||.+|.
T Consensus 470 vil--------ekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 470 VIL--------EKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHh--------hhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 222 2222 23444556677889999999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=269.41 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=206.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCC-EEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~-~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++..+-.||-|+||.|-+...+... .+|+|.++. .+..+.+....|-.||.+.+.|.||+++-.+.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999999875433 378887654 45566778889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|-|-||.|...|++. ..++......++..+.+|++|||.++ ||.|||||+|.+||.+|-+|
T Consensus 500 EaClGGElWTiLrdR----------------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----------------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred HhhcCchhhhhhhhc----------------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceE
Confidence 999999999999874 35777888889999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|.|||+|+.+..+.. +-+++||+.|.|||.+.+...+..+|.||+|++++||++|.+||...++...- ...+
T Consensus 561 LVDFGFAKki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY------n~IL 632 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY------NLIL 632 (732)
T ss_pred EeehhhHHHhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH------HHHH
Confidence 999999999865543 45689999999999999999999999999999999999999999866543221 1111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~L~ 618 (646)
. .--..++|........+|+++....+|.+|.- +.||-++-.
T Consensus 633 k---------Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 633 K---------GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred h---------hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 1 11112456666677889999999999999976 677776655
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=237.69 Aligned_cols=211 Identities=37% Similarity=0.621 Sum_probs=183.4
Q ss_pred ccccCcEEEEEEEcCC-CCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCchh
Q 046188 340 LGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSH 417 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 417 (646)
||+|++|.||++...+ ++.+++|+....... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998765432 34678899999999999999999999999889999999999999999
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCcEEEeecCCccc
Q 046188 418 HIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGTSRS 496 (646)
Q Consensus 418 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kI~DfGla~~ 496 (646)
++.... ..+++..++.++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+..
T Consensus 81 ~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 81 LLKENE---------------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred HHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 986531 25899999999999999999999998 999999999999999 89999999999987
Q ss_pred cCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHH
Q 046188 497 VPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 575 (646)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 575 (646)
...... ......+...|++||..... ..+.+.|+|++|+++++|
T Consensus 143 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 143 LTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred ccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 643321 12234578899999999877 788999999999999999
Q ss_pred hhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 576 LDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 576 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..+.+++.+|++.||.+||++.++++.+
T Consensus 188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=261.39 Aligned_cols=213 Identities=25% Similarity=0.389 Sum_probs=175.5
Q ss_pred HHHHHHHh---cCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEE
Q 046188 324 AEELQRAT---DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGC 396 (646)
Q Consensus 324 ~~el~~~t---~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~ 396 (646)
|-.|+++. .-|-.++.||-|+||.|.++. .++...+|+|.++.. ...+......|-.||..-..+-||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44555554 346678899999999999988 445678999987653 23455567789999999999999999999
Q ss_pred EEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 397 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
|.+.+.+|+||+|++||++-.+|.+.. -+.+.....++.++..|+++.|..| +|||||||+
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmg----------------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPD 758 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMG----------------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPD 758 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhc----------------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCcc
Confidence 999999999999999999999987643 4666777788889999999999999 999999999
Q ss_pred CEEECCCCcEEEeecCCccccC---C------CCC--------------------------------ccccccccCCccc
Q 046188 477 NILLDDKFSAKVSDFGTSRSVP---N------DKT--------------------------------HLTTAVQGTFGYF 515 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~---~------~~~--------------------------------~~~~~~~gt~~y~ 515 (646)
|||||.+|.+||+||||+.-+. + +.- ......+||+.|+
T Consensus 759 NILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 759 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred ceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 9999999999999999975431 0 000 0011246999999
Q ss_pred ChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 516 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 516 aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
|||++....++.-+|.||.||+||||+.|+.||......+
T Consensus 839 apevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 839 APEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 9999999999999999999999999999999997655443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=233.58 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=194.4
Q ss_pred hcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCC--ceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETE--VPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~--~~~LV 406 (646)
.++|+..+++|+|.++.||.|. ..+.+.++||.+++..+ +.+.+|++||+.+. ||||++|+++..+.. .+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3678889999999999999999 45788999999997544 46679999999997 999999999988653 67899
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCc
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFS 485 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~ 485 (646)
+||+++.+..... +.|+...+...+.+++.||.|+|+.| |.|||+||.|+++|. .-.
T Consensus 114 FE~v~n~Dfk~ly-------------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhhhccccHHHHh-------------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence 9999888775543 35888899999999999999999999 999999999999985 457
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
++|+|+|+|.....+..... .+.+..|.-||.+-+ ..+...-|+|||||+|.+|+..+.||....... .++.. +.
T Consensus 172 LrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVk-Ia 247 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVK-IA 247 (338)
T ss_pred eeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHH-HH
Confidence 99999999998754433322 134566888998765 567889999999999999999999997543221 12222 11
Q ss_pred HHHhhc---------------hhHHHhhhhhcc-------cCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 SLAKEN---------------KLLEILDARVAK-------EAS-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 ~~~~~~---------------~~~~~~d~~l~~-------~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.++..+ ....++....+. ... .-..++..+++.+.|..|.++|||++|.+.+
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 122211 111111111100 000 1123677899999999999999999998865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=231.57 Aligned_cols=205 Identities=25% Similarity=0.395 Sum_probs=164.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc-CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.+.......||+|++|.|-+-++ .+|...|+|+++. .+.+..++.++|+.+..+. ..|.+|.++|....+...++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34445567899999999977773 4799999999765 3445556778888876654 7999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|.| .-||..|-..-.. ....+++.-.=+||..+.+||.|||++-+ ++|||+||+|||++.+|++|
T Consensus 125 E~M-~tSldkfy~~v~~------------~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLK------------KGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred HHh-hhhHHHHHHHHHh------------cCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEE
Confidence 998 6677766544322 13468888889999999999999999764 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCc
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKPICLTR 552 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 552 (646)
|+|||++-.+.+.-. .+-..|...|||||.+.. ..|+-|+||||+|+.+.||.+++.|++...
T Consensus 190 iCDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred EcccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999999987643211 122347889999998754 368899999999999999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=246.08 Aligned_cols=262 Identities=22% Similarity=0.337 Sum_probs=195.1
Q ss_pred CCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-----ceEE
Q 046188 334 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPVL 405 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-----~~~L 405 (646)
.+..+-||-|+||.||.... ++|+.||+|++... +-...+.+.+|+++|..++|.|++..++...... +.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34567899999999999885 47999999998653 2334567899999999999999999888765432 3466
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
+.|.| ..+|...+-. ...|+-....-+..||++||.|||+.+ |.||||||.|.|+++|..
T Consensus 135 ~TELm-QSDLHKIIVS----------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCv 194 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS----------------PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCI 194 (449)
T ss_pred HHHHH-Hhhhhheecc----------------CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCce
Confidence 77776 4556555543 246888888899999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||+++.-..+...-.+.-+.|..|.|||.+.+. .|+.+.||||.||++.||+..+--|....+.+...+ +.
T Consensus 195 LKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l---It 271 (449)
T KOG0664|consen 195 LKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM---II 271 (449)
T ss_pred EEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH---HH
Confidence 99999999998655544445555678999999999875 689999999999999999998887765554443332 22
Q ss_pred HHHhhchhH-----------HHhhhhhccc---------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLL-----------EILDARVAKE---------ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~-----------~~~d~~l~~~---------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+.+....+. .++....+.+ -+..-......+...++..||++|.+..+.+.++-
T Consensus 272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 222222111 1111111110 01122234567778899999999999998877653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=233.65 Aligned_cols=199 Identities=37% Similarity=0.535 Sum_probs=172.0
Q ss_pred CCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 334 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
|+..+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 789999998765444 56788899999999999999999999998889999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+++||+++.++.++|+||
T Consensus 81 ~~~L~~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 81 GGDLFDYLRKKGG---------------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred CCCHHHHHHhccc---------------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeC
Confidence 9999999865321 2889999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhcc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICL 550 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 550 (646)
|.+...............++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 143 g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99987754321122334578899999998 667788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=239.05 Aligned_cols=132 Identities=27% Similarity=0.404 Sum_probs=111.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-----c---cCceeEEEEEEeC--
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-----H---RHIVKLLGCCLET-- 400 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----H---~niv~l~g~~~~~-- 400 (646)
.+|...++||.|.|++||++.. .+.+.||+|+.+.. ..-.+..+.||++|++++ | ..||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5888999999999999999984 35789999998863 233456789999999983 3 4799999999854
Q ss_pred --CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 401 --EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 401 --~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
.+.+||+|+. |.+|..++.... ...++.....+|+.||+.||.|||... +|||-||||+||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~--------------YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN--------------YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC--------------CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 4789999998 888988887653 346999999999999999999999987 499999999999
Q ss_pred EEC
Q 046188 479 LLD 481 (646)
Q Consensus 479 Ll~ 481 (646)
|+.
T Consensus 220 Ll~ 222 (590)
T KOG1290|consen 220 LLC 222 (590)
T ss_pred eee
Confidence 993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=233.70 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=190.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------Cc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EV 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------~~ 402 (646)
.+|-..+.+|.|.- .|-.+... .++.||+|++.. .+....++..+|..++..++|+|+++++.++.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46666778888887 55555421 478999998643 2334456778999999999999999999998754 35
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.|+|||+| .++|...++- .++-.....|..|++.|+.|||+.+ |+||||||+||++..
T Consensus 96 ~y~v~e~m-~~nl~~vi~~------------------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~ 153 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM------------------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNS 153 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH------------------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecc
Confidence 69999999 7888887762 3667788899999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
+..+||.|||+|+.-... ...+..+.|..|.|||.+.+..+.+.+||||.||++.||++|+--|.+.+--+ -+..
T Consensus 154 ~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id---Q~~k 228 (369)
T KOG0665|consen 154 DCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID---QWNK 228 (369)
T ss_pred hhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH---HHHH
Confidence 999999999999864322 45566789999999999998889999999999999999999998876332111 0111
Q ss_pred HHHHHhhc--hhH---------------H--------H-hhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046188 563 FISLAKEN--KLL---------------E--------I-LDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614 (646)
Q Consensus 563 ~~~~~~~~--~~~---------------~--------~-~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 614 (646)
+.+.++.. +.. + . -|..+. .+.+.-......+++.+||..||++|.++++++
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 11111100 000 0 0 000000 011122345678899999999999999999998
Q ss_pred HH
Q 046188 615 MD 616 (646)
Q Consensus 615 ~~ 616 (646)
++
T Consensus 309 ~H 310 (369)
T KOG0665|consen 309 RH 310 (369)
T ss_pred cC
Confidence 76
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=246.46 Aligned_cols=196 Identities=23% Similarity=0.392 Sum_probs=166.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCC--------HHHHHHHHHHHHHHhhcC---ccCceeEEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAID--------KTQIEQFINEVVILSQIN---HRHIVKLLGCCLE 399 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~---H~niv~l~g~~~~ 399 (646)
.+|...+.+|+|+||.|+.+..+. ...|+||.+...+ ....-..-.||.||..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468888999999999999999754 5678888755421 111112345999999997 9999999999999
Q ss_pred CCceEEEEEeccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 400 TEVPVLVYEYICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 400 ~~~~~LV~Ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
++..||+||-...| +|.+++..+ +.+++.+..-|+.||+-|+++||+++ |||||||-+|+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----------------p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenv 701 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----------------PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENV 701 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----------------CccchHHHHHHHHHHHhccccccccC---ceecccccccE
Confidence 99999999987544 899998764 46999999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPIC 549 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~ 549 (646)
.++.+|-+||+|||.|....++. ...++||.+|.|||++.+.+| +..-|||++|++||-++....|++
T Consensus 702 ivd~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999998764433 345679999999999998876 567999999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-28 Score=257.18 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=202.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|.....+|.|+||.|||++. +.++..|||.++........-..+|+-+++..+||||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46888899999999999999994 47899999998877777777788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+.+|+|.+.-+. ..+|++.++.......++||.|||+.+ =+|||||-.|||+++.+.+|++
T Consensus 94 cgggslQdiy~~----------------TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----------------TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred cCCCcccceeee----------------cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeec
Confidence 999999988766 347899999999999999999999999 6899999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|||.+-.+... -.......||+.|||||+. ..+.|..++|||+.|+...|+---++|.....+. +.. +
T Consensus 155 Dfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r~l--~ 225 (829)
T KOG0576|consen 155 DFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------RAL--F 225 (829)
T ss_pred ccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------HHH--H
Confidence 99998765321 1223456899999999975 4567899999999999999998877775322111 000 0
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
+.... ..++.-. +-...-...+.++++.|+.++|++||+++.++.
T Consensus 226 LmTkS---~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 226 LMTKS---GFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Hhhcc---CCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00000 0011000 112334567899999999999999999998775
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-27 Score=274.12 Aligned_cols=197 Identities=20% Similarity=0.224 Sum_probs=139.9
Q ss_pred hcCc-cCceeEEEEE-------EeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHH
Q 046188 384 QINH-RHIVKLLGCC-------LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455 (646)
Q Consensus 384 ~l~H-~niv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~ 455 (646)
.++| +||.+++++| .+.+..++++||+ +++|.++|.... ..+++.+++.|+.||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~ 91 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---------------RSVDAFECFHVFRQIVE 91 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---------------ccccHHHHHHHHHHHHH
Confidence 4456 6888888887 2334567788987 779999996532 35899999999999999
Q ss_pred HHHHHHcCCCCCeEecCCCCCCEEECC-------------------CCcEEEeecCCccccCCCCC--------------
Q 046188 456 AVAYMHSSASIPIFHRDIKSSNILLDD-------------------KFSAKVSDFGTSRSVPNDKT-------------- 502 (646)
Q Consensus 456 gL~yLH~~~~~~ivHrDIk~~NILl~~-------------------~~~~kI~DfGla~~~~~~~~-------------- 502 (646)
||.|||+++ |+||||||+||||+. ++.+||+|||+++.......
T Consensus 92 al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 168 (793)
T PLN00181 92 IVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPF 168 (793)
T ss_pred HHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCC
Confidence 999999999 999999999999965 44556666666653211000
Q ss_pred -ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhc
Q 046188 503 -HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 581 (646)
Q Consensus 503 -~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 581 (646)
.......||+.|||||++.+..++.++|||||||+||||++|..|+.... . .+.... ...+.+..
T Consensus 169 ~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~---~~~~~~-----~~~~~~~~- 234 (793)
T PLN00181 169 PMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----R---TMSSLR-----HRVLPPQI- 234 (793)
T ss_pred cccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----H---HHHHHH-----HhhcChhh-
Confidence 00111357889999999999999999999999999999999988753110 0 000000 00111111
Q ss_pred ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 582 KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 582 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.........++.+||+.||.+||+|.||+++-
T Consensus 235 ----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 235 ----LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred ----hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 11123456888999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=213.70 Aligned_cols=170 Identities=24% Similarity=0.230 Sum_probs=127.5
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++.... ..++|.+++.|+.|+++||+|||+++ ||+|||++.++.+|+ ||
T Consensus 1 GsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG 54 (176)
T smart00750 1 VSLADILEVRG---------------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DG 54 (176)
T ss_pred CcHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--cc
Confidence 68888886532 36999999999999999999999976 999999999999999 99
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++...... ..||+.|||||++.+..++.++|||||||++|||++|+.|+....... ..........
T Consensus 55 ~~~~~~~~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~-- 121 (176)
T smart00750 55 SVAFKTPEQ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGM-- 121 (176)
T ss_pred ceEeecccc------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHh--
Confidence 998754322 258899999999999999999999999999999999999985332111 0111111000
Q ss_pred HHHhhhhhcccCCHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 573 LEILDARVAKEASEEDIE--AVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~--~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.. .++. ....+..... .+.+++.+||+.||.+||++.|+++++..+...
T Consensus 122 ~~-~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 122 PA-DDPR-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cc-CCcc-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 00 0000 0011222223 689999999999999999999999999877653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.99 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=194.0
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCce
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~ 403 (646)
...+.|..+++||+|.|++||++... ..+.||+|.+..... .....+|+++|..+ .+.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34467888999999999999999943 367899998776332 34678999999999 599999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD- 482 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 482 (646)
.+|+||++.....++.. .++..+...++..+..||.++|.+| ||||||||+|+|.+.
T Consensus 111 ~ivlp~~~H~~f~~l~~-------------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR-------------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRR 168 (418)
T ss_pred EEEecccCccCHHHHHh-------------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccc
Confidence 99999999988888774 3778889999999999999999999 999999999999975
Q ss_pred CCcEEEeecCCccccCC--------C----------C---------------Cc----------cccccccCCcccChhc
Q 046188 483 KFSAKVSDFGTSRSVPN--------D----------K---------------TH----------LTTAVQGTFGYFDPEY 519 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~--------~----------~---------------~~----------~~~~~~gt~~y~aPE~ 519 (646)
.++-.|.|||+|..... . . .. ......||+||.|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 57789999999972100 0 0 00 0011349999999998
Q ss_pred ccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh--hcHHHHHH--HH----Hhhch--h---------HHH----
Q 046188 520 FQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE--RNLVAYFI--SL----AKENK--L---------LEI---- 575 (646)
Q Consensus 520 l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~--~~l~~~~~--~~----~~~~~--~---------~~~---- 575 (646)
+.. +.-++++||||-||+++-+++++.||.....+-. ..+...+. ++ ...++ + .+.
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f 328 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF 328 (418)
T ss_pred HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence 764 5678999999999999999999999865432210 00000000 00 00011 0 000
Q ss_pred --h--hhh-------hcc-cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 576 --L--DAR-------VAK-EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 576 --~--d~~-------l~~-~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+ ... ... ...+..+..+++++.+|++.||.+|.|++|.+++
T Consensus 329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 000 000 1112233478999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=233.52 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=200.9
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcC------ccCceeEEEEEEeCCc
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQIN------HRHIVKLLGCCLETEV 402 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~------H~niv~l~g~~~~~~~ 402 (646)
.-.+|...-..|+|-|++|-+|... .|..||||++...... .+.=+.|++||++|+ --|.++|+-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3467888888999999999999954 4789999998764332 334468999999995 3489999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
++||+|-+ ..+|.+.|.+... .-.|.......++.|+.-||..|...+ |+|.||||.|||+++
T Consensus 509 LClVFE~L-slNLRevLKKyG~-------------nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGR-------------NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCc-------------ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 99999987 7789999987654 346888999999999999999999999 999999999999987
Q ss_pred C-CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 K-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~-~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
. ..+||||||.|.......- +.+.....|.|||++.+-+|+...|+||.||.||||.||+-.|.+.....-..+..
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 5 5789999999987643322 22334568999999999999999999999999999999999987654322111111
Q ss_pred HHH-----HHHhhc---------------------------hhHHHhhh------hhcc--cCC---HHHHHHHHHHHHh
Q 046188 562 YFI-----SLAKEN---------------------------KLLEILDA------RVAK--EAS---EEDIEAVAELAMG 598 (646)
Q Consensus 562 ~~~-----~~~~~~---------------------------~~~~~~d~------~l~~--~~~---~~~~~~l~~Li~~ 598 (646)
... .++..+ .+...+.| .+.. .++ ......+.+|+..
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 000 000000 00001111 1111 122 3456788999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 046188 599 CLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 599 Cl~~dP~~RPs~~evl~~ 616 (646)
|+..||++|.|..+.+.+
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999998865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=209.10 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=184.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEE-EEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGC-CLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~-~~~~~~~~LV~E 408 (646)
+.|.+.+.+|+|.||.+-++..+ ....+++|-+... .....+|.+|...--.+ .|.||+.-+++ |...+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 67888999999999999999976 4568899977653 23456888888765555 58999987765 445566778999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE-C-CCCcE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-D-DKFSA 486 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl-~-~~~~~ 486 (646)
|++.|+|.+-+... .+.+....+++.|++.|+.|||+.+ +||||||.+|||| + +..++
T Consensus 103 ~aP~gdL~snv~~~-----------------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rv 162 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----------------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRV 162 (378)
T ss_pred cCccchhhhhcCcc-----------------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEE
Confidence 99999998877542 4677788899999999999999999 9999999999999 3 34589
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-----QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
||+|||+.+..+..- ....-+..|.+||..... ...+.+|||.||++++.++||+.|+....- .....+.
T Consensus 163 KlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~ 237 (378)
T KOG1345|consen 163 KLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWE 237 (378)
T ss_pred EeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHH
Confidence 999999998653211 122345679999976432 346789999999999999999999863221 1111122
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
|.. ....+ .+++...+ ...++.+..+.++-+..++++|=-..++.++-......
T Consensus 238 ~~~--w~~rk-----~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 238 WEQ--WLKRK-----NPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHH--Hhccc-----CccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 111 11110 11111111 12345678888999999999996666666665554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=217.40 Aligned_cols=166 Identities=19% Similarity=0.175 Sum_probs=129.6
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEcC--CCCEEEEEecccC-----CHHHHHHHHHHHHHHhhcCccCcee-EEEEEEe
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKAI-----DKTQIEQFINEVVILSQINHRHIVK-LLGCCLE 399 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~~--~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~H~niv~-l~g~~~~ 399 (646)
...-++|...+.||+|+||+||+|... +++.||||+.... .....+.|.+|+++|++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344578999999999999999999864 5778899985432 2334567899999999999999985 443
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI-KSSNI 478 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI-k~~NI 478 (646)
.+..+|||||+++++|... .. .. ...++.++++||.|||+++ |+|||| ||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~-------------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NI 143 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP-------------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNW 143 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc-------------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceE
Confidence 2457999999999999621 10 00 1357889999999999999 999999 99999
Q ss_pred EECCCCcEEEeecCCccccCCCCCc-------cccccccCCcccChhccccC
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKTH-------LTTAVQGTFGYFDPEYFQSS 523 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~ 523 (646)
|++.++.+||+|||+|+........ ..+...++..|+|||++...
T Consensus 144 Lv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 144 LMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999999999976432211 11356788999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-24 Score=206.23 Aligned_cols=246 Identities=21% Similarity=0.303 Sum_probs=193.5
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCC
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
..+|.+...|..|+|++. |..+++|+++. .......+|..|.-.|+-+.||||+.++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 456888888999999995 55566676543 333344578899999999999999999999999999999999999999
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe--ecC
Q 046188 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS--DFG 492 (646)
Q Consensus 415 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~--DfG 492 (646)
|...|+.... ...+-.+..+++.++|+|++|||+... -|.---+.+..+++|++.+++|+ |--
T Consensus 274 lynvlhe~t~--------------vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 274 LYNVLHEQTS--------------VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred HHHHHhcCcc--------------EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccce
Confidence 9999998643 357788999999999999999999873 24455699999999999998885 222
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCC---CccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT---DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s---~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
++... ....-.+.||+||.+...+-. ..+|+|||.++||||.|...||....+.+...
T Consensus 339 fsfqe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------- 399 (448)
T KOG0195|consen 339 FSFQE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------- 399 (448)
T ss_pred eeeec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------
Confidence 22111 011135789999998766543 47999999999999999999997554433211
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.+--..++...|+..+..+.+||.-|+..||.+||.+..|+-.|+++.
T Consensus 400 ----kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 400 ----KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 112234455678888899999999999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=202.88 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=193.5
Q ss_pred CCCcCccccccCcEEEEEEEcCCC--CEEEEEecccCCHHHHHHHHHHHHHHhhcCc----cCceeEEEEEE-eCCceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDG--SIVAVKRSKAIDKTQIEQFINEVVILSQINH----RHIVKLLGCCL-ETEVPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g--~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H----~niv~l~g~~~-~~~~~~L 405 (646)
+|...+.||+|+||.||++...+. ..+|+|............+..|..++..+.+ +++.++++... .+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996443 4788887654322222256678888888863 68999999884 6667899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC--
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-- 483 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-- 483 (646)
||+.. +.+|.++..... ...++....++|+.|++.+|++||+.| ++||||||.|+++...
T Consensus 99 VM~l~-G~sL~dl~~~~~--------------~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~ 160 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--------------PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSR 160 (322)
T ss_pred EEecc-CccHHHHHHhCC--------------CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCC
Confidence 99987 889998775442 247899999999999999999999999 9999999999999754
Q ss_pred ---CcEEEeecCCcc--ccCCCCC-----c-c-ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 484 ---FSAKVSDFGTSR--SVPNDKT-----H-L-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 484 ---~~~kI~DfGla~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
..+.|.|||+++ ....... . . .....||..|.+++...+...+.+.|+||++.++.|++.|..|+...
T Consensus 161 ~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 161 SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 469999999999 4321111 1 1 12355999999999999999999999999999999999999998543
Q ss_pred chHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
...... ..+...... ..... .....+..+.++...+-..+..++|....+...|+......
T Consensus 241 ~~~~~~---~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 241 EMTDLK---SKFEKDPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred cccchH---HHHHHHhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 322111 011111100 00000 12223345666666666689999999999999988877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-21 Score=198.13 Aligned_cols=260 Identities=30% Similarity=0.440 Sum_probs=195.5
Q ss_pred CCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHH---HHHHHHHHHHHHhhcCcc-CceeEEEEEEeCCceEEEEEe
Q 046188 334 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT---QIEQFINEVVILSQINHR-HIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~---~~~~~~~Ei~il~~l~H~-niv~l~g~~~~~~~~~LV~Ey 409 (646)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999975 78899987653222 466889999999999988 799999999777778999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-cEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI 488 (646)
+.++++.+++...... ..++......++.|++.++.|+|+.+ ++|||+||+||+++... .+++
T Consensus 80 ~~~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-------------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred CCCCcHHHHHHhcccc-------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEE
Confidence 9999999666543210 25888999999999999999999999 99999999999999988 7999
Q ss_pred eecCCccccCCCCCc-----cccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchH-HhhcH
Q 046188 489 SDFGTSRSVPNDKTH-----LTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREE-EERNL 559 (646)
Q Consensus 489 ~DfGla~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~-~~~~l 559 (646)
+|||+++........ ......|+..|+|||.+.. ...+...|+||+|++++++++|..|+...... .....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 999999865433322 2355679999999999987 57889999999999999999999996544321 00001
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.......... .................+.+++..|+..+|..|.++.+....
T Consensus 224 ----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 ----LKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----HHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111000000 000000000001223567899999999999999999988776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=219.16 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=185.2
Q ss_pred cCccccccCcEEEEEEEc-CCCCEEEEEecc-----cCCHHHH-HHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 336 QSRFLGQGGFGTVYKGML-PDGSIVAVKRSK-----AIDKTQI-EQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~-----~~~~~~~-~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..+.+|.|++|.|+.... ...+..+.|... ....... ..+..|+.+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467899999997777663 234444444322 2222222 225678888888999999887777666655555699
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++ +|..++... ..++-.++..++.|+..|+.|||+.| +.|||+|++|++++.++.+||
T Consensus 402 ~~~~-Dlf~~~~~~----------------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki 461 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----------------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKI 461 (601)
T ss_pred cccH-HHHHHHhcc----------------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEE
Confidence 9999 999888653 25888899999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCC---ccccccccCCcccChhccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 489 SDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTD-KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 489 ~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~-ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+|||.+..+..+.. ......+|...|+|||.+....|.+ ..||||.|+++..|++|+.|+......+... .
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~ 536 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----K 536 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----h
Confidence 99999987643322 4556678999999999999988865 6999999999999999999986443322111 0
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.............+ .......+.....++.++|+.||.+|.||++|++.=
T Consensus 537 ~~~~~~~~~~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred hhccccccccccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 00000000000000 011234456678899999999999999999998753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=178.74 Aligned_cols=139 Identities=18% Similarity=0.130 Sum_probs=107.9
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHH--H------------------------HHHHHHHHHHHhhcCccCc
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT--Q------------------------IEQFINEVVILSQINHRHI 390 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~--~------------------------~~~~~~Ei~il~~l~H~ni 390 (646)
...||+|++|.||+|...+|+.||||+++..... . ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999988653211 0 0122359999999988876
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeE
Q 046188 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYM-HSSASIPIF 469 (646)
Q Consensus 391 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yL-H~~~~~~iv 469 (646)
.....+.. ...+|||||++++++...... ...+++....+++.|++.+|.|| |+.+ |+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~l~H~~g---ii 140 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----------------DAPLSESKARELYLQVIQIMRILYQDCR---LV 140 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 44333322 233899999988877654322 12588999999999999999999 6888 99
Q ss_pred ecCCCCCCEEECCCCcEEEeecCCcccc
Q 046188 470 HRDIKSSNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 470 HrDIk~~NILl~~~~~~kI~DfGla~~~ 497 (646)
||||||+|||++ ++.++|+|||+|...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=183.54 Aligned_cols=170 Identities=15% Similarity=0.153 Sum_probs=131.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCC---HHHHHH------HHHHHHHHhhcCccCceeEEEEEEeC-
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID---KTQIEQ------FINEVVILSQINHRHIVKLLGCCLET- 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~---~~~~~~------~~~Ei~il~~l~H~niv~l~g~~~~~- 400 (646)
..+|...+.+|.|+||.||.... ++..+|||.+.... +...+. +.+|+..+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999766 57789999986532 222223 57899999999999999999886643
Q ss_pred -------CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 401 -------EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 401 -------~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------------~~~----~~~~~i~~~l~~lH~~g---i~H~Di 161 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------------------ISE----DVKAKIKASIESLHQHG---MVSGDP 161 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------------------ccH----HHHHHHHHHHHHHHHcC---CccCCC
Confidence 35789999999999977631 111 23558999999999999 999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHH
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELL 542 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ell 542 (646)
+|+||++++++ ++|+|||.......+... ..++....+..++|+|+||+.+.-+.
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999988 999999988765322111 01333445667999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=200.92 Aligned_cols=218 Identities=22% Similarity=0.418 Sum_probs=163.1
Q ss_pred HhhcCccCceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 046188 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 461 (646)
Q Consensus 382 l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 461 (646)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.... ..++|.-...+..+++.||+|||
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---------------~~~d~~F~~s~~rdi~~Gl~ylh 65 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---------------IKLDYFFILSFIRDISKGLAYLH 65 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---------------cCccHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999999999999999997742 36999999999999999999999
Q ss_pred cCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCC-CCccccccccCCcccChhccccC-------CCCCccchhh
Q 046188 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSS-------QYTDKSDVYS 533 (646)
Q Consensus 462 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwS 533 (646)
+.. -..|+.++++|.++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||
T Consensus 66 ~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 66 NSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred cCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 866 1399999999999999999999999998776321 11111112234579999998763 2577899999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHhh-cHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 534 FGVVLLELLTGKKPICLTREEEER-NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 534 fGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
||++++|+++.+.||......+.. .+...+. ..+ ....-|.+.. ..+....+..++.+||..+|.+||++++
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~---~~~--~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVK---KGG--SNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred HHHHHHHHHhccCccccccccCChHHHHHHHH---hcC--CCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHH
Confidence 999999999999999754322211 1111111 100 0001111110 0133347899999999999999999999
Q ss_pred HHHHHHHHHhh
Q 046188 613 VSMDLEGLRRS 623 (646)
Q Consensus 613 vl~~L~~i~~~ 623 (646)
|-..++.+...
T Consensus 217 i~~~~~~~~~~ 227 (484)
T KOG1023|consen 217 IRSKLLTINKG 227 (484)
T ss_pred HHhhhhhhccc
Confidence 99999987764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.4e-21 Score=212.73 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=178.3
Q ss_pred CCCcCccccccCcEEEEEEEcCCCCEEEEEecc-cCCHHHHHHH---HHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK-AIDKTQIEQF---INEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~-~~~~~~~~~~---~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++...+.||++.|=.|.+++.++|. |+||++- ....-..+.| ++|++ ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677889999999999999998886 8888753 2222233334 44455 556699999999888777777788888
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|. .-+|.|.+.. ++.|...+...|+.|++.||.-+|..+ |+|||||++||||++-.-+.|
T Consensus 102 yv-khnLyDRlST----------------RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 102 YV-KHNLYDRLST----------------RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HH-hhhhhhhhcc----------------chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhh
Confidence 87 6677777754 346788888999999999999999999 999999999999999999999
Q ss_pred eecCCcccc--CCCCC----ccccccccCCcccChhcccc-----------CCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 046188 489 SDFGTSRSV--PNDKT----HLTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLT-GKKPICL 550 (646)
Q Consensus 489 ~DfGla~~~--~~~~~----~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSfGvvl~Ellt-G~~p~~~ 550 (646)
+||..-+.. +.+.. ....+...-..|+|||.+-. ...+++.||||+||++.||++ |+++|..
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 999877653 22222 22222223347999997643 126789999999999999999 5666642
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
. ++..+ ...+....+.+-..+ ....+.+|+..|++.||.+|.++++.++.-++
T Consensus 242 S------QL~aY---r~~~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 242 S------QLLAY---RSGNADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred H------HHHhH---hccCccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1 11111 111010011100000 01257899999999999999999999988443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-19 Score=171.45 Aligned_cols=141 Identities=18% Similarity=0.152 Sum_probs=110.5
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHH--------------------------HHHHHHHHHHHHhhcCccCc
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT--------------------------QIEQFINEVVILSQINHRHI 390 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~--------------------------~~~~~~~Ei~il~~l~H~ni 390 (646)
...||+|++|.||+|...+|+.||||.++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999987653210 01223578999999999987
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeE
Q 046188 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIF 469 (646)
Q Consensus 391 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~iv 469 (646)
.....+... ..+|||||++++++...... ...++..+..+++.|++.++.+||+ .+ |+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----------------~~~~~~~~~~~i~~~l~~~l~~lH~~~g---iv 140 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----------------DVPLEEEEAEELYEQVVEQMRRLYQEAG---LV 140 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----------------hccCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 554444332 24899999988865433211 1257788899999999999999999 88 99
Q ss_pred ecCCCCCCEEECCCCcEEEeecCCccccCC
Q 046188 470 HRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499 (646)
Q Consensus 470 HrDIk~~NILl~~~~~~kI~DfGla~~~~~ 499 (646)
||||||+|||++ +++++|+|||++.....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999999 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=173.25 Aligned_cols=201 Identities=20% Similarity=0.321 Sum_probs=163.9
Q ss_pred cCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
-+|...++||+|+||..+.|+ +-+++.||||--... .+.-.+..|....+.+ ..++|...+-+......-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 378899999999999999999 447899999964321 1222455677777766 468888887776666677899999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-----CC
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KF 484 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~ 484 (646)
. |-||+|++.-.. ..++.+....||.|++.-++|+|++. +|.|||||+|+||.. ..
T Consensus 106 L-GPSLEDLFD~Cg---------------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG---------------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred h-CcCHHHHHHHhc---------------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCc
Confidence 8 778888875542 37899999999999999999999999 999999999999953 34
Q ss_pred cEEEeecCCccccCCCCCc------cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 485 SAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
.+.|+|||+|+...+.... ......||.+||+-....+..-+.+.|.=|+|.++...+.|..|+.....
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 6899999999987654332 23446799999999998888889999999999999999999999976543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=168.71 Aligned_cols=204 Identities=22% Similarity=0.323 Sum_probs=166.1
Q ss_pred hcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc-cCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H-~niv~l~g~~~~~~~~~LV~E 408 (646)
...|..+++||+|+||.+|.|. +.+|+.||||.-+.... ...+.-|.++...++| ..|..+..+..+.+.-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578999999999999999999 66899999997654221 2245678889988876 567777777878888899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC---Cc
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FS 485 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~ 485 (646)
.. +-+|++.+.-.. ..++.+..+-+|-|++.-++|+|.++ ++||||||+|+|..-+ ..
T Consensus 92 LL-GPsLEdLfnfC~---------------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS---------------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred cc-CccHHHHHHHHh---------------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccce
Confidence 98 889988886543 36888999999999999999999999 9999999999999643 57
Q ss_pred EEEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 486 AKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
+.++|||+|+...+-.. ...+...||.+|.+-....+..-+.+.|+=|+|.+|..+-.|..|+.......
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 89999999998743322 12234569999998887776667889999999999999999999998655443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=165.93 Aligned_cols=187 Identities=13% Similarity=0.049 Sum_probs=139.6
Q ss_pred CcCccccccCcEEEEEEEcCCCCEEEEEecccCCHH----HHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEe
Q 046188 335 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT----QIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~----~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.....|++|+||+||.+.- .+..++.+.++....- ....+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 6778887777654331 1225789999999995 5889999886 346999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI-KSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI-k~~NILl~~~~~~kI 488 (646)
+++.+|...+.. ....++.|++++|.++|+++ |+|||| ||+|||+++++.++|
T Consensus 80 I~G~~L~~~~~~-----------------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 80 LAGAAMYQRPPR-----------------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred ecCccHHhhhhh-----------------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEE
Confidence 998888543211 01246788999999999999 999999 799999999999999
Q ss_pred eecCCccccCCCCCc----c--------ccccccCCcccChhccccC-CCC-CccchhhHHHHHHHHHhCCCCCCCCc
Q 046188 489 SDFGTSRSVPNDKTH----L--------TTAVQGTFGYFDPEYFQSS-QYT-DKSDVYSFGVVLLELLTGKKPICLTR 552 (646)
Q Consensus 489 ~DfGla~~~~~~~~~----~--------~~~~~gt~~y~aPE~l~~~-~~s-~ksDVwSfGvvl~ElltG~~p~~~~~ 552 (646)
+|||++......... . ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...+.
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 999999865432210 0 0012367888888854321 223 46788899999999999998875443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=176.07 Aligned_cols=236 Identities=23% Similarity=0.308 Sum_probs=150.9
Q ss_pred CCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcC----------ccCceeEEEEEEe
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQIN----------HRHIVKLLGCCLE 399 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~----------H~niv~l~g~~~~ 399 (646)
+...+.||.|+++.||.++.. +|+.+|||.... ......+++.+|.-....+. |-.++.-++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999964 589999997432 22334566777765554432 3233333333221
Q ss_pred ---------C---C-----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc
Q 046188 400 ---------T---E-----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS 462 (646)
Q Consensus 400 ---------~---~-----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 462 (646)
. . +.+++|+-+ .++|.+++..-..... ....+....++.+..|+++.+++||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~---------~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ---------THSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT---------TSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc---------ccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 1 1 225667766 7788777654222100 01235567788899999999999999
Q ss_pred CCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC--------CCCCccchhhH
Q 046188 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--------QYTDKSDVYSF 534 (646)
Q Consensus 463 ~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~s~ksDVwSf 534 (646)
+| ++|+||+|+|++++++|.++|+||+....... .... ...+..|.+||..... .++.+.|.|++
T Consensus 164 ~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 164 YG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp TT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred cc---eEecccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 99 99999999999999999999999988765422 1111 2355789999976442 47889999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCC
Q 046188 535 GVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKR 607 (646)
Q Consensus 535 Gvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 607 (646)
|+++|.|++|..|+.......... .....+. +.++.+..|+..+|+.||.+|
T Consensus 237 G~~ly~lWC~~lPf~~~~~~~~~~--------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 237 GITLYSLWCGRLPFGLSSPEADPE--------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHSS-STCCCGGGSTSG--------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCCCCCCcccccc--------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999997654322110 0123455 778899999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=164.49 Aligned_cols=138 Identities=14% Similarity=0.138 Sum_probs=106.2
Q ss_pred CCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-----CccCceeEEEEEEeCC---c-eE
Q 046188 334 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-----NHRHIVKLLGCCLETE---V-PV 404 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-----~H~niv~l~g~~~~~~---~-~~ 404 (646)
++..+.||+|+||.||. .-.++. .+||+.........+.+.+|+.+++++ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 44577899999999996 222344 479987654444556789999999999 5799999999998864 2 33
Q ss_pred EEEEe--ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEecCCCCCCEEEC
Q 046188 405 LVYEY--ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV-AYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 405 LV~Ey--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL-~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
+|+|| ..+|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----------------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~ 139 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----------------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQ 139 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----------------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEe
Confidence 78999 5579999999542 23444 35677888787 9999999 99999999999997
Q ss_pred C----CCcEEEeecCCcc
Q 046188 482 D----KFSAKVSDFGTSR 495 (646)
Q Consensus 482 ~----~~~~kI~DfGla~ 495 (646)
. +++++|+||+.+.
T Consensus 140 ~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 140 RISESEVIPVVCDNIGES 157 (210)
T ss_pred ccCCCCCcEEEEECCCCc
Confidence 3 3489999955443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=191.76 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=182.0
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC---ccCceeEEEEEEeCCc
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEV 402 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~g~~~~~~~ 402 (646)
+.+.--+.|.+.+.||+|+||+||+|...+|+.||+|.-+....= +|.=-..++.+|+ -+.|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 444445678888999999999999999888999999987653210 1111122333333 2344444444555667
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD- 481 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~- 481 (646)
.+||+||.+.|+|.+++.. ...++|...+.|+.|+++-++.||..+ |||+||||+|+||.
T Consensus 769 S~lv~ey~~~Gtlld~~N~----------------~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT----------------NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRR 829 (974)
T ss_pred ceeeeeccccccHHHhhcc----------------CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeec
Confidence 7999999999999999974 346999999999999999999999999 99999999999994
Q ss_pred ------CCCcEEEeecCCccccCC-CCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 482 ------DKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 482 ------~~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+...++|+|||.+-.+.- .........++|-++--+|...+..++.+.|.|.|.-+++-|+.|+..-
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------ 903 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------ 903 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------
Confidence 345699999999987631 2223455677899999999999999999999999999999999996531
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
..++... .++..+..-...+. ..++...+|..|-..=|...++...|+.....+.
T Consensus 904 ------------~~~g~~~-~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 904 ------------VKNGSSW-MVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred ------------hcCCcce-eccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 0111000 01111111111222 2344444555555556888888888887776554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.9e-19 Score=189.72 Aligned_cols=224 Identities=27% Similarity=0.328 Sum_probs=174.5
Q ss_pred ccccCcEEEEEEE----cCCCCEEEEEecccCCHH--HHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEeccC
Q 046188 340 LGQGGFGTVYKGM----LPDGSIVAVKRSKAIDKT--QIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 340 IG~G~~g~Vy~g~----~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+|+|.||.|+... .+.|..+|+|.++..... .......|..++..++ ||.++++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999998754 224677888876542211 1114456788888887 99999999999999999999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|.|...+.... ..+..........++-+++++|+.+ ++|||+|++||+++.+|.+|+.|||
T Consensus 82 g~lft~l~~~~----------------~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 82 GDLFTRLSKEV----------------MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred chhhhccccCC----------------chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCch
Confidence 99988886643 3445555566778899999999999 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++..-..... +||..|||||.+. .....+|.||||++++||+||..||.. + ..
T Consensus 143 lske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~---------------~~ 196 (612)
T KOG0603|consen 143 LSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D---------------TM 196 (612)
T ss_pred hhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H---------------HH
Confidence 99876433322 7999999999998 457799999999999999999999863 0 01
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 610 (646)
..++.. ....|.........++..++..+|.+|--.
T Consensus 197 ~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 197 KRILKA--ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHhhh--ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 112111 223566677778888889999999999665
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-18 Score=181.46 Aligned_cols=175 Identities=25% Similarity=0.360 Sum_probs=132.8
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
.+|+.|+++...+|.+||...+. ....+|...+.++.|++.|+.| ++ .+|+|+||.||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-------------~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~ 390 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-------------GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFS 390 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-------------ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccc
Confidence 46889999999999999976543 3467889999999999999999 66 89999999999999
Q ss_pred CCCcEEEeecCCccccCCCC-----CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDK-----THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~ 555 (646)
.+..+||.|||+........ ....+...||..||+||.+.+..|+.|+||||+|++|+|+++ -..++.
T Consensus 391 ~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------ 464 (516)
T KOG1033|consen 391 DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------ 464 (516)
T ss_pred cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------
Confidence 99999999999988765443 233455679999999999999999999999999999999997 222221
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 614 (646)
.... . .+.....+++....++|.+ +.|+.+++...|.+||++.++.
T Consensus 465 r~~t----~----~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 465 RIAT----L----TDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred HHHh----h----hhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHHh
Confidence 0000 0 0111112233333344432 5788999999999999554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=157.94 Aligned_cols=134 Identities=22% Similarity=0.300 Sum_probs=113.4
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCCH--------HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK--------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~--------~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+.||+|++|.||+|.. +|..|+||+...... .....+.+|+.++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 677899997543211 1224577899999999999998888888778888999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+
T Consensus 81 ~~G~~L~~~~~~~-------------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 81 IEGEPLKDLINSN-------------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred eCCcCHHHHHHhc-------------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEE
Confidence 9999999887431 12 78899999999999999999 99999999999999 7899999
Q ss_pred ecCCccc
Q 046188 490 DFGTSRS 496 (646)
Q Consensus 490 DfGla~~ 496 (646)
|||++..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-16 Score=154.26 Aligned_cols=145 Identities=22% Similarity=0.191 Sum_probs=111.6
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCH----------------------HHHHHHHHHHHHHh
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK----------------------TQIEQFINEVVILS 383 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~----------------------~~~~~~~~Ei~il~ 383 (646)
++.+.-..|...+.||+|+||.||++...+|+.||||+...... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445777899999999999999987899999997543210 01123567899999
Q ss_pred hcCccC--ceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 046188 384 QINHRH--IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 461 (646)
Q Consensus 384 ~l~H~n--iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 461 (646)
++.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------------------~~~~~~~~~i~~~l~~lh 142 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------------------EDPEEVLDEILEEIVKAY 142 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------------------ccHHHHHHHHHHHHHHHH
Confidence 998874 444444 2455899999999998765321 233578889999999999
Q ss_pred cCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCC
Q 046188 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499 (646)
Q Consensus 462 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~ 499 (646)
+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 143 ~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 143 KHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred HCC---CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 988 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=158.68 Aligned_cols=142 Identities=17% Similarity=0.128 Sum_probs=110.2
Q ss_pred CCCcCccccccCcEEEEEEE--cCCCCEEEEEecccCCH----------------------H--HHHHHHHHHHHHhhcC
Q 046188 333 NYNQSRFLGQGGFGTVYKGM--LPDGSIVAVKRSKAIDK----------------------T--QIEQFINEVVILSQIN 386 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~--~~~g~~VAVK~l~~~~~----------------------~--~~~~~~~Ei~il~~l~ 386 (646)
.|...+.||+|++|.||+|. ..+|+.||||..+.... . ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 56799999998764221 0 1123568999999997
Q ss_pred ccC--ceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 046188 387 HRH--IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA 464 (646)
Q Consensus 387 H~n--iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~ 464 (646)
+.. +.++++. ...++||||+++++|..+.... ..+...+...++.|++.++++||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----------------VEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----------------CCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 633 4444443 2358999999998887765321 13455567899999999999999987
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeecCCcccc
Q 046188 465 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 465 ~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 497 (646)
. ++||||||+||+++ +++++|+|||.+...
T Consensus 169 ~--iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 E--LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred C--EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 3 99999999999999 889999999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-16 Score=152.74 Aligned_cols=130 Identities=22% Similarity=0.313 Sum_probs=106.8
Q ss_pred cccccCcEEEEEEEcCCCCEEEEEecccCC--------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 339 FLGQGGFGTVYKGMLPDGSIVAVKRSKAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.||+|++|.||+|.+ +|..|++|+..... ....+.+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57889999754311 112356778999999999987766666666677789999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++++|.+++.... . .++.+++.+|.+||+.+ ++|||++|.||+++ ++.+++.|
T Consensus 80 ~g~~l~~~~~~~~-----------------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred CCccHHHHHhhcH-----------------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEE
Confidence 9999988774321 0 78999999999999999 99999999999999 88999999
Q ss_pred cCCccc
Q 046188 491 FGTSRS 496 (646)
Q Consensus 491 fGla~~ 496 (646)
||++..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=161.24 Aligned_cols=197 Identities=21% Similarity=0.280 Sum_probs=136.1
Q ss_pred CccCceeEEEEEEeC---------------------------CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhc
Q 046188 386 NHRHIVKLLGCCLET---------------------------EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438 (646)
Q Consensus 386 ~H~niv~l~g~~~~~---------------------------~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 438 (646)
+|||||++.++|.++ ...|+||.-. .-+|.+++..+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---------------- 336 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---------------- 336 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----------------
Confidence 699999999887542 1236666544 45666666542
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE--CCC--CcEEEeecCCccccCCCC-----Cccccccc
Q 046188 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDK--FSAKVSDFGTSRSVPNDK-----THLTTAVQ 509 (646)
Q Consensus 439 ~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl--~~~--~~~kI~DfGla~~~~~~~-----~~~~~~~~ 509 (646)
..+...+.-|+.|+++|+.|||.++ +.|||+|++|||| |+| ..+.|+|||++-...... .......-
T Consensus 337 -~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~G 412 (598)
T KOG4158|consen 337 -HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLG 412 (598)
T ss_pred -CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCC
Confidence 4667778888999999999999999 9999999999999 333 358899999875432210 11111123
Q ss_pred cCCcccChhccccCC------CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhccc
Q 046188 510 GTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKE 583 (646)
Q Consensus 510 gt~~y~aPE~l~~~~------~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 583 (646)
|...-||||+....+ --.|+|.|+.|-+-||+++...||+...+ ...+... .++ .. ...
T Consensus 413 GNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~----------Yqe---~q-LPa 477 (598)
T KOG4158|consen 413 GNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT----------YQE---SQ-LPA 477 (598)
T ss_pred CcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh----------hhh---hh-CCC
Confidence 677789999876532 13599999999999999999999986321 1111110 111 11 123
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 584 ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 584 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.|..++..+.+++...|+.||.+|++..-....|.
T Consensus 478 lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 478 LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 45556677889999999999999998765554443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=177.42 Aligned_cols=137 Identities=20% Similarity=0.277 Sum_probs=111.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEe-ccc-CC------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR-SKA-ID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~-l~~-~~------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
...|...+.||+|+||.||+|.+.+. .+++|+ ... .. ....+.+.+|++++++++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556788999999999999997543 444443 211 11 1223568899999999999999998888887778
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++++|.+++. .+..++.+++++|.|||+.+ ++||||||+|||+ +
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~ 462 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-R 462 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-E
Confidence 899999999999988774 23468999999999999999 9999999999999 6
Q ss_pred CCcEEEeecCCccc
Q 046188 483 KFSAKVSDFGTSRS 496 (646)
Q Consensus 483 ~~~~kI~DfGla~~ 496 (646)
++.++|+|||+++.
T Consensus 463 ~~~~~liDFGla~~ 476 (535)
T PRK09605 463 DDRLYLIDFGLGKY 476 (535)
T ss_pred CCcEEEEeCccccc
Confidence 77999999999985
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-16 Score=171.60 Aligned_cols=133 Identities=17% Similarity=0.216 Sum_probs=99.4
Q ss_pred cccCCCCeEEecccceecCC----------------CCcccccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCC
Q 046188 80 YLLGSDASIIVPVSCSCSGS----------------LYQHNAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNL 143 (646)
Q Consensus 80 ~~~~~~~~l~vP~~c~c~~~----------------~~~~~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l 143 (646)
+.+.+|+.|.||..-.-... .......|+|++|||+|+|| ++|+ +++++|++||....+.|
T Consensus 439 ~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk~GDTL~sIA-kkyg--VSv~~L~~~N~l~s~~L 515 (592)
T PRK06347 439 DFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVAKGDSLWRIA-NNNK--VTIANLKSWNNLKSDFI 515 (592)
T ss_pred ceeccCcEEEEecCCcccccccccccccccccccccccccceeeeecCCCCHHHHH-HHHC--CCHHHHHHhcCCCcccc
Confidence 45778999999964210000 00112469999999999999 6675 49999999997777789
Q ss_pred CCCcEEEecccccCCCCcc-----ccCccceeeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccc
Q 046188 144 GSGLEVIVPLRCACPTAKQ-----IDNGVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIP 216 (646)
Q Consensus 144 ~~gq~l~ip~~c~c~~~~~-----~~~~~~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vP 216 (646)
++||+|.||....-..... .........+|+|++|||||+||+||||++++|++||++. .+.|++||.|.|+
T Consensus 516 ~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~sIA~KygvSv~~L~~~N~L~-~~~L~~GQ~L~I~ 592 (592)
T PRK06347 516 YPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLWAISRQYKTTVDNIKAWNKLT-SNMIHVGQKLTIK 592 (592)
T ss_pred cCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHHHHHHHhCCCHHHHHHhcCCC-cccCCCCCEEecC
Confidence 9999999998543211000 0011123468999999999999999999999999999996 4679999999885
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.5e-16 Score=173.91 Aligned_cols=207 Identities=27% Similarity=0.394 Sum_probs=142.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.+|+.++.|..|+||.||..+.+. .+..|+|.-+.. .+.+. |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee-------------------
Confidence 689999999999999999998753 567787543321 11111 22222333332
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
|+=...+... .++.- +++.+++|||+.+ |+|||+||+|.+|+.-|.+|++|
T Consensus 136 --gDc~tllk~~----------------g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 136 --GDCATLLKNI----------------GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred --chhhhhcccC----------------CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccc
Confidence 3222223221 12221 2378999999999 99999999999999999999999
Q ss_pred cCCccccCCC--------------CCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 491 FGTSRSVPND--------------KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 491 fGla~~~~~~--------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
||+++..... .......++||+.|.|||++....|...+|.|++|+++||.+-|+.||....+++-
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 9998764211 01112346899999999999999999999999999999999999999987665542
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
|..++.+. .+|. +.......+..+++.+.|+.+|..|-
T Consensus 267 ------fg~visd~--i~wp------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 267 ------FGQVISDD--IEWP------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------Hhhhhhhh--cccc------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 22222211 1121 11233345678899999999999994
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-16 Score=169.18 Aligned_cols=107 Identities=18% Similarity=0.229 Sum_probs=90.5
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecccccCCCCccccCccceeeEEeeecccchhhh
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSI 184 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~I 184 (646)
.+|+|++|||+++|| +.|+ ++.+.|+.+|....+.|.+||+|.||..|.|... ......++|+|++||||++|
T Consensus 344 ~~y~Vk~GDTL~sIA-~r~g--vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~----~~~~~~~~Y~Vr~GDTL~sI 416 (456)
T PRK10783 344 RSYKVRSGDTLSGIA-SRLN--VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRL----ANNSDSITYRVRKGDSLSSI 416 (456)
T ss_pred eEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCcccCCCCCEEEecCCcccccc----cccccceeEEeCCCCCHHHH
Confidence 479999999999999 5674 4889999999766688999999999987665321 12234578999999999999
Q ss_pred HhhhcCCchhhhccccCCCCcceeecccccccccC
Q 046188 185 GHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 185 a~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
|+||||++++|++||++..+ .|+|||+|.|+++.
T Consensus 417 A~kygVtv~~L~~~N~l~~~-~L~pGq~L~l~v~~ 450 (456)
T PRK10783 417 AKRHGVNIKDVMRWNSDTAK-NLQPGDKLTLFVKN 450 (456)
T ss_pred HHHhCCCHHHHHHhcCCCCC-cCCCCCEEEEecCC
Confidence 99999999999999998655 89999999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=140.91 Aligned_cols=136 Identities=20% Similarity=0.221 Sum_probs=98.6
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHH--HHHH----------------------HHHHHHHHhhcCccC--c
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT--QIEQ----------------------FINEVVILSQINHRH--I 390 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~--~~~~----------------------~~~Ei~il~~l~H~n--i 390 (646)
.+.||+|+||.||+|...+|+.||||..+..... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999986642211 1111 134566666665433 4
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeE
Q 046188 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIF 469 (646)
Q Consensus 391 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~iv 469 (646)
.+.+++ ...++||||++++++........ ... .+...++.+++.++.++|. .+ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----------------~~~-~~~~~~~~~~~~~l~~lh~~~~---iv 137 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----------------RLL-EDPEELYDQILELMRKLYREAG---LV 137 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----------------hhc-ccHHHHHHHHHHHHHHHhhccC---cC
Confidence 445443 24589999999976532211110 011 5677899999999999999 87 99
Q ss_pred ecCCCCCCEEECCCCcEEEeecCCcccc
Q 046188 470 HRDIKSSNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 470 HrDIk~~NILl~~~~~~kI~DfGla~~~ 497 (646)
||||||+||+++ ++.++|+|||.+...
T Consensus 138 H~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 138 HGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cCCCChhhEEEE-CCcEEEEECcccccc
Confidence 999999999999 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-14 Score=131.98 Aligned_cols=135 Identities=22% Similarity=0.210 Sum_probs=113.7
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc--cCceeEEEEEEeCCceEEEEEeccCC
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--~niv~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3577999999999999984 47899998765433 4568899999999977 58999999888778899999999888
Q ss_pred CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 414 NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 414 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
.+..+ ++.....++.+++++|.+||.....+++|+|++|+||++++++.+++.|||.
T Consensus 79 ~~~~~-----------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 79 TLDEV-----------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred ecccC-----------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 77543 3445667889999999999997555599999999999999999999999999
Q ss_pred ccc
Q 046188 494 SRS 496 (646)
Q Consensus 494 a~~ 496 (646)
+..
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-14 Score=142.04 Aligned_cols=136 Identities=19% Similarity=0.236 Sum_probs=105.0
Q ss_pred Ccccc-ccCcEEEEEEEcCCCCEEEEEecccCC-------------HHHHHHHHHHHHHHhhcCccCc--eeEEEEEEeC
Q 046188 337 SRFLG-QGGFGTVYKGMLPDGSIVAVKRSKAID-------------KTQIEQFINEVVILSQINHRHI--VKLLGCCLET 400 (646)
Q Consensus 337 ~~~IG-~G~~g~Vy~g~~~~g~~VAVK~l~~~~-------------~~~~~~~~~Ei~il~~l~H~ni--v~l~g~~~~~ 400 (646)
...|| .|+.|+||+... ++..++||+.+... ......+.+|++++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 899999999988 47789999764311 1223467889999999998875 7777775543
Q ss_pred Cc----eEEEEEeccC-CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 046188 401 EV----PVLVYEYICN-GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475 (646)
Q Consensus 401 ~~----~~LV~Ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~ 475 (646)
.. .++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----------------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp 170 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----------------PLSEE----QWQAIGQLIARFHDAG---VYHADLNA 170 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----------------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCc
Confidence 22 3599999997 5888887432 23332 3568999999999999 99999999
Q ss_pred CCEEECCCCcEEEeecCCcccc
Q 046188 476 SNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 476 ~NILl~~~~~~kI~DfGla~~~ 497 (646)
.|||++.++.++|+|||.+...
T Consensus 171 ~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 171 HNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred hhEEEcCCCCEEEEECCCcccC
Confidence 9999999999999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-15 Score=169.57 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=189.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC--CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKAID--KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~--~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV 406 (646)
..|...+.||+|+|+.|-..... ....+|+|...... ....+....|..+-..+. |+|++.+++...+.+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46777788999999999877643 24456777654432 222334445777777776 99999999999999999999
Q ss_pred EEeccCCCchhhh-hhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCCCCCCEEECCCC
Q 046188 407 YEYICNGNLSHHI-HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-SSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 407 ~Ey~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
.||.++|++.+.+ +... ...+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~---------------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---------------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESG 161 (601)
T ss_pred cCcccccccccccccCCc---------------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCC
Confidence 9999999998888 4332 14555667789999999999999 877 99999999999999999
Q ss_pred -cEEEeecCCccccCC--CCCcccccccc-CCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 485 -SAKVSDFGTSRSVPN--DKTHLTTAVQG-TFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 485 -~~kI~DfGla~~~~~--~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
..|++|||+|..... +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|.........
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--- 238 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--- 238 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---
Confidence 999999999988755 33444445678 9999999998873 457789999999999999999999764433221
Q ss_pred HHHHHHHHhhchhHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
....+++.... ............++..+++..+|..|.+.+++...=.
T Consensus 239 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 239 -----------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred -----------cceeecccccccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 11112222111 1112233355678888999999999999998865544
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.8e-14 Score=156.93 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=100.9
Q ss_pred cccCCCCeEEecccceecC--C---------------CCcccccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCC
Q 046188 80 YLLGSDASIIVPVSCSCSG--S---------------LYQHNAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKN 142 (646)
Q Consensus 80 ~~~~~~~~l~vP~~c~c~~--~---------------~~~~~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~ 142 (646)
+.+.+|+.|+||..-.-.. . -.....+|+|++|||+|.|| ..|+ ++..+|+.+|....+.
T Consensus 364 d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~~ytVk~GDTL~sIA-~kyg--VSv~~L~~~N~l~s~~ 440 (592)
T PRK06347 364 DFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAKVYTVVKGDSLWRIA-NNNK--VTIANLKSWNNLKSDF 440 (592)
T ss_pred cccccCcEEEEeccccccccccccccccccccccccccccCceeEEecCCCCHHHHH-HHhC--CCHHHHHHHhCCCcce
Confidence 4577899999997421100 0 01122479999999999999 6776 4999999999776778
Q ss_pred CCCCcEEEecccccC------CCCcc-----ccCccceeeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecc
Q 046188 143 LGSGLEVIVPLRCAC------PTAKQ-----IDNGVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFT 211 (646)
Q Consensus 143 l~~gq~l~ip~~c~c------~~~~~-----~~~~~~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~ 211 (646)
|.+||.|.||..-.- +.... ......-..+|+|+.||||++||++||+++++|++||++. .+.|++||
T Consensus 441 L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk~GDTL~sIAkkygVSv~~L~~~N~l~-s~~L~~GQ 519 (592)
T PRK06347 441 IYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVAKGDSLWRIANNNKVTIANLKSWNNLK-SDFIYPGQ 519 (592)
T ss_pred eccCcEEEEecCCcccccccccccccccccccccccccceeeeecCCCCHHHHHHHHCCCHHHHHHhcCCC-cccccCCc
Confidence 999999999974211 00000 0001112457999999999999999999999999999986 46799999
Q ss_pred cccccccC
Q 046188 212 PLLIPLKS 219 (646)
Q Consensus 212 ~l~vPl~~ 219 (646)
.|.||...
T Consensus 520 ~L~Ip~~~ 527 (592)
T PRK06347 520 KLKVSAGS 527 (592)
T ss_pred EEEEecCc
Confidence 99999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.7e-13 Score=144.55 Aligned_cols=141 Identities=23% Similarity=0.226 Sum_probs=101.2
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHH----------------------------------------HHH
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIE----------------------------------------QFI 376 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~----------------------------------------~~~ 376 (646)
.+.||.|++|.||+|++++|+.||||+.++....... +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999987654221110 234
Q ss_pred HHHHHHhhc----CccCceeEEEEEEe-CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHH
Q 046188 377 NEVVILSQI----NHRHIVKLLGCCLE-TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451 (646)
Q Consensus 377 ~Ei~il~~l----~H~niv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~ 451 (646)
+|+..+.++ +|.+-+.+-.++.+ ....+|||||++|++|.++...... .. .+.+++.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---------------~~---~~~~ia~ 263 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---------------GL---DRKALAE 263 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---------------CC---CHHHHHH
Confidence 455555544 23333333333332 3457999999999999887643211 12 2446777
Q ss_pred HHHH-HHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccC
Q 046188 452 EVAG-AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498 (646)
Q Consensus 452 qia~-gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~ 498 (646)
.++. .+..+|..+ ++|+|++|.||++++++++++.|||++....
T Consensus 264 ~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 264 NLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7666 478889988 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.4e-13 Score=134.66 Aligned_cols=204 Identities=18% Similarity=0.314 Sum_probs=140.2
Q ss_pred HhhcCccCceeEEEEEEeC-----CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHH
Q 046188 382 LSQINHRHIVKLLGCCLET-----EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456 (646)
Q Consensus 382 l~~l~H~niv~l~g~~~~~-----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~g 456 (646)
|-++-|.|||++..++.+. ....++.|||..|+|..+|++.+.. ...+......+|.-||..|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~------------~~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN------------QKALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh------------hhhhhHHHHHHHHHHHHhh
Confidence 4455799999999887653 2467899999999999999876542 2357778888999999999
Q ss_pred HHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCC---CCCccccccccCCcccChhccccCCCCCccchhh
Q 046188 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN---DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 533 (646)
Q Consensus 457 L~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS 533 (646)
|.|||+.. |+|+|+++..+.|++..++-+||+--.-...... ........-.+-++|.+||+-..-..+..+|||+
T Consensus 189 l~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~ 267 (458)
T KOG1266|consen 189 LSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK 267 (458)
T ss_pred hhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence 99999976 7899999999999999999888853221111110 0011111224678999999887777788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 046188 534 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613 (646)
Q Consensus 534 fGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 613 (646)
||...+||.-|.--........ . .+......+ ...+- ..-..++..|++..|..||+|+++
T Consensus 268 fgmcAlemailEiq~tnseS~~---~--------~ee~ia~~i---~~len-----~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 268 FGMCALEMAILEIQSTNSESKV---E--------VEENIANVI---IGLEN-----GLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred hhHHHHHHHHheeccCCCccee---e--------hhhhhhhhe---eeccC-----ccccCcCcccccCCCCCCcchhhh
Confidence 9999999988754321110000 0 000000000 00000 011367789999999999999998
Q ss_pred HHHH
Q 046188 614 SMDL 617 (646)
Q Consensus 614 l~~L 617 (646)
+.+.
T Consensus 329 lfHp 332 (458)
T KOG1266|consen 329 LFHP 332 (458)
T ss_pred hcCc
Confidence 8764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-12 Score=138.11 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=175.1
Q ss_pred CCCcCccccc--cCcEEEEEEEc---CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceE
Q 046188 333 NYNQSRFLGQ--GGFGTVYKGML---PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 333 ~~~~~~~IG~--G~~g~Vy~g~~---~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~ 404 (646)
.|.....+|. |.+|.||.+.. .++..+|+|+-+.- .......=.+|+.-..++ .|+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999986 35788999974331 112222334566666666 4999999888888888999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG----AVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~----gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+-.|++ +.+|..+-+... ..+.....+.+..+..+ ||.++|+.+ ++|-|+||.||+.
T Consensus 195 iqtE~~-~~sl~~~~~~~~---------------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC---------------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFT 255 (524)
T ss_pred eeeccc-cchhHHhhhccc---------------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheec
Confidence 999998 577777766542 24666777777777777 999999999 9999999999999
Q ss_pred CCC-CcEEEeecCCccccCCCCCc----cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 481 DDK-FSAKVSDFGTSRSVPNDKTH----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 481 ~~~-~~~kI~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
.++ ...+++|||+...+.+..-. ......|...|++||... +.++...|+|++|.++.|..+|.......-...
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 999 89999999999887654321 112234677899999875 566889999999999999999876643221000
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
+.. ++.+. +..++-..-...+...+..+++.+|..|++.+.+..
T Consensus 335 ----W~~---------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ----WSQ---------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccc---------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 00000 111111122234555888999999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.2e-11 Score=113.68 Aligned_cols=131 Identities=20% Similarity=0.109 Sum_probs=97.5
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCce-eEEEEEEeCCceEEEEEeccCCCc
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV-KLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv-~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
.+.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 456889999999999874 77899998765322 122456899999998765544 455443 3345899999999888
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCEEECCCCcEEEeecCC
Q 046188 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA--SIPIFHRDIKSSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 416 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~~~kI~DfGl 493 (646)
.+... ....++.+++++|..||..+ ...++|+|+++.||+++ ++.++++|||.
T Consensus 79 ~~~~~------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 79 LTEDF------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred ccccc------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 64300 01235678999999999987 23369999999999999 66899999998
Q ss_pred ccc
Q 046188 494 SRS 496 (646)
Q Consensus 494 a~~ 496 (646)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-10 Score=127.65 Aligned_cols=164 Identities=18% Similarity=0.237 Sum_probs=123.9
Q ss_pred CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHH
Q 046188 355 DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434 (646)
Q Consensus 355 ~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~ 434 (646)
++.+|.|...+..+....+...+-++.|+.++||||+++++....++..|||+|-+ -.|..++..
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------------- 100 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------------- 100 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------------
Confidence 67888888877655544555678889999999999999999999999999999986 344445533
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcc
Q 046188 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514 (646)
Q Consensus 435 ~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y 514 (646)
++-....-.+.||+.||.+||+.+. ++|++|.-..|+|++.|+.||++|.++........ .......-..|
T Consensus 101 ------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~ 171 (690)
T KOG1243|consen 101 ------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESF 171 (690)
T ss_pred ------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcc
Confidence 2233444567899999999997664 99999999999999999999999998865432211 11111223356
Q ss_pred cChhccccCCCCCccchhhHHHHHHHHHhC
Q 046188 515 FDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544 (646)
Q Consensus 515 ~aPE~l~~~~~s~ksDVwSfGvvl~ElltG 544 (646)
..|+.+.... ...|.|.||++++|++.|
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 7777654332 357999999999999999
|
|
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=7e-12 Score=133.74 Aligned_cols=112 Identities=23% Similarity=0.267 Sum_probs=87.0
Q ss_pred cccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEeccccc-----------------CCCCcc----
Q 046188 104 NAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCA-----------------CPTAKQ---- 162 (646)
Q Consensus 104 ~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~~c~-----------------c~~~~~---- 162 (646)
..+|+|++|||||.|| +.|.. ++++|+++|.+.++.|.+||+|.||..-. -|+.+.
T Consensus 27 a~tytVq~GDTLw~IA-~~ygv--tv~~I~~~N~l~~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIg 103 (481)
T PRK13914 27 ASTVVVEAGDTLWGIA-QSKGT--TVDAIKKANNLTTDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIIT 103 (481)
T ss_pred CceEEECCCCCHHHHH-HHHCC--CHHHHHHHhCCCcccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceee
Confidence 3579999999999999 56754 89999999987788999999999995420 000000
Q ss_pred ---------c----cCcc--------------------------------------------------------------
Q 046188 163 ---------I----DNGV-------------------------------------------------------------- 167 (646)
Q Consensus 163 ---------~----~~~~-------------------------------------------------------------- 167 (646)
. .+||
T Consensus 104 sl~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (481)
T PRK13914 104 SIKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPA 183 (481)
T ss_pred eecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCccccchhhhhccccccccchhcccchhccCCcccCCc
Confidence 0 0000
Q ss_pred -------------ceeeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccccccC
Q 046188 168 -------------SYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 168 -------------~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
.-..+|+|++||+||.||++||+++++|.+||++.. ..|++||.|.||-..
T Consensus 184 ~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s-~~L~pGQ~L~Ip~sa 247 (481)
T PRK13914 184 PKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSS-SSIYVGQKLAIKQTA 247 (481)
T ss_pred ccccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCc-cccCCCCEEEecCCC
Confidence 011579999999999999999999999999999964 579999999999653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=126.47 Aligned_cols=148 Identities=18% Similarity=0.185 Sum_probs=94.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHHH----------------------------------HH--
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQ----------------------------------IE-- 373 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~----------------------------------~~-- 373 (646)
...|+. +.||+|++|.||+|++++ |+.||||+.++.-... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446766 789999999999999877 9999999876532110 11
Q ss_pred ----HHHHHHHHHhhcC----ccCceeEEEEEEe-CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHH
Q 046188 374 ----QFINEVVILSQIN----HRHIVKLLGCCLE-TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444 (646)
Q Consensus 374 ----~~~~Ei~il~~l~----H~niv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~ 444 (646)
++.+|+.-+.+++ +.+.+.+-.++.+ ....+|||||++|+++.++-.-.... .+ ...+...
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---------~~~la~~ 267 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---------MKLLAER 267 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---------HHHHHHH
Confidence 1333443333332 3444444444433 34568999999999998742111000 00 0012222
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC----cEEEeecCCccccCC
Q 046188 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGTSRSVPN 499 (646)
Q Consensus 445 ~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kI~DfGla~~~~~ 499 (646)
....++.|+ +..| ++|+|++|.||+++.++ ++++.|||++..+..
T Consensus 268 ~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 268 GVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 223333343 3467 99999999999999888 999999999987643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.4e-10 Score=117.40 Aligned_cols=180 Identities=21% Similarity=0.255 Sum_probs=133.9
Q ss_pred EEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe----CCceEEEEEeccCC-Cchhhh
Q 046188 346 GTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVYEYICNG-NLSHHI 419 (646)
Q Consensus 346 g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~----~~~~~LV~Ey~~~g-sL~~~l 419 (646)
.+.||+.. .||..+++|+++............-+++++++.|+|+|++.+++.. +...+|||+|.++. +|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899883 4899999999965443333333456788999999999999998872 34678999998865 787766
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCC
Q 046188 420 HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499 (646)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~ 499 (646)
....... .+............++...|.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|+..|.......
T Consensus 370 F~~~~~t-~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFT-KRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCccc-cccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5543321 1111111122346788999999999999999999999 88899999999999999999999998877644
Q ss_pred CCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCC
Q 046188 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547 (646)
Q Consensus 500 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p 547 (646)
+.. |-+.. -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 2367999999999999999654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.1e-10 Score=109.08 Aligned_cols=143 Identities=21% Similarity=0.247 Sum_probs=99.7
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCc--cCceeEEEEEEeCC---ceEEEEEec
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK-TQIEQFINEVVILSQINH--RHIVKLLGCCLETE---VPVLVYEYI 410 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H--~niv~l~g~~~~~~---~~~LV~Ey~ 410 (646)
.+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999986668899998764322 124467889999999976 34677887766542 568999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS--------------------------- 463 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~--------------------------- 463 (646)
++.++.+.+.. ..++..++..++.+++++|..||+.
T Consensus 83 ~G~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (223)
T cd05154 83 DGRVLRDRLLR-----------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQ 145 (223)
T ss_pred CCEecCCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHH
Confidence 99988776531 0123333333333333333333321
Q ss_pred --------------------------CCCCeEecCCCCCCEEECC--CCcEEEeecCCccc
Q 046188 464 --------------------------ASIPIFHRDIKSSNILLDD--KFSAKVSDFGTSRS 496 (646)
Q Consensus 464 --------------------------~~~~ivHrDIk~~NILl~~--~~~~kI~DfGla~~ 496 (646)
....++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 146 YDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-09 Score=102.95 Aligned_cols=136 Identities=17% Similarity=0.157 Sum_probs=96.8
Q ss_pred ccccccCcEEEEEEEcCC-------CCEEEEEecccC-------------C---------HHHHHHH----HHHHHHHhh
Q 046188 338 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSKAI-------------D---------KTQIEQF----INEVVILSQ 384 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~-------g~~VAVK~l~~~-------------~---------~~~~~~~----~~Ei~il~~ 384 (646)
-.||.|-.+.||.|.-.+ +..+|||..+.. + ....+.+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999953210 0 0112222 379999999
Q ss_pred cCc--cCceeEEEEEEeCCceEEEEEeccCCCchhh-hhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHH-
Q 046188 385 INH--RHIVKLLGCCLETEVPVLVYEYICNGNLSHH-IHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYM- 460 (646)
Q Consensus 385 l~H--~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yL- 460 (646)
+.. -++.+++++ ...+|||||+.++.+..- +.. ..++..+...+..+++.+|..|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----------------~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----------------AKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----------------cccCHHHHHHHHHHHHHHHHHHH
Confidence 854 466677765 456899999976544211 111 1244455667889999999999
Q ss_pred HcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccC
Q 046188 461 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498 (646)
Q Consensus 461 H~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~ 498 (646)
|..+ ++|||+++.||++++ +.+.|+|||.+-...
T Consensus 142 H~~g---lVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KECN---LVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HhCC---eecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 8888 999999999999974 679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1e-10 Score=126.62 Aligned_cols=261 Identities=21% Similarity=0.227 Sum_probs=181.1
Q ss_pred ccCHHH-HHHHhcCCCcCccccccCcEEEEEEEcC--CCCEEEEEecccCCHHHHH--HHHHHHHHHhhc-CccCceeEE
Q 046188 321 IFTAEE-LQRATDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKAIDKTQIE--QFINEVVILSQI-NHRHIVKLL 394 (646)
Q Consensus 321 ~~~~~e-l~~~t~~~~~~~~IG~G~~g~Vy~g~~~--~g~~VAVK~l~~~~~~~~~--~~~~Ei~il~~l-~H~niv~l~ 394 (646)
+|.-.+ ....+.+|..+..||.|.|+.|++...+ ++..+++|.+......... .-+.|+.+...+ .|.+.+++.
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 3444578999999999999999987744 5678999987653322222 224555555555 488888877
Q ss_pred EEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 395 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
..+...+..|+=-||++++++...... ...++...++++..|++.++.++|+.. ++|+|+|
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~----------------~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~ 393 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVT----------------SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVK 393 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHH----------------HHhcCcchhhhhHHHHHhccccccchh---hhccccc
Confidence 777667777888999999988766622 225778888999999999999999988 9999999
Q ss_pred CCCEEECCC-CcEEEeecCCccccCCCCCccccccccCCcc-cChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCc
Q 046188 475 SSNILLDDK-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY-FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 552 (646)
Q Consensus 475 ~~NILl~~~-~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 552 (646)
|+||++..+ +..+++|||.+..+.-.. ......+..| .+|+......+-.+.|+||||.-+.|.++|..--....
T Consensus 394 psni~i~~~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 394 PSNILISNDGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred ccceeeccchhhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 999999886 889999999986421111 1111122333 35666667778889999999999999999865422110
Q ss_pred hHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 553 EEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+ +..+..... ...+... ..+..+.+.++..|+..||.+.+...+.+..+..
T Consensus 471 -----~-------------~~~i~~~~~-p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 471 -----Q-------------SLTIRSGDT-PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred -----c-------------ceeeecccc-cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 0 000111100 1112222 5677888899999999999999988877765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.8e-09 Score=99.90 Aligned_cols=131 Identities=24% Similarity=0.294 Sum_probs=101.2
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEec-cc-CC------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRS-KA-ID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l-~~-~~------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..+++|+-+.+|.+.+. |..+.+|.- +. .. +-..+...+|+.++.+++--.|.-..=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999874 555777742 11 11 11234567899999998766666555566677888999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++-.|.+.+... +..++..+-.-+.-||..+ |+|+|+.++||++..+. +.++
T Consensus 81 I~G~~lkd~l~~~-----------------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 81 IEGELLKDALEEA-----------------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred eCChhHHHHHHhc-----------------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEE
Confidence 9999998888553 2356677778888999999 99999999999998875 9999
Q ss_pred ecCCccc
Q 046188 490 DFGTSRS 496 (646)
Q Consensus 490 DfGla~~ 496 (646)
||||+..
T Consensus 134 DfGLg~~ 140 (204)
T COG3642 134 DFGLGEF 140 (204)
T ss_pred ECCcccc
Confidence 9999985
|
|
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.1e-11 Score=86.39 Aligned_cols=43 Identities=28% Similarity=0.521 Sum_probs=35.9
Q ss_pred EeeecccchhhhHhhhcCCchhhhccc-cCCCCcceeeccccccc
Q 046188 173 YMATWGDTISSIGHKFGADKQSILDAN-KLSEDDLIFTFTPLLIP 216 (646)
Q Consensus 173 Y~v~~gDtl~~Ia~~f~~s~~~l~~~N-~~~~~~~i~~g~~l~vP 216 (646)
|+|++|||+++||++||++.++|++|| ++..+. |.+||.|.||
T Consensus 1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence 899999999999999999999999999 775444 9999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.2e-09 Score=98.17 Aligned_cols=143 Identities=20% Similarity=0.240 Sum_probs=106.9
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEeccc--C------CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--I------DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~------~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
....|.+|+.+.|+++.+ .|+...||.-.. . .+-...+..+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999999 588888885211 1 1112346778999999987656655555666777779999
Q ss_pred EeccC-CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC--
Q 046188 408 EYICN-GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-- 484 (646)
Q Consensus 408 Ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-- 484 (646)
||.++ -++.+++..... ..-.......++..|-+.+.-||..+ |+|+||..+||+|.+++
T Consensus 90 E~~~g~~~vk~~i~~~~~--------------~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--------------DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred EeccchhHHHHHHHHHcc--------------CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence 99976 378888866432 11222233678888999999999999 99999999999996544
Q ss_pred -cEEEeecCCccc
Q 046188 485 -SAKVSDFGTSRS 496 (646)
Q Consensus 485 -~~kI~DfGla~~ 496 (646)
.+-++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 458999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.1e-10 Score=125.55 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=166.4
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
...+.+...+-+-+|.++.++.+.-. .|...++|..+. ....+.+....+-.++-..+||-+++..-.+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567777778889999999877632 243334443222 11222223333333333345566665554444566789
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
|+++|..+++|...|+... .++..-.......+..+++|||... +.|+|++|.|+|...++
T Consensus 881 L~~~~~~~~~~~Skl~~~~----------------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----------------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----------------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccC
Confidence 9999999999999887743 2444444455667889999999987 89999999999999999
Q ss_pred cEEEeecCCccccC------CC--C----------------------CccccccccCCcccChhccccCCCCCccchhhH
Q 046188 485 SAKVSDFGTSRSVP------ND--K----------------------THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 534 (646)
Q Consensus 485 ~~kI~DfGla~~~~------~~--~----------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSf 534 (646)
..+++|||...... .. . ........+|+.|.+||.+.+......+|.|++
T Consensus 942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 99999998433221 00 0 011223568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 535 GVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 535 Gvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
|++++|.++|..||....... .+..+... ... ....+...+....+++...+..+|.+|-.|.
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~------~f~ni~~~--~~~------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQ------IFENILNR--DIP------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhh------hhhccccC--CCC------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999999986443321 11111110 000 1122334455677888888888998887765
|
|
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.2e-09 Score=93.76 Aligned_cols=94 Identities=23% Similarity=0.303 Sum_probs=71.7
Q ss_pred ccCCCccHHHhhhcCCCC--CCCCCCCcEEEecccccCCCC-ccc-cCcc-c-----------eeeEEeeecccchhhhH
Q 046188 122 TYQGLTTCQALLGQNYYD--EKNLGSGLEVIVPLRCACPTA-KQI-DNGV-S-----------YLLAYMATWGDTISSIG 185 (646)
Q Consensus 122 ~~~~lt~~~~l~~~N~~~--~~~l~~gq~l~ip~~c~c~~~-~~~-~~~~-~-----------~~~tY~v~~gDtl~~Ia 185 (646)
+|.. ++..++.+|... .+.+.+||+|.+|..-.-+.. .+. .... + ...+|+|+.||+|+.||
T Consensus 4 ~~~~--~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~Ia 81 (124)
T COG1388 4 KYGV--SVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSKIA 81 (124)
T ss_pred cccc--cHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHHHH
Confidence 4544 899999999766 778999999999963111110 001 1111 1 13589999999999999
Q ss_pred hhhcCCchhhhccccCCCCcceeeccccccccc
Q 046188 186 HKFGADKQSILDANKLSEDDLIFTFTPLLIPLK 218 (646)
Q Consensus 186 ~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~ 218 (646)
++|++++.+|+++|++.++ .+++||.|.+|..
T Consensus 82 ~~~~~tv~~l~~~n~l~~~-~i~~gq~l~~~~~ 113 (124)
T COG1388 82 RKYGVTVAELKQLNNLSSD-KIKVGQKLKLPVS 113 (124)
T ss_pred HHhCCCHHHHHHHhccCCC-ceecCcEEEEecc
Confidence 9999999999999999665 9999999999873
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.6e-08 Score=98.20 Aligned_cols=133 Identities=16% Similarity=0.110 Sum_probs=97.3
Q ss_pred EEEEEEEcCCCCEEEEEecccCCHHH-HH----------HHHHHHHHHhhcCccC--ceeEEEEEEe-----CCceEEEE
Q 046188 346 GTVYKGMLPDGSIVAVKRSKAIDKTQ-IE----------QFINEVVILSQINHRH--IVKLLGCCLE-----TEVPVLVY 407 (646)
Q Consensus 346 g~Vy~g~~~~g~~VAVK~l~~~~~~~-~~----------~~~~Ei~il~~l~H~n--iv~l~g~~~~-----~~~~~LV~ 407 (646)
..|.+..+ +|+.+.||+........ .+ .+.+|...+.++...+ ..+++++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 45667766 67899999765433211 11 3678888888885433 3345556543 23468999
Q ss_pred EeccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC----
Q 046188 408 EYICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---- 482 (646)
Q Consensus 408 Ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---- 482 (646)
|++++. +|.+++..... ...+...+..++.+++..+.-||..| |+|+|++++|||++.
T Consensus 115 e~l~~~~sL~~~~~~~~~--------------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 115 EDLAPTISLEDYCADWAT--------------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred eeCCCCccHHHHHHhhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 999876 89888753211 13455677789999999999999999 999999999999975
Q ss_pred ---CCcEEEeecCCccc
Q 046188 483 ---KFSAKVSDFGTSRS 496 (646)
Q Consensus 483 ---~~~~kI~DfGla~~ 496 (646)
+..+.++||+.++.
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 57899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.7e-08 Score=93.64 Aligned_cols=125 Identities=28% Similarity=0.303 Sum_probs=82.2
Q ss_pred EEEEEcCCCCEEEEEecccC-------------------------CH-HHHHHHHHHHHHHhhcCcc--CceeEEEEEEe
Q 046188 348 VYKGMLPDGSIVAVKRSKAI-------------------------DK-TQIEQFINEVVILSQINHR--HIVKLLGCCLE 399 (646)
Q Consensus 348 Vy~g~~~~g~~VAVK~l~~~-------------------------~~-~~~~~~~~Ei~il~~l~H~--niv~l~g~~~~ 399 (646)
||.|...+|..+|||..+.. .. .......+|.+.|.++... ++.+++++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 89999888999999953210 00 1123456799999999765 566776553
Q ss_pred CCceEEEEEecc--CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEecCCCCC
Q 046188 400 TEVPVLVYEYIC--NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY-MHSSASIPIFHRDIKSS 476 (646)
Q Consensus 400 ~~~~~LV~Ey~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~y-LH~~~~~~ivHrDIk~~ 476 (646)
.-.|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+|+.+.
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~------------------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~ 136 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD------------------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEY 136 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG------------------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STT
T ss_pred --CCEEEEEecCCCccchhhHHhcc------------------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChh
Confidence 3489999998 44454433221 1234455677888886665 57888 999999999
Q ss_pred CEEECCCCcEEEeecCCccccC
Q 046188 477 NILLDDKFSAKVSDFGTSRSVP 498 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~ 498 (646)
||+++++ .+.|+|||.+....
T Consensus 137 NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 137 NILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp SEEEETT-CEEE--GTTEEETT
T ss_pred hEEeecc-eEEEEecCcceecC
Confidence 9999988 99999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-07 Score=96.83 Aligned_cols=264 Identities=19% Similarity=0.200 Sum_probs=156.7
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEE----EE--eCC-ceEEEE
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGC----CL--ETE-VPVLVY 407 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~----~~--~~~-~~~LV~ 407 (646)
..+-||+|+.+.+|---- -+..|| |+...-...... +.+..|.+. .||-+-.=+.+ .. ++. ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d~VA-KIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRDQVA-KIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch-hhchhh-eeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 456799999999985321 122333 554432222211 223333333 45533321111 01 111 234566
Q ss_pred EeccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 408 EYICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 408 Ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
..+.+- ....++.-.. ++ +.....+|.-.++.+..+|.+.+-||++| .+-+|++++|+|+.+++.+
T Consensus 90 P~v~g~~pI~~~y~p~t----RR------qs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 90 PKVSGKEPIHMIYSPAT----RR------QSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred ccCCCccchhhhcCchh----hc------ccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceE
Confidence 665443 2222322111 11 12456899999999999999999999999 8889999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCCCchHH-hhcH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTG-KKPICLTREEE-ERNL 559 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~-~~~l 559 (646)
.|.|-..-... .+.......+|...|.+||... +-.-+...|-|.+||++++++.| ++||....... ..+.
T Consensus 157 ~LVdsDsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 157 VLVDSDSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred EEEcccceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 99987655443 2233344457899999999765 23446789999999999999987 88886432100 0000
Q ss_pred HH-HHHHHHhhchhHHHhhhh--h---cccCC-HHHHHHHHHHHHhccccC--CCCCCCHHHHHHHHHHHHhh
Q 046188 560 VA-YFISLAKENKLLEILDAR--V---AKEAS-EEDIEAVAELAMGCLRLN--SKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 560 ~~-~~~~~~~~~~~~~~~d~~--l---~~~~~-~~~~~~l~~Li~~Cl~~d--P~~RPs~~evl~~L~~i~~~ 623 (646)
.+ .+.. +.....-|.+ + ..+.| .-....+..|..+|+... +.-|||++.++..|..+.++
T Consensus 235 ~E~~Ia~----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 235 LETDIAH----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred chhhhhc----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00 0000 0000000100 0 01112 223456777888888654 56899999999999988765
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=98.58 E-value=2e-08 Score=72.47 Aligned_cols=42 Identities=36% Similarity=0.575 Sum_probs=38.3
Q ss_pred eecccchhhhHhhhcCCchhhhcccc-CCCCcceeeccccccc
Q 046188 175 ATWGDTISSIGHKFGADKQSILDANK-LSEDDLIFTFTPLLIP 216 (646)
Q Consensus 175 v~~gDtl~~Ia~~f~~s~~~l~~~N~-~~~~~~i~~g~~l~vP 216 (646)
|++||||++||++||++.++|.++|+ +.++..+.+||+|.||
T Consensus 1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip 43 (44)
T TIGR02899 1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP 43 (44)
T ss_pred CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence 68899999999999999999999997 5566789999999998
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-08 Score=111.71 Aligned_cols=151 Identities=24% Similarity=0.317 Sum_probs=102.2
Q ss_pred HHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCcccc--------ccccCCcccChhcccc
Q 046188 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--------AVQGTFGYFDPEYFQS 522 (646)
Q Consensus 451 ~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~--------~~~gt~~y~aPE~l~~ 522 (646)
.+++.||.|+|.+.+ +||++|.|++|.+++++..||+.|+.+........+... -..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345699999998764 999999999999999999999999987655332211110 0224567999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhcccc
Q 046188 523 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRL 602 (646)
Q Consensus 523 ~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~ 602 (646)
...+.++|+||+|++++-+..|..+....... ...+. .....+..-...++.+.+.++.+=+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~~~~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LLSYS--------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCC----cchhh--------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 88899999999999999999555443211110 00000 0001111111123345556777778888999
Q ss_pred CCCCCCCHHHHHH
Q 046188 603 NSKKRPTMKQVSM 615 (646)
Q Consensus 603 dP~~RPs~~evl~ 615 (646)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777643
|
|
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.1e-08 Score=85.07 Aligned_cols=49 Identities=20% Similarity=0.301 Sum_probs=41.9
Q ss_pred eeEEeeecccchhhhHhhhcCC--------chhhhccccCCCCcceeecccccccccC
Q 046188 170 LLAYMATWGDTISSIGHKFGAD--------KQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 170 ~~tY~v~~gDtl~~Ia~~f~~s--------~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
..+|+|++|||||+||++|+++ ++.|.+.|++.+ +.|+|||.|.||...
T Consensus 36 ~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~ 92 (103)
T PRK14125 36 YVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLK 92 (103)
T ss_pred cEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCC
Confidence 4689999999999999999876 466777899965 469999999999864
|
|
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-08 Score=74.04 Aligned_cols=43 Identities=30% Similarity=0.584 Sum_probs=34.4
Q ss_pred EEEecCCceeeecccccCCCccHHHhhhcC-CCCCCCCCCCcEEEec
Q 046188 107 YTIKANDTYFLVANNTYQGLTTCQALLGQN-YYDEKNLGSGLEVIVP 152 (646)
Q Consensus 107 y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N-~~~~~~l~~gq~l~ip 152 (646)
|+|++|||+|+|| .+|. +++++|+++| ....+.|.+||+|.||
T Consensus 1 y~V~~gDtl~~IA-~~~~--~~~~~l~~~N~~~~~~~l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIA-KRYG--ISVDELMELNPNIDSDNLQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHH-HHTT--S-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred CEECcCCcHHHHH-hhhh--hhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence 8999999999999 5673 4999999999 6766679999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.6e-07 Score=85.80 Aligned_cols=139 Identities=21% Similarity=0.128 Sum_probs=103.3
Q ss_pred ccccCcEEEEEEEcCCCCEEEEEecccCC------HHHHHHHHHHHHHHhhcCcc--CceeEEEEEEeC----CceEEEE
Q 046188 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID------KTQIEQFINEVVILSQINHR--HIVKLLGCCLET----EVPVLVY 407 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~------~~~~~~~~~Ei~il~~l~H~--niv~l~g~~~~~----~~~~LV~ 407 (646)
-|+||.+.|++-.+ +|+.+-+|+....- +.....|.+|+..|+++... .+.+.+...... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999877 46689999754210 12345788999999998532 244555222221 2358999
Q ss_pred EeccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc-
Q 046188 408 EYICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS- 485 (646)
Q Consensus 408 Ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~- 485 (646)
|-+++- +|.+++.... ..+.+..++..+..+++..+.-||+.+ +.|+|+.+.||+++.++.
T Consensus 105 e~L~g~~~L~~~l~~~~--------------~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~ 167 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--------------VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKA 167 (216)
T ss_pred EeCCCCccHHHHHhcCC--------------cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCe
Confidence 987654 8988875532 235677888999999999999999999 999999999999986666
Q ss_pred -EEEeecCCccc
Q 046188 486 -AKVSDFGTSRS 496 (646)
Q Consensus 486 -~kI~DfGla~~ 496 (646)
++++||.-++.
T Consensus 168 ~v~lIDlEk~r~ 179 (216)
T PRK09902 168 EAGFLDLEKSRR 179 (216)
T ss_pred eEEEEEhhccch
Confidence 99999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.6e-07 Score=89.50 Aligned_cols=134 Identities=22% Similarity=0.208 Sum_probs=95.9
Q ss_pred CcCccccccCcEEEEEEEcCCCCEEEEEecc----------cC----------C--HHHHHHHHHHHHHHhhcCcc--Cc
Q 046188 335 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK----------AI----------D--KTQIEQFINEVVILSQINHR--HI 390 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~----------~~----------~--~~~~~~~~~Ei~il~~l~H~--ni 390 (646)
...+.||.|--+.||.|...+|..+|||--+ .. + .-......+|.++|+++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3467899999999999999899999999311 10 1 11223456799999998655 66
Q ss_pred eeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 046188 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH 470 (646)
Q Consensus 391 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 470 (646)
.+.+++ +...+||||+++-.|...- ++-+..-.|+..|++-+.-+-..| +||
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------------------~~~en~~~il~~il~~~~~~~~~G---iVH 225 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------------------LDVENPDEILDKILEEVRKAYRRG---IVH 225 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------------------CcccCHHHHHHHHHHHHHHHHHcC---ccc
Confidence 666544 4458999999887665332 223333345555555555555667 999
Q ss_pred cCCCCCCEEECCCCcEEEeecCCccc
Q 046188 471 RDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 471 rDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
+|+.+=||++++||.+.++||--+..
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999965543
|
|
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.8e-08 Score=69.51 Aligned_cols=45 Identities=36% Similarity=0.535 Sum_probs=42.3
Q ss_pred EEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccc
Q 046188 172 AYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIP 216 (646)
Q Consensus 172 tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vP 216 (646)
+|+|++|||+++||++||++..+|.++|+......+.+|+.+.||
T Consensus 2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence 699999999999999999999999999998667789999999987
|
This domain may have a general peptidoglycan binding function. |
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.5e-07 Score=100.99 Aligned_cols=109 Identities=18% Similarity=0.151 Sum_probs=77.5
Q ss_pred cEEEec--CCceeeecccccCCCccHHHhhhcCC-CCCCCCC-CC-cEEEecccccC------CCCc-------ccc-Cc
Q 046188 106 PYTIKA--NDTYFLVANNTYQGLTTCQALLGQNY-YDEKNLG-SG-LEVIVPLRCAC------PTAK-------QID-NG 166 (646)
Q Consensus 106 ~y~v~~--gdt~~~Ia~~~~~~lt~~~~l~~~N~-~~~~~l~-~g-q~l~ip~~c~c------~~~~-------~~~-~~ 166 (646)
.++|.. +.+|..|| +.++. +.++|+..|+ +..+.+. .| +.|.||..-.- .... ... +.
T Consensus 263 ~~~V~v~~~i~L~~iA-~~~gv--s~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~ 339 (456)
T PRK10783 263 LARVDLGQQIELAQAA-EMAGM--SLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNT 339 (456)
T ss_pred eEEEecCCCcCHHHHH-HHcCC--CHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccC
Confidence 355555 45899999 55644 9999999995 5544333 34 67888874210 0000 000 00
Q ss_pred cceeeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccccc
Q 046188 167 VSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLK 218 (646)
Q Consensus 167 ~~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~ 218 (646)
.....+|+|++|||+++||++||++.++|.+||++.. +.|.+||.|.||..
T Consensus 340 ~~~~~~y~Vk~GDTL~sIA~r~gvs~~~L~~~N~l~~-~~L~~Gq~L~Ip~~ 390 (456)
T PRK10783 340 PLNSRSYKVRSGDTLSGIASRLNVSTKDLQQWNNLRG-SKLKVGQTLTIGAG 390 (456)
T ss_pred cCCceEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCc-ccCCCCCEEEecCC
Confidence 1234589999999999999999999999999999965 78999999999964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.1e-06 Score=83.29 Aligned_cols=105 Identities=19% Similarity=0.219 Sum_probs=82.8
Q ss_pred HHHHHHHHHhhcCcc--CceeEEEEEEeCC----ceEEEEEeccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHH
Q 046188 374 QFINEVVILSQINHR--HIVKLLGCCLETE----VPVLVYEYICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446 (646)
Q Consensus 374 ~~~~Ei~il~~l~H~--niv~l~g~~~~~~----~~~LV~Ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 446 (646)
...+|...+..+... ...+.+++..... ..+||+|++++. +|.+++.... .++...+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----------------~~~~~~~ 120 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----------------QLDPSQR 120 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----------------ccchhhH
Confidence 567788877777533 3556677766532 348999999875 7988886531 2555667
Q ss_pred HHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC---cEEEeecCCcccc
Q 046188 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGTSRSV 497 (646)
Q Consensus 447 ~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kI~DfGla~~~ 497 (646)
..++.++++.+.-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 121 ~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 121 RELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 889999999999999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.4e-07 Score=94.46 Aligned_cols=96 Identities=22% Similarity=0.232 Sum_probs=78.7
Q ss_pred cEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecccccCCCCccccCccceeeEEeeecccchhhhH
Q 046188 106 PYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSIG 185 (646)
Q Consensus 106 ~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia 185 (646)
.|.|++||+.+.|| ..|.. ++.+ |...|.+..+.|.+||.+.||.- .-.|.|++||++++||
T Consensus 3 i~~~~pg~~~~~i~-~~~~~-~~~~-i~~~~~~~~d~~~~~q~~~v~~~---------------~~~y~~~~~d~~~Sia 64 (423)
T COG3858 3 IHLVGPGDSRLIIA-VYFPY-TNNR-IVNGNDYTNDDLVDGQTFVVPPS---------------GHFYDVGPGDTLTSIA 64 (423)
T ss_pred EEEccCCceeeeeh-hhccc-cccc-cccccccccccccCceeEEECCc---------------ceEEEecCCcchhhhh
Confidence 37899999999999 55654 3444 44445433388999999999962 1269999999999999
Q ss_pred hhhcCCchhhhccccCCCCcceeecccccccccC
Q 046188 186 HKFGADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 186 ~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
++|||+++.+...|....+..+++|-.+.+|-..
T Consensus 65 ~~~~vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~ 98 (423)
T COG3858 65 RTVGVTQDSAAIMNFVICPGYLQYGLNLYIPSAR 98 (423)
T ss_pred hhhcCCHHHHHhhcccccccceeeeeEEeccCCC
Confidence 9999999999999988788899999999999764
|
|
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.4e-07 Score=95.11 Aligned_cols=48 Identities=21% Similarity=0.187 Sum_probs=45.7
Q ss_pred EEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccccccC
Q 046188 172 AYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 172 tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
+|+|++||||++||.+||++..+|.+||++.++..|++||+|.||...
T Consensus 62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~~ 109 (319)
T PRK10871 62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNAS 109 (319)
T ss_pred ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCCC
Confidence 699999999999999999999999999999999999999999998653
|
|
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.1e-07 Score=78.88 Aligned_cols=49 Identities=18% Similarity=0.399 Sum_probs=39.7
Q ss_pred ccEEEecCCceeeecccccCC---Ccc---HHHhhhcCCCCCCCCCCCcEEEeccc
Q 046188 105 APYTIKANDTYFLVANNTYQG---LTT---CQALLGQNYYDEKNLGSGLEVIVPLR 154 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~---lt~---~~~l~~~N~~~~~~l~~gq~l~ip~~ 154 (646)
.+|+|++|||+|+|| +.|.. ++. +++|++.|..+++.|++||+|.||..
T Consensus 37 ~~~tV~~GDTLW~IA-~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~ 91 (103)
T PRK14125 37 VEITVQEGDTLWALA-DQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVL 91 (103)
T ss_pred EEEEECCCCCHHHHH-HHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence 569999999999999 66754 221 57778889777778999999999974
|
|
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.7e-07 Score=92.55 Aligned_cols=48 Identities=25% Similarity=0.329 Sum_probs=44.2
Q ss_pred ceeeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccc
Q 046188 168 SYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIP 216 (646)
Q Consensus 168 ~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vP 216 (646)
.-..+|+|++||||++||+|||+++++|.++|++. +..|.+||+|+||
T Consensus 291 ~~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~-~~~L~~GQ~L~IP 338 (338)
T TIGR02907 291 TKLRMCIVQEGDTIETIAERYEISVSQLIRHNQLE-DFEVNEGQILYIP 338 (338)
T ss_pred cccEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence 33468999999999999999999999999999996 7899999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.3e-05 Score=80.01 Aligned_cols=152 Identities=16% Similarity=0.162 Sum_probs=86.4
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC--ceeEEEEEEeCCceEEEEEeccCCC-
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH--IVKLLGCCLETEVPVLVYEYICNGN- 414 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~LV~Ey~~~gs- 414 (646)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24567788876532 2234578999999986543 4677888877777889999998864
Q ss_pred chhhhhhhhhh----HHHHHH----HHHhhhcCCCCHHHHHH-HHH----------HHHH-HHHHHHc-CCCCCeEecCC
Q 046188 415 LSHHIHDHQQQ----QEQKQE----LEEEQELSSLSWENRVR-VAC----------EVAG-AVAYMHS-SASIPIFHRDI 473 (646)
Q Consensus 415 L~~~l~~~~~~----~~~~~~----~~~~~~~~~l~~~~~~~-ia~----------qia~-gL~yLH~-~~~~~ivHrDI 473 (646)
+.+.+...... .....+ +-... ........+.. +.. ++.+ ...+|.. ...+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 32222111000 000000 00000 00000000000 000 0001 1222221 12345789999
Q ss_pred CCCCEEECCCCcEEEeecCCccc
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~ 496 (646)
.|.||++++++ +.|.||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=89.26 Aligned_cols=141 Identities=21% Similarity=0.228 Sum_probs=91.4
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCCHHHH------------------------------H----------HHHH
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQI------------------------------E----------QFIN 377 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~------------------------------~----------~~~~ 377 (646)
+-|+.++-|.||+|++++|+.||||+.++.-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999999999999997554321111 1 1233
Q ss_pred HHHHHhhc----CccCceeEEEEEEe-CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHH
Q 046188 378 EVVILSQI----NHRHIVKLLGCCLE-TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452 (646)
Q Consensus 378 Ei~il~~l----~H~niv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~q 452 (646)
|+.-+.++ ++..-+++=.++.+ .....|+|||++|-.+.+...-... ..+ +..|+..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---------------g~d---~k~ia~~ 272 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---------------GID---RKELAEL 272 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---------------CCC---HHHHHHH
Confidence 44333333 22222333344443 4566999999999999888532211 233 2233333
Q ss_pred HHHH-HHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCC
Q 046188 453 VAGA-VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499 (646)
Q Consensus 453 ia~g-L~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~ 499 (646)
++++ +.-+-..+ ++|.|..|.||+++.++++-+.|||+......
T Consensus 273 ~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 273 LVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3333 22333356 99999999999999999999999999887643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.9e-05 Score=75.84 Aligned_cols=137 Identities=18% Similarity=0.220 Sum_probs=89.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHH---------HHHHHHHhhcCc---cCceeEEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQF---------INEVVILSQINH---RHIVKLLGCCL 398 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~---------~~Ei~il~~l~H---~niv~l~g~~~ 398 (646)
..+|...+.+.......|.+-.. +|..+.+|..+.......+.| .+++..+.+++. .....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35677777777666666766666 678899997765433222222 233444444432 23333333322
Q ss_pred e-----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 399 E-----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 399 ~-----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
. ....+|+|||++|..|.++.. ++. .++..+++++.-||+.| ++|+|.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~ 161 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------------------IDE----DLAEKIVEAIKQLHKHG---FYHGDP 161 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------------------cCH----HHHHHHHHHHHHHHHcC---CccCCC
Confidence 2 123468999999998876642 111 24566778899999999 999999
Q ss_pred CCCCEEECCCCcEEEeecCCccc
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~ 496 (646)
.|.|++++++ .+++.||+..+.
T Consensus 162 hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 162 HPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred CcCcEEEECC-cEEEEECccccc
Confidence 9999999966 499999988764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.6e-06 Score=78.42 Aligned_cols=104 Identities=21% Similarity=0.310 Sum_probs=82.8
Q ss_pred HHHHHHhhcCc-cCceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHH
Q 046188 377 NEVVILSQINH-RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455 (646)
Q Consensus 377 ~Ei~il~~l~H-~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~ 455 (646)
.|.-+|+.+++ +++.+++|+|-+ ++|.||...+++...-.... ....-+|..|.+||.++++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~-------------~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLS-------------QFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccc-------------cccccCHHHHHHHHHHHHH
Confidence 58888888876 699999999933 78999998776643200000 0124689999999999999
Q ss_pred HHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCcccc
Q 046188 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 456 gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 497 (646)
.+.+|++...-.+...|++++|+-+++++++|+.|...+...
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999865555888999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.6e-06 Score=61.41 Aligned_cols=44 Identities=30% Similarity=0.465 Sum_probs=39.0
Q ss_pred EEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccc
Q 046188 172 AYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLI 215 (646)
Q Consensus 172 tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~v 215 (646)
+|+|++|||+++||++||++..++.++|+......+.+|+.+.|
T Consensus 1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~i 44 (44)
T smart00257 1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44 (44)
T ss_pred CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEeC
Confidence 48999999999999999999999999999656677889987754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.5e-07 Score=97.65 Aligned_cols=188 Identities=17% Similarity=0.126 Sum_probs=133.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC-ceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n-iv~l~g~~~~~~~~~LV~Ey 409 (646)
+..+...+-+++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++...+++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3444445678899999999987433333335544432 34456899999999999 77777777777788899999
Q ss_pred ccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+..| +-..-..... -.+...+...+...-+++++|||+.. =+|+| ||+..+ ...|.
T Consensus 316 ~s~~rs~~~~~~~se---------------~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~ 372 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSE---------------IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKL 372 (829)
T ss_pred hcCCccccccCChhh---------------Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccc
Confidence 9777 2221111100 02333444556667778999999865 48999 777766 58999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
+||+....+.... ......+|+.|+|||....+.+..+.|+|+.|+--.++--|-+|-
T Consensus 373 ~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 373 LDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 9999988764332 234467899999999999999999999999998777777776664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.1e-05 Score=74.76 Aligned_cols=152 Identities=13% Similarity=0.082 Sum_probs=86.9
Q ss_pred ccccCc-EEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEeccCCCchh
Q 046188 340 LGQGGF-GTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYICNGNLSH 417 (646)
Q Consensus 340 IG~G~~-g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 417 (646)
|..|.. ..||+.... +..+.||...... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 789998764 5788889876543 234567888888884 3446678887776667899999999888765
Q ss_pred hhhhhh--h----hHHHHHHHHHhhh-cCCCC--HHHHHH-----------------------HHHHHHHHHHHHH-cCC
Q 046188 418 HIHDHQ--Q----QQEQKQELEEEQE-LSSLS--WENRVR-----------------------VACEVAGAVAYMH-SSA 464 (646)
Q Consensus 418 ~l~~~~--~----~~~~~~~~~~~~~-~~~l~--~~~~~~-----------------------ia~qia~gL~yLH-~~~ 464 (646)
...... . ......++-.... ..+.. +..++. .+.++.+-|.-.. ...
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 431000 0 0000000000000 00000 000000 0111111121111 123
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeecCCcc
Q 046188 465 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495 (646)
Q Consensus 465 ~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 495 (646)
.+.++|+|+.+.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 4569999999999999998788999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.2e-06 Score=90.91 Aligned_cols=46 Identities=26% Similarity=0.271 Sum_probs=42.9
Q ss_pred EEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccccc
Q 046188 172 AYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLK 218 (646)
Q Consensus 172 tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~ 218 (646)
+|+|++|||||.||++||+++++|.++|++. ++.|++||.|.||..
T Consensus 29 tytVq~GDTLw~IA~~ygvtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~ 74 (481)
T PRK13914 29 TVVVEAGDTLWGIAQSKGTTVDAIKKANNLT-TDKIVPGQKLQVNEV 74 (481)
T ss_pred eEEECCCCCHHHHHHHHCCCHHHHHHHhCCC-cccccCCCEEEeCCC
Confidence 6999999999999999999999999999994 568999999999964
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.3e-05 Score=75.21 Aligned_cols=78 Identities=23% Similarity=0.271 Sum_probs=57.3
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC--ceeEEEEEEeC---CceEEEEEecc
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH--IVKLLGCCLET---EVPVLVYEYIC 411 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~g~~~~~---~~~~LV~Ey~~ 411 (646)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4568999999999999865 68999987653 34556778999998885443 56777655433 34689999999
Q ss_pred CCCchh
Q 046188 412 NGNLSH 417 (646)
Q Consensus 412 ~gsL~~ 417 (646)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 888877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=86.03 Aligned_cols=80 Identities=13% Similarity=0.229 Sum_probs=57.5
Q ss_pred CccccccCcEEEEEEEcCCC---CEEEEEecccCC-HHHHHHHHHHHHHHhhcC-ccCc--eeEEEEEEeC---CceEEE
Q 046188 337 SRFLGQGGFGTVYKGMLPDG---SIVAVKRSKAID-KTQIEQFINEVVILSQIN-HRHI--VKLLGCCLET---EVPVLV 406 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g---~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~-H~ni--v~l~g~~~~~---~~~~LV 406 (646)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788999999999876543 367777754321 112346779999999995 6665 7888888764 467999
Q ss_pred EEeccCCCch
Q 046188 407 YEYICNGNLS 416 (646)
Q Consensus 407 ~Ey~~~gsL~ 416 (646)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999876554
|
|
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=8.5e-06 Score=75.36 Aligned_cols=46 Identities=37% Similarity=0.465 Sum_probs=40.8
Q ss_pred eEEeeecccchhhhHhhhcC---Cchhhhcccc--CCCCcceeeccccccc
Q 046188 171 LAYMATWGDTISSIGHKFGA---DKQSILDANK--LSEDDLIFTFTPLLIP 216 (646)
Q Consensus 171 ~tY~v~~gDtl~~Ia~~f~~---s~~~l~~~N~--~~~~~~i~~g~~l~vP 216 (646)
.+|+|++|||||+||++|+. ....|.++|+ +.+++.|+|||+|.||
T Consensus 96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 47999999999999999954 4678999998 7788899999999998
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00044 Score=68.54 Aligned_cols=151 Identities=20% Similarity=0.200 Sum_probs=97.2
Q ss_pred cCHHHHHHHhcCCCcCcc---ccccCcEEEEEEEcCCCCEEEEEecccCCHHH-----------------------HH-H
Q 046188 322 FTAEELQRATDNYNQSRF---LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQ-----------------------IE-Q 374 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~---IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~-----------------------~~-~ 374 (646)
.+.+.+....++..+... |++|-...||+|...++..+|||+.+...... .. -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445666666666665554 55677788999998789999999765421110 00 1
Q ss_pred HHHHHHHHhhcC--ccCceeEEEEEEeCCceEEEEEeccCCC-chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHH
Q 046188 375 FINEVVILSQIN--HRHIVKLLGCCLETEVPVLVYEYICNGN-LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451 (646)
Q Consensus 375 ~~~Ei~il~~l~--H~niv~l~g~~~~~~~~~LV~Ey~~~gs-L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~ 451 (646)
..+|..-|+++. +=.+.+-+++.. -.|||||+.... -.-.|.. .++...+...+..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----------------v~~e~~e~~~~~~ 173 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----------------VPLELEEAEGLYE 173 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----------------CCcCchhHHHHHH
Confidence 134555555553 233444444432 379999985441 1111111 1233335667778
Q ss_pred HHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEEEeecCCcccc
Q 046188 452 EVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 452 qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 497 (646)
++++.+.-|-. .+ +||+||..=|||+. ++.+.|+|||-|-..
T Consensus 174 ~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 174 DVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 88888887777 55 99999999999999 789999999988754
|
|
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=9.7e-06 Score=83.44 Aligned_cols=48 Identities=25% Similarity=0.280 Sum_probs=40.8
Q ss_pred cccEEEecCCceeeecccccCCCccHHHhhhcCC-CCCCCCCCCcEEEeccc
Q 046188 104 NAPYTIKANDTYFLVANNTYQGLTTCQALLGQNY-YDEKNLGSGLEVIVPLR 154 (646)
Q Consensus 104 ~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~-~~~~~l~~gq~l~ip~~ 154 (646)
..+|+|++|||||.|| ..|+ +++.+|+++|. .+++.|++||+|.||..
T Consensus 60 ~~~y~Vk~GDTL~~IA-~~~g--~~~~~La~~N~l~~p~~I~~GQ~L~i~~~ 108 (319)
T PRK10871 60 GSTYTVKKGDTLFYIA-WITG--NDFRDLAQRNNIQAPYSLNVGQTLQVGNA 108 (319)
T ss_pred CCceEECCCCHHHHHH-HHHC--cCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence 3579999999999999 4454 49999999984 57789999999999863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00056 Score=66.58 Aligned_cols=135 Identities=22% Similarity=0.320 Sum_probs=91.7
Q ss_pred CcCccccccCcEEEEEEEcCCCCEEEEEecccCC----------------HHHHHHHHHHHHHHhhcC------ccCcee
Q 046188 335 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID----------------KTQIEQFINEVVILSQIN------HRHIVK 392 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~----------------~~~~~~~~~Ei~il~~l~------H~niv~ 392 (646)
+....||+|+.-.||.- ++.....||++.... .....+..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34668999999999863 344567888776544 222445666766665555 889999
Q ss_pred EEEEEEeCCceEEEEEeccC--C----CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 046188 393 LLGCCLETEVPVLVYEYICN--G----NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASI 466 (646)
Q Consensus 393 l~g~~~~~~~~~LV~Ey~~~--g----sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 466 (646)
++|+..++...-+|+|.+.+ | +|.+++... .++. . +...+-+-..||-+++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----------------~~~~-~---~~~~L~~f~~~l~~~~-- 138 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----------------GLTE-E---LRQALDEFKRYLLDHH-- 138 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----------------CccH-H---HHHHHHHHHHHHHHcC--
Confidence 99999999999999998754 3 466666332 3444 2 3333334456777777
Q ss_pred CeEecCCCCCCEEECCC---C-cEEEee-cCCcc
Q 046188 467 PIFHRDIKSSNILLDDK---F-SAKVSD-FGTSR 495 (646)
Q Consensus 467 ~ivHrDIk~~NILl~~~---~-~~kI~D-fGla~ 495 (646)
|+.+|++|.||++..+ . .+.|+| ||-..
T Consensus 139 -Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 139 -IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred -CeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 9999999999999532 2 566766 55433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00016 Score=67.77 Aligned_cols=128 Identities=17% Similarity=0.156 Sum_probs=89.3
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCce-eEEEEEEeCCceEEEEEeccCCC
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV-KLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv-~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
..+.|++|++|.||+|.+. |..+|+|.-+..+. ...+..|+++|..++-.++. +++.+..+ ++.|||++|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 3567999999999999995 56899998766433 45778999999998876655 34444332 45599998888
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC-CCCEEECCCCcEEEeecCC
Q 046188 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK-SSNILLDDKFSAKVSDFGT 493 (646)
Q Consensus 415 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk-~~NILl~~~~~~kI~DfGl 493 (646)
|.++-.... .+-...+++.---|...| |-|+.|. |..++|.++..+-|+||.-
T Consensus 99 L~~~~~~~~-----------------------rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 99 LGKLEIGGD-----------------------RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred hhhhhhccc-----------------------HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccc
Confidence 877664311 122334555544455566 8899886 5555555555999999998
Q ss_pred ccc
Q 046188 494 SRS 496 (646)
Q Consensus 494 a~~ 496 (646)
|..
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00067 Score=70.68 Aligned_cols=78 Identities=10% Similarity=0.096 Sum_probs=57.5
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc---cCceeEEEEEEeC---CceEEEEEe
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH---RHIVKLLGCCLET---EVPVLVYEY 409 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H---~niv~l~g~~~~~---~~~~LV~Ey 409 (646)
..+.||.|..+.||+-...++ .+.+|..+... ....+..|.+.|+.+.- -.+.++++++..+ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 356799999999999876555 46667644311 12467789999998853 3678889887643 568999999
Q ss_pred ccCCCch
Q 046188 410 ICNGNLS 416 (646)
Q Consensus 410 ~~~gsL~ 416 (646)
++++++.
T Consensus 95 i~G~~~~ 101 (297)
T PRK10593 95 LRGVSVE 101 (297)
T ss_pred cCCEecC
Confidence 9988774
|
|
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=97.71 E-value=1.8e-05 Score=56.54 Aligned_cols=44 Identities=34% Similarity=0.505 Sum_probs=37.6
Q ss_pred cEEEecCCceeeecccccCCCccHHHhhhcCCC-CCCCCCCCcEEEec
Q 046188 106 PYTIKANDTYFLVANNTYQGLTTCQALLGQNYY-DEKNLGSGLEVIVP 152 (646)
Q Consensus 106 ~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~-~~~~l~~gq~l~ip 152 (646)
.|+|++|||+++|| ..|. ++...++.+|.. ....+.+|+.|.||
T Consensus 2 ~~~v~~gdt~~~ia-~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIA-QRYG--ISVEELLKLNGLSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHH-HHHC--cCHHHHHHHcCCCCccccCCCCEEecC
Confidence 59999999999999 5663 388999999965 56689999999987
|
This domain may have a general peptidoglycan binding function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00039 Score=69.84 Aligned_cols=75 Identities=19% Similarity=0.218 Sum_probs=47.4
Q ss_pred ccccccCcE-EEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc---CceeEEEEEEeCC---ceEEEEEec
Q 046188 338 RFLGQGGFG-TVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR---HIVKLLGCCLETE---VPVLVYEYI 410 (646)
Q Consensus 338 ~~IG~G~~g-~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~---niv~l~g~~~~~~---~~~LV~Ey~ 410 (646)
+.|+.|+.. .||+. +..+++|..+... ....+.+|.++++.+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777665 58874 2357778655421 234677899999887532 3445555443322 358899999
Q ss_pred cCCCchhh
Q 046188 411 CNGNLSHH 418 (646)
Q Consensus 411 ~~gsL~~~ 418 (646)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99888654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00053 Score=75.92 Aligned_cols=141 Identities=17% Similarity=0.169 Sum_probs=88.4
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCCHHH-------------------------------H------HHHHHHHH
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQ-------------------------------I------EQFINEVV 380 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~-------------------------------~------~~~~~Ei~ 380 (646)
+-||.-+.|.||+|++++|+.||||+-++.-+.. . -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999755421111 0 02333433
Q ss_pred HHhh----cCccC---ceeEEEEEEe-CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHH
Q 046188 381 ILSQ----INHRH---IVKLLGCCLE-TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452 (646)
Q Consensus 381 il~~----l~H~n---iv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~q 452 (646)
-..+ +.|-+ -|++=.++.+ .....|+|||++|..+.+.-.-.. ..++-. .|+..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---------------~gi~~~---~i~~~ 308 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---------------RGISPH---DILNK 308 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---------------cCCCHH---HHHHH
Confidence 2222 34545 1222233333 346799999999998876632211 134443 34444
Q ss_pred HHHHHH-HHHcCCCCCeEecCCCCCCEEECC----CCcEEEeecCCccccCC
Q 046188 453 VAGAVA-YMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGTSRSVPN 499 (646)
Q Consensus 453 ia~gL~-yLH~~~~~~ivHrDIk~~NILl~~----~~~~kI~DfGla~~~~~ 499 (646)
+.++.. -|=..| ++|.|=.|.||+++. ++++.+-|||+......
T Consensus 309 l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 309 LVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 433322 223345 999999999999983 78999999999887643
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=97.65 E-value=1.6e-05 Score=57.08 Aligned_cols=41 Identities=20% Similarity=0.412 Sum_probs=34.4
Q ss_pred EecCCceeeecccccCCCccHHHhhhcCC-C-CCCCCCCCcEEEec
Q 046188 109 IKANDTYFLVANNTYQGLTTCQALLGQNY-Y-DEKNLGSGLEVIVP 152 (646)
Q Consensus 109 v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~-~-~~~~l~~gq~l~ip 152 (646)
|++|||+|+|| +.|.. +++.|.++|. . +++.+.+||+|.||
T Consensus 1 v~~gdtl~~IA-~~~~~--~~~~l~~~N~~~~~~~~~~~g~~l~ip 43 (44)
T TIGR02899 1 VQKGDTLWKIA-KKYGV--DFDELIQANPQLSNPNLIYPGMKIKIP 43 (44)
T ss_pred CCCCCCHHHHH-HHHCc--CHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence 68999999999 56744 8999999994 4 45679999999998
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=3.4e-05 Score=71.37 Aligned_cols=48 Identities=21% Similarity=0.334 Sum_probs=39.1
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcCC---CCCCCCCCCcEEEec
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNY---YDEKNLGSGLEVIVP 152 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~---~~~~~l~~gq~l~ip 152 (646)
..|+|++|||+|+||...|..-..++.|.++|. ..++.|++||+|.||
T Consensus 96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 469999999999999554444456889999983 456789999999998
|
|
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=97.55 E-value=3.7e-05 Score=78.28 Aligned_cols=47 Identities=17% Similarity=0.293 Sum_probs=41.2
Q ss_pred ccccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEec
Q 046188 103 HNAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVP 152 (646)
Q Consensus 103 ~~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip 152 (646)
....|+|++|||+|.|| ++|+. +++.|+++|...++.|.+||.|.||
T Consensus 292 ~~~~YiVq~GDTL~sIA-kRYGV--SV~~L~r~N~L~~~~L~~GQ~L~IP 338 (338)
T TIGR02907 292 KLRMCIVQEGDTIETIA-ERYEI--SVSQLIRHNQLEDFEVNEGQILYIP 338 (338)
T ss_pred ccEEEEECCCCCHHHHH-HHHCc--CHHHHHHHhCCCccccCCCCEEEeC
Confidence 34579999999999999 67754 9999999996668899999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00044 Score=80.98 Aligned_cols=201 Identities=18% Similarity=0.221 Sum_probs=138.5
Q ss_pred HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE----EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHH
Q 046188 371 QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446 (646)
Q Consensus 371 ~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~----LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 446 (646)
+.....-|++.+.++.|+|++.++++..++...- +..|++..-++...+.. ...++....
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----------------v~~i~~~~~ 288 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----------------VGSIPLETL 288 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----------------ccccCHHHH
Confidence 3444456778888899999999999987653222 23455655566555543 346888899
Q ss_pred HHHHHHHHHHHHHHHcCCCCCeEecCCCCC---CEEECCCCcEEEe--ecCCccccCCCCCccccccccCCcccChhccc
Q 046188 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSS---NILLDDKFSAKVS--DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521 (646)
Q Consensus 447 ~~ia~qia~gL~yLH~~~~~~ivHrDIk~~---NILl~~~~~~kI~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 521 (646)
+.+..++.+||.|+|+.. ..|.-+..+ +--.+..+...++ ||+.++...+...... ...+..|.+||...
T Consensus 289 r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~ 363 (1351)
T KOG1035|consen 289 RILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLK 363 (1351)
T ss_pred HHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccc
Confidence 999999999999999986 666665555 5556777788888 9998887654333222 23455688888877
Q ss_pred cCCCCC--ccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhc
Q 046188 522 SSQYTD--KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGC 599 (646)
Q Consensus 522 ~~~~s~--ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~C 599 (646)
...... ..|+|.+|..+..+..|..+-..... ...+++.. ....+.+...+|
T Consensus 364 ~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~--------~~~~~~d~~~~~ 417 (1351)
T KOG1035|consen 364 ENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------------------PVSLLDVL--------STSELLDALPKC 417 (1351)
T ss_pred cccchhhhhhHHHHHHHHHhhhhhcCcccccccc------------------hhhhhccc--------cchhhhhhhhhh
Confidence 655544 47999999999999998765321100 01111110 111466778899
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 046188 600 LRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 600 l~~dP~~RPs~~evl~~L~ 618 (646)
+..++++|++..+++.+..
T Consensus 418 ~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 418 LDEDSEERLSALELLTHPF 436 (1351)
T ss_pred cchhhhhccchhhhhhchh
Confidence 9999999999999998876
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00079 Score=68.53 Aligned_cols=151 Identities=14% Similarity=0.071 Sum_probs=78.9
Q ss_pred ccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-eeEEEEEEeCCceEEEEEeccCCCchhh
Q 046188 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYICNGNLSHH 418 (646)
Q Consensus 340 IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 418 (646)
+..|-...+|+... +++.+++|..........-+..+|..+++.+....+ .++++... ..+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998875 567788887543222110134678888888864433 34444432 3789999998776532
Q ss_pred hh-h---hhhhHHHHHHHHHhh-hcCCCCHHHH-HHHHH---------HHHHHHHHHHcC-----CCCCeEecCCCCCCE
Q 046188 419 IH-D---HQQQQEQKQELEEEQ-ELSSLSWENR-VRVAC---------EVAGAVAYMHSS-----ASIPIFHRDIKSSNI 478 (646)
Q Consensus 419 l~-~---~~~~~~~~~~~~~~~-~~~~l~~~~~-~~ia~---------qia~gL~yLH~~-----~~~~ivHrDIk~~NI 478 (646)
-. . .........++-... ...+++...+ ..... .+...+..+-.. ..+.++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 00 0 000000000000000 0011111111 11110 111112222111 124589999999999
Q ss_pred EECCCCcEEEeecCCccc
Q 046188 479 LLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~ 496 (646)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0017 Score=69.97 Aligned_cols=80 Identities=20% Similarity=0.260 Sum_probs=56.1
Q ss_pred CccccccCcEEEEEEEcCCC-CEEEEEecccC------C-HHHHHHHHHHHHHHhhcC---ccCceeEEEEEEeCCceEE
Q 046188 337 SRFLGQGGFGTVYKGMLPDG-SIVAVKRSKAI------D-KTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g-~~VAVK~l~~~------~-~~~~~~~~~Ei~il~~l~---H~niv~l~g~~~~~~~~~L 405 (646)
.+.||.|.+..||+....+| +.|+||.-.+. . ....+.+..|.+.|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35699999999999998776 48999974321 1 123456677888888763 3457777777 4566799
Q ss_pred EEEeccCCC-chhh
Q 046188 406 VYEYICNGN-LSHH 418 (646)
Q Consensus 406 V~Ey~~~gs-L~~~ 418 (646)
||||+++.. +.+.
T Consensus 109 VME~L~~~~~lr~~ 122 (401)
T PRK09550 109 VMEDLSDHKILRKG 122 (401)
T ss_pred EEecCCCccHHHHH
Confidence 999998754 4333
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0016 Score=63.12 Aligned_cols=125 Identities=27% Similarity=0.413 Sum_probs=87.5
Q ss_pred cCCCcCccccccCc-EEEEEEEcCCCCEEEEEeccc---CC------------H------HHHHHHHHHHHHHhhc---C
Q 046188 332 DNYNQSRFLGQGGF-GTVYKGMLPDGSIVAVKRSKA---ID------------K------TQIEQFINEVVILSQI---N 386 (646)
Q Consensus 332 ~~~~~~~~IG~G~~-g~Vy~g~~~~g~~VAVK~l~~---~~------------~------~~~~~~~~Ei~il~~l---~ 386 (646)
.+++..+.||.|.. |.|||+.+ +|+.+|+|..+. .. . .....|..|.....++ .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 688999998211 00 0 1123466777666655 4
Q ss_pred ccCc--eeEEEEEEeCC------------------ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHH
Q 046188 387 HRHI--VKLLGCCLETE------------------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446 (646)
Q Consensus 387 H~ni--v~l~g~~~~~~------------------~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 446 (646)
+.++ |+.+|+..-.. ...+|.||++... .++.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------------~~~~--- 167 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------------PLQI--- 167 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------------ccch---
Confidence 5667 89999874220 1256777765443 1112
Q ss_pred HHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCc
Q 046188 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494 (646)
Q Consensus 447 ~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 494 (646)
+=+.++.+-|.-+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 168 -~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 -RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 23445667778899999 999999999985 4689999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0027 Score=63.52 Aligned_cols=75 Identities=19% Similarity=0.131 Sum_probs=48.7
Q ss_pred CccccccCcEEEEEEEcCC--CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-eeEEEEEEeCCceEEEEEeccCC
Q 046188 337 SRFLGQGGFGTVYKGMLPD--GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYICNG 413 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~--g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~g 413 (646)
.+.|..|-...+|+....+ ++.+++|........ .-+..+|+.+++.+...++ .++++... ..++|||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3457778788999988754 578889976543221 1223468888888854333 44544332 24899999987
Q ss_pred Cch
Q 046188 414 NLS 416 (646)
Q Consensus 414 sL~ 416 (646)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00016 Score=65.01 Aligned_cols=73 Identities=19% Similarity=0.241 Sum_probs=55.0
Q ss_pred cccccCCCCeEEeccccee--cCCCCc---c--------------cccEEEecCCceeeecccccCCCccHHHhhhcCCC
Q 046188 78 IAYLLGSDASIIVPVSCSC--SGSLYQ---H--------------NAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYY 138 (646)
Q Consensus 78 ~~~~~~~~~~l~vP~~c~c--~~~~~~---~--------------~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~ 138 (646)
.++.+..|+.+.+|..-+- ..+... + ..+|+|++||||+.|| +.|+. +...|+.+|..
T Consensus 21 ~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~Ia-~~~~~--tv~~l~~~n~l 97 (124)
T COG1388 21 KSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSKIA-RKYGV--TVAELKQLNNL 97 (124)
T ss_pred CCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHHHH-HHhCC--CHHHHHHHhcc
Confidence 3678889999988864111 111110 1 2579999999999999 55655 99999999987
Q ss_pred CCCCCCCCcEEEecc
Q 046188 139 DEKNLGSGLEVIVPL 153 (646)
Q Consensus 139 ~~~~l~~gq~l~ip~ 153 (646)
..+.+.+||+|.+|.
T Consensus 98 ~~~~i~~gq~l~~~~ 112 (124)
T COG1388 98 SSDKIKVGQKLKLPV 112 (124)
T ss_pred CCCceecCcEEEEec
Confidence 777999999999986
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.011 Score=62.28 Aligned_cols=171 Identities=12% Similarity=0.148 Sum_probs=86.0
Q ss_pred cCHHHHHHHhcCCCc-----CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc--CceeEE
Q 046188 322 FTAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR--HIVKLL 394 (646)
Q Consensus 322 ~~~~el~~~t~~~~~-----~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~--niv~l~ 394 (646)
.+.+++......|.. .+.|+.|....+|+....+| .+++|+....... ....|+.++..+... .+.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcce
Confidence 345555555455543 34566777788999886555 6888887532222 233455555555321 233333
Q ss_pred EE------EEeCCceEEEEEeccCCCchhh----hhhhhhhHHHHHHHHHhh-----hcCCCCH-HHHHH----------
Q 046188 395 GC------CLETEVPVLVYEYICNGNLSHH----IHDHQQQQEQKQELEEEQ-----ELSSLSW-ENRVR---------- 448 (646)
Q Consensus 395 g~------~~~~~~~~LV~Ey~~~gsL~~~----l~~~~~~~~~~~~~~~~~-----~~~~l~~-~~~~~---------- 448 (646)
.. ....+..++++||++|..+... ...-...-.+.......- ....+.| .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 21 1224567899999988765321 110000000000000000 0001112 11111
Q ss_pred ---HHHHHHHHHHHHHcC----CCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 449 ---VACEVAGAVAYMHSS----ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 449 ---ia~qia~gL~yLH~~----~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
+...+...++.+... -...++|+|+.+.||+++++...-|.||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 111111222333211 223599999999999999776668999998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0067 Score=62.99 Aligned_cols=156 Identities=14% Similarity=0.151 Sum_probs=87.2
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC--ceeEEEE------EEeCCceEEEEE
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH--IVKLLGC------CLETEVPVLVYE 408 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~g~------~~~~~~~~LV~E 408 (646)
.+.|..|....+|+.... +..+++|+..... .+....|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777777899998764 4568889876522 234557888888875432 4454432 122345689999
Q ss_pred eccCCCchhh----hhhhhhhHHHHHHHHHhh-----hcCCCCHHHHH----------HHHHHHHHHHHHHHcC----CC
Q 046188 409 YICNGNLSHH----IHDHQQQQEQKQELEEEQ-----ELSSLSWENRV----------RVACEVAGAVAYMHSS----AS 465 (646)
Q Consensus 409 y~~~gsL~~~----l~~~~~~~~~~~~~~~~~-----~~~~l~~~~~~----------~ia~qia~gL~yLH~~----~~ 465 (646)
|++|..+... ...-...-.......... ......|.... .....+..++.++... ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998876441 111000000111110000 00112332211 0111233444555431 12
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 466 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 466 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
..++|+|+.|.||+++++....|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999988763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.01 Score=62.06 Aligned_cols=171 Identities=15% Similarity=0.160 Sum_probs=89.1
Q ss_pred CHHHHHHHhcCCCc-----CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc--CceeEEE
Q 046188 323 TAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR--HIVKLLG 395 (646)
Q Consensus 323 ~~~el~~~t~~~~~-----~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~--niv~l~g 395 (646)
+.++|....+.|.. .+.++.|....+|+....+| .+++|+...... .+....|++++..+... .+.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 34555554445543 45567777789999876545 577887654221 22344566777776422 2344443
Q ss_pred EE------EeCCceEEEEEeccCCCchhh----hhhhhhhHHHHHHHHHhh-h-----cCCCCHHHHH------------
Q 046188 396 CC------LETEVPVLVYEYICNGNLSHH----IHDHQQQQEQKQELEEEQ-E-----LSSLSWENRV------------ 447 (646)
Q Consensus 396 ~~------~~~~~~~LV~Ey~~~gsL~~~----l~~~~~~~~~~~~~~~~~-~-----~~~l~~~~~~------------ 447 (646)
.. ...+..++++||++|..+... .......-.........- . ...-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 123456899999988665321 111000000000000000 0 0001121100
Q ss_pred HHHHHHHHHHHHHHc----CCCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 448 RVACEVAGAVAYMHS----SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 448 ~ia~qia~gL~yLH~----~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
.....+.+.++++.. .....++|+|+.+.||++++++...|.||+.+..
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 011123344555542 2234599999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 646 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-05 | ||
| 4eby_A | 212 | Crystal Structure Of The Ectodomain Of A Receptor L | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-126
Identities = 118/315 (37%), Positives = 171/315 (54%), Gaps = 16/315 (5%)
Query: 311 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT 370
SS ++ +L+ AT+N++ +G G FG VYKG+L DG+ VA+KR
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 371 QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQ 430
IE+F E+ LS H H+V L+G C E +L+Y+Y+ NGNL H++
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM--- 134
Query: 431 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490
S+SWE R+ + A + Y+H+ I HRD+KS NILLD+ F K++D
Sbjct: 135 ---------SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182
Query: 491 FGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 549
FG S+ D+THL+T V+GT GY DPEYF + T+KSDVYSFGVVL E+L + I
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT 609
+ E NL + + +L +I+D +A + E + + A+ CL L+S+ RP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 610 MKQVSMDLEGLRRSQ 624
M V LE R Q
Sbjct: 303 MGDVLWKLEYALRLQ 317
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-120
Identities = 114/305 (37%), Positives = 180/305 (59%), Gaps = 17/305 (5%)
Query: 319 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIE-QFIN 377
K F+ ELQ A+DN++ LG+GGFG VYKG L DG++VAVKR K E QF
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
EV ++S HR++++L G C+ +LVY Y+ NG+++ + + + Q
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ----------- 125
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
L W R R+A A +AY+H I HRD+K++NILLD++F A V DFG ++ +
Sbjct: 126 -PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 498 PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR--EEE 555
TH+TTAV+GT G+ PEY + + ++K+DV+ +GV+LLEL+TG++ L R ++
Sbjct: 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ-VS 614
+ L+ + L KE KL ++D + +E++E + ++A+ C + + +RP M + V
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 615 MDLEG 619
M LEG
Sbjct: 305 M-LEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-111
Identities = 103/322 (31%), Positives = 168/322 (52%), Gaps = 33/322 (10%)
Query: 314 GSSEKAKIFTAEELQRATDNYNQ------SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAI 367
S + F+ EL+ T+N+++ +G+GGFG VYKG + + + VAVK+ A+
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 368 DKTQIEQ----FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQ 423
E+ F E+ ++++ H ++V+LLG + + LVY Y+ NG+L +
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 424 QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483
LSW R ++A A + ++H + I HRDIKS+NILLD+
Sbjct: 126 GTP-------------PLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEA 169
Query: 484 FSAKVSDFGTSRSVP-NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELL 542
F+AK+SDFG +R+ +T +T+ + GT Y PE + T KSD+YSFGVVLLE++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 543 TGKKPICLTREEEERNLVAYFISLAKENK-LLEILDARVAKEASEEDIEAVAELAMGCLR 601
TG + RE + L+ + E K + + +D ++ +A +EA+ +A CL
Sbjct: 229 TGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLH 285
Query: 602 LNSKKRPTMKQVSMDLEGLRRS 623
KRP +K+V L+ + S
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 4e-74
Identities = 70/345 (20%), Positives = 122/345 (35%), Gaps = 51/345 (14%)
Query: 306 LQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK 365
+ S E L + +G FG V+K VAVK
Sbjct: 1 MGHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP 56
Query: 366 AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV----LVYEYICNGNLSHHIHD 421
DK Q Q EV L + H +I++ +G L+ + G+LS +
Sbjct: 57 IQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115
Query: 422 HQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASI-------PIFHRDIK 474
+ +SW +A +A +AY+H I HRDIK
Sbjct: 116 NV-----------------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSS-----QYTDK 528
S N+LL + +A ++DFG + K+ T GT Y PE + + +
Sbjct: 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 529 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEA---- 584
D+Y+ G+VL EL + +E ++ + + + L ++ + V K+
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDE---YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL 275
Query: 585 -----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
+ + E C +++ R + V + ++R
Sbjct: 276 RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-67
Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 33/286 (11%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G G FGTV++ GS VAVK + ++ +F+ EV I+ ++ H +IV +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ +V EY+ G+L +H +++ L R+ +A +VA +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-------------LDERRRLSMAYDVAKGM 150
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
Y+H+ + PI HR++KS N+L+D K++ KV DFG SR + +A GT + P
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAP 208
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILD 577
E + +KSDVYSFGV+L EL T ++P N ++ + K LEI
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFKCKRLEI-- 260
Query: 578 ARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
VA + GC KRP+ + L L +S
Sbjct: 261 -------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 8e-66
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 37/285 (12%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 399
+G+G FG V K VA+K + +++ + FI E+ LS++NH +IVKL G CL
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 459
LV EY G+L + +H + L + + + + + VAY
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEP-------------LPYYTAAHAMSWCLQCSQGVAY 117
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFS-AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 518
+HS + HRD+K N+LL + K+ DFGT+ D T +G+ + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE 173
Query: 519 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 578
F+ S Y++K DV+S+G++L E++T +KP +E + +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPL--- 225
Query: 579 RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
+ + + L C + +RP+M+++ + L R
Sbjct: 226 ------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 50/296 (16%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKR-------SKAIDKTQIEQFINEVVILSQINHRHIV 391
+G+GGFG V+KG + D S+VA+K + + ++F EV I+S +NH +IV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
KL G P +V E++ G+L H + D + W ++R+
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP---------------IKWSVKLRLML 129
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-----FSAKVSDFGTSRSVPNDKTHLTT 506
++A + YM + + PI HRD++S NI L AKV+DFG S+ H +
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVS 184
Query: 507 AVQGTFGYFDPEYF--QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
+ G F + PE + YT+K+D YSF ++L +LTG+ P +E + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DEYSYGKIKFIN 240
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
+ +E I E+ + + C + KKRP + +L L
Sbjct: 241 MIREEGLRPTI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-63
Identities = 79/293 (26%), Positives = 125/293 (42%), Gaps = 48/293 (16%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLLG 395
+G GGFG VY+ G VAVK ++ IE E + + + H +I+ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
CL+ LV E+ G L+ + + + + V A ++A
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR-----------------IPPDILVNWAVQIAR 116
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFS--------AKVSDFGTSRSVPNDKTHLTTA 507
+ Y+H A +PI HRD+KSSNIL+ K K++DFG +R +T +A
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA 174
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
G + + PE ++S ++ SDV+S+GV+L ELLTG+ P + +A +A
Sbjct: 175 A-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVA 227
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
L I E A+L C + RP+ + L +
Sbjct: 228 MNKLALPI---------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-59
Identities = 55/290 (18%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT--QIEQFINEVVILSQINHRHIVKLLGCC 397
L + G ++KG G+ + VK K D + + F E L +H +++ +LG C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 398 LETEVP--VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
P L+ ++ G+L + +H+ + V+ A ++A
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--------------VDQSQAVKFALDMAR 122
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
+A++H+ I + S ++++D+ +A++S S + +
Sbjct: 123 GMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWV 175
Query: 516 DPEYFQSSQY---TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572
PE Q +D++SF V+L EL+T + P + + + + +A E
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVALEGLR 229
Query: 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
I V++L C+ + KRP + LE ++
Sbjct: 230 PTI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-58
Identities = 68/340 (20%), Positives = 123/340 (36%), Gaps = 59/340 (17%)
Query: 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVI 381
A E DN +G+G +G VYKG L D VAVK ++ + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 382 --LSQINHRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
+ + H +I + + LV EY NG+L ++ H
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------------ 106
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASI------PIFHRDIKSSNILLDDKFSAKV 488
+ W + R+A V +AY+H+ I HRD+ S N+L+ + + +
Sbjct: 107 -----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161
Query: 489 SDFGTSR-------SVPNDKTHLTTAVQGTFGYFDPEYFQSS-------QYTDKSDVYSF 534
SDFG S P ++ + + GT Y PE + + + D+Y+
Sbjct: 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 535 GVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAK----------EA 584
G++ E+ + E +A+ + ++ + +
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280
Query: 585 SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
+ + ++ E C +++ R T + + L
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 69/298 (23%), Positives = 116/298 (38%), Gaps = 46/298 (15%)
Query: 340 LGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
LG+G FG K G ++ +K D+ F+ EV ++ + H +++K +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+ + + EYI G L I Q W RV A ++A +A
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ---------------YPWSQRVSFAKDIASGMA 122
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------------- 505
Y+HS I HRD+ S N L+ + + V+DFG +R + ++KT
Sbjct: 123 YLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565
V G + PE Y +K DV+SFG+VL E++ ++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLP 227
Query: 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
+ L + + + + C L+ +KRP+ ++ LE LR
Sbjct: 228 RTMDFGLNVRGFLD--RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-57
Identities = 57/303 (18%), Positives = 113/303 (37%), Gaps = 51/303 (16%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G+G FG VY G G VA++ + ++ Q++ F EV+ Q H ++V +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ ++ L + D + L ++A E+ +
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIV---------------LDVNKTRQIAQEIVKGM 143
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR----SVPNDKTHLTTAVQGTFG 513
Y+H+ I H+D+KS N+ D+ ++DFG + G
Sbjct: 144 GYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 514 YFDPEYFQSSQ---------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
+ PE + ++ SDV++ G + EL + P + + + + +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF----KTQPAEAIIWQM 255
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
+ + KE ++++ + C ++RPT ++ LE L +
Sbjct: 256 G---TGMKPNLSQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
Query: 625 RCL 627
R L
Sbjct: 305 RRL 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-57
Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 42/291 (14%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G G FGTVYKG G VAVK A Q++ F NEV +L + H +I+ +G
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
T + +V ++ +L HH+H + + + + +A + A
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLHASETK---------------FEMKKLIDIARQTARG 132
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYF 515
+ Y+H+ I HRD+KS+NI L + + K+ DFG + +H + G+ +
Sbjct: 133 MDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 516 DPE---YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572
PE S+ Y+ +SDVY+FG+VL EL+TG+ P N + + +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMVGRGSLS 244
Query: 573 LEILDARVAKEASEEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
++ R + + + L CL+ +RP+ ++ ++E L R
Sbjct: 245 PDLSKVR-------SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-51
Identities = 62/314 (19%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINE--VVILSQINHRHIVKLLGCC 397
+G+G +G V+ G G VAVK T+ + E + + H +I+ +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKV---FFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 398 LETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
++ L+ +Y NG+L ++ +L ++ +++A
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST-----------------TLDAKSMLKLAYSS 143
Query: 454 AGAVAYMHSSASI-----PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL---T 505
+ ++H+ I HRD+KS NIL+ + ++D G + +D +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 506 TAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
GT Y PE Q +D+YSFG++L E+ C++ E
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR----CVSGGIVEEYQ 259
Query: 560 VAYFISLAKENKLLEILDARVAK---------EASEEDIEAVAELAMGCLRLNSKKRPTM 610
+ Y + + ++ + K +S+E + + +L C N R T
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 611 KQVSMDLEGLRRSQ 624
+V L + SQ
Sbjct: 320 LRVKKTLAKMSESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 59/314 (18%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINE--VVILSQINHRHIVKLLGCC 397
+G+G FG V++G G VAVK + + E + + H +I+ +
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 398 LETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
+ LV +Y +G+L +++ + +++ E +++A
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----------------TVTVEGMIKLALST 148
Query: 454 AGAVAYMHSSAS-----IPIFHRDIKSSNILLDDKFSAKVSDFGTSR---SVPNDKTHLT 505
A +A++H I HRD+KS NIL+ + ++D G + S +
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 506 TAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
GT Y PE + + ++D+Y+ G+V E+ C E
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR----CSIGGIHEDYQ 264
Query: 560 VAYFISLAKENKLLEILDARVAKE---------ASEEDIEAVAELAMGCLRLNSKKRPTM 610
+ Y+ + + + E+ ++ S E + +A++ C N R T
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 611 KQVSMDLEGLRRSQ 624
++ L L + +
Sbjct: 325 LRIKKTLSQLSQQE 338
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 9e-50
Identities = 56/311 (18%), Positives = 108/311 (34%), Gaps = 56/311 (18%)
Query: 340 LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVI--LSQINHRHIVKLLGCC 397
+G+G +G V++G G VAVK + + E + + H +I+ +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 398 LETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
+ + L+ Y G+L ++ +L + +R+ +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-----------------TLDTVSCLRIVLSI 114
Query: 454 AGAVAYMHSSASI-----PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL---T 505
A +A++H I HRD+KS NIL+ ++D G + L
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 506 TAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
GT Y PE + D+++FG+VL E+ + + +
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK---- 230
Query: 560 VAYFISLAKENKLLEILDARVAKE----------ASEEDIEAVAELAMGCLRLNSKKRPT 609
F + + E + V + S+ + ++A+L C N R T
Sbjct: 231 -PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 610 MKQVSMDLEGL 620
++ L +
Sbjct: 290 ALRIKKTLTKI 300
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQINH 387
N+ + +G+G F VY+ L DG VA+K+ +D I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+++K +E +V E G+LS I + ++QK+ + E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVW--------- 139
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
+ ++ A+ +MHS + HRDIK +N+ + K+ D G R + T +
Sbjct: 140 KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
V GT Y PE + Y KSD++S G +L E+ + P ++ NL +
Sbjct: 197 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLC---- 247
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+I S+ E + +L C+ + +KRP + V
Sbjct: 248 -----KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 72/289 (24%), Positives = 126/289 (43%), Gaps = 36/289 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
++Y +G G +G K DG I+ K ++ + + + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 389 HIVKLLGCCLETEVPVL--VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+IV+ ++ L V EY G+L+ I + +++Q L+EE L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVL-------- 114
Query: 447 VRVACEVAGAVAYMHS--SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
RV ++ A+ H + HRD+K +N+ LD K + K+ DFG +R + +D +
Sbjct: 115 -RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
T V GT Y PE Y +KSD++S G +L EL P +
Sbjct: 174 KTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELA- 225
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
K+ E R+ S+E + E+ L L RP+++++
Sbjct: 226 -----GKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 67/305 (21%), Positives = 122/305 (40%), Gaps = 43/305 (14%)
Query: 315 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQ 371
S + T ++ + Y + + +G+G FG DG +K + +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 372 IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQE 431
E+ EV +L+ + H +IV+ E +V +Y G+L I ++
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-----NAQKGVL 121
Query: 432 LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491
+E+Q L ++ A+ ++H I HRDIKS NI L + ++ DF
Sbjct: 122 FQEDQIL---------DWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 551
G +R + + + GT Y PE ++ Y +KSD+++ G VL EL T K
Sbjct: 170 GIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA---- 224
Query: 552 REEEERNLVAYFISLAKENKLLEILDARVAK---EASEEDIEAVAELAMGCLRLNSKKRP 608
F + + +N +L+I+ S + + L + N + RP
Sbjct: 225 -----------FEAGSMKNLVLKIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRP 269
Query: 609 TMKQV 613
++ +
Sbjct: 270 SVNSI 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 66/303 (21%), Positives = 114/303 (37%), Gaps = 61/303 (20%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN 386
+R ++ + +G GGFG V+K DG +KR + E+ EV L++++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLD 62
Query: 387 HRHIVKLLGCCLETEVPV----------------LVYEYICNGNLSHHIHDHQQQQEQKQ 430
H +IV GC + + E+ G L I ++ + +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----EKRRGE 117
Query: 431 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490
+L++ +L ++ V Y+HS + +RD+K SNI L D K+ D
Sbjct: 118 KLDKVL---ALEL------FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGD 165
Query: 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 550
FG S+ ND + GT Y PE S Y + D+Y+ G++L ELL
Sbjct: 166 FGLVTSLKNDGKRTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--- 220
Query: 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610
F ++ D ++ ++ L L + RP
Sbjct: 221 -----------AF---ETSKFFTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNT 262
Query: 611 KQV 613
++
Sbjct: 263 SEI 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 61/300 (20%), Positives = 118/300 (39%), Gaps = 57/300 (19%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKAIDKTQIEQFINEVVILSQINH--R 388
Y+ + +G GG V++ + I A+K + D ++ + NE+ L+++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
I++L + + +V E N +L+ + + S+ +
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----------------SID-PWERK 130
Query: 449 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT--HLT 505
+ AV +H I H D+K +N L+ D K+ DFG + + D T
Sbjct: 131 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 506 TAVQGTFGYFDPEYFQSS-----------QYTDKSDVYSFGVVLLELLTGKKPICLTREE 554
+ V GT Y PE + + + KSDV+S G +L + GK P
Sbjct: 187 SQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 238
Query: 555 EERNLVAYFISLAKE-NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
F + + +KL I+D E + + + ++ CL+ + K+R ++ ++
Sbjct: 239 --------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 45/305 (14%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+Y + LG+GGF V L DG A+KR ++ E+ E + NH +I+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 392 KLLGCCLETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+L+ CL L+ + G L + I ++ +++ L E+Q L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQIL--------- 137
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
+ + + +H+ HRD+K +NILL D+ + D G+ A
Sbjct: 138 WLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 508 VQ--------GTFGYFDPEYFQSSQY---TDKSDVYSFGVVLLELLTGKKPICLTREEEE 556
+ T Y PE F + +++DV+S G VL ++ G+ P +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DM 248
Query: 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616
++LA +N+L R + +L + ++ +RP + +
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALW--------QLLNSMMTVDPHQRPHIPLLLSQ 300
Query: 617 LEGLR 621
LE L+
Sbjct: 301 LEALQ 305
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 62/300 (20%), Positives = 119/300 (39%), Gaps = 57/300 (19%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKAIDKTQIEQFINEVVILSQINH--R 388
Y+ + +G GG V++ + I A+K + D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
I++L + + +V E N +L+ + + S+ +
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----------------SID-PWERK 111
Query: 449 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT--HLT 505
+ AV +H I H D+K +N L+ D K+ DFG + + D T
Sbjct: 112 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 167
Query: 506 TAVQGTFGYFDPEYFQ-----------SSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554
+ V GT Y PE + S+ + KSDV+S G +L + GK P
Sbjct: 168 SQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 219
Query: 555 EERNLVAYFISLAKE-NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
F + + +KL I+D E + + + ++ CL+ + K+R ++ ++
Sbjct: 220 --------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 72/310 (23%), Positives = 116/310 (37%), Gaps = 59/310 (19%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKT-QIEQFINEVVILSQIN 386
R ++ + LG+GGFG V++ D A+KR + ++ E+ + EV L+++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 387 HRHIVKLLGCCLE-------TEVPVLVYEYI----C-NGNLSHHIHDHQQQQEQKQELEE 434
H IV+ LE VY YI C NL + + +E E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM----NGRCTIEERER 117
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
L + ++A AV ++HS + HRD+K SNI KV DFG
Sbjct: 118 SVCL---------HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165
Query: 495 RSVPNDKTHLTTAVQ-----------GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543
++ D+ T GT Y PE + Y+ K D++S G++L ELL
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 544 GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLN 603
P + ER + + K + + E + L +
Sbjct: 226 ---PF---STQMERVRTLTDV---RNLKFPPLFTQKYPCEYV---------MVQDMLSPS 267
Query: 604 SKKRPTMKQV 613
+RP +
Sbjct: 268 PMERPEAINI 277
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 63/322 (19%), Positives = 122/322 (37%), Gaps = 57/322 (17%)
Query: 311 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKAID 368
+KA E + Y+ + +G GG V++ + I A+K + D
Sbjct: 35 LGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 94
Query: 369 KTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQ 426
++ + NE+ L+++ I++L + + +V E N +L+ + +
Sbjct: 95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--- 150
Query: 427 EQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485
S+ + + AV +H I H D+K +N L+ D
Sbjct: 151 -------------SID-PWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-M 192
Query: 486 AKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-----------QYTDKSDVY 532
K+ DFG + + D T + V G Y PE + + + KSDV+
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 533 SFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE-NKLLEILDARVAKEASEEDIEA 591
S G +L + GK P F + + +KL I+D E + +
Sbjct: 252 SLGCILYYMTYGKTP---------------FQQIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 592 VAELAMGCLRLNSKKRPTMKQV 613
+ ++ CL+ + K+R ++ ++
Sbjct: 297 LQDVLKCCLKRDPKQRISIPEL 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 43/281 (15%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
+G+G F TVYKG+ VA + + + K++ ++F E +L + H +IV+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 397 CLETEVP----VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
T VLV E + +G L ++ + + + +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK----------------VMKIKVLRSWCRQ 137
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+ + ++H+ + PI HRD+K NI + S K+ D G + AV GT
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGT 193
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
+ PE ++ +Y + DVY+FG+ +LE+ T + P E +N + + K
Sbjct: 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYRRVTSGVK 247
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
K A E V E+ GC+R N +R ++K
Sbjct: 248 PASF-----DKVAIPE----VKEIIEGCIRQNKDERYSIKD 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 69/316 (21%), Positives = 125/316 (39%), Gaps = 68/316 (21%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKT--QIEQFINEVVILSQI 385
R ++ + LGQG FG V K D A+K+ I T ++ ++EV++L+ +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASL 59
Query: 386 NHRHIVKLLGCCLETEVPV-------------LVYEYICNGNLSHHIHDHQQQQEQKQEL 432
NH+++V+ LE V + EY NG L I +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI------HSENLNQ 113
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
+ ++ W R+ ++ A++Y+HS I HRD+K NI +D+ + K+ DFG
Sbjct: 114 QRDE-----YW----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG 161
Query: 493 TSRSVPND--------------KTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVV 537
+++V +LT+A+ GT Y E + Y +K D+YS G++
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 538 LLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAM 597
E++ ER + + + + D K ++
Sbjct: 221 FFEMIYPFST------GMERVNILKKL-RSVSIEFPPDFDDNKMKVEK--------KIIR 265
Query: 598 GCLRLNSKKRPTMKQV 613
+ + KRP + +
Sbjct: 266 LLIDHDPNKRPGARTL 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 56/301 (18%)
Query: 338 RFLGQGGFGTVYKGMLPDGSI-VAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLG 395
+G+G FG V+ G L + VAVK + + +F+ E IL Q +H +IV+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 396 CCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
C + + P+ +V E + G+ + + L + +++ + A
Sbjct: 180 VCTQKQ-PIYIVMELVQGGDFLTFLRTEGAR---------------LRVKTLLQMVGDAA 223
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514
+ Y+ S I HRD+ + N L+ +K K+SDFG SR + + A G
Sbjct: 224 AGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGL-RQ 276
Query: 515 F-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 568
PE +Y+ +SDV+SFG++L E + G P Y
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP--------------Y-----P 317
Query: 569 ENKLLEILDARVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
+ + V K E +AV L C +RP+ + +L+ +R+
Sbjct: 318 NLSNQQTRE-FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
Query: 625 R 625
R
Sbjct: 377 R 377
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 61/290 (21%), Positives = 100/290 (34%), Gaps = 46/290 (15%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--AIDKTQIEQFINEVVILSQI 385
++ + LG G +G V+K DG + AVKRS + + EV ++
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 386 -NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H V+L E + L E C +L H + L E Q
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC------EAWGASLPEAQVW------ 160
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+ A+A++HS + H D+K +NI L + K+ DFG +
Sbjct: 161 ---GYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGA 212
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
+G Y PE Q Y +DV+S G+ +LE+ +
Sbjct: 213 GEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL---------------PH 256
Query: 565 SLAKENKLLE-ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+L + L S E + + + L + K R T + +
Sbjct: 257 GGEGWQQLRQGYLPPEFTAGLSSE----LRSVLVMMLEPDPKLRATAEAL 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 7e-40
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 37/299 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG V+ + S +VAVK K + F E +L+ + H HIV
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
K G C + + ++V+EY+ +G+L+ + H + + Q L + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++A + Y+ AS HRD+ + N L+ K+ DFG SR V + + G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193
Query: 512 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFI 564
PE ++T +SDV+SFGV+L E+ T GK+P L+ E I
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------VI 245
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
+ ++LE +E V ++ +GC + ++R +K++ L L ++
Sbjct: 246 ECITQGRVLERPRV-----CPKE----VYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 76/333 (22%), Positives = 142/333 (42%), Gaps = 44/333 (13%)
Query: 299 KQNGGYLLQQRLSSCGSSEKAKIFTAE------ELQRATDNYNQSRFLGQGGFGTVYKGM 352
L+ K I+ E++R + LG G +G VY+G+
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGV 240
Query: 353 LPDGSI-VAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411
S+ VAVK K D ++E+F+ E ++ +I H ++V+LLG C ++ E++
Sbjct: 241 WKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299
Query: 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR 471
GNL ++ + +Q+ L + +A +++ A+ Y+ I HR
Sbjct: 300 YGNLLDYLRECNRQEVSAVVL--------------LYMATQISSAMEYLEKKNFI---HR 342
Query: 472 DIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDV 531
++ + N L+ + KV+DFG SR + D + + PE ++++ KSDV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 532 YSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIE 590
++FGV+L E+ T G P + L+ +++ +E + E+
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPE-----GCPEK--- 447
Query: 591 AVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
V EL C + N RP+ ++ E + +
Sbjct: 448 -VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 71/301 (23%), Positives = 133/301 (44%), Gaps = 39/301 (12%)
Query: 338 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
+ LG+G FG+V G +VAVK+ + + + F E+ IL + H +IVK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 393 LLGCCLET-EVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
G C + L+ EY+ G+L ++ H+++ + ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---------------IDHIKLLQYT 120
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
++ + Y+ + I HRD+ + NIL++++ K+ DFG ++ +P DK G
Sbjct: 121 SQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 511 TFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL--VAYFISL 566
F PE S+++ SDV+SFGVVL EL T + E R + +
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 567 AKENKLLEILDA--RVAK--EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
L+E+L R+ + +E + + C N +RP+ + +++ ++ +R
Sbjct: 238 VFH--LIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
Query: 623 S 623
+
Sbjct: 292 N 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 5e-39
Identities = 65/356 (18%), Positives = 134/356 (37%), Gaps = 56/356 (15%)
Query: 314 GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI 372
S F + ++ R L +GGF VY+ + G A+KR + ++ +
Sbjct: 10 ASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN 69
Query: 373 EQFINEVVILSQI-NHRHIVKLLGCCLETEVP-------VLVYEYICNGNLSHHIHDHQQ 424
I EV + ++ H +IV+ + L+ +C G L + +
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL----VEFLK 125
Query: 425 QQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484
+ E + L + L ++ + AV +MH PI HRD+K N+LL ++
Sbjct: 126 KMESRGPLSCDTVL---------KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG 175
Query: 485 SAKVSDFGTSRSVPNDKTHLTTAVQ-----------GTFGYFDPEYFQSSQ---YTDKSD 530
+ K+ DFG++ ++ + + +A + T Y PE +K D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 531 VYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIE 590
+++ G +L L + P F ++ L I++ + + +
Sbjct: 236 IWALGCILYLLCFRQHP---------------F----EDGAKLRIVNGKYSIPPHDTQYT 276
Query: 591 AVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLTNEISLAQNS 646
L L++N ++R ++ +V L+ + ++ + +LL +
Sbjct: 277 VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSAT 332
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 80/308 (25%), Positives = 141/308 (45%), Gaps = 48/308 (15%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVK--RSKAIDKTQIEQFIN 377
E+ R + SR LGQG FG VY+G+ VA+K A + +IE F+N
Sbjct: 21 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 77
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
E ++ + N H+V+LLG + + +++ E + G+L ++ + +
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL------RPAMANNPV 131
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
L+ S +++A E+A +AY+ + HRD+ + N ++ + F+ K+ DFG +R +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 498 PNDKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-L 550
+ +G G PE + +T SDV+SFGVVL E+ T ++P L
Sbjct: 189 YETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610
+ E+ V F+ E LL+ D + + EL C + N K RP+
Sbjct: 245 SNEQ-----VLRFV---MEGGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSF 287
Query: 611 KQVSMDLE 618
++ ++
Sbjct: 288 LEIISSIK 295
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 35/228 (15%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG+V + L VAVK ++ I + IE+F+ E + + +H H+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 392 KLLGCCLETE------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
KL+G L + +P+++ ++ +G+L + + + +L +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP----------FNLPLQT 138
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
VR ++A + Y+ +S HRD+ + N +L + + V+DFG SR + + +
Sbjct: 139 LVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 506 TAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
QG E + YT SDV++FGV + E++T G+ P
Sbjct: 194 --RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
LG G FG V+ G + VAVK K + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 398 LETEVPVL-VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
T+ P+ + EY+ NG+L + + +L + +A ++A
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL--------------LDMAAQIAEG 121
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF- 515
+A++ I HRD++++NIL+ D S K++DFG +R + +++ TA +G F
Sbjct: 122 MAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREG--AKFP 173
Query: 516 ----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE +T KSDV+SFG++L E++T G+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 30/299 (10%)
Query: 340 LGQGGFGTVYKGMLP-----DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLL 394
LG+G FG+V G++VAVK+ + Q F E+ IL ++ IVK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 395 GCCLET-EVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
G + LV EY+ +G L + H+ + + + L + +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL---------------YSSQ 135
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ + Y+ S + HRD+ + NIL++ + K++DFG ++ +P DK + G
Sbjct: 136 ICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 513 GYF--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569
F PE + ++ +SDV+SFGVVL EL T K + E +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLE 628
LLE+L+ A V EL C + + RP+ + L+ L R E
Sbjct: 253 --LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 69/297 (23%), Positives = 130/297 (43%), Gaps = 31/297 (10%)
Query: 338 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK 392
+ LG+G FG+V G +VAVK+ + + + F E+ IL + H +IVK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 393 LLGCCLET-EVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
G C + L+ EY+ G+L ++ H+++ + ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---------------IDHIKLLQYT 151
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
++ + Y+ + I HRD+ + NIL++++ K+ DFG ++ +P DK + G
Sbjct: 152 SQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 511 TFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL--VAYFISL 566
F PE S+++ SDV+SFGVVL EL T + E R + +
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
L+E+L + + + + C N +RP+ + +++ ++ +R
Sbjct: 269 VFH--LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 31/296 (10%)
Query: 338 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG V G VAVK K I E+ IL + H +IV
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 392 KLLGCCLETEV-PV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
K G C E + L+ E++ +G+L ++ ++ + KQ+L+
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK---------------Y 131
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A ++ + Y+ S + HRD+ + N+L++ + K+ DFG ++++ DK + T
Sbjct: 132 AVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 510 GTFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 566
F PE S++ SDV+SFGV L ELLT + +
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
L+ L + V +L C R + + + E L +
Sbjct: 249 VTR--LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 52/227 (22%), Positives = 101/227 (44%), Gaps = 45/227 (19%)
Query: 338 RFLGQGGFGTVYKGML--PDGSI---VAVKRSKA-IDKTQIEQFINEVVILSQINHRHIV 391
+ LG G FGTVYKG+ + VA+K + ++ ++E +++ +++ H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+LLG CL + V L+ + + G L ++ +H+ + + +
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN---------------IGSQYLLNWCV 124
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------ 505
++A + Y+ + HRD+ + N+L+ K++DFG ++ + ++
Sbjct: 125 QIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 506 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
A E YT +SDV+S+GV + EL+T G KP
Sbjct: 182 PIKWMA---------LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGSI-VAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
LG G +G VY+G+ S+ VAVK K D ++E+F+ E ++ +I H ++V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
C ++ E++ GNL ++ + +Q+ L + +A +++ A
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL--------------LYMATQISSA 123
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF- 515
+ Y+ I HRD+ + N L+ + KV+DFG SR + D TA G F
Sbjct: 124 MEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG--AKFP 175
Query: 516 ----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE ++++ KSDV++FGV+L E+ T G P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 78/299 (26%), Positives = 130/299 (43%), Gaps = 38/299 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
LG+G FG V+ + +VAVK K ++ + F E +L+ + H+HIV
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+ G C E ++V+EY+ +G+L+ + H + E+ L + VA
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVAS 165
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+VA + Y+ A + HRD+ + N L+ K+ DFG SR + + + G
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV----GG 218
Query: 512 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFI 564
PE ++T +SDV+SFGVVL E+ T GK+P L+ E I
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------AI 270
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
+ + LE E V + GC + ++R ++K V L+ L ++
Sbjct: 271 DCITQGRELERPR-----ACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 64/313 (20%), Positives = 111/313 (35%), Gaps = 52/313 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI----EQFINEVVILSQIN 386
+ S LGQG V++G G + A+K + + + E +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65
Query: 387 HRHIVKLLGC--CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H++IVKL T VL+ E+ G+L + + L E + L
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP----SNAYGLPESEFL------ 115
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPND 500
V +V G + ++ + I HR+IK NI+ D + K++DFG +R + +D
Sbjct: 116 ---IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 501 KTHLTTAVQGTFGYFDPEYFQSS--------QYTDKSDVYSFGVVLLELLTGKKPICLTR 552
+ GT Y P+ ++ + +Y D++S GV TG P
Sbjct: 170 -EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 553 EEEERNLVAYFISLAKENKLLEILDARVAKEA------------SEEDIEAVAELAMGCL 600
V Y I K + + + S + + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 601 RLNSKKRPTMKQV 613
+ +K Q
Sbjct: 288 EADQEKCWGFDQF 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 72/301 (23%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 338 RFLGQGGFGTVYKGMLPD--------GSIVAVK--RSKAIDKTQIEQFINEVVILSQI-N 386
+ LG+G FG V VAVK + A +K + ++E+ ++ I
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H++I+ LLG C + ++ EY GNL ++ + + +++++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
V ++A + Y+ AS HRD+ + N+L+ + K++DFG +R + N +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213
Query: 507 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNL 559
+ T G PE YT +SDV+SFGV++ E+ T G P + EE
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 267
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619
L KE ++ + E + + C +RPT KQ+ DL+
Sbjct: 268 ---LFKLLKEGHRMDKPA-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 620 L 620
+
Sbjct: 316 I 316
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 47/303 (15%)
Query: 338 RFLGQGGFGTVYKGML------PDGSIVAVK--RSKAIDKTQIEQFINEVVILSQI-NHR 388
+ LG+G FG V + VAVK + A ++E+ IL I +H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 91
Query: 389 HIVKLLGCCLETEVPVLV-YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
++V LLG C + P++V E+ GNLS ++ + + + E+ L+ E+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
+ +VA + ++ AS HRD+ + NILL +K K+ DFG +R + D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 204
Query: 508 VQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561
V+ PE YT +SDV+SFGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------------- 250
Query: 562 YFISLAKENKLLEILDA--RVAK--EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
Y + + + L R+ + E + + + C +RPT ++ L
Sbjct: 251 YP-GVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305
Query: 618 EGL 620
L
Sbjct: 306 GNL 308
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 33/299 (11%)
Query: 338 RFLGQGGFGTVYKGML-----PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG V G +VAVK KA + E+ IL + H HI+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 392 KLLGCCLET-EVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
K GCC + + LV EY+ G+L ++ H S+ +
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----------------SIGLAQLLLF 139
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A ++ +AY+H+ I HRD+ + N+LLD+ K+ DFG +++VP +
Sbjct: 140 AQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196
Query: 510 GTFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 566
G F PE + ++ SDV+SFGV L ELLT + E +A
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625
L E+L+ ++ V L C + RPT + + L+ + +
Sbjct: 257 VLR--LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ LG G FG V G VAVK K ++F E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ +V EYI NG L +++ H + L + + +V +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---------------LEPSQLLEMCYDVCEGM 117
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF-- 515
A++ S I HRD+ + N L+D KVSDFG +R V +D+ + G F
Sbjct: 118 AFLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVG--TKFPV 169
Query: 516 ---DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE F +Y+ KSDV++FG+++ E+ + GK P
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 32/229 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGS------IVAVK--RSKAIDKTQIEQFINEVVILSQINHRH 389
LG+ FG VYKG L + VA+K + KA + E F +E ++ +++ H +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPN 73
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V LLG + + +++ Y +G+L + + ++ S+L + V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND----KTHLT 505
++A + Y+ +S + H+D+ + N+L+ DK + K+SD G R V +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 506 ------TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
A PE +++ SD++S+GVVL E+ + G +P
Sbjct: 191 LLPIRWMA---------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 47/289 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
Y + RFLG+GGF ++ + A K +S + Q E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+H+V G E V +V E +L ++++ L E E R
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH-------KRRKALTEP--------EAR 118
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
++ Y+H + + HRD+K N+ L++ K+ DFG + V D
Sbjct: 119 -YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF--I 564
GT Y PE ++ + DV+S G ++ LL GK P E L + I
Sbjct: 175 LC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETYLRI 227
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + K + A L L+ + RPT+ ++
Sbjct: 228 KKN---------EYSIPKHINPV----AASLIQKMLQTDPTARPTINEL 263
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVK 392
+G+G FG VY G L D AVK I D ++ QF+ E +I+ +H +++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 393 LLGCCLETEVPVL-VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
LLG CL +E L V Y+ +G+L + I + K +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---------------LIGFGL 135
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+VA + Y+ AS HRD+ + N +LD+KF+ KV+DFG +R + + + + + T
Sbjct: 136 QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKT 190
Query: 512 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
E Q+ ++T KSDV+SFGV+L EL+T G P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 47/289 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
Y + RFLG+GGF ++ + A K +S + Q E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+H+V G E V +V E +L ++++ L E E R
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH-------KRRKALTEP--------EAR 144
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
++ Y+H + + HRD+K N+ L++ K+ DFG + V D
Sbjct: 145 -YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF--I 564
GT Y PE ++ + DV+S G ++ LL GK P E L + I
Sbjct: 201 LC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETYLRI 253
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + K + A L L+ + RPT+ ++
Sbjct: 254 KKN---------EYSIPKHINPV----AASLIQKMLQTDPTARPTINEL 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 25/223 (11%)
Query: 338 RFLGQGGFGTVYKGMLPDGS---IVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVK 392
+G+G FG V K + A+KR K K F E+ +L ++ +H +I+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
LLG C L EY +GNL + + + S+LS + + A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLT------ 505
VA + Y+ + HRD+ + NIL+ + + AK++DFG SR K +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 506 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
A E S YT SDV+S+GV+L E+++ G P
Sbjct: 208 MA---------IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVK 392
+G+G FG VY G L D AVK I D ++ QF+ E +I+ +H +++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 393 LLGCCLETEVPVL-VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
LLG CL +E L V Y+ +G+L + I + K +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---------------LIGFGL 199
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+VA + ++ AS HRD+ + N +LD+KF+ KV+DFG +R + + + + T
Sbjct: 200 QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKT 254
Query: 512 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
E Q+ ++T KSDV+SFGV+L EL+T G P
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 30/216 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ LG G FG V G VA+K K ++FI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ ++ EY+ NG L +++ + + + + +Q LE + +V A+
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE---------------MCKDVCEAM 133
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF-- 515
Y+ S + HRD+ + N L++D+ KVSDFG SR V +D+ T+ G F
Sbjct: 134 EYLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVG--SKFPV 185
Query: 516 ---DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE S+++ KSD+++FGV++ E+ + GK P
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
LGQG FG V+ G + VA+K K E F+ E ++ ++ H +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+E P+ +V EY+ G+L + + + +L V +A ++A
Sbjct: 249 --SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--------------VDMAAQIASG 292
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 516
+AY+ + HRD++++NIL+ + KV+DFG +R + +++ + +
Sbjct: 293 MAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 517 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE ++T KSDV+SFG++L EL T G+ P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 71/316 (22%), Positives = 133/316 (42%), Gaps = 49/316 (15%)
Query: 338 RFLGQGGFGTVYKGMLPDG------SIVAVK--RSKAIDKTQIEQFINEVVILSQINHRH 389
R +G+G FG V++ P ++VAVK + +A Q + F E ++++ ++ +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNL--------SHHIHDHQQQQEQKQELEEEQELSSL 441
IVKLLG C + L++EY+ G+L H + + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501
S ++ +A +VA +AY+ + HRD+ + N L+ + K++DFG SR++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 502 THLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREE 554
+ PE ++YT +SDV+++GVVL E+ + G +P + EE
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614
I ++ +L + E + L C RP+ +
Sbjct: 285 --------VIYYVRDGNILACPE-----NCPLE----LYNLMRLCWSKLPADRPSFCSIH 327
Query: 615 MDLEG-LRRSQRCLEI 629
L+ R++ + +
Sbjct: 328 RILQRMCERAEGTVGV 343
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 64/256 (25%), Positives = 121/256 (47%), Gaps = 32/256 (12%)
Query: 299 KQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI 358
K+ L Q+ C SS+ K + + + ++ + LG G FG V+ +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK 214
Query: 359 VAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSH 417
VAVK K +E F+ E ++ + H +VKL T+ P+ ++ E++ G+L
Sbjct: 215 VAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLD 271
Query: 418 HIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477
+ + ++ +L + + ++A +A++ I HRD++++N
Sbjct: 272 FLKSDEGSKQPLPKL--------------IDFSAQIAEGMAFIEQRNYI---HRDLRAAN 314
Query: 478 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVY 532
IL+ K++DFG +R + +++ TA +G F PE +T KSDV+
Sbjct: 315 ILVSASLVCKIADFGLARVIEDNE---YTAREG--AKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 533 SFGVVLLELLT-GKKP 547
SFG++L+E++T G+ P
Sbjct: 370 SFGILLMEIVTYGRIP 385
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 73/319 (22%), Positives = 124/319 (38%), Gaps = 48/319 (15%)
Query: 324 AEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEV 379
+++ Q A +++ R LG+G FG VY I+A+K +++ Q EV
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 380 VILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
I S + H +I++L G V L+ EY G + + + EQ+
Sbjct: 61 EIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 112
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498
E+A A++Y HS + HRDIK N+LL K++DFG S P
Sbjct: 113 ---------TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
+ + GT Y PE + + +K D++S GV+ E L GK P E
Sbjct: 161 SSRRT-DLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANT 211
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD-- 616
+ ++ ++ +E +L L+ N +RP +++V
Sbjct: 212 YQETY------KRISR-VEFTFPDFVTEG----ARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 617 -LEGLRRSQRCLEIGKVNQ 634
+ C ++
Sbjct: 261 ITANSSKPSNCQNKESASK 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 72/301 (23%), Positives = 128/301 (42%), Gaps = 43/301 (14%)
Query: 338 RFLGQGGFGTVYKGML--------PDGSIVAVK--RSKAIDKTQIEQFINEVVILSQI-N 386
+ LG+G FG V + VAVK + A +K + ++E+ ++ I
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 145
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H++I+ LLG C + ++ EY GNL ++ + + +++++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
V ++A + Y+ AS HRD+ + N+L+ + K++DFG +R + N +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259
Query: 507 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNL 559
+ T G PE YT +SDV+SFGV++ E+ T G P + EE
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619
L KE ++ + E + + C +RPT KQ+ DL+
Sbjct: 314 ---LFKLLKEGHRMDKPA-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 620 L 620
+
Sbjct: 362 I 362
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 80/311 (25%), Positives = 135/311 (43%), Gaps = 48/311 (15%)
Query: 338 RFLGQGGFGTVYKGMLPDG------SIVAVK--RSKAIDKTQIEQFINEVVILSQINHRH 389
+ LG+G FG V K + VAVK + A + ++E +L Q+NH H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPH 87
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDH--------QQQQEQKQELEEEQELSSL 441
++KL G C + +L+ EY G+L + + + + + +L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501
+ + + A +++ + Y+ A + + HRD+ + NIL+ + K+SDFG SR V +
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 502 THLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREE 554
++ V+ + G E YT +SDV+SFGV+L E++T G P + E
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614
+L K +E D SEE + L + C + KRP +S
Sbjct: 261 --------LFNLLKTGHRMERPD-----NCSEE----MYRLMLQCWKQEPDKRPVFADIS 303
Query: 615 MDLEGLRRSQR 625
DLE + +R
Sbjct: 304 KDLEKMMVKRR 314
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 65/254 (25%), Positives = 120/254 (47%), Gaps = 27/254 (10%)
Query: 299 KQNGGYLLQQRLSSCGSSEKAKIFTAE---ELQRATDNYNQSRFLGQGGFGTVYKGMLPD 355
++ L + + C +S+ A+ E+ R ++ LGQG FG V+ G
Sbjct: 233 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNG 290
Query: 356 GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGN 414
+ VA+K K E F+ E ++ ++ H +V+L +E P+ +V EY+ G+
Sbjct: 291 TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGS 347
Query: 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474
L + + + +L V +A ++A +AY+ + HRD++
Sbjct: 348 LLDFLKGETGKYLRLPQL--------------VDMAAQIASGMAYVERMNYV---HRDLR 390
Query: 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 534
++NIL+ + KV+DFG +R + +++ + + PE ++T KSDV+SF
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450
Query: 535 GVVLLELLT-GKKP 547
G++L EL T G+ P
Sbjct: 451 GILLTELTTKGRVP 464
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 32/234 (13%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSKAI-DKTQIEQFINEVV 380
+ + R +G+G FG VY G D + A+K I + Q+E F+ E +
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 381 ILSQINHRHIVKLLGCCLETE-VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
++ +NH +++ L+G L E +P ++ Y+C+G+L I Q+ K
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD--------- 125
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
+ +VA + Y+ + HRD+ + N +LD+ F+ KV+DFG +R +
Sbjct: 126 ------LISFGLQVARGMEYLAEQKFV---HRDLAARNCMLDESFTVKVADFGLARDI-- 174
Query: 500 DKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ Q E Q+ ++T KSDV+SFGV+L ELLT G P
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 38/218 (17%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ +G+G FG V G G+ VAVK K + + F+ E +++Q+ H ++V+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+E + + +V EY+ G+L ++ + L ++ + +V A
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--------------LKFSLDVCEA 129
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------TAVQG 510
+ Y+ + + HRD+ + N+L+ + AKVSDFG ++ + TA
Sbjct: 130 MEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA--- 182
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE + +++ KSDV+SFG++L E+ + G+ P
Sbjct: 183 ------PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 27/320 (8%), Positives = 71/320 (22%), Gaps = 57/320 (17%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVI 381
L + L G V+ + A+K ++++E+
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 382 LSQINHRHIVKLLGCCLETEVP--------------------------VLVYEYICNGNL 415
+++ + +L+ + +L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDL 174
Query: 416 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475
+ + + ++ A + S + H
Sbjct: 175 ELLFSTLDFVYVFRGDEGILA---------LHILTAQLIRLAANLQSKG---LVHGHFTP 222
Query: 476 SNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYS 533
N+ + + D V A Y E+ +S +T + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 534 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVA 593
G+ + + P + + + + L + V
Sbjct: 279 LGLSIYRVWCLFLPF----GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF----VK 330
Query: 594 ELAMGCLRLNSKKRPTMKQV 613
L L + ++R +
Sbjct: 331 TLIGRFLNFDRRRRLLPLEA 350
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ +G G FG V+ G + VA+K + E FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
LE P+ LV E++ +G LS ++ + + L + +V
Sbjct: 73 LEQA-PICLVTEFMEHGCLSDYLRTQRGLFAAETLLG---------------MCLDVCEG 116
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF- 515
+AY+ + I HRD+ + N L+ + KVSDFG +R V +D+ T+ G F
Sbjct: 117 MAYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTG--TKFP 168
Query: 516 ----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE F S+Y+ KSDV+SFGV++ E+ + GK P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 23/242 (9%)
Query: 311 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDK 369
S + E E D LG+G +G VY G L + +A+K D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 370 TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQK 429
+ E+ + + H++IV+ LG E + E + G+LS + +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 430 QELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAK 487
E + ++ + Y+H + I HRDIK N+L++ K
Sbjct: 121 --------------EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 163
Query: 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGK 545
+SDFGTS+ + T GT Y PE Y +D++S G ++E+ TGK
Sbjct: 164 ISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 546 KP 547
P
Sbjct: 223 PP 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 66/342 (19%), Positives = 123/342 (35%), Gaps = 53/342 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI----EQFINEVVILSQIN 386
+ S LGQG V++G G + A+K + + + E +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65
Query: 387 HRHIVKLLGC--CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H++IVKL T VL+ E+ G+L + + L E + L
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP----SNAYGLPESEFL------ 115
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPND 500
V +V G + ++ + I HR+IK NI+ D + K++DFG +R + +D
Sbjct: 116 ---IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 501 KTHLTTAVQGTFGYFDPEYFQSS--------QYTDKSDVYSFGVVLLELLTGKKPICLTR 552
+ GT Y P+ ++ + +Y D++S GV TG P
Sbjct: 170 -EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 553 EEEERNLVAYFISLAKENKLLEILDARVAKEA------------SEEDIEAVAELAMGCL 600
V Y I K + + + S + + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 601 RLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLTNEISL 642
+ +K Q + + + + + + Q+ ++I +
Sbjct: 288 EADQEKCWGFDQFFAETSDI-LHRMVIHVFSLQQMTAHKIYI 328
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-37
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 48/293 (16%)
Query: 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIV 391
++ LG G GT+ + D VAVKR I EV +L + + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+ + + + E C L ++ EQK E +L ++
Sbjct: 82 RYFCTEKDRQFQYIAIEL-CAATLQEYV-------EQKDFAHLGLEPITL-----LQ--- 125
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-----FSAKVSDFGTSRSVPNDKTHLT- 505
+ +A++HS I HRD+K NIL+ A +SDFG + + + +
Sbjct: 126 QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 506 -TAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
+ V GT G+ PE T D++S G V +++ + + A
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----A 238
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
+ A L E+ + +A EL + ++ +KRP+ K V
Sbjct: 239 NILLGACSLDCLHP----------EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-37
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+ +G+G FG V G G+ VAVK K D T + F+ E +++Q+ H ++V+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 398 LETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 456
+E + + +V EY+ G+L ++ + L ++ + +V A
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--------------LKFSLDVCEA 301
Query: 457 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------TAVQG 510
+ Y+ + + HRD+ + N+L+ + AKVSDFG ++ + TA
Sbjct: 302 MEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA--- 354
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE + +++ KSDV+SFG++L E+ + G+ P
Sbjct: 355 ------PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 52/249 (20%)
Query: 316 SEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS-----IVAVKRSKAI-DK 369
A+IF EL++ + LG G FGTV+KG+ V +K + +
Sbjct: 4 KVLARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR 56
Query: 370 TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQK 429
+ + ++ + ++H HIV+LLG C LV +Y+ G+L H+ H+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA---- 111
Query: 430 QELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489
L + + ++A + Y+ + HR++ + N+LL +V+
Sbjct: 112 -----------LGPQLLLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVA 157
Query: 490 DFGTSRSVPNDKTHLT----------TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 539
DFG + +P D L A E +YT +SDV+S+GV +
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMA---------LESIHFGKYTHQSDVWSYGVTVW 208
Query: 540 ELLT-GKKP 547
EL+T G +P
Sbjct: 209 ELMTFGAEP 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 60/295 (20%), Positives = 104/295 (35%), Gaps = 48/295 (16%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQ 384
E + +G+G FG V++ G AVK+ + E+V +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK---VRLEVFRV--EELVACAG 106
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
++ IV L G E + E + G+L Q +++ L E
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLG-------------QLIKQMGCLP----E 149
Query: 445 NRVRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKT 502
+R + + Y+H+ I H D+K+ N+LL A + DFG + + D
Sbjct: 150 DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 503 HLTTA----VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
+ + GT + PE K D++S ++L +L G P T+
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP--WTQYFRGP- 263
Query: 559 LVAYFISLAKENK-LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
+ I A E + EI + +A+ E LR R + +
Sbjct: 264 -LCLKI--ASEPPPIREIPP-----SCAPLTAQAIQE----GLRKEPVHRASAME 306
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ LG+G FG+V +G L VAVK + + +IE+F++E + +H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 392 KLLGCCLETE-----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+LLG C+E P+++ ++ G+L ++ E + +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----------LYSRLETGPKHIPLQTL 149
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
++ ++A + Y+ ++ HRD+ + N +L D + V+DFG S+ + + +
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY--- 203
Query: 507 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
QG E YT KSDV++FGV + E+ T G P
Sbjct: 204 -RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 43/301 (14%)
Query: 338 RFLGQGGFGTVYKGMLPD--------GSIVAVK--RSKAIDKTQIEQFINEVVILSQI-N 386
+ LG+G FG V + VAVK +S A +K + I+E+ ++ I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK 133
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H++I+ LLG C + ++ EY GNL ++ + + LS ++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
V A +VA + Y+ AS HRD+ + N+L+ + K++DFG +R + + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 507 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNL 559
+ T G PE YT +SDV+SFGV+L E+ T G P + EE
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619
L KE ++ + E + + C +RPT KQ+ DL+
Sbjct: 302 ---LFKLLKEGHRMDKPS-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 620 L 620
+
Sbjct: 350 I 350
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 73/292 (25%), Positives = 115/292 (39%), Gaps = 52/292 (17%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI------EQFINEVVILSQ 384
+++ LG+G F VY+ + G VA+K IDK + ++ NEV I Q
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 385 INHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+ H I++L E V LV E NG ++ ++ + + E
Sbjct: 68 LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK------NRVKPFSE--------N 112
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
E R ++ + Y+HS I HRD+ SN+LL + K++DFG + +
Sbjct: 113 EAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
T GT Y PE S + +SDV+S G + LL G+ P + +
Sbjct: 169 HYTLC-GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF------DTDTVKNTL 221
Query: 564 --ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ LA D + S E +L LR N R ++ V
Sbjct: 222 NKVVLA---------DYEMPSFLSIE----AKDLIHQLLRRNPADRLSLSSV 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSKAIDKTQI------EQFINEVVILSQ 384
D+++ R LG+G FG VY + I+A+K + K+Q+ Q E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALK---VLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 385 INHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+ H +I+++ + L+ E+ G L + Q+ +
Sbjct: 71 LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-----QKHGR-----------FD- 112
Query: 444 ENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E R E+A A+ Y H + HRDIK N+L+ K K++DFG S P+ +
Sbjct: 113 EQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T GT Y PE + + +K D++ GV+ E L G P
Sbjct: 170 R-TMC--GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 76/305 (24%), Positives = 124/305 (40%), Gaps = 54/305 (17%)
Query: 338 RFLGQGGFGTVYKGMLPD------GSIVAVK--RSKAIDKTQIEQFINEVVILSQI-NHR 388
+ LG G FG V + VAVK +S A + ++E+ I+S + H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHE 110
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IV LLG C +++ EY C G+L + + + E S+ S + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN--STASTRDLLH 168
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND-------K 501
+ +VA +A++ AS HRD+ + N+LL + AK+ DFG +R + ND
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 502 THLT---TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI--CLTREEE 555
L A PE YT +SDV+S+G++L E+ + G P L +
Sbjct: 226 ARLPVKWMA---------PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275
Query: 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615
F L K+ + A + + + C L RPT +Q+
Sbjct: 276 -------FYKLVKDGYQMAQPA-----FAPKN----IYSIMQACWALEPTHRPTFQQICS 319
Query: 616 DLEGL 620
L+
Sbjct: 320 FLQEQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 77/309 (24%), Positives = 127/309 (41%), Gaps = 58/309 (18%)
Query: 338 RFLGQGGFGTVYKGMLPD------GSIVAVK--RSKAIDKTQIEQFINEVVILSQI-NHR 388
+ LG G FG V + VAVK + A + ++E+ +LS + NH
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHM 87
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHI--HDHQQQQEQKQELEEEQELSSLSWENR 446
+IV LLG C +++ EY C G+L + + + E + +L E+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND----KT 502
+ + +VA +A++ AS HRD+ + NILL K+ DFG +R + ND
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 503 HLT------TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555
A PE + YT +SDV+S+G+ L EL + G P
Sbjct: 205 GNARLPVKWMA---------PESIFNCVYTFESDVWSYGIFLWELFSLGSSP-------- 247
Query: 556 ERNLVAYFISLAKENKLLEILDA--RVAK--EASEEDIEAVAELAMGCLRLNSKKRPTMK 611
Y + ++K +++ R+ A E + ++ C + KRPT K
Sbjct: 248 ------YP-GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFK 296
Query: 612 QVSMDLEGL 620
Q+ +E
Sbjct: 297 QIVQLIEKQ 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQI 385
+ + LG GGFG V + + G VA+K+ + + E++ E+ I+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 386 NHRHIVKLLGCCLETE-------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL 438
NH ++V + +P+L EY G+L +++ E L+E
Sbjct: 70 NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF----ENCCGLKEGPIR 124
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSR 495
+ LS +++ A+ Y+H + I HRD+K NI+L K+ D G ++
Sbjct: 125 TLLS---------DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC------ 549
+ T V GT Y PE + +YT D +SFG + E +TG +P
Sbjct: 173 ELDQG-ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
Query: 550 -LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608
+ E++ + + S + L + ++R
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290
Query: 609 TMKQV 613
T Q
Sbjct: 291 TDPQN 295
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 54/321 (16%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVK--RSKAIDKTQIEQFIN 377
E+ R N R LG G FG VY+G + VAVK ++ +++ F+
Sbjct: 26 EVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLM 82
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
E +I+S+ NH++IV+ +G L++ ++ E + G+L + + + + Q L
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGTS 494
L VA ++A Y+ HRDI + N LL AK+ DFG +
Sbjct: 143 LH---------VARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 495 RSVPNDKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI 548
R + + +G PE F +T K+D +SFGV+L E+ + G P
Sbjct: 191 RDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 549 -CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKR 607
+ +E V F+ ++ V + C + + R
Sbjct: 247 PSKSNQE-----VLEFV---TSGGRMDPPK-----NCPGP----VYRIMTQCWQHQPEDR 289
Query: 608 PTMKQVSMDLEGLRRSQRCLE 628
P + +E + +
Sbjct: 290 PNFAIILERIEYCTQDPDVIN 310
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 51/227 (22%), Positives = 99/227 (43%), Gaps = 45/227 (19%)
Query: 338 RFLGQGGFGTVYKGML--PDGSI---VAVKRSKAI-DKTQIEQFINEVVILSQINHRHIV 391
+ LG G FGTVYKG+ + VA+K + ++ ++E +++ +++ H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+LLG CL L+ + + G L ++ +H+ + + +
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---------------IGSQYLLNWCV 124
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------ 505
++A + Y+ + HRD+ + N+L+ K++DFG ++ + ++
Sbjct: 125 QIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 506 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
A E YT +SDV+S+GV + EL+T G KP
Sbjct: 182 PIKWMA---------LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 338 RFLGQGGFGTVYKGML--PDGSI---VAVK--RSKAIDKTQIEQFINEVVILSQINHRHI 390
+ +G G FG VYKGML G VA+K ++ +K +++ F+ E I+ Q +H +I
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
++L G + + +++ EY+ NG L + + + S V +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---------------FSVLQLVGML 153
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
+A + Y+ + + HRD+ + NIL++ KVSDFG SR + +D T G
Sbjct: 154 RGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 511 TFGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE ++T SDV+SFG+V+ E++T G++P
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 52/309 (16%)
Query: 338 RFLGQGGFGTVYKGMLPDGS------IVAVK--RSKAIDKTQIEQFINEVVILSQINHRH 389
R LG G FG VY+G + VAVK ++ +++ F+ E +I+S+ NH++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV+ +G L++ ++ E + G+L + + + + Q L L V
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---------V 186
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGTSRSVPNDKTHLTT 506
A ++A Y+ HRDI + N LL AK+ DFG +R + +
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY--- 240
Query: 507 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEERNL 559
+G PE F +T K+D +SFGV+L E+ + G P + +E
Sbjct: 241 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 294
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619
V F+ ++ V + C + + RP + +E
Sbjct: 295 VLEFV---TSGGRMDPPK-----NCPGP----VYRIMTQCWQHQPEDRPNFAIILERIEY 342
Query: 620 LRRSQRCLE 628
+ +
Sbjct: 343 CTQDPDVIN 351
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 59/221 (26%), Positives = 112/221 (50%), Gaps = 30/221 (13%)
Query: 336 QSRFLGQGGFGTVYKGMLPDGSI---VAVK--RSKAIDKTQIEQFINEVVILSQINHRHI 390
+ + LG G FGTV KG + VAVK +++A D ++ + E ++ Q+++ +I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 391 VKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
V+++G C LV E G L+ ++ ++ + +N + +
Sbjct: 81 VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH----------------VKDKNIIEL 122
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
+V+ + Y+ S + HRD+ + N+LL + AK+SDFG S+++ D+ +
Sbjct: 123 VHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 510 GTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
G + ++ PE +++ KSDV+SFGV++ E + G+KP
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 55/312 (17%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-N 386
Q + + LG G GTV G VAVKR + + + E+ +L++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDD 67
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
H ++++ C T+ + + E CN NL + E + +E N
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKE---------YN 116
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-------------FSAKVSDFG 492
+ + ++A VA++HS I HRD+K NIL+ +SDFG
Sbjct: 117 PISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 493 TSRSVPNDK----THLTTAVQGTFGYFDPEYFQSS-------QYTDKSDVYSFGVVLLEL 541
+ + + + T+L GT G+ PE + S + T D++S G V +
Sbjct: 174 LCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 542 LTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLR 601
L+ K + E N++ + L+ + + E +L +
Sbjct: 233 LSKGKHPFGDKYSRESNII-------RGIFSLDEMKCLHDRSLIAEAT----DLISQMID 281
Query: 602 LNSKKRPTMKQV 613
+ KRPT +V
Sbjct: 282 HDPLKRPTAMKV 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 76/305 (24%), Positives = 137/305 (44%), Gaps = 45/305 (14%)
Query: 338 RFLGQGGFGTVYKGMLPDGS------IVAVK--RSKAIDKTQIEQFINEVVILSQI-NHR 388
+ LG G FG V S VAVK + KA + ++E+ +++Q+ +H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHE 109
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDH-------QQQQEQKQELEEEQELSSL 441
+IV LLG C + L++EY C G+L +++ + + E ++ LEEE++L+ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501
++E+ + A +VA + ++ HRD+ + N+L+ K+ DFG +R + +D
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 502 THLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555
+ V PE YT KSDV+S+G++L E+ + G P +
Sbjct: 227 NY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615
F L + ++ A+EE + + C +S+KRP+ ++
Sbjct: 283 N------FYKLIQNGFKMDQPF-----YATEE----IYIIMQSCWAFDSRKRPSFPNLTS 327
Query: 616 DLEGL 620
L
Sbjct: 328 FLGCQ 332
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 340 LGQGGFGTVYKGML--PDGSI-VAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG G FG+V +G+ I VA+K K +K E+ + E I+ Q+++ +IV+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 396 CCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 454
C + LV E G L + +++ + N + +V+
Sbjct: 78 VC--QAEALMLVMEMAGGGPLHKFLVGKREE---------------IPVSNVAELLHQVS 120
Query: 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 514
+ Y+ + HRD+ + N+LL ++ AK+SDFG S+++ D ++ T G +
Sbjct: 121 MGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 515 F--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE +++ +SDV+S+GV + E L+ G+KP
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 340 LGQGGFGTVYKGMLPD---GSIVAVK--RSK-AIDKTQIEQFINEVVILSQINHRHIVKL 393
LG GG TVY D VA+K + +++F EV SQ++H++IV +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
+ E + LV EYI LS +I H LS + + ++
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----------------LSVDTAINFTNQI 120
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
+ + H I HRDIK NIL+D + K+ DFG ++++ T V GT
Sbjct: 121 LDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
YF PE + + +D+YS G+VL E+L G+ P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ +G G G V G L VA+K ++ ++ + + F++E I+ Q +H +I+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L G + ++V EY+ NG+L + H Q + V +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---------------FTIMQLVGMLR 158
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
V + Y+ + HRD+ + N+L+D KVSDFG SR + +D T G
Sbjct: 159 GVGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 512 FGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE ++ SDV+SFGVV+ E+L G++P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 338 RFLGQGGFGTVYKGML--PDGSI--VAVKRSKA---IDKTQIEQFINEVVILSQINHRHI 390
LG G FG V +G P G VAVK K ++ FI EV + ++HR++
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 391 VKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
++L G L P+ +V E G+L + HQ R
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH---------------FLLGTLSRY 126
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
A +VA + Y+ S I HRD+ + N+LL + K+ DFG R++P + H
Sbjct: 127 AVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 510 GTFGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++ ++ SD + FGV L E+ T G++P
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 338 RFLGQGGFGTVYKGML--PDGSI--VAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
R +G+G FG V++G+ P+ VA+K ++ D + + F+ E + + Q +H HIV
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 79
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
KL+G TE PV ++ E G L + + L + + A
Sbjct: 80 KLIGVI--TENPVWIIMELCTLGELRSFLQVRKYS---------------LDLASLILYA 122
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT----- 505
+++ A+AY+ S + HRDI + N+L+ K+ DFG SR + + +
Sbjct: 123 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 506 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
A PE ++T SDV+ FGV + E+L G KP
Sbjct: 180 PIKWMA---------PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ +G G FG V G L S VA+K + +K + + F+ E I+ Q +H +I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L G +++ ++V EY+ NG+L + H Q + V +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---------------FTVIQLVGMLR 154
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+A + Y+ + HRD+ + NIL++ KVSDFG R + +D T G
Sbjct: 155 GIASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 512 FGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE ++T SDV+S+G+VL E+++ G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 47/227 (20%)
Query: 338 RFLGQGGFGTVYKGMLPDGSI----VAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
R LG+G FG VY+G+ + VAVK + + + F++E VI+ ++H HIV
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHIV 76
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
KL+G E P ++ E G L H++ ++ + + +
Sbjct: 77 KLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL---------------YS 119
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT----- 505
++ A+AY+ S + HRDI NIL+ K+ DFG SR + ++ +
Sbjct: 120 LQICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 506 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T SDV+ F V + E+L+ GK+P
Sbjct: 177 PIKWMS---------PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 67/342 (19%), Positives = 113/342 (33%), Gaps = 78/342 (22%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKT-QIEQFINEVVILSQIN 386
R ++ + +G+GGFG V++ D A+KR + ++ E+ + EV L+++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEE-QELSSLSWEN 445
H IV+ LET E + + + S +N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 446 RVRVA---------------CE----------------------------VAGAVAYMHS 462
V C +A AV ++HS
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ-----------GT 511
+ HRD+K SNI KV DFG ++ D+ T GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
Y PE + Y+ K D++S G++L ELL + ER + I+ + K
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QMERVRI---ITDVRNLK 290
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + +E + L + +RP +
Sbjct: 291 FPLLFTQKYPQE---------HMMVQDMLSPSPTERPEATDI 323
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 48/243 (19%), Positives = 94/243 (38%), Gaps = 44/243 (18%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--AIDKTQIEQFINEVVILSQI 385
R T +++ +G G FG+V+K + DG I A+KRSK + + EV + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 386 -NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H H+V+ E + ++ EY G+L+ I + +E +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELK------ 118
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-------------------DKFS 485
+ +V + Y+HS + + H DIK SNI + +K
Sbjct: 119 ---DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTG 544
K+ D G + + + +G + E Q + + K+D+++ + ++
Sbjct: 173 FKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
Query: 545 KKP 547
+
Sbjct: 228 EPL 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-34
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 340 LGQGGFGTVYKGML--PDGSI-VAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLG 395
LG G FG+V +G+ I VA+K K +K E+ + E I+ Q+++ +IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 396 CCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
C + +LV E G L + +++ + N + +V+
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---------------IPVSNVAELLHQVSM 447
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY- 514
+ Y+ + HR++ + N+LL ++ AK+SDFG S+++ D ++ T G +
Sbjct: 448 GMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 515 -FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE +++ +SDV+S+GV + E L+ G+KP
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 31/218 (14%)
Query: 338 RFLGQGGFGTVYKGMLPD---GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIV 391
R +G+GG G VY+ D IVA+K + + D + E ++ H+V
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+ + I +L+ + L+ V +
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----------------GPLAPPRAVAIVR 141
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--AVQ 509
++ A+ H++ HRD+K NIL+ A + DFG + + LT
Sbjct: 142 QIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTV 196
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE F S T ++D+Y+ VL E LTG P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 64/311 (20%), Positives = 118/311 (37%), Gaps = 50/311 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK-----------------RSKAIDKTQIEQ 374
++Y R L QG F + D A+K K K++ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELE 433
F NE+ I++ I + + + G + V ++YEY+ N ++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493
Q + + V + +Y+H+ +I HRD+K SNIL+D K+SDFG
Sbjct: 149 PIQVIK--------CIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 494 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD--KSDVYSFGVVLLELLTGKKPICLT 551
S + + K + GT+ + PE+F + + K D++S G+ L + P
Sbjct: 199 SEYMVDKKIK-GSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--- 252
Query: 552 REEEERNLVA---------YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRL 602
+ +LV L + + L + + + + E + + LR
Sbjct: 253 --SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI-DFLKLFLRK 309
Query: 603 NSKKRPTMKQV 613
N +R T +
Sbjct: 310 NPAERITSEDA 320
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-34
Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 43/303 (14%)
Query: 318 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSKAIDKTQIEQ 374
+F + ++ Y + + LG G +G V A+K R ++ + +
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELE 433
+ EV +L ++H +I+KL E + LV E G L I + E
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--- 138
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSD 490
+ +V V Y+H I HRD+K N+LL+ K K+ D
Sbjct: 139 -------------AVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182
Query: 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 550
FG S N K + + GT Y PE + Y +K DV+S GV+L LL G P
Sbjct: 183 FGLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGG 239
Query: 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610
++E V ++ K D+ K SE +L L+ +S++R +
Sbjct: 240 QTDQEILRKV-------EKGKY--TFDSPEWKNVSEG----AKDLIKQMLQFDSQRRISA 286
Query: 611 KQV 613
+Q
Sbjct: 287 QQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-34
Identities = 77/291 (26%), Positives = 115/291 (39%), Gaps = 44/291 (15%)
Query: 331 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQIN 386
+D Y R LG+G FG V G AVK + + KT E + EV +L Q++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
H +I+KL E + LV E G L I ++ E
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA--------------- 128
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPNDKT 502
R+ +V + YMH + I HRD+K N+LL+ K + ++ DFG S K
Sbjct: 129 -ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
+ + GT Y PE + Y +K DV+S GV+L LL+G P E + V
Sbjct: 185 -MKDKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-- 239
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
++ K + K+ SE +L L R + +
Sbjct: 240 -----EKGKY--TFELPQWKKVSES----AKDLIRKMLTYVPSMRISARDA 279
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-33
Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 4/159 (2%)
Query: 71 PFNTPVSIAYLLGSDASIIVPVSCSCS-GSLYQHNAPYTIKANDTYFLVANNTYQGLTTC 129
+N+ + + + ++VP C C G HN Y+++ DTY VA + Y LTT
Sbjct: 44 RYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTM 103
Query: 130 QALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSIGHKFG 189
++L +N + N+ + V + C+C + + + Y D++SSI G
Sbjct: 104 ESLQARNPFPATNIPLSATLNVLVNCSCGD-ESVSKDFGLFVTYPLRPEDSLSSIARSSG 162
Query: 190 ADKQSILDANKLSEDDLIFTFTPLLIPLKSESCSANPEK 228
+ N + + +P + + + P K
Sbjct: 163 VSADILQRYNPGV--NFNSGNGIVYVPGRDPNGAFPPFK 199
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 24/149 (16%), Positives = 48/149 (32%), Gaps = 25/149 (16%)
Query: 93 SCSCSGSLYQHNAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYYD----------EKN 142
SC +L A Y ++ T ++ N ++ N+ +
Sbjct: 2 RTSCPLAL----ASYYLENGTTLSVINQN-LN--SSIAPYDQINFDPILRYNSNIKDKDR 54
Query: 143 LGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSIGHKFGAD---KQSILDAN 199
+ G V+VP C C + + SY + DT + A+ +S+ N
Sbjct: 55 IQMGSRVLVPFPCECQPGDFLGHNFSYSVRQ----EDTYERVAISNYANLTTMESLQARN 110
Query: 200 KLSEDDLIFTFTPLLIPLKSESCSANPEK 228
++ + T L + + + K
Sbjct: 111 PFPATNIPLSAT-LNVLVNCSCGDESVSK 138
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 33/226 (14%)
Query: 334 YNQSRFLGQGGFGTVYKGMLPD---GSIVAVK--RSK-AIDKTQIEQFINEVVILSQINH 387
Y LG GG V+ D VAVK R+ A D + +F E + +NH
Sbjct: 14 YELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 388 RHIVKLL--GC--CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
IV + G +P +V EY+ L +H ++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----------------MTP 115
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
+ + V + A+ + H + I HRD+K +NI++ + KV DFG +R++ +
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 504 LTT--AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+T AV GT Y PE + +SDVYS G VL E+LTG+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-33
Identities = 44/218 (20%), Positives = 77/218 (35%), Gaps = 40/218 (18%)
Query: 340 LGQGGFGTVYKG--MLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLL- 394
+ GG G +Y +G V +K + D + E L+++ H IV++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVH-SGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 395 ----GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V +V EY+ +L L +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------------------LPVAEAIAYL 188
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
E+ A++Y+HS I + + D+K NI+L ++ K+ D G + + G
Sbjct: 189 LEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NS-FGYLYG 239
Query: 511 TFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGKKP 547
T G+ PE + T +D+Y+ G L L
Sbjct: 240 TPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 77/321 (23%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 309 RLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAI 367
++ C K+ +E + Y LG GGFG+VY G+ + D VA+K +
Sbjct: 20 HMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH---V 76
Query: 368 DKTQIEQFIN---------EVVILSQINHR--HIVKLLGCCLETEVP-VLVYEYICN-GN 414
+K +I + EVV+L +++ +++LL E VL+ E +
Sbjct: 77 EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQD 135
Query: 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474
L I ++ L+EE R +V AV + H+ + HRDIK
Sbjct: 136 LFDFI-------TERGALQEE--------LAR-SFFWQVLEAVRHCHNCG---VLHRDIK 176
Query: 475 SSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVY 532
NIL+D ++ K+ DFG+ + + T T GT Y PE+ + +Y + V+
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLKD--TVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 533 SFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAV 592
S G++L +++ G P E +E + + S E
Sbjct: 234 SLGILLYDMVCGDIPF----EHDEEIIRGQV---------------FFRQRVSSE----C 270
Query: 593 AELAMGCLRLNSKKRPTMKQV 613
L CL L RPT +++
Sbjct: 271 QHLIRWCLALRPSDRPTFEEI 291
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 49/232 (21%)
Query: 338 RFLGQGGFGTVYKGMLPDGSI--------VAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
LGQG F ++KG+ + V +K + E F ++S+++H+H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V G C+ + +LV E++ G+L ++ ++ +LE V
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE---------------V 118
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--------AKVSDFGTSRSVPNDK 501
A ++A A+ ++ + I H ++ + NILL + K+SD G S +V
Sbjct: 119 AKQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 502 THLT----TAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLT-GKKP 547
PE + +D +SFG L E+ + G KP
Sbjct: 176 ILQERIPWVP---------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-33
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIV 391
R +G+G FG V++G+ VA+K ++ D + + F+ E + + Q +H HIV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 454
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
KL+G TE PV ++ E G L + + L + + A
Sbjct: 455 KLIGVI--TENPVWIIMELCTLGELRSFLQVRKFS---------------LDLASLILYA 497
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
+++ A+AY+ S + HRDI + N+L+ K+ DFG SR + + + + +
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 547
+ PE ++T SDV+ FGV + E+L G KP
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 70/303 (23%), Positives = 117/303 (38%), Gaps = 58/303 (19%)
Query: 331 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK-------------RSKAIDKTQIEQFI 376
++Y + R LG G +G V S A+K + E+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 377 NEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE 435
NE+ +L ++H +I+KL E + LV E+ G L I + + E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDA----- 148
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFG 492
+ ++ + Y+H I HRDIK NILL++K + K+ DFG
Sbjct: 149 -----------ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 552
S D L + GT Y PE + Y +K DV+S GV++ LL G P
Sbjct: 195 LSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQN 251
Query: 553 EEEERNLVAYFISLAKENKLLEILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTM 610
+++ + ++ + + ++ ++I A EL L + KR T
Sbjct: 252 DQD---------------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 611 KQV 613
++
Sbjct: 297 EEA 299
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 43/247 (17%), Positives = 73/247 (29%), Gaps = 34/247 (13%)
Query: 320 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKAIDKTQIE 373
I E Q + LG+G F VY+ + +K K + +
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 374 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELE 433
+ L +K L VLV E G L + I+ ++ E+
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV---- 168
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA------- 486
+ + A + + +H I H DIK N +L + F
Sbjct: 169 -------MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 487 ----KVSDFGTSR--SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 540
+ D G S + T T T G+ E + + + D + +
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277
Query: 541 LLTGKKP 547
+L G
Sbjct: 278 MLFGTYM 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 44/318 (13%), Positives = 84/318 (26%), Gaps = 53/318 (16%)
Query: 338 RFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
LGQ + G V ++ I+Q EV+ L + K
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 394 LGCCLETEVPVLVYE-----------------YICNGNLSHHIHDHQQQQEQKQELEEEQ 436
L P + + ++ + + Q + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496
SL R+++ +V +A +H + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 497 VPNDKTHLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPICLT 551
Q T D ++ G+ + + P T
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NT 318
Query: 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDI-EAVAELAMGCLRLNSKKRPTM 610
+ F S ++I + V L G LR + R
Sbjct: 319 DDAALGGSEWIF--------------------RSCKNIPQPVRALLEGFLRYPKEDRLLP 358
Query: 611 KQVSMDLEGLRRSQRCLE 628
Q M+ + + L
Sbjct: 359 LQA-METPEYEQLRTELS 375
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 46/347 (13%), Positives = 88/347 (25%), Gaps = 79/347 (22%)
Query: 308 QRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---R 363
+S+ + EL + LGQ + G V
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 364 SKAIDKTQIEQFINEVVILSQI-------------------------NHRHIVKLLGCCL 398
++ I+Q EV+ L + + ++++
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 399 ETEVPVLVYEY-ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ V + Y NL + L R+++ +V +
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA---------RLQLTLQVIRLL 219
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
A +H + H ++ +I+LD + ++ F + + G+ P
Sbjct: 220 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPP 271
Query: 518 EYFQSSQ-----------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566
E T D ++ G+V+ + P
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---------------ITKD 316
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
A I R K + V L G LR + R Q
Sbjct: 317 AALGGSEWIF--RSCKNIPQP----VRALLEGFLRYPKEDRLLPLQA 357
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 76/302 (25%), Positives = 121/302 (40%), Gaps = 71/302 (23%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN---------EVVI 381
Y LG+GGFGTV+ G L D VA+K I + ++ + EV +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV---IPRNRVLGWSPLSDSVTCPLEVAL 87
Query: 382 LSQIN----HRHIVKLLGCCLETEVP-VLVYEYICNGN-LSHHIHDHQQQQEQKQELEEE 435
L ++ H +++LL ET+ +LV E L +I +K L E
Sbjct: 88 LWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI-------TEKGPLGEG 139
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTS 494
+R +V A+ + HS + HRDIK NIL+D + AK+ DFG+
Sbjct: 140 --------PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTRE 553
+ + T GT Y PE+ QY + V+S G++L +++ G P
Sbjct: 188 ALLHD--EPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF----- 239
Query: 554 EEERNLVAYFISLAKENKLLEILDA--RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611
E ++ EIL+A S + L CL RP+++
Sbjct: 240 ERDQ----------------EILEAELHFPAHVSPD----CCALIRRCLAPKPSSRPSLE 279
Query: 612 QV 613
++
Sbjct: 280 EI 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 70/341 (20%), Positives = 120/341 (35%), Gaps = 63/341 (18%)
Query: 315 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK-----RSKAID 368
S + F L Y+ +GQG +G V + +I A+K + + I+
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 369 KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQE 427
+E+ EV ++ +++H +I +L E E + LV E G+L ++
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 428 QKQELEEEQELSSLSWENRVRVACE------------------------VAGAVAYMHSS 463
K ++ + E + A+ Y+H+
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187
Query: 464 ASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSV----PNDKTHLTTAVQGTFGYFDP 517
I HRDIK N L S K+ DFG S+ + +TT GT + P
Sbjct: 188 G---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAP 243
Query: 518 EYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLE- 574
E ++ Y K D +S GV+L LL G P F + +
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP---------------FPG-VNDADTISQ 287
Query: 575 ILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
+L+ ++ E + +A +L L N +R +
Sbjct: 288 VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 73/290 (25%), Positives = 108/290 (37%), Gaps = 43/290 (14%)
Query: 331 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINH 387
+ YN LG+G FG V K AVK + + EV +L +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+I+KL E +V E G L I ++ E
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA---------------- 123
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPNDKTH 503
R+ +V + YMH I HRD+K NILL+ K K+ DFG S +
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
+ + GT Y PE + + Y +K DV+S GV+L LL+G P E + V
Sbjct: 180 MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--- 234
Query: 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ K D + S++ +L L + R T Q
Sbjct: 235 ----ETGKY--AFDLPQWRTISDD----AKDLIRKMLTFHPSLRITATQC 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 50/299 (16%)
Query: 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINE 378
+ + Q NY + +G+G F V + G VA+K +++ ++ T +++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 379 VVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
V I+ +NH +IVKL +ETE + L+ EY G + ++ H + +E+
Sbjct: 65 VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------- 114
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
E R ++ AV Y H I HRD+K+ N+LLD + K++DFG S +
Sbjct: 115 ------EAR-SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS-NE 163
Query: 498 PNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEE 556
L G Y PE FQ +Y + DV+S GV+L L++G P +
Sbjct: 164 FTVGGKLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF------DG 216
Query: 557 RNLVAYFISLAKENKLLEILDA--RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+NL +L R+ S + L L LN KR T++Q+
Sbjct: 217 QNLKELR---------ERVLRGKYRIPFYMSTD----CENLLKRFLVLNPIKRGTLEQI 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 33/292 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID----KTQIEQFINEVVILSQIN 386
D+Y +G G V P VA+KR I+ +T +++ + E+ +SQ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR---INLEKCQTSMDELLKEIQAMSQCH 71
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H +IV + + LV + + G++ I + E K + +E +++
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT------ 125
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
+ EV + Y+H + I HRD+K+ NILL + S +++DFG S +
Sbjct: 126 --ILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 507 AVQGTF-G---YFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
V+ TF G + PE Q Y K+D++SFG+ +EL TG P + V
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----KYPPMKVL 236
Query: 562 YFISLAKENKLLE-ILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
L + D + K+ + + ++ CL+ + +KRPT +
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAE 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
Y + +GQG GTVY M + G VA+++ + + E INE++++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV L L + +V EY+ G+L+ + + ++E Q +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--------ETCMDEGQ----------IAA 120
Query: 450 AC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
C E A+ ++HS+ I HRDIKS NILL S K++DFG + +++ +T V
Sbjct: 121 VCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT + PE Y K D++S G++ +E++ G+ P
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 74/291 (25%), Positives = 114/291 (39%), Gaps = 43/291 (14%)
Query: 331 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHR 388
D + R LG G FG V+ G +K +K + +EQ E+ +L ++H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 389 HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+I+K+ E + +V E G L I + + +LS E V
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERI------------VSAQARGKALS-EGYV 126
Query: 448 RVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDKTH 503
++ A+AY HS + H+D+K NIL D K+ DFG + +D+
Sbjct: 127 AELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
T A GT Y PE F+ T K D++S GVV+ LLTG P F
Sbjct: 183 STNAA-GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP---------------F 225
Query: 564 ISLAKENKLLEILDARVAKEASEEDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
+ E + + A +L L + ++RP+ QV
Sbjct: 226 TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 48/233 (20%), Positives = 78/233 (33%), Gaps = 36/233 (15%)
Query: 331 TDNYNQSRFLGQG--GFGTVYKGM-LPDGSIVAVKRSK--AIDKTQIEQFINEVVILSQI 385
Y +G+G TV P G V V+R A + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
NH +IV + +V ++ G+ I H + E
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-----MNELA--------- 129
Query: 446 RVRVAC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
+A V A+ Y+H + HR +K+S+IL+ +S ++ S+ +
Sbjct: 130 ---IAYILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 503 HLTTAVQ------GTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKP 547
+ PE Q + Y KSD+YS G+ EL G P
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ--IEQFINEVVILSQINH 387
+ + + +G+G FG V+KG+ +VA+K +++ + IE E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDS 79
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
++ K G L+ ++ EY+ G+ + + L+E Q +
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQ----------I 121
Query: 448 RVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
E+ + Y+HS I HRDIK++N+LL + K++DFG + + + + T
Sbjct: 122 ATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 549
V GT + PE + S Y K+D++S G+ +EL G+ P
Sbjct: 179 FV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 68/294 (23%), Positives = 113/294 (38%), Gaps = 43/294 (14%)
Query: 331 TDNYN---QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI- 385
+Y+ + + LG+G F K + AVK I K E+ L
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCE 63
Query: 386 NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
H +IVKL ++ LV E + G L I + E +
Sbjct: 64 GHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------------- 108
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDK 501
+ ++ AV++MH + HRD+K N+L D+ K+ DFG +R P D
Sbjct: 109 --SYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
L T T Y PE + Y + D++S GV+L +L+G+ P + +
Sbjct: 164 QPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF---QSHDRSLTCT 219
Query: 562 YFISLAKENKLLEILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
+ + K +I + E +++ A +L G L ++ KR M +
Sbjct: 220 SAVEIMK-----KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398
+G+G G V G VAVK + + E NEVVI+ H ++V++ L
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAV 457
E ++ E++ G L+ + + L EEQ + C V A+
Sbjct: 113 VGEELWVLMEFLQGGALTDIVS--------QVRLNEEQ----------IATVCEAVLQAL 154
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
AY+H+ I HRDIKS +ILL K+SDFG + D + V GT + P
Sbjct: 155 AYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
E S Y + D++S G++++E++ G+ P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 65/273 (23%), Positives = 109/273 (39%), Gaps = 41/273 (15%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN-----------EVV 380
Y+ LG G FG V+ + V VK I K ++ + E+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK---FIKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 381 ILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGN-LSHHIHDHQQQQEQKQELEEEQEL 438
ILS++ H +I+K+L E + LV E +G L I ++ L+E
Sbjct: 82 ILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFI-------DRHPRLDEP--- 130
Query: 439 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498
+ ++ AV Y+ I HRDIK NI++ + F+ K+ DFG++ +
Sbjct: 131 -----LAS-YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYL 180
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEER 557
T GT Y PE + Y + +++S GV L L+ + P C E E
Sbjct: 181 ERGKLFYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
Query: 558 NL-VAYFISLAKENKLLEILDARVAKEASEEDI 589
+ Y +S + + +L + + E +
Sbjct: 240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKL 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 65/299 (21%), Positives = 109/299 (36%), Gaps = 53/299 (17%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ--------IEQFINEVVI 381
D Y +G+G F V + + G AVK +D + E E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREASI 79
Query: 382 LSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSS 440
+ H HIV+LL ++ + +V+E++ +L I ++
Sbjct: 80 CHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEI------------VKRADAGFV 126
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSV 497
S ++ A+ Y H + I HRD+K +LL K ++ K+ FG + +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 498 PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557
V GT + PE + Y DV+ GV+L LL+G P
Sbjct: 184 GESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP---------- 232
Query: 558 NLVAYFISLAKENKLLE-ILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
F + +L E I+ + + I A +L L L+ +R T+ +
Sbjct: 233 -----F--YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 25/243 (10%)
Query: 315 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKA-IDKTQI 372
SS K KI + ++ +G+G +G+V K + P G I+AVKR ++ +D+ +
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 373 EQFINEV-VILSQINHRHIVKLLGCCL-ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQ 430
+Q + ++ V++ + +IV+ G E + + E + + +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMEL-MSTSFDKFYKYVYSVLDDVI 122
Query: 431 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490
E+ L ++ A+ ++ + I HRDIK SNILLD + K+ D
Sbjct: 123 P---EEILG--------KITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCD 169
Query: 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLLELLTGKK 546
FG S + + A G Y PE S Y +SDV+S G+ L EL TG+
Sbjct: 170 FGISGQLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
Query: 547 PIC 549
P
Sbjct: 228 PYP 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHR 388
+ ++ LG+G +G+VYK + G IVA+K+ + ++ +++ I E+ I+ Q +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ---VPVESDLQEIIKEISIMQQCDSP 84
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
H+VK G + +V EY G++S I + L E++ +
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT------LTEDE----------IA 128
Query: 449 VAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
+ Y+H I HRDIK+ NILL+ + AK++DFG + + + T
Sbjct: 129 TILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT + PE Q Y +D++S G+ +E+ GK P
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 44/290 (15%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
D Y+ LG G FG V++ + G + K NE+ I++Q++H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
++ L + VL+ E++ G L I E+ ++S N +R
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI------------AAEDYKMSEAEVINYMRQ 157
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTA 507
ACE + +MH + I H DIK NI+ + K ++ K+ DFG + + D+ +
Sbjct: 158 ACE---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVT 210
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
T + PE +D+++ GV+ LL+G P F
Sbjct: 211 T-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGED 254
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAM----GCLRLNSKKRPTMKQV 613
L + E E+ +V+ A L+ +KR T+
Sbjct: 255 DLETLQNVKRCDW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-29
Identities = 63/296 (21%), Positives = 104/296 (35%), Gaps = 53/296 (17%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINH 387
T+ Y LG+G F V + + + G A +K + ++ E I + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+IV+L E L+++ + G L I + E
Sbjct: 70 PNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSE------------------- 109
Query: 447 VRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPN 499
A + AV + H + HR++K N+LL K K++DFG + V
Sbjct: 110 -ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
++ GT GY PE + Y D+++ GV+L LL G P
Sbjct: 166 EQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP------------ 212
Query: 560 VAYFISLAKENKLLEILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
F + +I + E + + A +L L +N KR T +
Sbjct: 213 ---FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 56/289 (19%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEV-VILSQINHRHIVKLLGC 396
LG+G +G V K +P G I+AVKR ++ + ++ + ++ + + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 397 CL-ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
E +V + E + +L +Q K + E L ++A +
Sbjct: 75 LFREGDV-WICMEL-MDTSLD----KFYKQVIDKGQTIPEDILG--------KIAVSIVK 120
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
A+ ++HS S+ HRD+K SN+L++ K+ DFG S + +D A G Y
Sbjct: 121 ALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYM 176
Query: 516 DPE----YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
PE Y+ KSD++S G+ ++EL + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP------------------YDSWGT 218
Query: 572 LLEILDARVAKEA--------SEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
+ L V + + S E ++ + CL+ NSK+RPT +
Sbjct: 219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTS----QCLKKNSKERPTYPE 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 69/221 (31%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINHR 388
+Y LG G FG V G G VAVK R K + + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 389 HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
HI+KL + T +V EY+ G L +I H + +E E R
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---------------EAR- 114
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
R+ ++ AV Y H + HRD+K N+LLD +AK++DFG S ++ +D L T+
Sbjct: 115 RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS 170
Query: 508 VQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 547
G+ Y PE Y + D++S GV+L LL G P
Sbjct: 171 C-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 67/299 (22%), Positives = 104/299 (34%), Gaps = 63/299 (21%)
Query: 331 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSKAIDKTQI---EQFINEVVILSQIN 386
Y +G+G +G V A K+ I K + ++F E+ I+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSLD 64
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
H +I++L E + LV E G L + + +E
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRE------------------ 105
Query: 446 RVRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVP 498
A V AVAY H + HRD+K N L K+ DFG +
Sbjct: 106 --SDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
K + T V GT Y P+ + Y + D +S GV++ LL G P
Sbjct: 161 PGKM-MRTKV-GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP----------- 206
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELA----MGCLRLNSKKRPTMKQV 613
F + +L+I + E+D V+ A L + K+R T Q
Sbjct: 207 ----FSAPTDSEVMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
+ + LG G FG VYK G++ A K + + ++E +I E+ IL+ +H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IVKLLG ++ E+ G + + E + L E Q ++V
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQ----------IQV 121
Query: 450 AC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
C ++ A+ ++HS I HRD+K+ N+L+ + +++DFG S + +
Sbjct: 122 VCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 509 QGTFGYFDPE-----YFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT + PE + + Y K+D++S G+ L+E+ + P
Sbjct: 179 -GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 71/318 (22%), Positives = 117/318 (36%), Gaps = 54/318 (16%)
Query: 309 RLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSK 365
++ + F + +DNY+ LG+G F V + + G A K +K
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 366 AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQ 424
+ ++ E I ++ H +IV+L + E LV++ + G L I +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 425 QQEQKQELEEEQELSSLSWENRVRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILL 480
E A + ++AY HS+ I HR++K N+LL
Sbjct: 125 YSE--------------------ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLL 161
Query: 481 DDKFSA---KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV 537
K K++DFG + V + + GT GY PE + Y+ D+++ GV+
Sbjct: 162 ASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 538 LLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASE-EDIEAVA-EL 595
L LL G P F + +I + E + + A L
Sbjct: 220 LYILLVGYPP---------------FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 596 AMGCLRLNSKKRPTMKQV 613
L +N KKR T Q
Sbjct: 265 IDSMLTVNPKKRITADQA 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 73/296 (24%), Positives = 107/296 (36%), Gaps = 55/296 (18%)
Query: 331 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINH 387
+ YN LG+G FG V K AVK + + EV +L +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+I+KL E +V E G L I ++ E
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSE------------------- 120
Query: 447 VRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPN 499
A V + YMH I HRD+K NILL+ K K+ DFG S
Sbjct: 121 -HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
+ + + GT Y PE + + Y +K DV+S GV+L LL+G P
Sbjct: 177 NTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP------------ 221
Query: 560 VAYFISLAKENKLLEILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
F + + L + + A + + I A +L L + R T Q
Sbjct: 222 ---FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 79/348 (22%), Positives = 132/348 (37%), Gaps = 87/348 (25%)
Query: 338 RFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRH 389
+ LG+G FG V + VAVK K ++ ++E+ IL I +H +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 390 IVKLLGCCLETEVPVLV-YEYICNGNLSHHIHDHQQ------------------------ 424
+V LLG C + P++V E+ GNLS ++ +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 425 --------------------------QQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458
+++E E+ L+ E+ + + +VA +
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD-- 516
++ AS HRD+ + NILL +K K+ DFG +R + D + V+
Sbjct: 208 FL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLK 260
Query: 517 ---PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKL 572
PE YT +SDV+SFGV+L E+ + G P + +EE F KE
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR 314
Query: 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
+ D + E + + + C +RPT ++ L L
Sbjct: 315 MRAPD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 69/292 (23%), Positives = 115/292 (39%), Gaps = 49/292 (16%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ-IEQFINEVVILSQINHR 388
+D + LG+G VY+ A+K + KT + E+ +L +++H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRLSHP 108
Query: 389 HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+I+KL ET + LV E + G L I + E+
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDA----------------A 151
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDKTHL 504
++ AVAY+H + I HRD+K N+L K++DFG S+ V + +
Sbjct: 152 DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-M 207
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
T GT GY PE + Y + D++S G++ LL G +P F
Sbjct: 208 KTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FY 251
Query: 565 SLAKENKLLE-ILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
+ + IL+ + +++ A +L + L+ KKR T Q
Sbjct: 252 DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 340 LGQGGFGTVYKGML-PDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
LG G G V+K P G ++A K I Q I E+ +L + N +IV G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 457
+ E++ G+L + + EQ L +V+ V +
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRI--------PEQILG--------KVSIAVIKGL 144
Query: 458 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 517
Y+ I HRD+K SNIL++ + K+ DFG S + + + + V GT Y P
Sbjct: 145 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSP 199
Query: 518 EYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
E Q + Y+ +SD++S G+ L+E+ G+ PI
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 71/295 (24%), Positives = 110/295 (37%), Gaps = 55/295 (18%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI---EQFINEVVILSQIN 386
+ LG G F V+ G + A+K I K+ NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC---IKKSPAFRDSSLENEIAVLKKIK 64
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
H +IV L E+ LV + + G L I E + ++
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRI----------------LERGVYTEKD 107
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGTSRSVPNDKT 502
V +V AV Y+H + I HRD+K N+L ++ ++DFG S+ N
Sbjct: 108 ASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
++TA GT GY PE Y+ D +S GV+ LL G P EE E L
Sbjct: 164 -MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF---YEETESKL--- 215
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELA----MGCLRLNSKKRPTMKQV 613
+I + E + ++E A L + +R T ++
Sbjct: 216 ---------FEKIKEGYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 37/228 (16%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINH 387
+DNY+ LG+G F V + + G A K +K + ++ E I ++ H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+IV+L + E LV++ + G L I + E
Sbjct: 65 PNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSE------------------- 104
Query: 447 VRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPN 499
A + ++AY HS+ I HR++K N+LL K K++DFG + V +
Sbjct: 105 -ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT GY PE + Y+ D+++ GV+L LL G P
Sbjct: 161 SEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 66/301 (21%), Positives = 110/301 (36%), Gaps = 55/301 (18%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSKAIDKTQIEQFINEVVI 381
D Y S+ LG G G V VA++ A + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
L ++NH I+K+ + E +V E + G L + +++ +E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------- 242
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVP 498
++ AV Y+H + I HRD+K N+LL + K++DFG S+ +
Sbjct: 243 ------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL- 292
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
+ + + T GT Y PE S Y D +S GV+L L+G P
Sbjct: 293 GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-------- 343
Query: 556 ERNLVAYFISLAKENKLLE-ILDARVAKEASEED-IEAVA-ELAMGCLRLNSKKRPTMKQ 612
F + L + I + + A +L L ++ K R T ++
Sbjct: 344 -------FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 613 V 613
Sbjct: 397 A 397
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 58/290 (20%), Positives = 105/290 (36%), Gaps = 44/290 (15%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
D+Y+ LG G FG V++ G+ A K ++ E E+ +S + H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+V L + V++YE++ G L + +E ++S +R
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKV------------ADEHNKMSEDEAVEYMRQ 263
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTA 507
C+ + +MH + H D+K NI+ K S K+ DFG + + ++ +
Sbjct: 264 VCK---GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVT 316
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
GT + PE + +D++S GV+ LL+G P F
Sbjct: 317 T-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---------------FGGEN 360
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAM----GCLRLNSKKRPTMKQV 613
+ L + + ++E L + R T+ Q
Sbjct: 361 DDETLRNVKSCDW--NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 47/232 (20%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI----EQFINEVVILSQIN 386
++++ + LG+G +G V + VAVK +D + E E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE------QELS 439
H ++VK G L EY G L I E + E +L
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI-------EPDIGMPEPDAQRFFHQLM 115
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS---RS 496
+ V Y+H I HRDIK N+LLD++ + K+SDFG + R
Sbjct: 116 A---------------GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 497 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 547
++ L GT Y PE + ++ + DV+S G+VL +L G+ P
Sbjct: 158 NNRER-LLNKMC-GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQ 384
+ + Y + LG+G FG V++ + K + K D+ ++ E+ IL+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
HR+I+ L E V+++E+I ++ I EL+ E
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI------------NTSAFELN----E 101
Query: 445 NRVRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDK 501
+ +V A+ ++HS I H DI+ NI+ + S+ K+ +FG +R +
Sbjct: 102 REIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
Y+ PE Q + +D++S G ++ LL+G P
Sbjct: 159 N-FRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 52/295 (17%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQ-INHR 388
TD Y +G G + + + AVK IDK++ + E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 389 HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+I+ L + V +V E + G L I + E++
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFFSEREA----------------S 119
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPNDKTH 503
V + V Y+H+ + HRD+K SNIL + S ++ DFG ++ + +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
L T T + PE + Y D++S GV+L +LTG P F
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---------------F 220
Query: 564 ISLAKEN--KLLE-ILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
+ + ++L I + + + A +L L ++ +R T V
Sbjct: 221 ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 73/265 (27%), Positives = 111/265 (41%), Gaps = 31/265 (11%)
Query: 293 LKEKLFKQNGGYLLQQRLSSCGSSEKAKIFT---AEELQRAT-DNYNQSRFLGQGGFGTV 348
L ++L + YL + S F E Q T + + Q R LG+GGFG V
Sbjct: 141 LFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 349 YKGMLPD-GSIVAVKR-SKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404
+ G + A K+ K + +NE IL ++N R +V L ET+ +
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDAL 259
Query: 405 -LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHS 462
LV + G+L HI + E R A E+ + +H
Sbjct: 260 CLVLTLMNGGDLKFHI-----YHMGQAGFPEA----------RAVFYAAEICCGLEDLHR 304
Query: 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS 522
I +RD+K NILLDD ++SD G + VP +T GT GY PE ++
Sbjct: 305 ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN 359
Query: 523 SQYTDKSDVYSFGVVLLELLTGKKP 547
+YT D ++ G +L E++ G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQIN 386
++ R +G G FG VY + + +VA+K+ S + + I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H + ++ GC L LV EY C G+ S + H++ L+E +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKP------LQEVE---------- 155
Query: 447 VRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 505
+ +AY+HS I HRD+K+ NILL + K+ DFG++ + +
Sbjct: 156 IAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--- 209
Query: 506 TAVQGTFGYFDPE---YFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT + PE QY K DV+S G+ +EL K P
Sbjct: 210 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 45/231 (19%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI----EQFINEVVILSQIN 386
++++ + LG+G +G V + VAVK +D + E E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE------QELS 439
H ++VK G L EY G L I E + E +L
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI-------EPDIGMPEPDAQRFFHQLM 115
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVP 498
+ V Y+H I HRDIK N+LLD++ + K+SDFG +
Sbjct: 116 A---------------GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 499 NDKTH-LTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 547
N++ L GT Y PE + ++ + DV+S G+VL +L G+ P
Sbjct: 158 NNRERLLNKMC-GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 48/293 (16%)
Query: 331 TDNYN--QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH 387
Y ++ LG G FG V+K G +A K K E+ NE+ +++Q++H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
++++L E++ + LV EY+ G L I D + E +
Sbjct: 146 ANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIID-------ESYNLTELDTILF----- 192
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHL 504
++ CE + +MH I H D+K NIL ++ + K+ DFG +R + L
Sbjct: 193 MKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-L 245
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
GT + PE + +D++S GV+ LL+G P F+
Sbjct: 246 KVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP---------------FL 289
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAM----GCLRLNSKKRPTMKQV 613
L IL R + +E+ + ++E A L R + +
Sbjct: 290 GDNDAETLNNILACRW--DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 326 ELQRAT-DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKA--IDKTQIEQFINEVV 380
E Q D + R LG+GGFG V+ + G + A K+ +K + + + E
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 381 ILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
IL++++ R IV L ET+ + LV + G++ +HI++ + QE
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-------- 288
Query: 440 SLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 498
R ++ + ++H I +RD+K N+LLDD + ++SD G + +
Sbjct: 289 -----PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+T GT G+ PE +Y D ++ GV L E++ + P
Sbjct: 341 AGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 70/317 (22%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 310 LSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID 368
++S + L+ + +G G +G VYKG + G + A+K +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VT 60
Query: 369 KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV------LVYEYICNGNLSHHIHD 421
+ E+ E+ +L + +HR+I G ++ P LV E+ G+++ I +
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 422 HQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILL 480
+ L+EE + C E+ ++++H I HRDIK N+LL
Sbjct: 121 TKGNT-----LKEEW----------IAYICREILRGLSHLHQHKVI---HRDIKGQNVLL 162
Query: 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-----YFQSSQYTDKSDVYSFG 535
+ K+ DFG S + T + GT + PE + Y KSD++S G
Sbjct: 163 TENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 536 VVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAEL 595
+ +E+ G P+C + + I +L K+ S++ +
Sbjct: 222 ITAIEMAEGAPPLC----DMHPMRALFLIPRNPAPRLKS-------KKWSKKFQSFIES- 269
Query: 596 AMGCLRLNSKKRPTMKQ 612
CL N +RP +Q
Sbjct: 270 ---CLVKNHSQRPATEQ 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 65/291 (22%), Positives = 117/291 (40%), Gaps = 61/291 (20%)
Query: 340 LGQGGFGTVYKGM-LPDGSIVAVKRSKA-IDKTQIEQFINEV-VILSQINHRHIVKLLGC 396
+G G G V+K G ++AVK+ + +K + ++ + ++ V+L + +IV+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 397 CL-ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 455
+ T+V + E + ++ + + E L ++ +
Sbjct: 93 FITNTDV-FIAMEL-MGTCA------EKLKKRMQGPIPERI----LG-----KMTVAIVK 135
Query: 456 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 515
A+ Y+ + HRD+K SNILLD++ K+ DFG S + +DK +A G Y
Sbjct: 136 ALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYM 191
Query: 516 DPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570
PE Y ++DV+S G+ L+EL TG+ P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP------------------YKNCK 233
Query: 571 KLLEILDARVAKEA---------SEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
E+L + +E S + V + CL + +KRP +
Sbjct: 234 TDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD----CLTKDHRKRPKYNK 280
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 32/225 (14%)
Query: 332 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ 384
+++ + LG+G F TV A+K K I + ++ E ++S+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
++H VKL + E Y NG L + + + E
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY-------------IRKIGSFD----E 129
Query: 445 NRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
R E+ A+ Y+H I HRD+K NILL++ +++DFGT++ + +
Sbjct: 130 TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 504 LTTA-VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE SD+++ G ++ +L+ G P
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 46/238 (19%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI------------EQFIN 377
+NY LG+G V + + P AVK ID T E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKI---IDVTGGGSFSAEEVQELREATLK 72
Query: 378 EVVILSQIN-HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE 435
EV IL +++ H +I++L ET LV++ + G L ++ + E++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET----- 126
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
++ + + +H I HRD+K NILLDD + K++DFG S
Sbjct: 127 -----------RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 496 SVPNDKTHLTTAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ + L GT Y PE Y + D++S GV++ LL G P
Sbjct: 173 QLDPGEK-LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINHR 388
+Y LG G FG V G G VAVK R K + + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 389 HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
HI+KL + T + +V EY+ G L +I + + E+ E+R
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---------------ESR- 119
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
R+ ++ V Y H + HRD+K N+LLD +AK++DFG S ++ +D L T+
Sbjct: 120 RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTS 175
Query: 508 VQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 547
G+ Y PE Y + D++S GV+L LL G P
Sbjct: 176 C-GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 73/299 (24%), Positives = 110/299 (36%), Gaps = 55/299 (18%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKAIDKTQIEQFINEVVILS 383
D+Y LG G F V K G A K S + E+ EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 384 QINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+I H +I+ L E + V L+ E + G L + +K+ L E++
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL-------AEKESLTEDEA----- 110
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSRSVP 498
+ ++ V Y+HS I H D+K NI+L DK K+ DFG + +
Sbjct: 111 ----TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
GT + PE ++D++S GV+ LL+G P
Sbjct: 164 AGNE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----------- 210
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELA----MGCLRLNSKKRPTMKQV 613
F+ K+ L I + EE +ELA L + K+R T+ Q
Sbjct: 211 ----FLGETKQETLTNISAVNY--DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 50/296 (16%)
Query: 331 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQIN 386
+ Y S+ LG+G F V + + G A K + + + + ++E+ +L
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 387 HR-HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
++ L E + L+ EY G + + E+ E ++ L
Sbjct: 87 SCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRL--- 136
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDK 501
++ E V Y+H + I H D+K NILL + K+ DFG SR + +
Sbjct: 137 --IKQILE---GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
L + GT Y PE T +D+++ G++ LLT P
Sbjct: 189 E-LREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-------------- 232
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELA----MGCLRLNSKKRPTMKQV 613
F+ + L I V + SEE +V++LA L N +KRPT +
Sbjct: 233 -FVGEDNQETYLNISQVNV--DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 67/305 (21%), Positives = 107/305 (35%), Gaps = 63/305 (20%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSKAIDKTQIEQFINEVVI 381
D Y S+ LG G G V VA+K A + E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
L ++NH I+K+ + E +V E + G L + +++ +E
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE-------------- 113
Query: 442 SWENRVRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTS 494
+ AV Y+H + I HRD+K N+LL + K++DFG S
Sbjct: 114 ------ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLT 551
+ + + T GT Y PE S Y D +S GV+L L+G P
Sbjct: 165 KILGETSL-MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 218
Query: 552 REEEERNLVAYFISLAKENKLLE-ILDARVAKEASE-EDI-EAVAELAMGCLRLNSKKRP 608
F + L + I + ++ E +L L ++ K R
Sbjct: 219 -----------FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267
Query: 609 TMKQV 613
T ++
Sbjct: 268 TTEEA 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 68/302 (22%), Positives = 106/302 (35%), Gaps = 61/302 (20%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ---------IEQFINEVV 380
D Y+ LG G F V K G A K I K + E EV
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVS 66
Query: 381 ILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
IL +I H +++ L E + V L+ E + G L + + + E++
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEA--------- 116
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSR 495
++ V Y+HS I H D+K NI+L D+ K+ DFG +
Sbjct: 117 -------TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 496 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
+ GT + PE ++D++S GV+ LL+G P
Sbjct: 167 KIDFGNE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------- 216
Query: 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELA----MGCLRLNSKKRPTMK 611
F+ K+ L + E +E + LA L + KKR T++
Sbjct: 217 -------FLGDTKQETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 267
Query: 612 QV 613
Sbjct: 268 DS 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 70/299 (23%), Positives = 111/299 (37%), Gaps = 55/299 (18%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKAIDKTQIEQFINEVVILS 383
D Y+ LG G F V K G A K + E+ EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 384 QINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
Q+ H +++ L E V L+ E + G L + ++E E+E +S
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL--------AQKESLSEEEATSF- 120
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSRSVP 498
++ + V Y+H+ I H D+K NI+L DK K+ DFG + +
Sbjct: 121 ----IKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
+ GT + PE ++D++S GV+ LL+G P
Sbjct: 171 DGVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----------- 217
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAM----GCLRLNSKKRPTMKQV 613
F+ K+ L I + EE +ELA L ++KR T+++
Sbjct: 218 ----FLGDTKQETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINHR 388
Y LG+G FG V VA+K R + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 389 HIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
HI+KL + T + +V EY G L +I + ++ E E R
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEY-AGGELFDYIVEKKRMTED---------------EGR- 111
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
R ++ A+ Y H I HRD+K N+LLDD + K++DFG S ++ D L T+
Sbjct: 112 RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS 167
Query: 508 VQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 547
G+ Y PE Y + DV+S G+VL +L G+ P
Sbjct: 168 C-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 78/308 (25%), Positives = 122/308 (39%), Gaps = 50/308 (16%)
Query: 331 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ---IEQFINEVVILSQI 385
D Y Q LG+G V + L AVK I+K + EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQC 67
Query: 386 -NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
HR++++L+ E E LV+E + G++ HIH + E +
Sbjct: 68 QGHRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA------------- 113
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSV--- 497
V +VA A+ ++H+ I HRD+K NIL + K+ DF +
Sbjct: 114 ---SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 498 ----PNDKTHLTTAVQGTFGYFDPE-----YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
P L T G+ Y PE ++S Y + D++S GV+L LL+G P
Sbjct: 168 GDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
Query: 549 CLTREEEERNLVAYFISLAKENKLLE-ILDARVAKEASE-EDI-EAVAELAMGCLRLNSK 605
+ R + A +N L E I + + + I A +L L ++K
Sbjct: 227 -VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 606 KRPTMKQV 613
+R + QV
Sbjct: 286 QRLSAAQV 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 40/231 (17%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN-------EVVILSQ 384
Y LG+G +G V + + AVK + K ++ + N E+ +L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 385 INHRHIVKLLG-CCLETEVPV-LVYEYICNGN--LSHHIHDHQQQQEQKQELEEEQELSS 440
+ H+++++L+ E + + +V EY G + + ++
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--------PEKRFPV------ 108
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN- 499
+ C++ + Y+HS I H+DIK N+LL + K+S G + ++
Sbjct: 109 --CQAH-GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 500 -DKTHLTTAVQGTFGYFDPEYFQSSQYTD--KSDVYSFGVVLLELLTGKKP 547
T+ QG+ + PE K D++S GV L + TG P
Sbjct: 163 AADDTCRTS-QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 61/236 (25%), Positives = 90/236 (38%), Gaps = 44/236 (18%)
Query: 325 EELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQI--EQFINEVVI 381
+ +D Y+ + +G G FG +VAVK I++ E E++
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIIN 69
Query: 382 LSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE----- 435
+ H +IV+ + T + ++ EY G L I E+
Sbjct: 70 HRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERI-------CNAGRFSEDEARFF 121
Query: 436 -QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFG 492
Q+L S V+Y HS I HRD+K N LLD + K+ DFG
Sbjct: 122 FQQLLS---------------GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 547
S+S + V GT Y PE +Y +DV+S GV L +L G P
Sbjct: 164 YSKSSVLHS-QPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 47/238 (19%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSKAIDKTQIEQFINEVVI 381
Y+ +G+G V + + G AVK S + E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 382 LSQI-NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
L Q+ H HI+ L+ E+ + LV++ + G L ++ +K L E
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYL-------TEKVALSE----- 199
Query: 440 SLSWENRVRVACEV----AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
+ + AV+++H++ I HRD+K NILLDD ++SDFG S
Sbjct: 200 --------KETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 496 SVPNDKTHLTTAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ + L GT GY PE Y + D+++ GV+L LL G P
Sbjct: 249 HLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 70/298 (23%), Positives = 110/298 (36%), Gaps = 53/298 (17%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKAIDKTQIEQFINEVVILS 383
D Y+ LG G F V K G A K + E+ EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 384 QINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
Q+ H +I+ L VL+ E + G L + ++E E+E +S
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--------AQKESLSEEEATSF-- 120
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSRSVPN 499
++ + V Y+H+ I H D+K NI+L DK K+ DFG + + +
Sbjct: 121 ---IKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
GT + PE ++D++S GV+ LL+G P
Sbjct: 172 GVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------------ 217
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELA----MGCLRLNSKKRPTMKQV 613
F+ K+ L I + EE +ELA L ++KR T+++
Sbjct: 218 ---FLGDTKQETLANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 338 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
R +G+G FG V D + A+K + K +++ ++ E+ I+ + H +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 452
+ E +V + + G+L +H+ QQ + E V++ CE
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFK------------EETVKLFICE 123
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 512
+ A+ Y+ + I HRD+K NILLD+ ++DF + +P + T A GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTK 178
Query: 513 GYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKP 547
Y PE F S + Y+ D +S GV ELL G++P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKA--IDKTQIEQFINEVVILSQIN- 386
++++ R +G+GGFG VY D G + A+K K K +NE ++LS ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 387 --HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
IV + T + + + + G+L +H+ H E
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---------------- 291
Query: 444 ENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
+R A E+ + +MH+ + +RD+K +NILLD+ ++SD G + K
Sbjct: 292 -ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 503 HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKP 547
H +V GT GY PE Q Y +D +S G +L +LL G P
Sbjct: 348 H--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 48/295 (16%)
Query: 331 TDNYNQSR-FLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NH 387
TD+Y S+ LG G G V + G A+K + + + EV Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYDSPKAR--QEVDHHWQASGG 81
Query: 388 RHIVKLLGCCLETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
HIV +L ++ E + G L I QE+ + E+E + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI------QERGDQAFTEREAAEI-- 133
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPND 500
+R ++ A+ ++HS I HRD+K N+L K K++DFG ++ +
Sbjct: 134 ---MR---DIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
L T T Y PE +Y D++S GV++ LL G P + +
Sbjct: 185 A--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
Query: 561 AYFISLAKENKLLEILDARVAKEASE-EDI-EAVAELAMGCLRLNSKKRPTMKQV 613
I + E ++ E +L L+ + +R T+ Q
Sbjct: 242 -----------KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 332 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ 384
++Y + +G+G FG V K + A+K SK I ++ F E I++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
N +V+L + +V EY+ G+L + + ++ E+
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--------SNYDVPEK--------- 168
Query: 445 NRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
R EV A+ +HS + HRD+K N+LLD K++DFGT + +
Sbjct: 169 -WARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 504 LTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 70/300 (23%), Positives = 114/300 (38%), Gaps = 57/300 (19%)
Query: 331 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NH 387
D+Y S+ LG G G V + A+K + + EV + +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM---LQD--CPKARREVELHWRASQC 114
Query: 388 RHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
HIV+++ E +V E + G L I Q++ + E+E S +
Sbjct: 115 PHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREASEI- 166
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPN 499
++ + A+ Y+HS I I HRD+K N+L K K++DFG ++ +
Sbjct: 167 ----MK---SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
+ LTT T Y PE +Y D++S GV++ LL G P
Sbjct: 217 HNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP------------ 262
Query: 560 VAYFIS---LAKENKLLE-ILDARVAKEASE-EDI-EAVAELAMGCLRLNSKKRPTMKQV 613
F S LA + I + E ++ E V L L+ +R T+ +
Sbjct: 263 ---FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 41/247 (16%)
Query: 318 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKA--IDKT 370
+ + +E++ D++ + +G+G F V K G + A+K +K + +
Sbjct: 47 EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRG 103
Query: 371 QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQK 429
++ F E +L + R I +L + E + LV EY G+L + K
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--------SK 154
Query: 430 QELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488
+ + R E+ A+ +H HRDIK NILLD ++
Sbjct: 155 ----FGERIP----AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL 203
Query: 489 SDFGTS-RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVY-------SFGVVLLE 540
+DFG+ + + AV GT Y PE Q+ + Y + GV E
Sbjct: 204 ADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 541 LLTGKKP 547
+ G+ P
Sbjct: 263 MFYGQTP 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 33/275 (12%), Positives = 74/275 (26%), Gaps = 67/275 (24%)
Query: 340 LGQGGFGTVYKGMLPD---GSIVAVK---RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
G ++ + D VA+ + +++ ++ + LS+I+ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
L ++V E+I G+L S +R +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS------------------PSPVGAIRAMQSL 138
Query: 454 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 513
A A H + + S + + ++ T
Sbjct: 139 AAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------- 179
Query: 514 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 573
+P+ D+ G L LL + P L L A +
Sbjct: 180 --NPQ----------DDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEP 225
Query: 574 EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608
+D + ++ +A ++ + R
Sbjct: 226 ADIDRDIP--------FQISAVAARSVQGDGGIRS 252
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 59/247 (23%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 317 EKAKIFTAE--ELQRATDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKA--I 367
E AK FT++ +++ +++ + +G+G FG V K + A+K +K +
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEML 113
Query: 368 DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQ 426
+ + F E +L + + I L + + + LV +Y G+L + +
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL----SKF 168
Query: 427 EQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485
E + E R E+ A+ +H HRDIK NIL+D
Sbjct: 169 EDRLP------------EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213
Query: 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLE 540
+++DFG+ + D T ++ GT Y PE Q+ + Y + D +S GV + E
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 541 LLTGKKP 547
+L G+ P
Sbjct: 274 MLYGETP 280
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 47/239 (19%)
Query: 324 AEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN----- 377
A +++ Y + FLG+G F TVYK IVA+K+ K +++ + IN
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQ-------KQ 430
E+ +L +++H +I+ LL LV+++ +L I D+
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 431 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490
L+ + Y+H I HRD+K +N+LLD+ K++D
Sbjct: 121 TLQ----------------------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLAD 155
Query: 491 FGTSR--SVPNDK-THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
FG ++ PN TH V T Y PE F + Y D+++ G +L ELL
Sbjct: 156 FGLAKSFGSPNRAYTHQ--VV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 55/248 (22%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQ----------------- 371
Y +G+G +G V D + A+K + K I +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 372 ------IEQFINEVVILSQINHRHIVKL---LGCCLETEVPVLVYEYICNGNLSHHIHDH 422
IEQ E+ IL +++H ++VKL L E + +V+E + G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVP--- 129
Query: 423 QQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482
+ L E+Q ++ + Y+H I HRDIK SN+L+ +
Sbjct: 130 -----TLKPLSEDQA---------RFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGE 172
Query: 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YT-DKSDVYSFGVVLL 539
K++DFG S L+ V GT + PE ++ ++ DV++ GV L
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 540 ELLTGKKP 547
+ G+ P
Sbjct: 232 CFVFGQCP 239
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 49/234 (20%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQF--------INEV 379
Q + Y + +G+G +G VYK G IVA+K + +++ I E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK------RIRLDAEDEGIPSTAIREI 70
Query: 380 VILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQ-------KQEL 432
+L +++H +IV L+ LV+E+ +L + +++ + Q L
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEF-MEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
VA+ H I HRD+K N+L++ + K++DFG
Sbjct: 130 R----------------------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG 164
Query: 493 TSRSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
+R+ T V T Y P+ S +Y+ D++S G + E++TGK
Sbjct: 165 LARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 48/234 (20%), Positives = 95/234 (40%), Gaps = 50/234 (21%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF--------INEVVIL 382
Y + +G+G +GTV+K IVA+K + +++ + E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK------RVRLDDDDEGVPSSALREICLL 55
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQ-------KQELEEE 435
++ H++IV+L + LV+E+ C+ +L + + Q L+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLK-- 112
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
+ + HS + HRD+K N+L++ K+++FG +R
Sbjct: 113 --------------------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
Query: 496 SVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+ + V T Y P+ F + Y+ D++S G + EL +P+
Sbjct: 150 AFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 35/243 (14%)
Query: 323 TAEELQRATDNYNQSRF-LGQGGFGTVYKGM---LPDGSIVAVKRSKA--IDKTQIEQFI 376
+ E +R D + +G+G +G VYK D A+K+ + I +
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR--- 67
Query: 377 NEVVILSQINHRHIVKLLGCCLE-TEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELE- 433
E+ +L ++ H +++ L L + V L+++Y +L H I H+ + K+ ++
Sbjct: 68 -EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQL 125
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVS 489
+ SL ++ + + Y+H++ + HRD+K +NIL+ + K++
Sbjct: 126 PRGMVKSLLYQ--------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174
Query: 490 DFGTSR--SVPNDK-THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
D G +R + P L V TF Y PE + YT D+++ G + ELLT
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-S 232
Query: 546 KPI 548
+PI
Sbjct: 233 EPI 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ 384
D +++ + LG G FG V ML G+ A+K K + QIE +NE IL
Sbjct: 41 DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
+N +VKL + +V EY+ G + H L S E
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH-------------LRRIGRFS----E 140
Query: 445 NRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
R A ++ Y+HS + +RD+K N+L+D + +V+DFG ++ V
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T + GT PE S Y D ++ GV++ E+ G P
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 48/235 (20%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFIN-EVVILSQINHR 388
+Y ++ +G G FG VY+ L G +VA+K+ Q ++F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHC 107
Query: 389 HIVKLLGCCLET-----EVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE------- 435
+IV+L + EV + LV +Y+ + + + KQ L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRA---KQTLPVIYVKLYMY 163
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTS 494
Q SL AY+HS I HRDIK N+LLD D K+ DFG++
Sbjct: 164 QLFRSL----------------AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
+ + + + + + Y PE F ++ YT DV+S G VL ELL G +PI
Sbjct: 205 KQLVRGEP-NVSYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKA--IDKTQIEQFINEVVILSQINH 387
+ + + LG+G FG V G A+K K + K ++ + E +L H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 388 RHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+ L +T + V EY G L H+ +E+ E+R
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFS------------EDR 249
Query: 447 VRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHL 504
R E+ A+ Y+HS ++ +RD+K N++LD K++DFG + + + T
Sbjct: 250 ARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 305
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 46/238 (19%)
Query: 324 AEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFIN-EVVIL 382
+ ++ Y + +G G FG V++ L + VA+K+ Q ++F N E+ I+
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIM 86
Query: 383 SQINHRHIVKLLGCCLET-----EVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE- 435
+ H ++V L EV + LV EY+ + + + KQ +
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAK---LKQTMPMLL 142
Query: 436 ------QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKV 488
Q L SL AY+HS I HRDIK N+LLD K+
Sbjct: 143 IKLYMYQLLRSL----------------AYIHSIG---ICHRDIKPQNLLLDPPSGVLKL 183
Query: 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
DFG+++ + + +++ + Y PE F ++ YT D++S G V+ EL+ G+
Sbjct: 184 IDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 330 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF----INEVVILSQ 384
++ + Q LG G + TVYKG+ G VA+K K +D E I E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSE--EGTPSTAIREISLMKE 59
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
+ H +IV+L LV+E+ + +L ++ D + + LE + W+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEF-MDNDLKKYM-DSRTVGNTPRGLELN-LVKYFQWQ 116
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKT 502
+ +A+ H + I HRD+K N+L++ + K+ DFG +R +P +
Sbjct: 117 -----LLQ---GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT- 164
Query: 503 HLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
++ V T Y P+ S Y+ D++S G +L E++TGK
Sbjct: 165 -FSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQF----INEVVILSQINH 387
+ Y+ +G+G +G VYK G A+K+ + ++K E I E+ IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKED-EGIPSTTIREISILKELKH 59
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQ---QQEQKQELEEEQELSSLSWE 444
+IVKL + VLV+E+ + +L + + K L Q L+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEH-LDQDLKKLLDVCEGGLESVTAKSFLL--QLLN----- 111
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+AY H + HRD+K N+L++ + K++DFG +R+
Sbjct: 112 -----------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 505 TTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
T + T Y P+ S +Y+ D++S G + E++ G
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 47/229 (20%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQF----INEVVILSQIN 386
+ Y + LG+G + TVYKG ++VA+K + + E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQ-------KQELEEEQELS 439
H +IV L + LV+EY + +L ++ D Q L
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNIINMHNVKLFLFQLLR------ 111
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SV 497
+AY H + HRD+K N+L++++ K++DFG +R S+
Sbjct: 112 ----------------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152
Query: 498 PNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
P V T Y P+ S+ Y+ + D++ G + E+ TG+
Sbjct: 153 PTKT--YDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK------AIDKTQIEQFINEVVILSQ 384
+ Y + +G+G +G V+K G IVA+K+ I K + E+ +L Q
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
+ H ++V LL LV+EY C+ + H + ++ Q E + S++W+
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHEL-------DRYQRGVPEHLVKSITWQ 110
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
AV + H HRD+K NIL+ K+ DFG +R + +
Sbjct: 111 --------TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159
Query: 505 TTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
V T Y PE +QY DV++ G V ELL+G
Sbjct: 160 DDEVA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 340 LGQGGFGTVY---KGMLPD-GSIVAVK--RSKAI--DKTQIEQFINEVVILSQINHRHIV 391
LG+GG+G V+ K + G I A+K + I + E IL ++ H IV
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 449
L+ +T + L+ EY+ G L + ++E E+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQL-----EREGIFM------------EDTACFY 126
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAV 508
E++ A+ ++H I +RD+K NI+L+ + K++DFG + S+ + T
Sbjct: 127 LAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTF 181
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE S + D +S G ++ ++LTG P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 32/217 (14%)
Query: 340 LGQGGFGTVY---KGMLPD-GSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKL 393
LGQG FG V+ K D + A+K + + + E IL ++NH IVKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 394 LGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 451
+TE + L+ +++ G+L + +E E V+
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFT------------EEDVKFYLA 133
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQG 510
E+A A+ ++HS I +RD+K NILLD++ K++DFG S+ S+ ++K + G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T Y PE +T +D +SFGV++ E+LTG P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ 384
++ R LG G FG V L +G A+K K + Q+E +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
+ H I+++ G + + ++ +YI G L + ++ Q+
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-----RKSQRFP------------N 105
Query: 445 NRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 503
+ A EV A+ Y+HS I +RD+K NILLD K++DFG ++ VP D T+
Sbjct: 106 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY 161
Query: 504 LTTAVQGTF-G---YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T G Y PE + Y D +SFG+++ E+L G P
Sbjct: 162 -------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 38/233 (16%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-AIDKTQIEQF----INEVVIL 382
AT Y +G G +GTVYK G VA+K + + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 383 SQIN---HRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
++ H ++V+L+ C + LV+E+ + +L ++ L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPG-----LPA 119
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
E + L + + ++H++ I HRD+K NIL+ + K++DFG +
Sbjct: 120 ET-IKDLMRQ--------FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 495 R--SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
R S T + T Y PE S Y D++S G + E+ K
Sbjct: 168 RIYSYQMALTPVVV----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 49/253 (19%)
Query: 319 AKIFTAEELQ--RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF 375
AK + + E Y + +GQG FG V+K G VA+K+ ++ + E F
Sbjct: 2 AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEK-EGF 59
Query: 376 ----INEVVILSQINHRHIVKLLGCCLETEVPV--------LVYEYICNGNLSHHIHDHQ 423
+ E+ IL + H ++V L+ C P LV+++ C +L+ + +
Sbjct: 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVL 118
Query: 424 QQQEQKQELEEEQELSSLSWENRVRVAC---EVAGAVAYMHSSASIPIFHRDIKSSNILL 480
+ + + + + Y+H + I HRD+K++N+L+
Sbjct: 119 VKFTLSE------------------IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 157
Query: 481 DDKFSAKVSDFGTSRS----VPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFG 535
K++DFG +R+ + T V T Y PE Y D++ G
Sbjct: 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 536 VVLLELLTGKKPI 548
++ E+ T + PI
Sbjct: 217 CIMAEMWT-RSPI 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 50/236 (21%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQF--------INEV 379
+ D Y + LG+G +G VYK + VA+K + ++E I EV
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK------RIRLEHEEEGVPGTAIREV 84
Query: 380 VILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQ--QQEQKQELEEEQE 437
+L ++ HR+I++L L++EY +L ++ + + K L Q
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFL--YQL 141
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-----KVSDFG 492
++ V + HS HRD+K N+LL ++ K+ DFG
Sbjct: 142 IN----------------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
Query: 493 TSR--SVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
+R +P + T + T Y PE S Y+ D++S + E+L
Sbjct: 183 LARAFGIPIRQ--FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 36/227 (15%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK------AIDKTQIEQFINEVVI 381
++ + Y +G+G +G V K G IVA+K+ + K + E+ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 382 LSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
L Q+ H ++V LL C + + LV+E+ + + + + Q +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEF-VDHTILDDLELFPNGLD-------YQVVQKY 129
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPN 499
++ + + + HS I HRDIK NIL+ K+ DFG +R + P
Sbjct: 130 LFQ--------IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 500 DKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
+ V T Y PE +Y DV++ G ++ E+ G+
Sbjct: 179 EV--YDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 40/233 (17%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSKAIDKTQIEQF----INEVVIL 382
RA Y +G+G +G V+K + G VA+KR + + + E I EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGE-EGMPLSTIREVAVL 65
Query: 383 SQIN---HRHIVKLLGCCLETEVP-----VLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
+ H ++V+L C + LV+E+ + +L+ ++ +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKV------PEPGVP 118
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
+ + + ++ + + ++HS + HRD+K NIL+ K++DFG +
Sbjct: 119 TETIKDMMFQ--------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 495 R--SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
R S T + T Y PE S Y D++S G + E+ K
Sbjct: 168 RIYSFQMALTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKAIDKTQIEQFINEVVILSQ 384
++++ + LG+G FG V +L G A+K + I K ++ + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 385 INHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
H + L +T + V EY G L H+ +E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFT------------ 103
Query: 444 ENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDK 501
E R R E+ A+ Y+HS + +RDIK N++LD K++DFG + + +
Sbjct: 104 EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T GT Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 52/240 (21%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKAIDKTQIEQFINEVVILSQ 384
++ D + R GQG FGTV G G VA+K+ + + Q + + L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD---LAV 75
Query: 385 INHRHIVKLLGCCLETEVP-------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEE-- 435
++H +IV+L +V EY+ L ++ ++ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR---QVAPPPILI 131
Query: 436 -----QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVS 489
Q + S+ +H S+ + HRDIK N+L++ + K+
Sbjct: 132 KVFLFQLIRSI----------------GCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
DFG+++ + + ++ + Y PE F + YT D++S G + E++ G +PI
Sbjct: 175 DFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 332 DNYNQSRFLGQGGFGTVY---KGMLPD-GSIVAVK--RSKAI--DKTQIEQFINEVVILS 383
+N+ + LG G +G V+ K D G + A+K + I E E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 384 QINHRH-IVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
I +V L +TE + L+ +YI G L H+ Q ++
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-----SQRERFT---------- 157
Query: 442 SWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 500
E+ V++ E+ A+ ++H I +RDIK NILLD ++DFG S+ D
Sbjct: 158 --EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQY-TDKS-DVYSFGVVLLELLTGKKP 547
+T GT Y P+ + DK+ D +S GV++ ELLTG P
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 61/250 (24%), Positives = 105/250 (42%), Gaps = 57/250 (22%)
Query: 314 GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKA 366
G+ + + +++ R +G+G + V +L I A+K +
Sbjct: 1 GAMDPLGL----------QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELV 47
Query: 367 IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQ 424
D I+ E + Q NH +V L C +TE + V EY+ G+L H+
Sbjct: 48 NDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM----- 101
Query: 425 QQEQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483
Q+++K E R + E++ A+ Y+H I +RD+K N+LLD +
Sbjct: 102 QRQRKLP------------EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE 146
Query: 484 FSAKVSDFGTSRS--VPNDKTHLTTAVQGTF-G---YFDPEYFQSSQYTDKSDVYSFGVV 537
K++D+G + P D T TF G Y PE + Y D ++ GV+
Sbjct: 147 GHIKLTDYGMCKEGLRPGDTTS-------TFCGTPNYIAPEILRGEDYGFSVDWWALGVL 199
Query: 538 LLELLTGKKP 547
+ E++ G+ P
Sbjct: 200 MFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 340 LGQGGFGTVYKGML----PDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ-INHRHIV 391
+G+G FG V +L + AVK K + K + + ++E +L + + H +V
Sbjct: 46 IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 449
L +T + V +YI G L +H+ Q+E+ E R R
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHL-----QRERCFL------------EPRARFY 144
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS-RSVPNDKTHLTTAV 508
A E+A A+ Y+HS I +RD+K NILLD + ++DFG ++ ++ T T+
Sbjct: 145 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTF 199
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE Y D + G VL E+L G P
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 47/231 (20%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHR 388
D+Y R LG+G + V++ + + + V VK K + K +I E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91
Query: 389 HIVKLLGCCL--ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEE-------QELS 439
+I+ L + P LV+E++ N + Q L + + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILK 141
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVP 498
A+ Y HS I HRD+K N+++D + ++ D+G +
Sbjct: 142 ----------------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 499 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPI 548
+ V + + PE Q D S D++S G +L ++ K+P
Sbjct: 183 PGQE-YNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 72/249 (28%), Positives = 109/249 (43%), Gaps = 41/249 (16%)
Query: 314 GSSEKAKIFTAEELQRAT----DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVK--- 362
G E +K + + DN+ R LG+G FG V K G + AVK
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLK 57
Query: 363 RSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIH 420
+ + +E + E ILS NH + +L CC +T + V E++ G+L HI
Sbjct: 58 KDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI- 115
Query: 421 DHQQQQEQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479
Q+ ++ + E R R A E+ A+ ++H I +RD+K N+L
Sbjct: 116 ----QKSRRFD------------EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVL 156
Query: 480 LDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVL 538
LD + K++DFG + + N T T GT Y PE Q Y D ++ GV+L
Sbjct: 157 LDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 539 LELLTGKKP 547
E+L G P
Sbjct: 215 YEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 47/224 (20%)
Query: 340 LGQGGFGTVY----KGMLPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQI-NHRHIV 391
+G+G + V K I A++ + D I+ E + Q NH +V
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 449
L C +TE + V EY+ G+L H+ Q+++K E R
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLP------------EEHARFY 158
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTA 507
+ E++ A+ Y+H I +RD+K N+LLD + K++D+G + P D T
Sbjct: 159 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---- 211
Query: 508 VQGTF-G---YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
TF G Y PE + Y D ++ GV++ E++ G+ P
Sbjct: 212 ---TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 53/247 (21%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFIN-EVVILSQINHR 388
+ Y+ + LG G FG V + + G A+K+ Q ++ N E+ I+ ++H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKVLDHV 60
Query: 389 HIVKLLGC---CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQEL------- 438
+I+KL+ + E N + + + + + L
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 439 -SSLSWENRVRVACEVAG-----------------AVAYMHSSASIPIFHRDIKSSNILL 480
+L +V + +G AV ++HS I HRDIK N+L+
Sbjct: 121 PDTLH---KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLV 174
Query: 481 D-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVL 538
+ + K+ DFG+++ + + + + Y PE +++YT D++S G V
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 539 LELLTGK 545
EL+ GK
Sbjct: 233 GELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 332 DNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ 384
++N LG+G FG V KG + AVK K I +E + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 385 I-NHRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+ +L C +T + V EY+ G+L +HI QQ + +
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFK----------- 119
Query: 443 WENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPND 500
E A E+A + ++ S I +RD+K N++LD + K++DFG + ++ +
Sbjct: 120 -EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T T GT Y PE Y D ++FGV+L E+L G+ P
Sbjct: 176 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 64/351 (18%), Positives = 126/351 (35%), Gaps = 104/351 (29%)
Query: 332 DNYNQSRF-----LGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILS 383
+ Y +R+ LG G F TV+ + + + VA+K R K E +E+ +L
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQ 70
Query: 384 QIN-----------HRHIVKLLGC-----------CLETEVPVLVYEYICNGNLSHHIHD 421
++N HI+KLL + EV L ++
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV------------LGENLLA 118
Query: 422 HQQQQEQKQELEEEQELSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480
++ E + + V+ ++ ++ + YMH I I H DIK N+L+
Sbjct: 119 LIKKYEH-------RGIPL----IYVKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLM 165
Query: 481 DD------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 534
+ K++D G + H T ++Q Y PE + + +D++S
Sbjct: 166 EIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTRE-YRSPEVLLGAPWGCGADIWST 221
Query: 535 GVVLLELLTGK------KPICLTREEE---------------------------ERNLVA 561
++ EL+TG + T++++ +
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 281
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
IS K L ++L + S+++ + +++ L+L+ +KR
Sbjct: 282 RNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 8e-18
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSK---AIDKTQIEQFINEVVILSQIN- 386
++N LG+G FG V + AVK K I +E + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 387 HRHIVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
+ +L C +T + V EY+ G+L +HI QQ + + E
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFK------------EP 442
Query: 446 RVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTH 503
A E+A + ++ S I +RD+K N++LD + K++DFG + ++ + T
Sbjct: 443 HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT- 498
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
T GT Y PE Y D ++FGV+L E+L G+ P
Sbjct: 499 -TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 52/239 (21%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKAIDKTQIEQFIN---------EV 379
Y RF+ G +G V G+ +G VA+KR + D + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 380 VILSQINHRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
+L+ +H +I+ L + E P LV E + +L+ IHD + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRI------VISP 133
Query: 435 E-------QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487
+ L L +H + + HRD+ NILL D
Sbjct: 134 QHIQYFMYHILLGL----------------HVLHEAG---VVHRDLHPGNILLADNNDIT 174
Query: 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
+ DF +R D + T V Y PE Q +T D++S G V+ E+ K
Sbjct: 175 ICDFNLAREDTAD-ANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 340 LGQGGFGTV----YKGMLPDGSIVAVKR-SKA--IDKTQIEQFINEVVILSQ-INHRHIV 391
LG+G FG V +K A+K K + +E + E +LS H +
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 449
+ C +T+ + V EY+ G+L +HI Q K + +R
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFD------------LSRATFY 123
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAV 508
A E+ + ++HS I +RD+K NILLD K++DFG + ++ D T
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTF 178
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
GT Y PE +Y D +SFGV+L E+L G+ P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 60/296 (20%), Positives = 98/296 (33%), Gaps = 77/296 (26%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIV 391
S+ LG G G V + A+K + + EV + + HIV
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD--CPKARREVELHWRASQCPHIV 74
Query: 392 KLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+++ E +V E + G L I Q++ + E+E S +
Sbjct: 75 RIVDVY-ENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREASEI----- 122
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDKTH 503
++ + A+ Y+HS I HRD+K N+L K K++DFG
Sbjct: 123 MK---SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG----------- 165
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
F E Y D++S GV++ LL G P F
Sbjct: 166 -----------FAKETTGEK-YDKSCDMWSLGVIMYILLCGYPP---------------F 198
Query: 564 IS---LAKENKLLE-ILDARVAKEASE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 613
S LA + I + E ++ L L+ +R T+ +
Sbjct: 199 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 47/231 (20%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFI-NEVVILSQINH 387
Y + +G G G V VA+K+ S+ + E+V++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 388 RHIVKLL-----GCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEE------ 435
++I+ LL LE V +V E + + NL I + EL+ E
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI---------QMELDHERMSYLL 133
Query: 436 -QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
Q L + ++HS+ I HRD+K SNI++ + K+ DFG +
Sbjct: 134 YQMLC----------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
R+ +T V T Y PE Y + D++S G ++ E++ G
Sbjct: 175 RTAGTS-FMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFI-NEVVILSQINH 387
Y + +G G G V VA+K+ S+ + E+V++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 388 RHIVKLL-----GCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSL 441
++I+ LL LE V LV E + + NL I + EL+ E
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI---------QMELDHE------ 164
Query: 442 SWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 500
R+ + ++ + ++HS+ I HRD+K SNI++ + K+ DFG +R+
Sbjct: 165 ----RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
+T V T Y PE Y + D++S G ++ E++ K
Sbjct: 218 -FMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 55/258 (21%), Positives = 97/258 (37%), Gaps = 51/258 (19%)
Query: 307 QQRLSSCGSSEKAKIF-TAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRS 364
+++ ++ + ++ Y ++G+G +G V + VA+K+
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 365 KAIDKTQIEQFI-NEVVILSQINHRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHH 418
+ Q E+ IL + H +I+ + + +V + + +L
Sbjct: 61 SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKL 119
Query: 419 IHDHQQQQEQKQELEEE-------QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR 471
+ Q L + Q L L Y+HS+ + HR
Sbjct: 120 LK--------TQHLSNDHICYFLYQILRGL----------------KYIHSAN---VLHR 152
Query: 472 DIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEY-FQSSQYTD 527
D+K SN+LL+ K+ DFG +R D H LT V T Y PE S YT
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTK 211
Query: 528 KSDVYSFGVVLLELLTGK 545
D++S G +L E+L+ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 50/235 (21%), Positives = 85/235 (36%), Gaps = 56/235 (23%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKAIDKTQIEQFINEVVILSQ 384
Y +G G +G+V + G VA+K+ I + E+++L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLLKH 79
Query: 385 INHRHIVKLLGCCLETEVPV------LVYEYICNGNLSHHIHDHQQQQEQKQELEEE--- 435
+ H +++ LL LV ++ +L + + EE
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---------GLKFSEEKIQ 129
Query: 436 ----QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491
Q L L Y+HS+ + HRD+K N+ +++ K+ DF
Sbjct: 130 YLVYQMLKGL----------------KYIHSAG---VVHRDLKPGNLAVNEDCELKILDF 170
Query: 492 GTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 545
G +R + T T Y PE Y D++S G ++ E+LTGK
Sbjct: 171 GLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 49/232 (21%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFI-NEVVILSQINH 387
Y + +G G +G V + G+ VA+K+ + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 388 RHIVKLLGCCLETEVPV------LVYEYICNGNLSHHIHDHQQQQEQKQELEEE------ 435
+++ LL E LV ++ +L + ++L E+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--------HEKLGEDRIQFLV 134
Query: 436 -QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
Q L L Y+H++ I HRD+K N+ +++ K+ DFG +
Sbjct: 135 YQMLKGL----------------RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
R ++ +T V T Y PE +YT D++S G ++ E++TGK
Sbjct: 176 RQADSE---MTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 52/239 (21%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFI-NEVVILSQINHR 388
+ ++ LG+G +G V P G IVA+K+ + DK E+ IL H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 389 HIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEEE-------Q 436
+I+ + ++ E + +L I Q L ++ Q
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI--------STQMLSDDHIQYFIYQ 120
Query: 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496
L AV +H S + HRD+K SN+L++ KV DFG +R
Sbjct: 121 TLR----------------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 497 VPNDKTHLTTAVQGTFG---------YFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 545
+ + G Y PE S++Y+ DV+S G +L EL +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 62/245 (25%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQIN 386
Y + LG GG G V+ + VA+K+ + + E+ I+ +++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLD 66
Query: 387 HRHIVKLL------GCCLETEVPV--------LVYEYICNGNLSHHIHDHQQQQEQKQEL 432
H +IVK+ G L +V +V EY+ +L++ + + L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE--------QGPL 117
Query: 433 EEE-------QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF- 484
EE Q L L Y+HS+ + HRD+K +N+ ++ +
Sbjct: 118 LEEHARLFMYQLLRGL----------------KYIHSAN---VLHRDLKPANLFINTEDL 158
Query: 485 SAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLE 540
K+ DFG +R + +H L+ + T Y P + YT D+++ G + E
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
Query: 541 LLTGK 545
+LTGK
Sbjct: 218 MLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 53/257 (20%), Positives = 88/257 (34%), Gaps = 70/257 (27%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKAIDKTQIEQFINEVVILSQ 384
DNY +G+G +G VY VA+K+ ID +I + E+ IL++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNR 81
Query: 385 INHRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEEE---- 435
+ +I++L + ++ +V E + +L L EE
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFK-------TPIFLTEEHIKT 133
Query: 436 ---QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
L ++H S I HRD+K +N LL+ S KV DFG
Sbjct: 134 ILYNLLL----------------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFG 174
Query: 493 TSRSVPNDKTHLTTAVQGTFGYFDP----------EY------------FQSSQYTDKSD 530
+R++ ++K P + YT D
Sbjct: 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234
Query: 531 VYSFGVVLLELLTGKKP 547
++S G + ELL +
Sbjct: 235 IWSTGCIFAELLNMLQS 251
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 54/246 (21%), Positives = 89/246 (36%), Gaps = 61/246 (24%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR---- 388
Y + +G+G FG V K VA+K + + Q E+ IL + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQAAEEIRILEHLRKQDKDN 157
Query: 389 --HIVKLLGC-------CLETEVPVL---VYEYICNGNLS----HHIHDHQQQQEQKQEL 432
+++ +L C+ E+ L +YE I +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFEL--LSMNLYELIKKNKFQGFSLPLVRKFAHS------- 208
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSD 490
+ + +H + I H D+K NILL + + KV D
Sbjct: 209 --------------------ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID 245
Query: 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 550
FG+S + T +Q F Y PE ++Y D++S G +L ELLTG P+
Sbjct: 246 FGSSCYEHQ---RVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLP 300
Query: 551 TREEEE 556
+E +
Sbjct: 301 GEDEGD 306
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 59/255 (23%)
Query: 315 SSEKAKIFTAEELQRA----TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----S 364
S++ F +EL + + Y +G G +G+V G VAVK+
Sbjct: 8 HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 365 KAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV------LVYEYICNGNLSHH 418
I + E+ +L + H +++ LL LV + +L++
Sbjct: 68 SIIHAKRT---YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI 123
Query: 419 IHDHQQQQEQKQELEEE-------QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR 471
+ Q+L ++ Q L L Y+HS+ I HR
Sbjct: 124 VK--------CQKLTDDHVQFLIYQILRGL----------------KYIHSAD---IIHR 156
Query: 472 DIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSD 530
D+K SN+ +++ K+ DFG +R ++ +T V T Y PE Y D
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVA-TRWYRAPEIMLNWMHYNQTVD 212
Query: 531 VYSFGVVLLELLTGK 545
++S G ++ ELLTG+
Sbjct: 213 IWSVGCIMAELLTGR 227
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 57/247 (23%), Positives = 92/247 (37%), Gaps = 55/247 (22%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR- 388
D Y +G+G FG V K + VA+K K Q EV +L +N
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHD 111
Query: 389 -----HIVKLLGC-------CLETEVPVL---VYEYI-CNGNLSHHIHDHQQQQEQKQEL 432
+IV L CL E+ L +Y+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEM--LSYNLYDLLRNTNFRGVSL------------- 156
Query: 433 EEEQELSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAKVS 489
N R A ++ A+ ++ + + I H D+K NILL + + K+
Sbjct: 157 ------------NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 549
DFG+S + + +Q F Y PE Y D++S G +L+E+ TG +P+
Sbjct: 204 DFGSSCQLGQ---RIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLF 258
Query: 550 LTREEEE 556
E +
Sbjct: 259 SGANEVD 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 72/382 (18%), Positives = 120/382 (31%), Gaps = 121/382 (31%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI---- 385
Y+ R LG G F TV+ + VA+K K+ + E ++E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSD 94
Query: 386 ----NHRHIVKLLGCCLETEVP-----VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQ 436
N +V+LL + +V+E L HH+ + +
Sbjct: 95 PNDPNREMVVQLLDD-FKISGVNGTHICMVFEV-----LGHHLLKWIIKSNYQ------- 141
Query: 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---------------- 480
L ++ +V + Y+H+ I H DIK NILL
Sbjct: 142 ---GLPLPCVKKIIQQVLQGLDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 481 ---------------------------------DDKFSAKVSDFGTSRSVPNDKTHLTTA 507
+K K++D G + V H T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTED 253
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK---KPICLTREEEERNLVA--- 561
+Q T Y E S Y +D++S + EL TG +P + + +A
Sbjct: 254 IQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 562 -------------------YF--------ISLAKENKLLEILDARVAKEASEEDIEAVAE 594
+F I+ K L E+L + E S+E+ +
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTD 370
Query: 595 LAMGCLRLNSKKRPTMKQVSMD 616
+ L L +KR T +
Sbjct: 371 FLLPMLELIPEKRATAAECLRH 392
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 56/269 (20%), Positives = 91/269 (33%), Gaps = 75/269 (27%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKAIDKTQIEQFINEVVILSQ 384
D Y +G G +G V + + +VA+K+ ID +I + E+ IL++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108
Query: 385 INHRHIVKLLGCCLETEVPV-----LVYEYICNGNLSHHIHDHQQQQEQKQELEEE---- 435
+NH H+VK+L + +V +V E + + L E
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR-------TPVYLTELHIKT 160
Query: 436 ---QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
L V Y+HS+ I HRD+K +N L++ S KV DFG
Sbjct: 161 LLYNLLV----------------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFG 201
Query: 493 TSRSVPNDKTHLTTAVQGTFGYFDP---------------EY------------FQSSQY 525
+R+V + + + Y
Sbjct: 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261
Query: 526 TDKSDVYSFGVVLLELLTGKKPICLTREE 554
T+ DV+S G + ELL K +
Sbjct: 262 TEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 63/253 (24%), Positives = 101/253 (39%), Gaps = 70/253 (27%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKAIDKTQIEQFINEVVILSQ 384
Y + LG+G +G V+K + G +VAVK+ + D + E++IL++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64
Query: 385 IN-HRHIVKLLGCCLE---TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEE----- 435
++ H +IV LL +V LV++Y+ +L I LE
Sbjct: 65 LSGHENIVNLLNVLRADNDRDV-YLVFDYM-ETDLHAVIR--------ANILEPVHKQYV 114
Query: 436 --QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGT 493
Q + + Y+HS + HRD+K SNILL+ + KV+DFG
Sbjct: 115 VYQLIK----------------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155
Query: 494 SRSVPNDKTHLTTAVQGTFGYFDP---------EY------------FQSSQYTDKSDVY 532
SRS N + + +Y S++YT D++
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215
Query: 533 SFGVVLLELLTGK 545
S G +L E+L GK
Sbjct: 216 SLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (160), Expect = 9e-12
Identities = 36/270 (13%), Positives = 79/270 (29%), Gaps = 54/270 (20%)
Query: 310 LSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSKAI 367
+ C T+ + +G+G FG V++ + D + VA+K +
Sbjct: 2 MGECSQKG---PVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGP 56
Query: 368 DKTQ------IEQFINEVVILSQI---------NHRHIVKLLGCCL----ETEVPVLVYE 408
D E+ + E++I ++ + L + + ++
Sbjct: 57 DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
Query: 409 YICNGNLSHHIHDHQQQQEQK---QELE------EEQELSSLSWENRVRVACEVAGAVAY 459
+ + S + + +Q E E E+ S + ++ ++A
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176
Query: 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG------ 513
+S HRD+ N+LL K+ +S + +
Sbjct: 177 AEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS-TIPSCGLQVSIIDYTLSRLER 233
Query: 514 ---------YFDPEYFQSSQYTDKSDVYSF 534
D + F + D+Y
Sbjct: 234 DGIVVFCDVSMDEDLFT-GDGDYQFDIYRL 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 53/267 (19%), Positives = 90/267 (33%), Gaps = 79/267 (29%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM--LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR 388
+ Y LG+G FG V + + S VA+K + + K + E E+ +L +I +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARLEINVLKKIKEK 76
Query: 389 ------HIVKLLGC-------CLETEVPVL---VYEYICNGNLS----HHIHDHQQQQEQ 428
V + C+ E+ L +E++ N H+ Q
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFEL--LGKNTFEFLKENNFQPYPLPHVRHMAYQ--- 131
Query: 429 KQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-- 486
+ A+ ++H + + H D+K NIL +
Sbjct: 132 ------------------------LCHALRFLHENQ---LTHTDLKPENILFVNSEFETL 164
Query: 487 -----------------KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS 529
+V+DFG++ + + H TT V Y PE +
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHH-TTIVATRH-YRPPEVILELGWAQPC 220
Query: 530 DVYSFGVVLLELLTGKKPICLTREEEE 556
DV+S G +L E G + T E E
Sbjct: 221 DVWSIGCILFEYYRG-FTLFQTHENRE 246
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 63/266 (23%), Positives = 90/266 (33%), Gaps = 79/266 (29%)
Query: 334 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR---- 388
+ R +G G FG V + + AVK + I K E IL +I +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINN 95
Query: 389 -HIVKLLGC-------CLETEVPVL---VYEYIC-NGNLSHHIHDHQQQQEQKQELEEEQ 436
+IVK G CL E L +YE I N HI
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHI----------------- 136
Query: 437 ELSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--------- 486
++ E+ A+ Y+ + + H D+K NILLDD +
Sbjct: 137 --------EDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRV 185
Query: 487 ----------------KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSD 530
K+ DFG + H + + Y PE + + SD
Sbjct: 186 TDGKKIQIYRTKSTGIKLIDFGC--ATFKSDYH-GSIINTRQ-YRAPEVILNLGWDVSSD 241
Query: 531 VYSFGVVLLELLTGKKPICLTREEEE 556
++SFG VL EL TG + T E E
Sbjct: 242 MWSFGCVLAELYTG-SLLFRTHEHME 266
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 42/177 (23%), Positives = 68/177 (38%), Gaps = 26/177 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH-RH 389
+ Y R +G G FG +Y G + G VA+K KT+ Q E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
I + C E + V+V E L + D +K S + + +
Sbjct: 67 IPTIRWCGAEGDYNVMVMEL-----LGPSLEDLFNFCSRK-----------FSLKTVLLL 110
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGTSRSVPNDKTH 503
A ++ + Y+HS HRD+K N L+ + DFG ++ + +TH
Sbjct: 111 ADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 70/346 (20%), Positives = 123/346 (35%), Gaps = 103/346 (29%)
Query: 334 YNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR--- 388
Y LG+G FG V + G VAVK K +D+ E +E+ +L +N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPN 74
Query: 389 ---HIVKLLGC-------CLETEVPVL---VYEYIC-NGNLSHHIHDHQQQQEQKQELEE 434
V++L C+ E+ L Y++I NG L +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFEL--LGLSTYDFIKENGFLPFRL--------------- 117
Query: 435 EQELSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----------- 482
+ +R +A ++ +V ++HS + H D+K NIL
Sbjct: 118 ----------DHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 483 --------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 534
KV DFG++ +D+ H +T V Y PE + ++ DV+S
Sbjct: 165 KRDERTLINPDIKVVDFGSA--TYDDEHH-STLVSTRH-YRAPEVILALGWSQPCDVWSI 220
Query: 535 GVVLLELLTGKKPICLTREEEE-------------RNLVA------YFI---------SL 566
G +L+E G + T + +E ++++ YF S
Sbjct: 221 GCILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS 279
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
A + + + + E + +L L + KR T+++
Sbjct: 280 AGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 46/234 (19%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRH 389
+ + R +G G FG +Y G + VA+K KT+ Q + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
I + +E + VLV + L + D +K LS + + +
Sbjct: 65 IPNVRWFGVEGDYNVLVMDL-----LGPSLEDLFNFCSRK-----------LSLKTVLML 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK---VSDFGTSRS--VPNDKTHL 504
A ++ V ++HS + HRDIK N L+ A + DFG ++ + H+
Sbjct: 109 ADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 505 ----TTAVQGTFGYFDPEYFQSSQYTDKS-------DVYSFGVVLLELLTGKKP 547
+ GT Y +S T D+ S G VL+ L G P
Sbjct: 166 PYRENKNLTGTARY-------ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 4e-09
Identities = 97/652 (14%), Positives = 185/652 (28%), Gaps = 177/652 (27%)
Query: 7 YTYLSIWLMILCTFLHDLQQSNCQQTYLDNVQLDCYKSVSISKGY--LCNGPQKLCQS-- 62
Y Y I + F+ + +C+ D KS+ + + + +
Sbjct: 16 YQYKDILSVFEDAFVDNF---DCKDV------QDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 63 -FITFRSQPP------FNTPVSIAY--LLGS------DASIIVPVSCSCSGSLYQHNAPY 107
F T S+ + I Y L+ S++ + LY N +
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126
Query: 108 TIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNL------GSGLEVIVPLRC-ACPTA 160
Y + Y L QALL KN+ GSG + C +
Sbjct: 127 A-----KYNVSRLQPYLKLR--QALLELR--PAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177
Query: 161 KQIDNGVSYLLAYMATWGDTISSIGHKFGADK-----QSI---LDANKLSEDDLIFTFTP 212
++D + +L ++ + + Q + +D N S D
Sbjct: 178 CKMDFKIFWL------------NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN--- 222
Query: 213 LLIPLKSESCSANPEKFFC--QCKNGFLV-D-----EMLK--GLHCKPDGKKFPVKLVTL 262
I L+ S A + +N LV + L CK L+T
Sbjct: 223 --IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK--------ILLTT 272
Query: 263 LGLGIGLGFLSLVLLGCYLYKVIGAKRSRMLKEK----LFKQNGGYLLQ--QRLSS--CG 314
+ + L + S L L + YL Q L
Sbjct: 273 RFKQV-----TDFLSAATTTHISLDHHSMTLTPDEVKSLLLK---YLDCRPQDLPREVLT 324
Query: 315 SSEKA-KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRS-KAIDKTQI 372
++ + I AE ++ ++ +K + D ++ S ++ +
Sbjct: 325 TNPRRLSII-AESIRDGLATWDN------------WKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 373 EQFINEVVILSQINHRHI-VKLLG---CCLETEVPVLVYEYICNGNL--------SHHIH 420
+ + + + HI LL + ++V + +L + I
Sbjct: 372 RKMFDRLSVFP--PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 421 DHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIP-----IF-----H 470
E K +LE E L +R V + P + H
Sbjct: 430 S--IYLELKVKLENEYAL------HRSIVDH-YNIPKTFDSDDLIPPYLDQYFYSHIGHH 480
Query: 471 --------RDIKSSNILLDDKF-SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521
R + LD +F K+ T+ + + ++++
Sbjct: 481 LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ---------QLKFYK 531
Query: 522 SSQY-TDKSDVYSFGV-VLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
Y D Y V +L+ L + + + +L+ I+L E++
Sbjct: 532 --PYICDNDPKYERLVNAILDFLPKIEENLI--CSKYTDLLR--IALMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 5e-04
Identities = 48/351 (13%), Positives = 103/351 (29%), Gaps = 118/351 (33%)
Query: 321 IFTAEELQ---RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFIN 377
I + EE+ + D + + L F T+ SK + +++F+
Sbjct: 45 ILSKEEIDHIIMSKDAVSGTLRL----FWTL--------------LSK--QEEMVQKFVE 84
Query: 378 EVVILSQINHRHIV-KLLGCCLETEVPVLVYEY----ICNGNLS---HHIHDHQQQQEQK 429
EV+ +IN++ ++ + + + +Y + N N +++ Q + +
Sbjct: 85 EVL---RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141
Query: 430 QELEEEQELSSL----------SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479
Q L E + ++ +W VA +V K
Sbjct: 142 QALLELRPAKNVLIDGVLGSGKTW-----VALDVC----------------LSYK----- 175
Query: 480 LDDKFSAKVS--DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV 537
+ K K+ + S P + +Q DP + + +D S
Sbjct: 176 VQCKMDFKIFWLNLKNCNS-PET---VLEMLQKLLYQIDPNW---TSRSDHSSNIKL--- 225
Query: 538 LLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAM 597
R + + + L +L V ++ +A +
Sbjct: 226 --------------RIHSIQAELRRLLKSKPYENCLLVLL-NV------QNAKAWNAFNL 264
Query: 598 GCLRLNSKKRPTM-----KQVSMDLEGLRRSQRCLEIGKVNQLLTNEISLA 643
C + KQV+ L + L+ + LT + +
Sbjct: 265 SC--------KILLTTRFKQVTDFLSAATTTHISLD--HHSMTLTPDEVKS 305
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 37/179 (20%), Positives = 63/179 (35%), Gaps = 28/179 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRH 389
+Y R +G+G FG +++G L + VA+K ++ Q +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
I + E VLV + L + D +K S +
Sbjct: 68 IPNVYYFGQEGLHNVLVIDL-----LGPSLEDLLDLCGRK-----------FSVKTVAMA 111
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK-----VSDFGTSRSVPNDKTH 503
A ++ V +H + + +RDIK N L+ S V DFG + + T
Sbjct: 112 AKQMLARVQSIHEKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/178 (18%), Positives = 64/178 (35%), Gaps = 28/178 (15%)
Query: 333 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHI 390
N+ + +G G FG + G L VA+K K++ Q E Q+ + I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
++ + +V E L + D ++ S + + +A
Sbjct: 68 PQVYYFGPCGKYNAMVLEL-----LGPSLEDLFDLCDRT-----------FSLKTVLMIA 111
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS-----DFGTSRSVPNDKTH 503
++ + Y+HS I +RD+K N L+ + DF ++ + +T
Sbjct: 112 IQLISRMEYVHSKNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 38/243 (15%), Positives = 79/243 (32%), Gaps = 56/243 (23%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLG 395
+GQGGFG +Y + V + + + E+ + ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 396 CCLETE---VPVLVYEYICNGNLSHH-----------IHDHQQQQEQKQELEEEQELSSL 441
+ + VP + + N + + + ++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR-----------F 149
Query: 442 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV--SDFGTSRSVPN 499
S + ++++ + + Y+H + H DIK+SN+LL+ K +V D+G +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 500 DKTHL------TTAVQGTFGYFDPEY---------FQSSQYTDKSDVYSFGVVLLELLTG 544
+ H GT E+ S + D+ G +++ LTG
Sbjct: 207 EGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSR----RGDLEILGYCMIQWLTG 257
Query: 545 KKP 547
P
Sbjct: 258 HLP 260
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 3e-06
Identities = 16/43 (37%), Positives = 25/43 (58%)
Query: 178 GDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKSE 220
GDT++ + K+G + I AN+L +D IF L IP+ +E
Sbjct: 23 GDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILTE 65
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 27/180 (15%), Positives = 68/180 (37%), Gaps = 27/180 (15%)
Query: 338 RFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
+ +G GGFG +Y A K ++ + +E+ ++ + +K
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 397 CLETE---VPVLVYEYICNGNLSHHIHDHQQQ-------QEQKQELEEEQELS-SLSWEN 445
+ + +P+ + + + + + +L++ + +
Sbjct: 102 RKQLDYLGIPLFYG---------SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV--SDFGTSRSVPNDKTH 503
+++ + + Y+H + + H DIK++N+LL K +V +D+G S + H
Sbjct: 153 VLQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 16/54 (29%), Positives = 22/54 (40%)
Query: 173 YMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKSESCSANP 226
GDT+ IG +F D I N + +DLI+ L +P K S
Sbjct: 65 VTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAG 118
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 30/189 (15%), Positives = 63/189 (33%), Gaps = 42/189 (22%)
Query: 338 RFLGQGGFGTVYKGM---------LPDGSIVAVKRSKAIDKTQIEQF----------INE 378
F + G +Y+ P ++K + EQ +N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 379 VVILSQINHRHIVKLLGC-CLETEVPVLVYEYICNG-NLSHHIHDHQQQQEQKQELEEEQ 436
L I +G + + LV + G +L Q +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSL--------------QSALDVS 151
Query: 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV--SDFGTS 494
LS + ++VAC + A+ ++H + + H ++ + NI +D + ++V + +G +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 495 RSVPNDKTH 503
H
Sbjct: 209 FRYCPSGKH 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 646 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 99.04 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 98.58 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.12 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.83 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.39 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.15 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.23 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 94.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.68 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 93.31 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.79 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.54 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.5 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.69 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.79 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.46 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=463.05 Aligned_cols=272 Identities=27% Similarity=0.454 Sum_probs=214.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46677789999999999999864 367899999988777788899999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.++++........... .......+++|.++++|+.|||+||+|||+++ |+||||||+||||++++.
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAG-GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC------------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccc-cccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999875432111000 00111347999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCC-CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+|+...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+. +
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~------~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA------I 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH------H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH------H
Confidence 9999999999764332 223345679999999999999999999999999999999999 8999875433221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
. .+......+.|..++..+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 271 ~----------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 D----------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H----------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H----------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 1111122345566778899999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-56 Score=458.83 Aligned_cols=270 Identities=28% Similarity=0.470 Sum_probs=220.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 367899999988777788899999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.++|+........ .........++|.++++|+.|||+||+|||+++ |+||||||+||||++++.
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVL---MAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHH---C----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhcCccccc---ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence 99999999999999875421100 001112347999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+|+........ ......||+.|||||.+.++.++.|+|||||||+||||+| |+.||......+. +
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~------~ 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------I 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------H
Confidence 999999999876443322 2334569999999999999999999999999999999999 8999875433221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
. .+......+.|..++..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 241 ~----------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 E----------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 1111122345666778899999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=459.22 Aligned_cols=270 Identities=24% Similarity=0.416 Sum_probs=215.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
.+++..++||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556788999999999999863 4678999998753 2334568999999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
|||||+++|+|.++|+....................++|.++++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 999999999999999764321000000000111347999999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCC-CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+|+...... ........||++|||||++.++.++.++|||||||+||||+| |+.||......+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~------ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------ 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 99999999998764322 223345679999999999999999999999999999999999 8999875433221
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.+.+......+.|.+++..+.+|+.+||+.||++||||.||+++|+.+
T Consensus 257 ----------~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 ----------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111112222345667778899999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=445.36 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=208.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.+++...++||+|+||+||+|++++ .||||.++. ......+.|.+|+.+|++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577788999999999999999853 599998864 345667789999999999999999999999864 56899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.++|+... ..++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 112 y~~gGsL~~~l~~~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---------------TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CCSSCBHHHHHHTSC---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEE
T ss_pred cCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEE
Confidence 999999999997642 36999999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCC-CccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 489 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 489 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+|||+|+...... ........||+.|||||++.. +.++.++|||||||+||||+||+.||........ +.
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~ 247 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------II 247 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HH
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HH
Confidence 9999998764322 233445689999999999863 4689999999999999999999999965432211 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.....+ ...+.+ ...+.+++..+.+|+.+||+.||++||||.||+++|+.|+.+
T Consensus 248 ~~~~~~----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 248 FMVGRG----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHHTT----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHHhcC----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111111 011111 123455677899999999999999999999999999988653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=452.69 Aligned_cols=285 Identities=26% Similarity=0.390 Sum_probs=227.8
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEcCC------CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCc-cCceeE
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKAI-DKTQIEQFINEVVILSQINH-RHIVKL 393 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H-~niv~l 393 (646)
++.++++...++|+..+.||+|+||.||+|.+.. ++.||||+++.. .....+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 5567777778999999999999999999998532 357999998754 34556789999999999965 899999
Q ss_pred EEEEEeC-CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 394 LGCCLET-EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 394 ~g~~~~~-~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
+|+|.++ +..+|||||+++|+|.++|+....................++|.+++.|+.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999775 4689999999999999999875431100000001111346999999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 550 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~ 550 (646)
|||+||||++++.+||+|||+|+....+.. .......||+.|||||++.++.++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654333 33445679999999999999999999999999999999998 8999865
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
....+. +...+........|..++..+.+++.+||+.||++||||.||+++|+.+.+++
T Consensus 291 ~~~~~~---------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHH---------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 432211 11122222334456667788999999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=437.86 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=206.2
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|...+.||+|+||+||+|+. .+|+.||||+++. ......+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 4699999999764 345567789999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++..... ..+++.+.+.|+.||+.||+|||+++ |+||||||+||||++++.+||
T Consensus 104 y~~gg~L~~~i~~~~~--------------~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--------------VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp CCTTCBHHHHHHHTTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEE
T ss_pred CCCCCcHHHHHHHcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEE
Confidence 9999999999975432 35789999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||+|+..... ....+..+||+.|||||++.+..++.++|||||||+||||++|+.||......+ .+....
T Consensus 167 ~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~- 238 (350)
T 4b9d_A 167 GDFGIARVLNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKII- 238 (350)
T ss_dssp CSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH-
T ss_pred cccccceeecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-
Confidence 999999876322 123345679999999999999999999999999999999999999997543321 111111
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ....+...+..+.+|+.+||++||++|||+.|++++
T Consensus 239 --------~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 239 --------SGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --------HTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------cCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 112344556788999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=435.77 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=201.6
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC----ceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----VPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~----~~~LV~ 407 (646)
++|...++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3566778999999999999998 5899999998754322 122335666667899999999999998764 469999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCEEECC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-----ASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-----~~~~ivHrDIk~~NILl~~ 482 (646)
||+++|+|.++|+. ..++|..+++|+.|+|+||+|||++ ..++|+||||||+||||++
T Consensus 81 Ey~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp ECCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred cCCCCCcHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 99999999999964 2689999999999999999999987 2345999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCc---cccccccCCcccChhccccC------CCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 483 KFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
++++||+|||+|+........ .....+||+.|||||++.+. .++.++|||||||+||||+||+.|+.....
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 999999999999876443322 22345799999999998754 467899999999999999999887643221
Q ss_pred HHh--------hcHHHHHHHHHhhchhHHHhhhhhcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 554 EEE--------RNLVAYFISLAKENKLLEILDARVAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 554 ~~~--------~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
... ......... .+.+..+.... +.+....+.+|+.+||+.||++||||.||++.|++|
T Consensus 224 ~~~p~~~~~~~~~~~~~~~~--------~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 224 YQLPYYDLVPSDPSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHH--------HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccchhcccccchHHHHHH--------HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 100 000011111 11122222222 234567899999999999999999999999999998
Q ss_pred Hhh
Q 046188 621 RRS 623 (646)
Q Consensus 621 ~~~ 623 (646)
.+.
T Consensus 296 ~~~ 298 (303)
T 3hmm_A 296 SQQ 298 (303)
T ss_dssp HHC
T ss_pred HHH
Confidence 764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=422.17 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=198.6
Q ss_pred CcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe----CCceEEEE
Q 046188 335 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVY 407 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~----~~~~~LV~ 407 (646)
...++||+|+||+||+|... ++..||||++.. ......+.|.+|+++|++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45667999999999999954 588999998753 345567789999999999999999999999875 23579999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCcE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~ 486 (646)
||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ ++|+||||||+||||+. ++.+
T Consensus 109 Ey~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~v 171 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp ECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCE
T ss_pred eCCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCE
Confidence 999999999999753 36999999999999999999999987 45999999999999984 7999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+|+.... ......+||+.|||||++.+ .++.++|||||||+||||+||+.||....... ..+..
T Consensus 172 Kl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~- 241 (290)
T 3fpq_A 172 KIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRR- 241 (290)
T ss_dssp EECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHH-
T ss_pred EEEeCcCCEeCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHH-
Confidence 9999999986432 22345689999999998864 69999999999999999999999996433221 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+.. ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 242 i~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 242 VTSGVK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HTTTCC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHcCCC--------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111100 011122234568899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=433.72 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=209.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+.|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999964 69999999986544444557889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 154 ~gg~L~~~l~~-----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~D 213 (346)
T 4fih_A 154 EGGALTDIVTH-----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD 213 (346)
T ss_dssp TTEEHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred CCCcHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEec
Confidence 99999998854 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||+|+...... ......+||+.|||||++.+..++.++|||||||++|||++|+.||......+. +......
T Consensus 214 FGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~- 285 (346)
T 4fih_A 214 FGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDN- 285 (346)
T ss_dssp CTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-
T ss_pred CcCceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcC-
Confidence 99999764432 233457899999999999999999999999999999999999999975433221 1111110
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+ ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 286 -----~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 286 -----LPP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -----SCC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001 112233456778999999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=430.30 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=212.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+.|...++||+|+||.||+|+.. +|+.||||+++... ...+|+.+|++++|||||++++++.+++..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46777889999999999999954 68999999987532 2247999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-cEEEe
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVS 489 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI~ 489 (646)
++|+|.+++... ..+++.++..|+.||+.||+|||+++ |+||||||+||||+.++ ++||+
T Consensus 133 ~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 133 EGGSLGQLIKQM----------------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp TTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEEC
T ss_pred CCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEe
Confidence 999999999653 36999999999999999999999999 99999999999999987 69999
Q ss_pred ecCCccccCCCCCc----cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 490 DFGTSRSVPNDKTH----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 490 DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
|||+|+........ .....+||+.|||||++.+..++.++|||||||+||||++|+.||......+ +. ..
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~ 267 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LC---LK 267 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CH---HH
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HH
Confidence 99999976433211 1233679999999999999999999999999999999999999996433221 11 11
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhhcc
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEI 629 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~ 629 (646)
..... ....+.+..++..+.+++.+||++||.+|||+.|++++|..........++
T Consensus 268 i~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 268 IASEP--------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp HHHSC--------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred HHcCC--------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 11110 011234556677899999999999999999999999999988876665554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=423.33 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=210.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 46899999998642 1233567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.+...|+.||+.||+|||+++ |+||||||+||||++++.+|
T Consensus 112 Ey~~gG~L~~~i~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp CCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred ecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEE
Confidence 999999999999753 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCC-CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+|+.+.... .......+||+.|||||++.+..++.++||||+||+||||++|+.||......+ .+...
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i 246 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKI 246 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99999999875332 334456789999999999999999999999999999999999999997543221 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+... ..+|...+..+.+|+.+||++||++|||++|++.+
T Consensus 247 ---------~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 247 ---------IKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---------HHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---------HcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1111 12344556778999999999999999999997544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=434.95 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=210.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999954 68999999987654445567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 231 ~gG~L~~~i~~-----------------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~D 290 (423)
T 4fie_A 231 EGGALTDIVTH-----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD 290 (423)
T ss_dssp TTEEHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECC
T ss_pred CCCcHHHHHhc-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEec
Confidence 99999998853 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+. +......
T Consensus 291 FGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~- 362 (423)
T 4fie_A 291 FGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDN- 362 (423)
T ss_dssp CTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-
T ss_pred CccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcC-
Confidence 99999764432 233456899999999999999999999999999999999999999975433221 1111110
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+. ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 363 -----~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 363 -----LPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -----CCCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111 12233455778999999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=408.15 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=193.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 46899999987542 2233557899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+ +|+|.+++... ..+++.+...++.||+.||+|||+++ |+||||||+|||+++++++|
T Consensus 93 Ey~-~g~L~~~l~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----------------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp ECC-CEEHHHHHHHS----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEE
T ss_pred eCC-CCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEE
Confidence 999 78999998653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+|+...... .....+||+.|||||.+.+..+ +.++||||+||++|||++|+.||......+ .+...
T Consensus 153 l~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i 224 (275)
T 3hyh_A 153 IADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNI 224 (275)
T ss_dssp ECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH
Confidence 99999998764322 2344679999999999988776 579999999999999999999997543221 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
. ... ...+...+..+.+|+.+||+.||++|||++|++++=
T Consensus 225 ~---------~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 225 S---------NGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp H---------HTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred H---------cCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 1 111 123444567789999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=416.35 Aligned_cols=248 Identities=26% Similarity=0.330 Sum_probs=198.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999842 46899999875421 2223467889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 104 vmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~ 164 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGH 164 (304)
T ss_dssp EECCCTTCEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSC
T ss_pred EEEcCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCC
Confidence 99999999999999753 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+|||+|+...... ......+||+.|||||.+.+..++.++|||||||+||||++|+.||......+. +..
T Consensus 165 vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~ 237 (304)
T 3ubd_A 165 IKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTM 237 (304)
T ss_dssp EEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHH
Confidence 9999999998653322 223446799999999999999999999999999999999999999975433221 111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM-----KQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~~ 616 (646)
. ... ...+|...+..+.+|+.+||+.||++|||+ +|++++
T Consensus 238 i---------~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 238 I---------LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp H---------HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred H---------HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1 111 123445566788999999999999999984 566654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=408.42 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=189.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc-------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------- 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~------- 402 (646)
++|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999954 6899999998643 34456689999999999999999999999876542
Q ss_pred -----eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 403 -----PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 403 -----~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
.|+||||+++|+|.+++..... ....++..++.|+.||++||+|||+++ |+||||||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~N 148 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-------------IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSN 148 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-------------GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-------------CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHH
Confidence 6899999999999999976533 224667888999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCc-----------cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKTH-----------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 546 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~ 546 (646)
|||+.++.+||+|||+|+........ ..+..+||+.|||||.+.+..++.++|||||||++|||++
T Consensus 149 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp EEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred eEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence 99999999999999999876432211 1233579999999999999999999999999999999997
Q ss_pred CCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 547 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 547 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
||... .+. ...+... ...... +........+.+|+.+||+.||++|||+.|++++
T Consensus 226 Pf~~~--~~~---~~~~~~~-~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 226 PFSTQ--MER---VRTLTDV-RNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CCSSH--HHH---HHHHHHH-HTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCc--cHH---HHHHHHH-hcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 66421 111 0001110 011100 0112233456789999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=398.59 Aligned_cols=289 Identities=40% Similarity=0.678 Sum_probs=246.3
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
++..++..++++|+..+.||+|+||.||+|..++|+.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44455667789999999999999999999998889999999988766666778999999999999999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+++|+|.+++...... ...++|.+++.++.|+++||.|||+++ ++||||||+|||++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLP------------TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD 173 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCC------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEEC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCC------------ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEEC
Confidence 999999999999999999764320 236999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCC-CCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.++.+||+|||+++..... .........||+.|+|||.+.++.++.++||||||+++|||++|+.||......+.....
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 9999999999999875422 222233456899999999999899999999999999999999999999765554444555
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
.+.......+.+.+.+++.+....+.+.+..+.+++.+||+.||++|||+.||+++|+.+...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp HHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 55544455555666677777777788999999999999999999999999999999999876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=394.19 Aligned_cols=292 Identities=38% Similarity=0.677 Sum_probs=245.9
Q ss_pred cccccCHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHH-HHHHHHHHHHHHhhcCccCceeEEEE
Q 046188 318 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT-QIEQFINEVVILSQINHRHIVKLLGC 396 (646)
Q Consensus 318 ~~~~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~g~ 396 (646)
..+.|+..+++.+.++|+..+.||+|+||.||+|...+|+.||||+++..... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34678999999999999999999999999999999878999999998764322 22368899999999999999999999
Q ss_pred EEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 397 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
+.+.+..++||||+++|+|.+++...... ...++|..++.|+.|++.||.|||++..++|+||||||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPES------------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTT------------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred EecCCceEEEEEeccCCCHHHHHHhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 99999999999999999999999765321 346999999999999999999999993223999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCc--hH
Q 046188 477 NILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR--EE 554 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~--~~ 554 (646)
|||+++++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred hEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 9999999999999999999876555555555679999999999998899999999999999999999999985321 11
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.......+.........+..+.+..+....+...+..+.+++.+||+.||.+|||+.||+++|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 2233444444445555666677777777888999999999999999999999999999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=403.00 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=203.7
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------Cc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EV 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------~~ 402 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++. ......+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 4699999999864 3345566789999999999999999999997643 56
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.||||||++ |+|.+++... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----------------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----------------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNE 193 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECT
T ss_pred EEEEEeCCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCC
Confidence 899999995 7899988653 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCC---CCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 483 KFSAKVSDFGTSRSVPND---KTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
++.+||+|||+|+.+... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||......+..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l- 272 (398)
T 4b99_A 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL- 272 (398)
T ss_dssp TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-
T ss_pred CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 999999999999876432 12233457899999999998775 5699999999999999999999999765443321
Q ss_pred HHHHHHHHHhhc-----------hhHHHhhhhhc--ccCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 559 LVAYFISLAKEN-----------KLLEILDARVA--KEAS-----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 559 l~~~~~~~~~~~-----------~~~~~~d~~l~--~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+....... .....+. .+. ...+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 273 --~~I~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 273 --QLIMMVLGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp --HHHHHHHCCCCGGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --HHHHHhcCCCChHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111111110 0000000 000 0011 1234678899999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=392.24 Aligned_cols=263 Identities=21% Similarity=0.336 Sum_probs=200.1
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCc
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 402 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~ 402 (646)
....++|+..++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 344678999999999999999999742 46789999876533 234678999999998 69999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++|+|.+++. .+++.+...++.|++.||+|||+++ |+||||||+|||++.
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~ 152 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNR 152 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEET
T ss_pred EEEEEeCCCcccHHHHHc-------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeC
Confidence 999999999999998872 4889999999999999999999999 999999999999987
Q ss_pred C-CcEEEeecCCccccCCCCC---------------------------ccccccccCCcccChhccccC-CCCCccchhh
Q 046188 483 K-FSAKVSDFGTSRSVPNDKT---------------------------HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYS 533 (646)
Q Consensus 483 ~-~~~kI~DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS 533 (646)
+ +.+||+|||+|+....... ......+||+.|||||++.+. .++.++||||
T Consensus 153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS 232 (361)
T 4f9c_A 153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232 (361)
T ss_dssp TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence 7 7999999999986533211 112235799999999998775 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc----------------------hhHHHhhh---------hh--
Q 046188 534 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN----------------------KLLEILDA---------RV-- 580 (646)
Q Consensus 534 fGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------------------~~~~~~d~---------~l-- 580 (646)
+||++|||++|+.||.....+.. .+ ..+....... ......+. .+
T Consensus 233 lG~il~ell~G~~Pf~~~~~~~~-~l-~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~ 310 (361)
T 4f9c_A 233 AGVIFLSLLSGRYPFYKASDDLT-AL-AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTS 310 (361)
T ss_dssp HHHHHHHHHHTCSSSSCCSSHHH-HH-HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------
T ss_pred hHHHHHHHHHCCCCCCCCCCHHH-HH-HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccc
Confidence 99999999999999965443221 11 1111111100 00000000 00
Q ss_pred -------cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 581 -------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 581 -------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+.....+..+.+|+.+||+.||++|||++|+++|
T Consensus 311 ~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 311 DIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000112234667899999999999999999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=411.31 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=211.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|+..+.||+|+||.||+|+.+ +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999954 68999999988766667778999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC--CcEEE
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK--FSAKV 488 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~--~~~kI 488 (646)
++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 237 ~gg~L~~~i~~~~---------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 237 SGGELFEKVADEH---------------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp CCCBHHHHHTCTT---------------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEE
T ss_pred CCCcHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEE
Confidence 9999999986542 36899999999999999999999999 9999999999999854 89999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||+|+.+.... .....+||+.|||||++.+..++.++|||||||+||||++|+.||......+. +.....
T Consensus 299 ~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~ 370 (573)
T 3uto_A 299 IDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKS 370 (573)
T ss_dssp CCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHT
T ss_pred eeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHh
Confidence 9999999875432 23446799999999999999999999999999999999999999975443221 111111
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. +..+........+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 371 ~-------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 C-------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp T-------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001111122345678899999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=373.68 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=216.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999964 68999999988777778889999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ..++|.+++.|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 90 KGGTLRGIIKSMD---------------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp TTCBHHHHHHHCC---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECC
T ss_pred CCCcHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEee
Confidence 9999999997642 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCcc-------------ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 491 FGTSRSVPNDKTHL-------------TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 491 fGla~~~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764322211 11456999999999999999999999999999999999999987543221110
Q ss_pred cHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 558 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
. ........+. ..+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 232 ~----------~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 232 F----------GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp S----------SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----------hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0011112222 223344567899999999999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=366.91 Aligned_cols=284 Identities=35% Similarity=0.596 Sum_probs=232.3
Q ss_pred ccccCHHHHHHHhcCCCcC------ccccccCcEEEEEEEcCCCCEEEEEecccC----CHHHHHHHHHHHHHHhhcCcc
Q 046188 319 AKIFTAEELQRATDNYNQS------RFLGQGGFGTVYKGMLPDGSIVAVKRSKAI----DKTQIEQFINEVVILSQINHR 388 (646)
Q Consensus 319 ~~~~~~~el~~~t~~~~~~------~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~----~~~~~~~~~~Ei~il~~l~H~ 388 (646)
...|+++++..++++|+.. +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568999999999999988 8999999999999998 6889999987542 234466789999999999999
Q ss_pred CceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046188 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPI 468 (646)
Q Consensus 389 niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 468 (646)
||+++++++.+.+..++||||+++|+|.+++..... ...++|..++.|+.|++.||.|||+++ +
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 154 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-------------TPPLSWHMRCKIAQGAANGINFLHENH---H 154 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 999999999999999999999999999999975432 346999999999999999999999999 9
Q ss_pred EecCCCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCC
Q 046188 469 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547 (646)
Q Consensus 469 vHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p 547 (646)
+||||||+||++++++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987643322 22334578999999998864 578999999999999999999999
Q ss_pred CCCCchHHhhcHHHHHHHHHh-hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 548 ICLTREEEERNLVAYFISLAK-ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 548 ~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
|........ .......... ...+.+++++.+ ...+...+..+.+++.+||+.||.+|||+.||+++|+++.++
T Consensus 234 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 234 VDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp BCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred cccCcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 875432211 1111111111 223444554443 345677888999999999999999999999999999998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=404.04 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=201.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC------CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI------DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~------~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|+..+.||+|+||.||+++.. +|+.||||+++.. ..........++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999954 6999999987531 1112222334567778889999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
|||||++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|
T Consensus 269 lVmEy~~GGdL~~~l~~~----------------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH----------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHG 329 (689)
T ss_dssp EEECCCCSCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTS
T ss_pred EEEecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCC
Confidence 999999999999999753 36999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||+|+...... ....+||+.|||||++.. ..++.++|+|||||+||||++|+.||......+ .....
T Consensus 330 ~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~ 403 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEID 403 (689)
T ss_dssp CEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHH
T ss_pred CEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH
Confidence 99999999998764332 234689999999999975 578999999999999999999999996432211 11111
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
.. +.. ....+|...+..+.+|+.+||+.||.+|++ ++||.+|
T Consensus 404 ~~---------i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 404 RM---------TLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HH---------HHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred Hh---------hcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11 111 112345556678999999999999999998 6787765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=381.76 Aligned_cols=276 Identities=25% Similarity=0.410 Sum_probs=218.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
.++|...+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999842 3457999998754 345567899999999999 899999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.+++.....................+++.+++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 9999999999999999999875421100000000001236899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987643322 22233467889999999999999999999999999999999 999986543221
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
+...+........+..++..+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus 314 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 314 -------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111111222233455666789999999999999999999999999999987544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=372.79 Aligned_cols=266 Identities=25% Similarity=0.473 Sum_probs=214.6
Q ss_pred cCCCcCccccccCcEEEEEEEc-----CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~ 404 (646)
++|+..+.||+|+||+||++.+ .+++.||||+++.......+.+.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 6788899999999999999984 25789999999887777788899999999999999999999998654 4589
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 90 lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~ 151 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE---------------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENEN 151 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG---------------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred EEEEeCCCCCHHHHHHhccc---------------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCC
Confidence 99999999999999976432 5899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-------- 223 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------- 223 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------
Confidence 999999999987643322 1222345778899999999999999999999999999999999997532211
Q ss_pred HHHHHhh--------chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 563 FISLAKE--------NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 563 ~~~~~~~--------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+...... ..+.+.+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 224 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 012222223333345566778899999999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=384.43 Aligned_cols=261 Identities=26% Similarity=0.455 Sum_probs=216.8
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
..++|...+.||+|+||.||+|... +++.||||.++.. .....+.|.+|+.+|++++||||++++|++.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888999999999999999975 6899999998753 3444567889999999999999999999999989999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 192 e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~k 253 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG---------------ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLK 253 (377)
T ss_dssp ECCTTCBHHHHHHHHG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEE
Confidence 9999999999997542 25899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccc-cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
|+|||+++.......... ....+++.|+|||.+..+.++.++||||||+++|||++ |+.||......+.
T Consensus 254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--------- 324 (377)
T 3cbl_A 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--------- 324 (377)
T ss_dssp ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---------
T ss_pred ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence 999999986533221111 11235778999999999999999999999999999998 9999865433221
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.+.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+...+
T Consensus 325 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 325 -------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp -------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 1122222233445556678999999999999999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=373.73 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=214.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56778899999999999999964 3446999998764 455667899999999999999999999999988899999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 129 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD---------------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp EECCTTCBHHHHHHTTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred eeCCCCCcHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCE
Confidence 99999999999996542 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------- 263 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV------- 263 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------
Confidence 9999999987643322 12223456788999999998999999999999999999999 9999865433221
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
...+........+..++..+.+|+.+||+.||.+|||+.||++.|+.+..+...
T Consensus 264 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 264 ---------ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---------HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 111111222334555667899999999999999999999999999999876443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=372.56 Aligned_cols=269 Identities=30% Similarity=0.438 Sum_probs=210.8
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
+++....++|+..+.||+|+||+||+|.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33344467899999999999999999987 5889999997653 34556789999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA-------------REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH-------------HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECT
T ss_pred eEEEEecCCCCcHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeC
Confidence 9999999999999999976432 124899999999999999999999987 45999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 175 ~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------ 247 (309)
T 3p86_A 175 KYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------ 247 (309)
T ss_dssp TCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------
T ss_pred CCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 9999999999998643321 222345699999999999999999999999999999999999999975433221
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.... .........+...+..+.+|+.+||+.||.+|||+.|+++.|+.+..+.
T Consensus 248 ~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 248 VAAV---------GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHH---------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHH---------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1100 0011122344556678999999999999999999999999999988653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.21 Aligned_cols=261 Identities=26% Similarity=0.468 Sum_probs=206.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||++++|++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999864 4678999998754 455667899999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++.+++.|+.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 125 ~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD---------------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVC 186 (373)
T ss_dssp EECCTTCBHHHHHHTTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EeCCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCE
Confidence 99999999999997642 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------- 258 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------- 258 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 99999999876433221 1222345788999999999999999999999999999998 999986543221
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
+.+.++.......+..++..+.+++.+||+.||.+||++.||++.|+++......
T Consensus 259 --------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 259 --------VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp --------HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred --------HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 1112222233344556677899999999999999999999999999999875443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=363.69 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=215.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|...+.||+|+||.||+|...+++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57888999999999999999987888999999875432 23578899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 89 ~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 89 HGCLSDYLRTQR---------------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp TCBHHHHHHTTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHHhcC---------------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccc
Confidence 999999996642 36899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~~----- 219 (269)
T 4hcu_A 151 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VED----- 219 (269)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH-----
T ss_pred cccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HHH-----
Confidence 9998764433333334557888999999999999999999999999999999 8999865433221 111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+........+...+..+.+++.+||+.||.+||++.|++++|+++.++
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 220 -----ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -----HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111112223344557789999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=360.25 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=215.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|...+.||+|+||.||+|...++..||||+++.... ..+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467888999999999999999988888999999875432 2356889999999999999999999999988999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ..+++.+++.|+.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 86 ~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---------------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp TTCBHHHHHHHHG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECC
T ss_pred CCCcHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEcc
Confidence 9999999997642 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~--- 218 (268)
T 3sxs_A 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKV--- 218 (268)
T ss_dssp TTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHH---
T ss_pred CccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHH---
Confidence 99998775544433444557788999999998889999999999999999999 9999865443221 1111
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
........+...+..+.+++.+||+.||.+|||+.|++++|+.+.+.
T Consensus 219 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 219 -------SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11111122333456789999999999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.21 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=209.4
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36899999999999999999994 46899999998654444456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++.. ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~~~~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~ 158 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 158 (297)
T ss_dssp CTTCBHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred CCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEe
Confidence 999999999854 25899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 159 Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~ 231 (297)
T 3fxz_A 159 DFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATN 231 (297)
T ss_dssp CCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHH
T ss_pred eCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC
Confidence 9999987644332 23345799999999999999999999999999999999999999965433221 1111110
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.......+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 232 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 232 --------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --------CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001112234456778999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=393.52 Aligned_cols=265 Identities=23% Similarity=0.425 Sum_probs=219.9
Q ss_pred HHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 324 AEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 324 ~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++++...++|...+.||+|+||.||+|..+++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 344455667899999999999999999998878899999987643 34668999999999999999999999986 5678
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~ 320 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG--------------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS 320 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH--------------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTT
T ss_pred EEEEeecCCCcHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCC
Confidence 999999999999999976432 25889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
+.+||+|||+++..............+|+.|+|||.+..+.++.++||||||++||||++ |+.||......+.
T Consensus 321 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~------ 394 (454)
T 1qcf_A 321 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV------ 394 (454)
T ss_dssp CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------
T ss_pred CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 999999999998764332222233456789999999999999999999999999999999 9999865433221
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.+.+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 395 ----------~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 395 ----------IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ----------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ----------HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 111112222334556678899999999999999999999999999988654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=361.47 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=213.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|...+.||+|+||.||+|...++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468888999999999999999988888999999875432 2356889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ..+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 102 ~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 102 ANGCLLNYLREMR---------------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp TTCBHHHHHHCGG---------------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECS
T ss_pred CCCcHHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcc
Confidence 9999999997643 26999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~----- 232 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AE----- 232 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HH-----
T ss_pred ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HH-----
Confidence 99998764433333333457788999999999999999999999999999998 9999865443221 11
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.+........+...+..+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus 233 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 233 -----HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111112223344457789999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=375.63 Aligned_cols=286 Identities=26% Similarity=0.394 Sum_probs=223.7
Q ss_pred ccCHHHHHHHhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCcee
Q 046188 321 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVK 392 (646)
Q Consensus 321 ~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~ 392 (646)
.+...+++...++|...+.||+|+||.||+|.+ .+++.||||+++.. .....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355677777789999999999999999999973 24578999998763 445567899999999999 7999999
Q ss_pred EEEEEEeCCc-eEEEEEeccCCCchhhhhhhhhhHHH-------------------------------------------
Q 046188 393 LLGCCLETEV-PVLVYEYICNGNLSHHIHDHQQQQEQ------------------------------------------- 428 (646)
Q Consensus 393 l~g~~~~~~~-~~LV~Ey~~~gsL~~~l~~~~~~~~~------------------------------------------- 428 (646)
+++++.+.+. .++||||+++|+|.+++.........
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999765321000
Q ss_pred --HH-----HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 046188 429 --KQ-----ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 501 (646)
Q Consensus 429 --~~-----~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~ 501 (646)
.. ..........+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 00 0000000123899999999999999999999999 9999999999999999999999999998764332
Q ss_pred C-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhh
Q 046188 502 T-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDAR 579 (646)
Q Consensus 502 ~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 579 (646)
. .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. +...+...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~~~~~ 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKEG 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---------------HHHHHHHT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---------------HHHHHHcC
Confidence 2 23344568999999999999999999999999999999998 9999865432211 11111122
Q ss_pred hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 580 VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 580 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.....+...+..+.+++.+||+.||.+|||+.||+++|+.+.++.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 222334455677999999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.99 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=217.1
Q ss_pred cccCHHHHHHHhcC----------CCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc
Q 046188 320 KIFTAEELQRATDN----------YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR 388 (646)
Q Consensus 320 ~~~~~~el~~~t~~----------~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ 388 (646)
..++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788898888865 666789999999999999965 6999999998765555567789999999999999
Q ss_pred CceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046188 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPI 468 (646)
Q Consensus 389 niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 468 (646)
||+++++++...+..++||||+++|+|.+++.. ..+++..++.++.|+++||.|||+.+ |
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~---i 162 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----------------VRLNEEQIATVCEAVLQALAYLHAQG---V 162 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 999999999999999999999999999998854 25899999999999999999999998 9
Q ss_pred EecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 469 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 469 vHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
+||||||+|||++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999987643322 223457999999999999999999999999999999999999999
Q ss_pred CCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
........ ...... ...+.+ ..+...+..+.+++.+||+.||++|||+.|++++-.
T Consensus 242 ~~~~~~~~------~~~~~~------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 242 FSDSPVQA------MKRLRD------SPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp TTSCHHHH------HHHHHH------SSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCCHHHH------HHHHhc------CCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 75433211 111111 000000 112234567899999999999999999999998644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=375.40 Aligned_cols=289 Identities=26% Similarity=0.392 Sum_probs=221.6
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 399 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~ 399 (646)
..++|...+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468889999999999999999842 2357999998753 445567899999999999 99999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
++..++||||+++|+|.+++.....................+++.+++.|+.|++.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 99999999999999999999765320000000000000135999999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhh
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEER 557 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~ 557 (646)
+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987643322 22333457889999999999999999999999999999999 999986543221
Q ss_pred cHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhhccCccccccc
Q 046188 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLEIGKVNQLLT 637 (646)
Q Consensus 558 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 637 (646)
+.+.+........+..++..+.+|+.+||+.||++|||+.||+++|+++.......+.+....-..
T Consensus 302 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~ 367 (382)
T 3tt0_A 302 --------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHH 367 (382)
T ss_dssp --------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---------
T ss_pred --------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 111111222233344556789999999999999999999999999999998766665555444333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.16 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=208.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC----ceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----VPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~----~~~LV 406 (646)
.++|...+.||+|+||.||+|+.. ++.||||+++.... ....+..|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999984 78999999875433 3345567999999999999999999998754 36999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCCeEecCCCCC
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS----------ASIPIFHRDIKSS 476 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~----------~~~~ivHrDIk~~ 476 (646)
|||+++|+|.+++.. ..++|..++.|+.|+++||+|||+. + |+||||||+
T Consensus 101 ~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~ 160 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSK 160 (322)
T ss_dssp EECCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGG
T ss_pred EecCCCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChH
Confidence 999999999999954 2589999999999999999999998 7 999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccC-----CCCCccchhhHHHHHHHHHhCCCCCCC
Q 046188 477 NILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSS-----QYTDKSDVYSFGVVLLELLTGKKPICL 550 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSfGvvl~ElltG~~p~~~ 550 (646)
|||++.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876443322 22335799999999998763 456789999999999999999999865
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhh----hhhcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILD----ARVAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d----~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.......... ..........++.+ ....... .......+.+|+.+||+.||++|||+.||++.|++|.
T Consensus 241 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 241 PVDEYMLPFE---EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCCCCCCTTH---HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Ccchhccchh---hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4322111100 00000011111111 1111111 2245567999999999999999999999999999998
Q ss_pred hh
Q 046188 622 RS 623 (646)
Q Consensus 622 ~~ 623 (646)
+.
T Consensus 318 ~~ 319 (322)
T 3soc_A 318 RL 319 (322)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=362.34 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=211.3
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||++.. .+++.||+|.+.. ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5789999999999999999995 3688999998743 33455678899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 91 e~~~g~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH----------------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp ECCCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred eCCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 999999999999653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~ 225 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHI 225 (294)
T ss_dssp ECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHH
T ss_pred EEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh
Confidence 999999987654433334456799999999999999999999999999999999999999975443221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHhhhhhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~~ 627 (646)
... . +......+.+.+..+.+++.+||+.||.+|| +++++.+.|+.+....+..
T Consensus 226 ~~~-~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 226 QDS-V-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp SSC-C-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred hcc-C-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 110 0 0011112334457789999999999999998 9999999999877654443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.55 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=202.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.++|...+.||+|+||.||+|.... +..||+|+.+.. .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4688889999999999999998642 457999998753 3455668999999999999999999999984 567899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+|||++.++.
T Consensus 93 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 154 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---------------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC 154 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred EEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCC
Confidence 999999999999997542 26899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||+++..............+|+.|+|||.+....++.++||||||+++|||++ |..||......+. . .
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~---~ 228 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I---G 228 (281)
T ss_dssp EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H---H
T ss_pred EEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---H---H
Confidence 9999999998765443333334457889999999998999999999999999999997 8999865433221 1 0
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.+........+...+..+.+++.+||+.||.+|||+.|+++.|+.+.+..
T Consensus 229 ----------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 ----------RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111112334556678999999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=354.37 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=214.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|...+.||+|+||.||+|...+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57888999999999999999987888999999876432 23578899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 87 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 87 HGCLSDYLRTQR---------------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp TCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhCc---------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccc
Confidence 999999996542 36899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i---- 218 (267)
T 3t9t_A 149 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDI---- 218 (267)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHH----
T ss_pred ccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHH----
Confidence 9998764332222233457889999999998899999999999999999999 8999865432211 1111
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
........+...+..+.+++.+||+.||.+||++.|++++|+++.++
T Consensus 219 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 219 ------STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11111223334557789999999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=363.86 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=209.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999995 5789999998754 34556678899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 94 e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----------------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp CCCTTCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ECCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEE
Confidence 999999999999653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+++...... ......||+.|+|||.+.+..++ .++|||||||++|||++|+.||......+. ...
T Consensus 155 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~- 225 (328)
T 3fe3_A 155 IADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------RER- 225 (328)
T ss_dssp ECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-
T ss_pred EeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------HHH-
Confidence 99999998764332 23446799999999999887765 799999999999999999999975433221 111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
+.... ...|...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 226 --------i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 226 --------VLRGK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp --------HHHCC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred --------HHhCC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 11111 123344556788999999999999999999998863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=380.02 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=212.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-ceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~-~~~LV~Ey 409 (646)
.++|...+.||+|+||.||+|... |+.||||.++... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888899999999999999984 7899999988643 4567899999999999999999999988765 68999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+
T Consensus 269 ~~~g~L~~~l~~~~--------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG--------------RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp CTTCBHHHHHHHHC--------------TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEEC
T ss_pred cCCCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEe
Confidence 99999999997642 124799999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++...... ....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+
T Consensus 332 DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------------- 394 (450)
T 1k9a_A 332 DFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------- 394 (450)
T ss_dssp CCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------------
T ss_pred eCCCcccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------------
Confidence 999998643221 22357889999999999999999999999999999998 999986543221
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+...+........+..++..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 395 ---~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 395 ---VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1111122223345566778899999999999999999999999999998865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=366.86 Aligned_cols=257 Identities=23% Similarity=0.462 Sum_probs=207.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||+||+|+.. +++ .||+|.++.. .....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57888999999999999999953 444 3688887643 2344568899999999999999999999998654 789
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|+||+++|+|.+++.... ..+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 94 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp EEECCTTCBHHHHHHHST---------------TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCC
Confidence 999999999999997643 36999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------- 227 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 227 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------
Confidence 999999999876433322 2233457889999999999999999999999999999999 999986543322
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+...+........+..++..+.+++.+||+.||.+||++.|++++|+.+...
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 228 --------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1222222223344555667899999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=373.31 Aligned_cols=269 Identities=26% Similarity=0.420 Sum_probs=216.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|...+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367888999999999999999943 3568999998653 455566789999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++....... .....+++.+++.|+.|+++||+|||+++ |+||||||+|||++.+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP---------SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 217 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS---------SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEEEeCCCCCHHHHHHhhcccc---------CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecC
Confidence 99999999999999997653210 01246999999999999999999999999 9999999999999955
Q ss_pred C---cEEEeecCCccccCCC-CCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 484 F---SAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 484 ~---~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
+ .+||+|||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-- 295 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-- 295 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 4 5999999999864221 1122233568999999999999999999999999999999998 9999865433211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
.+.+........+..++..+.+|+.+||+.||.+||++.||+++|+.+.......
T Consensus 296 --------------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 296 --------------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp --------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred --------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 1111111122334455677999999999999999999999999999988765443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=389.10 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=218.5
Q ss_pred HhcCCCcCccccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..++|...+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.+|++++||||++++|++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678889999999999999999754 7899999987643 235689999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++.... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 297 ~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 297 FMTYGNLLDYLRECN--------------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp CCTTCBHHHHHHHSC--------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEE
T ss_pred ccCCCCHHHHHHhcC--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEE
Confidence 999999999997642 236899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++..............+++.|+|||.+..+.++.++||||||++||||++ |+.||......+
T Consensus 360 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------------ 427 (495)
T 1opk_A 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------ 427 (495)
T ss_dssp CCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------------
T ss_pred eecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence 9999999765443333334457789999999999999999999999999999999 889986543221
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+.+.+........+..++..+.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus 428 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 428 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 112223333344556667889999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=363.15 Aligned_cols=275 Identities=27% Similarity=0.444 Sum_probs=218.1
Q ss_pred HhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
..++|...+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357888999999999999999985 23578999998753 45566789999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHH--------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQE--------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
.++||||+++|+|.+++........ .............+++.+++.++.|+++||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976532100 0000000001235899999999999999999999999 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCc
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTR 552 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~ 552 (646)
|+|||+++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443322 2233457889999999998889999999999999999999 999986543
Q ss_pred hHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 553 EEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
... +.+.+........+...+..+.+++.+||+.||.+||++.|++++|+++...
T Consensus 258 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 322 1111111222234455667899999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=383.49 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=210.5
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
...++|...+.||+|+||.||+|...++..||||+++.... ..+.|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34567888999999999999999987778899999876432 34678999999999999999999999876 67899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++..... ..+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 259 ~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG--------------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp CCTTCBHHHHHSHHHH--------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred hhcCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEE
Confidence 9999999999975422 36899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++..............++..|+|||.+..+.++.++||||||+++|||++ |+.||......+. .
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~---- 391 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------L---- 391 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------H----
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------H----
Confidence 9999998765433333334457889999999999999999999999999999999 8999865433221 1
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 392 ------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 392 ------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11112222344556678899999999999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=353.04 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=200.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCH----HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK----TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~----~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|+..+.||+|+||.||+|.. .|+.||||.++.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999998 488999998765322 2346788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC----
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---- 482 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---- 482 (646)
|||+++|+|.+++.. ..+++..++.++.|+++||.|||+++..+++||||||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~-----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp EECCTTEEHHHHHTS-----------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EEcCCCCCHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 999999999998853 36899999999999999999999998666899999999999986
Q ss_pred ----CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 483 ----KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 483 ----~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
++.+||+|||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-- 222 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-- 222 (271)
T ss_dssp SCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--
T ss_pred ccccCcceEEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 77899999999986543222 234689999999999999999999999999999999999999975433221
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
. ............+..++..+.+++.+||+.||.+|||+.|++++|+.|
T Consensus 223 ----~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ----A---------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----H---------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----H---------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 111111222334455667899999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=381.52 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=213.7
Q ss_pred CHHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEEEEE
Q 046188 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCL 398 (646)
Q Consensus 323 ~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g~~~ 398 (646)
.+.+++..+++|+..++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35566667789999999999999999999965 478999999864211 11223788999999999999999999999
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
+.+..+|||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NI 206 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---------------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNI 206 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHe
Confidence 9999999999999999999997632 36999999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
||+.++.+||+|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||.....
T Consensus 207 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp EECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999877555444445568999999999987 56789999999999999999999999975443
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCC---HHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEAS---EEDIEAVAELAMGCLRLNSKK--RPTMKQVSMDL 617 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~L 617 (646)
.+. +.. ++.......+| ...+..+.+|+.+||+.+|++ ||+++|++++-
T Consensus 287 ~~~------~~~---------i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 287 VET------YGK---------IMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHH------HHH---------HHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hHH------HHh---------hhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 221 111 11111111112 235577899999999988888 99999998863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.27 Aligned_cols=278 Identities=27% Similarity=0.403 Sum_probs=218.6
Q ss_pred cCCCcCccccccCcEEEEEEEc-----CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe--CCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~--~~~~~ 404 (646)
++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999983 3578999999988777777889999999999999999999999874 45688
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++..... .+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~ 164 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA---------------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEA 164 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG---------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred EEEeecCCCCHHHHHHhccc---------------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCC
Confidence 99999999999999976432 5899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.......... ...
T Consensus 165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~ 243 (327)
T 3lxl_A 165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGC 243 (327)
T ss_dssp EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC-
T ss_pred CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccc
Confidence 9999999999876543322 2233458888999999999889999999999999999999999976432211000 000
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhhc
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLE 628 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 628 (646)
.........+.+.+........+..++..+.+|+.+||+.||.+|||+.|++++|+.+.......+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 244 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp ---CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 000000112233333444445566677889999999999999999999999999999987655444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.00 Aligned_cols=277 Identities=25% Similarity=0.404 Sum_probs=216.5
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET 400 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~ 400 (646)
....++|...+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344678999999999999999999964 3478999998764 344567899999999999999999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHH---HH-----HHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQ---EL-----EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~---~~-----~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
+..++||||+++|+|.+++........... .. ........+++.+++.|+.|+++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999976432100000 00 00001257999999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 550 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~ 550 (646)
|||+|||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987543221 12233568899999999999999999999999999999999 9999865
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
....+. . .....+ .....+..++..+.+++.+||+.||.+||++.||++.|+++.+.
T Consensus 280 ~~~~~~------~-~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAHEEV------I-YYVRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCHHHH------H-HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CChHHH------H-HHHhCC---------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 433221 1 111111 11223445567899999999999999999999999999988764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=352.07 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=210.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.++|...+.||+|+||.||+|...+ +..||||.++.. .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4688899999999999999998532 236999998754 44556789999999999999999999999764 45799
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.
T Consensus 90 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---------------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPEC 151 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTE
T ss_pred EEecCCCCCHHHHHHhcc---------------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCc
Confidence 999999999999996542 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 152 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~---- 224 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I---- 224 (281)
T ss_dssp EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H----
T ss_pred EEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H----
Confidence 9999999998765443333344557889999999998999999999999999999998 9999864433221 1
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
+.+........+...+..+.+++.+||+.||.+||++.|++++|+.+......
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 225 ---------GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp ---------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ---------HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 11111111223344557799999999999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.38 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=215.2
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
...++|+..+.||+|+||.||+|...++..||||.++.... ..+.+.+|++++++++||||+++++++. ++..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 34468889999999999999999987788999999875432 3467889999999999999999999986 456899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++..... ..+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||
T Consensus 88 ~~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG--------------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp CCTTCBHHHHTTSHHH--------------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred cCCCCCHHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEE
Confidence 9999999999976432 26899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||......+. ...
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~-- 222 (279)
T 1qpc_A 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQN-- 222 (279)
T ss_dssp CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHH--
T ss_pred CCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------HHH--
Confidence 9999998775443333344557889999999998889999999999999999999 8989865432211 111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
+........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 223 --------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 223 --------LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------HhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1111122234455678999999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=357.01 Aligned_cols=276 Identities=26% Similarity=0.417 Sum_probs=218.1
Q ss_pred HhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
..++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346888999999999999999984 246789999987543 34567899999999999 9999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHH--HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQ--ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
..++||||+++|+|.+++........... ..........+++.+++.++.|+++||.|||+++ ++||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976542100000 0000011236999999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhh
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEER 557 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~ 557 (646)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 999999999999999876543322 2233457889999999999999999999999999999999 9999865432211
Q ss_pred cHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 558 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
....+........+...+..+.+++.+||+.||.+|||+.|++++|+++...
T Consensus 257 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp --------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111222222233445567899999999999999999999999999988865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.42 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=201.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhh--cCccCceeEEEEEEeC----CceE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQ--INHRHIVKLLGCCLET----EVPV 404 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~H~niv~l~g~~~~~----~~~~ 404 (646)
.++|...+.||+|+||+||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998753 23455667777766 7999999999997653 3478
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH--------SSASIPIFHRDIKSS 476 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--------~~~~~~ivHrDIk~~ 476 (646)
+||||+++|+|.+++.. ..+++..+++|+.|++.||+||| +.+ |+||||||+
T Consensus 83 lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~ 142 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSK 142 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGG
T ss_pred EehhhccCCCHHHHHhh-----------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChH
Confidence 99999999999999953 26899999999999999999999 777 999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCCcc---ccccccCCcccChhccccC------CCCCccchhhHHHHHHHHHhC---
Q 046188 477 NILLDDKFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVLLELLTG--- 544 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSfGvvl~ElltG--- 544 (646)
|||++.++.+||+|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~ 222 (301)
T 3q4u_A 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222 (301)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence 9999999999999999998764332221 2234799999999999876 455799999999999999999
Q ss_pred -------CCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhc-ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 545 -------KKPICLTREEEERNLVAYFISLAKENKLLEILDARVA-KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 545 -------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+.||........ . ............. .+... ...+...+..+.+|+.+||+.||.+|||+.||++.
T Consensus 223 ~~~~~~~~~pf~~~~~~~~-~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 223 NGIVEDYKPPFYDVVPNDP-S-FEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTBCCCCCCTTTTTSCSSC-C-HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccccccccccCCCCc-c-hhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 778754322111 0 0111111111000 00000 01223467889999999999999999999999999
Q ss_pred HHHH
Q 046188 617 LEGL 620 (646)
Q Consensus 617 L~~i 620 (646)
|++|
T Consensus 297 L~~i 300 (301)
T 3q4u_A 297 LTKI 300 (301)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 9976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.02 Aligned_cols=267 Identities=26% Similarity=0.456 Sum_probs=200.8
Q ss_pred HhcCCCcCccccccCcEEEEEEEcCC-CC---EEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLPD-GS---IVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~~-g~---~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
..++|...+.||+|+||.||+|.... ++ .||||.++.. .....+.+.+|+.++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999653 22 7999998753 345567899999999999999999999999877654
Q ss_pred ------EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 404 ------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 404 ------~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
++||||+++|+|.+++....... ....+++.+++.|+.|+++||.|||+.+ |+||||||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~N 167 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGE----------NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARN 167 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC-------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccc----------cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcce
Confidence 99999999999999997653210 1236999999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHH
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~ 555 (646)
||+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999987643322 22223457889999999999999999999999999999999 899986543322
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
. ...+........+...+..+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus 248 ~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 248 I----------------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp H----------------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred H----------------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 01111111223344556789999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=364.09 Aligned_cols=280 Identities=25% Similarity=0.456 Sum_probs=214.5
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 399 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~ 399 (646)
+...++|...+.||+|+||.||+|.. .++..||||.++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 33457899999999999999999995 23568999998753 233456789999999999 89999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHH-------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQE-------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
.+..++||||+++|+|.+++........ .............+++..++.++.|++.||+|||+++ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 9999999999999999999976532100 0000111111245899999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 550 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~ 550 (646)
|||+|||++.++.+||+|||++........ .......+|+.|+|||.+.++.++.++||||||+++|||++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987643322 22334567889999999999999999999999999999998 9999865
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
...... ....+........+...+..+.+|+.+||+.||.+|||+.||+++|+.+.....
T Consensus 278 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 278 IPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCcHHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 432211 111222222233445556789999999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.34 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=215.5
Q ss_pred cCCCcCc-cccccCcEEEEEEEcC---CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~-~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+ .||+|+||.||+|... ++..||||.++.. .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999853 5778999998764 455677899999999999999999999999 55678999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+
T Consensus 88 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---------------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp EECCTTEEHHHHHTTCT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEE
T ss_pred EEeCCCCCHHHHHHhCC---------------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCE
Confidence 99999999999996532 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcc--ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------- 222 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------- 222 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------
Confidence 999999998775433222 223456889999999998889999999999999999998 9999865433221
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhhc
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCLE 628 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 628 (646)
...+........+...+..+.+++.+||+.||.+||++.|++++|+.+..+.....
T Consensus 223 ---------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 223 ---------MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ---------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ---------HHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 01111111233455666789999999999999999999999999999988765443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.63 Aligned_cols=264 Identities=18% Similarity=0.198 Sum_probs=211.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||+|.. .+|+.||||.+.... ..+.+.+|+.+++++ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 5789999999999999999994 578999999876432 233577899999999 899999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc----
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---- 485 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---- 485 (646)
+ +++|.+++.... ..+++..++.|+.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 88 ~-~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 88 L-GPSLEDLLDLCG---------------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp C-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred c-CCCHHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCC
Confidence 9 999999997542 26999999999999999999999999 999999999999987776
Q ss_pred -EEEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 486 -AKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 486 -~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 99999999987643322 12234579999999999999999999999999999999999999997643222111
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
....+......... +.+ ....+..+.+++.+||+.||.+||++.+|++.|+++.....
T Consensus 229 ~~~~~~~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 229 KYERIGEKKQSTPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHHHHSCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhhccCccH-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11111111100111 111 12334678999999999999999999999999999987543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=354.04 Aligned_cols=262 Identities=27% Similarity=0.451 Sum_probs=221.3
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..++|...+.||+|+||.||+|... ++..||||.++... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578889999999999999999965 47899999987543 345678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 90 ~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN--------------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp CCTTEEHHHHHHHCC--------------TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhcc--------------cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEE
Confidence 999999999997642 236899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~------------ 220 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------ 220 (288)
T ss_dssp CCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------------
T ss_pred ccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence 9999998775544444444567889999999999999999999999999999999 888886543221
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
..+.+........+...+..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 221 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp ----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 112222222334455566789999999999999999999999999999887644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=348.02 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=209.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV~ 407 (646)
++|...+.||+|+||.||+|+. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788899999999999999998 4889999997653 455567899999999999999999999999877 6789999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ...+++.+++.|+.|+++||.|||+++ ++++||||||+||+++.++.++
T Consensus 89 e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--------------NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp ECCTTCBHHHHHHSCS--------------SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEE
T ss_pred cccCCCcHHHHHhhcc--------------cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCccee
Confidence 9999999999997642 135899999999999999999999976 4599999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCC---ccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD---KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~---ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||++..... ....||+.|+|||.+.+...+. ++||||||+++|||++|+.||........ ..
T Consensus 154 l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~ 221 (271)
T 3kmu_A 154 ISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GM 221 (271)
T ss_dssp EEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HH
T ss_pred EEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HH
Confidence 999998765322 2235899999999998765544 79999999999999999999865433221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
...........+...+..+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 ---------KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111222233445566789999999999999999999999999998854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.49 Aligned_cols=264 Identities=25% Similarity=0.421 Sum_probs=211.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-----CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--Cce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~ 403 (646)
++|+..+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4688899999999999999983 358899999987532 33456788999999999999999999999876 568
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~ 162 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---------------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 162 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred EEEEEeCCCCcHHHHHHhcc---------------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCC
Confidence 99999999999999996542 36999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... .
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~ 234 (302)
T 4e5w_A 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM--------A 234 (302)
T ss_dssp TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--------H
T ss_pred CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh--------h
Confidence 9999999999987754332 22334568889999999999999999999999999999999998853211 1
Q ss_pred HHHHHHh-------hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 562 YFISLAK-------ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 562 ~~~~~~~-------~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.+..... ...+...+........+...+..+.+|+.+||+.||.+|||+.|+++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111110 01122222223333455666788999999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.17 Aligned_cols=245 Identities=23% Similarity=0.287 Sum_probs=195.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..++||+|+||+||+|... +|+.||||++.. ........+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 689999998754 2334445566676666665 8999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+ +|+|.+++.... ..++|..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 137 e~~-~~~L~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---------------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp ECC-CCBHHHHHHHHC---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEE
T ss_pred ecc-CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEE
Confidence 999 789998886542 36999999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||++....... ......||++|+|||++.+ .++.++||||||+++|||++|..++..... ... .
T Consensus 198 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~-~ 264 (311)
T 3p1a_A 198 LGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQ-L 264 (311)
T ss_dssp ECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHH-H
T ss_pred EccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHH-H
Confidence 99999998764322 2334569999999998875 789999999999999999999877643211 011 1
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ..+.+ +...+..+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~----~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQGY----LPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTTC----CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccC----CCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111 11111 12234678999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=359.84 Aligned_cols=277 Identities=25% Similarity=0.404 Sum_probs=217.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC--------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
.++|...+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999852 4678999998754 445567899999999999 899999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.+++.....................+++..++.++.|+++||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999765321000000000000235899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence 99999999999999876543322 2233457889999999998889999999999999999999 9999865432211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
. ..+........+..++..+.+++.+||+.||.+||++.|+++.|+++......
T Consensus 269 ----~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 269 ----F----------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ----H----------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----H----------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1 11111112233445567899999999999999999999999999999876544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=361.89 Aligned_cols=267 Identities=25% Similarity=0.463 Sum_probs=216.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-----CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC--ce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--~~ 403 (646)
.++|...+.||+|+||.||++.+ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35788899999999999999983 358899999998776777788999999999999999999999987654 68
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 181 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---------------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENE 181 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---------------TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEET
T ss_pred EEEEECCCCCCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCC
Confidence 99999999999999997642 25899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 182 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~------- 254 (326)
T 2w1i_A 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------- 254 (326)
T ss_dssp TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-------
T ss_pred CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-------
Confidence 99999999999876543322 122345778899999999888999999999999999999999986432110
Q ss_pred HHHHHHhh--------chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 562 YFISLAKE--------NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 562 ~~~~~~~~--------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+...... ..+.+.+........+..++..+.+++.+||+.||.+|||+.||++.|+.+++.
T Consensus 255 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 255 -FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp -HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111110 012222322223334556678899999999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.67 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=207.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+++.. +|+.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67889999999999999999964 6899999998642 1223557889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 85 E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp ECCTTCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred eCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEE
Confidence 999999999988653 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +....
T Consensus 146 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~ 218 (337)
T 1o6l_A 146 ITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELIL 218 (337)
T ss_dssp ECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred EeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH------HHHHH
Confidence 99999998643222 223446799999999999999999999999999999999999999975432211 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMDL 617 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~L 617 (646)
.. ...++...+..+.+|+.+||+.||.+|| ++.||+++-
T Consensus 219 ---------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 219 ---------ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ---------HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---------cC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 11 1123445567889999999999999999 899998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=357.30 Aligned_cols=271 Identities=27% Similarity=0.410 Sum_probs=216.4
Q ss_pred CCcCccccccCcEEEEEEEcC-----CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEE
Q 046188 334 YNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVL 405 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~~-----~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~L 405 (646)
|...+.||+|+||.||++.+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988642 5788999998754 345567899999999999999999999999884 46799
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++... .+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 113 v~e~~~~~~L~~~l~~~-----------------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~ 172 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----------------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRL 172 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEecccCCcHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCC
Confidence 99999999999998542 5899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........ ....+.
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~ 251 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIA 251 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSC
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhccc
Confidence 999999999887543321 22335688899999999998999999999999999999999999854221110 000000
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
........+.+.++.......+..++..+.+|+.+||+.||.+|||+.|+++.|+.+.+.-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp CHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 00111122333444444445566677889999999999999999999999999999887543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.57 Aligned_cols=262 Identities=16% Similarity=0.207 Sum_probs=209.6
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||+|.. .+|+.||||.+..... .+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788999999999999999994 4789999998764322 23577999999999 999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc----
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---- 485 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---- 485 (646)
+ +|+|.+++.... ..+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 87 ~-~~~L~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---------------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp C-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTT
T ss_pred C-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCc
Confidence 9 999999997542 36999999999999999999999999 999999999999999887
Q ss_pred -EEEeecCCccccCCCCCc------cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 486 -AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 486 -~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence 999999999876432221 1234679999999999999999999999999999999999999997543222111
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
....+........ ...+. ...+ .+.+++..||+.||.+||++.+|++.|+.+....
T Consensus 228 ~~~~i~~~~~~~~-----~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 228 RYQKIGDTKRATP-----IEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHHSC-----HHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhhhccCC-----HHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1111110000000 00011 1123 7899999999999999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=357.01 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=203.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|...+.||+|+||+||+|...+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999998889999999986432 2234678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 100 ~~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 100 FME-KDLKKVLDENK---------------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp CCS-EEHHHHHHTCT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred CCC-CCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEE
Confidence 997 58888876542 36999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+....
T Consensus 161 ~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~ 236 (311)
T 3niz_A 161 ADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSIL 236 (311)
T ss_dssp CCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHH
T ss_pred ccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHH
Confidence 99999987643222 2233568999999999876 5689999999999999999999999975543322 11122211
Q ss_pred hhc---h------hHHHhhhhhc--c-----cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KEN---K------LLEILDARVA--K-----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~---~------~~~~~d~~l~--~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... . +..+.+.... . .........+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 0 0000000000 0 0112234578899999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.25 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=207.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|...+.||+|+||.||+|.... +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466677899999999999998642 235999998753 34456678999999999999999999999999899999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+++ |+||||||+|||+++++.
T Consensus 124 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD---------------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLV 185 (333)
T ss_dssp EEECCTTEEHHHHHHHTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred EEeCCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCc
Confidence 999999999999996542 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------ 259 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------ 259 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH------
Confidence 999999999876433221 1222346789999999999999999999999999999999 9999865432211
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
.. .+........+..++..+.+++.+||+.||.+||++.|+++.|+++.......
T Consensus 260 ~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 260 MK----------AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp HH----------HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred HH----------HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 11 11111122334456678999999999999999999999999999988755443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.96 Aligned_cols=269 Identities=23% Similarity=0.349 Sum_probs=212.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC--ceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--~~~LV~ 407 (646)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999965 58999999987532 233567789999999999999999999998765 679999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----CCC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDK 483 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~ 483 (646)
||+++|+|.+++..... ...+++.+++.|+.|+++||+|||+.+ |+||||||+|||+ +.+
T Consensus 89 e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-------------AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSC
T ss_pred eCCCCCCHHHHHHHhcc-------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCC
Confidence 99999999999976543 235999999999999999999999999 9999999999999 888
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ--------SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
+.+||+|||+++....... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||.......
T Consensus 153 ~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 153 SVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp EEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred ceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 8999999999987644332 23356999999999886 5778999999999999999999999986433221
Q ss_pred hhcHHHHHHHHHhhch---hH---HHh--------hhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENK---LL---EIL--------DARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~---~~---~~~--------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
.. ............ .. ... +-......+......+.+++.+||+.||++|||++|++++.+..
T Consensus 231 ~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 231 RN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hh--HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11 111111111100 00 000 00111234577888999999999999999999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=358.79 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=199.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------ 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~------ 402 (646)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999965 7899999998643 33456788999999999999999999999876432
Q ss_pred ---------------------------------------------------eEEEEEeccCCCchhhhhhhhhhHHHHHH
Q 046188 403 ---------------------------------------------------PVLVYEYICNGNLSHHIHDHQQQQEQKQE 431 (646)
Q Consensus 403 ---------------------------------------------------~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~ 431 (646)
.++||||+++|+|.+++.....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------- 157 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS------- 157 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-------
Confidence 7899999999999999977543
Q ss_pred HHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCC---------
Q 046188 432 LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT--------- 502 (646)
Q Consensus 432 ~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~--------- 502 (646)
....++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 158 ------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 158 ------LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp ------GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------
T ss_pred ------ccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccc
Confidence 234678889999999999999999999 99999999999999999999999999987654321
Q ss_pred --ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhh
Q 046188 503 --HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 580 (646)
Q Consensus 503 --~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 580 (646)
.......||+.|+|||.+.+..++.++||||||+++|||++|..|+. +.. ..... ......
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~---~~~~~-~~~~~~-------- 291 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERV---RIITD-VRNLKF-------- 291 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHH---HHHHH-HHTTCC--------
T ss_pred ccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHH---HHHHH-hhccCC--------
Confidence 12233569999999999999999999999999999999999977631 100 00000 000000
Q ss_pred cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 581 AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 581 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..........+.+++.+||+.||.+|||+.|++++
T Consensus 292 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 292 -PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp -CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred -CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 01112334567899999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.87 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=204.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999964 689999998764322 234568899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 86 ~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl 146 (323)
T 3tki_A 86 YCSGGELFDRIEPD----------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKI 146 (323)
T ss_dssp CCTTEEGGGGSBTT----------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred cCCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEE
Confidence 99999999999653 35899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCC-CccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 489 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 489 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
+|||+++...... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... +..
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~~~- 220 (323)
T 3tki_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSD- 220 (323)
T ss_dssp CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-----HHH-
T ss_pred EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHH-
Confidence 9999998653222 222334679999999999987765 77999999999999999999999754332110 111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+................+.+|+.+||+.||.+|||+.|++++-.
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 221 --------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp --------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --------HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 11111111111334567889999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=359.54 Aligned_cols=278 Identities=24% Similarity=0.441 Sum_probs=221.8
Q ss_pred cccCHHHHHHHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCcee
Q 046188 320 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVK 392 (646)
Q Consensus 320 ~~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~ 392 (646)
..+..++++...++|...+.||+|+||.||+|... +++.||||.+... .......+.+|+.++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34555566677789999999999999999999854 3678999998753 3445567899999999999999999
Q ss_pred EEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 393 LLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 393 l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
+++++.+.+..++||||+++|+|.+++........ .......+++..+++++.|++.||.|||+++ |+|||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 163 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA------NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 163 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHH------HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhc------cCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 99999998999999999999999999976543110 0111246799999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 550 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~ 550 (646)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 164 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 999999999999999999999986533222 12223457889999999999999999999999999999999 8888865
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
...... ... +... .....+...+..+.+++.+||+.||.+|||+.|++++|+++..
T Consensus 244 ~~~~~~------~~~---------~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 244 LSNEQV------LRF---------VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp SCHHHH------HHH---------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCHHHH------HHH---------HHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 432211 111 1111 1122344556779999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=387.30 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=216.2
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++...++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++|+||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 334457788899999999999999998777889999987643 234678999999999999999999999876 678999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++..... ..+++.+++.|+.||++||+|||+++ |+||||||+|||+++++.+
T Consensus 340 ~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~ 402 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETG--------------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVC 402 (535)
T ss_dssp ECCCTTEEHHHHHSHHHH--------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred eehhcCCcHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcE
Confidence 999999999999975422 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++..............++..|+|||.+..+.++.++||||||++||||++ |+.||......+. .
T Consensus 403 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~-- 474 (535)
T 2h8h_A 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------L-- 474 (535)
T ss_dssp EECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------H--
T ss_pred EEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------H--
Confidence 999999998764322222233457789999999999999999999999999999999 8999865433221 1
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 475 --------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 475 --------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11112222334556677899999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.84 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=208.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||.||++... +++.||+|.++... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468899999999999999999964 58899999887543 3456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--CCcEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAK 487 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~k 487 (646)
+++|+|.+++.... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++. ++.+|
T Consensus 83 ~~g~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~k 144 (321)
T 1tki_A 83 ISGLDIFERINTSA---------------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp CCCCBHHHHHTSSS---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEE
T ss_pred CCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEE
Confidence 99999999996532 36999999999999999999999999 999999999999987 78999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....
T Consensus 145 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~ 216 (321)
T 1tki_A 145 IIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIM 216 (321)
T ss_dssp ECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred EEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHH
Confidence 99999998764432 22345689999999999988889999999999999999999999975443221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
... .. .+.... ...+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 217 ~~~-~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 217 NAE-YT--FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HTC-CC--CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cCC-CC--CChhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 110 00 000001 123467899999999999999999999999765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.90 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=202.0
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..+.||+|+||.||+|.. .++.||||+++.. ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788889999999999999998 4789999998753 34567899999999999999999999886 45799999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc-EEEee
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-AKVSD 490 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-~kI~D 490 (646)
+|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|
T Consensus 83 ~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 83 GGSLYNVLHGAEP-------------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp TCBHHHHHHCSSS-------------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred CCCHHHHHhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 9999999976432 235889999999999999999999932222999999999999998876 79999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 150 fg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~--- 218 (307)
T 2eva_A 150 FGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVH--- 218 (307)
T ss_dssp CCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHH---
T ss_pred cccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHh---
Confidence 9999865322 1234589999999999999999999999999999999999999864322111 0111100
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.......+...+..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 219 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 219 -------NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -------TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -------cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11112223344567899999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.70 Aligned_cols=270 Identities=16% Similarity=0.240 Sum_probs=209.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC------CCEEEEEecccCCHHHH-----------HHHHHHHHHHhhcCccCceeE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKAIDKTQI-----------EQFINEVVILSQINHRHIVKL 393 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~------g~~VAVK~l~~~~~~~~-----------~~~~~Ei~il~~l~H~niv~l 393 (646)
.++|...+.||+|+||.||+|...+ ++.||||.+........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998754 47899999766442211 123445667778889999999
Q ss_pred EEEEEeC----CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 046188 394 LGCCLET----EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIF 469 (646)
Q Consensus 394 ~g~~~~~----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 469 (646)
++++... ...+|||||+ +|+|.+++.... ..+++..++.|+.|++.||+|||+++ |+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---------------KRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 9998875 3479999999 999999997642 36999999999999999999999998 99
Q ss_pred ecCCCCCCEEEC--CCCcEEEeecCCccccCCCCCc------cccccccCCcccChhccccCCCCCccchhhHHHHHHHH
Q 046188 470 HRDIKSSNILLD--DKFSAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLEL 541 (646)
Q Consensus 470 HrDIk~~NILl~--~~~~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~El 541 (646)
||||||+|||++ .++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999 8899999999999876432111 11334599999999999999999999999999999999
Q ss_pred HhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 542 LTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 542 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
++|+.||........ ...... ......+.+++++.+.. ...+..+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 255 ~~g~~Pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 255 LTGHLPWEDNLKDPK--YVRDSK-IRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHSCCTTGGGTTCHH--HHHHHH-HHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HhCCCCccccccCHH--HHHHHH-HHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 999999974322111 111111 11122344555555431 233467899999999999999999999999999988
Q ss_pred hhhh
Q 046188 622 RSQR 625 (646)
Q Consensus 622 ~~~~ 625 (646)
....
T Consensus 329 ~~~~ 332 (364)
T 3op5_A 329 KAIG 332 (364)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 7543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=355.95 Aligned_cols=285 Identities=26% Similarity=0.402 Sum_probs=221.4
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeE
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKL 393 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l 393 (646)
+...++....++|...+.||+|+||.||+|.. .+++.||||.++.. .....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566666778999999999999999999983 34678999998753 344566789999999999 79999999
Q ss_pred EEEEEeCC-ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 394 LGCCLETE-VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 394 ~g~~~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
++++...+ ..++||||+++|+|.+++.....................+++..++.++.|+++||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998765 489999999999999999765321000000000000123899999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 046188 473 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 550 (646)
Q Consensus 473 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~ 550 (646)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987643322 22334568899999999999999999999999999999998 9999864
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
....+. +. ..+........+...+..+.+++.+||+.||.+|||+.||+++|+.+.+..
T Consensus 254 ~~~~~~------~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEE------FC---------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHH------HH---------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHH------HH---------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 432211 11 111111122234445577999999999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=372.92 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=211.8
Q ss_pred HHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEe
Q 046188 324 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLE 399 (646)
Q Consensus 324 ~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~ 399 (646)
..+++...++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999965 58899999876421 1112347789999999999999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
++..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NIL 200 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNML 200 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHee
Confidence 9999999999999999998854 25889999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
++.++.+||+|||+++.............+||+.|+|||++.... ++.++|||||||++|||++|+.||......+
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 999999999999999877554443444578999999999997655 7899999999999999999999997543322
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCC--HHHHHHHHHHHHhccccCCCC--CCCHHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEAS--EEDIEAVAELAMGCLRLNSKK--RPTMKQVSMDLE 618 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~--RPs~~evl~~L~ 618 (646)
. + ..++.......++ ...+..+.+|+.+||+.+|.+ ||+++||+++-.
T Consensus 281 ~------~---------~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 281 T------Y---------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp H------H---------HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred H------H---------HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 1 1 1122211111122 235577899999999999988 999999998744
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=361.61 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=206.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCE----EEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSI----VAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~----VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|...+.||+|+||.||+|... +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999954 4544 7888765422 223346778999999999999999999986 456899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 92 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---------------GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---------------GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSC
T ss_pred EEEeCCCCCHHHHHHHcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCe
Confidence 999999999999997643 25899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......+|..|+|||.+.++.++.++||||||+++|||++ |+.||......+.
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------- 226 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV------- 226 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------
Confidence 99999999998754332 22344568889999999999999999999999999999999 9999875432221
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.+.+........+..++..+.+++.+||+.||.+||++.|++++|+++....
T Consensus 227 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 227 ---------PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---------HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---------HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111122222334445567889999999999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.88 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=197.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH--------------------------HHHHHHHHHHHHHh
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK--------------------------TQIEQFINEVVILS 383 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~--------------------------~~~~~~~~Ei~il~ 383 (646)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999985 4688999998754321 12356889999999
Q ss_pred hcCccCceeEEEEEEe--CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 046188 384 QINHRHIVKLLGCCLE--TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 461 (646)
Q Consensus 384 ~l~H~niv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 461 (646)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++.+++.++.|+++||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----------------KPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----------------SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999987 4578999999999999887543 36999999999999999999999
Q ss_pred cCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCC---CCCccchhhHHHHH
Q 046188 462 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVL 538 (646)
Q Consensus 462 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSfGvvl 538 (646)
+++ |+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++
T Consensus 155 ~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp HTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred HCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 999 99999999999999999999999999987643322 223457999999999997765 37789999999999
Q ss_pred HHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 539 LELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 539 ~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
|||++|+.||....... ..... .............+..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~l~~g~~pf~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 231 YCFVFGQCPFMDERIMC------LHSKI---------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHSSCSSCCSSHHH------HHHHH---------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHCCCCCCCccHHH------HHHHH---------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999999986543211 11111 01111111122345678999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.35 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=205.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHH------HHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKT------QIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|...+.||+|+||.||++... +|+.||||.++..... ..+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999964 6899999987643211 346788999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~ 151 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----------------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----------------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCT
T ss_pred EEEEEcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCC
Confidence 9999999999999999653 36999999999999999999999999 9999999999999887
Q ss_pred C----cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 484 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 484 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+ .+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..||......+.
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--- 226 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 226 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---
T ss_pred CCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 7 79999999998764432 22345799999999999998999999999999999999999999975433221
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+....... . -.++... ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 227 ---~~~i~~~~-~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 227 ---LANITAVS-Y--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ---HHHHHTTC-C--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHhcC-C--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111100 0 0011111 1234678899999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.63 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=204.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH------HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|...+.||+|+||.||++... +|+.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57888999999999999999964 689999998764321 13567889999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 91 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRN 151 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----------------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSS
T ss_pred EEEEcCCCCCHHHHHHhc----------------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCC
Confidence 999999999999998653 36999999999999999999999999 99999999999999887
Q ss_pred ----cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 485 ----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 485 ----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---- 225 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---- 225 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----
T ss_pred CCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----
Confidence 899999999987643322 2345699999999999999999999999999999999999999975433221
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ . . ..... ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 226 --~~~~~~~~-~-~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 --LANVSAVN-Y-E-FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --HHHHHHTC-C-C-CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHhcC-C-C-cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111000 0 0 00000 11234678899999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.99 Aligned_cols=254 Identities=31% Similarity=0.533 Sum_probs=204.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH----HH---HHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK----TQ---IEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~----~~---~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
++|+..+.||+|+||.||+|.. .+++.||||++..... .. .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6788899999999999999996 4689999998754221 11 157889999999999999999999986544
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||||+|||++.+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA---------------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT---------------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCC
T ss_pred eEEEEecCCCCHHHHHhccc---------------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEecc
Confidence 79999999999999886542 37999999999999999999999987 359999999999999887
Q ss_pred Cc-----EEEeecCCccccCCCCCccccccccCCcccChhcc--ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 484 FS-----AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF--QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 484 ~~-----~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
+. +||+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 76 99999999985432 22345689999999998 445678999999999999999999999865432211
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
. .. ............+..++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 237 ~----~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 K----FI---------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp H----HH---------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred H----HH---------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 01 111112222334556667899999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=370.74 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=211.9
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEE
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCC 397 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~ 397 (646)
+.+++++...++|+..+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566667789999999999999999999964 68999999986421 12234578899999999999999999999
Q ss_pred EeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 398 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
.+.+..+|||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~N 192 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---------------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDN 192 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHH
Confidence 99999999999999999999997532 36999999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-------SSQYTDKSDVYSFGVVLLELLTGKKPICL 550 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 550 (646)
||++.++.+||+|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||..
T Consensus 193 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp EEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999999999999999887554443344567999999999987 35689999999999999999999999976
Q ss_pred CchHHhhcHHHHHHHHHhhchhHHHhhhhhc-ccCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHHHH
Q 046188 551 TREEEERNLVAYFISLAKENKLLEILDARVA-KEASEEDIEAVAELAMGCLRLNSKKR---PTMKQVSMDL 617 (646)
Q Consensus 551 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~R---Ps~~evl~~L 617 (646)
....+. +....... ..+. ...+...+..+.+|+.+||+ +|.+| |+++||+++-
T Consensus 273 ~~~~~~------~~~i~~~~-------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 273 DSTAET------YGKIVHYK-------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp SSHHHH------HHHHHTHH-------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred CCHHHH------HHHHHhcc-------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 443221 11111100 0010 11123455778999999999 99998 6899997763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=361.34 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=199.8
Q ss_pred cCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccCCC
Q 046188 336 QSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
..+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..+|||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356799999999999995 4689999999987666677789999999999999999999999999999999999999999
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE--CCCCcEEEeecC
Q 046188 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAKVSDFG 492 (646)
Q Consensus 415 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl--~~~~~~kI~DfG 492 (646)
|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 173 L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 173 LFDRIIDES---------------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp EHHHHHHTG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred HHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCC
Confidence 999986542 25899999999999999999999999 9999999999999 677899999999
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchh
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 572 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 572 (646)
+++....... .....||+.|+|||.+....++.++|||||||++|||++|+.||......+. ........ .
T Consensus 235 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~-~ 305 (373)
T 2x4f_A 235 LARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACR-W 305 (373)
T ss_dssp SCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-C
T ss_pred CceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcc-C
Confidence 9987643322 2334699999999999988999999999999999999999999975543221 11111110 0
Q ss_pred HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 573 LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 573 ~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 306 ------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 ------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001112344678999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.88 Aligned_cols=279 Identities=25% Similarity=0.425 Sum_probs=218.7
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcCC-C-----CEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEE
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLPD-G-----SIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCL 398 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~~-g-----~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~ 398 (646)
++...++|...+.||+|+||.||+|.... + ..||+|.++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34445789999999999999999999532 2 47999998754 344567789999999999 8999999999999
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
+.+..++||||+++|+|.+++............ .......+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--FAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhccccccccc--ccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 999999999999999999999765321000000 0001236899999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHh
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEE 556 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 556 (646)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986533322 22233457889999999999999999999999999999999 8888864332111
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
....+........+...+..+.+++.+||+.||.+|||+.||++.|+.+....+
T Consensus 276 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 276 ---------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp ---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 111222222223344456778999999999999999999999999999877544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.50 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=204.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCc--cCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H--~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++++++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 357889999999999999999988899999998754 345556788999999999976 9999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|| +.+|+|.+++... ..+++.++..|+.|++.||.|||+++ |+||||||+|||++ ++.+
T Consensus 88 ~e-~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK----------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp EC-CCSEEHHHHHHHS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEE
T ss_pred Ee-CCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcE
Confidence 99 4688999999753 36899999999999999999999999 99999999999997 5789
Q ss_pred EEeecCCccccCCCCCc-cccccccCCcccChhcccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 487 KVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 99999999876433222 2334579999999999865 67899999999999999999999998643221
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. ..+..++++......+......+.+|+.+||+.||.+|||+.|++++..
T Consensus 227 ~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 227 I--------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp H--------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred H--------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1 1122334444444455555677899999999999999999999998755
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.38 Aligned_cols=275 Identities=28% Similarity=0.436 Sum_probs=213.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCE--EEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSI--VAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~--VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|+||.||+|... ++.. ||||+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68888999999999999999964 4554 499987653 334456788999999999 999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.....................+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 9999999999999775421111111111122357999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------- 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------- 250 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---------
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---------
Confidence 99999999753211 11223357889999999998889999999999999999998 9999865432211
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
.+.+........+...+..+.+|+.+||+.||.+|||+.|++++|+++.......
T Consensus 251 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 251 -------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp -------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred -------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 1111111222334455678999999999999999999999999999998765433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=362.27 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=209.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||.||+|... +|+.||+|.+..........+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999964 6899999998876666667889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--CCcEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAK 487 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~k 487 (646)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 130 ~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vk 191 (387)
T 1kob_A 130 LSGGELFDRIAAED---------------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVK 191 (387)
T ss_dssp CCCCBHHHHTTCTT---------------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEE
T ss_pred CCCCcHHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceE
Confidence 99999999986542 36899999999999999999999999 999999999999974 57899
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. .....
T Consensus 192 L~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~ 263 (387)
T 1kob_A 192 IIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVK 263 (387)
T ss_dssp ECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHH
T ss_pred EEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999987644322 2334699999999999999999999999999999999999999975433211 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. +...........+..+.+++.+||+.||.+|||+.|++++
T Consensus 264 ~~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 264 RC-------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HC-------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hC-------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 10 0001111223445678999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=352.47 Aligned_cols=254 Identities=22% Similarity=0.409 Sum_probs=205.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-C-------CEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-G-------SIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g-------~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
++|...+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578889999999999999998542 3 46999998776666677899999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++..... .+++..++.|+.|++.||.|||+++ |+||||||+|||++.+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN---------------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIRE 149 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG---------------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCCC---------------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecC
Confidence 999999999999999976432 4899999999999999999999999 9999999999999988
Q ss_pred Cc--------EEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 484 FS--------AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 484 ~~--------~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+. +||+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+......
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 87 999999999754221 23458899999999987 67899999999999999999976655432221
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
... . .. ... ....+...+..+.+++.+||+.||.+|||+.|++++|+.+..+..
T Consensus 225 ~~~-----~-~~---------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 225 QRK-----L-QF---------YED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHH-----H-HH---------HHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HHH-----H-HH---------hhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 110 0 00 000 111222334568899999999999999999999999999877544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.48 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=201.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||+|...+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999987799999998765332 2235788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ ++|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE---------------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp CS-EEHHHHHHTST---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cC-CCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 96 48988886542 36899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +. .+.....
T Consensus 143 Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~ 218 (288)
T 1ob3_A 143 DFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LM-RIFRILG 218 (288)
T ss_dssp CTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHC
T ss_pred ECccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHHHC
Confidence 9999987643222 2233468999999999876 4589999999999999999999999976543321 11 1111111
Q ss_pred hch---hHH-----Hhhhhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENK---LLE-----ILDARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~---~~~-----~~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ... ..++... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 100 000 0011100 01122345678899999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.24 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=204.2
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc--CccCceeEEEEEEeC----
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI--NHRHIVKLLGCCLET---- 400 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l--~H~niv~l~g~~~~~---- 400 (646)
-....++|...+.||+|+||.||+|... |+.||||++.... ...+..|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3444578999999999999999999984 8999999986532 23445566666554 999999999999887
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCC
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA-----SIPIFHRDIKS 475 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-----~~~ivHrDIk~ 475 (646)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. .++|+||||||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred CceEEEEeccCCCcHHHHhhc-----------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence 678999999999999999954 25899999999999999999999981 11299999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCcc---ccccccCCcccChhccccCCCCCc------cchhhHHHHHHHHHhC--
Q 046188 476 SNILLDDKFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSSQYTDK------SDVYSFGVVLLELLTG-- 544 (646)
Q Consensus 476 ~NILl~~~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~k------sDVwSfGvvl~ElltG-- 544 (646)
+|||++.++.+||+|||+++......... .....||+.|+|||.+.+...+.+ +||||||+++|||++|
T Consensus 171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 99999999999999999998764332221 123569999999999987766665 9999999999999999
Q ss_pred --------CCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCC-----HHHHHHHHHHHHhccccCCCCCCCHH
Q 046188 545 --------KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAS-----EEDIEAVAELAMGCLRLNSKKRPTMK 611 (646)
Q Consensus 545 --------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~ 611 (646)
+.|+........ ........... .......+ ..++..+.+|+.+||+.||.+|||+.
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDP--SYEDMREIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred cccccccccccHhhhcCCCC--chhhhHHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 555543221110 00111111111 11111222 36778899999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q 046188 612 QVSMDLEGLRRSQ 624 (646)
Q Consensus 612 evl~~L~~i~~~~ 624 (646)
||+++|+++.++.
T Consensus 321 ell~~L~~l~~~~ 333 (337)
T 3mdy_A 321 RVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhhc
Confidence 9999999998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=346.81 Aligned_cols=259 Identities=26% Similarity=0.451 Sum_probs=208.9
Q ss_pred CCCcCccccccCcEEEEEEEcC-CC---CEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce-EEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP-VLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g---~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~-~LV 406 (646)
.|...+.||+|+||.||+|... ++ ..||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4555689999999999999853 22 37999998753 345567899999999999999999999999876654 999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+.+|+|.+++.... ..+++..++.|+.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 102 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~ 163 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---------------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTV 163 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---------------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EecccCCCHHHHHhccc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 99999999999997642 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCC---CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+........
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~------- 236 (298)
T 3pls_A 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------- 236 (298)
T ss_dssp EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------
T ss_pred EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------
Confidence 999999998654322 1122335678999999999999999999999999999999997766543222111
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
+...+........+...+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 237 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 237 --------LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------HHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111111222334455678999999999999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=358.72 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=204.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-----HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57889999999999999999954 68999999875321 1135678899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~g~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRAD------------AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp EEECCSSCBHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSST
T ss_pred EEeCCCCCCHHHHHHHhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCC
Confidence 9999999999988865432 1235899999999999999999999999 999999999999987655
Q ss_pred ---EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 486 ---AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 486 ---~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~ 240 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------L 240 (351)
T ss_dssp TCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------H
T ss_pred CCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------H
Confidence 99999999987654322 233457999999999999999999999999999999999999999753211 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
+....... . ...+... ...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 241 ~~~i~~~~-~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 241 FEGIIKGK-Y--KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp HHHHHHTC-C--CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHcCC-C--CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 11111100 0 0001111 12346789999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=384.67 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=207.5
Q ss_pred CCCcCc-cccccCcEEEEEEEcC---CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 333 NYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 333 ~~~~~~-~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++...+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|+++|++++||||+++++++.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333334 7999999999999863 45679999987642 3456789999999999999999999999975 5689999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+|
T Consensus 415 E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR---------------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp ECCTTCBHHHHHTTCT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEE
T ss_pred EeCCCCcHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEE
Confidence 9999999999997542 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccc--cccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||+++.......... ....+|+.|+|||++.++.++.++|||||||+||||++ |+.||......+.
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------- 548 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------- 548 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--------
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------
Confidence 999999987643332221 22346789999999999999999999999999999998 9999875443221
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
.+.+........+..++..+.+|+.+||+.||++||++.+|++.|+.+..+.
T Consensus 549 --------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 549 --------MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --------HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1112222233455667788999999999999999999999999999887654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=356.58 Aligned_cols=258 Identities=23% Similarity=0.453 Sum_probs=205.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCE----EEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSI----VAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~----VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..+.||+|+||.||+|... +++. ||+|.++.. .....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57889999999999999999953 4543 577876542 3345668899999999999999999999998654 789
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|+||+++|+|.+++.... ..+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 94 v~~~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCC
Confidence 999999999999997643 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 227 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 227 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------
Confidence 99999999987643222 22233457889999999999999999999999999999999 999986543322
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
+...+........+...+..+.+++.+||+.||.+||++.|+++.|+++....
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 228 --------ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --------HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11222222233345556678999999999999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=347.12 Aligned_cols=260 Identities=28% Similarity=0.506 Sum_probs=198.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|...+.||+|+||.||+|+.. ..||||+++. ......+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999874 3599998764 3455667899999999999999999999965 4566899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 100 ~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---------------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp CCCEEEHHHHHTTC------------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEE
T ss_pred ecCCCcHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEE
Confidence 999999999996543 36999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCC-CCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 489 SDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 489 ~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+|||+++..... .........||+.|+|||.+. ...++.++||||||+++|||++|+.||......+. ..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~ 235 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------II 235 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HH
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HH
Confidence 999999865321 222233456899999999986 56788899999999999999999999975433221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
........ .+. .......++..+.+|+.+||+.||.+|||+.|+++.|+++.+
T Consensus 236 ~~~~~~~~----~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 236 EMVGRGSL----SPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHTSC----CCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHhccccc----Ccc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111 000 011233455789999999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.82 Aligned_cols=261 Identities=27% Similarity=0.468 Sum_probs=199.8
Q ss_pred CCCcCccccccCcEEEEEEEcC--CC--CEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe-CCceEEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP--DG--SIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLV 406 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~--~g--~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-~~~~~LV 406 (646)
.|...+.||+|+||.||+|... ++ ..||||.++. ......+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999853 22 3689998865 334566789999999999999999999999765 4578999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+++ |+||||||+|||+++++.+
T Consensus 170 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 231 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---------------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTV 231 (373)
T ss_dssp EECCTTCBHHHHHHCTT---------------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EECCCCCCHHHHHhhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCE
Confidence 99999999999996542 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCc---cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHH
Q 046188 487 KVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 562 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 562 (646)
||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~- 307 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV- 307 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH-
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH-
Confidence 99999999876432211 1233457889999999999999999999999999999999 566664332211 110
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
.+........+..++..+.+++.+||+.||++||++.|+++.|+.+.......
T Consensus 308 ------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 308 ------------YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 00111112233445678999999999999999999999999999998765443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.82 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=207.3
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
..++|...+.||+|+||.||++... +|+.||+|+++. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999964 689999998764 3445667889999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC--
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-- 484 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-- 484 (646)
|||+++|+|.+++... ..+++..++.++.|+++||.|||+++ |+||||||+|||++.++
T Consensus 107 ~e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~ 167 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG 167 (362)
T ss_dssp ECCCCSCBHHHHHTTC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTT
T ss_pred EecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCC
Confidence 9999999999988653 36899999999999999999999999 99999999999998654
Q ss_pred -cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 -SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 -~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. .
T Consensus 168 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------~ 239 (362)
T 2bdw_A 168 AAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------Y 239 (362)
T ss_dssp CCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred CCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------H
Confidence 59999999998764332 22345799999999999998999999999999999999999999975433211 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..... +.. ..........+..+.+|+.+||+.||.+||++.|++++-
T Consensus 240 ~~i~~-~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 240 AQIKA-GAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp HHHHH-TCC------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred HHHHh-CCC------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 11111 000 000001123456789999999999999999999998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.13 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=209.3
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe----CCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~----~~~~~L 405 (646)
.++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999995 5789999999877667777889999999999999999999999873 236789
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 108 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~ 172 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD------------KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQ 172 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred EEEeCCCCcHHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCC
Confidence 9999999999999976432 1347999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc--------cccccccCCcccChhccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 486 AKVSDFGTSRSVPNDKTH--------LTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+||+|||++......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||......
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 999999998765321110 012245799999999987554 688999999999999999999998421100
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.......+........+...+..+.+++.+||+.||.+||++.|++++|+.+...
T Consensus 253 --------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 253 --------------GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --------------TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --------------cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0011111111112222334557899999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=347.25 Aligned_cols=263 Identities=20% Similarity=0.312 Sum_probs=202.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999964 6899999987642 33345678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++ +|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl 142 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---------------NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp CCSE-EHHHHHHHT---------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred cCCC-CHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9964 665555442 236999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+........ ....+....
T Consensus 143 ~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~ 219 (292)
T 3o0g_A 143 ANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLL 219 (292)
T ss_dssp CCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHH
T ss_pred eecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHh
Confidence 99999987643222 223456899999999997765 79999999999999999999988654332221 111111111
Q ss_pred hhch---hHHHhh---h---------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENK---LLEILD---A---------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~---~~~~~d---~---------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... ...+.+ . ..........+..+.+|+.+||+.||++|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1110 000000 0 00011122345678899999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.57 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=202.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~L 405 (646)
.++|+..+.||+|+||.||+++.. +|+.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999954 5899999998642 223445678899999988 79999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 102 v~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----------------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp EEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCC
Confidence 99999999999998653 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+|||+++..... .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. +..
T Consensus 163 ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~ 235 (353)
T 3txo_A 163 CKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEA 235 (353)
T ss_dssp EEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEEccccceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 999999999864322 2223446799999999999988899999999999999999999999975443221 111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM------KQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~evl~~ 616 (646)
. .... ..++......+.+|+.+||+.||.+||++ .||+++
T Consensus 236 i---------~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 236 I---------LNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp H---------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred H---------HcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 1111 12344456778999999999999999998 677664
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.58 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=204.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-CceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-~~~~LV~Ey 409 (646)
.++|+..+.||+|+||.||+|.. +|+.||||.++... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46888999999999999999998 58899999987643 456788999999999999999999997655 478999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++..... ..+++..++.++.|+++||+|||+++ ++||||||+||+++.++.+||+
T Consensus 97 ~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 159 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR--------------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 159 (278)
T ss_dssp CTTEEHHHHHHHHHH--------------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEEC
T ss_pred CCCCCHHHHHHhccc--------------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEe
Confidence 999999999975422 24889999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 160 Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------------ 223 (278)
T 1byg_A 160 DFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------ 223 (278)
T ss_dssp CCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH------------
T ss_pred eccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------------
Confidence 999998653221 22357889999999999999999999999999999998 9999865432211
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
...+........+...+..+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 224 ----VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ----HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111111222344556678999999999999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.30 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=193.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999964 68999999886432 2234578899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|++ |+|.+++...... .....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~~-~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVG----------NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp CCC-CBHHHHHHHHHSS----------SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred ecC-CCHHHHHHhcccc----------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEE
Confidence 997 6999998654320 01235899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ..+....
T Consensus 150 ~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~ 225 (317)
T 2pmi_A 150 GDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIM 225 (317)
T ss_dssp CCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred CcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHh
Confidence 99999987643222 2233468999999999876 46899999999999999999999999765543321 1111111
Q ss_pred hhc------------------------hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KEN------------------------KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~------------------------~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... .+.+.+.+.. +...+..+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 100 0111111111 12234678999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=357.92 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=202.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+.|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999994 57899999997642 2334567899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+. |+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||+++++.+|
T Consensus 134 e~~~-g~l~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 194 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 194 (348)
T ss_dssp ECCS-EEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEE
T ss_pred ecCC-CCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 9996 7888887543 237999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||+++..... ....||+.|+|||.+. .+.++.++||||||+++|||++|+.||........ ..
T Consensus 195 L~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~ 263 (348)
T 1u5q_A 195 LGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY 263 (348)
T ss_dssp ECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH
T ss_pred EeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HH
Confidence 9999999865322 2356899999999984 57789999999999999999999999865432211 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... ......+...+..+.+++.+||+.||.+|||+.|++++..
T Consensus 264 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 264 HIAQN---------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHhc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11111 0111112334567899999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.40 Aligned_cols=267 Identities=24% Similarity=0.385 Sum_probs=204.3
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc---CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||+|.. .+|+.||||+++. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999995 4789999998764 3455667889999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++..... ....+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+
T Consensus 111 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK------------QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVV 175 (310)
T ss_dssp EECCCSCBHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EecCCCCCHHHHHHHhcc------------cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCE
Confidence 999999999999975432 1346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 176 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~ 250 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI 250 (310)
T ss_dssp EECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH
T ss_pred EEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh
Confidence 9999999986543222 223346899999999999999999999999999999999999998643211 11111111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
. ........+...+..+.+++.+||+.||.+|||+.||++.|+++......
T Consensus 251 -~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 251 -E--------QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -H--------TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -h--------cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1 01111111233456789999999999999999999999999999876443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.15 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=206.0
Q ss_pred HhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
..++|...+.||+|+||.||++.. .+|+.+|+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356899999999999999999985 46899999987643 234556789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC---CC
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DK 483 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~ 483 (646)
|||+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+|||++ .+
T Consensus 89 ~E~~~gg~L~~~i~~~----------------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR----------------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp ECCCBCCBHHHHHHHC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTT
T ss_pred EEeCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCC
Confidence 9999999999998653 36999999999999999999999999 99999999999998 56
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. +
T Consensus 150 ~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------~ 222 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------Y 222 (444)
T ss_dssp CCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------H
T ss_pred CcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------H
Confidence 7899999999987644322 22345799999999999999999999999999999999999999975433221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... +.. ....+.....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 223 ~~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 223 QQIKA-GAY------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHH-TCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHh-CCC------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111 000 00011112345678999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=351.58 Aligned_cols=245 Identities=28% Similarity=0.394 Sum_probs=206.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+++.. +|+.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67889999999999999999964 68999999986421 123456788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 86 e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp CCCCSCBHHHHHHHT----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEE
T ss_pred eCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEE
Confidence 999999999999653 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .+..
T Consensus 147 L~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~-- 214 (318)
T 1fot_A 147 ITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEK-- 214 (318)
T ss_dssp ECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH--
T ss_pred EeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHH--
Confidence 9999999875432 234579999999999999999999999999999999999999997543221 1111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
++... ..++...+..+.+++.+||+.||.+|| +++||+++
T Consensus 215 -------i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 215 -------ILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -------HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------HHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111 123444567789999999999999999 88998865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=347.39 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=211.1
Q ss_pred hcCCCcCc-cccccCcEEEEEEEc---CCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 331 TDNYNQSR-FLGQGGFGTVYKGML---PDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 331 t~~~~~~~-~IG~G~~g~Vy~g~~---~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
.++|...+ .||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999964 246789999987532 33456789999999999999999999999 567789
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++... ..+++..++.++.|+++||+|||+++ ++||||||+||+++.++
T Consensus 94 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN----------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 154 (291)
T ss_dssp EEEECCTTEEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred EEEEeCCCCCHHHHHHhC----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCC
Confidence 999999999999999653 35899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCcc--ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----- 229 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----- 229 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----
Confidence 99999999998765443322 122346789999999998889999999999999999999 9999875443221
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
.+.+........+..++..+.+++.+||+.||.+||++.||++.|+.+..+....
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 230 -----------TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp -----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred -----------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 1111111122344556678999999999999999999999999999998765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=361.36 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=203.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~L 405 (646)
.++|+..+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 368999999999999999999964 5789999987642 233344678899999887 89999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.
T Consensus 131 V~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp EEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEcCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCC
Confidence 99999999999998653 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh--hcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE--RNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~--~~l~~~~ 563 (646)
+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .......
T Consensus 192 ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp EEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred EEEeecceeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 999999999863222 2223456799999999999999999999999999999999999999964322111 0000111
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM------KQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~evl~~ 616 (646)
.. .+... ...+|...+..+.+|+.+||+.||.+||++ .||+++
T Consensus 271 ~~--------~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 271 FQ--------VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HH--------HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HH--------HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11 11111 123455566788999999999999999995 566554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.16 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=200.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999964 5899999987543 23345678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 83 ~~~~~~l~~~~~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----------------RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp CCSEEHHHHHHHTS----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred eCCCchHHHHHhhh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEE
Confidence 99999998887542 36899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... .....
T Consensus 144 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~ 219 (311)
T 4agu_A 144 CDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTL 219 (311)
T ss_dssp CCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHH
T ss_pred eeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHh
Confidence 99999987643322 2234568999999999876 6789999999999999999999999976554432211 11111
Q ss_pred hhc--hhHHHhh-hhh------c---ccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KEN--KLLEILD-ARV------A---KEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~--~~~~~~d-~~l------~---~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ....... ... . ... ....+..+.+|+.+||+.||.+|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 100 0000000 000 0 000 02345668999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.43 Aligned_cols=271 Identities=21% Similarity=0.338 Sum_probs=200.2
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEe--------C
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLE--------T 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~--------~ 400 (646)
..+|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45888999999999999999995 468999999987766777778999999999996 9999999999953 2
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
...++||||+ +|+|.+++..... ...+++.+++.|+.|++.||.|||+++ ++|+||||||+|||+
T Consensus 107 ~~~~lv~e~~-~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 107 AEFLLLTELC-KGQLVEFLKKMES-------------RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLL 171 (337)
T ss_dssp EEEEEEEECC-SEEHHHHHHHHHT-------------TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEE
T ss_pred ceEEEEEEec-CCCHHHHHHHhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEE
Confidence 3478999999 5899999876432 346999999999999999999999986 359999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc-----------cccccccCCcccChhcc---ccCCCCCccchhhHHHHHHHHHhCCC
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTH-----------LTTAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKK 546 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSfGvvl~ElltG~~ 546 (646)
+.++.+||+|||+++........ ......||+.|+|||.+ .+..++.++||||||+++|||++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 99999999999999876432211 11134589999999998 56678999999999999999999999
Q ss_pred CCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 547 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 547 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
||...... ++++.......+......+.+|+.+||+.||.+||++.|++++|+.+......
T Consensus 252 p~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 252 PFEDGAKL-------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp CC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred CCcchhHH-------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 98532111 11111111112222334578999999999999999999999999999887655
Q ss_pred hccCccccc
Q 046188 627 LEIGKVNQL 635 (646)
Q Consensus 627 ~~~~~~~~~ 635 (646)
........+
T Consensus 313 ~~~~~~~~~ 321 (337)
T 3ll6_A 313 NPKSPITEL 321 (337)
T ss_dssp CTTSCCHHH
T ss_pred CCCccHHHH
Confidence 444444433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.92 Aligned_cols=266 Identities=20% Similarity=0.264 Sum_probs=206.6
Q ss_pred HhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEE-EeCCceEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC-LETEVPVLVY 407 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~-~~~~~~~LV~ 407 (646)
..++|...+.||+|+||.||+|.. .+++.||||...... ..+.+.+|++++++++|++++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999994 578899999865422 223577899999999988877777666 5566789999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCCC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKF 484 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~ 484 (646)
||+ +|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++
T Consensus 85 e~~-~~~L~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~ 145 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS---------------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp ECC-CCBHHHHHHHTT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTT
T ss_pred Ecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCC
Confidence 999 999999987532 36999999999999999999999999 9999999999999 7899
Q ss_pred cEEEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 485 SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 999999999987643322 12234579999999999999999999999999999999999999997544332222
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
............. .+... ...+..+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 226 ~~~~~~~~~~~~~-----~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 226 KYERISEKKMSTP-----IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHHHHHHHSC-----HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhhhhcccccch-----hhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 2111111100000 00111 1234678999999999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=361.00 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=203.7
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcC--ccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQIN--HRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~--H~niv~l~g~~~~~~~~~LV~ 407 (646)
.+|...+.||+|+||.||++...+++.||||++.. ......+.+.+|+.+|++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46899999999999999999987899999998754 34556678999999999996 599999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
| +.+++|.+++... ..+++.+++.|+.||+.||.|||+++ |+||||||+|||++ ++.+|
T Consensus 136 E-~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp E-CCSEEHHHHHHHC----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEE
T ss_pred e-cCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEE
Confidence 9 5689999998653 36899999999999999999999999 99999999999996 57999
Q ss_pred EeecCCccccCCCCC-ccccccccCCcccChhcccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 488 VSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 488 I~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 999999987643322 22344579999999999865 468899999999999999999999996432211
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..+..++++......+...+..+.+|+.+||+.||.+||++.|++++-.
T Consensus 275 --------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 275 --------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp --------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 1122333443333444444567899999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=356.74 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=191.5
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..++|...+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3568999999999999999999965 57899999987532 34567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC---CCc
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFS 485 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~ 485 (646)
|+++|+|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.
T Consensus 129 ~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~ 189 (349)
T 2w4o_A 129 LVTGGELFDRIVEK----------------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAP 189 (349)
T ss_dssp CCCSCBHHHHHTTC----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCC
T ss_pred eCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCC
Confidence 99999999998653 35899999999999999999999999 999999999999975 889
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+..
T Consensus 190 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~ 262 (349)
T 2w4o_A 190 LKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRR 262 (349)
T ss_dssp EEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHH
T ss_pred EEEccCccccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHH
Confidence 999999999875432 222345689999999999999999999999999999999999999865432211 0111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... . ....+.....+..+.+|+.+||+.||++|||+.|++++
T Consensus 263 i~~~~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 263 ILNCE-Y------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHTTC-C------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCC-C------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 0 00111123445678999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=351.42 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=197.7
Q ss_pred hcCCCcCccccccCcEEEEEEEc----CCCCEEEEEecccCC----HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
.++|+..+.||+|+||.||+++. .+|+.||||+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999986 468999999987532 2344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~ 156 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----------------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNH 156 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECT
T ss_pred EEEEEeCCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECC
Confidence 99999999999999998653 35899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------ 229 (327)
T 3a62_A 157 QGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------ 229 (327)
T ss_dssp TSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------
T ss_pred CCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------
Confidence 9999999999998643222 223345799999999999998999999999999999999999999975433211
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMDL 617 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~L 617 (646)
... +... ....+...+..+.+++.+||+.||.+|| ++.|++++-
T Consensus 230 ~~~---------i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 230 IDK---------ILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHH---------HHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHH---------HHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 111 1111 1123444567789999999999999999 778887753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=349.42 Aligned_cols=266 Identities=25% Similarity=0.444 Sum_probs=203.7
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC-
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE- 401 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~- 401 (646)
...++|...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888899999999999999853 2448999998643 4555678999999999999999999999998755
Q ss_pred ----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 402 ----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 402 ----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
..++||||+++|+|.+++...... .....+++..++.|+.|+++||.|||+++ |+||||||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLE----------TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBT----------TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhh----------cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 349999999999999998653210 01346999999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHH
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 555 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~ 555 (646)
||+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 9999999999999999987643322 12233457889999999999999999999999999999999 888876543221
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
. . +.+........+...+..+.+++.+||+.||.+||++.+++++|+++.+.
T Consensus 258 ~---~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 258 M---Y-------------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp H---H-------------HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---H-------------HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 0 11111111233445567899999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.60 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=205.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999964 5889999997642 345566788999999988 899999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 89 ~e~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp ECCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCE
Confidence 9999999999998653 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh--cHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER--NLVAYFI 564 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~--~l~~~~~ 564 (646)
||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .......
T Consensus 150 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 228 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228 (345)
T ss_dssp EECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH
T ss_pred EEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH
Confidence 999999998643222 2234467999999999999999999999999999999999999999643211100 0000011
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM------KQVSMD 616 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~------~evl~~ 616 (646)
..+... ...++...+..+.+|+.+||+.||.+||++ .|++++
T Consensus 229 --------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 229 --------QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp --------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred --------HHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111111 123445566788999999999999999995 566654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.57 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=211.5
Q ss_pred cCHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhh--cCccCceeEEEEEEe
Q 046188 322 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQ--INHRHIVKLLGCCLE 399 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~--l~H~niv~l~g~~~~ 399 (646)
.+...-....++|...+.||+|+||.||+|+. +|+.||||+++.. ....+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33444455567899999999999999999998 5899999998653 34567789998887 799999999999987
Q ss_pred CC----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCC
Q 046188 400 TE----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH--------SSASIP 467 (646)
Q Consensus 400 ~~----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--------~~~~~~ 467 (646)
.+ ..++||||+++|+|.+++.. ..+++.+++.++.|++.||.||| +.+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--- 167 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--- 167 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---
Confidence 76 78999999999999999954 25899999999999999999999 777
Q ss_pred eEecCCCCCCEEECCCCcEEEeecCCccccCCCCCc---cccccccCCcccChhccccC------CCCCccchhhHHHHH
Q 046188 468 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVL 538 (646)
Q Consensus 468 ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSfGvvl 538 (646)
|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++
T Consensus 168 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 999999999999999999999999999876443322 22345699999999998765 234689999999999
Q ss_pred HHHHhC----------CCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccC-----CHHHHHHHHHHHHhccccC
Q 046188 539 LELLTG----------KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEA-----SEEDIEAVAELAMGCLRLN 603 (646)
Q Consensus 539 ~ElltG----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~Li~~Cl~~d 603 (646)
|||++| ..||....... ..... ..... ....+.... ..+....+.+|+.+||+.|
T Consensus 248 ~el~tg~~~~~~~~~~~~p~~~~~~~~-~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (342)
T 1b6c_B 248 WEIARRCSIGGIHEDYQLPYYDLVPSD-PSVEE-MRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317 (342)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSS-CCHHH-HHHHH--------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred HHHHhccCcCCcccccccCccccCcCc-ccHHH-HHHHH--------HHHHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence 999999 66765432111 00111 11111 111111122 2356778999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhh
Q 046188 604 SKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 604 P~~RPs~~evl~~L~~i~~~~ 624 (646)
|.+|||+.||+++|+.+.+..
T Consensus 318 p~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 318 GAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp GGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=343.43 Aligned_cols=251 Identities=28% Similarity=0.441 Sum_probs=205.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe----------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE---------- 399 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~---------- 399 (646)
..+|+..+.||+|+||.||+|... +|+.||||+++... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457889999999999999999965 68999999987643 256689999999999999999999864
Q ss_pred ------CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 400 ------TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 400 ------~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 148 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--------------GEKLDKVLALELFEQITKGVDYIHSKK---LINRDL 148 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG--------------GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 334799999999999999997643 247999999999999999999999999 999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
||+|||+++++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 149 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--- 223 (284)
T 2a19_B 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--- 223 (284)
T ss_dssp SGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---
T ss_pred CHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---
Confidence 99999999999999999999987644322 2334689999999999999999999999999999999999988521
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
.. .... .+.+. ..+...+..+.+++.+||+.||.+|||+.|++++|+.+..+..
T Consensus 224 --~~---~~~~---------~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 224 --TS---KFFT---------DLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HH---HHHH---------HHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HH---HHHH---------Hhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 00 0000 11111 1222334568899999999999999999999999999886544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=346.30 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=205.1
Q ss_pred cCCCcCccccccCcEEEEEEEcCC----CCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe-CCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~-~~~~~L 405 (646)
.+|...+.||+|+||.||+|...+ +..||+|.++. ......+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467788999999999999998542 23589998875 344556789999999999999999999999765 457899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++..++.|+.|++.||+|||+++ ++||||||+|||+++++.
T Consensus 105 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 166 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---------------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFT 166 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCC
T ss_pred EEeCCCCCCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCC
Confidence 999999999999996532 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC---ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCC-CCCCchHHhhcHHH
Q 046188 486 AKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEERNLVA 561 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p-~~~~~~~~~~~l~~ 561 (646)
+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++|..| +......+ ..
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~- 242 (298)
T 3f66_A 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT- 242 (298)
T ss_dssp EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH-
T ss_pred EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH-
Confidence 99999999987643221 122334578899999999999999999999999999999995554 43222111 00
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
..+........+...+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 243 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 243 ------------VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00111111222334456799999999999999999999999999998874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=354.98 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=207.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+++.. +|+.||||.++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68889999999999999999964 68999999976421 123457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 121 e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp ECCTTCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred cCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEE
Confidence 999999999999653 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..
T Consensus 182 L~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~-- 249 (350)
T 1rdq_E 182 VTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEK-- 249 (350)
T ss_dssp ECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH--
T ss_pred EcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHH--
Confidence 9999999876432 234579999999999999999999999999999999999999997543221 1111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMDL 617 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~L 617 (646)
+.... ..++...+..+.+++.+||+.||.+||+ ++||+++-
T Consensus 250 -------i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 250 -------IVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -------HHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -------HHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 11111 1234455677899999999999999998 88887754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.59 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=209.4
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEE-EeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC-LETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~-~~~~~~~LV~E 408 (646)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.++++++|++++..++.+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999995 5789999998764322 23678999999999998877766665 45667799999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCCCc
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFS 485 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~ 485 (646)
|+ +++|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||+ ++++.
T Consensus 86 ~~-~~~L~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~ 146 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---------------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp CC-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTC
T ss_pred ec-CCCHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCe
Confidence 99 999999996532 36999999999999999999999999 9999999999999 48899
Q ss_pred EEEeecCCccccCCCCCc------cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 486 AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 3uzp_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence 999999999876443221 12345799999999999999999999999999999999999999975433222222
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
...+........ .+.+. ...+..+.+++.+||+.||.+|||+.||++.|+.+......
T Consensus 227 ~~~~~~~~~~~~-----~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 227 YERISEKKMSTP-----IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHHSC-----HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhhhcccccCCc-----hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 111111100000 01111 22346789999999999999999999999999999876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=350.73 Aligned_cols=269 Identities=25% Similarity=0.422 Sum_probs=212.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468999999999999999999842 4678999998643 455566889999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD- 482 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 482 (646)
++||||+++|+|.+++....... .....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP---------SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 176 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS---------SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEEecCCCCcHHHHHHhhcccc---------cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecC
Confidence 99999999999999997653210 00235999999999999999999999999 999999999999984
Q ss_pred --CCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 483 --KFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 483 --~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
+..+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 254 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-- 254 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH--
Confidence 45699999999986532221 22233567899999999999999999999999999999998 8888865432211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCL 627 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 627 (646)
. +.+........+..++..+.+++.+||+.||.+||++.||+++|+.+.......
T Consensus 255 ----~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 255 ----L----------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp ----H----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred ----H----------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 1 111111112234455678899999999999999999999999999988765443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.95 Aligned_cols=269 Identities=20% Similarity=0.259 Sum_probs=205.0
Q ss_pred hcCCCcCcccccc--CcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQG--GFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G--~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.++|+..+.||+| +||.||+|+.. +|+.||||+++. ......+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999965 689999998764 334556778899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++..... ..+++..+..|+.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--------------DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGK 166 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred EEEccCCCCHHHHHhhhcc--------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 9999999999999976422 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCC------CccccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 486 AKVSDFGTSRSVPNDK------THLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~------~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
+||+|||++....... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999987542211 111223468999999999987 57899999999999999999999999654322110
Q ss_pred --cHHHHHHHHHh------------------hchhHHHhh---------hhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 558 --NLVAYFISLAK------------------ENKLLEILD---------ARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 558 --~l~~~~~~~~~------------------~~~~~~~~d---------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
........... ...+.+.+. .......+...+..+.+|+.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 326 (389)
T 3gni_B 247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326 (389)
T ss_dssp HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence 00000000000 000000000 0000112344557799999999999999999
Q ss_pred CHHHHHHH
Q 046188 609 TMKQVSMD 616 (646)
Q Consensus 609 s~~evl~~ 616 (646)
|+.|++++
T Consensus 327 ta~ell~h 334 (389)
T 3gni_B 327 SASTLLNH 334 (389)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.28 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=195.9
Q ss_pred HHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCC--c
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETE--V 402 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~--~ 402 (646)
...++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.+++++. ||||+++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 4689999998754 34556677889999999997 999999999998654 6
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~ 144 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----------------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNA 144 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred EEEEecccC-cCHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcC
Confidence 899999996 688888754 26899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCC--------------------CCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHH
Q 046188 483 KFSAKVSDFGTSRSVPND--------------------KTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLEL 541 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~--------------------~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~El 541 (646)
++.+||+|||+++..... .........||+.|+|||.+.+ ..++.++|||||||++|||
T Consensus 145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 999999999999865321 1112234579999999999876 6789999999999999999
Q ss_pred HhCCCCCCCCchHHhhcHHHHHHHHHhhchh-----------HHHhh----------------------hhhcccCCHHH
Q 046188 542 LTGKKPICLTREEEERNLVAYFISLAKENKL-----------LEILD----------------------ARVAKEASEED 588 (646)
Q Consensus 542 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-----------~~~~d----------------------~~l~~~~~~~~ 588 (646)
++|+.||......+... .+......... ...++ ...........
T Consensus 225 l~g~~pf~~~~~~~~~~---~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 225 LCGKPIFPGSSTMNQLE---RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 99999997655433211 11111110000 00000 00000011133
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 589 IEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 589 ~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+..+.+|+.+||+.||.+|||+.|++++
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 4678999999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=357.03 Aligned_cols=271 Identities=24% Similarity=0.300 Sum_probs=210.7
Q ss_pred cccCHHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-----ccCceeE
Q 046188 320 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-----HRHIVKL 393 (646)
Q Consensus 320 ~~~~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----H~niv~l 393 (646)
..++..+.....++|...++||+|+||.||+|.. .+++.||||+++.. ....+.+..|+.++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3444555555678999999999999999999996 46889999998743 344556788999999986 9999999
Q ss_pred EEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 394 LGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 394 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
++++...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDl 163 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN--------------YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDL 163 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCC
Confidence 99999999999999999 999999997643 235999999999999999999999999 999999
Q ss_pred CCCCEEECC-------------------------CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCc
Q 046188 474 KSSNILLDD-------------------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDK 528 (646)
Q Consensus 474 k~~NILl~~-------------------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k 528 (646)
||+|||++. ++.+||+|||+++..... .....||+.|+|||.+.+..++.+
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCc
Confidence 999999975 789999999999865332 234568999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh---chhHH--------Hhhh-hhccc-------------
Q 046188 529 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE---NKLLE--------ILDA-RVAKE------------- 583 (646)
Q Consensus 529 sDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~--------~~d~-~l~~~------------- 583 (646)
+|||||||++|||++|+.||......+... .+...... ....+ .++. .+...
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 316 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTHEHMEHLA---MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHH
T ss_pred cchHHHHHHHHHHHHCCCCCCCCcHHHHHH---HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhh
Confidence 999999999999999999997654433211 11111110 00000 0000 00000
Q ss_pred ----C---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 584 ----A---SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 584 ----~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. +......+.+|+.+||+.||++|||+.|++++
T Consensus 317 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 01112568899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=359.21 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=204.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67889999999999999999954 58899999875421 223467889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 95 e~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----------------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp CCCTTEEHHHHHHTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEE
Confidence 999999999998653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||+++...... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||........... ..
T Consensus 156 L~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~ 230 (384)
T 4fr4_A 156 ITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VH 230 (384)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH---HH
T ss_pred EeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH---HH
Confidence 99999998764332 2344679999999999864 4589999999999999999999999975432221111 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-MKQVSM 615 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~evl~ 615 (646)
. +. .....++...+..+.+|+.+||+.||.+||+ +.+|..
T Consensus 231 ~----------~~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 T----------FE-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp H----------HH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred H----------Hh-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 00 1112345556678999999999999999999 666654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=356.87 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=205.9
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCce
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~ 403 (646)
...++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|..+++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999964 58899999986421 22345677899999887 999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 94 ~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC----------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKD 154 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTT
T ss_pred EEEEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCC
Confidence 9999999999999998653 36899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. +
T Consensus 155 g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~ 227 (345)
T 1xjd_A 155 GHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------F 227 (345)
T ss_dssp SCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred CCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------H
Confidence 999999999998643222 223456799999999999999999999999999999999999999975433221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK-QVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~~ 616 (646)
..... . ...++...+..+.+|+.+||+.||.+||++. ||.++
T Consensus 228 ~~i~~---------~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 228 HSIRM---------D--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHH---------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHh---------C--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11111 0 1123444567789999999999999999998 66543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.36 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=202.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999954 6889999998653 333456788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++... ..+++.+++.++.|+++||.|||+.+ |+||||||+|||++.++.+
T Consensus 113 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----------------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFA 173 (309)
T ss_dssp EECCCCEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred EEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCE
Confidence 9999999999998653 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~ 246 (309)
T 2h34_A 174 YLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAH 246 (309)
T ss_dssp EECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHH
T ss_pred EEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHH
Confidence 999999998765443333344568999999999999999999999999999999999999986533211 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHhhhh
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 625 (646)
.... . ......+...+..+.+++.+||+.||.+|| +++++++.|+.+.....
T Consensus 247 ~~~~-~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 247 INQA-I------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHSC-C------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred hccC-C------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1110 0 000122334456789999999999999999 99999999998766544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=380.82 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=204.0
Q ss_pred ccccccCcEEEEEEEcC---CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLP---DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
+.||+|+||.||+|.+. .++.||||+++.. .....+++.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999652 4678999998753 3344678999999999999999999999996 4568999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 454 g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 454 GPLNKYLQQN----------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTT
T ss_pred CCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcC
Confidence 9999999653 36999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 493 TSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 493 la~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
+++........ ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------------- 580 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------------- 580 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence 99876543321 2233457889999999999999999999999999999998 999987544322
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+.+........+..++..+.+|+.+||+.||++||++.+|++.|+.+..+
T Consensus 581 --~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 581 --VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1112222223345566778899999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.13 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=198.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce---
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP--- 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~--- 403 (646)
.++|...+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999995 57899999998653 344556789999999999999999999998876543
Q ss_pred -EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 404 -VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 404 -~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~ 151 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 151 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET
T ss_pred cEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcC
Confidence 9999999999999999653 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~---- 227 (311)
T 3ork_A 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---- 227 (311)
T ss_dssp TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----
T ss_pred CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----
Confidence 99999999999987643322 222335689999999999999999999999999999999999999975443221
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS-MDLEGLR 621 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl-~~L~~i~ 621 (646)
........... ... .....+..+.+++.+||+.||.+||++.+++ ..|.++.
T Consensus 228 --~~~~~~~~~~~---~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 228 --AYQHVREDPIP---PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --HHHHHHCCCCC---HHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --HHHHhcCCCCC---ccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11111111000 000 0122346788999999999999999766655 4555443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=353.23 Aligned_cols=274 Identities=21% Similarity=0.272 Sum_probs=203.0
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-----CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
....++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 45567899999999999999999995 46889999987542 3345678899999999999999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHH-----------------HHHHHH-------hhhcCCCCHHHHHHHHHHHHHHH
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQ-----------------KQELEE-------EQELSSLSWENRVRVACEVAGAV 457 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~-----------------~~~~~~-------~~~~~~l~~~~~~~ia~qia~gL 457 (646)
..++||||+++|+|.+++......... ...... ......+++..++.|+.|+++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998632110000 000000 00011245778889999999999
Q ss_pred HHHHcCCCCCeEecCCCCCCEEECCCC--cEEEeecCCccccCC---CCCccccccccCCcccChhcccc--CCCCCccc
Q 046188 458 AYMHSSASIPIFHRDIKSSNILLDDKF--SAKVSDFGTSRSVPN---DKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSD 530 (646)
Q Consensus 458 ~yLH~~~~~~ivHrDIk~~NILl~~~~--~~kI~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksD 530 (646)
+|||+.+ |+||||||+|||++.++ .+||+|||+++.... ..........||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999 99999999999998776 899999999986532 12222344579999999999865 67899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH
Q 046188 531 VYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610 (646)
Q Consensus 531 VwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 610 (646)
|||||+++|||++|+.||......+. .......... .........+..+.+|+.+||+.||.+||++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 99999999999999999975443221 1111111100 0001111245678999999999999999999
Q ss_pred HHHHHHH
Q 046188 611 KQVSMDL 617 (646)
Q Consensus 611 ~evl~~L 617 (646)
.|++++-
T Consensus 326 ~~~l~hp 332 (345)
T 3hko_A 326 MRALQHP 332 (345)
T ss_dssp HHHHHSH
T ss_pred HHHhcCh
Confidence 9998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=338.36 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=207.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|+..+.||+|+||.||+|... +|+.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999954 589999998754 34556678889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc--
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-- 485 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-- 485 (646)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 85 e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~ 145 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 145 (284)
T ss_dssp CCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTC
T ss_pred ecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCC
Confidence 999999999888653 36899999999999999999999999 999999999999987655
Q ss_pred -EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 486 -AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 -~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..
T Consensus 146 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~ 217 (284)
T 3kk8_A 146 AVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YA 217 (284)
T ss_dssp CEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred cEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH------HH
Confidence 99999999987643322 2345689999999999999999999999999999999999999965433221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.... ... ..........+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 218 ~~~~-~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 218 QIKA-GAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHH-TCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHh-ccc------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 1110 000 0001111234567899999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.22 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=205.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467889999999999999999964 4779999998764444567889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCCCcE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSA 486 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~ 486 (646)
+++++|.+++... ..+++..++.|+.|++.||+|||+++ ++||||||+||++ +.++.+
T Consensus 88 ~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 88 CTGGELFERVVHK----------------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp CCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred cCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcE
Confidence 9999999988653 35899999999999999999999999 9999999999999 888999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||++....... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. ....
T Consensus 149 ~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~ 219 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------MLKI 219 (277)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred EEEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------HHHH
Confidence 999999998764332 2234569999999998865 489999999999999999999999975443221 1111
Q ss_pred HhhchhHHHhhhhhcccCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASE----EDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~----~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.. .. ...+. ..+..+.+++.+||+.||.+|||+.|++++-
T Consensus 220 ~~-~~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 220 RE-GT----------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp HH-CC----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred Hh-CC----------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11 00 01111 2346789999999999999999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=344.27 Aligned_cols=259 Identities=25% Similarity=0.434 Sum_probs=200.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC--CCC--EEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP--DGS--IVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~--~g~--~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|+..+.||+|+||.||+|.+. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57889999999999999999853 333 6899988653 2345678899999999999999999999998654 89
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---------------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD 158 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---------------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred eeEecccCCCHHHHHHhcc---------------CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCC
Confidence 9999999999999997643 25899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----- 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----- 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----
Confidence 9999999999876543322 2233457889999999998889999999999999999999 9999865433211
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
..... ........+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 234 -~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 234 -LHKID---------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -HHHHH---------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -HHHHH---------ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11111 111112233455678999999999999999999999999999887643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=349.47 Aligned_cols=264 Identities=24% Similarity=0.305 Sum_probs=197.7
Q ss_pred cCCCcC-ccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~-~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~E 408 (646)
+.|... +.||+|+||.||+|.. .+++.||||+++.......+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 7899999999999995 46899999998765545566888999999985 79999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc---
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--- 485 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--- 485 (646)
|+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----------------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp CCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCS
T ss_pred cCCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCc
Confidence 99999999999653 36899999999999999999999999 999999999999998776
Q ss_pred EEEeecCCccccCCCCC------ccccccccCCcccChhcccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 486 AKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+||+|||++........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999999986532211 11223459999999999875 55789999999999999999999999754321
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASE----EDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+...................+.... ...+. ..+..+.+|+.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccchhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1000000000000000000111110 11121 234678999999999999999999999885
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=367.22 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=198.4
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|+..+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 46899999988642 334455778999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCc
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||||+.++.
T Consensus 227 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~ 287 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGH 287 (446)
T ss_dssp ECCCSSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSC
T ss_pred EeeCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCC
Confidence 9999999999998653 369999999999999999999998 88 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 288 ~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~ 360 (446)
T 4ejn_A 288 IKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FEL 360 (446)
T ss_dssp EEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHH
Confidence 9999999998643322 223446799999999999999999999999999999999999999975433221 111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMDL 617 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~L 617 (646)
.. .. ...++...+..+.+|+.+||+.||.+|| ++.|++++-
T Consensus 361 i~---------~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 361 IL---------ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp HH---------HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HH---------hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 11 11 1123444567789999999999999999 999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.59 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=206.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~L 405 (646)
.++|+..+.||+|+||.||+++.. +|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999965 47899999986421 22345678899999988 89999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 99 v~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp EEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEeCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCc
Confidence 99999999999998653 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..
T Consensus 160 vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~ 232 (353)
T 2i0e_A 160 IKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQS 232 (353)
T ss_dssp EEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH
T ss_pred EEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHHH
Confidence 9999999998643222 22344679999999999999999999999999999999999999997543321 1111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
++... ..++...+..+.+|+.+||+.||.+||+ ++||+++
T Consensus 233 ---------i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 233 ---------IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---------HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---------HHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 1234456678999999999999999995 5777665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.48 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=204.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999854 57799999875421 11245688999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 88 ~e~~~~~~l~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp ECCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCE
T ss_pred EecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCE
Confidence 9999999999998653 36899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~ 219 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRI 219 (279)
T ss_dssp EECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred EEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHH
Confidence 999999986543222 2345689999999999999999999999999999999999999875433221 1100
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. ......+...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 220 ~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 220 S-----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp H-----------HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred H-----------hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 0 1112334445677899999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=356.96 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=196.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999965 689999999865322 234678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc--EE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--AK 487 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--~k 487 (646)
+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +|
T Consensus 98 ~~~~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 98 ASGGELYERICNA----------------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp CCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEE
T ss_pred CCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEE
Confidence 9999999998653 36999999999999999999999999 999999999999987765 99
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDK-SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k-sDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+++...... ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||....... .......
T Consensus 159 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~-- 232 (361)
T 3uc3_A 159 ICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQ-- 232 (361)
T ss_dssp ECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHH--
T ss_pred EeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHH--
Confidence 99999998542221 2233569999999999988777655 899999999999999999996432211 1111111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+.......+.....+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 233 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 233 -------RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp -------HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred -------HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 111111111112234567899999999999999999999998744
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=354.82 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=204.3
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6889999999999999999995 5789999998764211 11346789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+ +|+|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 89 E~~-~g~l~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----------------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp CCC-CEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEE
T ss_pred ECC-CCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEE
Confidence 999 78999888653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 149 l~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------- 216 (336)
T 3h4j_B 149 IADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------- 216 (336)
T ss_dssp ECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------
T ss_pred EEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------
Confidence 99999998764332 2334579999999999988776 6899999999999999999999964322110
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+.+.. .....+...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 217 ------~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 217 ------FKKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ------BCCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ------HHHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 000000 011234445677899999999999999999999998755
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=341.00 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=202.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566899999999999995 468899999987766666678999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-CCcEEEe
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVS 489 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kI~ 489 (646)
++++|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+
T Consensus 102 ~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~ 165 (295)
T 2clq_A 102 PGGSLSALLRSKWG-------------PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKIS 165 (295)
T ss_dssp SEEEHHHHHHHTTC-------------CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEEC
T ss_pred CCCCHHHHHHhhcc-------------CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEe
Confidence 99999999976432 235778999999999999999999999 999999999999987 8999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|||+++....... ......||+.|+|||.+.++. ++.++||||||+++|||++|+.||......... ...
T Consensus 166 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~--- 237 (295)
T 2clq_A 166 DFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA----MFK--- 237 (295)
T ss_dssp CTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----HHH---
T ss_pred ecccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----HHh---
Confidence 9999987643221 223456899999999987653 789999999999999999999998643221110 000
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..........+...+..+.+++.+||+.||++||++.|++++
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 238 -------VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -------HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -------hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000111223445556788999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=339.55 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=202.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|+..+.||+|+||.||+|... +++.||||+++. ........+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999965 689999998765 2334556788999999999 999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC----
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---- 482 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---- 482 (646)
|||+++|+|.+++...... ...+++..++.|+.|+++||+|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI------------MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----
T ss_pred EEecCCCcHHHHHHhhccc------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCC
Confidence 9999999999999764321 246999999999999999999999999 999999999999984
Q ss_pred ---------------CCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCC
Q 046188 483 ---------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKK 546 (646)
Q Consensus 483 ---------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~ 546 (646)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 4489999999998764322 23589999999999765 56789999999999999999988
Q ss_pred CCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 547 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 547 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
++..... ... +.. ......+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 230 ~~~~~~~---------~~~---------~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 230 LPRNGDQ---------WHE---------IRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp CCSSSHH---------HHH---------HHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred CCcchhH---------HHH---------HHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 7643211 000 111 111223444557789999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=349.04 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=199.6
Q ss_pred HhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC-----HHHHHHHHHHHHHHhhc---CccCceeEEEEEEeC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID-----KTQIEQFINEVVILSQI---NHRHIVKLLGCCLET 400 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~-----~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~~~ 400 (646)
..++|+..+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 468999999875321 11123455677777666 499999999999876
Q ss_pred C-----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 046188 401 E-----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475 (646)
Q Consensus 401 ~-----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~ 475 (646)
. ..++||||++ |+|.+++..... ..+++.+++.|+.|++.||+|||+++ |+||||||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp 148 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--------------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 148 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 5 4789999996 699999876432 34999999999999999999999999 99999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 476 SNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 476 ~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 226 (308)
T 3g33_A 149 ENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226 (308)
T ss_dssp TTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred HHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998764322 2244578999999999999999999999999999999999999997654432
Q ss_pred hhcHHHHHHHHHhhchhHHH------hhhhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEI------LDARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~------~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ..+...........+ ...... .....+....+.+|+.+||+.||++|||+.|++++
T Consensus 227 ~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 227 QL---GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HH---HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH---HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 21 111111110000000 000000 00012344678999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=351.75 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=180.0
Q ss_pred CccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEeccCCC
Q 046188 337 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
.+.||+|+||.||++... +|+.||||++... ....+.+|+.+++++. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6899999998653 3456778999999997 9999999999999999999999999999
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC---cEEEeec
Q 046188 415 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDF 491 (646)
Q Consensus 415 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kI~Df 491 (646)
|.+++... ..+++.+++.|+.|++.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 93 L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 93 LFERIKKK----------------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp HHHHHHHC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCC
T ss_pred HHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecc
Confidence 99999653 36999999999999999999999999 99999999999997665 8999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................
T Consensus 154 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------ 226 (325)
T 3kn6_A 154 GFARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK------ 226 (325)
T ss_dssp TTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH------
T ss_pred ccceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH------
Confidence 99987643322 22345689999999999999999999999999999999999999965432111100000111
Q ss_pred hHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 572 LLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 572 ~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+...... .+.....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 227 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 227 --KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11111100 00012345778999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=351.64 Aligned_cols=273 Identities=24% Similarity=0.400 Sum_probs=200.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHH--HhhcCccCceeEEEEEEeC-----Cce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVI--LSQINHRHIVKLLGCCLET-----EVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~i--l~~l~H~niv~l~g~~~~~-----~~~ 403 (646)
.++|...+.||+|+||.||+|+. +++.||||+++.... ..+..|.++ +..++||||+++++.+... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36888999999999999999987 689999999875332 334444444 5568999999999876532 246
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCCeEecCCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS---------ASIPIFHRDIK 474 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~---------~~~~ivHrDIk 474 (646)
++||||+++|+|.+++... ..+|..+++|+.|+++||+|||+. + |+|||||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dik 147 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLN 147 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCS
T ss_pred EEEEecCCCCcHHHHHhhc-----------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccc
Confidence 8999999999999999542 468999999999999999999998 7 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCC-------CccccccccCCcccChhcccc-------CCCCCccchhhHHHHHHH
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDK-------THLTTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLE 540 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSfGvvl~E 540 (646)
|+|||++.++.+||+|||+++...... ........||+.|+|||.+.+ ..++.++||||||+++||
T Consensus 148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e 227 (336)
T 3g2f_A 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227 (336)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence 999999999999999999998764321 112223569999999999876 456679999999999999
Q ss_pred HHhCCCCCCCCchHHhhcHHHHHHHHHhhc---hhHHHh-hhhhcccC------CHHHHHHHHHHHHhccccCCCCCCCH
Q 046188 541 LLTGKKPICLTREEEERNLVAYFISLAKEN---KLLEIL-DARVAKEA------SEEDIEAVAELAMGCLRLNSKKRPTM 610 (646)
Q Consensus 541 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~-d~~l~~~~------~~~~~~~l~~Li~~Cl~~dP~~RPs~ 610 (646)
|++|+.|+............ ......... .....+ ........ ....+..+.+|+.+||+.||++|||+
T Consensus 228 ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (336)
T 3g2f_A 228 IFMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306 (336)
T ss_dssp HHTTBGGGSTTSCCCCCCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHhcCCcCCCccchhHHHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence 99998876543221110000 000000000 000000 01111111 23466789999999999999999999
Q ss_pred HHHHHHHHHHHhhhhhhc
Q 046188 611 KQVSMDLEGLRRSQRCLE 628 (646)
Q Consensus 611 ~evl~~L~~i~~~~~~~~ 628 (646)
.|+++.|+.+.......+
T Consensus 307 ~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 307 QXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHHHHHHHHHHCCCC--
T ss_pred HHHHHHHHHHHHHHHhcc
Confidence 999999999987655443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.00 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=207.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe--CCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~--~~~~~L 405 (646)
.++|+..+.||+|+||.||++... +|+.||+|++.. ......+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468889999999999999999964 689999998764 245566789999999999999999999998865 457899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCEEECCC
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA--SIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~ 483 (646)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ..+++||||||+||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS
T ss_pred EEeCCCCCCHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC
Confidence 9999999999999976432 1346999999999999999999999976 2349999999999999999
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------- 224 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------- 224 (279)
T ss_dssp SCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------
T ss_pred CCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-------
Confidence 9999999999987643322 22335689999999999998999999999999999999999999875432211
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
...... ......+...+..+.+++.+||+.||.+||++.||++++..
T Consensus 225 ~~~i~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 225 AGKIRE---------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHhh---------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111111 11122344556789999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.88 Aligned_cols=265 Identities=17% Similarity=0.234 Sum_probs=199.1
Q ss_pred cCCCcCccccccCcEEEEEEEcC----CCCEEEEEecccCCHH-----------HHHHHHHHHHHHhhcCccCceeEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKAIDKT-----------QIEQFINEVVILSQINHRHIVKLLGC 396 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~----~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~H~niv~l~g~ 396 (646)
++|...+.||+|+||.||+|... ++..||||+....... ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57889999999999999999964 5678999987653321 11236678889999999999999999
Q ss_pred EEe----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 046188 397 CLE----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 472 (646)
Q Consensus 397 ~~~----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 472 (646)
+.. ....++||||+ +++|.+++... ..+++.+++.|+.|++.||+|||+++ |+|||
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 176 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----------------GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGD 176 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----------------GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 988 56789999999 99999999763 25899999999999999999999998 99999
Q ss_pred CCCCCEEECCCC--cEEEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhC
Q 046188 473 IKSSNILLDDKF--SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544 (646)
Q Consensus 473 Ik~~NILl~~~~--~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG 544 (646)
|||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus 177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999887 999999999987632211 112345799999999999999999999999999999999999
Q ss_pred CCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 545 KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 545 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+.||......... . ........ ......+..... ....+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 257 ~~pf~~~~~~~~~-~-~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 257 KLPWEQNLKDPVA-V-QTAKTNLL-DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp SCTTGGGTTCHHH-H-HHHHHHHH-HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CCCccccccccHH-H-HHHHHhhc-ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 9999532111110 0 00010000 011111111110 11344679999999999999999999999999997654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.22 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=210.0
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
+.|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5788899999999999999985 468999999876432 33467889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 102 ~~~~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 102 LGGGSALDLLEP-----------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp CTTEEHHHHHTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred CCCCcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEe
Confidence 999999998854 26899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ...
T Consensus 162 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~---- 230 (303)
T 3a7i_A 162 DFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LFL---- 230 (303)
T ss_dssp CCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH----
T ss_pred ecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HHH----
Confidence 9999987643321 22345689999999999999999999999999999999999999865432211 000
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+........+...+..+.+++.+||+.||.+|||+.|++++..-...
T Consensus 231 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 231 ------IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ------HHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ------hhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 11111122233445678999999999999999999999998764443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.83 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=204.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367889999999999999999964 6899999987642 23345678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++++|.+++... ..+++..++.++.|+++||+|||+++ ++||||||+||+++.++.+||
T Consensus 86 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 86 YCSGGELFDRIEPD----------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp CCTTEEGGGGSBTT----------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred ecCCCcHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEE
Confidence 99999999998653 35899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCC-CccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 489 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 489 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
+|||++....... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... +...
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~ 221 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDW 221 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-----HHHH
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHh
Confidence 9999998653222 122334568999999999987665 77999999999999999999999754322110 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ............+..+.+++.+||+.||.+|||+.|++++
T Consensus 222 ~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 222 K---------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp H---------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred h---------hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1 1000011112345678899999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=356.67 Aligned_cols=272 Identities=22% Similarity=0.338 Sum_probs=213.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC--ceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~--~~~LV~ 407 (646)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57888999999999999999965 58999999987532 233567789999999999999999999998765 679999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----CCC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDK 483 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~ 483 (646)
||+++|+|.+++..... ...+++..++.|+.|++.||+|||+.+ |+||||||+|||+ +.+
T Consensus 89 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-------------AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSC
T ss_pred ecCCCCCHHHHHHhhhc-------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCc
Confidence 99999999999976533 234999999999999999999999999 9999999999999 888
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhcccc--------CCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--------SQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
+.+||+|||+++...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 153 ~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 153 SVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp EEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred eeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 889999999998764332 2234569999999998865 567889999999999999999999986433211
Q ss_pred hhcHHHHHHHHHhhch---h---HHHhh--------hhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 556 ERNLVAYFISLAKENK---L---LEILD--------ARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~---~---~~~~d--------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
.. ............ . ....+ .......+......+.+++.+||+.||++||++.|+++.++.+.
T Consensus 231 ~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 231 RN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp TC--HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred ch--HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 11 111122211110 0 00000 00112345778889999999999999999999999999999887
Q ss_pred hh
Q 046188 622 RS 623 (646)
Q Consensus 622 ~~ 623 (646)
..
T Consensus 309 ~~ 310 (396)
T 4eut_A 309 HR 310 (396)
T ss_dssp TC
T ss_pred hc
Confidence 54
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.85 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=205.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH------HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|...+.||+|+||.||++... +|+.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357889999999999999999964 689999998764321 1356788999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----------------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----------------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCT
T ss_pred EEEEEcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecC
Confidence 9999999999999999653 36899999999999999999999999 9999999999999988
Q ss_pred C----cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 484 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 484 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+ .+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--- 226 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 226 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---
T ss_pred CCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---
Confidence 8 799999999987644322 2345689999999999999999999999999999999999999975433221
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ . ..++... ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 227 ---~~~i~~~~-~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 227 ---LANITSVS-Y--DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---HHHHHTTC-C--CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHhcc-c--ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111100 0 0011111 1234568999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=356.78 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=207.0
Q ss_pred hcCCCcCccccccCcEEEEEEEc----CCCCEEEEEecccCC----HHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKAID----KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
.++|...+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999996 368999999876421 12234567899999999 6999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 193 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLD 193 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 999999999999999999653 36899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
.++.+||+|||+++..............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .
T Consensus 194 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~ 271 (355)
T 1vzo_A 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--Q 271 (355)
T ss_dssp TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--H
T ss_pred CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--H
Confidence 99999999999998765443444445679999999999985 3478999999999999999999999964322111 1
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMDLEG 619 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~L~~ 619 (646)
........ . ....++...+..+.+|+.+||+.||.+|| ++.|++++..-
T Consensus 272 ~~~~~~~~---------~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 272 AEISRRIL---------K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HHHHHHHH---------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHHHHh---------c--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 11111110 0 11234455667789999999999999999 99999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=351.79 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=198.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHH-HHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQ-IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||+||+|... +++.||||+++...... ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999964 68999999886533221 12456799999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 142 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---------------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLA 142 (324)
T ss_dssp CS-EEHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEEC
T ss_pred cc-cCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEc
Confidence 96 68988886542 36999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+.....
T Consensus 143 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~ 218 (324)
T 3mtl_A 143 DFGLARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILG 218 (324)
T ss_dssp SSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred cCcccccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhC
Confidence 9999986543222 2233468999999999876 56899999999999999999999999765543321 11212111
Q ss_pred h---chhHHHhhhh---------hc----ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 569 E---NKLLEILDAR---------VA----KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 569 ~---~~~~~~~d~~---------l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. ..+....... .. ..........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp CCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred CCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 1 1111111000 00 0001233467889999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=361.55 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=197.3
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999985 36889999998643 4556678899999999999999999999997543
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||++++ |.+.+. ..+++.++..++.|++.||+|||+++ |+||||||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 198 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eEEEEEeCCCCC-HHHHHh------------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEe
Confidence 469999999654 555552 25899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 199 ~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~---~ 273 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW---N 273 (464)
T ss_dssp TTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H
T ss_pred CCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 9999999999999876432 2234467999999999999999999999999999999999999999765433211 1
Q ss_pred HHHHHHhhc----------hhHHHhhh---------------hhccc---CCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 046188 562 YFISLAKEN----------KLLEILDA---------------RVAKE---ASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613 (646)
Q Consensus 562 ~~~~~~~~~----------~~~~~~d~---------------~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 613 (646)
.+....... ....+++. .+... ........+.+|+.+||+.||++|||++|+
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 111111100 01111110 00000 011225678999999999999999999999
Q ss_pred HHHH
Q 046188 614 SMDL 617 (646)
Q Consensus 614 l~~L 617 (646)
+++-
T Consensus 354 L~Hp 357 (464)
T 3ttj_A 354 LQHP 357 (464)
T ss_dssp HTST
T ss_pred hcCh
Confidence 9863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.66 Aligned_cols=253 Identities=28% Similarity=0.351 Sum_probs=198.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57888999999999999999954 6889999987643 223456788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCCCcE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSA 486 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~ 486 (646)
+++|+|.+++...... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 102 ~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 102 CEGGELLERIVSAQAR------------GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp CSCCBHHHHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCE
T ss_pred CCCCcHHHHHHhhhhc------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCE
Confidence 9999999998764321 347999999999999999999999999 9999999999999 556889
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+.. ...
T Consensus 167 kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~ 237 (285)
T 3is5_A 167 KIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKA 237 (285)
T ss_dssp EECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH
T ss_pred EEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhh
Confidence 999999998754322 223456899999999886 56899999999999999999999999754432211 000
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ..+..... ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~-------~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 238 TY-------KEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HH-------CCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cc-------CCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000000 01134678899999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.17 Aligned_cols=265 Identities=25% Similarity=0.368 Sum_probs=208.5
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999965 6899999998754 445567889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcEEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
+++|+|.+++... ..+++..+..|+.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 113 ~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp CTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEE
T ss_pred CCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEE
Confidence 9999999999653 3689999999999999999999995 7 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH-----
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF----- 563 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~----- 563 (646)
+|||++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+........
T Consensus 174 ~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 174 CDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp CCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred EECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 999999754221 123356899999999999999999999999999999999999999765433221110000
Q ss_pred ------------------HHHHhhchhHHHhhhhhcc----cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 564 ------------------ISLAKENKLLEILDARVAK----EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 564 ------------------~~~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..........+.++..... ..+...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000000111112211111 111234567999999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=351.21 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=208.1
Q ss_pred HHHhcCCCcCccccccCcEEEEEEE------cCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC---ccCceeEEEEEE
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN---HRHIVKLLGCCL 398 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~------~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~g~~~ 398 (646)
+...++|...+.||+|+||.||+|. ..+++.||||+++..... ++..|+.++++++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3345789999999999999999994 346889999998875443 5566777777665 999999999999
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
..+..++||||+++|+|.+++...... ....++|..++.|+.|+++||+|||+++ |+||||||+||
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NI 203 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNT-----------PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNF 203 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTS-----------TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGE
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcc-----------cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHE
Confidence 999999999999999999999764321 1246999999999999999999999999 99999999999
Q ss_pred EECC-----------CCcEEEeecCCccccC-CCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC
Q 046188 479 LLDD-----------KFSAKVSDFGTSRSVP-NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 546 (646)
Q Consensus 479 Ll~~-----------~~~~kI~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~ 546 (646)
||+. ++.+||+|||+++... ...........||++|+|||++.+..++.++|||||||++|||++|+.
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9998 8999999999997653 122333445679999999999999999999999999999999999999
Q ss_pred CCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHHHHHhhhh
Q 046188 547 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKR-PTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 547 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R-Ps~~evl~~L~~i~~~~~ 625 (646)
||........ .. ...+ ... .....+.+++..|++.+|.+| |+++++.+.|+.+.....
T Consensus 284 pf~~~~~~~~--------------~~----~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 284 MKVKNEGGEC--------------KP----EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp CCEEEETTEE--------------EE----CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccccCCCCce--------------ee----chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 9853322110 00 0000 111 124567789999999999998 789999999998876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.47 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=208.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367888999999999999999965 5789999987542 345567788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+++ ++||||||+||+++.++.+
T Consensus 94 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 154 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV 154 (294)
T ss_dssp EECCTTCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred EecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCE
Confidence 9999999999987542 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 155 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~ 227 (294)
T 2rku_A 155 KIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRI 227 (294)
T ss_dssp EECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred EEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 9999999987643222 22335689999999999998899999999999999999999999875433221 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
... ....+......+.+++.+||+.||++|||+.|++++-.
T Consensus 228 ---------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 228 ---------KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ---------HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---------hhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 111 11233445567899999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=376.34 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=210.7
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
+...++|...+.||+|+||.||+|.... +..||||+++.. .....+.+.+|+.++++++||||++++|++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3345678888999999999999998642 457999998753 4445578999999999999999999999984 466
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~ 526 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK---------------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSS 526 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT---------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEE
T ss_pred eEEEEEcCCCCcHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeC
Confidence 899999999999999997542 26899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 527 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----- 601 (656)
T 2j0j_A 527 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----- 601 (656)
T ss_dssp TTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-----
Confidence 9999999999998775444333344567889999999999999999999999999999997 9999865433221
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
... +........+..++..+.+++.+||+.||.+|||+.||++.|+.+.+.
T Consensus 602 -~~~----------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 602 -IGR----------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -HHH----------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHH----------HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111 111112234455667899999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=338.25 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=201.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH------HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|...+.||+|+||.||++... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999965 689999998754221 13567889999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----------------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKN 145 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred EEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCC
Confidence 999999999999998652 36899999999999999999999999 99999999999998877
Q ss_pred ----cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 485 ----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 485 ----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---- 219 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---- 219 (283)
T ss_dssp SSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----
T ss_pred CCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH----
Confidence 899999999987643322 2334689999999999999999999999999999999999999875433221
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ . -...... ...+..+.+++.+||+.||.+||++.|++++
T Consensus 220 --~~~~~~~~-~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 220 --LTNISAVN-Y--DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --HHHHHTTC-C--CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --HHHhHhcc-c--CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11111000 0 0001111 1234568999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.44 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=185.1
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||+|.. .+|+.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999995 4789999999864211 1235788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++.... ..+++.+++.++.|+++||.|||+++ ++||||||+||+++.++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~ 151 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---------------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNI 151 (278)
T ss_dssp EECCTTEEHHHHHHTCS---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCE
T ss_pred EecCCCCcHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCE
Confidence 99999999999987542 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 152 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (278)
T 3cok_A 152 KIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------- 220 (278)
T ss_dssp EECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred EEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------
Confidence 9999999987643222 12235689999999999988899999999999999999999999864332110
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+....... ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 221 -----~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 -----LNKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----HHHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00000000 12233445678999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.02 Aligned_cols=243 Identities=27% Similarity=0.412 Sum_probs=203.1
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC--------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
.++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999984 468899999876532 112335678999999999999999999999999
Q ss_pred ceEEEEEeccCC-CchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 402 VPVLVYEYICNG-NLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 402 ~~~LV~Ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
..++||||+.+| +|.+++... ..+++..++.|+.|++.||.|||+++ |+||||||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 163 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----------------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVI 163 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred EEEEEEEeCCCCccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEE
Confidence 999999999777 999988653 36999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+.++.+||+|||+++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----- 236 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----- 236 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----
T ss_pred cCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----
Confidence 9999999999999987644322 234569999999999988876 78999999999999999999998632110
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... ...+...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 237 ----------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 ----------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ----------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ----------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1111 112223456789999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.45 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=199.0
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC----CceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET----EVPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~----~~~~L 405 (646)
.|...+.||+|+||.||+|... ++..||+|.+.. ......+.+.+|+.++++++||||+++++++... ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999954 578999998754 3455677899999999999999999999998752 45799
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-CCC
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKF 484 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~ 484 (646)
||||+++|+|.+++... ..+++..++.|+.|++.||.|||+.+ ++++||||||+|||++ +++
T Consensus 107 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTS
T ss_pred EEEecCCCCHHHHHHHc----------------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCC
Confidence 99999999999999653 36899999999999999999999986 3599999999999998 789
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||........ ...
T Consensus 170 ~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~ 240 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYR 240 (290)
T ss_dssp CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHH
T ss_pred CEEEeeCCCccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHH
Confidence 9999999999764332 223456899999999886 4589999999999999999999999865332211 111
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... . ......+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~-~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 RVTS-G--------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHTT-T--------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhc-c--------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 0 00011122233568999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=362.08 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=206.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH---HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999964 689999999864221 23457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 96 E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 96 EYVSGGELFDYICKN----------------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp ECCSSEEHHHHTTSS----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEE
T ss_pred eCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeE
Confidence 999999999999653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+++...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....... .+..
T Consensus 157 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~- 227 (476)
T 2y94_A 157 IADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKK- 227 (476)
T ss_dssp ECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHH-
T ss_pred EEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHH-
Confidence 99999998764432 2334579999999999988765 689999999999999999999997543221 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
+.+.. ...+...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 228 --------i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 228 --------ICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp --------HHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --------HhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 11111 122334456789999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=353.16 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=195.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHH-HhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVI-LSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~i-l~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 67999999999999999999965 5889999987642 22334456677776 5778999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 118 ~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp EECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EeCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCE
Confidence 9999999999998653 35889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++...... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..
T Consensus 179 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~- 250 (373)
T 2r5t_A 179 VLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDN- 250 (373)
T ss_dssp EECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHH-
T ss_pred EEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHH-
Confidence 999999998643222 22344679999999999999999999999999999999999999997543322 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
++... ..++...+..+.+|+.+||+.||.+||++.+.++.+
T Consensus 251 --------i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 251 --------ILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --------HHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --------HHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11111 123344557789999999999999999986444333
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.78 Aligned_cols=265 Identities=15% Similarity=0.236 Sum_probs=206.7
Q ss_pred cCCCcCccccccCcEEEEEEEcCC---------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCcee----------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD---------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVK---------- 392 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~---------- 392 (646)
++|...+.||+|+||.||+|.... ++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999999653 789999998753 36779999999999999987
Q ss_pred -----EEEEEEe-CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 046188 393 -----LLGCCLE-TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASI 466 (646)
Q Consensus 393 -----l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 466 (646)
+++++.. ++..++||||+ +|+|.+++.... ...+++.+++.|+.|++.||.|||+++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~-- 179 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--------------KHVLSERSVLQVACRLLDALEFLHENE-- 179 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--------------GGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6788876 56789999999 999999997642 136999999999999999999999998
Q ss_pred CeEecCCCCCCEEECCCC--cEEEeecCCccccCCCCCc------cccccccCCcccChhccccCCCCCccchhhHHHHH
Q 046188 467 PIFHRDIKSSNILLDDKF--SAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVL 538 (646)
Q Consensus 467 ~ivHrDIk~~NILl~~~~--~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl 538 (646)
|+||||||+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++
T Consensus 180 -ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 180 -YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp -CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 99999999999999998 9999999999876432211 11334799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 539 LELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 539 ~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
|||++|+.||........ ............ ...+.+... .....+..+.+|+.+||+.||.+||++.||++.|+
T Consensus 259 ~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTE-DIMKQKQKFVDK--PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp HHHHHSCCTTGGGTTCHH-HHHHHHHHHHHS--CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHH-HHHHHHHhccCC--hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 999999999865431111 111111110000 000000000 00123467899999999999999999999999999
Q ss_pred HHHhhhh
Q 046188 619 GLRRSQR 625 (646)
Q Consensus 619 ~i~~~~~ 625 (646)
++.....
T Consensus 333 ~~~~~~~ 339 (352)
T 2jii_A 333 ALLQDLR 339 (352)
T ss_dssp HHHHHTT
T ss_pred HHHHhcC
Confidence 9987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.54 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=208.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367888999999999999999964 5789999987542 345567889999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++++|.+++... ..+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+
T Consensus 120 ~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp ECCCTTCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EecCCCCCHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCE
Confidence 9999999999987653 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 181 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~ 253 (335)
T 2owb_A 181 KIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRI 253 (335)
T ss_dssp EECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred EEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHH
Confidence 9999999987643222 22345689999999999998999999999999999999999999875432221 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. .. ....+......+.+|+.+||+.||.+||++.|++++-.
T Consensus 254 ~---------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 254 K---------KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp H---------HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred h---------cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 00 11223344567889999999999999999999998644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=355.10 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=193.1
Q ss_pred cCCCcC-ccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhh-cCccCceeEEEEEEe----CCceE
Q 046188 332 DNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQ-INHRHIVKLLGCCLE----TEVPV 404 (646)
Q Consensus 332 ~~~~~~-~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~-l~H~niv~l~g~~~~----~~~~~ 404 (646)
++|... +.||+|+||.||++... +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999954 6899999998642 346678888754 589999999999875 45689
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-- 482 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 482 (646)
+||||+++|+|.+++..... ..+++.+++.|+.|++.||.|||+++ |+||||||+|||++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~ 198 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--------------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR 198 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----------------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS
T ss_pred EEEEeCCCCcHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCC
Confidence 99999999999999976421 36999999999999999999999999 999999999999997
Q ss_pred -CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh-cHH
Q 046188 483 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER-NLV 560 (646)
Q Consensus 483 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~-~l~ 560 (646)
++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...
T Consensus 199 ~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 199 PNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp TTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred CCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 7899999999998754322 223457899999999999999999999999999999999999999754322110 000
Q ss_pred HHHHHHHhhchhHHHhhhhhc--ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. .+...... .......+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 277 ~------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 277 T------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp H------------HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred H------------HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 01111110 0111234567899999999999999999999998755
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.44 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=205.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||.||++... +|+.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357888999999999999999964 6899999998765544556788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCCCcE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSA 486 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~ 486 (646)
+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||++ ++++.+
T Consensus 88 ~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~ 148 (304)
T 2jam_A 88 VSGGELFDRILER----------------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKI 148 (304)
T ss_dssp CCSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCE
T ss_pred CCCccHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCE
Confidence 9999999998653 36899999999999999999999999 9999999999999 788999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....
T Consensus 149 kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i 219 (304)
T 2jam_A 149 MITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------FEKI 219 (304)
T ss_dssp EBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH
T ss_pred EEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH
Confidence 99999999764322 22334689999999999999999999999999999999999999865432211 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
. .... ..........+..+.+++.+||+.||.+||++.|++++-.
T Consensus 220 ~-~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 220 K-EGYY------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp H-HCCC------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred H-cCCC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1 1100 0011222345577899999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.26 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=194.7
Q ss_pred HHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
...++|...+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999984 4688999999865332 234567899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE-----
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----- 480 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl----- 480 (646)
||||++ |+|.+++... ..+++..++.|+.|++.||+|||+.+ |+||||||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN----------------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp EEECCS-EEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC---
T ss_pred EEecCC-CCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCC
Confidence 999996 6999988653 35899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
++++.+||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~ 247 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--L 247 (329)
T ss_dssp --CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H
T ss_pred CccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--H
Confidence 4556699999999987643222 22334689999999999874 489999999999999999999999976543321 1
Q ss_pred HHHHHHHHhhc---hhHHHh-------------hhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKEN---KLLEIL-------------DARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~---~~~~~~-------------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+ ...... ...... ...+....+......+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 248 FKIF-EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHH-HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 1111 111100 000000 0000000011134678899999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=338.74 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=201.3
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEe--CCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLE--TEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~--~~~~~LV~ 407 (646)
++|...+.||+|+||.||+|.. .+++.||||+++... .+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6788899999999999999984 578999999987644 356789999999997 9999999999987 55789999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-cE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~ 486 (646)
||+++++|.+++. .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+
T Consensus 113 e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp ECCCCCCHHHHGG-------------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred eccCchhHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEE
Confidence 9999999988873 3788999999999999999999999 99999999999999776 89
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++....... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+. ....
T Consensus 171 kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~-~~~~ 246 (330)
T 3nsz_A 171 RLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLV-RIAK 246 (330)
T ss_dssp EECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHH-HHHH
T ss_pred EEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHH-HHHH
Confidence 9999999987643322 233468999999999877 6789999999999999999999999865432211 111 1111
Q ss_pred HHhhchhHHHhhhh-----------------------hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDAR-----------------------VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~-----------------------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........+.++.. .....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111111111110 0011122246788999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=338.68 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=191.3
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHH-HHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~-~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|+..+.||+|+||.||++.. .+|+.||||+++.. ... ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46889999999999999999995 47899999998753 222 2334445556688899999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
||++ |+|.+++..... ....+++..++.|+.|++.||.|||++ + ++||||||+||+++.++.+
T Consensus 86 e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~ 149 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID------------KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQV 149 (290)
T ss_dssp ECCS-EEHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCE
T ss_pred ehhc-cchHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCE
Confidence 9996 688888865322 134799999999999999999999998 8 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
||+|||+++....... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||........ .
T Consensus 150 kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~ 222 (290)
T 3fme_A 150 KMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----Q 222 (290)
T ss_dssp EBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----H
T ss_pred EEeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----H
Confidence 9999999987643322 2234689999999996 556789999999999999999999999864322111 1
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.. ..+........+...+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 223 ~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 223 LK---------QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp HH---------HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HH---------HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 11 111111111122344567899999999999999999999998543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.01 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=206.0
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--------HHHHHHHHHHHHHHhhc-CccCceeEE
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--------KTQIEQFINEVVILSQI-NHRHIVKLL 394 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l-~H~niv~l~ 394 (646)
+......++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999975 69999999875432 12245678999999999 799999999
Q ss_pred EEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 395 GCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 395 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
+++......++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlk 227 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----------------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLK 227 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999999999998642 36999999999999999999999999 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc------CCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
|+|||++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||
T Consensus 228 p~NIl~~~~~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 228 PENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEECCCCCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999987643322 234579999999999863 35788999999999999999999999
Q ss_pred CCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........ ...... ... ....+.. ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 306 ~~~~~~~~------~~~i~~-~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 306 WHRRQILM------LRMIME-GQY-QFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCSSHHHH------HHHHHH-TCC-CCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHH------HHHHHh-CCC-CCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 65432211 111110 000 0000000 1224568899999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.04 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=187.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-----Cc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-----~~ 402 (646)
.++|...+.||+|+||.||+|... +|+.||||++.. ......+.+.+|+++|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999854 689999998764 3445667899999999999999999999999543 46
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.|+||||+ +|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~ 191 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----------------VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQ 191 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECT
T ss_pred EEEEEecc-ccchhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECC
Confidence 89999997 68898888652 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCC--------------------------ccccccccCCcccChhcc-ccCCCCCccchhhHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKT--------------------------HLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFG 535 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSfG 535 (646)
++.+||+|||+++....... ......+||+.|+|||++ ....++.++||||||
T Consensus 192 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG 271 (458)
T 3rp9_A 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271 (458)
T ss_dssp TCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred CCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHH
Confidence 99999999999987642211 122345789999999976 566799999999999
Q ss_pred HHHHHHHh-----------CCCCCCCCchH-----------------HhhcHHHHHHHHHhhch-----------hHHHh
Q 046188 536 VVLLELLT-----------GKKPICLTREE-----------------EERNLVAYFISLAKENK-----------LLEIL 576 (646)
Q Consensus 536 vvl~Ellt-----------G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~~-----------~~~~~ 576 (646)
|+||||++ |+++|...... ........+........ ....+
T Consensus 272 ~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 351 (458)
T 3rp9_A 272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351 (458)
T ss_dssp HHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHH
T ss_pred HHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHH
Confidence 99999999 45554332110 00011111111111110 00000
Q ss_pred hhhh------cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 577 DARV------AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 577 d~~l------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... ...........+.+|+.+||+.||.+|||+.|++++-
T Consensus 352 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp TTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 0000 0001122356788999999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.35 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=201.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||.||+|... +|+.||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367888999999999999999964 589999998754 33444567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 104 e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~k 164 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----------------NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVK 164 (331)
T ss_dssp ECCSEEHHHHHHHST----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred ecCCcchHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEE
Confidence 999999998876442 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+++....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+... ......
T Consensus 165 l~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~ 241 (331)
T 4aaa_A 165 LCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY--HIMMCL 241 (331)
T ss_dssp ECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHH
T ss_pred EEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHh
Confidence 999999987543222 22335689999999998775 78999999999999999999999997654432211 111000
Q ss_pred ----------Hh-hchhHHHhhhhhcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 ----------AK-ENKLLEILDARVAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ----------~~-~~~~~~~~d~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.. .........+...... ....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00 0000000000000011 123457799999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=349.69 Aligned_cols=258 Identities=20% Similarity=0.315 Sum_probs=198.0
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999995 4689999999854 33445667899999999999999999999998653
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVN 162 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEc
Confidence 459999999 8899988854 25899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l--- 235 (367)
T 1cm8_A 163 EDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--- 235 (367)
T ss_dssp TTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred CCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 9999999999999875432 234568999999999877 67899999999999999999999999765433211
Q ss_pred HHHHHHHhh-----------chhHHHhhhh------hcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 561 AYFISLAKE-----------NKLLEILDAR------VAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~~-----------~~~~~~~d~~------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+...... .....++... ............+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111111110 0011111100 0011123345678999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.55 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=206.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67889999999999999999964 57889999875421 112356889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+|
T Consensus 94 e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----------------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp CCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEE
T ss_pred EeCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEE
Confidence 999999999998653 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ..
T Consensus 155 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~--- 222 (284)
T 2vgo_A 155 IADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HR--- 222 (284)
T ss_dssp ECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH---
T ss_pred EecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HH---
Confidence 99999997653321 2345689999999999999999999999999999999999999975433221 11
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+... ....+...+..+.+++.+||+.||.+||++.|++++-.
T Consensus 223 ------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 223 ------RIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp ------HHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred ------HHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 11111 11234445577899999999999999999999998644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.08 Aligned_cols=270 Identities=22% Similarity=0.313 Sum_probs=203.4
Q ss_pred CHHHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccC-----------CHHHHHHHHHHHHHHhhcCccCce
Q 046188 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAI-----------DKTQIEQFINEVVILSQINHRHIV 391 (646)
Q Consensus 323 ~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~-----------~~~~~~~~~~Ei~il~~l~H~niv 391 (646)
...++....++|...+.||+|+||.||+|...+|+.||||++... .....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356788889999999999999999999999878999999987432 223346889999999999999999
Q ss_pred eEEEEEEeCC-----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 046188 392 KLLGCCLETE-----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASI 466 (646)
Q Consensus 392 ~l~g~~~~~~-----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 466 (646)
++++++...+ ..++||||++ |+|.+++.... ..+++..++.|+.|++.||.|||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~-- 154 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---------------IVISPQHIQYFMYHILLGLHVLHEAG-- 154 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 9999986533 4699999996 78888886542 36999999999999999999999999
Q ss_pred CeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCC
Q 046188 467 PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 545 (646)
Q Consensus 467 ~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~ 545 (646)
|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus 155 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 155 -VVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp -CCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred -CEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence 9999999999999999999999999998643322 2234568999999999877 67899999999999999999999
Q ss_pred CCCCCCchHHhhcHHHHHHHHHhhchh-----------HHHhhhhhcc-------cCCHHHHHHHHHHHHhccccCCCCC
Q 046188 546 KPICLTREEEERNLVAYFISLAKENKL-----------LEILDARVAK-------EASEEDIEAVAELAMGCLRLNSKKR 607 (646)
Q Consensus 546 ~p~~~~~~~~~~~l~~~~~~~~~~~~~-----------~~~~d~~l~~-------~~~~~~~~~l~~Li~~Cl~~dP~~R 607 (646)
.||......+.. ..+......... .+.+...... .........+.+|+.+||+.||.+|
T Consensus 232 ~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 232 ALFRGSTFYNQL---NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp CSCCCSSHHHHH---HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCHHHHH---HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 999765433221 111111111111 1111111100 0112334678999999999999999
Q ss_pred CCHHHHHHH
Q 046188 608 PTMKQVSMD 616 (646)
Q Consensus 608 Ps~~evl~~ 616 (646)
||+.|++++
T Consensus 309 pt~~ell~h 317 (362)
T 3pg1_A 309 ISTEQALRH 317 (362)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHHcC
Confidence 999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=347.25 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=201.0
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET-------- 400 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-------- 400 (646)
++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999996 468999999875432 22244678999999999999999999999874
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||++ |+|.+.+.... ..+++.+++.|+.|++.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 157 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL---------------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 157 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ceEEEEEeccC-CCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEE
Confidence 45799999996 57777775532 36999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCC---CccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 481 DDKFSAKVSDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
+.++.+||+|||+++...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999998764222 122234568999999998876 4579999999999999999999999976554332
Q ss_pred hcHHHHHHHHHhh---chhHHHhhhhhcc--------cCCH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 557 RNLVAYFISLAKE---NKLLEILDARVAK--------EASE-------EDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 557 ~~l~~~~~~~~~~---~~~~~~~d~~l~~--------~~~~-------~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.. .+...... .....+-+..... .... .....+.+|+.+||+.||++|||+.|++++-
T Consensus 238 ~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 238 LA---LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HH---HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HH---HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 21 11111111 0000000000000 0000 0134588999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.50 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=202.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|...+.||+|+||.||++... +|+.||||.++.... ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999964 688999999865332 344688888888 79999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC----C
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK----F 484 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~----~ 484 (646)
|+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+.++ +
T Consensus 97 ~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 97 LMKGGELLDKILRQ----------------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp CCCSCBHHHHHHTC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGG
T ss_pred CCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcC
Confidence 99999999998653 35899999999999999999999999 9999999999998543 3
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 158 ~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~~~ 233 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE---ILA 233 (342)
T ss_dssp GEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH---HHH
T ss_pred eEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH---HHH
Confidence 599999999987643322 2334578999999999988888999999999999999999999997532211111 111
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.. ..+.. .+........+..+.+|+.+||+.||++||++.|++++-.-
T Consensus 234 ~i-~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 234 RI-GSGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp HH-HHCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred HH-ccCCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 11 11100 01111223456778999999999999999999999987553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=367.64 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=208.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999964 68999999975421 12345678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 263 mEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~v 325 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--------------QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI 325 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred EEcCCCCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCe
Confidence 99999999999987542 135999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .. +..
T Consensus 326 KL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~-i~~- 399 (576)
T 2acx_A 326 RISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE-VER- 399 (576)
T ss_dssp EECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HH-HHH-
T ss_pred EEEecccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HH-HHH-
Confidence 9999999987644322 23357999999999999989999999999999999999999999754321110 00 000
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
.+. .....++...+..+.+|+.+||+.||.+|| ++.||+++
T Consensus 400 --------~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 400 --------LVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------HHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------Hhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 000 112234455667899999999999999999 78898876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.75 Aligned_cols=253 Identities=18% Similarity=0.181 Sum_probs=195.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc---CCHHHHHHHHHHH---HHHhhcCccCceeEE-------EE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA---IDKTQIEQFINEV---VILSQINHRHIVKLL-------GC 396 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~---~~~~~~~~~~~Ei---~il~~l~H~niv~l~-------g~ 396 (646)
.++|...+.||+|+||.||+|.. .+|+.||||+++. ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 4689999999763 3344567888999 555566899999998 66
Q ss_pred EEeCC-----------------ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH
Q 046188 397 CLETE-----------------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 459 (646)
Q Consensus 397 ~~~~~-----------------~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~y 459 (646)
+.+.+ ..++||||+ +|+|.+++........ ....++|..++.|+.|++.||+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS---------THKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT---------TTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc---------ccccccHHHHHHHHHHHHHHHHH
Confidence 66543 278999999 7899999976532100 01235678999999999999999
Q ss_pred HHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-----------CCCCc
Q 046188 460 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-----------QYTDK 528 (646)
Q Consensus 460 LH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~k 528 (646)
||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.+
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99999 99999999999999999999999999986422 2234567 999999999887 89999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 529 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 529 sDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
+|||||||++|||++|+.||....... ....+.. .....+..+.+|+.+||+.||.+||
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~---------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALG---------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------C---------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred hhHHHHHHHHHHHHHCCCCCccccccc---------------chhhhhh------hccCCCHHHHHHHHHHcCCCchhCC
Confidence 999999999999999999985322111 0111111 1123346789999999999999999
Q ss_pred CHHHHHHH--HHHHHh
Q 046188 609 TMKQVSMD--LEGLRR 622 (646)
Q Consensus 609 s~~evl~~--L~~i~~ 622 (646)
|+.|++++ ++.+..
T Consensus 353 t~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 353 LPLQAMETPEYEQLRT 368 (377)
T ss_dssp CHHHHHTSHHHHHHHH
T ss_pred CHHHHhhChHHHHHHH
Confidence 99999974 444443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.99 Aligned_cols=261 Identities=25% Similarity=0.311 Sum_probs=203.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC--------ccCceeEEEEEE---
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN--------HRHIVKLLGCCL--- 398 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~--------H~niv~l~g~~~--- 398 (646)
.++|...++||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999984 46889999998753 445567889999999985 788999999987
Q ss_pred -eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCC
Q 046188 399 -ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSS 476 (646)
Q Consensus 399 -~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~ 476 (646)
+....++||||+ +|+|.+++.... ...+++..++.|+.|++.||.|||++ + |+||||||+
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~ 176 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--------------YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPE 176 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--------------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGG
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 345789999999 677777665432 23699999999999999999999998 8 999999999
Q ss_pred CEEECCCC-------------------------------------------------cEEEeecCCccccCCCCCccccc
Q 046188 477 NILLDDKF-------------------------------------------------SAKVSDFGTSRSVPNDKTHLTTA 507 (646)
Q Consensus 477 NILl~~~~-------------------------------------------------~~kI~DfGla~~~~~~~~~~~~~ 507 (646)
|||++.++ .+||+|||+++..... ...
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~ 252 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTE 252 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCS
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----Ccc
Confidence 99999775 8999999999876432 233
Q ss_pred cccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHh---hcHHHHHHHHHhhchhH-----------
Q 046188 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE---RNLVAYFISLAKENKLL----------- 573 (646)
Q Consensus 508 ~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~---~~l~~~~~~~~~~~~~~----------- 573 (646)
..||+.|+|||.+.+..++.++|||||||+||||++|+.||......+. ......+..........
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 4689999999999999999999999999999999999999975432211 11111111111110000
Q ss_pred -------------------HHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 574 -------------------EILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 574 -------------------~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+.+.. ....+......+.+|+.+||+.||++|||+.|++++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCccccccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 113457778889999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.19 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=202.0
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
..++|+..+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3468999999999999999999965 58999999987532 34578899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 105 ~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 166 (314)
T 3com_A 105 YCGAGSVSDIIRLR---------------NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKL 166 (314)
T ss_dssp CCTTEEHHHHHHHH---------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred cCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEE
Confidence 99999999998643 237999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 167 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~ 239 (314)
T 3com_A 167 ADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPT 239 (314)
T ss_dssp CCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH
T ss_pred eecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhc
Confidence 99999987643222 22335689999999999999999999999999999999999999865432211 110000
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.. ......+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 240 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 240 NP--------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp SC--------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CC--------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 00 000112233456789999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=347.43 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=199.5
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHH-----HHHHHHHHHHHHhhcCccCceeEEEEEEeCCc
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKT-----QIEQFINEVVILSQINHRHIVKLLGCCLETEV 402 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~ 402 (646)
...++|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 5899999998643221 12367899999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++ +|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---------------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 147 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---------------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEEcCCC-CHHHHHHhcC---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcC
Confidence 9999999975 8888886542 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||+++....... ......||+.|+|||.+.+. .++.++||||||+++|||++|..||......+. +..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~ 224 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR 224 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH
T ss_pred CCCEEEEecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH
Confidence 99999999999987643322 22345689999999998764 578999999999999999999999875543221 111
Q ss_pred HHHHHHhhchhHHHhhh---------hhcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDA---------RVAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~---------~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+...........+.+. ...... ....+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 225 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 225 -IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp -HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred -HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 1111111000000000 000000 1233467899999999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=355.83 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=207.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc-cCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H-~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|...++||+|+||.||+|.. .+++.||||.++.... ...+.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36899999999999999999995 5689999998664322 2357789999999987 556666666777788899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCCCc
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFS 485 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~ 485 (646)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.
T Consensus 84 ~~-g~sL~~ll~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp CC-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTC
T ss_pred CC-CCCHHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCe
Confidence 99 999999997532 36999999999999999999999999 9999999999999 68899
Q ss_pred EEEeecCCccccCCCCCc------cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 486 AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||++|+.||...........
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence 999999999876433221 12246799999999999999999999999999999999999999976443222111
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
...+........+. .+.. .++..+.+|+..||+.||++||++.+|++.|+.+....
T Consensus 225 ~~~i~~~~~~~~~~-----~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 225 YEKISEKKVATSIE-----ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHHHHHSCHH-----HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhhccccccHH-----HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11111111111111 1111 22467899999999999999999999999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.32 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=191.9
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLET 400 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~ 400 (646)
..++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999954 58999999875421 112235789999999999999999999975 4
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.+++... ..+++.+++.|+.|++.||+|||+++ |+||||||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll 272 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN----------------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 272 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEE
Confidence 5679999999999999998653 36999999999999999999999999 9999999999999
Q ss_pred CCC---CcEEEeecCCccccCCCCCccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 481 DDK---FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 481 ~~~---~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+.+ +.+||+|||+++..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred ecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 754 45999999999876432 22344679999999999853 67788999999999999999999999643221
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
. .+... ....... ..+... ...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 351 ~--~~~~~----i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 351 V--SLKDQ----ITSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp C--CHHHH----HHTTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred H--HHHHH----HhcCCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 1 11110 0111000 000011 12346789999999999999999999998863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=340.70 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=200.6
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468889999999999999999965 5889999998766555677899999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 98 ~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---------------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp CTTEEHHHHHHHHT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CCCCcHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEE
Confidence 99999999886532 36999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhcc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF-----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|||++...... ........||+.|+|||.+ ....++.++||||||+++|||++|+.|+........ ..
T Consensus 160 Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~ 232 (302)
T 2j7t_A 160 DFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LL 232 (302)
T ss_dssp CCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH
T ss_pred ECCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HH
Confidence 99997643111 0111234689999999998 467789999999999999999999999865432211 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... .....+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 233 KIAKSDP--------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHSCC--------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHhccCC--------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111100 0011223445678999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.41 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=204.1
Q ss_pred HHHhcCCCcC-ccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCc
Q 046188 328 QRATDNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 402 (646)
Q Consensus 328 ~~~t~~~~~~-~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~ 402 (646)
+...+.|... +.||+|+||.||+|... +|+.||||+++.. .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3444567766 88999999999999954 6899999987642 223356788999999999 56999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+++|+|.+++.... ...+++.+++.|+.|++.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL--------------AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS 166 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred EEEEEEecCCCcHHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence 999999999999999986532 246999999999999999999999999 999999999999998
Q ss_pred ---CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 483 ---KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 483 ---~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--- 241 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--- 241 (327)
T ss_dssp BTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred CCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---
Confidence 7899999999998764322 22345699999999999999999999999999999999999999975443221
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
...... .............+..+.+++.+||+.||.+|||+.|++++-
T Consensus 242 ---~~~i~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 242 ---YLNISQ-------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp ---HHHHHH-------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred ---HHHHHh-------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 111000 001111122234556789999999999999999999998763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.82 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=204.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---------HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---------KTQIEQFINEVVILSQIN-HRHIVKLLGCCLE 399 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---------~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~ 399 (646)
.++|...+.||+|+||.||+|... +|+.||||.++... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999964 68899999876432 223456889999999995 9999999999999
Q ss_pred CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 400 TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 400 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil 156 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENIL 156 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEE
Confidence 99999999999999999999653 36899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ------SSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
++.++.+||+|||++........ .....||+.|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EcCCCcEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 99999999999999987643322 23456899999999885 45688999999999999999999999865432
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ...... ... ....+.....+..+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~------~~~~~~-~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 235 MLM------LRMIMS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHH------HHHHHH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHH------HHHHhc-CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 211 111111 000 00011113445678999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.31 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=200.0
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC----
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE---- 401 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~---- 401 (646)
++...++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|+.+++.++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345567899999999999999999985 5789999998865322 2347999999999999999999985432
Q ss_pred ----------------------------------ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHH
Q 046188 402 ----------------------------------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447 (646)
Q Consensus 402 ----------------------------------~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 447 (646)
..++||||++ |+|.+.+..... ....+++..+.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------~~~~l~~~~~~ 144 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR------------SGRSIPMNLIS 144 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHH------------TTCCCCHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh------------cCCCCCHHHHH
Confidence 3789999997 688888765322 13479999999
Q ss_pred HHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CC
Q 046188 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QY 525 (646)
Q Consensus 448 ~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~ 525 (646)
.++.|+++||.|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .+
T Consensus 145 ~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~ 219 (383)
T 3eb0_A 145 IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEY 219 (383)
T ss_dssp HHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCC
Confidence 99999999999999999 99999999999998 689999999999987643322 2335689999999998764 48
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHh--hh-------------hhcccCCHHHHH
Q 046188 526 TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL--DA-------------RVAKEASEEDIE 590 (646)
Q Consensus 526 s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--d~-------------~l~~~~~~~~~~ 590 (646)
+.++||||||+++|||++|+.||......+. ...+...........+. ++ .+....+...+.
T Consensus 220 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (383)
T 3eb0_A 220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296 (383)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH
T ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH
Confidence 9999999999999999999999976543322 11111111111111111 11 011112334556
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 591 AVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 591 ~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+.+|+.+||+.||.+|||+.|++++
T Consensus 297 ~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 297 LAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 78999999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.93 Aligned_cols=260 Identities=23% Similarity=0.423 Sum_probs=200.8
Q ss_pred CHHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe-
Q 046188 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE- 399 (646)
Q Consensus 323 ~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~- 399 (646)
+..++....++|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344455678899999999999999999996 468999999976432 2345788999999999 89999999999987
Q ss_pred -----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 400 -----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 400 -----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlk 156 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--------------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIK 156 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGG--------------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCS
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhccc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCc
Confidence 4578999999999999999976432 36899999999999999999999999 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCC
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPIC 549 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~ 549 (646)
|+|||++.++.+||+|||++........ ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 157 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 157 GQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp GGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999987543211 223346899999999987 5678999999999999999999999986
Q ss_pred CCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 550 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... ....... ......+...+..+.+++.+||+.||.+||++.|++++
T Consensus 236 ~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 236 DMHPMRA------LFLIPRN---------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TSCHHHH------HHHHHHS---------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHH------HHHhhcC---------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 5432211 1111110 00111122345678999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.58 Aligned_cols=267 Identities=23% Similarity=0.367 Sum_probs=189.5
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999954 68899999886532 33456788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++........ .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGE--------HKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTT--------TTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ehhccCCchHHHHHHHhhccc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCE
Confidence 999999999999975322100 01246999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCC----ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 487 KVSDFGTSRSVPNDKT----HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 487 kI~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
||+|||++........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.........
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---- 236 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---- 236 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH----
Confidence 9999999986643221 11233568999999999876 56899999999999999999999998754432211
Q ss_pred HHHHHHhhc--hh-HHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKEN--KL-LEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~--~~-~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
....... .. ....++. .....+..+.+++.+||+.||.+||++.|++++
T Consensus 237 --~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 237 --MLTLQNDPPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp --HHHHTSSCCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHHhccCCCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111110 00 0011111 122334678999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.19 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=202.9
Q ss_pred HhcCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcC--ccCceeEEEEEEeCCceEE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQIN--HRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~--H~niv~l~g~~~~~~~~~L 405 (646)
..++|...+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++++++ |+||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 3467999999999999999999988899999998754 34556678999999999997 4999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||| +.+++|.+++... ..+++.+++.++.|+++||.|||+++ |+||||||+|||+++ +.
T Consensus 106 v~e-~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK----------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp EEC-CCSEEHHHHHHHC----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TE
T ss_pred EEe-cCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-Ce
Confidence 999 5689999999753 36899999999999999999999999 999999999999975 79
Q ss_pred EEEeecCCccccCCCCCc-cccccccCCcccChhcccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 486 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
+||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 999999999876433221 2234568999999999875 4688899999999999999999999864322
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
... .+...+++......+...+..+.+++.+||+.||.+||++.|++++-.
T Consensus 245 ~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 245 QIS--------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHH--------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHH--------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 110 122233333333444444577899999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=330.05 Aligned_cols=248 Identities=29% Similarity=0.399 Sum_probs=197.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67889999999999999999965 68999999876422 123457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+|
T Consensus 91 e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----------------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp ECCCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEE
T ss_pred eccCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEE
Confidence 999999999998653 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....
T Consensus 152 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~ 223 (276)
T 2h6d_A 152 IADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------FKKI 223 (276)
T ss_dssp ECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred EeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHh
Confidence 99999998764332 2233468999999999987765 6899999999999999999999865432211 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
... ....+......+.+++.+||+.||.+|||+.|++++-
T Consensus 224 -~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 224 -RGG----------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp -HHC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -hcC----------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 000 0122334456789999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=354.52 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=198.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-----Cc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-----~~ 402 (646)
.++|...+.||+|+||.||+|... +|+.||||+++. ......+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999954 588999999865 3445567899999999999999999999999876 56
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||++ |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~ 164 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----------------IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQ 164 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred EEEEEecCC-cCHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECC
Confidence 899999985 6999988653 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCC---------------------ccccccccCCcccChhcc-ccCCCCCccchhhHHHHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKT---------------------HLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLE 540 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~---------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSfGvvl~E 540 (646)
++.+||+|||+++....... ...+..+||+.|+|||.+ ....++.++|||||||++||
T Consensus 165 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e 244 (432)
T 3n9x_A 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244 (432)
T ss_dssp TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence 99999999999987643221 122456799999999986 56679999999999999999
Q ss_pred HHhCCCCCCCCchH-------------------------HhhcHHHHHHHHHhhc-----------hhHHHhhhhh-ccc
Q 046188 541 LLTGKKPICLTREE-------------------------EERNLVAYFISLAKEN-----------KLLEILDARV-AKE 583 (646)
Q Consensus 541 lltG~~p~~~~~~~-------------------------~~~~l~~~~~~~~~~~-----------~~~~~~d~~l-~~~ 583 (646)
|++|..|+...... ........+....... .....+.... ...
T Consensus 245 ll~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (432)
T 3n9x_A 245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324 (432)
T ss_dssp HHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred HHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC
Confidence 99865444321100 0001111111111111 0111111000 000
Q ss_pred C-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 584 A-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 584 ~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. ....+..+.+|+.+||+.||.+|||++|++++
T Consensus 325 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 02245678999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=343.33 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=194.7
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
.++|...+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999853 688999999764 33455667889999999999999999999998654
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||++ |+|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------------------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 161 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred ceEEEEEcCC-CCHHHHHhh------------------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEc
Confidence 6799999996 577777632 5889999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~ 236 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---N 236 (371)
T ss_dssp TTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H
T ss_pred CCCCEEEEEeecccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 9999999999999865332 1223457899999999999999999999999999999999999999765432211 0
Q ss_pred HHHHHHhh----------chhHHHh---------------hhhhccc---CCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 046188 562 YFISLAKE----------NKLLEIL---------------DARVAKE---ASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613 (646)
Q Consensus 562 ~~~~~~~~----------~~~~~~~---------------d~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ev 613 (646)
.+...... ......+ ....... .+......+.+|+.+||+.||.+|||+.|+
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 00000000 0000000 0000000 012336778999999999999999999999
Q ss_pred HHHHH
Q 046188 614 SMDLE 618 (646)
Q Consensus 614 l~~L~ 618 (646)
+++-.
T Consensus 317 l~hp~ 321 (371)
T 2xrw_A 317 LQHPY 321 (371)
T ss_dssp HHSHH
T ss_pred hCCcc
Confidence 98754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=335.75 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=205.6
Q ss_pred cCCCcCccccccCcEEEEEEEc--CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC------ceeEEEEEEeCCce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH------IVKLLGCCLETEVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~--~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n------iv~l~g~~~~~~~~ 403 (646)
++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++++++|++ ++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5899999999999999999985 36889999998753 344567889999999997765 99999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD- 482 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 482 (646)
++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG--------------FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQS 154 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCC
T ss_pred EEEEcCC-CCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecc
Confidence 9999999 899999986643 236899999999999999999999999 999999999999987
Q ss_pred ------------------CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhC
Q 046188 483 ------------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 544 (646)
Q Consensus 483 ------------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG 544 (646)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 678999999999875332 2235689999999999999999999999999999999999
Q ss_pred CCCCCCCchHHhhcHHHHHHHHHhhc--hh-H----------------------HHhhhh-----hcccCCHHHHHHHHH
Q 046188 545 KKPICLTREEEERNLVAYFISLAKEN--KL-L----------------------EILDAR-----VAKEASEEDIEAVAE 594 (646)
Q Consensus 545 ~~p~~~~~~~~~~~l~~~~~~~~~~~--~~-~----------------------~~~d~~-----l~~~~~~~~~~~l~~ 594 (646)
+.||......+.... +....... .+ . ...... .....+......+.+
T Consensus 231 ~~pf~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 231 FTVFPTHDSKEHLAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp SCSCCCSCHHHHHHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCChHHHHHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 999976554332111 11111100 00 0 000000 001123455678999
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 046188 595 LAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 595 Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
|+.+||+.||.+|||+.|++++
T Consensus 308 li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhCcCcccccCHHHHhcC
Confidence 9999999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=352.57 Aligned_cols=255 Identities=11% Similarity=0.066 Sum_probs=185.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhc--CccCceeEE-------EEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQI--NHRHIVKLL-------GCC 397 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l--~H~niv~l~-------g~~ 397 (646)
..+|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346888999999999999999954 78999999987643 23455677885544444 699988755 555
Q ss_pred EeCC-----------------ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHH------HHHHHHHH
Q 046188 398 LETE-----------------VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR------VRVACEVA 454 (646)
Q Consensus 398 ~~~~-----------------~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~------~~ia~qia 454 (646)
...+ ..++||||++ |+|.+++..... .+.+..+ +.++.|++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------------~~~~~~~~~~~vk~~i~~qi~ 204 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------------VYVFRGDEGILALHILTAQLI 204 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------------SCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------------ccchhhhhhhhhHHHHHHHHH
Confidence 4332 3799999998 999999977532 3566666 88889999
Q ss_pred HHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc--CCCCCccchh
Q 046188 455 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVY 532 (646)
Q Consensus 455 ~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVw 532 (646)
+||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||
T Consensus 205 ~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 205 RLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp HHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHH
Confidence 9999999999 999999999999999999999999999875321 113457799999999987 6789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 046188 533 SFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612 (646)
Q Consensus 533 SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 612 (646)
||||++|||++|+.||.......... ......................+..+.+|+.+||+.||++|||+.|
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99999999999999997543221100 0000000000111111122345678999999999999999999999
Q ss_pred HHHH
Q 046188 613 VSMD 616 (646)
Q Consensus 613 vl~~ 616 (646)
++++
T Consensus 350 ~l~h 353 (371)
T 3q60_A 350 AMET 353 (371)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.93 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=196.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEE------------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL------------ 398 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~------------ 398 (646)
++|...+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 67888999999999999999965 48999999988777777788999999999999999999999874
Q ss_pred --eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 399 --ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 399 --~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+++ |+||||||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 149 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----------------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 149 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----------------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 3356799999997 799988853 26899999999999999999999999 999999999
Q ss_pred CEEEC-CCCcEEEeecCCccccCCCCC--ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCc
Q 046188 477 NILLD-DKFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTR 552 (646)
Q Consensus 477 NILl~-~~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 552 (646)
|||++ +++.+||+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99997 577999999999987643211 12233457999999998865 678999999999999999999999997654
Q ss_pred hHHhhcHHHHHHHHHh---hchhH-------HHhhhhhccc------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 553 EEEERNLVAYFISLAK---ENKLL-------EILDARVAKE------ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~---~~~~~-------~~~d~~l~~~------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+... .+..... ..... ..+....... .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 230 ELEQMQ---LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHH---HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHH---HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 332111 1110000 00000 0111111100 112345678999999999999999999999876
Q ss_pred H
Q 046188 617 L 617 (646)
Q Consensus 617 L 617 (646)
-
T Consensus 307 p 307 (320)
T 2i6l_A 307 P 307 (320)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=333.07 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=194.7
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC---------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--------- 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--------- 400 (646)
.++|+..+.||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46788999999999999999995 47899999998643 44567889999999999999999999998653
Q ss_pred ----CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 401 ----EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 401 ----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
+..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ ++||||||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~ 145 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---------------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPM 145 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---------------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---------------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHH
Confidence 45789999999999999997542 25788999999999999999999999 999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCC-------------CccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHH
Q 046188 477 NILLDDKFSAKVSDFGTSRSVPNDK-------------THLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELL 542 (646)
Q Consensus 477 NILl~~~~~~kI~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~Ell 542 (646)
|||++.++.+||+|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||+
T Consensus 146 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp GEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred hEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999999999998754221 1122335689999999998764 7899999999999999999
Q ss_pred hCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 543 TGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 543 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+ |+... .+... ...... . ....+....+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 226 ~---p~~~~--~~~~~---~~~~~~-~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 226 Y---PFSTG--MERVN---ILKKLR-S------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp S---CCSSH--HHHHH---HHHHHH-S------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---ccCCc--hhHHH---HHHhcc-c------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 8 44321 11111 111110 0 01112223444556778999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=360.87 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=207.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999964 68999999986421 123457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++...... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 265 E~~~gg~L~~~l~~~~~~------------~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED------------NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT------------SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred EeccCCCHHHHHHHhhcc------------cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEE
Confidence 999999999998764320 236999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........
T Consensus 330 L~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~-- 404 (543)
T 3c4z_A 330 ISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR-- 404 (543)
T ss_dssp ECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHH--
T ss_pred EeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHH--
Confidence 999999987643322 2334579999999999999999999999999999999999999997542211 11111111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM-----KQVSM 615 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~ 615 (646)
+... ...++...+..+.+|+.+||+.||.+||++ .||++
T Consensus 405 -------i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 405 -------VLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------Hhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111 123445566788999999999999999976 55654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.69 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=199.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||+||+|... ++..||||+++... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357889999999999999999964 68899999876432 223457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC---C
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---F 484 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~ 484 (646)
||+++|+|.+++... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.+ +
T Consensus 116 e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----------------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp ECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTC
T ss_pred ecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCC
Confidence 999999999988653 36899999999999999999999999 9999999999999764 4
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||......+. ..
T Consensus 177 ~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~ 247 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LR 247 (494)
T ss_dssp CEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred cEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 59999999998764332 223456999999999886 5689999999999999999999999975543221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.... ... ....+.....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 248 ~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 248 KVEK-GKY------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp HHHH-TCC------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred HHHh-CCC------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 1111 000 000000123446788999999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=351.82 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=203.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhc------CccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQI------NHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l------~H~niv~l~g~~~~~~~~ 403 (646)
..+|...+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357899999999999999999854 5889999998753 34455677888888887 577999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+. ++|.+++.... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--------------FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQ 236 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESST
T ss_pred EEEEeccC-CCHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccC
Confidence 99999995 79999887643 235999999999999999999999998 9999999999999998
Q ss_pred Cc--EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 484 FS--AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 484 ~~--~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
+. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 237 ~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l---~ 309 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL---A 309 (429)
T ss_dssp TSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H
T ss_pred CCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 87 999999999765322 22356899999999999999999999999999999999999999765543321 1
Q ss_pred HHHHHHhh---------chhHHHhhhhhc------------------------------------ccCCHHHHHHHHHHH
Q 046188 562 YFISLAKE---------NKLLEILDARVA------------------------------------KEASEEDIEAVAELA 596 (646)
Q Consensus 562 ~~~~~~~~---------~~~~~~~d~~l~------------------------------------~~~~~~~~~~l~~Li 596 (646)
.+...... .....+++..-. ...+......+.+|+
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 11111110 011111111000 000111246689999
Q ss_pred HhccccCCCCCCCHHHHHHHH
Q 046188 597 MGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 597 ~~Cl~~dP~~RPs~~evl~~L 617 (646)
.+||+.||++|||+.|++++-
T Consensus 390 ~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHTST
T ss_pred HHHCCCChhhCCCHHHHhCCh
Confidence 999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=371.78 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=207.3
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceE
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~ 404 (646)
..++|+..+.||+|+||.||+|... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999964 5889999998642 122345678899999987 7999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
|||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++
T Consensus 419 lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g 479 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 479 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSS
T ss_pred EEEeCcCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCC
Confidence 999999999999999753 36999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+ .+.
T Consensus 480 ~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~ 552 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQ 552 (674)
T ss_dssp CEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred cEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHH
Confidence 99999999998643222 22345679999999999999999999999999999999999999997543322 111
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM-----KQVSMD 616 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~-----~evl~~ 616 (646)
.++... ..++...+..+.+|+.+||+.||.+||++ +||+++
T Consensus 553 ---------~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 553 ---------SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---------HHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---------HHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111111 23455566789999999999999999998 666653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.17 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=203.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-----Cce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-----~~~ 403 (646)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999954 6889999998753 344557889999999999999999999999764 357
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||++ |+|.+++.. ..+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~ 164 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTT 164 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred EEEEcccC-cCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCC
Confidence 99999996 689888753 26999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc--cccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+.+||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--- 241 (364)
T 3qyz_A 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--- 241 (364)
T ss_dssp CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---
T ss_pred CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---
Confidence 99999999999876432221 1234579999999998654 45899999999999999999999999765433221
Q ss_pred HHHHHHHhhchh-----------HHHhhhhh-ccc-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 561 AYFISLAKENKL-----------LEILDARV-AKE-----ASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 561 ~~~~~~~~~~~~-----------~~~~d~~l-~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..+......... ........ ... .....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 242 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 111111111100 00000000 000 0122346789999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.99 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=201.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC----HHHHHHHHHHHHHHhhcCccCceeEEEEEEe--CCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID----KTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~--~~~~ 403 (646)
.++|...+.||+|+||.||++... +++.||||.++... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68899999886532 2345678999999999999999999999854 4578
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++| |.+++.... ...+++..++.++.|+++||.|||+++ ++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--------------EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--------------TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEehhccCC-HHHHHHhCc--------------ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCC
Confidence 9999999876 767665432 236999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCC-CCccccccccCCcccChhccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 484 FSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+.+||+|||++...... .........||+.|+|||.+.+.. .+.++||||||+++|||++|+.||......+
T Consensus 146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----- 220 (305)
T 2wtk_C 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----- 220 (305)
T ss_dssp CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----
Confidence 99999999999876432 222233456899999999987644 3779999999999999999999997543221
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... ... ....+..+...+.+++.+||+.||.+|||+.|++++-.
T Consensus 221 -~~~~i-~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 221 -LFENI-GKG----------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp -HHHHH-HHC----------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred -HHHHH-hcC----------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 11111 111 11233445577899999999999999999999998744
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.56 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=186.9
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------C
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------E 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------~ 401 (646)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999984 4689999999864 3345567888999999999999999999998754 4
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~ 166 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 166 (367)
T ss_dssp CCEEEEECC-CEECC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eEEEEeccc-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEEC
Confidence 579999999 7899988854 26999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 167 ~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l--- 239 (367)
T 2fst_X 167 EDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--- 239 (367)
T ss_dssp TTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---
T ss_pred CCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 9999999999999865322 234578999999999877 67899999999999999999999999765433221
Q ss_pred HHHHHHHhhc-----------hhHHHhhhhhc-ccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 561 AYFISLAKEN-----------KLLEILDARVA-KEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 561 ~~~~~~~~~~-----------~~~~~~d~~l~-~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..+....... ....++..-.. ... .......+.+|+.+||+.||.+|||+.|++++-
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 1111111110 01111110000 000 012346689999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=356.53 Aligned_cols=253 Identities=27% Similarity=0.371 Sum_probs=202.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCH-------------HHHHHHHHHHHHHhhcCccCceeEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-------------TQIEQFINEVVILSQINHRHIVKLLGC 396 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-------------~~~~~~~~Ei~il~~l~H~niv~l~g~ 396 (646)
.++|...+.||+|+||+||+|... +++.||||.++.... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999964 578999998764321 234578899999999999999999999
Q ss_pred EEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 046188 397 CLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 476 (646)
Q Consensus 397 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~ 476 (646)
+.+....++||||+++|+|.+++... ..+++..++.|+.|++.||.|||+.+ |+||||||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~ 175 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----------------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPE 175 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHH
Confidence 99999999999999999999988653 36999999999999999999999999 999999999
Q ss_pred CEEECCCC---cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 477 NILLDDKF---SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 477 NILl~~~~---~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
|||++.++ .+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99998775 69999999998764432 223456999999999987 5689999999999999999999999975443
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.+. ...... +... .+.... ...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 253 ~~~------~~~i~~-~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 253 QDI------IKKVEK-GKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHH------HHHHHH-CCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHH------HHHHHc-CCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 221 111111 1000 000000 123467899999999999999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=342.08 Aligned_cols=271 Identities=21% Similarity=0.273 Sum_probs=193.6
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc-
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV- 402 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~- 402 (646)
++.....++|...+.||+|+||.||+|... +|+.||||++.... .....+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677789999999999999999999964 68999999875432 223356678888999999999999999976443
Q ss_pred ------eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEecCCC
Q 046188 403 ------PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH--SSASIPIFHRDIK 474 (646)
Q Consensus 403 ------~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--~~~~~~ivHrDIk 474 (646)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||.||| +.+ |+|||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlk 158 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR------------RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIK 158 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT------------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCC
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh------------cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCC
Confidence 7899999975 55554433211 1347899999999999999999999 887 9999999
Q ss_pred CCCEEECC-CCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCc
Q 046188 475 SSNILLDD-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTR 552 (646)
Q Consensus 475 ~~NILl~~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 552 (646)
|+|||++. ++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999996 89999999999987643322 2345689999999998665 48999999999999999999999997654
Q ss_pred hHHhhcHHHHHHHHHhhc--hhHHHhhh----------------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046188 553 EEEERNLVAYFISLAKEN--KLLEILDA----------------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~~~--~~~~~~d~----------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl 614 (646)
..... ..+....... .....+++ ......+...+..+.+|+.+||+.||.+|||+.|++
T Consensus 237 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 237 SAGQL---HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp HHHHH---HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred hHHHH---HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 33221 1111111110 00001110 111112233567899999999999999999999999
Q ss_pred HHH
Q 046188 615 MDL 617 (646)
Q Consensus 615 ~~L 617 (646)
++-
T Consensus 314 ~hp 316 (360)
T 3e3p_A 314 CHP 316 (360)
T ss_dssp TSG
T ss_pred cCc
Confidence 873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.87 Aligned_cols=253 Identities=29% Similarity=0.384 Sum_probs=206.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
.++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357889999999999999999964 6899999987532 133456788999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---CCC
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDK 483 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~ 483 (646)
|||+.+|+|.+++... ..+++..++.|+.|++.||.|||+++ |+||||||+|||+ +.+
T Consensus 105 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR----------------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp ECCCCSCBHHHHHHTC----------------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTT
T ss_pred EecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCC
Confidence 9999999999988653 36999999999999999999999999 9999999999999 567
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+.+||+|||+++....... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+. .
T Consensus 166 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~ 236 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------L 236 (484)
T ss_dssp CCEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred CcEEEEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH------H
Confidence 8999999999987644332 234569999999999865 689999999999999999999999975443221 1
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... ... ....+.....+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 237 ~~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 237 KKVEK-GKY------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp HHHHH-CCC------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHc-CCC------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 11111 100 0000111234567899999999999999999999998755
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=356.42 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=203.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||+||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 367999999999999999999964 6899999987531 1223567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC---CCC
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKF 484 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~ 484 (646)
||+++|+|.+++... ..+++..+..|+.|++.||.|||+++ |+||||||+|||++ .++
T Consensus 101 e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp CCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTC
T ss_pred EcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCC
Confidence 999999999988653 36999999999999999999999999 99999999999995 456
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||+++...... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+. ..
T Consensus 162 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~ 232 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LK 232 (486)
T ss_dssp CEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred CEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 79999999998764332 2234569999999999875 589999999999999999999999975443221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.... ... ....+.....+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 233 ~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 233 RVET-GKY------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHH-TCC------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHh-CCC------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 1111 000 0000111234567899999999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=343.65 Aligned_cols=264 Identities=20% Similarity=0.366 Sum_probs=201.8
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++...++|...+.||+|+||.||+|...+ .||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33445789999999999999999999743 4999987642 2223346778999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++ ++
T Consensus 106 iv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~ 166 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAK---------------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NG 166 (319)
T ss_dssp EECBCCCSEEHHHHTTSSC---------------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---
T ss_pred EEeecccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CC
Confidence 9999999999999997642 36899999999999999999999999 99999999999998 67
Q ss_pred cEEEeecCCccccCCC----CCccccccccCCcccChhcccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 485 SAKVSDFGTSRSVPND----KTHLTTAVQGTFGYFDPEYFQS---------SQYTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~l~~---------~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
.+||+|||+++..... .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998765321 1112223458999999999864 45788999999999999999999998754
Q ss_pred chHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
..... ..... .. ..+ ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+......
T Consensus 247 ~~~~~------~~~~~-~~-----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 247 PAEAI------IWQMG-TG-----MKP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CHHHH------HHHHH-TT-----CCC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CHHHH------HHHhc-cC-----CCC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 43221 11111 00 001 111122345689999999999999999999999999998876544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.90 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=196.1
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc------eEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------PVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~------~~L 405 (646)
.+|...+.||+|+||.||+|+..++..||+|++..... ...+|+.++++++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 57889999999999999999987667799998754321 22369999999999999999999975443 789
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-CCC
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKF 484 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~ 484 (646)
||||++++.+......... ...+++..+..++.|+++||+|||+++ |+||||||+|||++ .++
T Consensus 116 v~e~~~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 179 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKL-------------KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSG 179 (394)
T ss_dssp EEECCSEEHHHHHHHHHHT-------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred EeeccCccHHHHHHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCC
Confidence 9999976544333222111 347999999999999999999999999 99999999999999 799
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +.. +
T Consensus 180 ~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~-i 254 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVE-I 254 (394)
T ss_dssp EEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-H
T ss_pred cEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-H
Confidence 999999999987643322 2345689999999998764 589999999999999999999999976543322 111 1
Q ss_pred HHHHhhchhH--HHhhhhhc-------------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 564 ISLAKENKLL--EILDARVA-------------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~--~~~d~~l~-------------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.......... ..+++... ..++...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 1111111111 11111110 01122345689999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=336.36 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=196.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC--------HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLETE 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~ 401 (646)
.++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999954 57899999876421 122345789999999999999999999987654
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
.++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN----------------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 148 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEES
T ss_pred -eEEEEecCCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEe
Confidence 89999999999999988653 36899999999999999999999999 99999999999998
Q ss_pred CCCc---EEEeecCCccccCCCCCccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHH
Q 046188 482 DKFS---AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555 (646)
Q Consensus 482 ~~~~---~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 555 (646)
.++. +||+|||+++..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||.......
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred cCCCCCeEEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 7664 999999999876432 2223456899999999874 5678999999999999999999999986432211
Q ss_pred hhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 556 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+...+ ...... ..+... ...+..+.+++.+||+.||.+||++.|++++
T Consensus 227 --~~~~~~----~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 227 --SLKDQI----TSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --CHHHHH----HHTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHH----HhCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111111 111000 001111 1234678999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.45 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=204.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHH-----------------HHHHHHHHHHHHhhcCccCceeE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKT-----------------QIEQFINEVVILSQINHRHIVKL 393 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~-----------------~~~~~~~Ei~il~~l~H~niv~l 393 (646)
.++|...+.||+|+||.||+|.. +|+.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 8999999987642111 11678899999999999999999
Q ss_pred EEEEEeCCceEEEEEeccCCCchhh------hhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCC
Q 046188 394 LGCCLETEVPVLVYEYICNGNLSHH------IHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASI 466 (646)
Q Consensus 394 ~g~~~~~~~~~LV~Ey~~~gsL~~~------l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~ 466 (646)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||.|||+ .+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~-- 172 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--------------TCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--------------CCCCCHHHHHHHHHHHHHHHHHHHHTSC--
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--------------ccCCCHHHHHHHHHHHHHHHHHHhccCC--
Confidence 9999999999999999999999999 54321 2479999999999999999999999 88
Q ss_pred CeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCC-ccchhhHHHHHHHHHhC
Q 046188 467 PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTD-KSDVYSFGVVLLELLTG 544 (646)
Q Consensus 467 ~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-ksDVwSfGvvl~ElltG 544 (646)
++||||||+||+++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|
T Consensus 173 -i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 173 -ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred -EeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875332 23345689999999999887 6666 99999999999999999
Q ss_pred CCCCCCCchHHhhcHHHHHHHHHhhchhH------HHhh---hhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 545 KKPICLTREEEERNLVAYFISLAKENKLL------EILD---ARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 545 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~~d---~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
+.||........ ..... ...... .+.. +..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~pf~~~~~~~~-----~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 249 VVPFSLKISLVE-----LFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSSCCSSCSHH-----HHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCcHHH-----HHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999975433111 11111 111000 0000 00000011345578899999999999999999999988
Q ss_pred H
Q 046188 616 D 616 (646)
Q Consensus 616 ~ 616 (646)
+
T Consensus 323 h 323 (348)
T 2pml_X 323 H 323 (348)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=350.73 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=196.2
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------ceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------VPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------~~~ 404 (646)
.+|...+.||+|+||.||+|+.. +|+.||||++..... .+.+|+++|++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999964 589999998865321 2347999999999999999999986421 257
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC-
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK- 483 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~- 483 (646)
+||||+++ +|.+.+..... ....+++..++.++.||++||.|||+++ |+||||||+||||+.+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~ 193 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR------------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDT 193 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTT
T ss_pred eehhcccc-cHHHHHHHHhh------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCC
Confidence 89999964 66666543211 1347999999999999999999999999 9999999999999965
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+. +..
T Consensus 194 ~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~- 268 (420)
T 1j1b_A 194 AVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVE- 268 (420)
T ss_dssp TEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-
T ss_pred CeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-
Confidence 6789999999987643322 2335689999999998764 789999999999999999999999976543321 111
Q ss_pred HHHHHhhchhHHH--hhhhhc-------------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 563 FISLAKENKLLEI--LDARVA-------------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 563 ~~~~~~~~~~~~~--~d~~l~-------------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
+...........+ +++... ..++...+..+.+|+.+||+.||.+||++.|++++-
T Consensus 269 i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 1111111111111 111100 012233456789999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.50 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=201.6
Q ss_pred HhcCCCcCccccccCcEEEEEEEc--CCCCEEEEEecccCC--HHHHHHHHHHHHHHhhc---CccCceeEEEEEE----
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSKAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCL---- 398 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~--~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~---- 398 (646)
+.++|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 467899999875421 11123456777777766 8999999999987
Q ss_pred -eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 399 -ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 399 -~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~N 150 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--------------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 150 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHH
Confidence 4456899999997 799999876432 35899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhh
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 557 (646)
|+++.++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 151 ili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 227 (326)
T 1blx_A 151 ILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ- 227 (326)
T ss_dssp EEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred eEEcCCCCEEEecCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-
Confidence 99999999999999999865322 223345689999999999999999999999999999999999999976543321
Q ss_pred cHHHHHHHHHhhchhHHHh----------h---hhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 558 NLVAYFISLAKENKLLEIL----------D---ARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 558 ~l~~~~~~~~~~~~~~~~~----------d---~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
...+...........+. . ...........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 228 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 228 --LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp --HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111111100000000 0 000011223455778999999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.87 Aligned_cols=274 Identities=21% Similarity=0.311 Sum_probs=185.9
Q ss_pred cCCCc-CccccccCcEEEEEEEcC---CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe--CCceEE
Q 046188 332 DNYNQ-SRFLGQGGFGTVYKGMLP---DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVL 405 (646)
Q Consensus 332 ~~~~~-~~~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~--~~~~~L 405 (646)
+.|.. .++||+|+||.||+|... +++.||||+++.... .+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 458999999999999964 478999999875322 2367799999999999999999999965 557899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----C
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----D 481 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl----~ 481 (646)
||||++ |+|.+++........ ......+++..++.|+.||+.||.|||+.+ |+||||||+|||| +
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKA-------NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC--------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred EEeCCC-CCHHHHHHHhccccc-------cccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 999995 688888865432110 001235999999999999999999999999 9999999999999 7
Q ss_pred CCCcEEEeecCCccccCCCCC--ccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHh--
Q 046188 482 DKFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE-- 556 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-- 556 (646)
.++.+||+|||+++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 789999999999987643221 222346789999999998874 589999999999999999999999965433210
Q ss_pred ----hcHHHHHHHHHhhc---hhHH---------Hhh---hhhccc---------CCHHHHHHHHHHHHhccccCCCCCC
Q 046188 557 ----RNLVAYFISLAKEN---KLLE---------ILD---ARVAKE---------ASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 557 ----~~l~~~~~~~~~~~---~~~~---------~~d---~~l~~~---------~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
......+....... .+.. ... ...... ........+.+|+.+||+.||.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 00111111111100 0000 000 000000 0011135678999999999999999
Q ss_pred CHHHHHHHHH
Q 046188 609 TMKQVSMDLE 618 (646)
Q Consensus 609 s~~evl~~L~ 618 (646)
|+.|++++-.
T Consensus 327 ta~e~L~hp~ 336 (405)
T 3rgf_A 327 TSEQAMQDPY 336 (405)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcChh
Confidence 9999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.22 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=201.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-----Cce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-----~~~ 403 (646)
.++|...+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999964 6889999998653 344556788999999999999999999998764 568
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~ 148 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----------------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSN 148 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEeccC-ccHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCC
Confidence 99999996 688888754 26899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCCc---------cccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 484 FSAKVSDFGTSRSVPNDKTH---------LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
+.+||+|||+++........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999876432211 1123468999999998764 6789999999999999999999999976543
Q ss_pred HHhhcHHHHHHHHHhhc------------hhHHHhhhhhc------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 554 EEERNLVAYFISLAKEN------------KLLEILDARVA------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~------------~~~~~~d~~l~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
..... .+....... ...+.+..... .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 229 RHQLL---LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHH---HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHH---HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 32111 111111100 01111110000 0001234567899999999999999999999998
Q ss_pred HH
Q 046188 616 DL 617 (646)
Q Consensus 616 ~L 617 (646)
+-
T Consensus 306 hp 307 (353)
T 2b9h_A 306 HP 307 (353)
T ss_dssp SG
T ss_pred Cc
Confidence 53
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=342.44 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=198.4
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce----
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP---- 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~---- 403 (646)
.++|...+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368888999999999999999854 6899999998652 344567888999999999999999999999876654
Q ss_pred --EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 404 --VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 404 --~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
++||||++ |+|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 178 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN 178 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEcccc-ccHHHHhh------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEEC
Confidence 99999996 68877763 25899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 179 ~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--- 251 (371)
T 4exu_A 179 EDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--- 251 (371)
T ss_dssp TTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---
T ss_pred CCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---
Confidence 9999999999999865322 233568999999999877 67899999999999999999999999765433211
Q ss_pred HHHHHHHhhc-----------hhHHHhhhhhcc------cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 561 AYFISLAKEN-----------KLLEILDARVAK------EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 561 ~~~~~~~~~~-----------~~~~~~d~~l~~------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..+....... ....+....... ......+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 252 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 252 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 1111111000 000011000000 01123356789999999999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.87 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-----------ccCceeEEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-----------HRHIVKLLGCCLE 399 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------H~niv~l~g~~~~ 399 (646)
++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999995 46889999998753 344567889999999886 8999999999886
Q ss_pred CC----ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCC
Q 046188 400 TE----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIK 474 (646)
Q Consensus 400 ~~----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk 474 (646)
.+ ..++||||+ +++|.+++..... ..+++..++.|+.|++.||+|||++ + |+|||||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dik 159 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--------------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIK 159 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCS
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--------------cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCC
Confidence 54 678999999 9999999876432 3599999999999999999999998 8 9999999
Q ss_pred CCCEEEC------CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 475 SSNILLD------DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 475 ~~NILl~------~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
|+|||++ .++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 9999994 4558999999999876432 22346899999999999999999999999999999999999999
Q ss_pred CCCchHHhhcH---HHHHHHHHhhc--------h----------------------hHHHhhhhhcccCCHHHHHHHHHH
Q 046188 549 CLTREEEERNL---VAYFISLAKEN--------K----------------------LLEILDARVAKEASEEDIEAVAEL 595 (646)
Q Consensus 549 ~~~~~~~~~~l---~~~~~~~~~~~--------~----------------------~~~~~d~~l~~~~~~~~~~~l~~L 595 (646)
........... ...+....... . +.+.+.. ....+...+..+.+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDF 313 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHH
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHH
Confidence 75432211111 11111111100 0 0011111 123567788899999
Q ss_pred HHhccccCCCCCCCHHHHHHHHH
Q 046188 596 AMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 596 i~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
+.+||+.||.+|||+.|++++-.
T Consensus 314 i~~~L~~dP~~Rpt~~ell~hp~ 336 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVNHPW 336 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGG
T ss_pred HHHHhccCccccCCHHHHhhChh
Confidence 99999999999999999988643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.70 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=198.8
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc------
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------ 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~------ 402 (646)
++|...+.||+|+||.||+|... +|+.||||++.. ......+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999954 689999999864 234456678999999999999999999999987654
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||++ |+|.+++.. .+++.+++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------------------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------------------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECT
T ss_pred EEEEecccc-CCHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECC
Confidence 499999996 688887732 5899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ..
T Consensus 162 ~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~ 234 (353)
T 3coi_A 162 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LT 234 (353)
T ss_dssp TCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HH
T ss_pred CCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 999999999999865322 233568999999999877 6789999999999999999999999976543221 11
Q ss_pred HHHHHHhh-----------chhHHHhhhh---hc---ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 562 YFISLAKE-----------NKLLEILDAR---VA---KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 562 ~~~~~~~~-----------~~~~~~~d~~---l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.+...... .....++... .. .......+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 11111100 0000111000 00 111234567899999999999999999999998763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=331.43 Aligned_cols=260 Identities=19% Similarity=0.273 Sum_probs=202.8
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CC-CEEEEEecccCCHHHHHHHHHHHHHHhhcCccC------ceeEEEEEEeCCc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DG-SIVAVKRSKAIDKTQIEQFINEVVILSQINHRH------IVKLLGCCLETEV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g-~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n------iv~l~g~~~~~~~ 402 (646)
.++|...+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999953 34 68999998753 344567889999999998776 9999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE--
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-- 480 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl-- 480 (646)
.++||||+ +++|.+++.... ...+++.+++.|+.|++.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--------------FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVN 158 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESC
T ss_pred EEEEEecc-CCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEec
Confidence 99999999 777777775532 236999999999999999999999998 9999999999999
Q ss_pred -----------------CCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh
Q 046188 481 -----------------DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543 (646)
Q Consensus 481 -----------------~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt 543 (646)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 568899999999998653322 33568999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHhhcHHHHHHHHHhhc---hhH----------------------HHhhhh-----hcccCCHHHHHHHH
Q 046188 544 GKKPICLTREEEERNLVAYFISLAKEN---KLL----------------------EILDAR-----VAKEASEEDIEAVA 593 (646)
Q Consensus 544 G~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~----------------------~~~d~~-----l~~~~~~~~~~~l~ 593 (646)
|+.||......+... .+....... ... ...... ............+.
T Consensus 235 g~~pf~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 235 GFTLFQTHENREHLV---MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp SSCSCCCSSHHHHHH---HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred CCCCCCCCCHHHHHH---HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 999997654433211 111111100 000 000000 00112234456899
Q ss_pred HHHHhccccCCCCCCCHHHHHHH
Q 046188 594 ELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 594 ~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+|+.+||+.||.+|||+.|++++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.37 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=202.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999964 6899999987542 2234567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC---C
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---F 484 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~ 484 (646)
||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.+ +
T Consensus 101 e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 101 ELYTGGELFDEIIKR----------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp CCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred EccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcc
Confidence 999999999988653 36899999999999999999999999 9999999999999764 4
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||++........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. ..
T Consensus 162 ~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~ 232 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LK 232 (287)
T ss_dssp CEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred cEEEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 799999999987643322 223358899999998875 489999999999999999999999875433221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
.. ..+... ...+.....+..+.+++.+||+.||.+|||+.|++++-
T Consensus 233 ~~-~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 233 RV-ETGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp HH-HHCCCC------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HH-HcCCCC------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 11 111000 00000123346789999999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.17 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=201.9
Q ss_pred HhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-cc-----CceeEEEEEEeCCc
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HR-----HIVKLLGCCLETEV 402 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~-----niv~l~g~~~~~~~ 402 (646)
..++|...+.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+ +++++.+++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999954 6889999998753 334556778999988885 44 49999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD- 481 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~- 481 (646)
.++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++. .+|+||||||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN--------------FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCN 194 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT--------------TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESS
T ss_pred eEEEEecCC-CCHHHHHhhcC--------------cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEec
Confidence 999999995 69999987643 236999999999999999999999532 1299999999999994
Q ss_pred -CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 -DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 -~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~--- 267 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM--- 267 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred CCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 5788999999999876432 22356899999999999999999999999999999999999999765443221
Q ss_pred HHHHHHHhh---------chhHHHhhhhh-----------------------------------------cccCCHHHHH
Q 046188 561 AYFISLAKE---------NKLLEILDARV-----------------------------------------AKEASEEDIE 590 (646)
Q Consensus 561 ~~~~~~~~~---------~~~~~~~d~~l-----------------------------------------~~~~~~~~~~ 590 (646)
..+...... ....++++.-. ..........
T Consensus 268 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (382)
T 2vx3_A 268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL 347 (382)
T ss_dssp HHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHH
T ss_pred HHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhH
Confidence 111111110 00011110000 0001223446
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 591 AVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 591 ~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+.+|+.+||+.||++|||+.|++++
T Consensus 348 ~~~dli~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 348 KFKDLILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCCChhhCCCHHHHhcC
Confidence 78999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.56 Aligned_cols=245 Identities=28% Similarity=0.412 Sum_probs=193.3
Q ss_pred HHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH------HHHHHHHHHHHHHhhc----CccCceeEEEE
Q 046188 328 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK------TQIEQFINEVVILSQI----NHRHIVKLLGC 396 (646)
Q Consensus 328 ~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l----~H~niv~l~g~ 396 (646)
+...++|...+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44457899999999999999999985 4688999999865322 1233456799999998 89999999999
Q ss_pred EEeCCceEEEEEe-ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 046188 397 CLETEVPVLVYEY-ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS 475 (646)
Q Consensus 397 ~~~~~~~~LV~Ey-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~ 475 (646)
+.+.+..++|||| +.+++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 167 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK----------------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKD 167 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSG
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 9998999999999 7899999999653 35899999999999999999999999 99999999
Q ss_pred CCEEEC-CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCch
Q 046188 476 SNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTRE 553 (646)
Q Consensus 476 ~NILl~-~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~ 553 (646)
+||+++ +++.+||+|||+++...... .....||..|+|||.+.+..+. .++||||||+++|||++|+.||.....
T Consensus 168 ~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 244 (312)
T 2iwi_A 168 ENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244 (312)
T ss_dssp GGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred hhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH
Confidence 999999 88999999999998764322 2345689999999998877664 589999999999999999999853210
Q ss_pred HHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 554 EEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 554 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
..+. ....+......+.+++.+||+.||++|||+.|++++-
T Consensus 245 ---------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 245 ---------------------ILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp ---------------------HHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ---------------------Hhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0011 1123344556789999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.12 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=183.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC-CHHHHHHHHHHHH-HHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI-DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~-il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||.||+|... +|+.||||+++.. .......+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368889999999999999999964 6899999998653 3344455666666 778889999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
||++ |+|.+++..... .....+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+
T Consensus 101 e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYS-----------VLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp CCCS-EEHHHHHHHHHH-----------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEE
T ss_pred eecC-CChHHHHHHHHh-----------hhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCE
Confidence 9997 588877754221 0134799999999999999999999998 8 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhcc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
||+|||+++....... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 166 kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------ 237 (327)
T 3aln_A 166 KLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------ 237 (327)
T ss_dssp EECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred EEccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------
Confidence 9999999987643221 2234689999999998 456789999999999999999999999864321100
Q ss_pred HHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 563 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
. .. .......+.+........+..+.+|+.+||+.||.+||++.|++++-.-
T Consensus 238 --~-~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 238 --Q-LT--QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp -----C--CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred --H-HH--HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 0 00 0000000111111122345679999999999999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=335.82 Aligned_cols=248 Identities=27% Similarity=0.414 Sum_probs=199.6
Q ss_pred HHHHHHHhcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH------HHHHHHHHHHHHHhhcC--ccCceeEE
Q 046188 324 AEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK------TQIEQFINEVVILSQIN--HRHIVKLL 394 (646)
Q Consensus 324 ~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~------~~~~~~~~Ei~il~~l~--H~niv~l~ 394 (646)
..+.+...++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++++++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344455567899999999999999999984 4688999998764211 11235668999999996 59999999
Q ss_pred EEEEeCCceEEEEEeccC-CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 395 GCCLETEVPVLVYEYICN-GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 395 g~~~~~~~~~LV~Ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
+++.+.+..++|||++.+ ++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 175 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER----------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDI 175 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCC
Confidence 999999999999999976 8999998653 36899999999999999999999999 999999
Q ss_pred CCCCEEEC-CCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 474 KSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 474 k~~NILl~-~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
||+|||++ +++.+||+|||+++...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 176 KDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred CHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99999999 78999999999998764322 233568999999999887765 68899999999999999999998532
Q ss_pred chHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ... . ....+...+..+.+|+.+||+.||++|||+.||+++
T Consensus 253 ~~------------~~~---------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 253 EE------------IIR---------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH------------HHH---------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hh------------hhc---------c--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 000 0 011223345678999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=344.09 Aligned_cols=256 Identities=24% Similarity=0.312 Sum_probs=187.7
Q ss_pred CCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEecc
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~- 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC- 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-
Confidence 34456789999999997665557999999998653 234677899999987 8999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC--------
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-------- 483 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-------- 483 (646)
+|+|.+++......... ....++..++.|+.|++.||+|||+++ |+||||||+|||++.+
T Consensus 92 ~gsL~~~l~~~~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 92 NLNLQDLVESKNVSDEN---------LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp SEEHHHHHHTC---------------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCT
T ss_pred CCCHHHHHhccCCCchh---------hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccc
Confidence 47999999765321100 112345567899999999999999999 9999999999999754
Q ss_pred -----CcEEEeecCCccccCCCCCc---cccccccCCcccChhcccc-------CCCCCccchhhHHHHHHHHHh-CCCC
Q 046188 484 -----FSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKP 547 (646)
Q Consensus 484 -----~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSfGvvl~Ellt-G~~p 547 (646)
+.+||+|||+++........ ......||++|+|||.+.+ ..++.++|||||||++|||++ |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 48999999999987543322 1234579999999999865 678999999999999999999 8999
Q ss_pred CCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 548 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 548 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
|......+. ...... . -.+......+...+..+.+|+.+||+.||.+|||+.||+++
T Consensus 240 f~~~~~~~~--------~i~~~~-~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 240 FGDKYSRES--------NIIRGI-F---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TCSTTTHHH--------HHHHTC-C---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCchhhHH--------HHhcCC-C---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 864322210 000000 0 00001112245667889999999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=331.01 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=175.5
Q ss_pred hcCCCcCc-cccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe----CCceE
Q 046188 331 TDNYNQSR-FLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPV 404 (646)
Q Consensus 331 t~~~~~~~-~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~----~~~~~ 404 (646)
.++|...+ .||+|+||.||+|... +|+.||||++.... ... .+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46888854 6999999999999965 68999999986532 111 223334566799999999999876 33479
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-- 482 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 482 (646)
+||||+++|+|.+++.... ...+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--------------DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---------------CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred EEEeccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecC
Confidence 9999999999999997643 236999999999999999999999999 999999999999986
Q ss_pred -CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||+++...... .....||+.|+|||.+....++.++||||||+++|||++|+.||..........
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 239 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--- 239 (336)
T ss_dssp TTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred CCceEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---
Confidence 4559999999998654221 233568999999999988889999999999999999999999986433221100
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
...... ...............+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 240 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 240 GMKRRI------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hHHHhh------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000000 000000111112344567899999999999999999999998655
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.67 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=180.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHH-HHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQI-EQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~-~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
.++|...+.||+|+||.||+|... +|+.||||++.... .... +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999964 68999999986532 2233 33445556788889999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCEEECCCCcE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
||+ ++.+..+.... ...+++..++.++.|+++||.|||+. + ++||||||+||+++.++.+
T Consensus 104 e~~-~~~~~~l~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---------------QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp CCC-SEEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCE
T ss_pred ecc-CCcHHHHHHHh---------------ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCE
Confidence 999 44444333221 24699999999999999999999995 8 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
||+|||++........ .....||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .
T Consensus 165 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~ 237 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----E 237 (318)
T ss_dssp EECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H
T ss_pred EEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----H
Confidence 9999999976543221 23346899999999984 5568899999999999999999999986432211 1
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L 617 (646)
......... .+ ........+..+.+++.+||+.||.+||++.|++++-
T Consensus 238 ~~~~~~~~~------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 238 VLTKVLQEE------PP--LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp HHHHHHHSC------CC--CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHHHhccC------CC--CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 111111110 00 0011123456789999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.97 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=187.2
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+.+|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356888899999999995544444789999999865322 2356899999999 799999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-----CC
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KF 484 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~ 484 (646)
++ |+|.+++..... .+.+..++.|+.|++.||.|||+++ |+||||||+|||++. ..
T Consensus 100 ~~-g~L~~~l~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF---------------AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp CS-EEHHHHHHSSSC---------------CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBC
T ss_pred CC-CCHHHHHHhcCC---------------CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCce
Confidence 95 799999976432 4556677899999999999999999 999999999999953 34
Q ss_pred cEEEeecCCccccCCCCC--ccccccccCCcccChhccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 485 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
.+||+|||+++....... .......||++|+|||.+. ...++.++|||||||++|||++ |..||........
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-- 238 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-- 238 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--
Confidence 689999999987643321 2233467999999999997 4567889999999999999999 8888853322110
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......... . ...........+.+|+.+||+.||.+|||+.||+++
T Consensus 239 -----~~~~~~~~~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 239 -----NILLGACSL-D------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -----HHHTTCCCC-T------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----HHHhccCCc-c------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 001110000 0 001122345567899999999999999999999953
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=351.78 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=195.7
Q ss_pred cCCCcCccccccCcEEEEEEEcC--CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc-----e
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV-----P 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~--~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~-----~ 403 (646)
++|...+.||+|+||.||+|... +|+.||||++.. ......+.+.+|+.++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999964 588999998864 344556678999999999999999999999987665 6
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
||||||+++++|.+++.. .++|.+++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 160 ~lv~E~~~g~~L~~~~~~------------------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~ 218 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------------------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE 218 (681)
T ss_dssp EEEEECCCCEECC----C------------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS
T ss_pred EEEEEeCCCCcHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC
Confidence 999999999999887632 5899999999999999999999999 9999999999999986
Q ss_pred CcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 484 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 484 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||+++..... ....||++|+|||++.++. +.++|||||||++|||++|..|+.......
T Consensus 219 -~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------- 283 (681)
T 2pzi_A 219 -QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------- 283 (681)
T ss_dssp -CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------
T ss_pred -cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------
Confidence 9999999999876432 3456999999999987664 889999999999999999988864311100
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~i~~~ 623 (646)
+.. ..........+.+|+.+||+.||.+|| +++++...|..+...
T Consensus 284 --------~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 284 --------LPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp --------CCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred --------ccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 000 000112235688999999999999999 577777777766543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=349.36 Aligned_cols=269 Identities=23% Similarity=0.379 Sum_probs=206.2
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEe------CCce
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE------TEVP 403 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~------~~~~ 403 (646)
++|...+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999996 46899999998753 45566789999999999999999999999765 5677
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
++||||+++|+|.+++..... ...+++..++.|+.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-------------~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-------------CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPG 157 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-------------TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecC
Confidence 999999999999999976432 236899999999999999999999999 9999999999999976
Q ss_pred Cc---EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 484 FS---AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 484 ~~---~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
+. +||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 158 g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~---- 231 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ---- 231 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH----
T ss_pred CCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh----
Confidence 65 9999999998764332 22345799999999999999999999999999999999999999965432110
Q ss_pred HHHHHHHhhc----hhHHHhhh--------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHH-----HHHHHHHHHhh
Q 046188 561 AYFISLAKEN----KLLEILDA--------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ-----VSMDLEGLRRS 623 (646)
Q Consensus 561 ~~~~~~~~~~----~~~~~~d~--------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e-----vl~~L~~i~~~ 623 (646)
+........ ...+.... ......+...+..+.+++.+||+.||.+|||+.| +.+.++.+...
T Consensus 232 -~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 232 -WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred -hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000000 00000000 0011234567789999999999999999999998 55666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.71 Aligned_cols=232 Identities=13% Similarity=0.084 Sum_probs=184.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|...+.||+|+||.||+|... +|+.||||.++.. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999964 4899999998753 2445578999999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++++|.+++.. .....+..+|+.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 111 e~~~g~~L~~~l~~------------------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 111 EWIRGGSLQEVADT------------------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp ECCCEEEHHHHHTT------------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEE
T ss_pred EecCCCCHHHHHhc------------------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEE
Confidence 99999999999843 2345578899999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+++| |++| ++.++||||||+++|||++|+.||..........
T Consensus 170 l~~~~---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------- 212 (286)
T 3uqc_A 170 LAYPA---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------- 212 (286)
T ss_dssp ECSCC---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------
T ss_pred EEecc---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------
Confidence 98443 3333 5889999999999999999999997543221000
Q ss_pred hhchhHHHhhhhh--cccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 568 KENKLLEILDARV--AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 568 ~~~~~~~~~d~~l--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
.....+.... ........+..+.+++.+||+.||.+| |+.|+++.|+++.....
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 213 ---PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp ---ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ---HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000000000 001122344678999999999999999 99999999999886543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.21 Aligned_cols=248 Identities=17% Similarity=0.173 Sum_probs=181.7
Q ss_pred HhcCCCcCccccccCcEEEEEEE-cCCCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCc-cCc---------ee---
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAID---KTQIEQFINEVVILSQINH-RHI---------VK--- 392 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H-~ni---------v~--- 392 (646)
.+.+|...+.||+|+||.||+|. ..+|+.||||+++... ....+.+.+|+.+++.++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34567778899999999999999 4569999999887322 2235678899999999977 221 11
Q ss_pred ---------EEEEEEe-----CCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHH
Q 046188 393 ---------LLGCCLE-----TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 458 (646)
Q Consensus 393 ---------l~g~~~~-----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~ 458 (646)
+..++.. ....+++|+++ +++|.+++....... .....++|..++.|+.|+++||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~ 225 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---------STHKSLVHHARLQLTLQVIRLLA 225 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---------TTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---------ccCCCCCHHHHHHHHHHHHHHHH
Confidence 1111111 12345666654 799999885432100 01225788999999999999999
Q ss_pred HHHcCCCCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhcc----------ccCCCCCc
Q 046188 459 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF----------QSSQYTDK 528 (646)
Q Consensus 459 yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~k 528 (646)
|||+++ |+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.+
T Consensus 226 ~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp HHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred HHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 999999 999999999999999999999999999865322 334567 999999999 55568889
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC
Q 046188 529 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608 (646)
Q Consensus 529 sDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 608 (646)
+|||||||++|||++|+.||......+. ...+ +.. ....+..+.+|+.+||+.||++||
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~---------------~~~~----~~~--~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGG---------------SEWI----FRS--CKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGG----GSS--CCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhh---------------HHHH----Hhh--cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999999999999999964332110 1111 110 112346789999999999999999
Q ss_pred CHHHHHHH
Q 046188 609 TMKQVSMD 616 (646)
Q Consensus 609 s~~evl~~ 616 (646)
++.|++++
T Consensus 357 t~~~~l~~ 364 (413)
T 3dzo_A 357 LPLQAMET 364 (413)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 99888665
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.98 Aligned_cols=229 Identities=23% Similarity=0.311 Sum_probs=179.7
Q ss_pred cCCCcC-ccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHH-hhcCccCceeEEEEEEe----CCceE
Q 046188 332 DNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVIL-SQINHRHIVKLLGCCLE----TEVPV 404 (646)
Q Consensus 332 ~~~~~~-~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il-~~l~H~niv~l~g~~~~----~~~~~ 404 (646)
++|... +.||+|+||.||++.. .+++.||||+++.. ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567766 7799999999999995 46899999998752 3566788888 55699999999999887 56789
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-- 482 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 482 (646)
+||||+++|+|.+++.... ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 154 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--------------DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR 154 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS
T ss_pred EEEeecCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCC
Confidence 9999999999999997643 236999999999999999999999999 999999999999998
Q ss_pred -CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+||+|||++.... +..++.++||||||+++|||++|+.||.........
T Consensus 155 ~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---- 207 (299)
T 3m2w_A 155 PNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---- 207 (299)
T ss_dssp TTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------
T ss_pred CCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----
Confidence 7899999999997542 134577999999999999999999998643221100
Q ss_pred HHHHHHhhchhHHHhhhhhcccCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEAS----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
......+.... ...+ ...+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 208 -------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 208 -------PGMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp -------CCSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -------HHHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 00000000000 0111 224567899999999999999999999998755
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.83 Aligned_cols=244 Identities=16% Similarity=0.196 Sum_probs=185.1
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCC--------HHHHHHHHHHHHHHhhcC---------ccCceeE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID--------KTQIEQFINEVVILSQIN---------HRHIVKL 393 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~--------~~~~~~~~~Ei~il~~l~---------H~niv~l 393 (646)
.++|...+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35788899999999999999998 68999999976532 223467889999998885 8888888
Q ss_pred EEEEE------------------------------eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCH
Q 046188 394 LGCCL------------------------------ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443 (646)
Q Consensus 394 ~g~~~------------------------------~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 443 (646)
.+++. +.+..++||||+++|++.+.+.+ ..+++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------------~~~~~ 160 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------------KLSSL 160 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------------TCCCH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------------cCCCH
Confidence 87753 15678999999999987777643 25899
Q ss_pred HHHHHHHHHHHHHHHHHH-cCCCCCeEecCCCCCCEEECCCC--------------------cEEEeecCCccccCCCCC
Q 046188 444 ENRVRVACEVAGAVAYMH-SSASIPIFHRDIKSSNILLDDKF--------------------SAKVSDFGTSRSVPNDKT 502 (646)
Q Consensus 444 ~~~~~ia~qia~gL~yLH-~~~~~~ivHrDIk~~NILl~~~~--------------------~~kI~DfGla~~~~~~~~ 502 (646)
.+++.|+.||+.||+||| +++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 161 ~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-- 235 (336)
T 2vuw_A 161 ATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--
Confidence 999999999999999999 898 99999999999999887 9999999999876432
Q ss_pred ccccccccCCcccChhccccCCCCCccchhhHHHH-HHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhchhHHHhhhhhc
Q 046188 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV-LLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 581 (646)
Q Consensus 503 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvv-l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 581 (646)
...||+.|+|||.+.+.. +.++||||||++ .+++++|..||.. ................ ......
T Consensus 236 ----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~~~~~~~~~~~~~~~~----~~~~~~ 301 (336)
T 2vuw_A 236 ----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----VLWLHYLTDKMLKQMT----FKTKCN 301 (336)
T ss_dssp ----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----HHHHHHHHHHHHHTCC----CSSCCC
T ss_pred ----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----hhhhhHHHHhhhhhhc----cCcccc
Confidence 347999999999998766 899999998777 7888999998621 0000000000000000 000001
Q ss_pred ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHH-HH
Q 046188 582 KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS-MD 616 (646)
Q Consensus 582 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl-~~ 616 (646)
...+...+..+.+|+.+||+.| |+.|++ ++
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 1123457788999999999976 888887 53
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=247.25 Aligned_cols=166 Identities=20% Similarity=0.363 Sum_probs=137.5
Q ss_pred CCcc-ceeccccCCC---------CCccc----------------cc--ccccCCCCeEEecccceecCC-CCcccccEE
Q 046188 58 KLCQ-SFITFRSQPP---------FNTPV----------------SI--AYLLGSDASIIVPVSCSCSGS-LYQHNAPYT 108 (646)
Q Consensus 58 ~~c~-~~~~~~~~~~---------~~~~~----------------~~--~~~~~~~~~l~vP~~c~c~~~-~~~~~~~y~ 108 (646)
++|+ +|+.|+.++. |+... .+ .+.+.+||.|+||++|+|.++ +.....+|+
T Consensus 3 ~~C~~a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y~ 82 (212)
T 4eby_A 3 TSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYS 82 (212)
T ss_dssp CCCSCEEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEEEE
T ss_pred CCCccceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceEEE
Confidence 5799 9999997764 33221 11 456778999999999999854 456678999
Q ss_pred EecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecccccCCCCccccCccceeeEEeeecccchhhhHhhh
Q 046188 109 IKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSIGHKF 188 (646)
Q Consensus 109 v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia~~f 188 (646)
|++|||||.||++.|++|+++++|+++|...++.|.+||+|.||..|+|++.. ...+.+..++|+|++||||++||++|
T Consensus 83 V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~~-~~~~~~~~~~Y~V~~GDTL~~IA~~f 161 (212)
T 4eby_A 83 VRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDES-VSKDFGLFVTYPLRPEDSLSSIARSS 161 (212)
T ss_dssp CCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCTT-TCSSCCCEEEEECCTTCCHHHHHHHH
T ss_pred ecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCcc-cccCCCCeEEEEECCCCcHHHHHHHH
Confidence 99999999999778999999999999998888899999999999999998764 34556678899999999999999999
Q ss_pred cCCchhhhccccCCCCcceeecccccccccCCccCCCC
Q 046188 189 GADKQSILDANKLSEDDLIFTFTPLLIPLKSESCSANP 226 (646)
Q Consensus 189 ~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~~p~~~~~ 226 (646)
|+++++|++||++.+ ..+.+|+ |+||.+......+|
T Consensus 162 gvsv~~L~~~N~~~~-~~~~~g~-l~IP~~~~~~~~~~ 197 (212)
T 4eby_A 162 GVSADILQRYNPGVN-FNSGNGI-VYVPGRDPNGAFPP 197 (212)
T ss_dssp TSCHHHHHHHSTTCC-TTSCSSE-EEEECCCTTSCCCC
T ss_pred CcCHHHHHHhcCCCc-cCCCCCE-EEecCCCCCCccCC
Confidence 999999999999854 4566666 99999875544443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-29 Score=281.15 Aligned_cols=185 Identities=18% Similarity=0.125 Sum_probs=129.5
Q ss_pred cccccCcEEEEEEE-cCCCCEEEEEecccC----------CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 339 FLGQGGFGTVYKGM-LPDGSIVAVKRSKAI----------DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 339 ~IG~G~~g~Vy~g~-~~~g~~VAVK~l~~~----------~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
..+.|+.|.+..++ .--|+.+|+|.+... .....++|.+|+++|+++ +|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666655544 224889999987542 123456799999999999 799999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||++||+|.+++... .+++.. +|+.||+.||+|||+++ ||||||||+||||++++++
T Consensus 321 MEyv~G~~L~d~i~~~----------------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~v 378 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----------------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHA 378 (569)
T ss_dssp EECCCSEEHHHHHHTT----------------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCE
T ss_pred EecCCCCcHHHHHHhC----------------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCE
Confidence 9999999999999763 245543 58999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCC
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p 547 (646)
||+|||+|+....... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 379 KL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 379 RLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EEeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999987654332 2344679999999999875 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-26 Score=254.16 Aligned_cols=184 Identities=16% Similarity=0.209 Sum_probs=145.3
Q ss_pred CcCccccccCcEEEEEEEcCCCCEEEEEecccCC---H-----HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 335 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID---K-----TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~---~-----~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
...+.||+|+||.||+|.. .++.+++|+..... . ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999976 57889999743311 1 1234588999999999999999777777788888999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.. ++.|+.|+++||+|||+++ |+||||||+|||+++ ++
T Consensus 418 mE~~~ggsL~~~l~~------------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~ 468 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DL 468 (540)
T ss_dssp EECCCSEEHHHHSTT------------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SE
T ss_pred EECCCCCCHHHHHHH------------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eE
Confidence 999999999999853 3479999999999999999 999999999999999 99
Q ss_pred EEeecCCccccCCCCCcc------ccccccCCcccChhcccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 487 KVSDFGTSRSVPNDKTHL------TTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
||+|||+++......... .....||+.|||||++.. ..|+.+.|+|+..+-.++.+.++.++
T Consensus 469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999999875432211 235679999999999976 56788899999999999988877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=211.76 Aligned_cols=152 Identities=20% Similarity=0.137 Sum_probs=121.6
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCH------------------HHHHHHHHHHHHHhhcC
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDK------------------TQIEQFINEVVILSQIN 386 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~il~~l~ 386 (646)
..+......|...+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.+|++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344444556667799999999999999987789999999864221 23557889999999999
Q ss_pred ccCceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 046188 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASI 466 (646)
Q Consensus 387 H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 466 (646)
| +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+.+
T Consensus 163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------------------~~~~~i~~qi~~~l~~lH~~g-- 213 (282)
T 1zar_A 163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------------------ENPDEVLDMILEEVAKFYHRG-- 213 (282)
T ss_dssp --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------------------SCHHHHHHHHHHHHHHHHHTT--
T ss_pred --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------------------hhHHHHHHHHHHHHHHHHHCC--
Confidence 4 56666543 356699999999999988 421 123469999999999999999
Q ss_pred CeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccc
Q 046188 467 PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 521 (646)
Q Consensus 467 ~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 521 (646)
|+||||||+|||++ ++.+||+|||+++. +..++|||++.
T Consensus 214 -iiHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 214 -IVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -EECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CEeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999999 99999999999974 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=178.03 Aligned_cols=140 Identities=16% Similarity=0.136 Sum_probs=105.8
Q ss_pred CCcCccccccCcEEEEEEEc-CCCCE--EEEEecccCCH------------------------HHHHHHHHHHHHHhhcC
Q 046188 334 YNQSRFLGQGGFGTVYKGML-PDGSI--VAVKRSKAIDK------------------------TQIEQFINEVVILSQIN 386 (646)
Q Consensus 334 ~~~~~~IG~G~~g~Vy~g~~-~~g~~--VAVK~l~~~~~------------------------~~~~~~~~Ei~il~~l~ 386 (646)
|...+.||+|+||.||+|.. .+|+. ||||.++.... .....+.+|+.+|++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999997 67888 99998643211 11235788999999999
Q ss_pred ccCc--eeEEEEEEeCCceEEEEEecc-CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-c
Q 046188 387 HRHI--VKLLGCCLETEVPVLVYEYIC-NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-S 462 (646)
Q Consensus 387 H~ni--v~l~g~~~~~~~~~LV~Ey~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-~ 462 (646)
|+++ .+++++ +..+|||||+. +|.+...+..... ..++.....++.|++.||.||| +
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR---------------ELKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG---------------GGGGSCHHHHHHHHHHHHHHHHHT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh---------------ccChHHHHHHHHHHHHHHHHHHHH
Confidence 8864 444443 35699999995 2533333322111 1234567789999999999999 8
Q ss_pred CCCCCeEecCCCCCCEEECCCCcEEEeecCCcccc
Q 046188 463 SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497 (646)
Q Consensus 463 ~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 497 (646)
.+ |+||||||+|||+++ .++|+|||+|...
T Consensus 190 ~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 AE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 88 999999999999998 9999999999864
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-19 Score=173.76 Aligned_cols=109 Identities=17% Similarity=0.299 Sum_probs=92.7
Q ss_pred ccccEEEecCCceeeecccccCCCccH--------HHhhhcC-CC-CCCCCCCCcEEEecccccCCCCccccCccceeeE
Q 046188 103 HNAPYTIKANDTYFLVANNTYQGLTTC--------QALLGQN-YY-DEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLA 172 (646)
Q Consensus 103 ~~~~y~v~~gdt~~~Ia~~~~~~lt~~--------~~l~~~N-~~-~~~~l~~gq~l~ip~~c~c~~~~~~~~~~~~~~t 172 (646)
+-.+|+|++|||||.|| +.|+. ++ ++|+++| .+ +++.|.+||+|.||..|.|.+.. ......+
T Consensus 8 a~~~Y~V~~GDTL~~IA-~~~~v--sv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~~ 80 (212)
T 4eby_A 8 ALASYYLENGTTLSVIN-QNLNS--SIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNFS 80 (212)
T ss_dssp EEEEEECCTTCCHHHHH-HHTCC--SSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEEE
T ss_pred ceEEEEeCCCCCHHHHH-HHHCC--CchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCceE
Confidence 44679999999999999 56754 55 9999999 66 47889999999999999996432 1233568
Q ss_pred EeeecccchhhhH-hhhc--CCchhhhccccCCCCcceeecccccccccC
Q 046188 173 YMATWGDTISSIG-HKFG--ADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 173 Y~v~~gDtl~~Ia-~~f~--~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
|+|++||||+.|| ++|+ +++++|+++|++ +++.|++||+|.||..+
T Consensus 81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~-~~~~l~~Gq~L~IP~~~ 129 (212)
T 4eby_A 81 YSVRQEDTYERVAISNYANLTTMESLQARNPF-PATNIPLSATLNVLVNC 129 (212)
T ss_dssp EECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS-CTTCCCTTCEEEEEEEC
T ss_pred EEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC-CcccCCCCCEEEEcCCC
Confidence 9999999999999 8999 999999999996 66789999999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.1e-16 Score=163.24 Aligned_cols=137 Identities=12% Similarity=0.140 Sum_probs=99.8
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCC--------------HHHHHH--------HHHHHHHHhhcCccC
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID--------------KTQIEQ--------FINEVVILSQINHRH 389 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~--------------~~~~~~--------~~~Ei~il~~l~H~n 389 (646)
.-|+..+.||+|++|.||+|...+|+.||||.++... ...... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3488899999999999999998889999999754210 000111 234666666665544
Q ss_pred ce--eEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 046188 390 IV--KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIP 467 (646)
Q Consensus 390 iv--~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 467 (646)
+. +.+++ ...+|||||+++++|.++... .....++.|++.+|.|||+.+
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------------------~~~~~l~~qll~~l~~lH~~g--- 225 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------------------PDPASLYADLIALILRLAKHG--- 225 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------------------SCHHHHHHHHHHHHHHHHHTT---
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc----------------------HHHHHHHHHHHHHHHHHHHCC---
Confidence 32 22222 234799999998888655421 223468899999999999999
Q ss_pred eEecCCCCCCEEECCCC----------cEEEeecCCcccc
Q 046188 468 IFHRDIKSSNILLDDKF----------SAKVSDFGTSRSV 497 (646)
Q Consensus 468 ivHrDIk~~NILl~~~~----------~~kI~DfGla~~~ 497 (646)
||||||||.|||+++++ .+.|+||+-+-..
T Consensus 226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999999999998876 4899999977654
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.4e-13 Score=125.03 Aligned_cols=96 Identities=14% Similarity=0.072 Sum_probs=73.6
Q ss_pred cccccEEEecCCceeeecccccCCCccHHHhhhcC-CCCCCCCCCCcEEEecccccCCCCccccCccceeeEEeeecccc
Q 046188 102 QHNAPYTIKANDTYFLVANNTYQGLTTCQALLGQN-YYDEKNLGSGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDT 180 (646)
Q Consensus 102 ~~~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N-~~~~~~l~~gq~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDt 180 (646)
.+..+|+||+|||||.|| .+|. +++.+|+.+| ..+++.|++||+|.||..-.-+.... .........|+|+.||+
T Consensus 60 ~~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~-~~~~~~~~~~~v~~Gdt 135 (167)
T 2l9y_A 60 GGTATVTVQQGDTLRDIG-RRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAG-NFWDSARDVRLVDGGKV 135 (167)
T ss_dssp CSCEEEEECTTCCHHHHH-HHTT--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSC-CGGGGEEEEEEETTTTE
T ss_pred CCCceEEECCCCcHHHHH-HHcC--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCcccccc-ccccccceEEEeCCcCC
Confidence 345689999999999999 5673 5999999999 55668999999999997532111000 01112245799999999
Q ss_pred hhhhHhhhcCCchhhhccccC
Q 046188 181 ISSIGHKFGADKQSILDANKL 201 (646)
Q Consensus 181 l~~Ia~~f~~s~~~l~~~N~~ 201 (646)
|+.||++||.+...++++|..
T Consensus 136 L~aIA~r~G~~v~s~i~Ln~~ 156 (167)
T 2l9y_A 136 LEAELRYSGGWNRSRIYLDEH 156 (167)
T ss_dssp EEEEEEETTEEEEEEECGGGT
T ss_pred hHHHHHHcCCceEEEEEcccc
Confidence 999999999999998988863
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=124.80 Aligned_cols=148 Identities=17% Similarity=0.116 Sum_probs=112.6
Q ss_pred HHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEE
Q 046188 327 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 327 l~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~L 405 (646)
+.....+|.....++.|+.+.||+... +++.+++|............+.+|+.+++.+. |..+.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344456788888888888899999986 46889999876421122235778999999884 6778899999998888999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcC----------------------
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSS---------------------- 463 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~---------------------- 463 (646)
||||++|.+|.+.+.. ......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~~---------------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEECCSSEEHHHHCCT---------------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEecCCeehhhccCC---------------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 9999999998765311 122346777888888888871
Q ss_pred ----------------------------------CCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 464 ----------------------------------ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 464 ----------------------------------~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
..+.++|+|+++.||+++++..+.|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998876678999998753
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-12 Score=103.72 Aligned_cols=62 Identities=32% Similarity=0.447 Sum_probs=55.6
Q ss_pred CCcEEEecccccCCCCccccCccceeeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccccccC
Q 046188 145 SGLEVIVPLRCACPTAKQIDNGVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 145 ~gq~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
.||.|.+|.. ....+|+|++|||||.||++||+++++|+++|++.++..|++||+|.||...
T Consensus 3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~ 64 (77)
T 2djp_A 3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT 64 (77)
T ss_dssp CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence 6899999852 2457899999999999999999999999999999878899999999999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=5.7e-11 Score=119.01 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=95.1
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC--ceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH--IVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~LV~Ey 409 (646)
.++......+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++..+.+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344433333456669999998777888999987653 1235678999999986544 55688888877788999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA------------------------- 464 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~------------------------- 464 (646)
++|.+|. .... + ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~~-------------------~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (264)
T 1nd4_A 97 VPGQDLL--SSHL-------------------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGL 152 (264)
T ss_dssp CSSEETT--TSCC-------------------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTC
T ss_pred cCCcccC--cCcC-------------------C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCC
Confidence 9999885 2110 0 0123334444444444321
Q ss_pred ------------------------------CCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 465 ------------------------------SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 465 ------------------------------~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 153 VDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 22399999999999998877678999998763
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=99.04 E-value=5.5e-11 Score=86.90 Aligned_cols=46 Identities=22% Similarity=0.356 Sum_probs=43.0
Q ss_pred eEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccccc
Q 046188 171 LAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLK 218 (646)
Q Consensus 171 ~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~ 218 (646)
.+|+|++||||++||++||++.++|.++|+ ++..|+|||.|.||+.
T Consensus 3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~--~~~~l~~G~~l~ip~~ 48 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS--DTANLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCS--CGGGCCTTEEEECCCC
T ss_pred EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC--CCCcCCcCCEEEEecC
Confidence 379999999999999999999999999999 7788999999999973
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.9e-11 Score=125.86 Aligned_cols=108 Identities=14% Similarity=0.109 Sum_probs=82.9
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcCCCC-----CCCCCCCcEEEecccccCCCCcc-----------------
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNYYD-----EKNLGSGLEVIVPLRCACPTAKQ----------------- 162 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~-----~~~l~~gq~l~ip~~c~c~~~~~----------------- 162 (646)
.+|+|++|||||.|| ++|. ++.++|.++|... .+.|++||+|.||..- +...
T Consensus 8 ~~~~Vk~GDTL~~Ia-~r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~---~~~l~~l~~~~~~~~~~~~~~ 81 (361)
T 2gu1_A 8 IHYMVKVGDTLSGIF-AQLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDD---MGQLSRLIYHMSIVEKAIYTR 81 (361)
T ss_dssp EEEECCTTCCHHHHH-HHTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECT---TSCEEEEEEEEETTEEEEEEE
T ss_pred eEEEECCCCcHHHHH-HHcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECC---CCcceEEEEEcCccceEEEEe
Confidence 579999999999999 5664 3899999988433 4689999999999741 1100
Q ss_pred c-cC----------ccceeeEEeeecccchhhhHhhhcCCchhhhccccCCCC-----cceeeccccccccc
Q 046188 163 I-DN----------GVSYLLAYMATWGDTISSIGHKFGADKQSILDANKLSED-----DLIFTFTPLLIPLK 218 (646)
Q Consensus 163 ~-~~----------~~~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~-----~~i~~g~~l~vPl~ 218 (646)
. .+ ......+|.|+.||||+.||++||++.+.|++||++... ..|++||.+.|+..
T Consensus 82 ~~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~ 153 (361)
T 2gu1_A 82 ENDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK 153 (361)
T ss_dssp CTTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred cCCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence 0 00 011245799999999999999999999999999997543 45999999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.7e-09 Score=114.14 Aligned_cols=142 Identities=16% Similarity=0.240 Sum_probs=107.0
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecc--cCC-HHHHHHHHHHHHHHhhcC--ccCceeEEEEEEeC---CceEEEE
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSK--AID-KTQIEQFINEVVILSQIN--HRHIVKLLGCCLET---EVPVLVY 407 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~--~~~-~~~~~~~~~Ei~il~~l~--H~niv~l~g~~~~~---~~~~LV~ 407 (646)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999875 4678888775 322 122346778999999997 45688999998776 3489999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA----------------------- 464 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~----------------------- 464 (646)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~------------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3dxp_A 121 EFVSGRVLWDQS------------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERW 182 (359)
T ss_dssp ECCCCBCCCCTT------------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHH
T ss_pred EecCCeecCCCc------------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHH
Confidence 999998885422 124678888899999999999999731
Q ss_pred --------------------------------CCCeEecCCCCCCEEECCCCc--EEEeecCCccc
Q 046188 465 --------------------------------SIPIFHRDIKSSNILLDDKFS--AKVSDFGTSRS 496 (646)
Q Consensus 465 --------------------------------~~~ivHrDIk~~NILl~~~~~--~kI~DfGla~~ 496 (646)
.+.++|||+++.||++++++. +.|.||+.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 183 TKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-09 Score=112.40 Aligned_cols=185 Identities=19% Similarity=0.235 Sum_probs=116.3
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccC--ceeEEEEEEeCC---ceEEEEEec
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRH--IVKLLGCCLETE---VPVLVYEYI 410 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~n--iv~l~g~~~~~~---~~~LV~Ey~ 410 (646)
.+.++.|....||+.. ..+++|.... ......+.+|..+|+.+. +.. +.++++.....+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999852 4688888653 234567889999998883 333 445555543333 358999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc----------------------------
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS---------------------------- 462 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~---------------------------- 462 (646)
+|.+|.+.... .++..++..++.++++.|..||+
T Consensus 99 ~G~~l~~~~~~------------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (304)
T 3sg8_A 99 KGVPLTPLLLN------------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKL 160 (304)
T ss_dssp CCEECCHHHHH------------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHH
T ss_pred CCeECCccccc------------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHH
Confidence 99888753321 24444455555555555555553
Q ss_pred ---------------------------CCCCCeEecCCCCCCEEECC--CCcEEEeecCCccccCCCCCccccc------
Q 046188 463 ---------------------------SASIPIFHRDIKSSNILLDD--KFSAKVSDFGTSRSVPNDKTHLTTA------ 507 (646)
Q Consensus 463 ---------------------------~~~~~ivHrDIk~~NILl~~--~~~~kI~DfGla~~~~~~~~~~~~~------ 507 (646)
...+.++|+|+++.||++++ +..+.|+||+.+..... .......
T Consensus 161 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~ 239 (304)
T 3sg8_A 161 LSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEE 239 (304)
T ss_dssp HTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTS
T ss_pred hcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccc
Confidence 12245899999999999998 56689999999875321 1110000
Q ss_pred --------cccCCcccC-hhccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 046188 508 --------VQGTFGYFD-PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548 (646)
Q Consensus 508 --------~~gt~~y~a-PE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~ 548 (646)
.....+... |+.... .....+.|++|.++|++.+|..++
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000111122 222211 112368999999999999998764
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-09 Score=102.11 Aligned_cols=49 Identities=31% Similarity=0.516 Sum_probs=46.5
Q ss_pred eEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccccccC
Q 046188 171 LAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 171 ~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~~ 219 (646)
.+|+||+|||||.||++||++..+|.+||++.+++.|+|||+|.||...
T Consensus 63 ~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~ 111 (167)
T 2l9y_A 63 ATVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKG 111 (167)
T ss_dssp EEEEECTTCCHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCCC
T ss_pred ceEEECCCCcHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCCC
Confidence 5799999999999999999999999999999999999999999999753
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=1e-08 Score=74.61 Aligned_cols=45 Identities=18% Similarity=0.248 Sum_probs=40.2
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecc
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPL 153 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~ 153 (646)
.+|+|++|||+|+|| .+|.. ++++|+++|. .++.|.+||+|.||+
T Consensus 3 ~~y~V~~GDtl~~Ia-~~~~~--~~~~l~~~N~-~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIA-KRHGV--NIKDVMRWNS-DTANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHH-HHHTC--CHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred EEEEEcCCCcHHHHH-HHHCc--CHHHHHHhCC-CCCcCCcCCEEEEec
Confidence 579999999999999 66744 8999999999 778899999999996
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.43 E-value=2.1e-08 Score=80.95 Aligned_cols=60 Identities=18% Similarity=0.143 Sum_probs=48.6
Q ss_pred CCCeEEecccceecCCCCcccccEEEecCCceeeecccccCCCccHHHhhhcCCC-CCCCCCCCcEEEeccc
Q 046188 84 SDASIIVPVSCSCSGSLYQHNAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYY-DEKNLGSGLEVIVPLR 154 (646)
Q Consensus 84 ~~~~l~vP~~c~c~~~~~~~~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~-~~~~l~~gq~l~ip~~ 154 (646)
.||.+.||..- ...+|+|++|||||.|| +.|.. ++++|+++|.. .++.|.+||+|.||..
T Consensus 3 ~Gq~l~ip~~~--------~~~~y~V~~GDTL~~IA-~~~~~--~~~~l~~~N~l~~~~~l~~Gq~l~iP~~ 63 (77)
T 2djp_A 3 SGSSGCSPVRE--------RRLEHQLEPGDTLAGLA-LKYGV--TMEQIKRANRLYTNDSIFLKKTLYIPIL 63 (77)
T ss_dssp CCCCCCCCCCE--------EEEEECCCTTCCHHHHH-HHHTC--CHHHHHHHHTCCCSSCGGGSSCEEEEEE
T ss_pred CCcEeeccCCC--------CcEEEEECCCCcHHHHH-HHHCc--CHHHHHHHcCCCCccccCCCCEEEECCC
Confidence 57777777532 23579999999999999 66754 89999999955 4678999999999984
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.9e-06 Score=87.34 Aligned_cols=75 Identities=13% Similarity=0.088 Sum_probs=56.0
Q ss_pred CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc---CceeEEEEEE-eCCceEEEEEeccC
Q 046188 337 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR---HIVKLLGCCL-ETEVPVLVYEYICN 412 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~---niv~l~g~~~-~~~~~~LV~Ey~~~ 412 (646)
.+.++.|....||+. |..+++|.... ......+.+|..+|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 46688887532 33456788999999999753 3567777765 34567899999999
Q ss_pred CCchh
Q 046188 413 GNLSH 417 (646)
Q Consensus 413 gsL~~ 417 (646)
.+|.+
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 88876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.6e-06 Score=85.61 Aligned_cols=78 Identities=14% Similarity=0.100 Sum_probs=57.6
Q ss_pred cccccCcE-EEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 339 FLGQGGFG-TVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 339 ~IG~G~~g-~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
.+..|..| .||+.... ++..+.+|+-.. ....++.+|..+|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 68987754 466789998654 23456778999998884 33467889999999999999999999887
Q ss_pred hhhh
Q 046188 416 SHHI 419 (646)
Q Consensus 416 ~~~l 419 (646)
.+..
T Consensus 108 ~~~~ 111 (272)
T 4gkh_A 108 FQVL 111 (272)
T ss_dssp HHHH
T ss_pred cccc
Confidence 7654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=4.7e-06 Score=87.49 Aligned_cols=82 Identities=5% Similarity=-0.029 Sum_probs=56.8
Q ss_pred Cccc-cccCcEEEEEEEcC-------CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCc---cCceeEEEEEEeC--
Q 046188 337 SRFL-GQGGFGTVYKGMLP-------DGSIVAVKRSKAID---KTQIEQFINEVVILSQINH---RHIVKLLGCCLET-- 400 (646)
Q Consensus 337 ~~~I-G~G~~g~Vy~g~~~-------~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H---~niv~l~g~~~~~-- 400 (646)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+.. -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88888999988764 26678898765321 0011356688888888853 3577888887665
Q ss_pred -CceEEEEEeccCCCchhh
Q 046188 401 -EVPVLVYEYICNGNLSHH 418 (646)
Q Consensus 401 -~~~~LV~Ey~~~gsL~~~ 418 (646)
+..++||||++|.++.+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp TSSCEEEEECCCCBCCCBT
T ss_pred cCCceEEEEecCCCChhhc
Confidence 356899999998887653
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.1e-06 Score=79.78 Aligned_cols=47 Identities=28% Similarity=0.403 Sum_probs=41.8
Q ss_pred eeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccccc
Q 046188 170 LLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPL 217 (646)
Q Consensus 170 ~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl 217 (646)
+++|+|++||||+.||++|+++..+|+++|+..++ .+.+|+.+.||-
T Consensus 2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~-~l~~g~~i~ip~ 48 (165)
T 4a1k_A 2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQA-GLTAGQSIVIPG 48 (165)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGG-CCCTTCEEEETT
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCC-ccCCCccccCcc
Confidence 47999999999999999999999999999986444 478999999984
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00018 Score=74.41 Aligned_cols=154 Identities=14% Similarity=0.120 Sum_probs=80.8
Q ss_pred ccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc--cCceeEEE------EEEeCCceEEEEEe
Q 046188 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH--RHIVKLLG------CCLETEVPVLVYEY 409 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--~niv~l~g------~~~~~~~~~LV~Ey 409 (646)
+.|+.|..+.||+....+| .+++|+.... . ..+..|..+++.+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677889999887544 5889987752 2 223345555555531 12333332 12245667899999
Q ss_pred ccCCCchh----hhhhhhhhHHHHHHHHHhh--h------cCCCCHHHH-------------------------------
Q 046188 410 ICNGNLSH----HIHDHQQQQEQKQELEEEQ--E------LSSLSWENR------------------------------- 446 (646)
Q Consensus 410 ~~~gsL~~----~l~~~~~~~~~~~~~~~~~--~------~~~l~~~~~------------------------------- 446 (646)
++|.++.. .+..-.............. . ...-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876641 0000000000000000000 0 001123211
Q ss_pred HHHHHHHHHHHHHHHc----------CCCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 447 VRVACEVAGAVAYMHS----------SASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 447 ~~ia~qia~gL~yLH~----------~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
..+...+.+++++|++ ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111224446667763 1234599999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=8.6e-05 Score=79.06 Aligned_cols=76 Identities=17% Similarity=0.208 Sum_probs=50.0
Q ss_pred CccccccCcEEEEEEEcC-CCCEEEEEecccCCH-------HHHHHHHHHHHHHhhcCc--c-CceeEEEEEEeCCceEE
Q 046188 337 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDK-------TQIEQFINEVVILSQINH--R-HIVKLLGCCLETEVPVL 405 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~-------~~~~~~~~Ei~il~~l~H--~-niv~l~g~~~~~~~~~L 405 (646)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 467899997543211 112345678888887742 3 34456654 4556789
Q ss_pred EEEeccCCC
Q 046188 406 VYEYICNGN 414 (646)
Q Consensus 406 V~Ey~~~gs 414 (646)
||||+++..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999997643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00028 Score=71.50 Aligned_cols=80 Identities=16% Similarity=0.103 Sum_probs=57.3
Q ss_pred CCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc---CceeEEEEEEeCCceEEEEEe
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR---HIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~---niv~l~g~~~~~~~~~LV~Ey 409 (646)
.....+.+|.|..+.||+....||+.|.+|+...........|..|+..|+.+.-. -+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 34456779999999999999989999999986543333233567899998888422 345555542 34899999
Q ss_pred ccCCCch
Q 046188 410 ICNGNLS 416 (646)
Q Consensus 410 ~~~gsL~ 416 (646)
.+.+...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9877654
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=97.59 E-value=1.1e-05 Score=84.79 Aligned_cols=48 Identities=23% Similarity=0.254 Sum_probs=43.9
Q ss_pred eEEeeecccchhhhHhhhcCCchhhhccccCCC----Ccceeeccccccccc
Q 046188 171 LAYMATWGDTISSIGHKFGADKQSILDANKLSE----DDLIFTFTPLLIPLK 218 (646)
Q Consensus 171 ~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~----~~~i~~g~~l~vPl~ 218 (646)
.+|+|++||||++||++||++.++|.++|++.. .+.|+|||+|.||..
T Consensus 8 ~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~ 59 (361)
T 2gu1_A 8 IHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD 59 (361)
T ss_dssp EEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC
T ss_pred eEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC
Confidence 579999999999999999999999999999753 478999999999975
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0012 Score=67.80 Aligned_cols=77 Identities=14% Similarity=0.064 Sum_probs=61.1
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC---ccCceeEEEEEEeCCceEEEEEeccC
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
..+.|+.|....+|+... ++..+++|..... ....+..|...|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999887 4678889986542 2456788999998884 35688899988877889999999998
Q ss_pred CCch
Q 046188 413 GNLS 416 (646)
Q Consensus 413 gsL~ 416 (646)
..+.
T Consensus 116 ~~~~ 119 (312)
T 3jr1_A 116 SKNK 119 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00089 Score=71.78 Aligned_cols=77 Identities=12% Similarity=0.119 Sum_probs=47.8
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCcccccc-ccCCcccChhccccC---CCCCccchhhHHHHHHHH
Q 046188 466 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV-QGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLEL 541 (646)
Q Consensus 466 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~---~~s~ksDVwSfGvvl~El 541 (646)
+.++|+|+++.|||+++++ ++|.||+.+..-... ....... .-...|++|+..... ......++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4599999999999999876 999999998753211 1110000 011346666654311 112235566888888888
Q ss_pred HhC
Q 046188 542 LTG 544 (646)
Q Consensus 542 ltG 544 (646)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0029 Score=65.00 Aligned_cols=94 Identities=12% Similarity=0.023 Sum_probs=57.1
Q ss_pred ccCHHHHHHHhcCCCc-----CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC--ceeE
Q 046188 321 IFTAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH--IVKL 393 (646)
Q Consensus 321 ~~~~~el~~~t~~~~~-----~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l 393 (646)
.++.+++....+.|.. ...++ |....||+....+|+.+++|....... ..+.+..|..+++.+.... +.++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecce
Confidence 3455556555544432 23466 777899998776777899998763211 1235556888877774222 3444
Q ss_pred EEE-----EEeCCceEEEEEeccCCCch
Q 046188 394 LGC-----CLETEVPVLVYEYICNGNLS 416 (646)
Q Consensus 394 ~g~-----~~~~~~~~LV~Ey~~~gsL~ 416 (646)
+.. ....+..+++|||++|.++.
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~ 115 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFE 115 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCC
Confidence 432 12244567899999876654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0018 Score=66.48 Aligned_cols=172 Identities=10% Similarity=0.097 Sum_probs=89.3
Q ss_pred cCHHHHHHHhcCCCc-----CccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC--ceeEE
Q 046188 322 FTAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH--IVKLL 394 (646)
Q Consensus 322 ~~~~el~~~t~~~~~-----~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~ 394 (646)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... ...+.+..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 556677766666654 23466788889999887555 5788987652 11224456777777764322 23333
Q ss_pred EE------EEeCCceEEEEEeccCCCchhh----hhhhhhhHHHHHHHHHhhhcC---C---CCHHHHHH----------
Q 046188 395 GC------CLETEVPVLVYEYICNGNLSHH----IHDHQQQQEQKQELEEEQELS---S---LSWENRVR---------- 448 (646)
Q Consensus 395 g~------~~~~~~~~LV~Ey~~~gsL~~~----l~~~~~~~~~~~~~~~~~~~~---~---l~~~~~~~---------- 448 (646)
.. ....+..+++++|++|..+... ...-.............-... . ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1223567899999988765321 100000000000000000000 0 01222110
Q ss_pred --HHHHHHHHHHHHHcC----CCCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 449 --VACEVAGAVAYMHSS----ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 449 --ia~qia~gL~yLH~~----~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
+...+.+.++.+++. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001234445555432 223599999999999999876668999998763
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00011 Score=68.16 Aligned_cols=46 Identities=26% Similarity=0.369 Sum_probs=38.5
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecc
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPL 153 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~ 153 (646)
.+|+||+||||..|| ++|+. ..++|+++|+.....|++|++|.||-
T Consensus 3 ~~y~V~~GdtL~~IA-~~f~~--g~~~l~~aNp~vd~~l~~g~~i~ip~ 48 (165)
T 4a1k_A 3 LTYQVKQGDTLNSIA-ADFRI--STAALLQANPSLQAGLTAGQSIVIPG 48 (165)
T ss_dssp EEEECCTTCCHHHHH-HHTTC--CHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred EEEEECCCCCHHHHH-HHhCC--CHHHHHHhCccCCCccCCCccccCcc
Confidence 579999999999999 67865 89999999954333489999999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0025 Score=64.89 Aligned_cols=74 Identities=15% Similarity=0.114 Sum_probs=46.4
Q ss_pred CcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-eeEEEEEEeCCceEEEEEec-cC
Q 046188 335 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYI-CN 412 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~-~~ 412 (646)
...+.|+.|....+|+. +.+++|+....... ..+..+|+.+++.+...++ .+++++ +.+.-++++||+ ++
T Consensus 21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred cceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 33678888999999998 45888876542111 1123467877777753333 456554 344457899999 55
Q ss_pred CCch
Q 046188 413 GNLS 416 (646)
Q Consensus 413 gsL~ 416 (646)
.+|.
T Consensus 93 ~~l~ 96 (301)
T 3dxq_A 93 QTMS 96 (301)
T ss_dssp EECC
T ss_pred ccCC
Confidence 5664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0055 Score=63.16 Aligned_cols=154 Identities=15% Similarity=0.106 Sum_probs=75.8
Q ss_pred ccccccCcEE-EEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCcc--CceeEEEEEEeCCceEEEEEeccCCC
Q 046188 338 RFLGQGGFGT-VYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHR--HIVKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 338 ~~IG~G~~g~-Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~--niv~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
+.|+.|.... +|+....+|..+++|....... +++..|+.+++.+... .+.+++.+.. +.-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4565554444 6677654467777876543211 2334567777766432 3556776643 23378999997777
Q ss_pred chhhhhhhhhh-HHH-------HHHHHHhh--hcCCCCHHHH---------------H-----HHHHHHHHHHHHHH---
Q 046188 415 LSHHIHDHQQQ-QEQ-------KQELEEEQ--ELSSLSWENR---------------V-----RVACEVAGAVAYMH--- 461 (646)
Q Consensus 415 L~~~l~~~~~~-~~~-------~~~~~~~~--~~~~l~~~~~---------------~-----~ia~qia~gL~yLH--- 461 (646)
+.+++...... ... ..++-... ....++.... + .....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 77666432210 000 00000000 0000111000 0 00011112222221
Q ss_pred cCCCCCeEecCCCCCCEEECCC----CcEEEeecCCccc
Q 046188 462 SSASIPIFHRDIKSSNILLDDK----FSAKVSDFGTSRS 496 (646)
Q Consensus 462 ~~~~~~ivHrDIk~~NILl~~~----~~~kI~DfGla~~ 496 (646)
....+.++|||+.+.||+++.+ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1223459999999999999875 6899999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0054 Score=64.66 Aligned_cols=155 Identities=18% Similarity=0.216 Sum_probs=84.0
Q ss_pred CccccccCcEEEEEEEcC--------CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC-ceeEEEEEEeCCceEEEE
Q 046188 337 SRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~--------~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n-iv~l~g~~~~~~~~~LV~ 407 (646)
.+.|..|-...+|+.... +++.+.+|+.... ........+|..+++.+.-.+ ..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345666777788998864 2468999986332 122445668999998885323 3567766543 3999
Q ss_pred EeccCCCchhh-hhhh---hhhHHHHHHHHHhh--hcCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 046188 408 EYICNGNLSHH-IHDH---QQQQEQKQELEEEQ--ELSSL--SWENRVRVACEVAG-------------------AVAYM 460 (646)
Q Consensus 408 Ey~~~gsL~~~-l~~~---~~~~~~~~~~~~~~--~~~~l--~~~~~~~ia~qia~-------------------gL~yL 460 (646)
||++|.+|..- +... ........++-... ..... -|.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998776532 1110 00000111111000 00111 24444445443321 22222
Q ss_pred ----HcC-CCCCeEecCCCCCCEEECCC----CcEEEeecCCccc
Q 046188 461 ----HSS-ASIPIFHRDIKSSNILLDDK----FSAKVSDFGTSRS 496 (646)
Q Consensus 461 ----H~~-~~~~ivHrDIk~~NILl~~~----~~~kI~DfGla~~ 496 (646)
... ....++|+|+.+.||+++++ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 22358999999999999876 7899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.009 Score=64.16 Aligned_cols=74 Identities=22% Similarity=0.235 Sum_probs=50.4
Q ss_pred CccccccCcEEEEEEEcCC--------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-eeEEEEEEeCCceEEEE
Q 046188 337 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVY 407 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~LV~ 407 (646)
.+.|+.|-...+|+....+ ++.+.+|+...... .+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998643 47899998744211 1345579998888854444 567776532 3899
Q ss_pred EeccCCCch
Q 046188 408 EYICNGNLS 416 (646)
Q Consensus 408 Ey~~~gsL~ 416 (646)
||+++.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999865654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.025 Score=61.09 Aligned_cols=75 Identities=13% Similarity=0.010 Sum_probs=47.9
Q ss_pred CccccccCcEEEEEEEcCC-CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-eeEEEEEEeCCceEEEEEeccCCC
Q 046188 337 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYICNGN 414 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gs 414 (646)
.+.|+.|-...+|+....+ +..+++|+....... .-+..+|..+++.+...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567778889999998754 467888876432111 1112478888888865544 56777762 2 35999998766
Q ss_pred ch
Q 046188 415 LS 416 (646)
Q Consensus 415 L~ 416 (646)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0065 Score=63.66 Aligned_cols=74 Identities=12% Similarity=0.113 Sum_probs=44.8
Q ss_pred CccccccCcEEEEEEEcCC---------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC-ceeEEEEEEeCCceEEE
Q 046188 337 SRFLGQGGFGTVYKGMLPD---------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLV 406 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n-iv~l~g~~~~~~~~~LV 406 (646)
.+.|+.|....+|+....+ +..+++|....... ...+...|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3457777778899988643 26788887654221 1112357888888875444 34676554 2 3789
Q ss_pred EEeccCCCc
Q 046188 407 YEYICNGNL 415 (646)
Q Consensus 407 ~Ey~~~gsL 415 (646)
|||+++.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987665
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.15 E-value=0.022 Score=54.60 Aligned_cols=103 Identities=13% Similarity=0.051 Sum_probs=66.3
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
-+|.+.|... ..+++++++|-++.|.+.+|.-+-....+ ..+=+.+..|++..+|.+.+.+ +
T Consensus 33 vSL~eIL~~~---------------~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~ 94 (229)
T 2yle_A 33 LSLEEILRLY---------------NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-A 94 (229)
T ss_dssp EEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C
T ss_pred ccHHHHHHHc---------------CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-c
Confidence 3688888665 34899999999999999998776221111 1222346899999999988874 2
Q ss_pred CccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCC
Q 046188 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547 (646)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p 547 (646)
.+. .....+.+||... ...+.+.-|||+|++||.-+--..|
T Consensus 95 ~s~-------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 95 ADD-------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccc-------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 211 0122356888763 3447899999999999998864443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.021 Score=59.10 Aligned_cols=31 Identities=23% Similarity=0.366 Sum_probs=27.8
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 466 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 466 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
+.++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.011 Score=61.82 Aligned_cols=108 Identities=7% Similarity=-0.024 Sum_probs=68.3
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcC-----CCCCCCCCCCcEEEecccccCCCCcc------c-cCccc-ee-
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQN-----YYDEKNLGSGLEVIVPLRCACPTAKQ------I-DNGVS-YL- 170 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N-----~~~~~~l~~gq~l~ip~~c~c~~~~~------~-~~~~~-~~- 170 (646)
..|+|++||||..|- ..+ |+ +.+++.+.+ ..+...|++||+|.+.+.- +... . ..+.. +.
T Consensus 15 ~~~~V~~GDTL~~IL-~r~-Gl-s~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~---~~~l~~l~~~~~~~~~~~~v~ 88 (371)
T 3slu_A 15 VQEAVQPGDSLADVL-ARS-GM-ARDEIARITEKYGGEADLRHLRADQSVHVLVGG---DGGAREVQFFTDEDGERNLVA 88 (371)
T ss_dssp EEEECCTTCCHHHHH-HHT-TC-CHHHHHHHHTTC------CCBCSSSEEEEEECT---TSCEEEEEEEECCTTEEEEEE
T ss_pred EEEEECCCCcHHHHH-HHc-CC-CHHHHHHHHHhccccCchhhCCCCCEEEEEECC---CCCeEEEEEEecCCCceeEEE
Confidence 369999999999998 344 44 444454432 2345689999999998741 1100 0 00000 00
Q ss_pred ---------------------eEEeeecccchhhhHhhhcCCchhhhccccCCCCc----ceeeccccccccc
Q 046188 171 ---------------------LAYMATWGDTISSIGHKFGADKQSILDANKLSEDD----LIFTFTPLLIPLK 218 (646)
Q Consensus 171 ---------------------~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~----~i~~g~~l~vPl~ 218 (646)
..+.+.-++||+..|.+.|++.+.+.+.+.+-..+ .|++|+.+.|...
T Consensus 89 i~~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~ 161 (371)
T 3slu_A 89 LEKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD 161 (371)
T ss_dssp EEEETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred EEecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence 01223448999999999999998888877643222 3899999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.68 E-value=0.13 Score=54.99 Aligned_cols=75 Identities=7% Similarity=0.004 Sum_probs=47.9
Q ss_pred CccccccCcEEEEEEEcCC--------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccC-ceeEEEEEEeCCceEEEE
Q 046188 337 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~n-iv~l~g~~~~~~~~~LV~ 407 (646)
.+.+..|-...+|+....+ ++.+++|+....... .-+..+|..+++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3456667778899988643 578999886442211 112346888888775333 34566543 2 37899
Q ss_pred EeccCCCch
Q 046188 408 EYICNGNLS 416 (646)
Q Consensus 408 Ey~~~gsL~ 416 (646)
||++|.+|.
T Consensus 150 efI~G~~l~ 158 (424)
T 3mes_A 150 EFIDGEPLT 158 (424)
T ss_dssp ECCCSEECC
T ss_pred EEeCCccCC
Confidence 999987764
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=93.31 E-value=0.036 Score=57.81 Aligned_cols=52 Identities=10% Similarity=0.128 Sum_probs=43.1
Q ss_pred ceeeEEeeecccchhhhHhhhcCCchhhhccccCC----CCcceeecccccccccC
Q 046188 168 SYLLAYMATWGDTISSIGHKFGADKQSILDANKLS----EDDLIFTFTPLLIPLKS 219 (646)
Q Consensus 168 ~~~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~----~~~~i~~g~~l~vPl~~ 219 (646)
.+-.+|+|++||||+.|-+++|++..++.+++... +...|+|||++.+.+..
T Consensus 12 ~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~ 67 (371)
T 3slu_A 12 AYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGG 67 (371)
T ss_dssp CEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECT
T ss_pred CceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECC
Confidence 45678999999999999999999999999876532 45789999999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.79 E-value=0.09 Score=36.52 Aligned_cols=7 Identities=0% Similarity=-0.111 Sum_probs=2.7
Q ss_pred HHhHhhh
Q 046188 282 YKVIGAK 288 (646)
Q Consensus 282 ~~~~~~~ 288 (646)
++++|+|
T Consensus 32 ~~~~RRr 38 (44)
T 2ks1_B 32 GLFMRRR 38 (44)
T ss_dssp HHHHHTT
T ss_pred HHHhhhh
Confidence 3333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.54 E-value=1.1 Score=47.05 Aligned_cols=29 Identities=34% Similarity=0.442 Sum_probs=24.9
Q ss_pred eEecCCCCCCEEE------CCCCcEEEeecCCccc
Q 046188 468 IFHRDIKSSNILL------DDKFSAKVSDFGTSRS 496 (646)
Q Consensus 468 ivHrDIk~~NILl------~~~~~~kI~DfGla~~ 496 (646)
++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.50 E-value=0.26 Score=34.16 Aligned_cols=7 Identities=14% Similarity=-0.012 Sum_probs=2.7
Q ss_pred HHhHhhh
Q 046188 282 YKVIGAK 288 (646)
Q Consensus 282 ~~~~~~~ 288 (646)
++++|+|
T Consensus 31 ~~~~RRR 37 (44)
T 2l2t_A 31 AVYVRRK 37 (44)
T ss_dssp HHHHHTT
T ss_pred HHHhhhh
Confidence 3333433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.69 E-value=0.54 Score=32.50 Aligned_cols=6 Identities=17% Similarity=0.263 Sum_probs=2.2
Q ss_pred HhHhhh
Q 046188 283 KVIGAK 288 (646)
Q Consensus 283 ~~~~~~ 288 (646)
.++|||
T Consensus 33 ~~~RRR 38 (44)
T 2jwa_A 33 ILIKRR 38 (44)
T ss_dssp HHHHHH
T ss_pred hheehh
Confidence 333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.79 E-value=2.3 Score=40.67 Aligned_cols=113 Identities=12% Similarity=0.121 Sum_probs=74.2
Q ss_pred CccCceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHH-HHHcCC
Q 046188 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA-YMHSSA 464 (646)
Q Consensus 386 ~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~-yLH~~~ 464 (646)
.||++ -...-.+++...+.|+--+++ ..|-. ...++...+++++.+++.... +++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~--~~f~~-----------------i~~~~~~eKlrll~nl~~L~~~~~~~-- 104 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSF--LTFAA-----------------IRKTTLLSRIRAAIHLVSKVKHHSAR-- 104 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTC--EEHHH-----------------HHTSCHHHHHHHHHHHHHHHSSCCSS--
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCccc--CcHHH-----------------HHhcCHHHHHHHHHHHHHHHHHhhhC--
Confidence 67777 334445566666666654333 22221 125788999999999988776 5554
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchh-hHHHHHHHHHh
Q 046188 465 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVY-SFGVVLLELLT 543 (646)
Q Consensus 465 ~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVw-SfGvvl~Ellt 543 (646)
-+|--+.|+||++|.++.++|.-.|+-..+ +|.-+ + ..|.| .+=+++..++.
T Consensus 105 ---r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~-ee~fl~qyKali~all~ 157 (219)
T 4ano_A 105 ---RLIFIVCPENLMFNRALEPFFLHVGVKESL------------------PPDEW-----D-DERLLREVKATVLALTE 157 (219)
T ss_dssp ---SEECCCCGGGEEECTTCCEEESCCEETTTB------------------SSCSC-----C-HHHHHHHHHHHHHHHTT
T ss_pred ---ceeEEEeCceEEEeCCCcEEEEEcCCcccC------------------CCCCC-----C-HHHHHHHHHHHHHHHHc
Confidence 467889999999999999999988764432 23211 1 22333 56777888888
Q ss_pred CCCCC
Q 046188 544 GKKPI 548 (646)
Q Consensus 544 G~~p~ 548 (646)
++..|
T Consensus 158 ~K~~F 162 (219)
T 4ano_A 158 GEYRF 162 (219)
T ss_dssp CSSCH
T ss_pred CCCCH
Confidence 87765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.46 E-value=2.5 Score=40.23 Aligned_cols=114 Identities=9% Similarity=0.135 Sum_probs=77.0
Q ss_pred CccCceeEEEEEEeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 046188 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSAS 465 (646)
Q Consensus 386 ~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 465 (646)
.||+++.. .+-.+++...+.|+. ..+...|-. ...++...+++++.+|+...++++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~-----------------ik~~~~~eKlr~l~ni~~l~~~~~~--- 99 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDN-----------------IKSFTKNEKLRYLLNIKNLEEVNRT--- 99 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGG-----------------GGGSCHHHHHHHHHHGGGGGGGGGS---
T ss_pred cCCcccce-EEEEcccEEEEEEEc--CcccCCHHH-----------------HHhcCHHHHHHHHHHHHHHHHHhcC---
Confidence 67888866 455555655555554 333333322 1247889999999999988866665
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccch-hhHHHHHHHHHhC
Q 046188 466 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDV-YSFGVVLLELLTG 544 (646)
Q Consensus 466 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDV-wSfGvvl~ElltG 544 (646)
-+|--+.|+|+++|.++.++|.-.|+-..+ +|. ..+ +.|. -.+=+++..++++
T Consensus 100 --r~tf~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~-ee~fL~qyKAliiall~~ 153 (215)
T 4ann_A 100 --RYTFVLAPDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVS-EAEFLTRYKALVICAFNE 153 (215)
T ss_dssp --SEECCCSGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCC-HHHHHHHHHHHHHHHHCT
T ss_pred --ceEEEEecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCC-HHHHHHHHHHHHHHHHcC
Confidence 358889999999999999999988765432 221 111 2233 3677888889998
Q ss_pred CCCC
Q 046188 545 KKPI 548 (646)
Q Consensus 545 ~~p~ 548 (646)
+..|
T Consensus 154 K~~F 157 (215)
T 4ann_A 154 KQSF 157 (215)
T ss_dssp TCCH
T ss_pred CCCH
Confidence 8876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 646 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-75 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-67 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-58 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-47 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 7e-75
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 36/302 (11%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI 385
E+ + +G G FGTVYKG V + A Q++ F NEV +L +
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
H +I+ +G +V ++ +L HH+H + +
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE---------------TKFEMIK 105
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHL 504
+ +A + A + Y+H+ I HRD+KS+NI L + + K+ DFG + +H
Sbjct: 106 LIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 505 TTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
+ G+ + PE + Y+ +SDVY+FG+VL EL+TG+ P N
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRD 216
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
I + L L + +A+ L CL+ +RP Q+ +E L
Sbjct: 217 QIIFMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
Query: 622 RS 623
RS
Sbjct: 272 RS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 6e-69
Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ +G G FG V+ G + VA+K + E FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L G CLE LV+E++ +G LS ++ + + E + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---------------AAETLLGMCL 108
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+V +AY+ + + HRD+ + N L+ + KVSDFG +R V +D+ +T +
Sbjct: 109 DVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
+ PE F S+Y+ KSDV+SFGV++ E+ + K R E
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------------- 210
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
++E + V ++ C + + RP ++ L + S
Sbjct: 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-68
Identities = 63/287 (21%), Positives = 121/287 (42%), Gaps = 34/287 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ LG G FG V+ G + VAVK K + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L + + ++ EY+ NG+L + + L+ + +A
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--------------LTINKLLDMAA 116
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++A +A++ HRD++++NIL+ D S K++DFG +R + +++ +
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
+ PE +T KSDV+SFG++L E++T + E
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------------- 218
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
+++ L+ + E + +L C + + RPT + LE
Sbjct: 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 1e-67
Identities = 70/316 (22%), Positives = 122/316 (38%), Gaps = 50/316 (15%)
Query: 327 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQ 384
++ D++ + LG G G V+K P G ++A K I Q I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
N +IV G + E++ G+L + + + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----------------IPEQ 104
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+V+ V + Y+ I HRD+K SNIL++ + K+ DFG S + +
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 160
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--------- 555
+ GT Y PE Q + Y+ +SD++S G+ L+E+ G+ PI +E
Sbjct: 161 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 556 --------------ERNLVAYFISLAKENKLLEILDARVAKEASEEDI----EAVAELAM 597
R L +Y + + E+LD V + + +
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 598 GCLRLNSKKRPTMKQV 613
CL N +R +KQ+
Sbjct: 280 KCLIKNPAERADLKQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (558), Expect = 4e-67
Identities = 72/300 (24%), Positives = 132/300 (44%), Gaps = 36/300 (12%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQ 384
E++R + LG G +G VY+G+ VAVK K D ++E+F+ E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
I H ++V+LLG C ++ E++ GNL ++ + +Q+ +S
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------------VSAV 115
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+ +A +++ A+ Y+ HRD+ + N L+ + KV+DFG SR + D
Sbjct: 116 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
+ + PE ++++ KSDV++FGV+L E+ T
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PY 217
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
+++ E+L+ E E E V EL C + N RP+ ++ E + +
Sbjct: 218 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (551), Expect = 7e-66
Identities = 67/312 (21%), Positives = 126/312 (40%), Gaps = 34/312 (10%)
Query: 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKR-SKAIDKTQIEQFIN 377
L+ +N R +G+G FG V++ P ++VAVK + F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 378 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
E ++++ ++ +IVKLLG C + L++EY+ G+L+ + +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 438 LSS--------LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489
+ LS ++ +A +VA +AY+ HRD+ + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIA 182
Query: 490 DFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 548
DFG SR++ + D + PE ++YT +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP 608
+ +A E + + D + E + L C RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRP 287
Query: 609 TMKQVSMDLEGL 620
+ + L+ +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (547), Expect = 3e-65
Identities = 66/325 (20%), Positives = 132/325 (40%), Gaps = 51/325 (15%)
Query: 322 FTAEELQRATDNYNQS---------RFLGQGGFGTVYKGMLP----DGSIVAVKR-SKAI 367
FT E+ A + + + +G G FG V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 368 DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQE 427
+ Q F++E I+ Q +H +++ L G ++ +++ E++ NG+L + + Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 428 QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487
+ V + +A + Y+ + HRD+ + NIL++ K
Sbjct: 126 --------------TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCK 168
Query: 488 VSDFGTSRSVPNDKTHLTT----AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 543
VSDFG SR + +D + T + + PE Q ++T SDV+S+G+V+ E+++
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
Query: 544 GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLN 603
+ ++ ++ ++ + A+ +L + C + +
Sbjct: 229 YGERPYWDMTNQD---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKD 273
Query: 604 SKKRPTMKQVSMDLEGLRRSQRCLE 628
RP Q+ L+ + R+ L+
Sbjct: 274 RNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-65
Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 34/292 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
++ LGQG FG V+ G + VA+K K E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L E + +V EY+ G+L + + + V +A
Sbjct: 76 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLR--------------LPQLVDMAA 120
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
++A +AY+ HRD++++NIL+ + KV+DFG +R + +++ +
Sbjct: 121 QIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
+ PE ++T KSDV+SFG++L EL T + E
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------- 222
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
+L+ ++ E E++ +L C R ++RPT + + LE S
Sbjct: 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-64
Identities = 64/294 (21%), Positives = 131/294 (44%), Gaps = 40/294 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ +G+G FG V G G+ VAVK K + + F+ E +++Q+ H ++V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 392 KLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+LLG +E + + +V EY+ G+L ++ + S L + ++ +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--------------SVLGGDCLLKFS 109
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 510
+V A+ Y+ + HRD+ + N+L+ + AKVSDFG ++ + + +
Sbjct: 110 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKL 162
Query: 511 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570
+ PE + +++ KSDV+SFG++L E+ + + ++ + ++
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKG 216
Query: 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624
++ D V E+ C L++ RP+ Q+ LE ++ +
Sbjct: 217 YKMDAPD-----GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-64
Identities = 64/287 (22%), Positives = 119/287 (41%), Gaps = 34/287 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIV 391
+ + LG G FG V G VA+K K ++FI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
+L G C + ++ EY+ NG L +++ + + + + + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---------------FQTQQLLEMCK 107
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+V A+ Y+ S HRD+ + N L++D+ KVSDFG SR V +D+ + +
Sbjct: 108 DVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
+ PE S+++ KSD+++FGV++ E+ + K E
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------------- 209
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
E + + E V + C + +RPT K + ++
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-64
Identities = 69/298 (23%), Positives = 137/298 (45%), Gaps = 33/298 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVKR-SKAIDKTQIEQFINEVVILSQ 384
+N + LG G FG V S VAVK + D ++ E ++E+ +++Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 385 I-NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQ-------QEQKQELEEEQ 436
+ +H +IV LLG C + L++EY C G+L +++ +++ E ++ LEEE+
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 437 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496
+L+ L++E+ + A +VA + ++ HRD+ + N+L+ K+ DFG +R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 497 VPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 555
+ +D ++ + + PE YT KSDV+S+G++L E+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266
Query: 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + + +++ + E + + C +S+KRP+ +
Sbjct: 267 -------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 8e-64
Identities = 72/305 (23%), Positives = 129/305 (42%), Gaps = 41/305 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGS-----IVAVKR-SKAIDKTQIEQFINEVVILSQI 385
+ + +G G FG VYKGML S VA+K + Q F+ E I+ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
+H +I++L G + + +++ EY+ NG L + + + S
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---------------FSVLQ 111
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND--KTH 503
V + +A + Y+ + HRD+ + NIL++ KVSDFG SR + +D T+
Sbjct: 112 LVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
T+ + + PE ++T SDV+SFG+V+ E++T + E
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------- 221
Query: 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623
+++ ++ + A+ +L M C + +RP + L+ L R+
Sbjct: 222 --------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
Query: 624 QRCLE 628
L+
Sbjct: 274 PDSLK 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-63
Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 36/289 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
++Y +G G +G K DG I+ K ++ + + + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 389 HIVKLLGCCLETE--VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
+IV+ ++ +V EY G+L+ I ++++ L E
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ------------YLDEEFV 111
Query: 447 VRVACEVAGAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+RV ++ A+ H S + HRD+K +N+ LD K + K+ DFG +R + +D +
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 171
Query: 505 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
GT Y PE Y +KSD++S G +L EL P ++E +
Sbjct: 172 KA-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---- 226
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+E K I R + E E+ L L RP+++++
Sbjct: 227 ---REGKFRRI-PYRYSDEL--------NEIITRMLNLKDYHRPSVEEI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-63
Identities = 73/306 (23%), Positives = 128/306 (41%), Gaps = 30/306 (9%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SKAIDKTQIEQFINE 378
E R + + + LG G FG V + VAVK + T+ E ++E
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 379 VVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE--E 435
+ +LS + NH +IV LLG C +++ EY C G+L + + + + E
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
+ +L E+ + + +VA +A++ S HRD+ + NILL K+ DFG +R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 496 SVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554
+ ND + + + + PE + YT +SDV+S+G+ L EL +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614
+ K +++ + E + ++ C + KRPT KQ+
Sbjct: 254 DS--------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 615 MDLEGL 620
+E
Sbjct: 300 QLIEKQ 305
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-62
Identities = 71/299 (23%), Positives = 119/299 (39%), Gaps = 25/299 (8%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGS---IVAVKR-SKAIDKTQIEQFINEVVILSQI-N 386
++ +G+G FG V K + A+KR + K F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H +I+ LLG C L EY +GNL + + + S+LS +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
+ A +VA + Y+ HRD+ + NIL+ + + AK++DFG SR T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566
+ + E S YT SDV+S+GV+L E+++ E
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------- 234
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625
L E L E + V +L C R +RP+ Q+ + L + ++
Sbjct: 235 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 8e-62
Identities = 75/318 (23%), Positives = 146/318 (45%), Gaps = 42/318 (13%)
Query: 315 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKR-SKAIDK 369
+ E + + ++ + + +G+G FG VY G L D AVK ++ D
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 370 TQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEYICNGNLSHHIHDHQQQQEQ 428
++ QF+ E +I+ +H +++ LLG CL +E P++V Y+ +G+L + I +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--- 126
Query: 429 KQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488
+ ++ + +VA + ++ S HRD+ + N +LD+KF+ KV
Sbjct: 127 ------------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 171
Query: 489 SDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 545
+DFG +R + + + H T + + E Q+ ++T KSDV+SFGV+L EL+T
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 546 KPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSK 605
P + N + L + +LL+ E + + E+ + C ++
Sbjct: 232 APP-----YPDVNTFDITVYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAE 276
Query: 606 KRPTMKQVSMDLEGLRRS 623
RP+ ++ + + +
Sbjct: 277 MRPSFSELVSRISAIFST 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 9e-62
Identities = 56/310 (18%), Positives = 118/310 (38%), Gaps = 42/310 (13%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 397
+G+G FG V++G G VAVK + + + E+ + H +I+ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 398 LETEVPV----LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 453
+ LV +Y +G+L +++ + +++ E +++A
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----------------TVTVEGMIKLALST 109
Query: 454 AGAVAYMHSSA-----SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL---T 505
A +A++H I HRD+KS NIL+ + ++D G + + +
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 506 TAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVLLELLTGKKPICLTREEE---- 555
GT Y PE S + ++D+Y+ G+V E+ + + +
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 556 ERNLVAYFISLAKENKLLEILDARV-AKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614
+ + ++ + L + + S E + +A++ C N R T ++
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 615 MDLEGLRRSQ 624
L L + +
Sbjct: 290 KTLSQLSQQE 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-61
Identities = 68/286 (23%), Positives = 113/286 (39%), Gaps = 43/286 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
+++ R LG+G FG VY I+A+K +++ Q EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+I++L G + L+ EY G + + + +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----------------FDEQRTA 109
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
E+A A++Y HS + HRDIK N+LL K++DFG S P+ +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---T 163
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
+ GT Y PE + + +K D++S GV+ E L GK P +E +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SR 218
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
E + + E +L L+ N +RP +++V
Sbjct: 219 VEFTFPDFVT------------EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 5e-61
Identities = 67/285 (23%), Positives = 123/285 (43%), Gaps = 38/285 (13%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
Y + +GQG GTVY M + G VA+++ + + E INE++++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IV L L + +V EY+ G+L+ + + V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----------------DEGQIAAV 121
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
E A+ ++HS+ + HRDIKS NILL S K++DFG + +++ +T V
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569
GT + PE Y K D++S G++ +E++ G+ P +++
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPL 222
Query: 570 NKLLEILDARVAKEASEEDI-EAVAELAMGCLRLNSKKRPTMKQV 613
L I + + E + + CL ++ +KR + K++
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 6e-61
Identities = 68/301 (22%), Positives = 131/301 (43%), Gaps = 41/301 (13%)
Query: 325 EELQRATDNYNQSRF-LGQGGFGTVYKGML---PDGSIVAVKR-SKAIDKTQIEQFINEV 379
++L DN + LG G FG+V +G+ VA+K + +K E+ + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 380 VILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
I+ Q+++ +IV+L+G C + E +LV E G L + +++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-------------- 105
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
+ N + +V+ + Y+ HRD+ + N+LL ++ AK+SDFG S+++
Sbjct: 106 -IPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161
Query: 500 DKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 557
D ++ T +A + ++ PE +++ +SDV+S+GV + E L+ + + E
Sbjct: 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE- 220
Query: 558 NLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 617
++ ++ K +E E E + L C + RP V +
Sbjct: 221 -----VMAFIEQGKRMECPP-----ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 618 E 618
Sbjct: 267 R 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-60
Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 43/282 (15%)
Query: 340 LGQGGFGTVYKGMLPD-GSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHIVKLLGC 396
+G+G F TVYKG+ + VA + + + K++ ++F E +L + H +IV+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 397 CLET----EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 452
T + VLV E + +G L ++ + + + +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----------------MKIKVLRSWCRQ 120
Query: 453 VAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+ + ++H+ + PI HRD+K NI + S K+ D G + + AV GT
Sbjct: 121 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGT 176
Query: 512 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571
+ PE ++ +Y + DVY+FG+ +LE+ T + P Y
Sbjct: 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQI 221
Query: 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + I V E+ GC+R N +R ++K +
Sbjct: 222 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-60
Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 42/290 (14%)
Query: 336 QSRFLGQGGFGTVYKGMLPD---GSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRHI 390
+ + LG G FGTV KG VAVK +++A D ++ + E ++ Q+++ +I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V+++G C E E +LV E G L+ ++ ++ + +N + +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----------------VKDKNIIELV 113
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--AV 508
+V+ + Y+ S HRD+ + N+LL + AK+SDFG S+++ D+ +
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
+ ++ PE +++ KSDV+SFGV++ E + + + E
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------------ 218
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
+ +L+ + +L C + + RP V + L
Sbjct: 219 ---VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-60
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 41/305 (13%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKR-SKAIDKTQIEQFINEVV 380
E+QR + R +G+G FG V++G+ VA+K + E+F+ E +
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 381 ILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSS 440
+ Q +H HIVKL+G E V ++ E G L + + S
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY---------------S 104
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 500
L + + A +++ A+AY+ S HRDI + N+L+ K+ DFG SR + +
Sbjct: 105 LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
+ + + + PE ++T SDV+ FGV + E+L + +
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---- 217
Query: 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620
I + + L + + L C + +RP ++ L +
Sbjct: 218 --VIGRIENGERLPMPP-----NCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
Query: 621 RRSQR 625
++
Sbjct: 267 LEEEK 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-60
Identities = 65/289 (22%), Positives = 110/289 (38%), Gaps = 39/289 (13%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRH 389
D + LG G FG VYK + + A K + ++E ++ E+ IL+ +H +
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IVKLL ++ E+ G + + + ++ L+ V
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---------------PLTESQIQVV 115
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
+ A+ Y+H + I HRD+K+ NIL K++DFG S + +
Sbjct: 116 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI- 171
Query: 510 GTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564
GT + PE Y K+DV+S G+ L+E+ + P E N + +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLL 225
Query: 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+AK +R + + CL N R T Q+
Sbjct: 226 KIAKSEPPTLAQPSRWSSNF--------KDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 8e-60
Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 49/304 (16%)
Query: 317 EKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQI 372
+ A++F ++ ++ R +G G FG VY + + +VA+K+ S +
Sbjct: 3 DVAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 373 EQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQEL 432
+ I EV L ++ H + ++ GC L LV EY +
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--------- 110
Query: 433 EEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492
L V +AY+HS + HRD+K+ NILL + K+ DFG
Sbjct: 111 -------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160
Query: 493 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPIC 549
++ + + GT + PE + QY K DV+S G+ +EL K P
Sbjct: 161 SASIMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-- 213
Query: 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT 609
++ + L I S E CL+ + RPT
Sbjct: 214 -------------LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
Query: 610 MKQV 613
+ +
Sbjct: 261 SEVL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 69/286 (24%), Positives = 110/286 (38%), Gaps = 37/286 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHRH 389
++++ + LG+G +G V + VAVK E E+ I +NH +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
+VK G E + L EY G L I + + R
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------------GMPEPDAQRF 108
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAV 508
++ V Y+H I I HRDIK N+LLD++ + K+SDFG + N++ L +
Sbjct: 109 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 509 QGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
GT Y PE + ++ + DV+S G+VL +L G+ P + + S
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDW 219
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
KE K ++ L L N R T+ +
Sbjct: 220 KEKKTYLNPWKKIDSAP--------LALLHKILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-58
Identities = 64/309 (20%), Positives = 134/309 (43%), Gaps = 43/309 (13%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKR-SKAIDKTQIEQFINEVVIL 382
+ T+ + + + LG G FGTVYKG+ +P+G VA+K +A ++ ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 383 SQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+ +++ H+ +LLG CL + V L+ + + G L ++ +H+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI---------------G 109
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDK 501
+ + ++A + Y+ + HRD+ + N+L+ K++DFG ++ + +K
Sbjct: 110 SQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
+ + + E YT +SDV+S+GV + EL+T
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------- 212
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
+++ IL+ V + + C +++ RP +++ ++ +
Sbjct: 213 -PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
Query: 622 RS-QRCLEI 629
R QR L I
Sbjct: 272 RDPQRYLVI 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-58
Identities = 74/310 (23%), Positives = 140/310 (45%), Gaps = 32/310 (10%)
Query: 319 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SKAIDKTQ 371
A ++ +E + A + SR LGQG FG VY+G+ + VA+K ++A +
Sbjct: 7 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 66
Query: 372 IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQE 431
+F+NE ++ + N H+V+LLG + + +++ E + G+L ++ +
Sbjct: 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL------RPA 120
Query: 432 LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491
+ L+ S +++A E+A +AY++++ HRD+ + N ++ + F+ K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 492 GTSRSVP-NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 550
G +R + D + PE + +T SDV+SFGVVL E+ T +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 551 TREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTM 610
E+ + E LL+ D + + EL C + N K RP+
Sbjct: 238 GLSNEQ------VLRFVMEGGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSF 282
Query: 611 KQVSMDLEGL 620
++ ++
Sbjct: 283 LEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 70/302 (23%), Positives = 124/302 (41%), Gaps = 27/302 (8%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQ 384
D + LG+G FG V + VAVK + ++ ++E+ IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 385 INHRH-IVKLLGCCLETEVPV-LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
I H +V LLG C + P+ ++ E+ GNLS ++ + + + E+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E+ + + +VA + ++ S HRD+ + NILL +K K+ DFG +R + D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 503 HL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
++ + + PE YT +SDV+SFGV+L E+ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
F KE + D + + + C +RPT ++ L L
Sbjct: 245 EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
Query: 622 RS 623
++
Sbjct: 296 QA 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-57
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 31/306 (10%)
Query: 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKR-SKAIDKTQIEQFI 376
EL R D + LG+G FG V + VAVK + + I
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 377 NEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEE 435
+E+ ++ I H++I+ LLG C + ++ EY GNL ++ + +
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 436 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 495
LS ++ V A +VA + Y+ S HRD+ + N+L+ + K++DFG +R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 496 SVPNDKTHLTTAV-QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554
+ + + T + + PE YT +SDV+SFGV+L E+ T
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVS 614
EE L ++L + + + C +RPT KQ+
Sbjct: 244 EE---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 615 MDLEGL 620
DL+ +
Sbjct: 289 EDLDRI 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-56
Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 45/302 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKR---SKAIDKTQIEQFINEVVILSQ 384
+ LG G FG V +G VAVK ++ FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
++HR++++L G L + +V E G+L + HQ
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ---------------GHFLLG 111
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH- 503
R A +VA + Y+ S HRD+ + N+LL + K+ DFG R++P + H
Sbjct: 112 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 504 -LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
+ + F + PE ++ ++ SD + FGV L E+ T +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------P 214
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622
+I L L +I E+ + + + + C + RPT + + L
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLE 271
Query: 623 SQ 624
+Q
Sbjct: 272 AQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (483), Expect = 2e-55
Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 36/285 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
D+Y+ LG G FG V++ G+ A K ++ E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
V L + V++YE++ G L + D + +S + V
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---------------MSEDEAVEYM 130
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--AKVSDFGTSRSVPNDKTHLTTAV 508
+V + +MH + H D+K NI+ K S K+ DFG + + ++ T
Sbjct: 131 RQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-- 185
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
GT + PE + +D++S GV+ LL+G P ++E V +
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSC 240
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + + + ++++ + L + R T+ Q
Sbjct: 241 DWNMDDSAFSGISEDG--------KDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 41/299 (13%)
Query: 328 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILS 383
++ +++ + LG+G F TV L A+K + I + ++ E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 384 QINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
+++H VKL + E Y NG L +I S
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------------SFDE 107
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKT 502
E+ A+ Y+H I HRD+K NILL++ +++DFGT++ + P K
Sbjct: 108 TCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562
+ GT Y PE SD+++ G ++ +L+ G P
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--------------- 209
Query: 563 FISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621
F + + +I+ + E+ +L L L++ KR +++
Sbjct: 210 FRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 180 bits (457), Expect = 1e-52
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 43/303 (14%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKAIDKTQIEQFINEVVILSQIN 386
+D Y LG GG V+ L VAVK A D + +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 387 HRHIVKLLGCCLETE----VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
H IV + +P +V EY+ L +H ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----------------MT 109
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
+ + V + A+ + H + I HRD+K +NI++ + KV DFG +R++ +
Sbjct: 110 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
Query: 503 HL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
+ T AV GT Y PE + +SDVYS G VL E+LTG+ P + +
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVS 221
Query: 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEG 619
+ + ++ ++ + + + L N + R T ++ DL
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADL--------DAVVLKALAKNPENRYQTAAEMRADLVR 273
Query: 620 LRR 622
+
Sbjct: 274 VHN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 58/285 (20%), Positives = 106/285 (37%), Gaps = 37/285 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
+ Y + LG+G FG V++ + K K + T E+ IL+ HR+I
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+ L E V+++E+I ++ I+ + L+ V
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE---------------LNEREIVSYV 108
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTAV 508
+V A+ ++HS I H DI+ NI+ + S+ K+ +FG +R +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-- 163
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
Y+ PE Q + +D++S G ++ LL+G P ++ + +
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNA 218
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
E E ++ EA + L K R T +
Sbjct: 219 EYTFDEEAFKEISIEA--------MDFVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (454), Expect = 2e-51
Identities = 59/285 (20%), Positives = 105/285 (36%), Gaps = 36/285 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
D Y+ LG G FG V++ + G + K NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+ L + VL+ E++ G L I + +S +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---------------MSEAEVINYM 133
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTAV 508
+ + +MH I H DIK NI+ + K ++ K+ DFG + + D+ T
Sbjct: 134 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-- 188
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
T + PE +D+++ GV+ LL+G P + E V
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----KRC 243
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + E + V+ EA + L+ +KR T+
Sbjct: 244 DWEFDEDAFSSVSPEA--------KDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (446), Expect = 1e-50
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 33/285 (11%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHR 388
D Y+ LG G F V +VA+K +K + + NE+ +L +I H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IV L L+ + + G L I + + + R
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----------------YTERDASR 111
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
+ +V AV Y+H + + LD+ +SDFG S+ D + +
Sbjct: 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTA 169
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568
GT GY PE Y+ D +S GV+ LL G P + + + L
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKA 224
Query: 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
E + ++ A + + + +KR T +Q
Sbjct: 225 EYEFDSPYWDDISDSA--------KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-50
Identities = 61/304 (20%), Positives = 114/304 (37%), Gaps = 32/304 (10%)
Query: 327 LQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVK--RSKAIDKTQIEQFINEVVIL 382
L RA Y +G+G +G V+K + G VA+K R + ++ I EV +L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 383 SQI---NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELS 439
+ H ++V+L C + + ++ + + + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---------- 111
Query: 440 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 499
+ E + ++ + ++HS + HRD+K NIL+ K++DFG +R
Sbjct: 112 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
T+V T Y PE S Y D++S G + E+ K + + ++
Sbjct: 169 QMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226
Query: 560 VAYFISLAKE----------NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT 609
+ I L E + A+ ++ + E +L + CL N KR +
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286
Query: 610 MKQV 613
Sbjct: 287 AYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 172 bits (437), Expect = 9e-50
Identities = 64/299 (21%), Positives = 112/299 (37%), Gaps = 51/299 (17%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---------SKAIDKTQIEQFINEVVI 381
+NY LG+G V + + P AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 382 LSQIN-HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSS 440
L +++ H +I++L LV++ + G L ++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------------- 106
Query: 441 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 500
LS + ++ + + +H I HRD+K NILLDD + K++DFG S + D
Sbjct: 107 LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--D 161
Query: 501 KTHLTTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLTREE 554
V GT Y PE + S Y + D++S GV++ LL G P
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----W 216
Query: 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ ++ + ++ + + +L L + +KR T ++
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 171 bits (435), Expect = 2e-49
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 33/296 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHRH 389
+ Y+ +G+G +G VYK G A+K R + D+ I E+ IL ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 390 IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 449
IVKL + VLV+E++ L
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------------LESVTAKSF 105
Query: 450 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 509
++ +AY H + HRD+K N+L++ + K++DFG +R+ T +
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 510 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV--------- 560
+ S +Y+ D++S G + E++ G E ++ +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 561 ---AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
L K + + + + + E+ +L L+L+ +R T KQ
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (432), Expect = 1e-48
Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 48/291 (16%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
++ R LG G FG V+ +G A+K + + Q+E +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
I+++ G + + ++ +YI G L + Q+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----------------PNPVAK 107
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
A EV A+ Y+HS I +RD+K NILLD K++DFG ++ VP+ L
Sbjct: 108 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-- 162
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
GT Y PE + Y D +SFG+++ E+L G P F
Sbjct: 163 --GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP---------------FYDSN 205
Query: 568 KENKLLEILDARVA--KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616
+IL+A + +E+ V +L + + +R Q +
Sbjct: 206 TMKTYEKILNAELRFPPFFNED----VKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (430), Expect = 9e-48
Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 44/293 (15%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSKAIDKTQIEQFINEVV---ILSQ 384
++++ R +G+GGFG VY D G + A+K + + K +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 385 INHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
+ IV + + + + + G+L +H+ H E
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----------------A 107
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 504
+ A E+ + +MH+ + +RD+K +NILLD+ ++SD G + K H
Sbjct: 108 DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 164
Query: 505 TTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563
+ GT GY PE Q Y +D +S G +L +LL G P + +++ +
Sbjct: 165 S---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616
+++A E L + E L G L+ + +R
Sbjct: 222 LTMAVE------LPDSFSPEL--------RSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 62/286 (21%), Positives = 105/286 (36%), Gaps = 42/286 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILS-QIN 386
+++ + LG+G FG V+ A+K + + +E + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 387 HRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 446
H + + E V EY+ G+L +HI +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----------------FDLSRA 105
Query: 447 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 506
A E+ + ++HS I +RD+K NILLD K++DFG + T
Sbjct: 106 TFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162
Query: 507 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566
GT Y PE +Y D +SFGV+L E+L G+ P ++ F S+
Sbjct: 163 FC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSI 215
Query: 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
+N + +E +L + +KR ++
Sbjct: 216 RMDNPFYP-------RWLEKE----AKDLLVKLFVREPEKRLGVRG 250
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 56/297 (18%), Positives = 104/297 (35%), Gaps = 33/297 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
+N+ + +G+G +G VYK G +VA+K R + I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IVKLL LV+E++ +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---------------GIPLPLIKS 106
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ +A+ HS + HRD+K N+L++ + + K++DFG +R+ T V
Sbjct: 107 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------------ICLTREEEE 556
+ Y+ D++S G + E++T + I T +
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ S+ + + E L L + KR + K
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-47
Identities = 60/302 (19%), Positives = 115/302 (38%), Gaps = 35/302 (11%)
Query: 331 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKAIDKTQIEQFINEVVILSQINHR 388
Y ++G+G +G V + VA+K+ S +T ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+I+ + + + Y+ + ++ + Q LS ++
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-------------HLSNDHICY 113
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT--T 506
++ + Y+HS+ + HRD+K SN+LL+ K+ DFG +R D H T
Sbjct: 114 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 507 AVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565
T Y PE +S+ KS D++S G +L E+L+ + ++ N + +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 566 LAKENKLLEILDARVAK--------------EASEEDIEAVAELAMGCLRLNSKKRPTMK 611
+ L I++ + +L L N KR ++
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
Query: 612 QV 613
Q
Sbjct: 291 QA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-46
Identities = 49/298 (16%), Positives = 102/298 (34%), Gaps = 35/298 (11%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
Y + +G+G +GTV+K IVA+K R D+ + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 389 HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 448
+IV+L + LV+E+ + + E
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----------------PEIVKS 105
Query: 449 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 508
++ + + HS + HRD+K N+L++ K+++FG +R+ + V
Sbjct: 106 FLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 509 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE------------ 556
+ F + Y+ D++S G + EL +P+ + ++
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 557 -RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
L + +L L+ N +R + ++
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-46
Identities = 67/304 (22%), Positives = 110/304 (36%), Gaps = 48/304 (15%)
Query: 321 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SKAIDKTQIE 373
+F E + D Y+ LG G F V K G A K + E
Sbjct: 2 VFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 374 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELE 433
EV IL +I H +++ L +L+ E + G L + + +
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------- 108
Query: 434 EEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVS 489
SL+ E ++ V Y+HS + I H D+K NI+L D K K+
Sbjct: 109 ------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 549
DFG + + D + + GT + PE ++D++S GV+ LL+G P
Sbjct: 160 DFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 550 LTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT 609
++E +LA + + + S + L + KKR T
Sbjct: 218 GDTKQE---------TLANVSAVNYEFEDEYFSNTSAL----AKDFIRRLLVKDPKKRMT 264
Query: 610 MKQV 613
++
Sbjct: 265 IQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 63/298 (21%), Positives = 108/298 (36%), Gaps = 46/298 (15%)
Query: 338 RFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQ-----IEQFINEVVILSQINHRHIV 391
FLG+G F TVYK IVA+K+ K +++ + E+ +L +++H +I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 392 KLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 451
LL LV++++ + L+ +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----------------LTPSHIKAYML 107
Query: 452 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 511
+ Y+H I HRD+K +N+LLD+ K++DFG ++S + T V T
Sbjct: 108 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VT 163
Query: 512 FGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKP---------------ICLTREEE 555
Y PE ++ Y D+++ G +L ELL T EE
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 556 ERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
+ + I + A ++ + +L G N R T Q
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDD----LLDLIQGLFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 3e-45
Identities = 56/306 (18%), Positives = 97/306 (31%), Gaps = 39/306 (12%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH 387
R + Y R +G G FG +Y G + G VA+K KT+ Q E I +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQG 61
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+ + C ++ + +L + ++ S + +
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---------------FSLKTVL 106
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNIL---LDDKFSAKVSDFGTSRSVPNDKTH- 503
+A ++ + Y+HS HRD+K N L + DFG ++ + +TH
Sbjct: 107 LLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
Query: 504 -----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558
+ GT Y + + + D+ S G VL+ G P + +R
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
Query: 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618
K + + K E A C L +P +
Sbjct: 224 KY-----ERISEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 619 GLRRSQ 624
L Q
Sbjct: 275 NLFHRQ 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 7e-45
Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 41/302 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
+Y ++ +G G FG VY+ L D G +VA+K+ + + + E+ I+ +++H +I
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDK-RFKNRELQIMRKLDHCNI 75
Query: 391 VKLLGCCLETEVP------VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
V+L + LV +Y+ H + +Q +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-------------TLPVI 122
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTH 503
++ ++AY+HS I HRDIK N+LLD D K+ DFG+++ + + +
Sbjct: 123 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 504 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------------ICLT 551
++ + + F ++ YT DV+S G VL ELL G+ I
Sbjct: 180 VSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK 611
R + E K +I K L L R T
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 612 QV 613
+
Sbjct: 299 EA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 59/292 (20%), Positives = 103/292 (35%), Gaps = 43/292 (14%)
Query: 332 DNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHR 388
D+Y S+ LG G G V + A+K + + EV + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCP 65
Query: 389 HIVKLLGCC----LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWE 444
HIV+++ + ++V E + G L I D Q + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--------------AFTER 111
Query: 445 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGTSRSVPNDK 501
+ + A+ Y+HS I HRD+K N+L K K++DFG ++ +
Sbjct: 112 EASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561
+ T T Y PE +Y D++S GV++ LL G P +
Sbjct: 169 SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226
Query: 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
I + + + V++E L L+ +R T+ +
Sbjct: 227 TRI-RMGQYEFPNPEWSEVSEEV--------KMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 68/293 (23%), Positives = 112/293 (38%), Gaps = 55/293 (18%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SKAIDKTQIEQFINEVVILSQ 384
Y LG GGFG+VY G+ + D VA+K S + + EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 385 INHRH--IVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
++ +++LL + VL+ E + +L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---------------ALQ 108
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDK 501
E +V AV + H+ + HRDIK NIL+D ++ K+ DFG+ + +
Sbjct: 109 EELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPICLTREEEERNLV 560
T GT Y PE+ + +Y +S V+S G++L +++ G P
Sbjct: 166 ---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------- 209
Query: 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQV 613
F + + RV+ E L CL L RPT +++
Sbjct: 210 --FEHDEEIIRGQVFFRQRVSSEC--------QHLIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 41/285 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
++++ + LG+G FG V G A+K + I K ++ + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+ L + V EY G L H+ + + E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----------------FTEERAR 108
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
E+ A+ Y+H S + +RDIK N++LD K++DFG + +D + T
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567
GT Y PE + + Y D + GVV+ E++ G+ P + + + + L
Sbjct: 166 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILM 219
Query: 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQ 612
+E + L L G L+ + K+R
Sbjct: 220 EEIRFPRTLS------------PEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 59/315 (18%), Positives = 112/315 (35%), Gaps = 49/315 (15%)
Query: 329 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQI 385
Y + +GQG FG V+K G VA+K + + + E+ IL +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 386 NHRHIVKLLGCCLETEVPV--------LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQE 437
H ++V L+ C P LV+++ + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------- 113
Query: 438 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 497
+ RV + + Y+H I HRD+K++N+L+ K++DFG +R+
Sbjct: 114 ---FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 167
Query: 498 PNDKT---HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTRE 553
K + T T Y PE + Y D++ G ++ E+ T + E
Sbjct: 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227
Query: 554 EEERNLVAYFI--------------SLAKENKLLEILDARVAKEASEEDIEAVA-ELAMG 598
+ + L++ L ++ +L++ +V + A +L
Sbjct: 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287
Query: 599 CLRLNSKKRPTMKQV 613
L L+ +R
Sbjct: 288 LLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-41
Identities = 55/314 (17%), Positives = 112/314 (35%), Gaps = 41/314 (13%)
Query: 322 FTAEELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQ 374
F +E+ + Y + +G G +G V + G+ VA+K + ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
E+ +L + H +++ LL E ++ + E+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------ 117
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
L + + ++ + Y+H++ I HRD+K N+ +++ K+ DFG +
Sbjct: 118 ------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------- 547
R + +T V + +YT D++S G ++ E++TGK
Sbjct: 169 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 548 --------ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGC 599
+ T E + + L E+ A + AV L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV-NLLEKM 284
Query: 600 LRLNSKKRPTMKQV 613
L L++++R T +
Sbjct: 285 LVLDAEQRVTAGEA 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 2e-40
Identities = 46/309 (14%), Positives = 93/309 (30%), Gaps = 41/309 (13%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI 390
+Y R +G+G FG +++G L + VA+K ++ Q +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 391 VKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 450
+ + + + ++ + +L + ++ S + A
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---------------FSVKTVAMAA 107
Query: 451 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-----AKVSDFGTSRSVPNDKT--- 502
++ V +H + +RDIK N L+ S V DFG + + T
Sbjct: 108 KQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 503 ---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559
+ GT Y + + + D+ + G V + L G P +
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--- 221
Query: 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619
K ++ E + +E E + L P +
Sbjct: 222 ------KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
Query: 620 LRRSQRCLE 628
+ E
Sbjct: 276 VLERLNTTE 284
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-40
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKAIDKTQIEQFINEVVILSQINH 387
D +++ + LG G FG V G+ A+K + K + QIE +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 388 RHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
+VKL + +V EY+ G + H+ + S +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----------------FSEPHAR 144
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 507
A ++ Y+H S+ + +RD+K N+L+D + +V+DFG ++ V
Sbjct: 145 FYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 197
Query: 508 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 547
+ GT PE S Y D ++ GV++ E+ G P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 142 bits (358), Expect = 3e-38
Identities = 53/309 (17%), Positives = 115/309 (37%), Gaps = 54/309 (17%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRH 389
D+Y R LG+G + V++ + + + V VK + + ++ E+ IL + +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 390 IVKLLGCCLE--TEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 447
I+ L + + P LV+E++ N + +L+ +
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------------------TLTDYDIR 132
Query: 448 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTT 506
E+ A+ Y HS + I HRD+K N+++D + ++ D+G + + +
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 187
Query: 507 AVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI- 564
+ + PE Q Y D++S G +L ++ K+P + ++ + +
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 565 ------------SLAKENKLLEILDARVAK--------EASEEDIEAVAELAMGCLRLNS 604
++ + + +IL K E + LR +
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307
Query: 605 KKRPTMKQV 613
+ R T ++
Sbjct: 308 QSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 43/296 (14%)
Query: 332 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKAIDKTQ-IEQFINEVVILS 383
+N+ + LG G +G V+ G + A+K ++ + K + E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 384 QINHR-HIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
I +V L L+ +YI G L H+ ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------------FT 127
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E+ A+ ++H + I +RDIK NILLD ++DFG S+ D+T
Sbjct: 128 EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 503 HLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560
GT Y P+ + + D +S GV++ ELLTG P + E+
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----- 239
Query: 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616
S A+ ++ + + +E S +L L + KKR D
Sbjct: 240 ----SQAEISRRILKSEPPYPQEMSAL----AKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-36
Identities = 60/314 (19%), Positives = 114/314 (36%), Gaps = 41/314 (13%)
Query: 322 FTAEELQRA----TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQ 374
F +EL + + Y +G G +G+V G VAVK ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 375 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEE 434
E+ +L + H +++ LL + +L ++ + ++
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------ 117
Query: 435 EQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 494
L+ ++ + ++ + Y+HS+ I HRD+K SN+ +++ K+ DFG +
Sbjct: 118 ------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 495 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------- 547
R + +T V + Y D++S G ++ ELLTG+
Sbjct: 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 548 --------ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGC 599
+ T E ++ + L ++ A + AV +L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV-DLLEKM 284
Query: 600 LRLNSKKRPTMKQV 613
L L+S KR T Q
Sbjct: 285 LVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 58/316 (18%), Positives = 106/316 (33%), Gaps = 58/316 (18%)
Query: 332 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKAIDKTQIEQFINEVVILSQINHR 388
Y + +G G G V VA+K ++T ++ E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 389 HIVKLLGCCL------ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLS 442
+I+ LL E + LV E + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------------------D 117
Query: 443 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 502
E + ++ + ++HS I HRD+K SNI++ + K+ DFG +R+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTS 172
Query: 503 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE------ 556
+ T T Y PE Y + D++S G ++ E++ K ++
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 557 -----------------RNLVAYFISLAKEN--KLLEILDARVAKEASEEDIEAVAELAM 597
RN V A KL E ++ +L
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 598 GCLRLNSKKRPTMKQV 613
L ++ KR ++
Sbjct: 293 KMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 4e-35
Identities = 60/327 (18%), Positives = 120/327 (36%), Gaps = 54/327 (16%)
Query: 332 DNYNQSRF-----LGQGGFGTVYKGM-LPDGSIVAVKRSKAIDKTQIEQFINEVVILSQI 385
+ Y +R+ LG G F TV+ + + + VA+K + DK E +E+ +L ++
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRV 66
Query: 386 NHRHIVKLLGCCLETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 445
N K + +L + N H + + E L ++ E +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 446 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD------DKFSAKVSDFGTSRSVPN 499
+++ ++ + YMH I H DIK N+L++ + K++D G +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 500 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------------ 547
T+ T Y PE + + +D++S ++ EL+TG
Sbjct: 185 HYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 548 ---------------------ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEASE 586
TR + IS K L ++L + + S+
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY--KFSK 298
Query: 587 EDIEAVAELAMGCLRLNSKKRPTMKQV 613
++ + +++ L+L+ +KR +
Sbjct: 299 DEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 2e-22
Identities = 36/219 (16%), Positives = 62/219 (28%), Gaps = 49/219 (22%)
Query: 338 RFLGQGGFGTVYKGMLPDGSIVAVK----------RSKAIDKTQIEQFINEVVILSQINH 387
+ +G+G V+ VK + K F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 388 RHIVKLLGCC----LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSW 443
R + KL G E ++ E I L ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD------------------- 106
Query: 444 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDK 501
V + VA + I H D+ N+L+ + + DF S V +
Sbjct: 107 ----EVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWR 158
Query: 502 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 540
L V+ YF S Y + D+ S +L+
Sbjct: 159 EILERDVRNIITYF------SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 646 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 99.36 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 99.33 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 98.97 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 98.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.8 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=433.71 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=206.0
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688889999999999999998888899999987543 234679999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ..++|..+++|+.|+|+||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 84 ~g~L~~~l~~~~---------------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---------------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp TCBHHHHHHTTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSC
T ss_pred CCcHHHHhhccc---------------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEeccc
Confidence 999999987643 36899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhch
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 571 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 571 (646)
|+++..............||+.|+|||.+.++.++.++|||||||++|||+|++.|+....... ...
T Consensus 146 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~-------- 212 (263)
T d1sm2a_ 146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVV-------- 212 (263)
T ss_dssp C------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHH--------
T ss_pred chheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHH--------
Confidence 9998775544444445679999999999999999999999999999999999655543322111 111
Q ss_pred hHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 572 LLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 572 ~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+........|..++..+.+|+.+||+.||++||||+||+++|++|.++
T Consensus 213 --~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 213 --EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11122222334555667899999999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=433.08 Aligned_cols=259 Identities=24% Similarity=0.462 Sum_probs=204.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC---EEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS---IVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~---~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..++||+|+||+||+|..+ +++ .||||++.. ......++|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34555689999999999999964 232 689998765 4555677899999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..++|.++++|+.|||+||+|||+++ |+||||||+||||++++.+
T Consensus 106 ~Ey~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---------------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp EECCTTEEHHHHHHTTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcceeeecccc---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcE
Confidence 99999999999887643 36999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCc----cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 487 KVSDFGTSRSVPNDKTH----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
||+|||+++........ ......||+.|||||.+.++.++.++|||||||+||||+| |+.||......+.
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----- 242 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV----- 242 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH-----
Confidence 99999999876433221 1122457999999999999999999999999999999998 8999865433211
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
...+......+.+.+++..+.+|+.+||+.||.+||||.||++.|+++.++.
T Consensus 243 -----------~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 243 -----------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp -----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----------HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 1112222233455667788999999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=429.72 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=216.4
Q ss_pred HhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
..++|+..+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+++|++++|||||+++|++. ++..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 356888899999999999999999888899999987543 23457999999999999999999999875 4567999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++..... ..++|.++++|+.||++||+|||+++ |+||||||+||||++++.+||+
T Consensus 89 ~~~g~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~ 151 (272)
T d1qpca_ 89 MENGSLVDFLKTPSG--------------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151 (272)
T ss_dssp CTTCBHHHHTTSHHH--------------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred CCCCcHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeec
Confidence 999999998866432 26999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
|||+|+..............||+.|||||.+.++.++.++|||||||++|||+||+.|+.......+ ..
T Consensus 152 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-----~~------ 220 (272)
T d1qpca_ 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VI------ 220 (272)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HH------
T ss_pred cccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-----HH------
Confidence 9999998765544445556799999999999999999999999999999999997766543322111 11
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+........+..++..+.+|+.+||+.||++||||.||++.|+.+-.+
T Consensus 221 ----~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 221 ----QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 11112223334556667899999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=427.20 Aligned_cols=261 Identities=29% Similarity=0.484 Sum_probs=208.0
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|...+.||+|+||+||+|+++ ..||||+++. ......+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 468889999999999999999974 3599999864 345567789999999999999999999999754 56899999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+++|+|.++++... ..++|.+++.|+.|||+||+|||+++ |+||||||+||||+.++.+||
T Consensus 84 y~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---------------TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CCCEEEHHHHHHTSC---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEE
T ss_pred cCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEE
Confidence 999999999997642 36999999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCC-CccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 489 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 489 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
+|||+|+...... ........||+.|||||.+.. +.++.++|||||||+||||+||+.||........ +.
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~ 219 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------II 219 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HH
Confidence 9999998764322 233345679999999999864 4589999999999999999999999975433221 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.....+ ...+. ....+..++..+.+|+.+||+.||++||||.||+++|+.|.++
T Consensus 220 ~~~~~~----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 220 FMVGRG----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHT----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHhcC----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111111 00111 1123445567899999999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-53 Score=432.50 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=222.1
Q ss_pred HHhcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 329 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 329 ~~t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
...++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+.+|++++|||||+++|++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34568888999999999999999965 58899999987543 34567999999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++.... ...++|..++.|+.|+|+||+|||+++ |+||||||+||||++++.+|
T Consensus 93 E~~~~g~l~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN--------------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp ECCTTCBHHHHHHHSC--------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred ecccCcchHHHhhhcc--------------ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEE
Confidence 9999999999997643 247999999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+|+..............||+.|+|||++.++.++.++|||||||++|||++|+.|+.......
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------------ 223 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------ 223 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred EccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------------
Confidence 99999999876555554555678999999999999999999999999999999999887765332211
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
.+.+.+......+.+..++..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 224 ---~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 224 ---QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---HHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11223333344455666778899999999999999999999999999987643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=415.22 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=216.3
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEecc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIC 411 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 411 (646)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999876433 34579999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeec
Q 046188 412 NGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 491 (646)
Q Consensus 412 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 491 (646)
+|+|.+++.... ..++|..+++|+.|+++||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 83 ~g~l~~~~~~~~---------------~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 83 NGCLLNYLREMR---------------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp TEEHHHHHHSGG---------------GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCcHHHhhhccc---------------cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcc
Confidence 999999986653 36899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 492 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
|+++..............||+.|+|||.+.++.++.|+|||||||++|||+| |+.||......+. ..
T Consensus 145 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------~~------ 212 (258)
T d1k2pa_ 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AE------ 212 (258)
T ss_dssp SSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HH------
T ss_pred hhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------HH------
Confidence 9998765544444445679999999999999999999999999999999998 7889865443221 11
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 619 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~ 619 (646)
.+........|...+..+.+|+.+||+.||++|||++||+++|..
T Consensus 213 ----~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 213 ----HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----HHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111122234455666789999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=419.42 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=209.9
Q ss_pred cCCCcCccccccCcEEEEEEEcCCC-----CEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDG-----SIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g-----~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
+.|+..++||+|+||+||+|.+++. ..||||+++. .......+|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999996532 3699999865 344556679999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+.+|+|.+++.... ..++|.++++|+.|++.||+|||+++ |+||||||+||||+.++.
T Consensus 87 v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD---------------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLV 148 (283)
T ss_dssp EEECCTTEEHHHHHHHTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred EEEecccCcchhhhhccc---------------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCe
Confidence 999999999998876542 37999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCC--ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||++|+.|+........
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------- 221 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------- 221 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-------
Confidence 99999999987643322 222335689999999999999999999999999999999997776543322111
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 625 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 625 (646)
+.+.+......+.+.+++..+.+|+.+||+.||++||||.||++.|+++.++..
T Consensus 222 --------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 222 --------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp --------HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred --------HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 112223333445566677889999999999999999999999999999887543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=417.27 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=212.6
Q ss_pred cCCCcCc-cccccCcEEEEEEEcC---CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~-~IG~G~~g~Vy~g~~~---~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+ +||+|+||+||+|.++ ++..||||+++. ......++|.+|+++|++++|||||+++|++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999864 345799999875 345567789999999999999999999999864 568999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++.... ..++|.++++|+.|+|+||+|||+++ |+||||||+||||+.++.+
T Consensus 87 mE~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---------------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp EECCTTEEHHHHHTTCT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEE
T ss_pred EEeCCCCcHHHHhhccc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCce
Confidence 99999999999986543 36999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
||+|||+++........ ......||+.|||||.+..+.++.++|||||||++|||+| |+.||......+.
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~------- 221 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------- 221 (285)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------
T ss_pred eeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999987543332 2233568999999999999999999999999999999998 8999865432211
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
. ..+......+.|..++..+.+|+.+||+.||++||||.+|++.|+.+..+
T Consensus 222 ~---------~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 222 M---------AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp H---------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---------HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 11112223345566778899999999999999999999999999877654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=411.92 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=204.1
Q ss_pred ccccccCcEEEEEEEcCC---CCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEeccC
Q 046188 338 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYICN 412 (646)
Q Consensus 338 ~~IG~G~~g~Vy~g~~~~---g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 412 (646)
++||+|+||+||+|.+++ ++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 467999998642 33445689999999999999999999999864 567999999999
Q ss_pred CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEeecC
Q 046188 413 GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 492 (646)
Q Consensus 413 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 492 (646)
|+|.+++... ..++|.++++|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 92 g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 92 GPLNKYLQQN----------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp EEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchh
Confidence 9999998653 36999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcc--ccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 493 TSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 493 la~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
+++......... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------------- 218 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------------- 218 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------------
Confidence 999765433322 233568999999999999999999999999999999998 899986543221
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
+...+......+.|..++..+.+|+.+||+.||++||||.||++.|+..-.
T Consensus 219 --~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 219 --VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 111112222334556667889999999999999999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=412.92 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=199.1
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC--CceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~--~~~~LV 406 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+. +..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999995 46899999987643 455667899999999999999999999998753 457999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCEEECCCC
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA--SIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~ 484 (646)
|||+++|+|.+++...... ...+++..++.|+.|++.||+|||+.+ ..+|+||||||+||||++++
T Consensus 84 mEy~~~g~L~~~i~~~~~~------------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE------------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EecCCCCcHHHHHHhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 9999999999999764321 347999999999999999999999865 23499999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
.+||+|||+|+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......+. ..
T Consensus 152 ~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~------~~ 224 (269)
T d2java1 152 NVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AG 224 (269)
T ss_dssp CEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HH
T ss_pred cEEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH------HH
Confidence 99999999999864432 223456799999999999999999999999999999999999999975433211 11
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. +.+.. ....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ~---------i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 225 K---------IREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp H---------HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H---------HHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 11111 122344556789999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=413.54 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=204.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++||||+++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999964 68999999976532 23345788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+++|+|.+++... ..+++.++..|+.|+++||+|||+++ |+||||||+|||+++++.+||+
T Consensus 85 ~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 85 CSGGELFDRIEPD----------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp CTTEEGGGGSBTT----------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cCCCcHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEc
Confidence 9999999999653 36999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCC-CccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 490 DFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 490 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|||+|+...... .......+||+.|||||.+.+..+ +.++|||||||++|||++|+.||......... +..
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~-- 218 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSD-- 218 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHH--
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----HHH--
Confidence 999999764332 223345679999999999988776 57899999999999999999999654322110 111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+.............+..+.+|+.+||+.||++|||++|++++
T Consensus 219 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 -------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111123345678899999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=413.44 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=209.2
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999995 469999999986544445567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 100 ~gg~L~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~D 159 (293)
T d1yhwa1 100 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 159 (293)
T ss_dssp TTCBHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred CCCcHHHHhhc-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeecc
Confidence 99999987643 26899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||+|+....... ......||+.|+|||.+.++.++.++|||||||++|||++|+.||........ ........
T Consensus 160 FG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~ 232 (293)
T d1yhwa1 160 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG 232 (293)
T ss_dssp CTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC
T ss_pred chhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCC
Confidence 999997644332 23445799999999999999999999999999999999999999965432211 11111110
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 233 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 --------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112334556788999999999999999999999765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=414.61 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=209.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
.++|+..+.||+|+||.||+|+.++++.||||+++.... ..+.|.+|+.+|++++|||||+++|++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 468999999999999999999998888899999875432 3467999999999999999999999985 45679999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++..... ..++|.+++.|+.||++||+|||+.+ |+||||||+|||||.++.+||+|
T Consensus 94 ~~g~l~~~~~~~~~--------------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 94 SKGSLLDFLKGETG--------------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp TTCBHHHHHSHHHH--------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCchhhhhhhccc--------------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcc
Confidence 99999999876532 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHhhc
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 570 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 570 (646)
||+++..............||+.|+|||++..+.++.++||||||+++|||++|+.|+.......+
T Consensus 157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-------------- 222 (285)
T d1fmka3 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------------- 222 (285)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------
T ss_pred cchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--------------
Confidence 999987754444444456799999999999999999999999999999999998777654332211
Q ss_pred hhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 571 KLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 571 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+...+......+.+..++..+.+|+.+||+.||++||+|++|++.|+....+
T Consensus 223 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 223 -VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -HHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1111122223345666778899999999999999999999999999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=419.76 Aligned_cols=271 Identities=26% Similarity=0.482 Sum_probs=212.0
Q ss_pred HhcCCCcCccccccCcEEEEEEEcCC-C-----CEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGMLPD-G-----SIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~~~-g-----~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
..++|+..+.||+|+||+||+|+... + ..||||++... .......+.+|+.+|+++ +|||||+++|++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34688889999999999999998642 2 26999987643 334456789999999998 8999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHH-------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQE-------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 474 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 474 (646)
..++||||+++|+|.++++....... .............++|..++.|+.|+++||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999976542100 0001111122346999999999999999999999998 9999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCc
Q 046188 475 SSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTR 552 (646)
Q Consensus 475 ~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~ 552 (646)
|+|||++.++.+||+|||+|+....... .......||+.|||||.+.++.++.++|||||||+||||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987643332 23334568999999999999999999999999999999998 899986433
Q ss_pred hHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 553 EEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 553 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
.... +.+++......+.|..++..+.+|+.+||+.||++||||+||+++|.
T Consensus 272 ~~~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH---------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 12222333334556667788999999999999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=405.46 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=207.9
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57889999999999999999964 68999999875421 223457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.++..|+.||++||+|||+++ |+||||||+|||++.++.+|
T Consensus 86 Ey~~~g~L~~~l~~~----------------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp ECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred eecCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEe
Confidence 999999999999653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+|+...... .....||+.|||||.+.+..++.++|||||||+||||++|+.||......+. +....
T Consensus 147 l~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 217 (263)
T d2j4za1 147 IADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRIS 217 (263)
T ss_dssp ECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred ecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHHHH
Confidence 99999998764332 2346799999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. ....|...+..+.+|+.+||+.||++|||++|++++
T Consensus 218 ---------~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 218 ---------RV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---------TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11 122344566788999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=411.89 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=208.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56888999999999999999954 68999999987766666778999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++.... ..+++.++..|+.||++||+|||+++ |+||||||+|||++.++++||+|
T Consensus 92 ~~g~L~~~~~~~~---------------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~D 153 (288)
T d2jfla1 92 AGGAVDAVMLELE---------------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLAD 153 (288)
T ss_dssp TTEEHHHHHHHHT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEe
Confidence 9999999886542 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|+..... ........||+.|||||++. ...++.++|||||||++|||++|+.||......+. +..
T Consensus 154 FG~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~ 226 (288)
T d2jfla1 154 FGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLK 226 (288)
T ss_dssp CTTCEECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHH
T ss_pred chhhhccCCC-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHH
Confidence 9999764221 11233467999999999984 45688999999999999999999999965433221 111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... ......+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 227 i~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 227 IAKSE--------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHSC--------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHcCC--------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 00112234556788999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=408.43 Aligned_cols=259 Identities=24% Similarity=0.421 Sum_probs=203.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC----CCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
.++|+..+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|+.+|++++||||++++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4688889999999999999998642 346999988653 4445678999999999999999999999985 567899
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
||||+++|+|.+++.... ..+++.+++.++.||++||.|||+++ |+||||||+||++++++.
T Consensus 85 v~E~~~~g~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~ 146 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---------------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC 146 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred EEEeccCCcHHhhhhccC---------------CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCc
Confidence 999999999999876542 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 564 (646)
+||+|||+|+..............||+.|+|||.+.++.++.++|||||||++|||++ |..|+......+ +. .
T Consensus 147 ~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~---~ 220 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---G 220 (273)
T ss_dssp EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---H
T ss_pred EEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH---H
Confidence 9999999999775544444555678999999999999999999999999999999998 888886543322 11 1
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
. +......+.+..++..+.+|+.+||+.||++|||+.||+++|+.+.+..
T Consensus 221 ~----------i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 221 R----------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp H----------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----------HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1 1111122345566788999999999999999999999999999987653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-50 Score=414.33 Aligned_cols=277 Identities=25% Similarity=0.380 Sum_probs=217.3
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEE
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCL 398 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~ 398 (646)
+++..+++|+..+.||+|+||+||+|+.+ +++.||||+++.. .....++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44556788999999999999999999853 3568999998754 3445668999999999999999999999999
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHHHH--------HHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQE--------LEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH 470 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 470 (646)
+.+..++||||+++|+|.++++........... .........++|.+++.|+.|++.||+|||+++ ++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 999999999999999999999764321110000 001112346999999999999999999999999 999
Q ss_pred cCCCCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC-CC
Q 046188 471 RDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PI 548 (646)
Q Consensus 471 rDIk~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~-p~ 548 (646)
|||||+|||||.++.+||+|||+|+....... ...+...||+.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987643322 23334678999999999999999999999999999999999964 55
Q ss_pred CCCchHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 046188 549 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 621 (646)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~ 621 (646)
......+. ... +.+ ....+.+..++..+.+|+.+||+.||++||||.||+++|++|.
T Consensus 244 ~~~~~~e~------~~~---------v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEV------IYY---------VRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHH------HHH---------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHH------HHH---------HHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54332221 111 111 1123345566678999999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=401.02 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=197.9
Q ss_pred CcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEe----CCceEEEE
Q 046188 335 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVY 407 (646)
Q Consensus 335 ~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~----~~~~~LV~ 407 (646)
+..++||+|+||+||+|... +++.||+|++.. ......+.+.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999964 688999998754 345667789999999999999999999999875 23578999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC-CCCcE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~ 486 (646)
||+++|+|.+++... ..+++..++.|+.||++||+|||+++ ++|+||||||+||||+ +++.+
T Consensus 92 E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~ 154 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSV 154 (270)
T ss_dssp ECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCE
T ss_pred eCCCCCcHHHHHhcc----------------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCE
Confidence 999999999999653 36999999999999999999999986 4599999999999996 57899
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+|+..... ......||+.|||||.+.+ .++.++|||||||++|||++|+.||........ .....
T Consensus 155 Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i 225 (270)
T d1t4ha_ 155 KIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRV 225 (270)
T ss_dssp EECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHH
T ss_pred EEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHH
Confidence 99999999864322 2345679999999998865 699999999999999999999999964332211 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. +. .....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~-~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TS-GV--------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TT-TC--------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hc-CC--------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 10 0011122234568899999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=409.75 Aligned_cols=283 Identities=26% Similarity=0.382 Sum_probs=211.1
Q ss_pred CHHHHHHHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhc-CccCceeEE
Q 046188 323 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKA-IDKTQIEQFINEVVILSQI-NHRHIVKLL 394 (646)
Q Consensus 323 ~~~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~ 394 (646)
+..+++...++|+..++||+|+||.||+|... +++.||||+++. ......+.+.+|..++.++ +|+||++++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34455555678999999999999999999853 246899999875 3445566788888888887 689999999
Q ss_pred EEEEeCC-ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 046188 395 GCCLETE-VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 473 (646)
Q Consensus 395 g~~~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 473 (646)
+++.+++ ..++||||+++|+|.++++....................++|.+++.++.||++||+|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9987654 689999999999999999765431110000011111346999999999999999999999999 999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC-CCCCC
Q 046188 474 KSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PICLT 551 (646)
Q Consensus 474 k~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~-p~~~~ 551 (646)
||+||||++++.+||+|||+|+....... .......||+.|||||.+.++.++.++|||||||++|||++|.. ||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987643332 23345679999999999999999999999999999999999754 55433
Q ss_pred chHHhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 552 REEEERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 552 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
...+. + ...+......+.+...+..+.+|+.+||+.||++|||+.||+++|+++.++
T Consensus 241 ~~~~~------~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KIDEE------F---------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSHH------H---------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHH------H---------HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22110 1 112222223345556667899999999999999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=402.13 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=204.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-CceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-~~~~LV~Ey~ 410 (646)
++|+..+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++||||++++|+|.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5677889999999999999998 47899999997643 456789999999999999999999999764 5689999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.+++..... ..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 84 AKGSLVDYLRSRGR--------------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp TTEEHHHHHHHHHH--------------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred CCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecc
Confidence 99999999976432 25899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHHHHHHhh
Q 046188 491 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 569 (646)
Q Consensus 491 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 569 (646)
||+++..... .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+......+
T Consensus 147 fg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------------- 208 (262)
T d1byga_ 147 FGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------------- 208 (262)
T ss_dssp CCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------------
T ss_pred cccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------------
Confidence 9999865322 223457899999999999999999999999999999998 677765432221
Q ss_pred chhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 570 NKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 570 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+...+......+.+...+..+.+|+.+||+.||.+||||.||+++|++++..
T Consensus 209 --~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 --VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1111222233455666678899999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=410.03 Aligned_cols=258 Identities=23% Similarity=0.460 Sum_probs=209.0
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCC----EEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~L 405 (646)
++|+..++||+|+||+||+|.+. +|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999964 444 5899988653 334567899999999999999999999999764 5688
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCc
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 485 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 485 (646)
++||+.+|+|.+++.... ..++|..+++|+.|||+||+|||+++ |+||||||+||||+.++.
T Consensus 88 v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~ 149 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 149 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEeccCCcccccccccc---------------cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCC
Confidence 899999999999887643 47999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 563 (646)
+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||......+
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------- 221 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 221 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------
T ss_pred eEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------
Confidence 999999999987543332 2334568999999999999999999999999999999999 777775433221
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
+...+......+.+..++..+.+|+.+||+.||.+|||+.||+++|+++....
T Consensus 222 --------~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 222 --------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp --------HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred --------HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 11222223334456667788999999999999999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=408.55 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=202.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC---HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
+.|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999995 468899999876432 344567899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|..++.. ...+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 95 E~~~~g~l~~~~~~----------------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp ECCSEEHHHHHHHH----------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEE
T ss_pred EecCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEE
Confidence 99999998766543 246999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhcccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 564 (646)
|+|||+|+..... ....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+ .+.
T Consensus 156 l~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~ 224 (309)
T d1u5ra_ 156 LGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY 224 (309)
T ss_dssp ECCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH
T ss_pred EeecccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHH
Confidence 9999999865322 23579999999999853 568999999999999999999999986443221 111
Q ss_pred HHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 SLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ........+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ~i~---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 225 HIA---------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHH---------HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHH---------hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 1111111223445779999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=415.68 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=207.4
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999995 46899999998643 33445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCEEECCCCcEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
|+++|+|.+++.+. ..+++..+..++.|+++||+|||+ ++ |+||||||+||||++++++|
T Consensus 85 y~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vk 145 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIK 145 (322)
T ss_dssp CCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEE
T ss_pred cCCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEE
Confidence 99999999999753 369999999999999999999997 47 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH-HH--
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY-FI-- 564 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~-~~-- 564 (646)
|+|||+|+..... .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+....... ..
T Consensus 146 l~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 222 (322)
T d1s9ja_ 146 LCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222 (322)
T ss_dssp ECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------
T ss_pred EeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCC
Confidence 9999999875321 22346799999999999999999999999999999999999999976543221100000 00
Q ss_pred --------------------HHHhhchhHHHhhhhhccc---CC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 565 --------------------SLAKENKLLEILDARVAKE---AS-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 565 --------------------~~~~~~~~~~~~d~~l~~~---~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.........+..+...... .+ ...+..+.+|+.+||+.||.+|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000001111111111110 11 1234678899999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=406.69 Aligned_cols=272 Identities=28% Similarity=0.425 Sum_probs=214.5
Q ss_pred cCCCcCccccccCcEEEEEEEcCC-CC--EEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~~~~LV 406 (646)
++|+..+.||+|+||.||+|++++ |. .||||+++.. .....++|.+|+++|+++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999999753 43 5888987643 344566899999999998 799999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.++++....................++|.++++++.|||+||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999876432222222222233567999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCC-CCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. |+......+
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---------- 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------- 234 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----------
Confidence 999999998653221 1223468999999999999999999999999999999999876 454322111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
+.+.+......+.+..++..+.+|+.+||+.||++||||.||+++|+++.+..
T Consensus 235 ------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 235 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11111222233455667788999999999999999999999999999998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=402.65 Aligned_cols=257 Identities=27% Similarity=0.471 Sum_probs=209.1
Q ss_pred CccccccCcEEEEEEEcCCC----CEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-CceEEEEEec
Q 046188 337 SRFLGQGGFGTVYKGMLPDG----SIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYI 410 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~g----~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-~~~~LV~Ey~ 410 (646)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996432 2589999874 4566778899999999999999999999998865 5789999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEee
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 490 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 490 (646)
++|+|.++++... ..+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|
T Consensus 112 ~~g~l~~~~~~~~---------------~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~D 173 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---------------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD 173 (311)
T ss_dssp TTCBHHHHHHCTT---------------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred ecCchhhhhcccc---------------ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEec
Confidence 9999999987643 36889999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCC---ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 491 FGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 491 fGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
||+++....... .......||+.|+|||.+..+.++.++||||||+++|||++|+.|+....... +...
T Consensus 174 FG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~--- 245 (311)
T d1r0pa_ 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV--- 245 (311)
T ss_dssp SGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHH---
T ss_pred ccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHH---
Confidence 999997643322 22233568999999999999999999999999999999999888875432111 0011
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhhhh
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 626 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 626 (646)
.+-.......|..++..+.+|+.+||+.||++||+|.||+++|+++.++-..
T Consensus 246 -------~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 246 -------YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -------HHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1111112233455567899999999999999999999999999999875433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=404.16 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=206.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999996 46899999987642 1223457889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 88 Ey~~gg~L~~~~~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vk 148 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ 148 (288)
T ss_dssp CCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred EccCCCCHHHhhhcc----------------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEE
Confidence 999999999988653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCC-CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 488 I~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
|+|||+|+...... ........||+.|||||++.+..++.++|||||||++|||++|+.||......+ .+...
T Consensus 149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i 222 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKI 222 (288)
T ss_dssp ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHH
Confidence 99999999775332 223345679999999999999999999999999999999999999997543221 11111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
... ...++...+..+.+|+.+||+.||.+|||++|++.+-.
T Consensus 223 ---------~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 223 ---------IKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ---------HTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ---------HcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 111 11234455677899999999999999999999866544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-48 Score=409.02 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=211.1
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999995 46899999998877777778899999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC--CCCcEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD--DKFSAK 487 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~k 487 (646)
+++|+|.+++.... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++ .++.+|
T Consensus 105 ~~gg~L~~~l~~~~---------------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vk 166 (350)
T d1koaa2 105 MSGGELFEKVADEH---------------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELK 166 (350)
T ss_dssp CCSCBHHHHHTCTT---------------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEE
T ss_pred CCCCCHHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEE
Confidence 99999999986542 36999999999999999999999999 99999999999996 467899
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++....... .....||+.|||||++.+..++.++|||||||++|||++|+.||......+. +....
T Consensus 167 L~DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 238 (350)
T d1koaa2 167 LIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVK 238 (350)
T ss_dssp ECCCTTCEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred Eeecchheecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999997654332 3346799999999999999999999999999999999999999975433221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... ...........+..+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 SCD-------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HTC-------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred hCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 000111122345678999999999999999999999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=398.59 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=200.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC--CC--CEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP--DG--SIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~--~g--~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|+..+.||+|+||.||+|++. ++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 23 36899988652 33446789999999999999999999999965 5678
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++.... ..++|..+++++.|+|+||.|||+++ |+||||||+||||+.++
T Consensus 87 lv~e~~~~~~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---------------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD 148 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---------------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred eeeeeecCcchhhhhhccc---------------CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccccc
Confidence 9999999999999887643 26999999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCc--cccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhcHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 561 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 561 (646)
.+||+|||+++........ ......||..|+|||.+.+..++.++|||||||++|||+| |+.||......+.
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----- 223 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----- 223 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----
Confidence 9999999999987543322 2334568889999999999999999999999999999998 8999865433221
Q ss_pred HHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 046188 562 YFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 620 (646)
Q Consensus 562 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i 620 (646)
...+ .......+.+...+..+.+|+.+||+.||.+||||.||++.|.++
T Consensus 224 -~~~i---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 -LHKI---------DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -HHHH---------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHH---------HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 112222334455667899999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-48 Score=403.23 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=192.9
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCC-HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
.+.|+..+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999964 68999999976432 2234567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC---CCCc
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFS 485 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~ 485 (646)
|+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++ +++.
T Consensus 88 ~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----------------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp CCCSCBHHHHHHTC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCC
T ss_pred ccCCCcHHHhhhcc----------------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCce
Confidence 99999999999653 46999999999999999999999999 99999999999994 5789
Q ss_pred EEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 486 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 486 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
+||+|||+|+...... .....+||+.|||||.+.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 149 vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~ 220 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQ 220 (307)
T ss_dssp EEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH
T ss_pred EEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 9999999998754322 23346799999999999999999999999999999999999999975433221 111
Q ss_pred HHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... .....+.+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 221 i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 221 ILKAE-------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHTTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhccC-------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11110 011112234456778999999999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.1e-48 Score=406.38 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=211.6
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEec
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 410 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 410 (646)
++|+..+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999995 469999999987766666678889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC--CCCcEEE
Q 046188 411 CNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD--DKFSAKV 488 (646)
Q Consensus 411 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~kI 488 (646)
++|+|.+++.... .++++.+++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||
T Consensus 109 ~gg~L~~~~~~~~---------------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 109 SGGELFDRIAAED---------------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp CCCBHHHHTTCTT---------------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEE
T ss_pred CCChHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEE
Confidence 9999998876542 36999999999999999999999999 99999999999998 6789999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+. +.....
T Consensus 171 ~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~ 242 (352)
T d1koba_ 171 IDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKR 242 (352)
T ss_dssp CCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHH
T ss_pred eecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh
Confidence 9999999875433 23445799999999999999999999999999999999999999975443221 111111
Q ss_pred hchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
. +...........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 243 ~-------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 C-------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp C-------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C-------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1111122334456778999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=398.41 Aligned_cols=274 Identities=27% Similarity=0.408 Sum_probs=212.5
Q ss_pred hcCCCcCccccccCcEEEEEEEcCC--------CCEEEEEecccC-CHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeC
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~~--------g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~ 400 (646)
.++|...+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +|||||+++|+|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678888999999999999998532 247999998764 345567889999999888 899999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||+++|+|.+++.....................+++.++++++.|++.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 9999999999999999999765421111111111112457999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCchHHhhc
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 558 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 558 (646)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |..||.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999997643322 23344678999999999999999999999999999999998 677765333221
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+.+......+.+...+..+.+|+.+||+.||.+|||+.||++.|++|.+.
T Consensus 246 -------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1112222333445556667899999999999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=404.05 Aligned_cols=272 Identities=25% Similarity=0.427 Sum_probs=219.5
Q ss_pred HHHHHhcCCCcCccccccCcEEEEEEEcC------CCCEEEEEeccc-CCHHHHHHHHHHHHHHhhcCccCceeEEEEEE
Q 046188 326 ELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCL 398 (646)
Q Consensus 326 el~~~t~~~~~~~~IG~G~~g~Vy~g~~~------~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~ 398 (646)
+++...++|...+.||+|+||+||+|.++ +++.||||+++. ........|.+|++++++++||||++++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34444578889999999999999999863 256899999875 34555667999999999999999999999999
Q ss_pred eCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 399 ETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 399 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
.++..++||||+++|+|.++++....... .......++|..+.+++.|+|+||.|||+++ |+||||||+||
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~Ni 164 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMA------NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 164 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHH------HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccc------cccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCce
Confidence 99999999999999999999987543211 1122456899999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCchHHh
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK-KPICLTREEEE 556 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~-~p~~~~~~~~~ 556 (646)
|+++++++||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+||+ .|+......+
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~- 243 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 243 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-
T ss_pred eecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987643322 2233456899999999999999999999999999999999986 5554322211
Q ss_pred hcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 046188 557 RNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 622 (646)
Q Consensus 557 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~ 622 (646)
.+. .+.+ ....+.+..++..+.+|+.+||+.||.+||||.||+++|++..+
T Consensus 244 -----~~~---------~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 -----VLR---------FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----HHH---------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----HHH---------HHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1111 11233455666789999999999999999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=398.28 Aligned_cols=277 Identities=26% Similarity=0.399 Sum_probs=219.8
Q ss_pred HhcCCCcCccccccCcEEEEEEEc------CCCCEEEEEeccc-CCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEeCC
Q 046188 330 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKA-IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 401 (646)
Q Consensus 330 ~t~~~~~~~~IG~G~~g~Vy~g~~------~~g~~VAVK~l~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~~~ 401 (646)
..++|+..++||+|+||.||+|++ .+++.||||+++. ........|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346888899999999999999985 2356899999875 3445566899999999999 7999999999999999
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHH--HHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQ--ELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 479 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NIL 479 (646)
..++||||+++|+|.++++.......... ..........+++..+++|+.||++||+|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 99999999999999999987543211100 0011112347999999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCC-ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 480 LDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 480 l~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
++.++.+||+|||+++....... ...+...||+.|+|||.+.++.++.++|||||||++|||+|++.|+.......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999998754333 33345679999999999999999999999999999999999555543222111
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
+.+.++++.......+...+..+.+|+.+||+.||.+||||.||+++|+++.++
T Consensus 255 -----------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -----------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -----------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 112233344444455556678899999999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=395.56 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=206.0
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC------CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCce
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI------DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 403 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~------~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~ 403 (646)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999996 46899999987532 112356789999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCC
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK 483 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 483 (646)
+|||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 149 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCS
T ss_pred EEEEEcCCCccccchhccc----------------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecC
Confidence 9999999999999998653 36999999999999999999999999 9999999999999877
Q ss_pred C----cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 484 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 484 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
+ .+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--- 224 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 224 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred CCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---
Confidence 6 59999999998764332 23345689999999999999999999999999999999999999975443221
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+....... .......+...+..+.+|+.+||+.||.+|||++|++++
T Consensus 225 ---~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 ---LANVSAVN-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---HHHHHTTC-------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHhcC-------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111100 000000112234678899999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=399.38 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=200.0
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHH--HHHHHhhcCccCceeEEEEEEeCC----ceEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFIN--EVVILSQINHRHIVKLLGCCLETE----VPVL 405 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~--Ei~il~~l~H~niv~l~g~~~~~~----~~~L 405 (646)
++|...+.||+|+||.||+|++ +|+.||||+++... .+++.. |+..+.+++||||++++|++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3566778999999999999998 68899999987532 233334 555556789999999999998754 4789
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCCEEE
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSA-----SIPIFHRDIKSSNILL 480 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-----~~~ivHrDIk~~NILl 480 (646)
||||+++|+|.+++++. .++|.++++++.|+|.||+|||+.. ..+|+||||||+||||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl 141 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE
T ss_pred EEecccCCCHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE
Confidence 99999999999999652 5899999999999999999999741 2349999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc---cccccccCCcccChhccccCC------CCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
+.++.+||+|||+++........ ......||++|+|||++.+.. ++.|+|||||||+||||+||..|+...
T Consensus 142 ~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 99999999999999876433322 223467999999999987643 577999999999999999998876432
Q ss_pred chHHh--------hcHHHHHHHHHhhchhHHHhhhhhcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 046188 552 REEEE--------RNLVAYFISLAKENKLLEILDARVAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 618 (646)
Q Consensus 552 ~~~~~--------~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~ 618 (646)
..... .......... ..+..+.... +.+....+.+|+.+||+.||++||||.||+++|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 222 EDYQLPYYDLVPSDPSVEEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHH--------HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cccccchhhcccccchHHHHHHH--------HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 21110 0001111111 1111121111 2345567999999999999999999999999999
Q ss_pred HHHhh
Q 046188 619 GLRRS 623 (646)
Q Consensus 619 ~i~~~ 623 (646)
++.+.
T Consensus 294 ~i~~~ 298 (303)
T d1vjya_ 294 QLSQQ 298 (303)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-47 Score=388.51 Aligned_cols=259 Identities=27% Similarity=0.384 Sum_probs=205.2
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCc----
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV---- 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~---- 402 (646)
.++|...+.||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|+.++++++||||+++++++..++.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999995 47899999998642 34456689999999999999999999999987543
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.||||||+++|+|.+++... ..+++.+++.|+.||++||+|||+++ |+||||||+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 146 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EEEEEECCCCCEehhhhccc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCc
Confidence 78999999999999887653 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCC--CccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 483 KFSAKVSDFGTSRSVPNDK--THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++..+|+|||.++...... ........||+.|||||++.+..++.++|||||||++|||+||+.||......+
T Consensus 147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----- 221 (277)
T d1o6ya_ 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----- 221 (277)
T ss_dssp TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----
Confidence 9999999999988653322 223344679999999999999999999999999999999999999997543322
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLR 621 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-s~~evl~~L~~i~ 621 (646)
.+......... .......+.+..+.+++.+||+.||.+|| |++++.+.|.++.
T Consensus 222 -~~~~~~~~~~~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 222 -VAYQHVREDPI-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHHHCCCC-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCC-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111111110 01112234457789999999999999999 8999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=394.44 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=208.8
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999995 47999999998642 1224567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|.+++... ..+++.....++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 85 ey~~gg~L~~~~~~~----------------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp ECCTTCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred eccCCCchhhhhhcc----------------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEE
Confidence 999999999998763 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+|+....... .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+. +...
T Consensus 146 l~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~i- 217 (337)
T d1o6la_ 146 ITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELI- 217 (337)
T ss_dssp ECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-
T ss_pred EeecccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH------HHHH-
Confidence 999999987543322 23446799999999999999999999999999999999999999976543221 1111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
... ...+|...+..+.+|+.+||++||.+||+ +.|++++
T Consensus 218 --------~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 218 --------LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------hcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111 12345556677899999999999999995 8888875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-47 Score=392.19 Aligned_cols=245 Identities=28% Similarity=0.401 Sum_probs=206.9
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5788999999999999999995 46899999998642 1223567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+|
T Consensus 84 E~~~gg~l~~~~~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp CCCCSCBHHHHHHHT----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEE
T ss_pred eecCCcccccccccc----------------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEE
Confidence 999999999888653 36889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+|+..... .....||+.|||||.+.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 145 L~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~-- 212 (316)
T d1fota_ 145 ITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEK-- 212 (316)
T ss_dssp ECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH--
T ss_pred EecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHH--
Confidence 9999999976432 2346799999999999999999999999999999999999999975433221 111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
+.... ...+...+..+.+++.+||+.||.+|| |++|++++
T Consensus 213 -------i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 -------ILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -------HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------HHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11111 123445567789999999999999996 89999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-46 Score=381.10 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=205.4
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC---------HHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeC
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID---------KTQIEQFINEVVILSQIN-HRHIVKLLGCCLET 400 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~---------~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~ 400 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6889999999999999999995 478999999875421 123346889999999997 99999999999999
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..||||||+++|+|.+++... .++++.+++.++.||++||+|||+++ |+||||||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----------------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill 143 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILL 143 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceEEEEEcCCCchHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEE
Confidence 9999999999999999999653 36999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCchH
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 554 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 554 (646)
+.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp CTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 999999999999999865432 2344679999999998853 35788999999999999999999999755432
Q ss_pred HhhcHHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 555 EERNLVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 555 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
+. ........ . ..........+..+.+|+.+||+.||.+|||++||+++
T Consensus 222 ~~------~~~i~~~~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 LM------LRMIMSGN-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HH------HHHHHHTC-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HH------HHHHHhCC-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 21 11111110 0 01111223456789999999999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=386.15 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=206.3
Q ss_pred hcCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.++|...+.||+|+||+||+|... +|+.||||.++.... +...+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999964 688999999876543 345688999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC--CCcEE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAK 487 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~k 487 (646)
+++|+|.+++.... ..+++.++..|+.||++||+|||+++ |+||||||+|||++. ...+|
T Consensus 83 ~~gg~L~~~i~~~~---------------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ik 144 (321)
T d1tkia_ 83 ISGLDIFERINTSA---------------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp CCCCBHHHHHTSSS---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEE
T ss_pred CCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEE
Confidence 99999999997642 26999999999999999999999999 999999999999985 45899
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+....
T Consensus 145 l~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~ 216 (321)
T d1tkia_ 145 IIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIM 216 (321)
T ss_dssp ECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH
T ss_pred EcccchhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 99999998764332 2334568999999999999999999999999999999999999997554322 111111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..... .+.... ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 217 ~~~~~---~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 217 NAEYT---FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTCCC---CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCC---CChhhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11000 000000 1234568899999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-45 Score=391.79 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=200.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC------CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI------DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 404 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~------~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~ 404 (646)
++|+..+.||+|+||.||+|+.. +|+.||||++... .........+|+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999954 6899999987531 1111222334577788889999999999999999999
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 84 ivmE~~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHG 144 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSS
T ss_pred EEEEecCCCcHHHHHHhc----------------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCC
Confidence 999999999999999653 36889999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||+|+...... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......+.. . .
T Consensus 145 ~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~-~ 217 (364)
T d1omwa3 145 HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-I 217 (364)
T ss_dssp CEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H-H
T ss_pred cEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H-H
Confidence 99999999999764332 234579999999999875 46899999999999999999999999754322110 0 0
Q ss_pred HHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 046188 564 ISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 616 (646)
Q Consensus 564 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----~~evl~~ 616 (646)
.. .. .......+...+..+.+|+.+||+.||.+||| ++|++++
T Consensus 218 ~~--------~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 218 DR--------MT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HH--------HS--SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HH--------hc--ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 00 00112234455677899999999999999999 6888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-46 Score=391.65 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=206.6
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC---CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~ 407 (646)
++|+..+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999996 46999999987532 1223567889999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 487 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 487 (646)
||+.+|+|.+++... ..+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 121 e~~~~g~l~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp ECCTTCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ccccccchhhhHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEE
Confidence 999999999998653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 488 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 488 I~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
|+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 182 L~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i- 250 (350)
T d1rdqe_ 182 VTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKI- 250 (350)
T ss_dssp ECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-
T ss_pred eeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHH-
Confidence 9999999976432 234579999999999999999999999999999999999999997543221 11111
Q ss_pred hhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 568 KENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 568 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
.... ...+...+..+.+|+.+||+.||.+|+ |++|++++
T Consensus 251 --------~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 251 --------VSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------HHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------hcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1111 123445567789999999999999994 89999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=386.80 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=204.3
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccC---CHHHHHHHHHHHHHHh-hcCccCceeEEEEEEeCCceEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAI---DKTQIEQFINEVVILS-QINHRHIVKLLGCCLETEVPVLV 406 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~il~-~l~H~niv~l~g~~~~~~~~~LV 406 (646)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999964 6899999998642 1223456677777765 68999999999999999999999
Q ss_pred EEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcE
Q 046188 407 YEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 486 (646)
Q Consensus 407 ~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 486 (646)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 mEy~~~g~L~~~i~~~----------------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EeecCCCcHHHHhhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCce
Confidence 9999999999999753 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 566 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 566 (646)
||+|||+++...... .......||+.|+|||++.++.++.++|||||||++|||++|+.||........ ....
T Consensus 143 kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i 215 (320)
T d1xjda_ 143 KIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSI 215 (320)
T ss_dssp EECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred eccccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 999999998764332 223445799999999999999999999999999999999999999975443221 1111
Q ss_pred HhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046188 567 AKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMK-QVSM 615 (646)
Q Consensus 567 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~-evl~ 615 (646)
.. . ...+|...+..+.+|+.+||+.||.+||++. |+++
T Consensus 216 ~~---------~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 RM---------D--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HH---------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred Hc---------C--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 10 0 1233445567789999999999999999996 7764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=382.57 Aligned_cols=258 Identities=22% Similarity=0.259 Sum_probs=196.1
Q ss_pred cCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHH-----HHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 336 QSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQ-----IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~-----~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
.+++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 68999999986532221 24688999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+.++++..+... ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 82 ~~~~~~~~~~~~----------------~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~ 142 (299)
T d1ua2a_ 82 METDLEVIIKDN----------------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 142 (299)
T ss_dssp CSEEHHHHHTTC----------------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred hcchHHhhhhhc----------------ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccc
Confidence 988877666543 236899999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||+++........ .....||+.|+|||.+..+ .++.++|||||||++|||++|+.||......+. ...+.....
T Consensus 143 DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~ 218 (299)
T d1ua2a_ 143 DFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLG 218 (299)
T ss_dssp CCGGGSTTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHC
T ss_pred cCccccccCCCccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcC
Confidence 99999876443322 2345799999999998654 579999999999999999999999876543321 111111111
Q ss_pred hchhHHHhhhh---------hcccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILDAR---------VAKEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d~~---------l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......+.+.. ..... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 11000000000 00000 11234678999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=377.98 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=200.2
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCH--HHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999995 4689999999865322 235678899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
|+.++ +.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~-~~~~~~~~~--------------~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl 143 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA--------------LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKL 143 (298)
T ss_dssp CCSEE-HHHHHHHTT--------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ecCCc-hhhhhhhhc--------------ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCccee
Confidence 99654 444443321 246999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||+|+....... ......||+.|+|||.+.... .+.++|||||||++|||++|+.||......+. +...+....
T Consensus 144 ~DFG~a~~~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~ 220 (298)
T d1gz8a_ 144 ADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLG 220 (298)
T ss_dssp CSTTHHHHHCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred ccCCcceeccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcC
Confidence 99999987644332 233457999999999877655 58899999999999999999999975543221 111111110
Q ss_pred hh-c-hhHHHh-hhhhcccC-----------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KE-N-KLLEIL-DARVAKEA-----------SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~-~-~~~~~~-d~~l~~~~-----------~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.. + ...... .+...... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0 000000 00000000 11234678899999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=387.52 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=198.2
Q ss_pred hcCCCcCc-cccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhc-CccCceeEEEEEEe----CCce
Q 046188 331 TDNYNQSR-FLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE----TEVP 403 (646)
Q Consensus 331 t~~~~~~~-~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~g~~~~----~~~~ 403 (646)
.++|.... .||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788765 599999999999995 56899999998752 3566899987655 89999999999875 3467
Q ss_pred EEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-
Q 046188 404 VLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD- 482 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 482 (646)
|+||||+++|+|.+++.... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--------------~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~ 147 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--------------DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSK 147 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--------------CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCS
T ss_pred EEEEECCCCCcHHHHHHhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccc
Confidence 99999999999999997532 236999999999999999999999999 999999999999985
Q ss_pred --CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 483 --KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 483 --~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||+||||+||+.||.........
T Consensus 148 ~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--- 222 (335)
T d2ozaa1 148 RPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--- 222 (335)
T ss_dssp STTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred cccccccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---
Confidence 56799999999987654332 23457999999999999999999999999999999999999999643321110
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
........... ..+........+..+.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 223 PGMKTRIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CCCSCS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhcCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000000000 000001112455778999999999999999999999885
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-45 Score=373.39 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=202.0
Q ss_pred cCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCC--HHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|+..++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5889999999999999999998889999999986532 22356789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEEe
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 489 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 489 (646)
+.++.+..+... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----------------EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp CSEEHHHHHHTS----------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred ehhhhHHHHHhh----------------cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEec
Confidence 987776666543 236999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHHh
Q 046188 490 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 568 (646)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 568 (646)
|||++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +.. ......
T Consensus 143 DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~ 218 (286)
T d1ob3a_ 143 DFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILG 218 (286)
T ss_dssp CTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHC
T ss_pred ccccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhC
Confidence 9999987643322 22334689999999998754 568999999999999999999999975543221 111 111111
Q ss_pred hchhHHHhh---------------hhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 569 ENKLLEILD---------------ARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 569 ~~~~~~~~d---------------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......+.+ +..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110000000 000011223345678899999999999999999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=375.01 Aligned_cols=240 Identities=27% Similarity=0.418 Sum_probs=195.4
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCC---H---HHHHHHHHHHHHHhhcC--ccCceeEEEEEEeCCc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAID---K---TQIEQFINEVVILSQIN--HRHIVKLLGCCLETEV 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~---~---~~~~~~~~Ei~il~~l~--H~niv~l~g~~~~~~~ 402 (646)
++|...+.||+|+||+||+|+. .+|+.||||+++... . .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788999999999999999995 478999999875321 0 11234668999999996 8999999999999999
Q ss_pred eEEEEEeccC-CCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 403 PVLVYEYICN-GNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 403 ~~LV~Ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
.++||||+.+ +++.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----------------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 144 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred EEEEEEeccCcchHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEe
Confidence 9999999976 5677776542 36999999999999999999999999 99999999999998
Q ss_pred C-CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCchHHhhcH
Q 046188 482 D-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 559 (646)
Q Consensus 482 ~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l 559 (646)
. ++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------ 215 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 215 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred cCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------
Confidence 5 479999999999875332 2334679999999999987765 5679999999999999999999853210
Q ss_pred HHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 560 VAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 560 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... . ...++...+..+.+|+.+||+.||++|||++|++++
T Consensus 216 ------i~~---------~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 ------IIR---------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------HHH---------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------Hhh---------c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 0 011233345678999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=375.65 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=198.6
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CC-CCEEEEEecccC--CHHHHHHHHHHHHHHhhc---CccCceeEEEEEEeC---
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PD-GSIVAVKRSKAI--DKTQIEQFINEVVILSQI---NHRHIVKLLGCCLET--- 400 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~-g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l---~H~niv~l~g~~~~~--- 400 (646)
.++|+..+.||+|+||+||+|+. .+ ++.||||+++.. .......+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999995 33 667999987532 122223456777777766 799999999998642
Q ss_pred --CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 046188 401 --EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 478 (646)
Q Consensus 401 --~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NI 478 (646)
...+++|||+++|++....... ...+++.....++.|++.||+|||+++ |+||||||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NI 147 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---------------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 147 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cCceEEEEEEeccCCchhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEE
Confidence 3578999999888776544332 246899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 479 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 479 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
|+++++.+||+|||+++.... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||......+..
T Consensus 148 Li~~~~~~kl~dfg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~- 224 (305)
T d1blxa_ 148 LVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL- 224 (305)
T ss_dssp EECTTCCEEECSCCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-
T ss_pred EEcCCCCeeecchhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 999999999999999986532 22334567999999999999999999999999999999999999999765433221
Q ss_pred HHHHHHHHHhhchhHHH----------h---hhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 559 LVAYFISLAKENKLLEI----------L---DARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~----------~---d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
..+...........+ . ............+..+.+|+.+||+.||++|||+.|++++
T Consensus 225 --~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 225 --GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp --HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111111000000 0 0000011223345678899999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=373.21 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=196.8
Q ss_pred CCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------ceEE
Q 046188 333 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------VPVL 405 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------~~~L 405 (646)
+|+..++||+|+||+||+|+.. +|+.||||+++.... ...+|+++|++++||||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999964 689999999865332 2347999999999999999999986432 3689
Q ss_pred EEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-
Q 046188 406 VYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF- 484 (646)
Q Consensus 406 V~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~- 484 (646)
||||+++|.+....+.... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~-------------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~ 160 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA-------------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTA 160 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTC
T ss_pred EEeccCCccHHHHHhhhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCC
Confidence 9999976644443322211 347999999999999999999999999 99999999999999775
Q ss_pred cEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHH
Q 046188 485 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 563 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 563 (646)
.+||+|||+++....... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +.. +
T Consensus 161 ~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~-i 235 (350)
T d1q5ka_ 161 VLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVE-I 235 (350)
T ss_dssp CEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHH-H
T ss_pred ceeEecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHH-H
Confidence 899999999987644332 233579999999998765 5689999999999999999999999976543321 111 1
Q ss_pred HHHHhhc---hhHHHhhh------------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHH
Q 046188 564 ISLAKEN---KLLEILDA------------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 621 (646)
Q Consensus 564 ~~~~~~~---~~~~~~d~------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~ 621 (646)
....... .+...... ..........+..+.+|+.+||+.||++|||+.|++++ ++.+.
T Consensus 236 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1111111 01110000 00011122345678999999999999999999999975 44444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=367.45 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=196.2
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEe--------C
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE--------T 400 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~--------~ 400 (646)
++|+..++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999995 47999999987542 23344578899999999999999999999865 3
Q ss_pred CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 046188 401 EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 480 (646)
Q Consensus 401 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl 480 (646)
+..++||||++++.+..+... ...++...+..|+.|+++||.|||+.+ |+||||||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----------------~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl 150 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----------------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 150 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred ceEEEEEeccCCCccchhhhc----------------ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheee
Confidence 457899999988777655433 236889999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCC---ccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHh
Q 046188 481 DDKFSAKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 556 (646)
Q Consensus 481 ~~~~~~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 556 (646)
++++.+||+|||+++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+.
T Consensus 151 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 9999999999999987643221 122335699999999998764 689999999999999999999999976543332
Q ss_pred hcHHHHHHHHHhh---ch--------hHHHhhhhhcccCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 557 RNLVAYFISLAKE---NK--------LLEILDARVAKEAS-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 557 ~~l~~~~~~~~~~---~~--------~~~~~d~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
... +...... .. .............+ ......+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 231 LAL---ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHH---HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH---HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 211 1111110 00 00000000000000 1113456789999999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=370.64 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=199.0
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC-CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC----ceE
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----VPV 404 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~----~~~ 404 (646)
+++|+..++||+|+||+||+|+. .+|+.||||+++.. .....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 47999999998653 3555678999999999999999999999997653 235
Q ss_pred EEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC
Q 046188 405 LVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 484 (646)
Q Consensus 405 LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 484 (646)
++++|+.+|+|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||+++++
T Consensus 87 ~l~~~~~~g~L~~~l~~-----------------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~ 146 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 146 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred EEEEeecCCchhhhhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCC
Confidence 55667779999999854 26999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccCCCCC--ccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 485 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
.+||+|||+++....... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+....
T Consensus 147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-- 224 (345)
T d1pmea_ 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-- 224 (345)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--
T ss_pred CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH--
Confidence 999999999987643222 22344679999999999854 5678999999999999999999999976543322111
Q ss_pred HHHHHHhhch-----------hHHHhhhh-hcccCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKENK-----------LLEILDAR-VAKEAS-----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~~-----------~~~~~d~~-l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
......... ........ .....+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 225 -ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp -HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111000 00000000 000011 1223568899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-42 Score=358.93 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=198.2
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCceeEE-EEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHIVKLL-GCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~niv~l~-g~~~~~~~~~LV~Ey 409 (646)
++|+..+.||+|+||.||+|+. .+|+.||||.+..... .+++..|++++++++|+|++..+ ++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4689999999999999999995 4689999998665322 23577899999999877765554 555667788899999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC---CCcE
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFSA 486 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~ 486 (646)
+ +|+|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+
T Consensus 85 ~-~~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~v 145 (299)
T d1ckia_ 85 L-GPSLEDLFNFC---------------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 145 (299)
T ss_dssp C-CCBHHHHHHHT---------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCE
T ss_pred c-CCchhhhhhhc---------------cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCcee
Confidence 8 66666665443 236999999999999999999999999 999999999999864 5679
Q ss_pred EEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 487 KVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 487 kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
||+|||+|+....... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~ 225 (299)
T d1ckia_ 146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225 (299)
T ss_dssp EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence 9999999998643322 1233467999999999999999999999999999999999999999754433221111
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhh
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 623 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 623 (646)
....... . ....+.+ ...++..+.+++..||+.||.+||++.++.+.|+.+...
T Consensus 226 ~~~~~~~----~-~~~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 226 ERISEKK----M-STPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHHH----H-HSCHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhhccc----C-CCChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1000000 0 0001111 123346789999999999999999999999999887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=367.88 Aligned_cols=266 Identities=20% Similarity=0.315 Sum_probs=197.5
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCC------
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 401 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~------ 401 (646)
.++|+..+.||+|+||+||+|.. .+|+.||||+++. ......+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999995 4699999999864 34455678899999999999999999999998654
Q ss_pred ceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEC
Q 046188 402 VPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 481 (646)
Q Consensus 402 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~ 481 (646)
..++||||+ +++|..+.+. ..+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~ 155 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVN 155 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred eEEEEEecc-cccHHHHHHh-----------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcc
Confidence 469999999 5566665532 36999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCccccccccCCcccChhcccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 482 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 482 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
.++.+||+|||+|+..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............
T Consensus 156 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~ 231 (346)
T d1cm8a_ 156 EDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231 (346)
T ss_dssp TTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence 9999999999999876432 234579999999999876 45689999999999999999999999765433221110
Q ss_pred HHHH-----HHHhh--chhHHHhhhhhc-------ccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHH
Q 046188 561 AYFI-----SLAKE--NKLLEILDARVA-------KEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 621 (646)
Q Consensus 561 ~~~~-----~~~~~--~~~~~~~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~--L~~i~ 621 (646)
.... ..... ..........+. ..........+.+|+.+||+.||.+|||+.|++++ ++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00000 000000000000 01122344677899999999999999999999987 55443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-42 Score=355.34 Aligned_cols=263 Identities=17% Similarity=0.193 Sum_probs=206.6
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc-cCceeEEEEEEeCCceEEEEEe
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKAIDKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYEY 409 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H-~niv~l~g~~~~~~~~~LV~Ey 409 (646)
++|...+.||+|+||+||+|+.. +|+.||||.++.... ...+.+|+++++.++| +|++++++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57899999999999999999954 689999998754322 2346688899999865 8999999999999999999999
Q ss_pred ccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC-----CC
Q 046188 410 ICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KF 484 (646)
Q Consensus 410 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~ 484 (646)
+ +|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++
T Consensus 83 ~-~~~l~~~~~~~~---------------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---------------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp C-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred c-CCCHHHHHHhhc---------------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCC
Confidence 8 789998886542 36999999999999999999999999 999999999999974 57
Q ss_pred cEEEeecCCccccCCCCC------ccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhc
Q 046188 485 SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 558 (646)
Q Consensus 485 ~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 558 (646)
.+||+|||+|+....... .......||+.|||||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 899999999987643211 12234679999999999999999999999999999999999999997543322211
Q ss_pred HHHHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhhh
Q 046188 559 LVAYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 624 (646)
Q Consensus 559 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 624 (646)
....+......... +.+... ++..+.+++..|++.+|++||+++.+.+.|+.+.+..
T Consensus 224 ~~~~i~~~~~~~~~-----~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 224 KYERIGEKKQSTPL-----RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHHHHHSCH-----HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhccCCCCh-----HHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11111111000111 111122 3356899999999999999999999999998876543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=353.51 Aligned_cols=263 Identities=20% Similarity=0.304 Sum_probs=205.1
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeCCceEEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 408 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~~~~~LV~E 408 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++. ......+.+.+|+.+|++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999995 4789999998754 234456788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCCcEEE
Q 046188 409 YICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 488 (646)
Q Consensus 409 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 488 (646)
++.+++|..++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl 142 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----------------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp CCSEEHHHHHHHTT----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred eccccccccccccc----------------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceee
Confidence 99999888777543 36889999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCccccccccCCcccChhccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHHHH
Q 046188 489 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 567 (646)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 567 (646)
+|||.++....... ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+ ....+....
T Consensus 143 ~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~ 219 (292)
T d1unla_ 143 ANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLL 219 (292)
T ss_dssp CCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHH
T ss_pred eecchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhc
Confidence 99999997644332 223345788999999887654 68999999999999999999999764433221 111111111
Q ss_pred hhch------hHHHhhh---------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 568 KENK------LLEILDA---------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 568 ~~~~------~~~~~d~---------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.... .....+. .............+.+|+.+||+.||.+|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1100 0000000 00011223345678899999999999999999999764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=363.58 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=204.4
Q ss_pred cCCCcCccccccCcEEEEEEEc----CCCCEEEEEecccC----CHHHHHHHHHHHHHHhhcCc-cCceeEEEEEEeCCc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKAI----DKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEV 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~----~~g~~VAVK~l~~~----~~~~~~~~~~Ei~il~~l~H-~niv~l~g~~~~~~~ 402 (646)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999984 24789999987532 12234567899999999976 899999999999999
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.++||||+.+|+|.+++... ..+.......++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----------------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDS 164 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeeeeecccccHHHHHHHhc----------------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecC
Confidence 99999999999999998764 35778899999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 560 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~ 560 (646)
++.+||+|||+++..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+. ..
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~ 242 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QA 242 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HH
T ss_pred CCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH
Confidence 99999999999987755444444556799999999998754 468899999999999999999999965432211 11
Q ss_pred HHHHHHHhhchhHHHhhhhhcccCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046188 561 AYFISLAKENKLLEILDARVAKEASEEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 616 (646)
Q Consensus 561 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----s~~evl~~ 616 (646)
..... .. ......+...+..+.+|+.+||+.||++|| |++|++++
T Consensus 243 ~i~~~---------~~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 243 EISRR---------IL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHH---------HH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHh---------cc--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 10000 00 112234556678899999999999999999 47888874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=355.54 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=197.5
Q ss_pred cCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeC--CceEEEE
Q 046188 332 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLVY 407 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~--~~~~LV~ 407 (646)
++|+..++||+|+||+||+|+. .+|+.||||+++... .+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5899999999999999999995 468999999987644 346789999999995 99999999999854 4689999
Q ss_pred EeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECCCC-cE
Q 046188 408 EYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SA 486 (646)
Q Consensus 408 Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~ 486 (646)
||+++|+|..+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 112 e~~~~~~L~~~~-------------------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~v 169 (328)
T d3bqca1 112 EHVNNTDFKQLY-------------------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 169 (328)
T ss_dssp ECCCSCBGGGTT-------------------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred eecCCCcHHHHh-------------------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCee
Confidence 999999997664 25899999999999999999999999 99999999999998654 69
Q ss_pred EEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHHHHH
Q 046188 487 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 565 (646)
Q Consensus 487 kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 565 (646)
||+|||+|+....... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... ..+..
T Consensus 170 kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~ 245 (328)
T d3bqca1 170 RLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAK 245 (328)
T ss_dssp EECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHH
T ss_pred eecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH--HHHHH
Confidence 9999999987644322 2345689999999998765 47999999999999999999999997554322111 11111
Q ss_pred HHhhchhHHHhhh-----------------------hhcccCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 566 LAKENKLLEILDA-----------------------RVAKEASEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 566 ~~~~~~~~~~~d~-----------------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.........+... ..........+..+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111000000000 00001112344678899999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=356.94 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=191.4
Q ss_pred cCCCcCccccccCcEEEEEEEcC-CCCEEEEEeccc--CCHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC------Cc
Q 046188 332 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EV 402 (646)
Q Consensus 332 ~~~~~~~~IG~G~~g~Vy~g~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~------~~ 402 (646)
++|+..++||+|+||+||+|... +|+.||||+++. ......+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999954 699999999864 3455566789999999999999999999999643 56
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.|+||||+.++.+ +.+. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 97 ~~iv~Ey~~~~l~-~~~~------------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 154 (355)
T ss_dssp EEEEEECCSEEHH-HHHT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred eEEEEeccchHHH-Hhhh------------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccccc
Confidence 7999999965544 3332 25899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 562 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 562 (646)
++.+|++|||+++..... .......+|+.|+|||.+.+..++.++||||+||+++||++|+.||.......... ..
T Consensus 155 ~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~--~i 230 (355)
T d2b1pa1 155 DCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KV 230 (355)
T ss_dssp TCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH
T ss_pred ccceeeechhhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH--HH
Confidence 999999999998875432 22344578999999999999999999999999999999999999997554322111 00
Q ss_pred HHHH-------Hhh--chhHHHhh---------------hhhcc---cCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046188 563 FISL-------AKE--NKLLEILD---------------ARVAK---EASEEDIEAVAELAMGCLRLNSKKRPTMKQVSM 615 (646)
Q Consensus 563 ~~~~-------~~~--~~~~~~~d---------------~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~ 615 (646)
.... ... .......+ ..... ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000 00111111 11111 012345677899999999999999999999997
Q ss_pred H
Q 046188 616 D 616 (646)
Q Consensus 616 ~ 616 (646)
+
T Consensus 311 H 311 (355)
T d2b1pa1 311 H 311 (355)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=357.05 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=196.5
Q ss_pred hcCCCcCccccccCcEEEEEEEc-CCCCEEEEEecccC--CHHHHHHHHHHHHHHhhcCccCceeEEEEEEeC-----Cc
Q 046188 331 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 402 (646)
Q Consensus 331 t~~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~g~~~~~-----~~ 402 (646)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999994 47999999998643 345566789999999999999999999998643 34
Q ss_pred eEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEECC
Q 046188 403 PVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD 482 (646)
Q Consensus 403 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 482 (646)
.+++++|+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----------------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 156 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEEeecCCchhhhccc-----------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccc
Confidence 4677788889999998854 26999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCccccccccCCcccChhccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCchHHhhcHHH
Q 046188 483 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 561 (646)
Q Consensus 483 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~l~~ 561 (646)
++.+|++|||++.... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 157 ~~~~kl~dfg~a~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~--- 229 (348)
T d2gfsa1 157 DCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK--- 229 (348)
T ss_dssp TCCEEECCC----CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---
T ss_pred cccccccccchhcccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 9999999999997642 223345689999999987664 46889999999999999999999997654332211
Q ss_pred HHHHHHhhc-----------hhHHHhhhhhc-ccC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046188 562 YFISLAKEN-----------KLLEILDARVA-KEA-----SEEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 616 (646)
Q Consensus 562 ~~~~~~~~~-----------~~~~~~d~~l~-~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~evl~~ 616 (646)
.+....... ........... ... ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 111111000 00000000000 000 11234568899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=321.66 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=192.4
Q ss_pred CCCcCccccccCcEEEEEEEc-CCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-----------ccCceeEEEEEEeC
Q 046188 333 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-----------HRHIVKLLGCCLET 400 (646)
Q Consensus 333 ~~~~~~~IG~G~~g~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------H~niv~l~g~~~~~ 400 (646)
+|...++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 588999999999999999995 47999999998753 334457788999988875 57899999988653
Q ss_pred --CceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCC
Q 046188 401 --EVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSN 477 (646)
Q Consensus 401 --~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIk~~N 477 (646)
...++++++...+........... ...+++..+..++.|+++||+|||+ .+ |+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~N 156 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE-------------HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPEN 156 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT-------------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGG
T ss_pred cccceeeeeeeccccccccccccccc-------------ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhH
Confidence 456677777766654433332221 4578999999999999999999998 77 9999999999
Q ss_pred EEECCCC------cEEEeecCCccccCCCCCccccccccCCcccChhccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 046188 478 ILLDDKF------SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 551 (646)
Q Consensus 478 ILl~~~~------~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 551 (646)
|||+.++ .+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||...
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 9998665 4999999999865322 23356999999999999999999999999999999999999998654
Q ss_pred chHHhhcHHHHH---HHHHhhc---------hhHHHhh-------------------hhhcccCCHHHHHHHHHHHHhcc
Q 046188 552 REEEERNLVAYF---ISLAKEN---------KLLEILD-------------------ARVAKEASEEDIEAVAELAMGCL 600 (646)
Q Consensus 552 ~~~~~~~l~~~~---~~~~~~~---------~~~~~~d-------------------~~l~~~~~~~~~~~l~~Li~~Cl 600 (646)
............ ...+... ......+ ...........+..+.+|+.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 322111111111 1111100 0000000 00112345677888999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 046188 601 RLNSKKRPTMKQVSMD 616 (646)
Q Consensus 601 ~~dP~~RPs~~evl~~ 616 (646)
+.||.+|||++|++++
T Consensus 313 ~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNH 328 (362)
T ss_dssp CSSTTTCBCHHHHHTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.8e-22 Score=192.79 Aligned_cols=162 Identities=21% Similarity=0.215 Sum_probs=119.8
Q ss_pred cCccccccCcEEEEEEEcCCCCEEEEEecccCC------------------HHHHHHHHHHHHHHhhcCccCceeEEEEE
Q 046188 336 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAID------------------KTQIEQFINEVVILSQINHRHIVKLLGCC 397 (646)
Q Consensus 336 ~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~------------------~~~~~~~~~Ei~il~~l~H~niv~l~g~~ 397 (646)
..++||+|+||.||+|...+|+.||||.++... ......+.+|...+.++.|.++++.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999999999998789999999754311 01123445688899999999999988663
Q ss_pred EeCCceEEEEEeccCCCchhhhhhhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 046188 398 LETEVPVLVYEYICNGNLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 477 (646)
Q Consensus 398 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk~~N 477 (646)
..+++|||++++.+.+ +++....+++.|++++|+|||+++ |+||||||+|
T Consensus 84 ----~~~lvme~~~~~~~~~-----------------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~N 133 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 133 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred ----CCEEEEEeeccccccc-----------------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhh
Confidence 2389999998765432 344556689999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCccccccccCCcccC------hhccccCCCCCccchhhHHHHH
Q 046188 478 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD------PEYFQSSQYTDKSDVYSFGVVL 538 (646)
Q Consensus 478 ILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~s~ksDVwSfGvvl 538 (646)
||++++ .++|+|||+|......... .|.. .|.+ ...++.++|+||..--+
T Consensus 134 ILv~~~-~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 134 VLVSEE-GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEEETT-EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eeeeCC-CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999975 5899999999875432211 0111 1111 35677899999976443
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=99.36 E-value=7.5e-14 Score=99.73 Aligned_cols=47 Identities=28% Similarity=0.403 Sum_probs=43.6
Q ss_pred eeEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeecccccccc
Q 046188 170 LLAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPL 217 (646)
Q Consensus 170 ~~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl 217 (646)
+++|+|++|||||+||++||+++++|++||++.++ .|++||.|.||.
T Consensus 1 ~i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~-~l~~Gq~L~IPg 47 (48)
T d1y7ma2 1 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQA-GLTAGQSIVIPG 47 (48)
T ss_dssp CEEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCS-SCCTTCEEEETT
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCC-CCCCCCEEEeCC
Confidence 36899999999999999999999999999999665 699999999994
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=99.33 E-value=1.4e-13 Score=97.87 Aligned_cols=46 Identities=22% Similarity=0.318 Sum_probs=42.7
Q ss_pred eEEeeecccchhhhHhhhcCCchhhhccccCCCCcceeeccccccccc
Q 046188 171 LAYMATWGDTISSIGHKFGADKQSILDANKLSEDDLIFTFTPLLIPLK 218 (646)
Q Consensus 171 ~tY~v~~gDtl~~Ia~~f~~s~~~l~~~N~~~~~~~i~~g~~l~vPl~ 218 (646)
++|+|++||||++||++||+++++|++||++. +.|+|||.|.||++
T Consensus 3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~--~~l~~Gq~L~i~vk 48 (48)
T d1e0ga_ 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG--GGCCTTEEEECCCC
T ss_pred EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc--ccCcCCCEEEEEeC
Confidence 58999999999999999999999999999984 46999999999974
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=98.97 E-value=5e-11 Score=84.41 Aligned_cols=46 Identities=15% Similarity=0.195 Sum_probs=40.3
Q ss_pred cccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecc
Q 046188 104 NAPYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPL 153 (646)
Q Consensus 104 ~~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~ 153 (646)
..+|+|++|||+|.|| +.|+. ++++|+++|... +.|++||+|.||+
T Consensus 2 ~v~y~V~~GDTl~~IA-~~y~v--s~~~i~~~N~l~-~~l~~Gq~L~i~v 47 (48)
T d1e0ga_ 2 SITYRVRKGDSLSSIA-KRHGV--NIKDVMRWNSDT-ANLQPGDKLTLFV 47 (48)
T ss_dssp CCEEEECTTCCHHHHH-HHHTC--CHHHHHHHCSCG-GGCCTTEEEECCC
T ss_pred cEEEEECCCCCHHHHH-HHHCC--CHHHHHHHcCCc-ccCcCCCEEEEEe
Confidence 3689999999999999 66764 999999999765 4699999999997
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=98.93 E-value=6.5e-11 Score=84.18 Aligned_cols=46 Identities=26% Similarity=0.369 Sum_probs=40.2
Q ss_pred ccEEEecCCceeeecccccCCCccHHHhhhcCCCCCCCCCCCcEEEecc
Q 046188 105 APYTIKANDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGLEVIVPL 153 (646)
Q Consensus 105 ~~y~v~~gdt~~~Ia~~~~~~lt~~~~l~~~N~~~~~~l~~gq~l~ip~ 153 (646)
.+|+|++|||+|+|| ++|.. +.++|+++|....+.|++||+|.||-
T Consensus 2 i~y~V~~GDTL~~IA-~~y~v--~~~~i~~~N~~~~~~l~~Gq~L~IPg 47 (48)
T d1y7ma2 2 LTYQVKQGDTLNSIA-ADFRI--STAALLQANPSLQAGLTAGQSIVIPG 47 (48)
T ss_dssp EEEECCTTCCHHHHH-HHTTS--CCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred EEEEECCCCCHHHHH-HHhCC--CHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence 479999999999999 66764 89999999976666899999999983
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=2.2e-07 Score=90.69 Aligned_cols=94 Identities=14% Similarity=0.020 Sum_probs=65.8
Q ss_pred HHHHHHhcCCCcCccccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcC-ccCceeEEEEEEeCCce
Q 046188 325 EELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVP 403 (646)
Q Consensus 325 ~el~~~t~~~~~~~~IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~g~~~~~~~~ 403 (646)
.|+.+..+.|...+..+-++...||+... +++.+.||+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667777666554444578999876 56678888866543333345667888887764 33467788888888889
Q ss_pred EEEEEeccCCCchhhh
Q 046188 404 VLVYEYICNGNLSHHI 419 (646)
Q Consensus 404 ~LV~Ey~~~gsL~~~l 419 (646)
++||+++++.++.+..
T Consensus 86 ~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEECCSSEEHHHHT
T ss_pred EEEEEecccccccccc
Confidence 9999999888876543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=2.4e-05 Score=75.20 Aligned_cols=76 Identities=14% Similarity=0.073 Sum_probs=54.5
Q ss_pred cccccCc-EEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCc--cCceeEEEEEEeCCceEEEEEeccCCCc
Q 046188 339 FLGQGGF-GTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 339 ~IG~G~~-g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H--~niv~l~g~~~~~~~~~LV~Ey~~~gsL 415 (646)
.+..|.. ..||+....++..+.+|........ .+..|+..++.+.. -.+.+++++..+.+..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444443 6799999877888999986654332 45577887777643 3356788888888888999999988777
Q ss_pred hh
Q 046188 416 SH 417 (646)
Q Consensus 416 ~~ 417 (646)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00044 Score=70.98 Aligned_cols=77 Identities=17% Similarity=0.212 Sum_probs=48.8
Q ss_pred CccccccCcEEEEEEEcCC-CCEEEEEeccc------C-CHHHHHHHHHHHHHHhhcC-c--cCceeEEEEEEeCCceEE
Q 046188 337 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSKA------I-DKTQIEQFINEVVILSQIN-H--RHIVKLLGCCLETEVPVL 405 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~-g~~VAVK~l~~------~-~~~~~~~~~~Ei~il~~l~-H--~niv~l~g~~~~~~~~~L 405 (646)
.+.||.|....||+....+ ++.++||.-.. . ......+...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 67899996322 1 1112233456777777663 2 345566654 5667789
Q ss_pred EEEeccCCCc
Q 046188 406 VYEYICNGNL 415 (646)
Q Consensus 406 V~Ey~~~gsL 415 (646)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.00 E-value=0.014 Score=57.49 Aligned_cols=70 Identities=14% Similarity=0.060 Sum_probs=44.9
Q ss_pred cEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-----eeEE--EEEEeCCceEEEEEeccCCCc
Q 046188 345 FGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-----VKLL--GCCLETEVPVLVYEYICNGNL 415 (646)
Q Consensus 345 ~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-----v~l~--g~~~~~~~~~LV~Ey~~~gsL 415 (646)
.-.||+....+|+.+++|..+.... ..+++..|...+..+....+ +..- .....++..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3589999998999999998765422 23456678888877743222 1111 112334567889999876544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.89 E-value=0.0079 Score=61.22 Aligned_cols=74 Identities=23% Similarity=0.239 Sum_probs=49.0
Q ss_pred CccccccCcEEEEEEEcCC--------CCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-eeEEEEEEeCCceEEEE
Q 046188 337 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVY 407 (646)
Q Consensus 337 ~~~IG~G~~g~Vy~g~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~LV~ 407 (646)
++.|+-|-.-.+|+....+ .+.|.++..... .. .-+..+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567778778999988643 345666665422 22 2345578999888854444 478887643 7899
Q ss_pred EeccCCCch
Q 046188 408 EYICNGNLS 416 (646)
Q Consensus 408 Ey~~~gsL~ 416 (646)
||+++.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.80 E-value=0.033 Score=54.20 Aligned_cols=172 Identities=9% Similarity=0.070 Sum_probs=86.7
Q ss_pred cCHHHHHHHhcCCCcCcc-----ccccCcEEEEEEEcCCCCEEEEEecccCCHHHHHHHHHHHHHHhhcCccCc-----e
Q 046188 322 FTAEELQRATDNYNQSRF-----LGQGGFGTVYKGMLPDGSIVAVKRSKAIDKTQIEQFINEVVILSQINHRHI-----V 391 (646)
Q Consensus 322 ~~~~el~~~t~~~~~~~~-----IG~G~~g~Vy~g~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~il~~l~H~ni-----v 391 (646)
++.+|++....+|...+. |..|---+.|+....+| .+++|+..... ..++...|++++..+...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 567888888888877543 34566678899887655 48889875421 12234456677776643221 1
Q ss_pred eEE-E--EEEeCCceEEEEEeccCCCchhhhhhhhhhH-HHHHHH------------------------HHhhhcCCCCH
Q 046188 392 KLL-G--CCLETEVPVLVYEYICNGNLSHHIHDHQQQQ-EQKQEL------------------------EEEQELSSLSW 443 (646)
Q Consensus 392 ~l~-g--~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~-~~~~~~------------------------~~~~~~~~l~~ 443 (646)
... | +.........++.+..+......-....... ...... ...........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 0112344566677766544332111100000 000000 00000001111
Q ss_pred HHHHHHHHHHHHHHHHHHcCC-CCCeEecCCCCCCEEECCCCcEEEeecCCccc
Q 046188 444 ENRVRVACEVAGAVAYMHSSA-SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 496 (646)
Q Consensus 444 ~~~~~ia~qia~gL~yLH~~~-~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 496 (646)
......+......+.-.+... .-+++|+|+.+.||+++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 222233333333333333221 22499999999999999988788999998863
|